407296070 | GWAS945046_H | total cholesterol measurement QTL GWAS945046 (human) | | 2e-13 | total cholesterol measurement | | 10 | 94278929 | 94278930 | Human |
596968340 | GWAS1087859_H | functional brain measurement QTL GWAS1087859 (human) | | 2e-27 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
597312409 | GWAS1408483_H | cortical thickness QTL GWAS1408483 (human) | | 2e-14 | cortical thickness | | 10 | 94256036 | 94256037 | Human |
597607325 | GWAS1664185_H | prostate carcinoma QTL GWAS1664185 (human) | | 8e-27 | prostate carcinoma | | 10 | 102662289 | 102662290 | Human |
597033874 | GWAS1129948_H | sensory perception of bitter taste QTL GWAS1129948 (human) | | 0.000008 | sensory perception of bitter taste | | 10 | 80520171 | 80520172 | Human |
597099411 | GWAS1195485_H | type 2 diabetes mellitus QTL GWAS1195485 (human) | | 8e-43 | type 2 diabetes mellitus | | 10 | 92675916 | 92675917 | Human |
596968337 | GWAS1087856_H | functional brain measurement QTL GWAS1087856 (human) | | 2e-37 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
597099410 | GWAS1195484_H | type 2 diabetes mellitus QTL GWAS1195484 (human) | | 5e-08 | type 2 diabetes mellitus | | 10 | 87939533 | 87939534 | Human |
596968336 | GWAS1087855_H | functional brain measurement QTL GWAS1087855 (human) | | 3e-56 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
597099409 | GWAS1195483_H | type 2 diabetes mellitus QTL GWAS1195483 (human) | | 1e-14 | type 2 diabetes mellitus | | 10 | 79184084 | 79184085 | Human |
596968339 | GWAS1087858_H | functional brain measurement QTL GWAS1087858 (human) | | 1e-47 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
596968338 | GWAS1087857_H | functional brain measurement QTL GWAS1087857 (human) | | 4e-46 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
407050308 | GWAS699284_H | metabolite measurement QTL GWAS699284 (human) | | 8e-15 | metabolite measurement | | 10 | 98397096 | 98397097 | Human |
597246878 | GWAS1342952_H | alkaline phosphatase measurement QTL GWAS1342952 (human) | | 1e-23 | milk saturated fatty acid amount (VT:0010304) | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 100315722 | 100315723 | Human |
597386129 | GWAS1482203_H | coenzyme Q10 measurement QTL GWAS1482203 (human) | | 0.000006 | coenzyme Q10 measurement | | 10 | 85451360 | 85451361 | Human |
597435287 | GWAS1531361_H | atrial fibrillation QTL GWAS1531361 (human) | | 2e-13 | atrial fibrillation | | 10 | 101306718 | 101306719 | Human |
597164947 | GWAS1261021_H | myocardial infarction QTL GWAS1261021 (human) | | 5e-16 | myocardial infarction | | 10 | 102892566 | 102892567 | Human |
597304214 | GWAS1400288_H | neutrophil count QTL GWAS1400288 (human) | | 5e-11 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 102856743 | 102856744 | Human |
597189525 | GWAS1285599_H | level of Sphingomyelin (d38:1) in blood serum QTL GWAS1285599 (human) | | 5e-08 | level of Sphingomyelin (d38:1) in blood serum | | 10 | 101642127 | 101642128 | Human |
597164950 | GWAS1261024_H | myocardial infarction QTL GWAS1261024 (human) | | 2e-14 | myocardial infarction | | 10 | 89243047 | 89243048 | Human |
597435283 | GWAS1531357_H | colorectal cancer QTL GWAS1531357 (human) | | 2e-10 | colorectal cancer | | 10 | 79059375 | 79059376 | Human |
407386200 | GWAS1035176_H | obsolete_red blood cell distribution width QTL GWAS1035176 (human) | | 3e-38 | obsolete_red blood cell distribution width | | 10 | 94545747 | 94545748 | Human |
406976595 | GWAS625571_H | reticulocyte count QTL GWAS625571 (human) | | 3e-55 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 103107201 | 103107202 | Human |
597181324 | GWAS1277398_H | protocadherin alpha-7 measurement QTL GWAS1277398 (human) | | 9e-32 | protocadherin alpha-7 measurement | | 10 | 100069757 | 100069758 | Human |
597312398 | GWAS1408472_H | cortical thickness QTL GWAS1408472 (human) | | 7e-15 | cortical thickness | | 10 | 100564926 | 100564927 | Human |
597107587 | GWAS1203661_H | Red cell distribution width QTL GWAS1203661 (human) | | 1e-15 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 101404997 | 101404998 | Human |
597107586 | GWAS1203660_H | Red cell distribution width QTL GWAS1203660 (human) | | 1e-09 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 94687805 | 94687806 | Human |
597205901 | GWAS1301975_H | grip strength measurement QTL GWAS1301975 (human) | | 3e-09 | grip strength measurement | | 10 | 98018469 | 98018470 | Human |
597107585 | GWAS1203659_H | Red cell distribution width QTL GWAS1203659 (human) | | 2e-29 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 94546848 | 94546849 | Human |
596968333 | GWAS1087852_H | functional brain measurement QTL GWAS1087852 (human) | | 1e-48 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
596968332 | GWAS1087851_H | functional brain measurement QTL GWAS1087851 (human) | | 1e-57 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
596968335 | GWAS1087854_H | functional brain measurement QTL GWAS1087854 (human) | | 1e-43 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
596968334 | GWAS1087853_H | functional brain measurement QTL GWAS1087853 (human) | | 4e-44 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
596968331 | GWAS1087850_H | functional brain measurement QTL GWAS1087850 (human) | | 2e-17 | hypertension | | 10 | 94278929 | 94278930 | Human |
407386199 | GWAS1035175_H | obsolete_red blood cell distribution width QTL GWAS1035175 (human) | | 1e-20 | obsolete_red blood cell distribution width | | 10 | 79041217 | 79041218 | Human |
597058486 | GWAS1154560_H | BMI-adjusted waist circumference QTL GWAS1154560 (human) | | 1e-10 | body size trait (VT:0100005) | | 10 | 91255322 | 91255323 | Human |
597337019 | GWAS1433093_H | sexual dimorphism measurement QTL GWAS1433093 (human) | | 4e-09 | sexual dimorphism measurement | | 10 | 102520216 | 102520217 | Human |
597615546 | GWAS1672406_H | pyelonephritis QTL GWAS1672406 (human) | | 3e-13 | pyelonephritis | | 10 | 102652959 | 102652960 | Human |
597222334 | GWAS1318408_H | COVID-19 QTL GWAS1318408 (human) | | 0.000002 | COVID-19 | | 10 | 78069803 | 78069804 | Human |
597058480 | GWAS1154554_H | BMI-adjusted waist circumference QTL GWAS1154554 (human) | | 3e-08 | body size trait (VT:0100005) | | 10 | 94912317 | 94912318 | Human |
597066686 | GWAS1162760_H | triglyceride measurement QTL GWAS1162760 (human) | | 6e-12 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079885 | 93079886 | Human |
597205936 | GWAS1302010_H | open-angle glaucoma QTL GWAS1302010 (human) | | 6e-19 | open-angle glaucoma | | 10 | 94263320 | 94263321 | Human |
597066687 | GWAS1162761_H | triglyceride measurement QTL GWAS1162761 (human) | | 5e-16 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079885 | 93079886 | Human |
597369777 | GWAS1465851_H | asthma QTL GWAS1465851 (human) | | 7e-10 | asthma | | 10 | 92669710 | 92669711 | Human |
597402551 | GWAS1498625_H | myocardial infarction QTL GWAS1498625 (human) | | 1e-09 | myocardial infarction | | 10 | 102831636 | 102831637 | Human |
597345207 | GWAS1441281_H | generalised epilepsy QTL GWAS1441281 (human) | | 4e-14 | generalised epilepsy | | 10 | 101943006 | 101943007 | Human |
597181367 | GWAS1277441_H | tumor necrosis factor receptor superfamily member 6 measurement QTL GWAS1277441 (human) | | 8e-08 | tumor necrosis factor receptor superfamily member 6 measurement | | 10 | 88904913 | 88904914 | Human |
597402537 | GWAS1498611_H | putamen volume change measurement, age at assessment QTL GWAS1498611 (human) | | 0.0000003 | putamen volume change measurement, age at assessment | | 10 | 96297297 | 96297298 | Human |
597615528 | GWAS1672388_H | systolic blood pressure QTL GWAS1672388 (human) | | 4e-24 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94279840 | 94279841 | Human |
407369841 | GWAS1018817_H | platelet crit QTL GWAS1018817 (human) | | 4e-10 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 10 | 99518968 | 99518969 | Human |
597205935 | GWAS1302009_H | open-angle glaucoma QTL GWAS1302009 (human) | | 1e-09 | open-angle glaucoma | | 10 | 93169359 | 93169360 | Human |
597615529 | GWAS1672389_H | systolic blood pressure QTL GWAS1672389 (human) | | 3e-41 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103182487 | 103182488 | Human |
597468069 | GWAS1564143_H | adolescent idiopathic scoliosis QTL GWAS1564143 (human) | | 2e-55 | adolescent idiopathic scoliosis | | 10 | 101219450 | 101219451 | Human |
597312416 | GWAS1408490_H | X-22162 measurement QTL GWAS1408490 (human) | | 3e-13 | X-22162 measurement | | 10 | 98388596 | 98388597 | Human |
597386203 | GWAS1482277_H | susceptibility to rubella infection measurement QTL GWAS1482277 (human) | | 0.000006 | response to viral infection trait (VT:0010439) | | 10 | 78966660 | 78966661 | Human |
406976513 | GWAS625489_H | basophil count QTL GWAS625489 (human) | | 2e-09 | basophil quantity (VT:0002607) | blood granulocyte count (CMO:0000111) | 10 | 100359243 | 100359244 | Human |
597337054 | GWAS1433128_H | N6,N6-dimethyllysine measurement QTL GWAS1433128 (human) | | 2e-17 | N6,N6-dimethyllysine measurement | | 10 | 98388301 | 98388302 | Human |
597337055 | GWAS1433129_H | N6,N6-dimethyllysine measurement QTL GWAS1433129 (human) | | 2e-16 | N6,N6-dimethyllysine measurement | | 10 | 98392616 | 98392617 | Human |
597222366 | GWAS1318440_H | Thrombocytopenia QTL GWAS1318440 (human) | | 4e-08 | Thrombocytopenia | | 10 | 95806295 | 95806296 | Human |
597238737 | GWAS1334811_H | type 2 diabetes mellitus QTL GWAS1334811 (human) | | 5e-08 | type 2 diabetes mellitus | | 10 | 86359258 | 86359259 | Human |
597074910 | GWAS1170984_H | body mass index QTL GWAS1170984 (human) | | 1e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100666192 | 100666193 | Human |
597058527 | GWAS1154601_H | BMI-adjusted waist circumference QTL GWAS1154601 (human) | | 2e-10 | body size trait (VT:0100005) | | 10 | 94254865 | 94254866 | Human |
597500887 | GWAS1596961_H | lean body mass QTL GWAS1596961 (human) | | 2e-10 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 77943497 | 77943498 | Human |
597238738 | GWAS1334812_H | type 2 diabetes mellitus QTL GWAS1334812 (human) | | 2e-10 | type 2 diabetes mellitus | | 10 | 97296433 | 97296434 | Human |
597058522 | GWAS1154596_H | open-angle glaucoma QTL GWAS1154596 (human) | | 2e-08 | open-angle glaucoma | | 10 | 94256036 | 94256037 | Human |
597066694 | GWAS1162768_H | fear of minor pain measurement QTL GWAS1162768 (human) | | 0.0000006 | fear-related behavior trait (VT:0010715) | | 10 | 92050985 | 92050986 | Human |
597509065 | GWAS1605139_H | total cholesterol measurement QTL GWAS1605139 (human) | | 3e-10 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 88045653 | 88045654 | Human |
597337039 | GWAS1433113_H | breast density QTL GWAS1433113 (human) | | 1e-08 | breast density | | 10 | 84298935 | 84298936 | Human |
597238732 | GWAS1334806_H | type 2 diabetes mellitus QTL GWAS1334806 (human) | | 9e-12 | type 2 diabetes mellitus | | 10 | 92725454 | 92725455 | Human |
597509067 | GWAS1605141_H | total cholesterol measurement QTL GWAS1605141 (human) | | 4e-23 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 100244149 | 100244150 | Human |
597509066 | GWAS1605140_H | total cholesterol measurement QTL GWAS1605140 (human) | | 2e-13 | total cholesterol measurement | | 10 | 94278929 | 94278930 | Human |
597287872 | GWAS1383946_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1383946 (human) | | 1e-10 | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93083778 | 93083779 | Human |
597238727 | GWAS1334801_H | type 2 diabetes mellitus QTL GWAS1334801 (human) | | 3e-10 | type 2 diabetes mellitus | | 10 | 92719350 | 92719351 | Human |
406968352 | GWAS617328_H | neutrophil count, basophil count QTL GWAS617328 (human) | | 1e-37 | basophil quantity (VT:0002607) | blood granulocyte count (CMO:0000111) | 10 | 97314229 | 97314234 | Human |
597419000 | GWAS1515074_H | executive function measurement QTL GWAS1515074 (human) | | 0.000007 | executive function measurement | | 10 | 77985511 | 77985512 | Human |
597189627 | GWAS1285701_H | preeclampsia QTL GWAS1285701 (human) | | 3e-09 | preeclampsia | | 10 | 94133031 | 94133032 | Human |
597312508 | GWAS1408582_H | cognitive function measurement QTL GWAS1408582 (human) | | 0.000003 | cognitive behavior trait (VT:0010450) | | 10 | 86306779 | 86306780 | Human |
597296125 | GWAS1392199_H | BMI-adjusted fasting blood insulin measurement QTL GWAS1392199 (human) | | 5e-10 | blood insulin amount (VT:0001560) | | 10 | 88006188 | 88006189 | Human |
597165055 | GWAS1261129_H | erythrocyte count QTL GWAS1261129 (human) | | 5e-09 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 102502299 | 102502300 | Human |
597140479 | GWAS1236553_H | uric acid measurement QTL GWAS1236553 (human) | | 5e-23 | uric acid measurement | blood uric acid level (CMO:0000501) | 10 | 87149628 | 87149629 | Human |
597173232 | GWAS1269306_H | protein measurement QTL GWAS1269306 (human) | | 2e-15 | protein measurement | | 10 | 103057626 | 103057627 | Human |
597361651 | GWAS1457725_H | atrial fibrillation QTL GWAS1457725 (human) | | 4e-16 | atrial fibrillation | | 10 | 103582915 | 103582916 | Human |
597173233 | GWAS1269307_H | protein measurement QTL GWAS1269307 (human) | | 3e-35 | protein measurement | | 10 | 103174639 | 103174640 | Human |
597074939 | GWAS1171013_H | asthma QTL GWAS1171013 (human) | | 0.000005 | asthma | | 10 | 86305355 | 86305356 | Human |
597058534 | GWAS1154608_H | BMI-adjusted waist circumference QTL GWAS1154608 (human) | | 2e-11 | body size trait (VT:0100005) | | 10 | 79159919 | 79159920 | Human |
597058535 | GWAS1154609_H | BMI-adjusted waist circumference QTL GWAS1154609 (human) | | 1e-10 | body size trait (VT:0100005) | | 10 | 79134804 | 79134805 | Human |
597058532 | GWAS1154606_H | BMI-adjusted waist circumference QTL GWAS1154606 (human) | | 2e-12 | body size trait (VT:0100005) | | 10 | 79182874 | 79182875 | Human |
597337064 | GWAS1433138_H | N6-methyllysine measurement QTL GWAS1433138 (human) | | 3e-41 | N6-methyllysine measurement | | 10 | 98392616 | 98392617 | Human |
597058533 | GWAS1154607_H | BMI-adjusted waist circumference QTL GWAS1154607 (human) | | 2e-12 | body size trait (VT:0100005) | | 10 | 79157529 | 79157530 | Human |
597337065 | GWAS1433139_H | N6-methyllysine measurement QTL GWAS1433139 (human) | | 4e-34 | N6-methyllysine measurement | | 10 | 98408103 | 98408104 | Human |
597058530 | GWAS1154604_H | BMI-adjusted waist circumference QTL GWAS1154604 (human) | | 8e-09 | body size trait (VT:0100005) | | 10 | 79404401 | 79404402 | Human |
597058531 | GWAS1154605_H | BMI-adjusted waist circumference QTL GWAS1154605 (human) | | 3e-36 | body size trait (VT:0100005) | | 10 | 79158760 | 79158761 | Human |
597369838 | GWAS1465912_H | blood protein measurement QTL GWAS1465912 (human) | | 7e-104 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 88766035 | 88766036 | Human |
406960182 | GWAS609158_H | BMI-adjusted waist-hip ratio QTL GWAS609158 (human) | | 8e-11 | BMI-adjusted waist-hip ratio | | 10 | 87843667 | 87843668 | Human |
597156847 | GWAS1252921_H | triglyceride:HDL cholesterol ratio QTL GWAS1252921 (human) | | 3e-09 | blood triglyceride amount (VT:0002644) | | 10 | 92995002 | 92995003 | Human |
597320674 | GWAS1416748_H | metabolite measurement QTL GWAS1416748 (human) | | 7e-31 | metabolite measurement | | 10 | 94983471 | 94983472 | Human |
597337058 | GWAS1433132_H | N6-methyllysine measurement QTL GWAS1433132 (human) | | 1e-40 | N6-methyllysine measurement | | 10 | 98395539 | 98395540 | Human |
597418979 | GWAS1515053_H | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa, major depressive disorder QTL GWAS1515053 (human) | | 2e-09 | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa, major depressive disorder | | 10 | 102666420 | 102666421 | Human |
597337059 | GWAS1433133_H | N6-methyllysine measurement QTL GWAS1433133 (human) | | 2e-39 | N6-methyllysine measurement | | 10 | 98388551 | 98388552 | Human |
597320672 | GWAS1416746_H | X-21834 measurement QTL GWAS1416746 (human) | | 2e-16 | X-21834 measurement | | 10 | 94934834 | 94934835 | Human |
597337056 | GWAS1433130_H | N6,N6-dimethyllysine measurement QTL GWAS1433130 (human) | | 2e-13 | N6,N6-dimethyllysine measurement | | 10 | 98408103 | 98408104 | Human |
597337057 | GWAS1433131_H | N6-methyllysine measurement QTL GWAS1433131 (human) | | 1e-32 | N6-methyllysine measurement | | 10 | 98397611 | 98397612 | Human |
597337062 | GWAS1433136_H | N6-methyllysine measurement QTL GWAS1433136 (human) | | 1e-41 | N6-methyllysine measurement | | 10 | 98387303 | 98387304 | Human |
597287909 | GWAS1383983_H | serum gamma-glutamyl transferase measurement QTL GWAS1383983 (human) | | 2e-33 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 99833993 | 99833994 | Human |
597337063 | GWAS1433137_H | N6-methyllysine measurement QTL GWAS1433137 (human) | | 2e-44 | N6-methyllysine measurement | | 10 | 98388301 | 98388302 | Human |
597058536 | GWAS1154610_H | BMI-adjusted waist circumference QTL GWAS1154610 (human) | | 1e-08 | body size trait (VT:0100005) | | 10 | 79250866 | 79250867 | Human |
597337060 | GWAS1433134_H | N6-methyllysine measurement QTL GWAS1433134 (human) | | 2e-44 | N6-methyllysine measurement | | 10 | 98388419 | 98388420 | Human |
597058537 | GWAS1154611_H | BMI-adjusted waist circumference QTL GWAS1154611 (human) | | 2e-09 | body size trait (VT:0100005) | | 10 | 93238351 | 93238352 | Human |
597337061 | GWAS1433135_H | N6-methyllysine measurement QTL GWAS1433135 (human) | | 7e-40 | N6-methyllysine measurement | | 10 | 98388247 | 98388248 | Human |
597287910 | GWAS1383984_H | serum gamma-glutamyl transferase measurement QTL GWAS1383984 (human) | | 1e-15 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 100904851 | 100904852 | Human |
597214183 | GWAS1310257_H | empathy measurement QTL GWAS1310257 (human) | | 0.000005 | empathy measurement | | 10 | 102553638 | 102553639 | Human |
596960023 | GWAS1079542_H | glomerular filtration rate QTL GWAS1079542 (human) | | 5e-08 | glomerular filtration rate | | 10 | 78285355 | 78285356 | Human |
597287706 | GWAS1383780_H | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1383780 (human) | | 6e-14 | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079885 | 93079886 | Human |
597246746 | GWAS1342820_H | serum alanine aminotransferase measurement QTL GWAS1342820 (human) | | 2e-21 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 99830729 | 99830730 | Human |
597058322 | GWAS1154396_H | asthma, Eczematoid dermatitis, allergic rhinitis QTL GWAS1154396 (human) | | 1e-09 | asthma, Eczematoid dermatitis, allergic rhinitis | | 10 | 102466075 | 102466076 | Human |
597492501 | GWAS1588575_H | S-warfarin measurement QTL GWAS1588575 (human) | | 0.0000004 | S-warfarin measurement | | 10 | 92799519 | 92799520 | Human |
596951838 | GWAS1071357_H | COVID-19 QTL GWAS1071357 (human) | | 2e-11 | COVID-19 | | 10 | 79963939 | 79963940 | Human |
597246740 | GWAS1342814_H | serum alanine aminotransferase measurement QTL GWAS1342814 (human) | | 8e-24 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 99692460 | 99692461 | Human |
597074695 | GWAS1170769_H | type 2 diabetes mellitus QTL GWAS1170769 (human) | | 2e-20 | type 2 diabetes mellitus | | 10 | 79182874 | 79182875 | Human |
597476110 | GWAS1572184_H | serum alanine aminotransferase measurement QTL GWAS1572184 (human) | | 2e-11 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 96700824 | 96700825 | Human |
597320457 | GWAS1416531_H | serum metabolite measurement QTL GWAS1416531 (human) | | 7e-28 | serum metabolite measurement | | 10 | 100315722 | 100315723 | Human |
597492489 | GWAS1588563_H | colorectal cancer, hormone replacement therapy QTL GWAS1588563 (human) | | 0.000004 | colorectal cancer, hormone replacement therapy | | 10 | 93595641 | 93595642 | Human |
597410575 | GWAS1506649_H | neuroticism measurement QTL GWAS1506649 (human) | | 1e-09 | neuroticism measurement | | 10 | 102876898 | 102876899 | Human |
597361421 | GWAS1457495_H | atrial fibrillation QTL GWAS1457495 (human) | | 3e-21 | atrial fibrillation | | 10 | 103582915 | 103582916 | Human |
597213952 | GWAS1310026_H | blood protein measurement QTL GWAS1310026 (human) | | 1e-56 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95841946 | 95841947 | Human |
597402371 | GWAS1498445_H | ulcerative colitis QTL GWAS1498445 (human) | | 2e-36 | ulcerative colitis | | 10 | 99524480 | 99524481 | Human |
597304064 | GWAS1400138_H | Alzheimer disease QTL GWAS1400138 (human) | | 2e-19 | Alzheimer disease | | 10 | 80494228 | 80494229 | Human |
596984591 | GWAS1104110_H | sex hormone-binding globulin measurement QTL GWAS1104110 (human) | | 4e-08 | sex hormone-binding globulin measurement | | 10 | 93079885 | 93079886 | Human |
597304065 | GWAS1400139_H | Alzheimer disease QTL GWAS1400139 (human) | | 7e-11 | Alzheimer disease | | 10 | 96266650 | 96266651 | Human |
406976733 | GWAS625709_H | blood protein measurement QTL GWAS625709 (human) | | 2e-16 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 80104208 | 80104209 | Human |
597107467 | GWAS1203541_H | putamen volume change measurement, age at assessment QTL GWAS1203541 (human) | | 0.0000003 | putamen volume change measurement, age at assessment | | 10 | 96290759 | 96290760 | Human |
597107466 | GWAS1203540_H | pallidum volume change measurement, age at assessment QTL GWAS1203540 (human) | | 0.000009 | pallidum volume change measurement, age at assessment | | 10 | 97080319 | 97080320 | Human |
597074696 | GWAS1170770_H | type 2 diabetes mellitus QTL GWAS1170770 (human) | | 6e-39 | type 2 diabetes mellitus | | 10 | 92703125 | 92703126 | Human |
406976734 | GWAS625710_H | blood protein measurement QTL GWAS625710 (human) | | 3e-09 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 80434574 | 80434575 | Human |
597246776 | GWAS1342850_H | bilirubin measurement QTL GWAS1342850 (human) | | 2e-09 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 10 | 93081350 | 93081351 | Human |
597394239 | GWAS1490313_H | appendicular lean mass QTL GWAS1490313 (human) | | 2e-10 | appendicular lean mass | | 10 | 94325620 | 94325621 | Human |
597599034 | GWAS1655894_H | serum alanine aminotransferase measurement QTL GWAS1655894 (human) | | 4e-12 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 102406747 | 102406748 | Human |
597263164 | GWAS1359238_H | hydroxyhexadecanoylcarnitine measurement QTL GWAS1359238 (human) | | 9e-19 | hydroxyhexadecanoylcarnitine measurement | | 10 | 98388551 | 98388552 | Human |
596960049 | GWAS1079568_H | brain measurement QTL GWAS1079568 (human) | | 2e-08 | brain measurement | | 10 | 103081213 | 103081214 | Human |
597599032 | GWAS1655892_H | serum alanine aminotransferase measurement QTL GWAS1655892 (human) | | 3e-14 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 96710097 | 96710098 | Human |
596960050 | GWAS1079569_H | brain measurement QTL GWAS1079569 (human) | | 2e-08 | brain measurement | | 10 | 102948494 | 102948495 | Human |
597336893 | GWAS1432967_H | anxiety QTL GWAS1432967 (human) | | 0.000004 | anxiety | | 10 | 83774348 | 83774349 | Human |
597599033 | GWAS1655893_H | serum alanine aminotransferase measurement QTL GWAS1655893 (human) | | 3e-154 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100152437 | 100152438 | Human |
596960051 | GWAS1079570_H | brain measurement QTL GWAS1079570 (human) | | 3e-08 | brain measurement | | 10 | 103193790 | 103193791 | Human |
597148479 | GWAS1244553_H | smoking initiation QTL GWAS1244553 (human) | | 1e-13 | smoking initiation | | 10 | 85665531 | 85665532 | Human |
597590838 | GWAS1647698_H | hypothyroidism QTL GWAS1647698 (human) | | 2e-13 | hypothyroidism | | 10 | 88089762 | 88089763 | Human |
597148478 | GWAS1244552_H | smoking initiation QTL GWAS1244552 (human) | | 5e-20 | smoking initiation | | 10 | 85641640 | 85641641 | Human |
597148477 | GWAS1244551_H | smoking initiation QTL GWAS1244551 (human) | | 5e-15 | smoking initiation | | 10 | 81036786 | 81036787 | Human |
597222195 | GWAS1318269_H | serum gamma-glutamyl transferase measurement QTL GWAS1318269 (human) | | 1e-10 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 100006605 | 100006606 | Human |
597500726 | GWAS1596800_H | protein measurement QTL GWAS1596800 (human) | | 4e-34 | protein measurement | | 10 | 100130207 | 100130208 | Human |
597222196 | GWAS1318270_H | serum gamma-glutamyl transferase measurement QTL GWAS1318270 (human) | | 3e-10 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 100057584 | 100057585 | Human |
596968248 | GWAS1087767_H | body mass index QTL GWAS1087767 (human) | | 2e-09 | body mass index | | 10 | 102460544 | 102460545 | Human |
597443377 | GWAS1539451_H | cardiovascular age measurement QTL GWAS1539451 (human) | | 1e-08 | cardiovascular age measurement | | 10 | 103488060 | 103488061 | Human |
597173046 | GWAS1269120_H | cigarettes per day measurement QTL GWAS1269120 (human) | | 1e-08 | cigarettes per day measurement | | 10 | 92252042 | 92252043 | Human |
597173047 | GWAS1269121_H | cigarettes per day measurement QTL GWAS1269121 (human) | | 2e-09 | cigarettes per day measurement | | 10 | 98018469 | 98018470 | Human |
596960036 | GWAS1079555_H | glomerular filtration rate QTL GWAS1079555 (human) | | 3e-12 | glomerular filtration rate | | 10 | 80434933 | 80434934 | Human |
597590830 | GWAS1647690_H | Abdominal Aortic Aneurysm QTL GWAS1647690 (human) | | 5e-15 | Abdominal Aortic Aneurysm | | 10 | 89243047 | 89243048 | Human |
597599023 | GWAS1655883_H | HbA1c measurement QTL GWAS1655883 (human) | | 4e-22 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 10 | 79184390 | 79184391 | Human |
597115685 | GWAS1211759_H | pulse pressure measurement QTL GWAS1211759 (human) | | 1e-14 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 80455532 | 80455533 | Human |
597074722 | GWAS1170796_H | body mass index QTL GWAS1170796 (human) | | 2e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 92722160 | 92722161 | Human |
596960034 | GWAS1079553_H | glomerular filtration rate QTL GWAS1079553 (human) | | 4e-14 | glomerular filtration rate | | 10 | 102816113 | 102816114 | Human |
596960044 | GWAS1079563_H | glomerular filtration rate QTL GWAS1079563 (human) | | 7e-14 | glomerular filtration rate | | 10 | 95506844 | 95506845 | Human |
596960045 | GWAS1079564_H | glomerular filtration rate QTL GWAS1079564 (human) | | 1e-10 | glomerular filtration rate | | 10 | 100960997 | 100960998 | Human |
406960376 | GWAS609352_H | systolic blood pressure QTL GWAS609352 (human) | | 1e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 102794772 | 102794773 | Human |
596960046 | GWAS1079565_H | glomerular filtration rate QTL GWAS1079565 (human) | | 2e-11 | glomerular filtration rate | | 10 | 102094023 | 102094024 | Human |
596960040 | GWAS1079559_H | glomerular filtration rate QTL GWAS1079559 (human) | | 3e-08 | glomerular filtration rate | | 10 | 89551314 | 89551315 | Human |
406952188 | GWAS601164_H | systolic blood pressure QTL GWAS601164 (human) | | 2e-27 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103076162 | 103076163 | Human |
596960043 | GWAS1079562_H | glomerular filtration rate QTL GWAS1079562 (human) | | 3e-41 | glomerular filtration rate | | 10 | 93079885 | 93079886 | Human |
597058389 | GWAS1154463_H | basophil percentage of leukocytes QTL GWAS1154463 (human) | | 6e-09 | basophil quantity (VT:0002607) | blood basophil count to total leukocyte count ratio (CMO:0000368) | 10 | 96778019 | 96778020 | Human |
597599066 | GWAS1655926_H | serum alanine aminotransferase measurement QTL GWAS1655926 (human) | | 3e-147 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100152437 | 100152438 | Human |
597369695 | GWAS1465769_H | intelligence QTL GWAS1465769 (human) | | 1e-08 | intelligence | | 10 | 101760027 | 101760028 | Human |
597599067 | GWAS1655927_H | serum alanine aminotransferase measurement QTL GWAS1655927 (human) | | 3e-11 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 102406747 | 102406748 | Human |
597042000 | GWAS1138074_H | appendicular lean mass QTL GWAS1138074 (human) | | 5e-11 | appendicular lean mass | | 10 | 95059638 | 95059639 | Human |
597312348 | GWAS1408422_H | N,N,N-trimethyl-5-aminovalerate measurement QTL GWAS1408422 (human) | | 2e-494 | N,N,N-trimethyl-5-aminovalerate measurement | | 10 | 98391548 | 98391549 | Human |
597295958 | GWAS1392032_H | lysophosphatidylcholine 16:1 measurement QTL GWAS1392032 (human) | | 3e-26 | glycerophosphocholine amount (VT:0011004) | | 10 | 100315722 | 100315723 | Human |
597295959 | GWAS1392033_H | lysophosphatidylcholine 16:1 measurement QTL GWAS1392033 (human) | | 2e-31 | glycerophosphocholine amount (VT:0011004) | | 10 | 100315722 | 100315723 | Human |
406952079 | GWAS601055_H | celiac disease QTL GWAS601055 (human) | | 1e-08 | celiac disease | | 10 | 79306017 | 79306018 | Human |
597459794 | GWAS1555868_H | hypertension QTL GWAS1555868 (human) | | 1e-09 | hypertension | | 10 | 86412952 | 86412953 | Human |
597492556 | GWAS1588630_H | opioid dependence QTL GWAS1588630 (human) | | 0.00001 | opioid dependence | | 10 | 99472046 | 99472047 | Human |
597320520 | GWAS1416594_H | executive function measurement QTL GWAS1416594 (human) | | 4e-09 | executive function measurement | | 10 | 99782821 | 99782822 | Human |
597590861 | GWAS1647721_H | temporal measurement QTL GWAS1647721 (human) | | 2e-11 | temporal measurement | | 10 | 84416049 | 84416050 | Human |
597369672 | GWAS1465746_H | serum alanine aminotransferase measurement QTL GWAS1465746 (human) | | 0.000003 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 99569213 | 99569214 | Human |
597148482 | GWAS1244556_H | smoking initiation QTL GWAS1244556 (human) | | 7e-15 | smoking initiation | | 10 | 81036778 | 81036779 | Human |
597476169 | GWAS1572243_H | cryptococcosis QTL GWAS1572243 (human) | | 0.000001 | cryptococcosis | | 10 | 90177983 | 90177984 | Human |
597148481 | GWAS1244555_H | smoking initiation QTL GWAS1244555 (human) | | 2e-14 | smoking initiation | | 10 | 88446781 | 88446782 | Human |
597394253 | GWAS1490327_H | appendicular lean mass QTL GWAS1490327 (human) | | 7e-26 | appendicular lean mass | | 10 | 94278929 | 94278930 | Human |
597148480 | GWAS1244554_H | smoking initiation QTL GWAS1244554 (human) | | 2e-14 | smoking initiation | | 10 | 88445442 | 88445443 | Human |
596951884 | GWAS1071403_H | aspartate aminotransferase measurement QTL GWAS1071403 (human) | | 1e-09 | neuroimaging measurement | | 10 | 94279840 | 94279841 | Human |
406960282 | GWAS609258_H | Myopia QTL GWAS609258 (human) | | 6e-19 | Myopia | | 10 | 84255817 | 84255818 | Human |
597320519 | GWAS1416593_H | executive function measurement QTL GWAS1416593 (human) | | 4e-13 | executive function measurement | | 10 | 101800564 | 101800565 | Human |
597607293 | GWAS1664153_H | prostate carcinoma QTL GWAS1664153 (human) | | 4e-12 | prostate carcinoma | | 10 | 79077568 | 79077569 | Human |
406919332 | GWAS568308_H | systolic blood pressure QTL GWAS568308 (human) | | 2e-10 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 80436193 | 80436194 | Human |
597271420 | GWAS1367494_H | systolic blood pressure QTL GWAS1367494 (human) | | 1e-57 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103192742 | 103192743 | Human |
597500794 | GWAS1596868_H | systolic blood pressure QTL GWAS1596868 (human) | | 0.0000001 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 102831636 | 102831637 | Human |
597295986 | GWAS1392060_H | phosphatidylcholine measurement QTL GWAS1392060 (human) | | 3e-18 | phosphatidylcholine measurement | | 10 | 100315722 | 100315723 | Human |
597263221 | GWAS1359295_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1359295 (human) | | 5e-09 | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 98012647 | 98012648 | Human |
597263220 | GWAS1359294_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1359294 (human) | | 1e-13 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 93079885 | 93079886 | Human |
597295991 | GWAS1392065_H | phosphatidylcholine measurement QTL GWAS1392065 (human) | | 9e-09 | phosphatidylcholine measurement | | 10 | 100315722 | 100315723 | Human |
596951909 | GWAS1071428_H | COVID-19 QTL GWAS1071428 (human) | | 0.000003 | COVID-19 | | 10 | 79645176 | 79645177 | Human |
597345131 | GWAS1441205_H | smoking initiation QTL GWAS1441205 (human) | | 9e-13 | smoking initiation | | 10 | 102200594 | 102200595 | Human |
597214057 | GWAS1310131_H | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa, major depressive disorder QTL GWAS1310131 (human) | | 3e-16 | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa, major depressive disorder | | 10 | 102869116 | 102869117 | Human |
597287787 | GWAS1383861_H | triglycerides in very large VLDL measurement QTL GWAS1383861 (human) | | 8e-12 | blood VLDL triglyceride amount (VT:0010700) | | 10 | 93083778 | 93083779 | Human |
597345134 | GWAS1441208_H | smoking initiation QTL GWAS1441208 (human) | | 2e-16 | smoking initiation | | 10 | 102881922 | 102881923 | Human |
597345132 | GWAS1441206_H | smoking initiation QTL GWAS1441206 (human) | | 1e-09 | smoking initiation | | 10 | 102320061 | 102320062 | Human |
596951907 | GWAS1071426_H | COVID-19 QTL GWAS1071426 (human) | | 0.000009 | COVID-19 | | 10 | 79468285 | 79468286 | Human |
597017442 | GWAS1113516_H | basophil count QTL GWAS1113516 (human) | | 3e-10 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 94311804 | 94311805 | Human |
596976482 | GWAS1096001_H | body height QTL GWAS1096001 (human) | | 2e-18 | body height | | 10 | 96975483 | 96975484 | Human |
597345133 | GWAS1441207_H | smoking initiation QTL GWAS1441207 (human) | | 1e-08 | smoking initiation | | 10 | 102800007 | 102800008 | Human |
597361507 | GWAS1457581_H | atrial fibrillation QTL GWAS1457581 (human) | | 0.000002 | atrial fibrillation | | 10 | 103582915 | 103582916 | Human |
597099373 | GWAS1195447_H | body mass index QTL GWAS1195447 (human) | | 2e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100660414 | 100660415 | Human |
597287778 | GWAS1383852_H | ulcerative colitis QTL GWAS1383852 (human) | | 8e-10 | ulcerative colitis | | 10 | 96837270 | 96837271 | Human |
597361504 | GWAS1457578_H | atrial fibrillation QTL GWAS1457578 (human) | | 2e-22 | atrial fibrillation | | 10 | 103582915 | 103582916 | Human |
596976488 | GWAS1096007_H | body height QTL GWAS1096007 (human) | | 1e-11 | body height | | 10 | 103585570 | 103585571 | Human |
597246823 | GWAS1342897_H | alkaline phosphatase measurement QTL GWAS1342897 (human) | | 4e-13 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 101655306 | 101655307 | Human |
597295973 | GWAS1392047_H | calpastatin measurement QTL GWAS1392047 (human) | | 1e-12 | calpastatin measurement | | 10 | 100050547 | 100050548 | Human |
597099154 | GWAS1195228_H | prostate carcinoma QTL GWAS1195228 (human) | | 7e-10 | prostate carcinoma | | 10 | 79076241 | 79076242 | Human |
597074576 | GWAS1170650_H | type 2 diabetes mellitus QTL GWAS1170650 (human) | | 3e-11 | type 2 diabetes mellitus | | 10 | 79182874 | 79182875 | Human |
597222046 | GWAS1318120_H | platelet count QTL GWAS1318120 (human) | | 2e-08 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 79187911 | 79187912 | Human |
597254815 | GWAS1350889_H | aspartate aminotransferase measurement QTL GWAS1350889 (human) | | 2e-11 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99913702 | 99913703 | Human |
597222047 | GWAS1318121_H | platelet count QTL GWAS1318121 (human) | | 6e-13 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 95784756 | 95784757 | Human |
597254814 | GWAS1350888_H | aspartate aminotransferase measurement QTL GWAS1350888 (human) | | 4e-11 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99378769 | 99378770 | Human |
597607062 | GWAS1663922_H | total cholesterol measurement QTL GWAS1663922 (human) | | 8e-17 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 93079885 | 93079886 | Human |
597041823 | GWAS1137897_H | retinal detachment, retinal break QTL GWAS1137897 (human) | | 0.0000002 | retinal detachment, retinal break | | 10 | 77859703 | 77859704 | Human |
597402256 | GWAS1498330_H | age at assessment, lateral ventricle volume change measurement QTL GWAS1498330 (human) | | 0.000002 | age at assessment, lateral ventricle volume change measurement | | 10 | 78469564 | 78469565 | Human |
597385879 | GWAS1481953_H | physical activity measurement, body mass index QTL GWAS1481953 (human) | | 0.0000002 | wellness/fitness trait (VT:1000152) | body mass index (BMI) (CMO:0000105) | 10 | 102641875 | 102641876 | Human |
597475985 | GWAS1572059_H | blood protein measurement QTL GWAS1572059 (human) | | 4e-58 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 100130207 | 100130208 | Human |
597336724 | GWAS1432798_H | C-reactive protein measurement QTL GWAS1432798 (human) | | 5e-29 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 89251701 | 89251702 | Human |
597590670 | GWAS1647530_H | diabetes mellitus QTL GWAS1647530 (human) | | 3e-24 | pancreas integrity trait (VT:0010560) | | 10 | 79187681 | 79187682 | Human |
597475981 | GWAS1572055_H | blood protein measurement QTL GWAS1572055 (human) | | 8e-17 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 89307012 | 89307013 | Human |
597590671 | GWAS1647531_H | diabetes mellitus QTL GWAS1647531 (human) | | 3e-46 | pancreas integrity trait (VT:0010560) | | 10 | 92704022 | 92704023 | Human |
597295759 | GWAS1391833_H | calcium/calmodulin-dependent protein kinase type 1 measurement QTL GWAS1391833 (human) | | 1e-48 | calcium/calmodulin-dependent protein kinase type 1 measurement | | 10 | 100050547 | 100050548 | Human |
597516933 | GWAS1613007_H | age of onset of multiple sclerosis QTL GWAS1613007 (human) | | 0.000008 | age of onset of multiple sclerosis | | 10 | 90146080 | 90146081 | Human |
597254790 | GWAS1350864_H | apolipoprotein B measurement QTL GWAS1350864 (human) | | 8e-16 | apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 10 | 100315722 | 100315723 | Human |
406952289 | GWAS601265_H | platelet crit QTL GWAS601265 (human) | | 2e-22 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
597099191 | GWAS1195265_H | body mass index QTL GWAS1195265 (human) | | 6e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 103183291 | 103183292 | Human |
597189305 | GWAS1285379_H | free androgen index QTL GWAS1285379 (human) | | 2e-14 | free androgen index | | 10 | 79314368 | 79314369 | Human |
597099188 | GWAS1195262_H | body mass index QTL GWAS1195262 (human) | | 3e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98047289 | 98047290 | Human |
407230822 | GWAS879798_H | systolic blood pressure QTL GWAS879798 (human) | | 4e-18 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 100844757 | 100844758 | Human |
597418685 | GWAS1514759_H | self reported educational attainment QTL GWAS1514759 (human) | | 2e-09 | self reported educational attainment | | 10 | 101716541 | 101716542 | Human |
597099184 | GWAS1195258_H | body mass index QTL GWAS1195258 (human) | | 7e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 85731093 | 85731094 | Human |
597418684 | GWAS1514758_H | self reported educational attainment QTL GWAS1514758 (human) | | 5e-09 | self reported educational attainment | | 10 | 91682483 | 91682484 | Human |
597156543 | GWAS1252617_H | testosterone measurement QTL GWAS1252617 (human) | | 7e-19 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 102863296 | 102863297 | Human |
597156542 | GWAS1252616_H | testosterone measurement QTL GWAS1252616 (human) | | 0.0000006 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 95064055 | 95064056 | Human |
597156541 | GWAS1252615_H | testosterone measurement QTL GWAS1252615 (human) | | 2e-09 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 92682235 | 92682237 | Human |
597099197 | GWAS1195271_H | body mass index QTL GWAS1195271 (human) | | 9e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 95494548 | 95494549 | Human |
597156540 | GWAS1252614_H | testosterone measurement QTL GWAS1252614 (human) | | 0.000008 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 89000159 | 89000160 | Human |
407296362 | GWAS945338_H | non-high density lipoprotein cholesterol measurement QTL GWAS945338 (human) | | 4e-10 | non-high density lipoprotein cholesterol measurement | | 10 | 94278929 | 94278930 | Human |
597459632 | GWAS1555706_H | eosinophil count QTL GWAS1555706 (human) | | 3e-10 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 97338780 | 97338781 | Human |
597189301 | GWAS1285375_H | free androgen index QTL GWAS1285375 (human) | | 2e-09 | free androgen index | | 10 | 91882000 | 91882001 | Human |
407058807 | GWAS707783_H | heel bone mineral density QTL GWAS707783 (human) | | 2e-18 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 87709196 | 87709197 | Human |
407058806 | GWAS707782_H | heel bone mineral density QTL GWAS707782 (human) | | 9e-11 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 86844812 | 86844813 | Human |
407361906 | GWAS1010882_H | mean corpuscular hemoglobin QTL GWAS1010882 (human) | | 1e-15 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 87986057 | 87986058 | Human |
597074595 | GWAS1170669_H | body mass index QTL GWAS1170669 (human) | | 3e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 92717782 | 92717783 | Human |
407058805 | GWAS707781_H | heel bone mineral density QTL GWAS707781 (human) | | 4e-14 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 80439507 | 80439508 | Human |
597140128 | GWAS1236202_H | retinol measurement QTL GWAS1236202 (human) | | 2e-18 | blood vitamin A amount (VT:0010627) | blood retinol level (CMO:0002457) | 10 | 93601207 | 93601208 | Human |
597607078 | GWAS1663938_H | sodium measurement QTL GWAS1663938 (human) | | 2e-15 | sodium measurement | blood sodium level (CMO:0000499) | 10 | 95875759 | 95875760 | Human |
407058811 | GWAS707787_H | heel bone mineral density QTL GWAS707787 (human) | | 4e-09 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 101673991 | 101673992 | Human |
597303971 | GWAS1400045_H | level of membrane protein FAM174A in blood serum QTL GWAS1400045 (human) | | 3e-47 | level of membrane protein FAM174A in blood serum | | 10 | 88673588 | 88673589 | Human |
597099182 | GWAS1195256_H | body mass index QTL GWAS1195256 (human) | | 8e-16 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100710675 | 100710676 | Human |
407058809 | GWAS707785_H | heel bone mineral density QTL GWAS707785 (human) | | 1e-08 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 96987996 | 96987997 | Human |
597099181 | GWAS1195255_H | body mass index QTL GWAS1195255 (human) | | 3e-17 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100866753 | 100866754 | Human |
597328550 | GWAS1424624_H | N-methylpipecolate measurement QTL GWAS1424624 (human) | | 2e-195 | N-methylpipecolate measurement | | 10 | 98422528 | 98422529 | Human |
597197479 | GWAS1293553_H | lean body mass QTL GWAS1293553 (human) | | 2e-09 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 94836395 | 94836396 | Human |
597328549 | GWAS1424623_H | N-methylpipecolate measurement QTL GWAS1424623 (human) | | 5e-243 | N-methylpipecolate measurement | | 10 | 98385025 | 98385026 | Human |
407058812 | GWAS707788_H | heel bone mineral density QTL GWAS707788 (human) | | 2e-11 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 101987381 | 101987382 | Human |
597148375 | GWAS1244449_H | high density lipoprotein cholesterol measurement QTL GWAS1244449 (human) | | 9e-13 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 98012433 | 98012434 | Human |
597148374 | GWAS1244448_H | high density lipoprotein cholesterol measurement QTL GWAS1244448 (human) | | 5e-08 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 93279507 | 93279508 | Human |
596968148 | GWAS1087667_H | functional brain measurement QTL GWAS1087667 (human) | | 3e-41 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
597148373 | GWAS1244447_H | high density lipoprotein cholesterol measurement QTL GWAS1244447 (human) | | 6e-09 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 79194494 | 79194495 | Human |
597148372 | GWAS1244446_H | smoking initiation QTL GWAS1244446 (human) | | 2e-13 | smoking initiation | | 10 | 81008572 | 81008573 | Human |
597467871 | GWAS1563945_H | high density lipoprotein cholesterol measurement QTL GWAS1563945 (human) | | 2e-09 | high density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 93079967 | 93079968 | Human |
597197532 | GWAS1293606_H | serum gamma-glutamyl transferase measurement QTL GWAS1293606 (human) | | 1e-39 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 77920676 | 77920677 | Human |
597148371 | GWAS1244445_H | smoking initiation QTL GWAS1244445 (human) | | 1e-10 | smoking initiation | | 10 | 78724292 | 78724293 | Human |
596968145 | GWAS1087664_H | functional brain measurement QTL GWAS1087664 (human) | | 9e-47 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
597197533 | GWAS1293607_H | serum gamma-glutamyl transferase measurement QTL GWAS1293607 (human) | | 5e-10 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 93572760 | 93572761 | Human |
596968144 | GWAS1087663_H | functional brain measurement QTL GWAS1087663 (human) | | 3e-39 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
596968147 | GWAS1087666_H | functional brain measurement QTL GWAS1087666 (human) | | 6e-53 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
597197534 | GWAS1293608_H | serum gamma-glutamyl transferase measurement QTL GWAS1293608 (human) | | 5e-11 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 94371904 | 94371905 | Human |
597344988 | GWAS1441062_H | body mass index QTL GWAS1441062 (human) | | 2e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100943376 | 100943377 | Human |
597033681 | GWAS1129755_H | balding measurement QTL GWAS1129755 (human) | | 4e-09 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 10 | 79382609 | 79382610 | Human |
596968146 | GWAS1087665_H | functional brain measurement QTL GWAS1087665 (human) | | 6e-62 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
597197535 | GWAS1293609_H | serum gamma-glutamyl transferase measurement QTL GWAS1293609 (human) | | 5e-09 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 99802512 | 99802513 | Human |
597344989 | GWAS1441063_H | body mass index QTL GWAS1441063 (human) | | 3e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102177487 | 102177488 | Human |
597336786 | GWAS1432860_H | COVID-19 QTL GWAS1432860 (human) | | 0.000005 | COVID-19 | | 10 | 91071533 | 91071534 | Human |
597246672 | GWAS1342746_H | alkaline phosphatase measurement QTL GWAS1342746 (human) | | 3e-09 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 102462097 | 102462098 | Human |
597517015 | GWAS1613089_H | triglycerides in small HDL measurement QTL GWAS1613089 (human) | | 3e-10 | triglycerides in small HDL measurement | blood high density lipoprotein triglyceride level (CMO:0002686) | 10 | 93063586 | 93063587 | Human |
596951775 | GWAS1071294_H | serum alanine aminotransferase measurement QTL GWAS1071294 (human) | | 5e-10 | cup-to-disc ratio measurement | | 10 | 94279840 | 94279841 | Human |
406952204 | GWAS601180_H | parental longevity QTL GWAS601180 (human) | | 0.000002 | total life span (VT:0001661) | | 10 | 100288886 | 100288887 | Human |
597189334 | GWAS1285408_H | sex hormone-binding globulin measurement QTL GWAS1285408 (human) | | 2e-27 | sex hormone-binding globulin measurement | | 10 | 91854918 | 91854919 | Human |
597385941 | GWAS1482015_H | Red cell distribution width QTL GWAS1482015 (human) | | 3e-38 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 94545747 | 94545748 | Human |
597385940 | GWAS1482014_H | Red cell distribution width QTL GWAS1482014 (human) | | 1e-20 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 79041217 | 79041218 | Human |
597099203 | GWAS1195277_H | body mass index QTL GWAS1195277 (human) | | 3e-20 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100687890 | 100687891 | Human |
596968141 | GWAS1087660_H | functional brain measurement QTL GWAS1087660 (human) | | 9e-29 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
596968140 | GWAS1087659_H | functional brain measurement QTL GWAS1087659 (human) | | 9e-55 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
596968143 | GWAS1087662_H | functional brain measurement QTL GWAS1087662 (human) | | 3e-43 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
597476038 | GWAS1572112_H | blood protein measurement QTL GWAS1572112 (human) | | 3e-30 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 100130207 | 100130208 | Human |
596968142 | GWAS1087661_H | functional brain measurement QTL GWAS1087661 (human) | | 4e-58 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
596976329 | GWAS1095848_H | mean arterial pressure QTL GWAS1095848 (human) | | 3e-29 | mean arterial pressure | | 10 | 94278929 | 94278930 | Human |
597598915 | GWAS1655775_H | HbA1c measurement QTL GWAS1655775 (human) | | 5e-43 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 10 | 92711838 | 92711839 | Human |
597590720 | GWAS1647580_H | hypothyroidism QTL GWAS1647580 (human) | | 6e-21 | hypothyroidism | | 10 | 99523573 | 99523574 | Human |
597607167 | GWAS1664027_H | total cholesterol measurement QTL GWAS1664027 (human) | | 4e-18 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 89243047 | 89243048 | Human |
597099252 | GWAS1195326_H | aspartate aminotransferase measurement QTL GWAS1195326 (human) | | 5e-24 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99372525 | 99372526 | Human |
597140212 | GWAS1236286_H | myristate 14:0-to-myristoleate 14:1n5 ratio QTL GWAS1236286 (human) | | 1e-115 | myristate 14:0-to-myristoleate 14:1n5 ratio | | 10 | 100315722 | 100315723 | Human |
597041906 | GWAS1137980_H | Myopia QTL GWAS1137980 (human) | | 4e-11 | Myopia | | 10 | 84261268 | 84261269 | Human |
597213948 | GWAS1310022_H | blood protein measurement QTL GWAS1310022 (human) | | 8e-22 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95853495 | 95853496 | Human |
597279486 | GWAS1375560_H | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS1375560 (human) | | 2e-15 | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 93083778 | 93083779 | Human |
406919462 | GWAS568438_H | large artery stroke, coronary artery disease QTL GWAS568438 (human) | | 2e-08 | large artery stroke, coronary artery disease | | 10 | 102959339 | 102959340 | Human |
597213936 | GWAS1310010_H | schizophrenia QTL GWAS1310010 (human) | | 5e-08 | schizophrenia | | 10 | 102981826 | 102981827 | Human |
597205745 | GWAS1301819_H | grip strength measurement QTL GWAS1301819 (human) | | 8e-09 | grip strength measurement | | 10 | 100866753 | 100866754 | Human |
597164785 | GWAS1260859_H | angina pectoris QTL GWAS1260859 (human) | | 3e-13 | angina pectoris | | 10 | 103179458 | 103179459 | Human |
597099261 | GWAS1195335_H | sex hormone-binding globulin measurement QTL GWAS1195335 (human) | | 2e-40 | sex hormone-binding globulin measurement | | 10 | 93079885 | 93079886 | Human |
597238517 | GWAS1334591_H | type 2 diabetes mellitus QTL GWAS1334591 (human) | | 2e-11 | type 2 diabetes mellitus | | 10 | 92719350 | 92719351 | Human |
597607152 | GWAS1664012_H | total cholesterol measurement QTL GWAS1664012 (human) | | 2e-15 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 89243047 | 89243048 | Human |
596951781 | GWAS1071300_H | dementia QTL GWAS1071300 (human) | | 0.000006 | dementia | | 10 | 96359803 | 96359804 | Human |
597500655 | GWAS1596729_H | lean body mass QTL GWAS1596729 (human) | | 8e-14 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 103202254 | 103202255 | Human |
597238511 | GWAS1334585_H | type 2 diabetes mellitus QTL GWAS1334585 (human) | | 5e-10 | type 2 diabetes mellitus | | 10 | 92725454 | 92725455 | Human |
597385955 | GWAS1482029_H | white matter hyperintensity measurement QTL GWAS1482029 (human) | | 0.000007 | white matter hyperintensity measurement | | 10 | 87638490 | 87638491 | Human |
596951791 | GWAS1071310_H | dementia QTL GWAS1071310 (human) | | 0.000007 | dementia | | 10 | 95945574 | 95945575 | Human |
597385956 | GWAS1482030_H | white matter hyperintensity measurement QTL GWAS1482030 (human) | | 0.0000005 | white matter hyperintensity measurement | | 10 | 95980704 | 95980705 | Human |
597213927 | GWAS1310001_H | high density lipoprotein cholesterol measurement QTL GWAS1310001 (human) | | 7e-11 | schizophrenia, type 2 diabetes mellitus | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 100152437 | 100152438 | Human |
597058070 | GWAS1154144_H | eosinophil count QTL GWAS1154144 (human) | | 2e-16 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 89089947 | 89089948 | Human |
597058071 | GWAS1154145_H | eosinophil count QTL GWAS1154145 (human) | | 2e-49 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 92672243 | 92672244 | Human |
597180956 | GWAS1277030_H | legumain measurement QTL GWAS1277030 (human) | | 6e-12 | legumain measurement | | 10 | 89243170 | 89243171 | Human |
597238301 | GWAS1334375_H | blood protein measurement QTL GWAS1334375 (human) | | 2e-19 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 100081475 | 100081476 | Human |
597377566 | GWAS1473640_H | smoking behavior QTL GWAS1473640 (human) | | 6e-10 | smoking behavior | | 10 | 91588363 | 91588364 | Human |
597058064 | GWAS1154138_H | intelligence QTL GWAS1154138 (human) | | 4e-12 | intelligence | | 10 | 102364848 | 102364849 | Human |
597238302 | GWAS1334376_H | blood protein measurement QTL GWAS1334376 (human) | | 3e-141 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 100083012 | 100083013 | Human |
597606935 | GWAS1663795_H | sodium measurement QTL GWAS1663795 (human) | | 1e-11 | sodium measurement | blood sodium level (CMO:0000499) | 10 | 79194494 | 79194495 | Human |
597516823 | GWAS1612897_H | color vision disorder QTL GWAS1612897 (human) | | 2e-09 | color vision disorder | | 10 | 89646863 | 89646864 | Human |
597418512 | GWAS1514586_H | monocyte count QTL GWAS1514586 (human) | | 4e-48 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 97349972 | 97349973 | Human |
597336599 | GWAS1432673_H | COVID-19 QTL GWAS1432673 (human) | | 0.000002 | COVID-19 | | 10 | 77822493 | 77822494 | Human |
597328407 | GWAS1424481_H | complex trait QTL GWAS1424481 (human) | | 2e-08 | complex trait | | 10 | 93153570 | 93153571 | Human |
597058072 | GWAS1154146_H | eosinophil count QTL GWAS1154146 (human) | | 1e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 97297164 | 97297165 | Human |
597418517 | GWAS1514591_H | monocyte count QTL GWAS1514591 (human) | | 7e-36 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 99532633 | 99532634 | Human |
597058073 | GWAS1154147_H | eosinophil count QTL GWAS1154147 (human) | | 8e-13 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 102578181 | 102578182 | Human |
597221899 | GWAS1317973_H | serum gamma-glutamyl transferase measurement QTL GWAS1317973 (human) | | 4e-16 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 78159799 | 78159800 | Human |
597410318 | GWAS1506392_H | C-reactive protein measurement QTL GWAS1506392 (human) | | 9e-19 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 79059375 | 79059376 | Human |
597312012 | GWAS1408086_H | Drugs used in diabetes use measurement QTL GWAS1408086 (human) | | 2e-26 | Drugs used in diabetes use measurement | | 10 | 79187681 | 79187682 | Human |
597156353 | GWAS1252427_H | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS1252427 (human) | | 5e-08 | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 98012647 | 98012648 | Human |
597451274 | GWAS1547348_H | alkaline phosphatase measurement QTL GWAS1547348 (human) | | 2e-41 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 102820522 | 102820523 | Human |
597606921 | GWAS1663781_H | Red cell distribution width QTL GWAS1663781 (human) | | 3e-14 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 79045259 | 79045260 | Human |
597312013 | GWAS1408087_H | Drugs used in diabetes use measurement QTL GWAS1408087 (human) | | 9e-49 | Drugs used in diabetes use measurement | | 10 | 92707530 | 92707531 | Human |
597156352 | GWAS1252426_H | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS1252426 (human) | | 4e-10 | omega-3 polyunsaturated fatty acid measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 93079885 | 93079886 | Human |
597238286 | GWAS1334360_H | type 2 diabetes mellitus QTL GWAS1334360 (human) | | 0.0000002 | type 2 diabetes mellitus | | 10 | 97296433 | 97296434 | Human |
597058062 | GWAS1154136_H | intelligence QTL GWAS1154136 (human) | | 6e-14 | intelligence | | 10 | 102274330 | 102274331 | Human |
597058063 | GWAS1154137_H | intelligence QTL GWAS1154137 (human) | | 8e-10 | intelligence | | 10 | 102312216 | 102312217 | Human |
597221893 | GWAS1317967_H | serum gamma-glutamyl transferase measurement QTL GWAS1317967 (human) | | 4e-17 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 77884301 | 77884302 | Human |
597262905 | GWAS1358979_H | amino acid measurement QTL GWAS1358979 (human) | | 0.0000003 | amino acid measurement | | 10 | 82673225 | 82673226 | Human |
597500478 | GWAS1596552_H | protein measurement QTL GWAS1596552 (human) | | 2e-55 | protein measurement | | 10 | 87661032 | 87661033 | Human |
597189181 | GWAS1285255_H | cholesterol in very large HDL measurement QTL GWAS1285255 (human) | | 7e-10 | total lipids in large HDL | | 10 | 93083778 | 93083779 | Human |
597434938 | GWAS1531012_H | colorectal cancer QTL GWAS1531012 (human) | | 2e-12 | colorectal cancer | | 10 | 79059375 | 79059376 | Human |
406968808 | GWAS617784_H | gout QTL GWAS617784 (human) | | 4e-08 | gout | | 10 | 87159562 | 87159563 | Human |
597451312 | GWAS1547386_H | anxiety disorder QTL GWAS1547386 (human) | | 8e-09 | anxiety disorder | | 10 | 102831636 | 102831637 | Human |
597320234 | GWAS1416308_H | X-21470 measurement QTL GWAS1416308 (human) | | 2e-19 | X-21470 measurement | | 10 | 99820390 | 99820391 | Human |
406968819 | GWAS617795_H | gout QTL GWAS617795 (human) | | 0.0000006 | gout | | 10 | 87159562 | 87159563 | Human |
597271083 | GWAS1367157_H | electrocardiography QTL GWAS1367157 (human) | | 3e-09 | electrocardiography | | 10 | 90946348 | 90946349 | Human |
597361192 | GWAS1457266_H | FEV/FVC ratio, response to bronchodilator QTL GWAS1457266 (human) | | 0.0000009 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 78637093 | 78637094 | Human |
597271085 | GWAS1367159_H | electrocardiography QTL GWAS1367159 (human) | | 3e-08 | electrocardiography | | 10 | 90946348 | 90946349 | Human |
597271084 | GWAS1367158_H | electrocardiography QTL GWAS1367158 (human) | | 1e-08 | electrocardiography | | 10 | 90946348 | 90946349 | Human |
597164591 | GWAS1260665_H | lipid measurement QTL GWAS1260665 (human) | | 0.000008 | lipid measurement | blood lipid measurement (CMO:0000050) | 10 | 79610769 | 79610770 | Human |
596976175 | GWAS1095694_H | body height QTL GWAS1095694 (human) | | 2e-12 | body height | | 10 | 79474750 | 79474751 | Human |
407124479 | GWAS773455_H | diabetic nephropathy QTL GWAS773455 (human) | | 0.0000006 | kidney integrity trait (VT:0010580) | | 10 | 95524324 | 95524325 | Human |
597279321 | GWAS1375395_H | N6-methyllysine measurement QTL GWAS1375395 (human) | | 8e-2182 | N6-methyllysine measurement | | 10 | 98388419 | 98388420 | Human |
597025364 | GWAS1121438_H | type 2 diabetes mellitus QTL GWAS1121438 (human) | | 2e-08 | type 2 diabetes mellitus | | 10 | 92703125 | 92703126 | Human |
597590623 | GWAS1647483_H | hypertension QTL GWAS1647483 (human) | | 2e-13 | hypertension | blood total cholesterol level (CMO:0000051) | 10 | 94278929 | 94278930 | Human |
596968022 | GWAS1087541_H | body mass index QTL GWAS1087541 (human) | | 1e-13 | body mass index | | 10 | 100866753 | 100866754 | Human |
406960520 | GWAS609496_H | autosomal dominant compelling helio-ophthalmic outburst syndrome QTL GWAS609496 (human) | | 2e-12 | autosomal dominant compelling helio-ophthalmic outburst syndrome | | 10 | 82962863 | 82962864 | Human |
407370126 | GWAS1019102_H | eosinophil percentage of leukocytes QTL GWAS1019102 (human) | | 2e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 10 | 87939452 | 87939453 | Human |
597312086 | GWAS1408160_H | vaginal microbiome measurement QTL GWAS1408160 (human) | | 0.000009 | vaginal microbiome measurement | | 10 | 89422096 | 89422097 | Human |
597312087 | GWAS1408161_H | vaginal microbiome measurement QTL GWAS1408161 (human) | | 0.000002 | vaginal microbiome measurement | | 10 | 89419538 | 89419539 | Human |
597271112 | GWAS1367186_H | large artery stroke QTL GWAS1367186 (human) | | 4e-15 | large artery stroke | | 10 | 89243170 | 89243171 | Human |
596951618 | GWAS1071137_H | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement QTL GWAS1071137 (human) | | 3e-28 | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | | 10 | 94279840 | 94279841 | Human |
597271105 | GWAS1367179_H | cardioembolic stroke QTL GWAS1367179 (human) | | 3e-12 | cardioembolic stroke | | 10 | 103565017 | 103565018 | Human |
597107277 | GWAS1203351_H | reticulocyte count QTL GWAS1203351 (human) | | 3e-147 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 103046897 | 103046898 | Human |
597107276 | GWAS1203350_H | reticulocyte count QTL GWAS1203350 (human) | | 2e-09 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 93589148 | 93589149 | Human |
597377600 | GWAS1473674_H | ulcerative colitis QTL GWAS1473674 (human) | | 0.000002 | ulcerative colitis | | 10 | 99530544 | 99530545 | Human |
597107275 | GWAS1203349_H | reticulocyte count QTL GWAS1203349 (human) | | 9e-22 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 79366624 | 79366625 | Human |
597582463 | GWAS1639323_H | neutrophil count QTL GWAS1639323 (human) | | 2e-11 | neutrophil quantity (VT:0000222) | blood neutrophil count to total leukocyte count ratio (CMO:0000370) | 10 | 89243047 | 89243048 | Human |
597140085 | GWAS1236159_H | interleukin-27 measurement QTL GWAS1236159 (human) | | 5e-18 | interleukin-27 measurement | | 10 | 100049236 | 100049237 | Human |
596968054 | GWAS1087573_H | body mass index QTL GWAS1087573 (human) | | 1e-17 | body mass index | | 10 | 100687890 | 100687891 | Human |
597320316 | GWAS1416390_H | executive function measurement QTL GWAS1416390 (human) | | 8e-15 | executive function measurement | | 10 | 100152307 | 100152308 | Human |
597123697 | GWAS1219771_H | self reported educational attainment QTL GWAS1219771 (human) | | 5e-11 | self reported educational attainment | | 10 | 103107106 | 103107107 | Human |
597516922 | GWAS1612996_H | free androgen index QTL GWAS1612996 (human) | | 2e-10 | free androgen index | | 10 | 79334368 | 79334369 | Human |
597230193 | GWAS1326267_H | Hypermetropia, Myopia QTL GWAS1326267 (human) | | 6e-08 | Hypermetropia, Myopia | | 10 | 88329768 | 88329769 | Human |
596976253 | GWAS1095772_H | Crohn's disease QTL GWAS1095772 (human) | | 0.000003 | Crohn's disease | | 10 | 92669710 | 92669711 | Human |
597394035 | GWAS1490109_H | triglyceride measurement, physical activity QTL GWAS1490109 (human) | | 1e-15 | triglyceride measurement, physical activity | blood triglyceride level (CMO:0000118) | 10 | 93079967 | 93079968 | Human |
596976252 | GWAS1095771_H | Crohn's disease QTL GWAS1095771 (human) | | 9e-12 | Crohn's disease | | 10 | 80511585 | 80511586 | Human |
597230192 | GWAS1326266_H | Hypermetropia, Myopia QTL GWAS1326266 (human) | | 0.000001 | Hypermetropia, Myopia | | 10 | 83439164 | 83439165 | Human |
597230194 | GWAS1326268_H | Hypermetropia, Myopia QTL GWAS1326268 (human) | | 0.000006 | Hypermetropia, Myopia | | 10 | 101064592 | 101064593 | Human |
596976251 | GWAS1095770_H | Crohn's disease QTL GWAS1095770 (human) | | 4e-33 | Crohn's disease | | 10 | 79286696 | 79286697 | Human |
597443180 | GWAS1539254_H | triglyceride:HDL cholesterol ratio QTL GWAS1539254 (human) | | 5e-15 | blood triglyceride amount (VT:0002644) | | 10 | 93549265 | 93549266 | Human |
597426796 | GWAS1522870_H | gout QTL GWAS1522870 (human) | | 3e-11 | gout | | 10 | 102940687 | 102940688 | Human |
597148261 | GWAS1244335_H | cervical artery dissection QTL GWAS1244335 (human) | | 5e-11 | cervical artery dissection | | 10 | 94263320 | 94263321 | Human |
597582445 | GWAS1639305_H | lymphoid leukemia QTL GWAS1639305 (human) | | 1e-19 | lymphoid leukemia | | 10 | 88991759 | 88991760 | Human |
597516910 | GWAS1612984_H | testosterone measurement QTL GWAS1612984 (human) | | 3e-08 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 93063586 | 93063587 | Human |
597328494 | GWAS1424568_H | hearing loss QTL GWAS1424568 (human) | | 0.0000004 | hearing loss | | 10 | 93028047 | 93028048 | Human |
597582440 | GWAS1639300_H | lymphoid leukemia QTL GWAS1639300 (human) | | 2e-17 | lymphoid leukemia | | 10 | 88991759 | 88991760 | Human |
597271139 | GWAS1367213_H | metabolite measurement QTL GWAS1367213 (human) | | 5e-13 | metabolite measurement | | 10 | 99835096 | 99835097 | Human |
597287522 | GWAS1383596_H | total lipids in large VLDL QTL GWAS1383596 (human) | | 8e-13 | total lipids in large VLDL | | 10 | 93083778 | 93083779 | Human |
596968040 | GWAS1087559_H | BMI-adjusted hip circumference QTL GWAS1087559 (human) | | 1e-08 | BMI-adjusted hip circumference | | 10 | 87834823 | 87834824 | Human |
597230183 | GWAS1326257_H | stroke, type 2 diabetes mellitus, coronary artery disease QTL GWAS1326257 (human) | | 2e-09 | stroke, type 2 diabetes mellitus, coronary artery disease | | 10 | 92722319 | 92722320 | Human |
597279335 | GWAS1375409_H | N2-acetyl,N6-methyllysine measurement QTL GWAS1375409 (human) | | 3e-844 | N2-acetyl,N6-methyllysine measurement | | 10 | 98386156 | 98386157 | Human |
597107093 | GWAS1203167_H | reticulocyte measurement QTL GWAS1203167 (human) | | 6e-156 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 10 | 103046897 | 103046898 | Human |
597107092 | GWAS1203166_H | reticulocyte measurement QTL GWAS1203166 (human) | | 1e-12 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 10 | 99515392 | 99515393 | Human |
597107091 | GWAS1203165_H | reticulocyte measurement QTL GWAS1203165 (human) | | 2e-20 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 10 | 79366624 | 79366625 | Human |
597336466 | GWAS1432540_H | atrial fibrillation QTL GWAS1432540 (human) | | 8e-10 | atrial fibrillation | | 10 | 79139212 | 79139213 | Human |
597123481 | GWAS1219555_H | blood protein measurement QTL GWAS1219555 (human) | | 5e-46 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 100045685 | 100045686 | Human |
597328264 | GWAS1424338_H | breast density QTL GWAS1424338 (human) | | 0.000009 | breast density | | 10 | 100511909 | 100511910 | Human |
597148032 | GWAS1244106_H | prostate carcinoma QTL GWAS1244106 (human) | | 3e-16 | prostate carcinoma | | 10 | 79076241 | 79076242 | Human |
597401984 | GWAS1498058_H | alkaline phosphatase measurement QTL GWAS1498058 (human) | | 6e-11 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 91884222 | 91884223 | Human |
597164420 | GWAS1260494_H | Calcium channel blocker use measurement QTL GWAS1260494 (human) | | 1e-17 | Calcium channel blocker use measurement | | 10 | 103151202 | 103151203 | Human |
597295492 | GWAS1391566_H | lymphocyte count QTL GWAS1391566 (human) | | 2e-10 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 79275156 | 79275157 | Human |
597410180 | GWAS1506254_H | BMI-adjusted waist-hip ratio QTL GWAS1506254 (human) | | 4e-10 | body size trait (VT:0100005) | | 10 | 79012834 | 79012835 | Human |
597295493 | GWAS1391567_H | lymphocyte count QTL GWAS1391567 (human) | | 4e-12 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 94348940 | 94348941 | Human |
597377412 | GWAS1473486_H | schizophrenia QTL GWAS1473486 (human) | | 6e-09 | schizophrenia | | 10 | 102882480 | 102882481 | Human |
597123510 | GWAS1219584_H | blood protein measurement QTL GWAS1219584 (human) | | 7e-19 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 87537750 | 87537751 | Human |
597361081 | GWAS1457155_H | mean arterial pressure QTL GWAS1457155 (human) | | 1e-11 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 102856906 | 102856907 | Human |
597361080 | GWAS1457154_H | diastolic blood pressure QTL GWAS1457154 (human) | | 8e-09 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 102856906 | 102856907 | Human |
597369279 | GWAS1465353_H | prostate carcinoma QTL GWAS1465353 (human) | | 5e-20 | prostate carcinoma | | 10 | 79067076 | 79067077 | Human |
597377470 | GWAS1473544_H | lymphocyte count QTL GWAS1473544 (human) | | 2e-09 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 94311804 | 94311805 | Human |
406895206 | GWAS544182_H | basophil percentage of granulocytes QTL GWAS544182 (human) | | 2e-09 | basophil quantity (VT:0002607) | | 10 | 97314229 | 97314234 | Human |
597066161 | GWAS1162235_H | type 2 diabetes mellitus QTL GWAS1162235 (human) | | 0.000005 | type 2 diabetes mellitus | | 10 | 79182128 | 79182129 | Human |
597598644 | GWAS1655504_H | HbA1c measurement QTL GWAS1655504 (human) | | 8e-21 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 10 | 79194494 | 79194495 | Human |
597598645 | GWAS1655505_H | HbA1c measurement QTL GWAS1655505 (human) | | 2e-41 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 10 | 92704188 | 92704189 | Human |
597344695 | GWAS1440769_H | glucose measurement QTL GWAS1440769 (human) | | 0.000001 | glucose measurement | blood glucose level (CMO:0000046) | 10 | 93629326 | 93629327 | Human |
597189032 | GWAS1285106_H | 16a-hydroxy DHEA 3-sulfate measurement QTL GWAS1285106 (human) | | 7e-13 | 16a-hydroxy DHEA 3-sulfate measurement | | 10 | 95091596 | 95091597 | Human |
597344681 | GWAS1440755_H | eosinophil measurement QTL GWAS1440755 (human) | | 2e-09 | eosinophil measurement | | 10 | 79093818 | 79093819 | Human |
596976035 | GWAS1095554_H | body height QTL GWAS1095554 (human) | | 3e-13 | body height | | 10 | 100557846 | 100557847 | Human |
597098913 | GWAS1194987_H | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder QTL GWAS1194987 (human) | | 1e-09 | major depressive disorder | | 10 | 103004514 | 103004515 | Human |
597139884 | GWAS1235958_H | HbA1c measurement QTL GWAS1235958 (human) | | 5e-16 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 10 | 92706682 | 92706683 | Human |
597189028 | GWAS1285102_H | andro steroid monosulfate C19H28O6S (1) measurement QTL GWAS1285102 (human) | | 6e-17 | andro steroid monosulfate C19H28O6S (1) measurement | | 10 | 95081791 | 95081792 | Human |
597582241 | GWAS1639101_H | systolic blood pressure QTL GWAS1639101 (human) | | 1e-10 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 103146454 | 103146455 | Human |
596951504 | GWAS1071023_H | response to selective serotonin reuptake inhibitor, major depressive disorder QTL GWAS1071023 (human) | | 4e-09 | response to selective serotonin reuptake inhibitor, major depressive disorder | | 10 | 94922089 | 94922090 | Human |
596951505 | GWAS1071024_H | response to selective serotonin reuptake inhibitor, major depressive disorder QTL GWAS1071024 (human) | | 2e-16 | response to selective serotonin reuptake inhibitor, major depressive disorder | | 10 | 94922089 | 94922090 | Human |
597418462 | GWAS1514536_H | self reported educational attainment QTL GWAS1514536 (human) | | 5e-08 | self reported educational attainment | | 10 | 103270400 | 103270401 | Human |
597418461 | GWAS1514535_H | self reported educational attainment QTL GWAS1514535 (human) | | 2e-08 | self reported educational attainment | | 10 | 103236552 | 103236553 | Human |
597418460 | GWAS1514534_H | self reported educational attainment QTL GWAS1514534 (human) | | 9e-13 | self reported educational attainment | | 10 | 103199730 | 103199731 | Human |
597254609 | GWAS1350683_H | apolipoprotein B measurement QTL GWAS1350683 (human) | | 3e-16 | apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 10 | 93082720 | 93082721 | Human |
407132685 | GWAS781661_H | schizophrenia QTL GWAS781661 (human) | | 2e-09 | pulse pressure measurement | | 10 | 103146454 | 103146455 | Human |
597172692 | GWAS1268766_H | redox-regulatory protein FAM213A measurement QTL GWAS1268766 (human) | | 4e-23 | redox-regulatory protein FAM213A measurement | | 10 | 80409842 | 80409843 | Human |
597221847 | GWAS1317921_H | COVID-19 QTL GWAS1317921 (human) | | 4e-08 | COVID-19 | | 10 | 78069803 | 78069804 | Human |
597361108 | GWAS1457182_H | forced expiratory volume, response to bronchodilator QTL GWAS1457182 (human) | | 0.000004 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 10 | 80527771 | 80527772 | Human |
597254614 | GWAS1350688_H | aspartate aminotransferase measurement QTL GWAS1350688 (human) | | 1e-13 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99370406 | 99370407 | Human |
597123526 | GWAS1219600_H | self reported educational attainment QTL GWAS1219600 (human) | | 2e-09 | self reported educational attainment | | 10 | 85362370 | 85362371 | Human |
597123525 | GWAS1219599_H | self reported educational attainment QTL GWAS1219599 (human) | | 2e-09 | self reported educational attainment | | 10 | 80462942 | 80462943 | Human |
597041600 | GWAS1137674_H | appendicular lean mass QTL GWAS1137674 (human) | | 2e-12 | appendicular lean mass | | 10 | 94588937 | 94588938 | Human |
597041601 | GWAS1137675_H | appendicular lean mass QTL GWAS1137675 (human) | | 3e-13 | appendicular lean mass | | 10 | 94732916 | 94732917 | Human |
597066190 | GWAS1162264_H | diastolic blood pressure QTL GWAS1162264 (human) | | 1e-09 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103086421 | 103086422 | Human |
597164483 | GWAS1260557_H | type 2 diabetes mellitus QTL GWAS1260557 (human) | | 1e-26 | type 2 diabetes mellitus | | 10 | 79183098 | 79183099 | Human |
597123532 | GWAS1219606_H | psoriasis, type 2 diabetes mellitus QTL GWAS1219606 (human) | | 2e-20 | psoriasis, type 2 diabetes mellitus | | 10 | 92706738 | 92706739 | Human |
597123531 | GWAS1219605_H | psoriasis, type 2 diabetes mellitus QTL GWAS1219605 (human) | | 3e-11 | psoriasis, type 2 diabetes mellitus | | 10 | 79283816 | 79283817 | Human |
597164484 | GWAS1260558_H | type 2 diabetes mellitus QTL GWAS1260558 (human) | | 3e-14 | type 2 diabetes mellitus | | 10 | 87857400 | 87857401 | Human |
597139915 | GWAS1235989_H | tumor necrosis factor receptor superfamily member 6 measurement QTL GWAS1235989 (human) | | 4e-15 | tumor necrosis factor receptor superfamily member 6 measurement | | 10 | 89006456 | 89006457 | Human |
597164485 | GWAS1260559_H | type 2 diabetes mellitus QTL GWAS1260559 (human) | | 2e-65 | type 2 diabetes mellitus | | 10 | 92704205 | 92704206 | Human |
597164486 | GWAS1260560_H | type 2 diabetes mellitus QTL GWAS1260560 (human) | | 3e-11 | type 2 diabetes mellitus | | 10 | 97324003 | 97324004 | Human |
596951498 | GWAS1071017_H | high density lipoprotein cholesterol measurement QTL GWAS1071017 (human) | | 7e-11 | high density lipoprotein cholesterol measurement | | 10 | 100152437 | 100152438 | Human |
597336571 | GWAS1432645_H | S-warfarin to R-warfarin ratio measurement QTL GWAS1432645 (human) | | 2e-17 | S-warfarin to R-warfarin ratio measurement | | 10 | 94808278 | 94808279 | Human |
597033463 | GWAS1129537_H | lean body mass QTL GWAS1129537 (human) | | 1e-12 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 100914591 | 100914592 | Human |
597205498 | GWAS1301572_H | handedness QTL GWAS1301572 (human) | | 2e-08 | handedness | | 10 | 87962974 | 87962975 | Human |
597590524 | GWAS1647384_H | diabetic retinopathy QTL GWAS1647384 (human) | | 2e-32 | diabetic retinopathy | | 10 | 92711838 | 92711839 | Human |
597148149 | GWAS1244223_H | migraine disorder QTL GWAS1244223 (human) | | 1e-14 | migraine disorder | | 10 | 94263320 | 94263321 | Human |
597393913 | GWAS1489987_H | appendicular lean mass QTL GWAS1489987 (human) | | 9e-12 | appendicular lean mass | | 10 | 94264600 | 94264601 | Human |
597336569 | GWAS1432643_H | S-warfarin to R-warfarin ratio measurement QTL GWAS1432643 (human) | | 0.0000004 | S-warfarin to R-warfarin ratio measurement | | 10 | 95237722 | 95237723 | Human |
597590523 | GWAS1647383_H | diabetic retinopathy QTL GWAS1647383 (human) | | 7e-14 | diabetic retinopathy | | 10 | 79190117 | 79190118 | Human |
597377534 | GWAS1473608_H | cotinine measurement QTL GWAS1473608 (human) | | 0.000002 | cotinine measurement | | 10 | 100865580 | 100865581 | Human |
597336572 | GWAS1432646_H | S-warfarin to R-warfarin ratio measurement QTL GWAS1432646 (human) | | 5e-10 | S-warfarin to R-warfarin ratio measurement | | 10 | 94773070 | 94773071 | Human |
406919719 | GWAS568695_H | vaccenic acid measurement QTL GWAS568695 (human) | | 2e-16 | fatty acid amount (VT:0010046) | diastolic blood pressure (CMO:0000005) | 10 | 100315722 | 100315723 | Human |
597041663 | GWAS1137737_H | interleukin 27 receptor subunit alpha measurement QTL GWAS1137737 (human) | | 3e-13 | interleukin 27 receptor subunit alpha measurement | | 10 | 100045685 | 100045686 | Human |
406919720 | GWAS568696_H | palmitoleic acid measurement QTL GWAS568696 (human) | | 4e-15 | fatty acid amount (VT:0010046) | blood lymphocyte count (CMO:0000031) | 10 | 100315722 | 100315723 | Human |
597524980 | GWAS1621054_H | body mass index QTL GWAS1621054 (human) | | 4e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 103462691 | 103462692 | Human |
597508593 | GWAS1604667_H | type 2 diabetes mellitus QTL GWAS1604667 (human) | | 0.000003 | type 2 diabetes mellitus | | 10 | 88006611 | 88006612 | Human |
597615090 | GWAS1671950_H | Red cell distribution width QTL GWAS1671950 (human) | | 6e-12 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 99479225 | 99479226 | Human |
597524977 | GWAS1621051_H | body mass index QTL GWAS1621051 (human) | | 2e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 101299234 | 101299235 | Human |
597377526 | GWAS1473600_H | autoimmune thyroid disease QTL GWAS1473600 (human) | | 8e-12 | autoimmune thyroid disease | | 10 | 99523573 | 99523574 | Human |
597524976 | GWAS1621050_H | body mass index QTL GWAS1621050 (human) | | 1e-14 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100875718 | 100875719 | Human |
597524979 | GWAS1621053_H | body mass index QTL GWAS1621053 (human) | | 6e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102837723 | 102837724 | Human |
597524978 | GWAS1621052_H | body mass index QTL GWAS1621052 (human) | | 1e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102660453 | 102660454 | Human |
406919731 | GWAS568707_H | vaccenic acid measurement QTL GWAS568707 (human) | | 6e-17 | fatty acid amount (VT:0010046) | | 10 | 100315722 | 100315723 | Human |
597025249 | GWAS1121323_H | Cleft palate QTL GWAS1121323 (human) | | 0.0000004 | Cleft palate | | 10 | 96354046 | 96354047 | Human |
597311968 | GWAS1408042_H | vaginal microbiome measurement QTL GWAS1408042 (human) | | 0.000006 | vaginal microbiome measurement | | 10 | 97069912 | 97069913 | Human |
597393895 | GWAS1489969_H | appendicular lean mass QTL GWAS1489969 (human) | | 1e-08 | appendicular lean mass | | 10 | 94385106 | 94385107 | Human |
597229849 | GWAS1325923_H | heel bone mineral density QTL GWAS1325923 (human) | | 7e-31 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 100315722 | 100315723 | Human |
597229848 | GWAS1325922_H | heel bone mineral density QTL GWAS1325922 (human) | | 4e-16 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 87709196 | 87709197 | Human |
597229850 | GWAS1325924_H | heel bone mineral density QTL GWAS1325924 (human) | | 6e-13 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 101983376 | 101983377 | Human |
597156113 | GWAS1252187_H | sarcoidosis QTL GWAS1252187 (human) | | 0.000009 | sarcoidosis | | 10 | 95533120 | 95533121 | Human |
597066014 | GWAS1162088_H | BMI-adjusted waist circumference QTL GWAS1162088 (human) | | 0.000002 | body size trait (VT:0100005) | | 10 | 79147390 | 79147391 | Human |
597451024 | GWAS1547098_H | electrocardiography QTL GWAS1547098 (human) | | 4e-15 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597606674 | GWAS1663534_H | erythrocyte count QTL GWAS1663534 (human) | | 4e-16 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 101578251 | 101578252 | Human |
597164310 | GWAS1260384_H | cleft lip QTL GWAS1260384 (human) | | 0.0000002 | cleft lip | | 10 | 95726073 | 95726074 | Human |
597401876 | GWAS1497950_H | protein measurement QTL GWAS1497950 (human) | | 2e-08 | protein measurement | | 10 | 89451015 | 89451016 | Human |
597319957 | GWAS1416031_H | 5alpha-pregnan-diol disulfate measurement QTL GWAS1416031 (human) | | 4e-26 | 5alpha-pregnan-diol disulfate measurement | | 10 | 99820390 | 99820391 | Human |
596975898 | GWAS1095417_H | cardioembolic stroke QTL GWAS1095417 (human) | | 0.0000006 | cardioembolic stroke | | 10 | 103547967 | 103547968 | Human |
597451022 | GWAS1547096_H | electrocardiography QTL GWAS1547096 (human) | | 1e-15 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597451023 | GWAS1547097_H | electrocardiography QTL GWAS1547097 (human) | | 2e-15 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597377295 | GWAS1473369_H | type 2 diabetes mellitus QTL GWAS1473369 (human) | | 0.000007 | type 2 diabetes mellitus | | 10 | 92588073 | 92588074 | Human |
597582084 | GWAS1638944_H | systolic blood pressure QTL GWAS1638944 (human) | | 1e-23 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103146454 | 103146455 | Human |
597582083 | GWAS1638943_H | systolic blood pressure QTL GWAS1638943 (human) | | 4e-14 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94266818 | 94266819 | Human |
597025035 | GWAS1121109_H | acute myeloid leukemia QTL GWAS1121109 (human) | | 0.0000001 | leukocyte integrity trait (VT:0010898) | | 10 | 98529811 | 98529812 | Human |
597369092 | GWAS1465166_H | parental longevity QTL GWAS1465166 (human) | | 0.000006 | total life span (VT:0001661) | | 10 | 96621434 | 96621435 | Human |
597098805 | GWAS1194879_H | protein measurement QTL GWAS1194879 (human) | | 2e-08 | protein measurement | | 10 | 100742278 | 100742279 | Human |
597074226 | GWAS1170300_H | intelligence, self reported educational attainment QTL GWAS1170300 (human) | | 3e-09 | intelligence, self reported educational attainment | | 10 | 102057071 | 102057072 | Human |
406993637 | GWAS642613_H | intelligence QTL GWAS642613 (human) | | 0.000008 | intelligence | | 10 | 101382346 | 101382347 | Human |
597025085 | GWAS1121159_H | acute myeloid leukemia QTL GWAS1121159 (human) | | 5e-09 | leukocyte integrity trait (VT:0010898) | | 10 | 98417112 | 98417113 | Human |
597336371 | GWAS1432445_H | COVID-19 QTL GWAS1432445 (human) | | 0.000003 | COVID-19 | | 10 | 77822493 | 77822494 | Human |
597025084 | GWAS1121158_H | acute myeloid leukemia QTL GWAS1121158 (human) | | 4e-24 | leukocyte integrity trait (VT:0010898) | | 10 | 98417112 | 98417113 | Human |
597270835 | GWAS1366909_H | type 2 diabetes mellitus QTL GWAS1366909 (human) | | 8e-27 | type 2 diabetes mellitus | | 10 | 79184084 | 79184085 | Human |
597188914 | GWAS1284988_H | cigarettes per day measurement QTL GWAS1284988 (human) | | 4e-14 | cigarettes per day measurement | | 10 | 92202367 | 92202368 | Human |
597213490 | GWAS1309564_H | protein measurement QTL GWAS1309564 (human) | | 2e-08 | protein measurement | | 10 | 103073291 | 103073292 | Human |
597025086 | GWAS1121160_H | acute myeloid leukemia QTL GWAS1121160 (human) | | 1e-12 | leukocyte integrity trait (VT:0010898) | | 10 | 98529811 | 98529812 | Human |
597467447 | GWAS1563521_H | Crohn's disease QTL GWAS1563521 (human) | | 2e-24 | intestine integrity trait (VT:0010554) | | 10 | 99524480 | 99524481 | Human |
597270837 | GWAS1366911_H | type 2 diabetes mellitus QTL GWAS1366911 (human) | | 0.000001 | type 2 diabetes mellitus | | 10 | 97296433 | 97296434 | Human |
597246261 | GWAS1342335_H | serum alanine aminotransferase measurement QTL GWAS1342335 (human) | | 2e-161 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100152307 | 100152308 | Human |
597270836 | GWAS1366910_H | type 2 diabetes mellitus QTL GWAS1366910 (human) | | 5e-08 | type 2 diabetes mellitus | | 10 | 92700893 | 92700894 | Human |
597025082 | GWAS1121156_H | acute myeloid leukemia QTL GWAS1121156 (human) | | 2e-18 | leukocyte integrity trait (VT:0010898) | | 10 | 95456597 | 95456598 | Human |
597131559 | GWAS1227633_H | systolic blood pressure QTL GWAS1227633 (human) | | 0.0000001 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 95502784 | 95502785 | Human |
597131558 | GWAS1227632_H | systolic blood pressure QTL GWAS1227632 (human) | | 5e-50 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94279840 | 94279841 | Human |
597246248 | GWAS1342322_H | sex hormone-binding globulin measurement QTL GWAS1342322 (human) | | 8e-10 | sex hormone-binding globulin measurement | | 10 | 96102823 | 96102824 | Human |
597467438 | GWAS1563512_H | interleukin 13 measurement QTL GWAS1563512 (human) | | 0.000006 | blood interleukin-13 amount (VT:0008607) | | 10 | 78928178 | 78928179 | Human |
597074212 | GWAS1170286_H | type 2 diabetes mellitus QTL GWAS1170286 (human) | | 3e-26 | type 2 diabetes mellitus | | 10 | 92703125 | 92703126 | Human |
597131557 | GWAS1227631_H | systolic blood pressure QTL GWAS1227631 (human) | | 8e-45 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94136183 | 94136184 | Human |
597115173 | GWAS1211247_H | intraocular pressure measurement QTL GWAS1211247 (human) | | 8e-09 | intraocular pressure measurement | | 10 | 101064592 | 101064593 | Human |
597295400 | GWAS1391474_H | mean arterial pressure QTL GWAS1391474 (human) | | 5e-34 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 103186066 | 103186067 | Human |
597131556 | GWAS1227630_H | systolic blood pressure QTL GWAS1227630 (human) | | 4e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 92708928 | 92708929 | Human |
597516590 | GWAS1612664_H | testosterone measurement QTL GWAS1612664 (human) | | 3e-11 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 102838849 | 102838850 | Human |
597131555 | GWAS1227629_H | systolic blood pressure QTL GWAS1227629 (human) | | 4e-13 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 87921931 | 87921932 | Human |
597131554 | GWAS1227628_H | systolic blood pressure QTL GWAS1227628 (human) | | 2e-15 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 80455532 | 80455533 | Human |
596967712 | GWAS1087231_H | non-high density lipoprotein cholesterol measurement QTL GWAS1087231 (human) | | 4e-10 | non-high density lipoprotein cholesterol measurement | | 10 | 94278929 | 94278930 | Human |
597131563 | GWAS1227637_H | systolic blood pressure QTL GWAS1227637 (human) | | 5e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 101943006 | 101943007 | Human |
597229860 | GWAS1325934_H | heel bone mineral density QTL GWAS1325934 (human) | | 3e-16 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 87717352 | 87717353 | Human |
406911741 | GWAS560717_H | multiple sclerosis QTL GWAS560717 (human) | | 5e-09 | body height at birth | body height (CMO:0000106) | 10 | 92722160 | 92722161 | Human |
597131562 | GWAS1227636_H | systolic blood pressure QTL GWAS1227636 (human) | | 6e-38 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 100792906 | 100792907 | Human |
597295399 | GWAS1391473_H | mean arterial pressure QTL GWAS1391473 (human) | | 1e-13 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 100857962 | 100857963 | Human |
597131561 | GWAS1227635_H | systolic blood pressure QTL GWAS1227635 (human) | | 1e-10 | lysophosphatidylcholine 17:1 measurement | blood hemoglobin A1c level (CMO:0002786) | 10 | 100315722 | 100315723 | Human |
597131560 | GWAS1227634_H | systolic blood pressure QTL GWAS1227634 (human) | | 7e-10 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 95560648 | 95560649 | Human |
597582174 | GWAS1639034_H | systolic blood pressure QTL GWAS1639034 (human) | | 9e-22 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94266818 | 94266819 | Human |
597582175 | GWAS1639035_H | systolic blood pressure QTL GWAS1639035 (human) | | 7e-33 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103146454 | 103146455 | Human |
597598554 | GWAS1655414_H | HbA1c measurement QTL GWAS1655414 (human) | | 6e-38 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 10 | 92704188 | 92704189 | Human |
597180766 | GWAS1276840_H | monounsaturated fatty acids; 16:1, 18:1 measurement QTL GWAS1276840 (human) | | 7e-10 | monounsaturated fatty acids; 16:1, 18:1 measurement | | 10 | 100492258 | 100492259 | Human |
597598553 | GWAS1655413_H | HbA1c measurement QTL GWAS1655413 (human) | | 7e-18 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 10 | 79194494 | 79194495 | Human |
597172560 | GWAS1268634_H | body mass index QTL GWAS1268634 (human) | | 1e-15 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 101446358 | 101446359 | Human |
597172561 | GWAS1268635_H | body mass index QTL GWAS1268635 (human) | | 7e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102207159 | 102207160 | Human |
407132814 | GWAS781790_H | platelet count QTL GWAS781790 (human) | | 3e-10 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 79404390 | 79404391 | Human |
597172562 | GWAS1268636_H | body mass index QTL GWAS1268636 (human) | | 3e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102940000 | 102940006 | Human |
597172563 | GWAS1268637_H | body mass index QTL GWAS1268637 (human) | | 2e-44 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102959339 | 102959340 | Human |
597500241 | GWAS1596315_H | systolic blood pressure QTL GWAS1596315 (human) | | 6e-17 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94311804 | 94311805 | Human |
597172564 | GWAS1268638_H | body mass index QTL GWAS1268638 (human) | | 5e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102961968 | 102961969 | Human |
597500240 | GWAS1596314_H | systolic blood pressure QTL GWAS1596314 (human) | | 0.0000002 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 92669710 | 92669711 | Human |
597172565 | GWAS1268639_H | body mass index QTL GWAS1268639 (human) | | 6e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 103011273 | 103011274 | Human |
597172566 | GWAS1268640_H | body mass index QTL GWAS1268640 (human) | | 1e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 103192742 | 103192743 | Human |
597500242 | GWAS1596316_H | systolic blood pressure QTL GWAS1596316 (human) | | 2e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 101353278 | 101353279 | Human |
597172552 | GWAS1268626_H | body mass index QTL GWAS1268626 (human) | | 7e-27 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100635683 | 100635684 | Human |
597295435 | GWAS1391509_H | hematocrit QTL GWAS1391509 (human) | | 6e-11 | hematocrit | hematocrit (CMO:0000037) | 10 | 87142045 | 87142046 | Human |
597172553 | GWAS1268627_H | body mass index QTL GWAS1268627 (human) | | 5e-14 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100652186 | 100652187 | Human |
597500239 | GWAS1596313_H | systolic blood pressure QTL GWAS1596313 (human) | | 6e-10 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 87844975 | 87844976 | Human |
597172554 | GWAS1268628_H | body mass index QTL GWAS1268628 (human) | | 3e-26 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100687890 | 100687891 | Human |
597295433 | GWAS1391507_H | hematocrit QTL GWAS1391507 (human) | | 7e-12 | hematocrit | hematocrit (CMO:0000037) | 10 | 80404334 | 80404335 | Human |
597287242 | GWAS1383316_H | progression free survival, response to tyrosine kinase inhibitor QTL GWAS1383316 (human) | | 0.0000001 | progression free survival, response to tyrosine kinase inhibitor | survival measurement (CMO:0001021) | 10 | 96724017 | 96724018 | Human |
597295438 | GWAS1391512_H | hematocrit QTL GWAS1391512 (human) | | 5e-09 | hematocrit | hematocrit (CMO:0000037) | 10 | 95500358 | 95500359 | Human |
597172556 | GWAS1268630_H | body mass index QTL GWAS1268630 (human) | | 9e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100715410 | 100715411 | Human |
597172557 | GWAS1268631_H | body mass index QTL GWAS1268631 (human) | | 4e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100811803 | 100811804 | Human |
597295436 | GWAS1391510_H | hematocrit QTL GWAS1391510 (human) | | 1e-09 | hematocrit | hematocrit (CMO:0000037) | 10 | 88533767 | 88533768 | Human |
597172558 | GWAS1268632_H | body mass index QTL GWAS1268632 (human) | | 6e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100860798 | 100860799 | Human |
597467460 | GWAS1563534_H | inflammatory bowel disease QTL GWAS1563534 (human) | | 2e-34 | inflammatory bowel disease | | 10 | 99524480 | 99524481 | Human |
597164352 | GWAS1260426_H | Antithrombotic agent use measurement QTL GWAS1260426 (human) | | 6e-12 | Antithrombotic agent use measurement | | 10 | 103574950 | 103574951 | Human |
597057868 | GWAS1153942_H | type 2 diabetes mellitus QTL GWAS1153942 (human) | | 6e-15 | type 2 diabetes mellitus | | 10 | 79193069 | 79193070 | Human |
597057869 | GWAS1153943_H | type 2 diabetes mellitus QTL GWAS1153943 (human) | | 5e-27 | type 2 diabetes mellitus | | 10 | 92707530 | 92707531 | Human |
597287237 | GWAS1383311_H | Crohn's disease QTL GWAS1383311 (human) | | 4e-33 | intestine integrity trait (VT:0010554) | | 10 | 79286696 | 79286697 | Human |
407067295 | GWAS716271_H | BMI-adjusted waist-hip ratio QTL GWAS716271 (human) | | 1e-12 | BMI-adjusted waist-hip ratio | | 10 | 87843667 | 87843668 | Human |
597074251 | GWAS1170325_H | disease progression measurement QTL GWAS1170325 (human) | | 0.000003 | disease progression measurement | disease progression measurement (CMO:0001110) | 10 | 84651798 | 84651799 | Human |
597139786 | GWAS1235860_H | glutamine measurement QTL GWAS1235860 (human) | | 2e-13 | glutamine measurement | blood amino acid measurement (CMO:0003730) | 10 | 97597874 | 97597875 | Human |
597287238 | GWAS1383312_H | Crohn's disease QTL GWAS1383312 (human) | | 9e-12 | intestine integrity trait (VT:0010554) | | 10 | 80511585 | 80511586 | Human |
597320005 | GWAS1416079_H | diastolic blood pressure, systolic blood pressure QTL GWAS1416079 (human) | | 3e-15 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 98254058 | 98254059 | Human |
597172551 | GWAS1268625_H | body mass index QTL GWAS1268625 (human) | | 5e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98275126 | 98275127 | Human |
597057910 | GWAS1153984_H | adolescent idiopathic scoliosis QTL GWAS1153984 (human) | | 6e-08 | adolescent idiopathic scoliosis | | 10 | 83807087 | 83807088 | Human |
597057906 | GWAS1153980_H | adolescent idiopathic scoliosis QTL GWAS1153980 (human) | | 3e-08 | adolescent idiopathic scoliosis | | 10 | 85687295 | 85687296 | Human |
597238140 | GWAS1334214_H | Orofacial cleft QTL GWAS1334214 (human) | | 0.0000008 | Orofacial cleft | | 10 | 102523753 | 102523754 | Human |
407083689 | GWAS732665_H | systolic blood pressure QTL GWAS732665 (human) | | 1e-08 | systolic blood pressure | | 10 | 87844975 | 87844976 | Human |
597475702 | GWAS1571776_H | cognitive function measurement, self reported educational attainment QTL GWAS1571776 (human) | | 7e-15 | cognitive behavior trait (VT:0010450) | | 10 | 102230055 | 102230056 | Human |
597107067 | GWAS1203141_H | pallidum volume change measurement, age at assessment QTL GWAS1203141 (human) | | 0.000005 | pallidum volume change measurement, age at assessment | | 10 | 97083068 | 97083069 | Human |
597057912 | GWAS1153986_H | adolescent idiopathic scoliosis QTL GWAS1153986 (human) | | 8e-08 | adolescent idiopathic scoliosis | | 10 | 99420879 | 99420880 | Human |
407124651 | GWAS773627_H | mortality QTL GWAS773627 (human) | | 0.000007 | mortality | ratio of deaths to total study population during a period of time (CMO:0001023) | 10 | 77684995 | 77684996 | Human |
596951419 | GWAS1070938_H | sex hormone-binding globulin measurement QTL GWAS1070938 (human) | | 1e-08 | sex hormone-binding globulin measurement | | 10 | 94253193 | 94253194 | Human |
597410158 | GWAS1506232_H | BMI-adjusted waist-hip ratio QTL GWAS1506232 (human) | | 9e-10 | body size trait (VT:0100005) | | 10 | 93549066 | 93549067 | Human |
407001783 | GWAS650759_H | schizophrenia QTL GWAS650759 (human) | | 3e-09 | schizophrenia | | 10 | 102696929 | 102696930 | Human |
597410156 | GWAS1506230_H | BMI-adjusted waist-hip ratio QTL GWAS1506230 (human) | | 1e-09 | body size trait (VT:0100005) | | 10 | 102643553 | 102643554 | Human |
597270883 | GWAS1366957_H | pulse pressure measurement QTL GWAS1366957 (human) | | 6e-21 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 94140247 | 94140248 | Human |
597279076 | GWAS1375150_H | sex hormone-binding globulin measurement QTL GWAS1375150 (human) | | 7e-09 | sex hormone-binding globulin measurement | | 10 | 79314006 | 79314007 | Human |
597066088 | GWAS1162162_H | breast carcinoma QTL GWAS1162162 (human) | | 0.000003 | mammary gland integrity trait (VT:0010552) | | 10 | 102125800 | 102125801 | Human |
597188967 | GWAS1285041_H | forced expiratory volume QTL GWAS1285041 (human) | | 6e-15 | forced expiratory volume | forced expiratory volume (CMO:0000254) | 10 | 91284101 | 91284102 | Human |
596951403 | GWAS1070922_H | smoking status measurement, diastolic blood pressure QTL GWAS1070922 (human) | | 1e-17 | smoking status measurement, diastolic blood pressure | | 10 | 103086421 | 103086422 | Human |
597582177 | GWAS1639037_H | systolic blood pressure QTL GWAS1639037 (human) | | 4e-13 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103195021 | 103195022 | Human |
597475484 | GWAS1571558_H | smoking initiation QTL GWAS1571558 (human) | | 4e-11 | smoking initiation | | 10 | 102198894 | 102198895 | Human |
597213336 | GWAS1309410_H | schizophrenia QTL GWAS1309410 (human) | | 1e-17 | schizophrenia | | 10 | 102869116 | 102869117 | Human |
597475485 | GWAS1571559_H | smoking initiation QTL GWAS1571559 (human) | | 1e-16 | smoking initiation | | 10 | 102852007 | 102852008 | Human |
406969154 | GWAS618130_H | appendicular lean mass QTL GWAS618130 (human) | | 1e-34 | appendicular lean mass | | 10 | 94278929 | 94278930 | Human |
597360799 | GWAS1456873_H | monocyte percentage of leukocytes QTL GWAS1456873 (human) | | 2e-25 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 10 | 99532633 | 99532634 | Human |
597131410 | GWAS1227484_H | childhood gender nonconformity QTL GWAS1227484 (human) | | 2e-08 | childhood gender nonconformity | | 10 | 86378408 | 86378409 | Human |
597213342 | GWAS1309416_H | triglyceride measurement QTL GWAS1309416 (human) | | 3e-28 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079885 | 93079886 | Human |
597115039 | GWAS1211113_H | DNA methylation QTL GWAS1211113 (human) | | 2e-08 | DNA methylation | | 10 | 95809031 | 95809032 | Human |
597450900 | GWAS1546974_H | BMI-adjusted waist circumference QTL GWAS1546974 (human) | | 9e-09 | body size trait (VT:0100005) | | 10 | 96065211 | 96065212 | Human |
597581974 | GWAS1638834_H | pulse pressure measurement QTL GWAS1638834 (human) | | 2e-09 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 103146454 | 103146455 | Human |
407124808 | GWAS773784_H | childhood onset asthma QTL GWAS773784 (human) | | 5e-08 | childhood onset asthma | | 10 | 99095945 | 99095946 | Human |
597401750 | GWAS1497824_H | magnesium measurement QTL GWAS1497824 (human) | | 0.0000004 | magnesium measurement | serum magnesium level (CMO:0000541) | 10 | 87655391 | 87655392 | Human |
597459091 | GWAS1555165_H | C-reactive protein measurement QTL GWAS1555165 (human) | | 4e-13 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 79059375 | 79059376 | Human |
597598353 | GWAS1655213_H | high density lipoprotein cholesterol measurement QTL GWAS1655213 (human) | | 2e-27 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 100152307 | 100152308 | Human |
597049478 | GWAS1145552_H | breast carcinoma QTL GWAS1145552 (human) | | 3e-38 | mammary gland integrity trait (VT:0010552) | | 10 | 79081391 | 79081392 | Human |
597155973 | GWAS1252047_H | sex hormone-binding globulin measurement QTL GWAS1252047 (human) | | 0.0000001 | sex hormone-binding globulin measurement | | 10 | 100164661 | 100164662 | Human |
597115012 | GWAS1211086_H | cognitive function measurement QTL GWAS1211086 (human) | | 6e-16 | cognitive behavior trait (VT:0010450) | | 10 | 102322931 | 102322932 | Human |
597115011 | GWAS1211085_H | cognitive function measurement QTL GWAS1211085 (human) | | 2e-28 | cognitive behavior trait (VT:0010450) | | 10 | 102042651 | 102042652 | Human |
597115010 | GWAS1211084_H | cognitive function measurement QTL GWAS1211084 (human) | | 1e-10 | cognitive behavior trait (VT:0010450) | | 10 | 100164661 | 100164662 | Human |
597590152 | GWAS1647012_H | insulin measurement QTL GWAS1647012 (human) | | 1e-11 | insulin measurement | pancreatic islet insulin release measurement (CMO:0001216) | 10 | 92709177 | 92709178 | Human |
597401729 | GWAS1497803_H | type 2 diabetes mellitus QTL GWAS1497803 (human) | | 6e-20 | type 2 diabetes mellitus | | 10 | 92713872 | 92713873 | Human |
597270661 | GWAS1366735_H | low density lipoprotein cholesterol measurement QTL GWAS1366735 (human) | | 1e-34 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 93079885 | 93079886 | Human |
597155979 | GWAS1252053_H | sex hormone-binding globulin measurement QTL GWAS1252053 (human) | | 0.0000008 | sex hormone-binding globulin measurement | | 10 | 96097142 | 96097143 | Human |
597270660 | GWAS1366734_H | low density lipoprotein cholesterol measurement QTL GWAS1366734 (human) | | 8e-09 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 89243047 | 89243048 | Human |
597270663 | GWAS1366737_H | low density lipoprotein cholesterol measurement QTL GWAS1366737 (human) | | 1e-15 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 100315722 | 100315723 | Human |
597270662 | GWAS1366736_H | low density lipoprotein cholesterol measurement QTL GWAS1366736 (human) | | 1e-09 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 94273109 | 94273110 | Human |
597057718 | GWAS1153792_H | basophil count QTL GWAS1153792 (human) | | 2e-12 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 99512032 | 99512033 | Human |
597278910 | GWAS1374984_H | X-11445--5-alpha-pregnan-3beta,20alpha-disulfate measurement QTL GWAS1374984 (human) | | 6e-11 | X-11445--5-alpha-pregnan-3beta,20alpha-disulfate measurement | | 10 | 102877098 | 102877099 | Human |
597180586 | GWAS1276660_H | protein FAM163B measurement QTL GWAS1276660 (human) | | 2e-30 | protein FAM163B measurement | | 10 | 100043668 | 100043669 | Human |
406977399 | GWAS626375_H | forced expiratory volume, response to bronchodilator QTL GWAS626375 (human) | | 0.000004 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 10 | 80494228 | 80494229 | Human |
597295276 | GWAS1391350_H | lymphocyte count QTL GWAS1391350 (human) | | 2e-08 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 102401718 | 102401719 | Human |
597508261 | GWAS1604335_H | eosinophil count QTL GWAS1604335 (human) | | 4e-15 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 87972113 | 87972114 | Human |
597385378 | GWAS1481452_H | monocyte percentage of leukocytes QTL GWAS1481452 (human) | | 3e-61 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 10 | 99532633 | 99532634 | Human |
597385377 | GWAS1481451_H | monocyte percentage of leukocytes QTL GWAS1481451 (human) | | 9e-11 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 10 | 99492628 | 99492629 | Human |
597590179 | GWAS1647039_H | open-angle glaucoma QTL GWAS1647039 (human) | | 3e-25 | open-angle glaucoma | | 10 | 94263320 | 94263321 | Human |
597401765 | GWAS1497839_H | Moderate albuminuria QTL GWAS1497839 (human) | | 0.000006 | Moderate albuminuria | | 10 | 102876898 | 102876899 | Human |
597057750 | GWAS1153824_H | insulin measurement QTL GWAS1153824 (human) | | 2e-14 | insulin measurement | pancreatic islet insulin release measurement (CMO:0001216) | 10 | 92603171 | 92603172 | Human |
597049558 | GWAS1145632_H | hypertension QTL GWAS1145632 (human) | | 1e-17 | hypertension | | 10 | 102959339 | 102959340 | Human |
596967639 | GWAS1087158_H | body mass index QTL GWAS1087158 (human) | | 1e-11 | body mass index | | 10 | 85731093 | 85731094 | Human |
597049557 | GWAS1145631_H | hypertension QTL GWAS1145631 (human) | | 5e-14 | hypertension | | 10 | 94279840 | 94279841 | Human |
597164252 | GWAS1260326_H | Beta blocking agent use measurement QTL GWAS1260326 (human) | | 2e-12 | Beta blocking agent use measurement | | 10 | 102947259 | 102947260 | Human |
597303519 | GWAS1399593_H | grip strength measurement QTL GWAS1399593 (human) | | 9e-08 | grip strength measurement | | 10 | 85774936 | 85774937 | Human |
596951251 | GWAS1070770_H | cataract QTL GWAS1070770 (human) | | 6e-24 | cataract | | 10 | 94279840 | 94279841 | Human |
597303507 | GWAS1399581_H | grip strength measurement QTL GWAS1399581 (human) | | 9e-09 | grip strength measurement | | 10 | 85774936 | 85774937 | Human |
406903561 | GWAS552537_H | diastolic blood pressure QTL GWAS552537 (human) | | 0.0000001 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94136183 | 94136184 | Human |
597336272 | GWAS1432346_H | dyslexia QTL GWAS1432346 (human) | | 4e-09 | dyslexia | | 10 | 103304140 | 103304141 | Human |
597074141 | GWAS1170215_H | coronary artery disease QTL GWAS1170215 (human) | | 2e-24 | coronary artery disease | | 10 | 89245129 | 89245130 | Human |
596951263 | GWAS1070782_H | sex hormone-binding globulin measurement QTL GWAS1070782 (human) | | 8e-11 | sex hormone-binding globulin measurement | | 10 | 100164661 | 100164662 | Human |
597467344 | GWAS1563418_H | systolic blood pressure QTL GWAS1563418 (human) | | 1e-16 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103199143 | 103199144 | Human |
597074139 | GWAS1170213_H | coronary artery disease QTL GWAS1170213 (human) | | 2e-10 | coronary artery disease | | 10 | 80517585 | 80517586 | Human |
597311701 | GWAS1407775_H | vaginal microbiome measurement QTL GWAS1407775 (human) | | 0.000002 | vaginal microbiome measurement | | 10 | 80511458 | 80511459 | Human |
597409994 | GWAS1506068_H | anxiety QTL GWAS1506068 (human) | | 6e-09 | anxiety | | 10 | 102832918 | 102832919 | Human |
597409993 | GWAS1506067_H | anxiety QTL GWAS1506067 (human) | | 4e-12 | anxiety | | 10 | 102876898 | 102876899 | Human |
597098692 | GWAS1194766_H | body mass index QTL GWAS1194766 (human) | | 9e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102875591 | 102875592 | Human |
597098691 | GWAS1194765_H | body mass index QTL GWAS1194765 (human) | | 3e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 97229697 | 97229698 | Human |
407059222 | GWAS708198_H | mean corpuscular hemoglobin QTL GWAS708198 (human) | | 2e-14 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 87895485 | 87895486 | Human |
597426372 | GWAS1522446_H | gout QTL GWAS1522446 (human) | | 4e-30 | gout | | 10 | 87194125 | 87194126 | Human |
597164224 | GWAS1260298_H | bilirubin measurement QTL GWAS1260298 (human) | | 2e-10 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 10 | 93027199 | 93027200 | Human |
597278913 | GWAS1374987_H | glycocholenate sulfate measurement QTL GWAS1374987 (human) | | 2e-32 | glycocholenate sulfate measurement | | 10 | 99811603 | 99811604 | Human |
597508292 | GWAS1604366_H | high density lipoprotein cholesterol measurement QTL GWAS1604366 (human) | | 3e-46 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079967 | 93079968 | Human |
406944536 | GWAS593512_H | urinary metabolite measurement QTL GWAS593512 (human) | | 4e-144 | urinary metabolite measurement | | 10 | 98388419 | 98388420 | Human |
597098702 | GWAS1194776_H | body mass index QTL GWAS1194776 (human) | | 9e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102261784 | 102261785 | Human |
597098699 | GWAS1194773_H | body mass index QTL GWAS1194773 (human) | | 3e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98058263 | 98058264 | Human |
597098698 | GWAS1194772_H | body mass index QTL GWAS1194772 (human) | | 7e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 97939041 | 97939042 | Human |
406977311 | GWAS626287_H | platelet component distribution width QTL GWAS626287 (human) | | 4e-09 | platelet size trait (VT:0010457) | platelet distribution width (CMO:0001350) | 10 | 79190231 | 79190232 | Human |
597098697 | GWAS1194771_H | body mass index QTL GWAS1194771 (human) | | 6e-23 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98013128 | 98013129 | Human |
597311738 | GWAS1407812_H | vaginal microbiome measurement QTL GWAS1407812 (human) | | 0.000005 | vaginal microbiome measurement | | 10 | 93404449 | 93404450 | Human |
597311739 | GWAS1407813_H | vaginal microbiome measurement QTL GWAS1407813 (human) | | 0.000005 | vaginal microbiome measurement | | 10 | 93405076 | 93405077 | Human |
597287164 | GWAS1383238_H | free cholesterol in large VLDL measurement QTL GWAS1383238 (human) | | 5e-13 | blood VLDL cholesterol amount (VT:0005144) | | 10 | 93083778 | 93083779 | Human |
597270769 | GWAS1366843_H | type 2 diabetes mellitus QTL GWAS1366843 (human) | | 6e-09 | type 2 diabetes mellitus | | 10 | 92708490 | 92708491 | Human |
596959484 | GWAS1079003_H | glomerular filtration rate QTL GWAS1079003 (human) | | 3e-09 | glomerular filtration rate | | 10 | 102094023 | 102094024 | Human |
597270768 | GWAS1366842_H | type 2 diabetes mellitus QTL GWAS1366842 (human) | | 2e-23 | type 2 diabetes mellitus | | 10 | 92700893 | 92700894 | Human |
596959485 | GWAS1079004_H | glomerular filtration rate QTL GWAS1079004 (human) | | 2e-22 | glomerular filtration rate | | 10 | 102816113 | 102816114 | Human |
597336304 | GWAS1432378_H | S-warfarin to R-warfarin ratio measurement QTL GWAS1432378 (human) | | 4e-15 | S-warfarin to R-warfarin ratio measurement | | 10 | 94445558 | 94445559 | Human |
597270770 | GWAS1366844_H | type 2 diabetes mellitus QTL GWAS1366844 (human) | | 6e-11 | type 2 diabetes mellitus | | 10 | 92719350 | 92719351 | Human |
597221619 | GWAS1317693_H | central corneal thickness QTL GWAS1317693 (human) | | 3e-23 | central corneal thickness | | 10 | 93294633 | 93294634 | Human |
597336305 | GWAS1432379_H | S-warfarin to R-warfarin ratio measurement QTL GWAS1432379 (human) | | 5e-13 | S-warfarin to R-warfarin ratio measurement | | 10 | 94704121 | 94704122 | Human |
597041400 | GWAS1137474_H | triglyceride measurement QTL GWAS1137474 (human) | | 1e-08 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 102186723 | 102186724 | Human |
597254390 | GWAS1350464_H | aspartate aminotransferase measurement QTL GWAS1350464 (human) | | 3e-14 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 100164546 | 100164547 | Human |
596967655 | GWAS1087174_H | body height QTL GWAS1087174 (human) | | 3e-28 | body height | | 10 | 96102823 | 96102824 | Human |
597213419 | GWAS1309493_H | celiac disease QTL GWAS1309493 (human) | | 1e-14 | celiac disease | | 10 | 79285523 | 79285524 | Human |
596975840 | GWAS1095359_H | systolic blood pressure QTL GWAS1095359 (human) | | 3e-31 | systolic blood pressure | | 10 | 94278929 | 94278930 | Human |
597065952 | GWAS1162026_H | BMI-adjusted waist circumference QTL GWAS1162026 (human) | | 9e-09 | body size trait (VT:0100005) | | 10 | 79147390 | 79147391 | Human |
597270767 | GWAS1366841_H | type 2 diabetes mellitus QTL GWAS1366841 (human) | | 7e-13 | type 2 diabetes mellitus | | 10 | 79184084 | 79184085 | Human |
597254383 | GWAS1350457_H | aspartate aminotransferase measurement QTL GWAS1350457 (human) | | 8e-12 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99007452 | 99007453 | Human |
597336291 | GWAS1432365_H | S-warfarin to R-warfarin ratio measurement QTL GWAS1432365 (human) | | 2e-16 | S-warfarin to R-warfarin ratio measurement | | 10 | 94998551 | 94998552 | Human |
597459174 | GWAS1555248_H | C-reactive protein measurement QTL GWAS1555248 (human) | | 4e-15 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 79059375 | 79059376 | Human |
597500134 | GWAS1596208_H | memory performance QTL GWAS1596208 (human) | | 0.000008 | memory performance | | 10 | 86569212 | 86569213 | Human |
597483744 | GWAS1579818_H | spine bone mineral density QTL GWAS1579818 (human) | | 6e-16 | spine bone mineral density | bone mineral density (CMO:0001226) | 10 | 77641558 | 77641559 | Human |
597500129 | GWAS1596203_H | memory performance QTL GWAS1596203 (human) | | 0.000007 | memory performance | | 10 | 86585711 | 86585712 | Human |
597459169 | GWAS1555243_H | C-reactive protein measurement QTL GWAS1555243 (human) | | 4e-16 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 93079967 | 93079968 | Human |
597172454 | GWAS1268528_H | lipase member N measurement QTL GWAS1268528 (human) | | 7e-36 | lipase member N measurement | | 10 | 88773598 | 88773599 | Human |
597172455 | GWAS1268529_H | lipase member N measurement QTL GWAS1268529 (human) | | 1e-105 | lipase member N measurement | | 10 | 88807288 | 88807289 | Human |
597336293 | GWAS1432367_H | S-warfarin to R-warfarin ratio measurement QTL GWAS1432367 (human) | | 0.000002 | S-warfarin to R-warfarin ratio measurement | | 10 | 95893313 | 95893314 | Human |
597319706 | GWAS1415780_H | systolic blood pressure QTL GWAS1415780 (human) | | 2e-18 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103086421 | 103086422 | Human |
597262360 | GWAS1358434_H | insomnia QTL GWAS1358434 (human) | | 7e-10 | insomnia | | 10 | 103421153 | 103421154 | Human |
597418003 | GWAS1514077_H | colorectal cancer QTL GWAS1514077 (human) | | 3e-16 | colorectal cancer | | 10 | 79059375 | 79059376 | Human |
597377043 | GWAS1473117_H | eosinophilic esophagitis QTL GWAS1473117 (human) | | 0.000009 | eosinophilic esophagitis | | 10 | 83663098 | 83663099 | Human |
597262357 | GWAS1358431_H | insomnia QTL GWAS1358431 (human) | | 8e-09 | insomnia | | 10 | 82824678 | 82824679 | Human |
597458960 | GWAS1555034_H | Progressive visual loss QTL GWAS1555034 (human) | | 8e-10 | Progressive visual loss | | 10 | 88270362 | 88270363 | Human |
597319702 | GWAS1415776_H | hypertension QTL GWAS1415776 (human) | | 2e-14 | hypertension | | 10 | 103141274 | 103141275 | Human |
597262359 | GWAS1358433_H | insomnia QTL GWAS1358433 (human) | | 5e-10 | insomnia | | 10 | 102877751 | 102877752 | Human |
597262358 | GWAS1358432_H | insomnia QTL GWAS1358432 (human) | | 3e-08 | insomnia | | 10 | 99736753 | 99736754 | Human |
597311496 | GWAS1407570_H | Agents acting on the renin-angiotensin system use measurement QTL GWAS1407570 (human) | | 8e-12 | Agents acting on the renin-angiotensin system use measurement | | 10 | 94135370 | 94135371 | Human |
597606413 | GWAS1663273_H | serum alanine aminotransferase measurement QTL GWAS1663273 (human) | | 2e-139 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100152437 | 100152438 | Human |
596967430 | GWAS1086949_H | body mass index QTL GWAS1086949 (human) | | 1e-11 | body mass index | | 10 | 102875346 | 102875347 | Human |
407174103 | GWAS823079_H | obsolete_red blood cell distribution width QTL GWAS823079 (human) | | 6e-15 | obsolete_red blood cell distribution width | | 10 | 102875591 | 102875592 | Human |
406920146 | GWAS569122_H | smoking behavior QTL GWAS569122 (human) | | 4e-22 | smoking behavior | | 10 | 103085115 | 103085116 | Human |
597311503 | GWAS1407577_H | vaginal microbiome measurement QTL GWAS1407577 (human) | | 0.000009 | vaginal microbiome measurement | | 10 | 80511458 | 80511459 | Human |
597114894 | GWAS1210968_H | platelet component distribution width QTL GWAS1210968 (human) | | 5e-10 | platelet size trait (VT:0010457) | platelet distribution width (CMO:0001350) | 10 | 99535699 | 99535700 | Human |
407157723 | GWAS806699_H | gut microbiome measurement QTL GWAS806699 (human) | | 0.0000004 | gut microbiome measurement | | 10 | 98288218 | 98288219 | Human |
597024821 | GWAS1120895_H | colorectal cancer QTL GWAS1120895 (human) | | 0.000008 | colorectal cancer | | 10 | 81288281 | 81288282 | Human |
597139508 | GWAS1235582_H | X-11308 measurement QTL GWAS1235582 (human) | | 2e-41 | X-11308 measurement | | 10 | 94822917 | 94822918 | Human |
597229629 | GWAS1325703_H | plasma clozapine-to-N-desmethylclozapine ratio measurement QTL GWAS1325703 (human) | | 5e-14 | plasma clozapine-to-N-desmethylclozapine ratio measurement | | 10 | 94787706 | 94787707 | Human |
597442617 | GWAS1538691_H | pulse pressure measurement QTL GWAS1538691 (human) | | 1e-19 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 103199143 | 103199144 | Human |
596959292 | GWAS1078811_H | glomerular filtration rate QTL GWAS1078811 (human) | | 2e-38 | glomerular filtration rate | | 10 | 93079885 | 93079886 | Human |
596959293 | GWAS1078812_H | glomerular filtration rate QTL GWAS1078812 (human) | | 9e-14 | glomerular filtration rate | | 10 | 95506844 | 95506845 | Human |
597123133 | GWAS1219207_H | blood protein measurement QTL GWAS1219207 (human) | | 2e-13 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 100069757 | 100069758 | Human |
596959294 | GWAS1078813_H | glomerular filtration rate QTL GWAS1078813 (human) | | 3e-09 | glomerular filtration rate | | 10 | 100960997 | 100960998 | Human |
597213235 | GWAS1309309_H | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa, major depressive disorder QTL GWAS1309309 (human) | | 3e-14 | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa, major depressive disorder | | 10 | 103111522 | 103111523 | Human |
597098554 | GWAS1194628_H | sex hormone-binding globulin measurement QTL GWAS1194628 (human) | | 3e-22 | sex hormone-binding globulin measurement | | 10 | 91856146 | 91856147 | Human |
596959290 | GWAS1078809_H | glomerular filtration rate QTL GWAS1078809 (human) | | 4e-11 | glomerular filtration rate | | 10 | 80434933 | 80434934 | Human |
597229623 | GWAS1325697_H | heel bone mineral density QTL GWAS1325697 (human) | | 6e-13 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 86928665 | 86928666 | Human |
596959291 | GWAS1078810_H | glomerular filtration rate QTL GWAS1078810 (human) | | 4e-12 | glomerular filtration rate | | 10 | 89551314 | 89551315 | Human |
597164087 | GWAS1260161_H | brain aneurysm QTL GWAS1260161 (human) | | 2e-08 | brain aneurysm | | 10 | 103192742 | 103192743 | Human |
597065766 | GWAS1161840_H | BMI-adjusted waist circumference QTL GWAS1161840 (human) | | 0.0000005 | body size trait (VT:0100005) | | 10 | 79147390 | 79147391 | Human |
597123111 | GWAS1219185_H | schizophrenia, anorexia nervosa QTL GWAS1219185 (human) | | 5e-09 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 103300139 | 103300140 | Human |
597123110 | GWAS1219184_H | schizophrenia, anorexia nervosa QTL GWAS1219184 (human) | | 4e-11 | schizophrenia, anorexia nervosa | | 10 | 102989968 | 102989969 | Human |
597065765 | GWAS1161839_H | BMI-adjusted waist circumference QTL GWAS1161839 (human) | | 0.0000003 | body size trait (VT:0100005) | | 10 | 79147390 | 79147391 | Human |
597467176 | GWAS1563250_H | self reported educational attainment QTL GWAS1563250 (human) | | 4e-08 | self reported educational attainment | | 10 | 89832855 | 89832856 | Human |
597458984 | GWAS1555058_H | neutrophil-to-lymphocyte ratio QTL GWAS1555058 (human) | | 5e-09 | neutrophil quantity (VT:0000222) | | 10 | 97264397 | 97264398 | Human |
597467177 | GWAS1563251_H | self reported educational attainment QTL GWAS1563251 (human) | | 4e-18 | self reported educational attainment | | 10 | 101781259 | 101781260 | Human |
597336097 | GWAS1432171_H | S-warfarin to R-warfarin ratio measurement QTL GWAS1432171 (human) | | 0.0000002 | S-warfarin to R-warfarin ratio measurement | | 10 | 94241723 | 94241724 | Human |
597123115 | GWAS1219189_H | age at onset, coronary stenosis QTL GWAS1219189 (human) | | 0.0000004 | age at onset, coronary stenosis | | 10 | 80468431 | 80468432 | Human |
597164068 | GWAS1260142_H | Agents acting on the renin-angiotensin system use measurement QTL GWAS1260142 (human) | | 2e-11 | Agents acting on the renin-angiotensin system use measurement | | 10 | 103069712 | 103069713 | Human |
406985603 | GWAS634579_H | reticulocyte count QTL GWAS634579 (human) | | 2e-19 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 79357419 | 79357420 | Human |
597065811 | GWAS1161885_H | BMI-adjusted waist circumference QTL GWAS1161885 (human) | | 6e-09 | body size trait (VT:0100005) | | 10 | 79147390 | 79147391 | Human |
596951122 | GWAS1070641_H | platelet count QTL GWAS1070641 (human) | | 5e-13 | platelet count | | 10 | 94278929 | 94278930 | Human |
597221470 | GWAS1317544_H | bilirubin measurement QTL GWAS1317544 (human) | | 4e-12 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 10 | 99830729 | 99830730 | Human |
597311570 | GWAS1407644_H | vaginal microbiome measurement QTL GWAS1407644 (human) | | 0.000001 | vaginal microbiome measurement | | 10 | 98953678 | 98953679 | Human |
597278800 | GWAS1374874_H | clonal hematopoiesis QTL GWAS1374874 (human) | | 5e-11 | hematopoietic system development trait (VT:0010255) | | 10 | 99512238 | 99512239 | Human |
597368919 | GWAS1464993_H | prostate carcinoma QTL GWAS1464993 (human) | | 8e-12 | prostate carcinoma | | 10 | 78484866 | 78484867 | Human |
597590098 | GWAS1646958_H | open-angle glaucoma QTL GWAS1646958 (human) | | 5e-19 | open-angle glaucoma | | 10 | 94253193 | 94253194 | Human |
597475408 | GWAS1571482_H | platelet crit QTL GWAS1571482 (human) | | 1e-29 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 10 | 99520522 | 99520523 | Human |
597221461 | GWAS1317535_H | bilirubin measurement QTL GWAS1317535 (human) | | 5e-13 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 10 | 93082720 | 93082721 | Human |
597475409 | GWAS1571483_H | platelet crit QTL GWAS1571483 (human) | | 2e-15 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 10 | 102469616 | 102469618 | Human |
597254231 | GWAS1350305_H | alkaline phosphatase measurement QTL GWAS1350305 (human) | | 6e-20 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 94892563 | 94892564 | Human |
597221462 | GWAS1317536_H | bilirubin measurement QTL GWAS1317536 (human) | | 2e-13 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 10 | 100006605 | 100006606 | Human |
597049432 | GWAS1145506_H | hypertension QTL GWAS1145506 (human) | | 3e-20 | hypertension | | 10 | 103146454 | 103146455 | Human |
596951109 | GWAS1070628_H | COVID-19 QTL GWAS1070628 (human) | | 0.000008 | COVID-19 | | 10 | 95515777 | 95515778 | Human |
597311561 | GWAS1407635_H | vaginal microbiome measurement QTL GWAS1407635 (human) | | 0.000001 | vaginal microbiome measurement | | 10 | 80511458 | 80511459 | Human |
597475407 | GWAS1571481_H | platelet crit QTL GWAS1571481 (human) | | 4e-09 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 10 | 99492628 | 99492629 | Human |
597434440 | GWAS1530514_H | interferon gamma measurement QTL GWAS1530514 (human) | | 0.000003 | blood interferon-gamma amount (VT:0008551) | mononuclear cell interferon gamma expression (CMO:0003222) | 10 | 90320085 | 90320086 | Human |
597475403 | GWAS1571477_H | platelet crit QTL GWAS1571477 (human) | | 1e-11 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 10 | 95875759 | 95875760 | Human |
597385284 | GWAS1481358_H | schizophrenia QTL GWAS1481358 (human) | | 2e-08 | schizophrenia | | 10 | 102876898 | 102876899 | Human |
597459068 | GWAS1555142_H | hemoglobin measurement QTL GWAS1555142 (human) | | 8e-09 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 79745802 | 79745803 | Human |
596951156 | GWAS1070675_H | body fat percentage QTL GWAS1070675 (human) | | 7e-29 | body fat percentage | | 10 | 94279840 | 94279841 | Human |
597598335 | GWAS1655195_H | high density lipoprotein cholesterol measurement QTL GWAS1655195 (human) | | 1e-38 | glomerular filtration rate | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079885 | 93079886 | Human |
597278843 | GWAS1374917_H | sex hormone-binding globulin measurement QTL GWAS1374917 (human) | | 3e-11 | sex hormone-binding globulin measurement | | 10 | 79314368 | 79314369 | Human |
597254257 | GWAS1350331_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1350331 (human) | | 5e-15 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 10 | 99692460 | 99692461 | Human |
597254256 | GWAS1350330_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1350330 (human) | | 1e-15 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 10 | 99406195 | 99406196 | Human |
597450871 | GWAS1546945_H | serum gamma-glutamyl transferase measurement QTL GWAS1546945 (human) | | 5e-10 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 78053936 | 78053937 | Human |
597278836 | GWAS1374910_H | sex hormone-binding globulin measurement QTL GWAS1374910 (human) | | 9e-09 | sex hormone-binding globulin measurement | | 10 | 91775436 | 91775437 | Human |
597270644 | GWAS1366718_H | pulse pressure measurement QTL GWAS1366718 (human) | | 9e-15 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 100792906 | 100792907 | Human |
597598319 | GWAS1655179_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1655179 (human) | | 4e-88 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 10 | 99397681 | 99397682 | Human |
597590124 | GWAS1646984_H | multinodular goiter QTL GWAS1646984 (human) | | 9e-12 | multinodular goiter | | 10 | 99130419 | 99130420 | Human |
597098596 | GWAS1194670_H | sex hormone-binding globulin measurement QTL GWAS1194670 (human) | | 3e-28 | sex hormone-binding globulin measurement | | 10 | 100152307 | 100152308 | Human |
597074021 | GWAS1170095_H | coronary artery disease QTL GWAS1170095 (human) | | 2e-12 | coronary artery disease | | 10 | 102938024 | 102938025 | Human |
406985652 | GWAS634628_H | reticulocyte count QTL GWAS634628 (human) | | 6e-135 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 103046897 | 103046898 | Human |
597090401 | GWAS1186475_H | schizophrenia QTL GWAS1186475 (human) | | 3e-15 | schizophrenia | | 10 | 102869116 | 102869117 | Human |
597098606 | GWAS1194680_H | sex hormone-binding globulin measurement QTL GWAS1194680 (human) | | 3e-16 | sex hormone-binding globulin measurement | | 10 | 96097142 | 96097143 | Human |
597024873 | GWAS1120947_H | colorectal adenoma QTL GWAS1120947 (human) | | 0.000009 | colorectal adenoma | | 10 | 102789467 | 102789468 | Human |
597164133 | GWAS1260207_H | Uveal Melanoma QTL GWAS1260207 (human) | | 0.000001 | Uveal Melanoma | | 10 | 84598750 | 84598751 | Human |
597024872 | GWAS1120946_H | colorectal adenoma QTL GWAS1120946 (human) | | 0.000006 | colorectal adenoma | | 10 | 96220965 | 96220966 | Human |
597387162 | GWAS1483236_H | acute myeloid leukemia QTL GWAS1483236 (human) | | 3e-10 | leukocyte integrity trait (VT:0010898) | | 10 | 92411094 | 92411095 | Human |
597387161 | GWAS1483235_H | acute myeloid leukemia QTL GWAS1483235 (human) | | 0.000008 | leukocyte integrity trait (VT:0010898) | | 10 | 83872776 | 83872777 | Human |
597305244 | GWAS1401318_H | spine bone mineral density QTL GWAS1401318 (human) | | 1e-12 | spine bone mineral density | bone mineral density (CMO:0001226) | 10 | 77687470 | 77687471 | Human |
597223327 | GWAS1319401_H | cataract QTL GWAS1319401 (human) | | 6e-24 | cataract | | 10 | 94279840 | 94279841 | Human |
597444500 | GWAS1540574_H | 2-hydroxystearate measurement QTL GWAS1540574 (human) | | 0.000003 | 2-hydroxystearate measurement | | 10 | 97599982 | 97599983 | Human |
597321619 | GWAS1417693_H | X-11440 measurement QTL GWAS1417693 (human) | | 2e-21 | X-11440 measurement | | 10 | 99820390 | 99820391 | Human |
597034908 | GWAS1130982_H | high density lipoprotein cholesterol measurement QTL GWAS1130982 (human) | | 3e-13 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 98009631 | 98009632 | Human |
597141405 | GWAS1237479_H | arginine measurement QTL GWAS1237479 (human) | | 2e-23 | arginine measurement | | 10 | 98395539 | 98395540 | Human |
597419921 | GWAS1515995_H | mathematical ability QTL GWAS1515995 (human) | | 2e-16 | mathematical ability | | 10 | 101760027 | 101760028 | Human |
597419927 | GWAS1516001_H | cognitive behavioural therapy QTL GWAS1516001 (human) | | 0.000002 | cognitive behavioural therapy | | 10 | 103240612 | 103240613 | Human |
406977612 | GWAS626588_H | white matter microstructure measurement QTL GWAS626588 (human) | | 7e-09 | white matter microstructure measurement | | 10 | 102559209 | 102559210 | Human |
597026693 | GWAS1122767_H | body mass index QTL GWAS1122767 (human) | | 5e-21 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100687890 | 100687891 | Human |
597026692 | GWAS1122766_H | body mass index QTL GWAS1122766 (human) | | 1e-22 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98018469 | 98018470 | Human |
407002192 | GWAS651168_H | systolic blood pressure QTL GWAS651168 (human) | | 2e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 100796696 | 100796697 | Human |
597026695 | GWAS1122769_H | body mass index QTL GWAS1122769 (human) | | 4e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102261784 | 102261785 | Human |
597026694 | GWAS1122768_H | body mass index QTL GWAS1122768 (human) | | 1e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100913950 | 100913951 | Human |
597026689 | GWAS1122763_H | body mass index QTL GWAS1122763 (human) | | 1e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 91278773 | 91278774 | Human |
597026688 | GWAS1122762_H | body mass index QTL GWAS1122762 (human) | | 2e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 86336290 | 86336291 | Human |
597026691 | GWAS1122765_H | body mass index QTL GWAS1122765 (human) | | 6e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 95494548 | 95494549 | Human |
597190542 | GWAS1286616_H | testosterone measurement QTL GWAS1286616 (human) | | 4e-10 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 99975358 | 99975359 | Human |
597026690 | GWAS1122764_H | body mass index QTL GWAS1122764 (human) | | 4e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 92051115 | 92051116 | Human |
597436292 | GWAS1532366_H | N-methylpipecolate measurement QTL GWAS1532366 (human) | | 1e-60 | N-methylpipecolate measurement | | 10 | 98388419 | 98388420 | Human |
597206912 | GWAS1302986_H | colorectal cancer QTL GWAS1302986 (human) | | 2e-15 | colorectal cancer | | 10 | 99586852 | 99586853 | Human |
597165953 | GWAS1262027_H | triglyceride measurement, low density lipoprotein cholesterol measurement QTL GWAS1262027 (human) | | 7e-11 | triglyceride measurement, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 93079885 | 93079886 | Human |
597616517 | GWAS1673377_H | Abnormal nasolacrimal system morphology QTL GWAS1673377 (human) | | 2e-11 | Abnormal nasolacrimal system morphology | | 10 | 102401434 | 102401435 | Human |
597215109 | GWAS1311183_H | total cholesterol measurement QTL GWAS1311183 (human) | | 7e-17 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 93079885 | 93079886 | Human |
597436290 | GWAS1532364_H | N6-methyllysine measurement QTL GWAS1532364 (human) | | 3e-473 | N6-methyllysine measurement | | 10 | 98391432 | 98391433 | Human |
407059555 | GWAS708531_H | inflammatory bowel disease QTL GWAS708531 (human) | | 9e-16 | inflammatory bowel disease | | 10 | 80494291 | 80494292 | Human |
597059510 | GWAS1155584_H | BMI-adjusted waist circumference QTL GWAS1155584 (human) | | 4e-12 | body size trait (VT:0100005) | | 10 | 86787149 | 86787150 | Human |
407059554 | GWAS708530_H | inflammatory bowel disease QTL GWAS708530 (human) | | 3e-18 | inflammatory bowel disease | | 10 | 79272775 | 79272776 | Human |
597059508 | GWAS1155582_H | BMI-adjusted waist circumference QTL GWAS1155582 (human) | | 3e-13 | body size trait (VT:0100005) | | 10 | 102767194 | 102767195 | Human |
597395384 | GWAS1491458_H | total cholesterol measurement QTL GWAS1491458 (human) | | 5e-14 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 89251935 | 89251936 | Human |
597206971 | GWAS1303045_H | protein measurement QTL GWAS1303045 (human) | | 4e-09 | protein measurement | | 10 | 95786870 | 95786871 | Human |
597059509 | GWAS1155583_H | BMI-adjusted waist circumference QTL GWAS1155583 (human) | | 9e-11 | body size trait (VT:0100005) | | 10 | 96024117 | 96024118 | Human |
596961200 | GWAS1080719_H | metabolic syndrome QTL GWAS1080719 (human) | | 3e-08 | metabolic syndrome | | 10 | 100875718 | 100875719 | Human |
597198780 | GWAS1294854_H | hematocrit QTL GWAS1294854 (human) | | 4e-08 | hematocrit | hematocrit (CMO:0000037) | 10 | 102509101 | 102509102 | Human |
597166014 | GWAS1262088_H | open-angle glaucoma QTL GWAS1262088 (human) | | 4e-08 | open-angle glaucoma | | 10 | 80165074 | 80165075 | Human |
597059504 | GWAS1155578_H | BMI-adjusted waist circumference QTL GWAS1155578 (human) | | 9e-27 | body size trait (VT:0100005) | | 10 | 102626552 | 102626553 | Human |
597477307 | GWAS1573381_H | prostate carcinoma QTL GWAS1573381 (human) | | 2e-12 | prostate carcinoma | | 10 | 78477242 | 78477243 | Human |
407059556 | GWAS708532_H | inflammatory bowel disease QTL GWAS708532 (human) | | 3e-08 | inflammatory bowel disease | | 10 | 92677094 | 92677095 | Human |
597166015 | GWAS1262089_H | open-angle glaucoma QTL GWAS1262089 (human) | | 7e-10 | open-angle glaucoma | | 10 | 93002168 | 93002169 | Human |
597133247 | GWAS1229321_H | pulse pressure measurement QTL GWAS1229321 (human) | | 4e-20 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 100792906 | 100792907 | Human |
597190577 | GWAS1286651_H | sex hormone-binding globulin measurement QTL GWAS1286651 (human) | | 2e-22 | sex hormone-binding globulin measurement | | 10 | 79314368 | 79314369 | Human |
597133246 | GWAS1229320_H | pulse pressure measurement QTL GWAS1229320 (human) | | 5e-10 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 98257696 | 98257697 | Human |
597157821 | GWAS1253895_H | cardiovascular age measurement QTL GWAS1253895 (human) | | 2e-11 | cardiovascular age measurement | | 10 | 94146109 | 94146110 | Human |
597133245 | GWAS1229319_H | pulse pressure measurement QTL GWAS1229319 (human) | | 0.000008 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 95560648 | 95560649 | Human |
597133244 | GWAS1229318_H | pulse pressure measurement QTL GWAS1229318 (human) | | 3e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 95502784 | 95502785 | Human |
597256117 | GWAS1352191_H | total cholesterol measurement QTL GWAS1352191 (human) | | 2e-11 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 79314368 | 79314369 | Human |
597133243 | GWAS1229317_H | pulse pressure measurement QTL GWAS1229317 (human) | | 9e-15 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 94279840 | 94279841 | Human |
597428145 | GWAS1524219_H | urate measurement QTL GWAS1524219 (human) | | 6e-10 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 80377785 | 80377786 | Human |
597133242 | GWAS1229316_H | pulse pressure measurement QTL GWAS1229316 (human) | | 1e-33 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 94136183 | 94136184 | Human |
597428146 | GWAS1524220_H | urate measurement QTL GWAS1524220 (human) | | 5e-26 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 87120932 | 87120933 | Human |
597616560 | GWAS1673420_H | mean corpuscular hemoglobin concentration QTL GWAS1673420 (human) | | 2e-12 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 89246195 | 89246196 | Human |
597133241 | GWAS1229315_H | pulse pressure measurement QTL GWAS1229315 (human) | | 1e-09 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 92708928 | 92708929 | Human |
597133240 | GWAS1229314_H | pulse pressure measurement QTL GWAS1229314 (human) | | 1e-09 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 87921931 | 87921932 | Human |
597370792 | GWAS1466866_H | aspartate aminotransferase measurement QTL GWAS1466866 (human) | | 3e-14 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 98367794 | 98367795 | Human |
406895734 | GWAS544710_H | pulse pressure measurement QTL GWAS544710 (human) | | 3e-10 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 94136183 | 94136184 | Human |
407059578 | GWAS708554_H | response to anticoagulant QTL GWAS708554 (human) | | 5e-12 | response to anticoagulant | | 10 | 94645745 | 94645746 | Human |
597215139 | GWAS1311213_H | body mass index QTL GWAS1311213 (human) | | 8e-16 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98257696 | 98257697 | Human |
597182374 | GWAS1278448_H | cholesteryl ester measurement QTL GWAS1278448 (human) | | 4e-10 | blood lipid amount (VT:0003949) | | 10 | 93038216 | 93038217 | Human |
597280679 | GWAS1376753_H | sex hormone-binding globulin measurement QTL GWAS1376753 (human) | | 4e-14 | sex hormone-binding globulin measurement | | 10 | 100152307 | 100152308 | Human |
407051267 | GWAS700243_H | economic and social preference QTL GWAS700243 (human) | | 0.000005 | economic and social preference | | 10 | 90873142 | 90873143 | Human |
597370843 | GWAS1466917_H | eosinophil count QTL GWAS1466917 (human) | | 7e-20 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 93063839 | 93063840 | Human |
597141463 | GWAS1237537_H | palmitoleoyl-linoleoyl-glycerol (16:1/18:2) [1] measurement QTL GWAS1237537 (human) | | 2e-11 | lysophosphatidylcholine 17:1 measurement | | 10 | 100315722 | 100315723 | Human |
597370841 | GWAS1466915_H | eosinophil count QTL GWAS1466915 (human) | | 1e-53 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 92669710 | 92669711 | Human |
597141461 | GWAS1237535_H | palmitoleate 16:1n7 measurement QTL GWAS1237535 (human) | | 5e-16 | palmitoleate 16:1n7 measurement | | 10 | 100315722 | 100315723 | Human |
597477337 | GWAS1573411_H | protein measurement QTL GWAS1573411 (human) | | 3e-08 | protein measurement | | 10 | 97153383 | 97153384 | Human |
597370844 | GWAS1466918_H | eosinophil count QTL GWAS1466918 (human) | | 4e-10 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 97336188 | 97336189 | Human |
597125087 | GWAS1221161_H | Myopia QTL GWAS1221161 (human) | | 3e-08 | Myopia | | 10 | 84200393 | 84200394 | Human |
597125086 | GWAS1221160_H | Myopia QTL GWAS1221160 (human) | | 0.000001 | Myopia | | 10 | 81193160 | 81193161 | Human |
597469141 | GWAS1565215_H | triglyceride measurement, response to selective serotonin reuptake inhibitor QTL GWAS1565215 (human) | | 1e-08 | triglyceride measurement, response to selective serotonin reuptake inhibitor | blood triglyceride level (CMO:0000118) | 10 | 84588366 | 84588367 | Human |
597419985 | GWAS1516059_H | trait in response to ethanol QTL GWAS1516059 (human) | | 0.000006 | trait in response to ethanol | | 10 | 100108590 | 100108591 | Human |
406920204 | GWAS569180_H | birth weight QTL GWAS569180 (human) | | 8e-09 | birth weight | neonatal body weight (CMO:0002079) | 10 | 103184236 | 103184237 | Human |
597469132 | GWAS1565206_H | Hypermetropia, Myopia QTL GWAS1565206 (human) | | 0.0000006 | Hypermetropia, Myopia | | 10 | 89394766 | 89394767 | Human |
597329866 | GWAS1425940_H | 16a-hydroxy DHEA 3-sulfate measurement QTL GWAS1425940 (human) | | 1e-13 | 16a-hydroxy DHEA 3-sulfate measurement | | 10 | 95040017 | 95040018 | Human |
597141445 | GWAS1237519_H | N-methylpipecolate measurement QTL GWAS1237519 (human) | | 5e-946 | N-methylpipecolate measurement | | 10 | 98388419 | 98388420 | Human |
597133253 | GWAS1229327_H | pulse pressure measurement QTL GWAS1229327 (human) | | 3e-74 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 103146454 | 103146455 | Human |
597133252 | GWAS1229326_H | pulse pressure measurement QTL GWAS1229326 (human) | | 4e-42 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 103138228 | 103138229 | Human |
597133251 | GWAS1229325_H | pulse pressure measurement QTL GWAS1229325 (human) | | 2e-09 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 102535625 | 102535626 | Human |
597133250 | GWAS1229324_H | pulse pressure measurement QTL GWAS1229324 (human) | | 3e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 102119174 | 102119175 | Human |
597133249 | GWAS1229323_H | pulse pressure measurement QTL GWAS1229323 (human) | | 2e-12 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 101943006 | 101943007 | Human |
597133248 | GWAS1229322_H | pulse pressure measurement QTL GWAS1229322 (human) | | 0.000006 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 101355588 | 101355589 | Human |
597166016 | GWAS1262090_H | open-angle glaucoma QTL GWAS1262090 (human) | | 6e-15 | open-angle glaucoma | | 10 | 93202957 | 93202958 | Human |
597084110 | GWAS1180184_H | migraine disorder, pulse pressure measurement QTL GWAS1180184 (human) | | 2e-29 | migraine disorder, pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 94263320 | 94263321 | Human |
597166017 | GWAS1262091_H | open-angle glaucoma QTL GWAS1262091 (human) | | 1e-24 | open-angle glaucoma | | 10 | 94263320 | 94263321 | Human |
597092300 | GWAS1188374_H | exploratory eye movement measurement QTL GWAS1188374 (human) | | 0.000002 | exploratory eye movement measurement | eye physiological measurement (CMO:0003652) | 10 | 80808928 | 80808929 | Human |
407002136 | GWAS651112_H | systolic blood pressure QTL GWAS651112 (human) | | 1e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94890571 | 94890572 | Human |
597616580 | GWAS1673440_H | diverticular disease QTL GWAS1673440 (human) | | 2e-14 | diverticular disease | | 10 | 95688415 | 95688416 | Human |
597084107 | GWAS1180181_H | migraine disorder, diastolic blood pressure QTL GWAS1180181 (human) | | 6e-09 | migraine disorder, diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 98900544 | 98900545 | Human |
597207032 | GWAS1303106_H | Agents acting on the renin-angiotensin system use measurement QTL GWAS1303106 (human) | | 8e-13 | Agents acting on the renin-angiotensin system use measurement | | 10 | 94135370 | 94135371 | Human |
597485566 | GWAS1581640_H | gut microbiome measurement QTL GWAS1581640 (human) | | 8e-09 | gut microbiome measurement | | 10 | 90195403 | 90195404 | Human |
597141492 | GWAS1237566_H | andro steroid monosulfate C19H28O6S (1) measurement QTL GWAS1237566 (human) | | 2e-64 | andro steroid monosulfate C19H28O6S (1) measurement | | 10 | 95090032 | 95090033 | Human |
597059571 | GWAS1155645_H | refractive error, age at onset, Myopia QTL GWAS1155645 (human) | | 9e-17 | refractive error, age at onset, Myopia | | 10 | 84226798 | 84226799 | Human |
597460987 | GWAS1557061_H | balding measurement QTL GWAS1557061 (human) | | 2e-11 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 10 | 77819493 | 77819494 | Human |
597100528 | GWAS1196602_H | protein measurement QTL GWAS1196602 (human) | | 1e-18 | protein measurement | | 10 | 100742278 | 100742279 | Human |
596961276 | GWAS1080795_H | metabolic syndrome QTL GWAS1080795 (human) | | 5e-24 | metabolic syndrome | | 10 | 79182179 | 79182180 | Human |
597100543 | GWAS1196617_H | sex hormone-binding globulin measurement QTL GWAS1196617 (human) | | 1e-19 | sex hormone-binding globulin measurement | | 10 | 100157116 | 100157117 | Human |
597354483 | GWAS1450557_H | colorectal cancer QTL GWAS1450557 (human) | | 2e-08 | colorectal cancer | | 10 | 79059375 | 79059376 | Human |
596961277 | GWAS1080796_H | metabolic syndrome QTL GWAS1080796 (human) | | 9e-11 | metabolic syndrome | | 10 | 79230979 | 79230980 | Human |
597403634 | GWAS1499708_H | neuroticism measurement QTL GWAS1499708 (human) | | 5e-10 | neuroticism measurement | | 10 | 102876898 | 102876899 | Human |
596961278 | GWAS1080797_H | metabolic syndrome QTL GWAS1080797 (human) | | 7e-13 | metabolic syndrome | | 10 | 79299578 | 79299579 | Human |
407264300 | GWAS913276_H | neutrophil count QTL GWAS913276 (human) | | 1e-21 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 88017202 | 88017203 | Human |
596961279 | GWAS1080798_H | metabolic syndrome QTL GWAS1080798 (human) | | 3e-14 | metabolic syndrome | | 10 | 85651147 | 85651148 | Human |
597313521 | GWAS1409595_H | cortical thickness QTL GWAS1409595 (human) | | 3e-10 | cortical thickness | | 10 | 89714782 | 89714783 | Human |
597141497 | GWAS1237571_H | androsterone sulfate measurement QTL GWAS1237571 (human) | | 2e-09 | androsterone sulfate measurement | | 10 | 94827532 | 94827533 | Human |
597354484 | GWAS1450558_H | colorectal cancer QTL GWAS1450558 (human) | | 0.0000007 | colorectal cancer | | 10 | 99529178 | 99529179 | Human |
596961275 | GWAS1080794_H | metabolic syndrome QTL GWAS1080794 (human) | | 4e-08 | metabolic syndrome | | 10 | 78221056 | 78221057 | Human |
597247977 | GWAS1344051_H | chronic obstructive pulmonary disease QTL GWAS1344051 (human) | | 9e-08 | lung integrity trait (VT:0010906) | | 10 | 79946568 | 79946569 | Human |
597510125 | GWAS1606199_H | risk-taking behaviour QTL GWAS1606199 (human) | | 2e-21 | risk-taking behaviour | | 10 | 102880295 | 102880296 | Human |
597592047 | GWAS1648907_H | open-angle glaucoma QTL GWAS1648907 (human) | | 1e-17 | open-angle glaucoma | | 10 | 93201869 | 93201870 | Human |
597338091 | GWAS1434165_H | sexual dimorphism measurement QTL GWAS1434165 (human) | | 3e-08 | sexual dimorphism measurement | | 10 | 102745930 | 102745931 | Human |
597157861 | GWAS1253935_H | omega-3 polyunsaturated fatty acid measurement QTL GWAS1253935 (human) | | 2e-11 | omega-3 polyunsaturated fatty acid measurement | | 10 | 94968412 | 94968413 | Human |
407051312 | GWAS700288_H | response to iloperidone QTL GWAS700288 (human) | | 0.000002 | response to iloperidone | | 10 | 82059369 | 82059370 | Human |
407157808 | GWAS806784_H | systolic blood pressure QTL GWAS806784 (human) | | 2e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94827994 | 94827995 | Human |
407157809 | GWAS806785_H | systolic blood pressure QTL GWAS806785 (human) | | 2e-12 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 100844757 | 100844758 | Human |
597125089 | GWAS1221163_H | Myopia QTL GWAS1221163 (human) | | 0.000009 | Myopia | | 10 | 98540798 | 98540799 | Human |
597125088 | GWAS1221162_H | Myopia QTL GWAS1221162 (human) | | 0.000002 | Myopia | | 10 | 84502366 | 84502367 | Human |
597280737 | GWAS1376811_H | hydroxy-CMPF measurement QTL GWAS1376811 (human) | | 4e-11 | hydroxy-CMPF measurement | | 10 | 95059420 | 95059421 | Human |
597444581 | GWAS1540655_H | systolic blood pressure QTL GWAS1540655 (human) | | 2e-19 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103199143 | 103199144 | Human |
597157869 | GWAS1253943_H | sex hormone-binding globulin measurement QTL GWAS1253943 (human) | | 6e-10 | sex hormone-binding globulin measurement | | 10 | 91872199 | 91872200 | Human |
597583844 | GWAS1640704_H | mean corpuscular hemoglobin concentration QTL GWAS1640704 (human) | | 2e-40 | mean corpuscular volume | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 99520522 | 99520523 | Human |
597157868 | GWAS1253942_H | sex hormone-binding globulin measurement QTL GWAS1253942 (human) | | 6e-14 | sex hormone-binding globulin measurement | | 10 | 79314368 | 79314369 | Human |
597583845 | GWAS1640705_H | mean corpuscular hemoglobin concentration QTL GWAS1640705 (human) | | 3e-28 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 102869254 | 102869255 | Human |
407059519 | GWAS708495_H | psoriasis, Crohn's disease QTL GWAS708495 (human) | | 7e-14 | intestine integrity trait (VT:0010554) | | 10 | 79273128 | 79273129 | Human |
597493728 | GWAS1589802_H | tumor necrosis factor receptor superfamily member 6 measurement QTL GWAS1589802 (human) | | 4e-24 | tumor necrosis factor receptor superfamily member 6 measurement | | 10 | 88979722 | 88979723 | Human |
597592032 | GWAS1648892_H | sarcoidosis QTL GWAS1648892 (human) | | 3e-16 | sarcoidosis | | 10 | 80193615 | 80193616 | Human |
597329892 | GWAS1425966_H | neuroticism measurement, cognitive function measurement QTL GWAS1425966 (human) | | 4e-11 | cognitive behavior trait (VT:0010450) | | 10 | 91682622 | 91682623 | Human |
597092329 | GWAS1188403_H | Crohn's disease QTL GWAS1188403 (human) | | 3e-19 | intestine integrity trait (VT:0010554) | | 10 | 79272775 | 79272776 | Human |
597034774 | GWAS1130848_H | balding measurement QTL GWAS1130848 (human) | | 7e-19 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 10 | 77778976 | 77778977 | Human |
597149463 | GWAS1245537_H | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1245537 (human) | | 4e-09 | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 98012433 | 98012434 | Human |
407026881 | GWAS675857_H | serum IgG glycosylation measurement QTL GWAS675857 (human) | | 0.000005 | serum IgG glycosylation measurement | | 10 | 95541247 | 95541248 | Human |
597067538 | GWAS1163612_H | basophil count QTL GWAS1163612 (human) | | 2e-10 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 87896399 | 87896400 | Human |
596977425 | GWAS1096944_H | Red cell distribution width QTL GWAS1096944 (human) | | 6e-13 | Red cell distribution width | | 10 | 94486139 | 94486140 | Human |
597313311 | GWAS1409385_H | X-21467 measurement QTL GWAS1409385 (human) | | 5e-20 | X-21467 measurement | | 10 | 99921716 | 99921717 | Human |
597067550 | GWAS1163624_H | erythrocyte count QTL GWAS1163624 (human) | | 3e-08 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 101405830 | 101405831 | Human |
597190417 | GWAS1286491_H | sex hormone-binding globulin measurement QTL GWAS1286491 (human) | | 3e-23 | sex hormone-binding globulin measurement | | 10 | 93079885 | 93079886 | Human |
597255952 | GWAS1352026_H | response to beta blocker QTL GWAS1352026 (human) | | 0.000001 | response to beta blocker | | 10 | 103286975 | 103286976 | Human |
597346064 | GWAS1442138_H | cannabis dependence QTL GWAS1442138 (human) | | 1e-08 | cannabis dependence | | 10 | 102320061 | 102320062 | Human |
597092125 | GWAS1188199_H | chronic lymphocytic leukemia QTL GWAS1188199 (human) | | 9e-14 | leukocyte integrity trait (VT:0010898) | | 10 | 88999967 | 88999968 | Human |
597346065 | GWAS1442139_H | cannabis dependence QTL GWAS1442139 (human) | | 2e-10 | cannabis dependence | | 10 | 103173692 | 103173693 | Human |
597272341 | GWAS1368415_H | diastolic blood pressure QTL GWAS1368415 (human) | | 1e-18 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 102626552 | 102626553 | Human |
407108814 | GWAS757790_H | lean body mass QTL GWAS757790 (human) | | 2e-11 | cervical artery dissection | | 10 | 94278929 | 94278930 | Human |
597174024 | GWAS1270098_H | phospholipids in VLDL measurement QTL GWAS1270098 (human) | | 2e-10 | blood lipid amount (VT:0003949) | blood very low density lipoprotein phospholipid level (CMO:0001571) | 10 | 93038216 | 93038217 | Human |
596952838 | GWAS1072357_H | functional brain measurement QTL GWAS1072357 (human) | | 2e-47 | functional brain measurement | | 10 | 94279840 | 94279841 | Human |
597591817 | GWAS1648677_H | erythematosquamous dermatosis QTL GWAS1648677 (human) | | 3e-18 | erythematosquamous dermatosis | | 10 | 79287626 | 79287627 | Human |
596952847 | GWAS1072366_H | hypertension QTL GWAS1072366 (human) | | 8e-09 | hypertension | | 10 | 95502784 | 95502785 | Human |
597255999 | GWAS1352073_H | schizophrenia QTL GWAS1352073 (human) | | 7e-10 | schizophrenia | | 10 | 91029731 | 91029732 | Human |
597493563 | GWAS1589637_H | COVID-19 QTL GWAS1589637 (human) | | 0.000003 | COVID-19 | | 10 | 94607436 | 94607437 | Human |
597321533 | GWAS1417607_H | myristoleate 14:1n5 measurement QTL GWAS1417607 (human) | | 7e-19 | myristoleate 14:1n5 measurement | | 10 | 100315722 | 100315723 | Human |
597231409 | GWAS1327483_H | triglyceride measurement, response to selective serotonin reuptake inhibitor QTL GWAS1327483 (human) | | 0.0000002 | triglyceride measurement, response to selective serotonin reuptake inhibitor | blood triglyceride level (CMO:0000118) | 10 | 102768223 | 102768224 | Human |
597165874 | GWAS1261948_H | valine measurement QTL GWAS1261948 (human) | | 1e-12 | valine measurement | blood amino acid measurement (CMO:0003730) | 10 | 87060835 | 87060836 | Human |
597182259 | GWAS1278333_H | body mass index QTL GWAS1278333 (human) | | 8e-20 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102925542 | 102925543 | Human |
597182260 | GWAS1278334_H | body mass index QTL GWAS1278334 (human) | | 1e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 103192742 | 103192743 | Human |
597083963 | GWAS1180037_H | white matter hyperintensity measurement QTL GWAS1180037 (human) | | 1e-08 | white matter hyperintensity measurement | | 10 | 80462942 | 80462943 | Human |
597182263 | GWAS1278337_H | body mass index QTL GWAS1278337 (human) | | 3e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102224303 | 102224304 | Human |
597280552 | GWAS1376626_H | glycine conjugate of C10H14O2 (1) measurement QTL GWAS1376626 (human) | | 1e-30 | glycine conjugate of C10H14O2 (1) measurement | | 10 | 94937146 | 94937147 | Human |
597083943 | GWAS1180017_H | coronary artery disease QTL GWAS1180017 (human) | | 6e-09 | phosphatidylcholine measurement | | 10 | 100315722 | 100315723 | Human |
597280554 | GWAS1376628_H | metabolonic lactone sulfate measurement QTL GWAS1376628 (human) | | 2e-29 | metabolonic lactone sulfate measurement | | 10 | 94971838 | 94971839 | Human |
597436207 | GWAS1532281_H | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1532281 (human) | | 1e-12 | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 102438354 | 102438355 | Human |
597075744 | GWAS1171818_H | insulin response measurement QTL GWAS1171818 (human) | | 3e-08 | insulin secretion trait (VT:0003564) | calculated blood insulin level (CMO:0000353) | 10 | 92710223 | 92710224 | Human |
597042977 | GWAS1139051_H | schizophrenia QTL GWAS1139051 (human) | | 1e-15 | schizophrenia | | 10 | 102776603 | 102776604 | Human |
597313314 | GWAS1409388_H | X-21467 measurement QTL GWAS1409388 (human) | | 2e-18 | X-21467 measurement | | 10 | 99872116 | 99872117 | Human |
597272352 | GWAS1368426_H | diastolic blood pressure QTL GWAS1368426 (human) | | 2e-17 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103319036 | 103319037 | Human |
407092472 | GWAS741448_H | hair color QTL GWAS741448 (human) | | 3e-10 | hair color | | 10 | 79184390 | 79184391 | Human |
597231394 | GWAS1327468_H | Bell's palsy QTL GWAS1327468 (human) | | 0.0000001 | Bell's palsy | | 10 | 97618304 | 97618305 | Human |
597370656 | GWAS1466730_H | platelet aggregation QTL GWAS1466730 (human) | | 0.0000002 | platelet aggregation | | 10 | 103498029 | 103498030 | Human |
597026601 | GWAS1122675_H | systolic blood pressure QTL GWAS1122675 (human) | | 4e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 102794772 | 102794773 | Human |
407387381 | GWAS1036357_H | basophil count, eosinophil count QTL GWAS1036357 (human) | | 1e-13 | eosinophil quantity (VT:0002602) | blood granulocyte count (CMO:0000111) | 10 | 87895485 | 87895486 | Human |
597313319 | GWAS1409393_H | X-21471 measurement QTL GWAS1409393 (human) | | 3e-13 | X-21471 measurement | | 10 | 99914844 | 99914845 | Human |
597083944 | GWAS1180018_H | coronary artery disease QTL GWAS1180018 (human) | | 1e-23 | coronary artery disease | | 10 | 102892566 | 102892567 | Human |
597026602 | GWAS1122676_H | systolic blood pressure QTL GWAS1122676 (human) | | 5e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 102712218 | 102712219 | Human |
597174104 | GWAS1270178_H | protein measurement QTL GWAS1270178 (human) | | 1e-14 | protein measurement | | 10 | 102583671 | 102583672 | Human |
597059415 | GWAS1155489_H | vital capacity QTL GWAS1155489 (human) | | 1e-19 | vital capacity | | 10 | 79165820 | 79165821 | Human |
597100373 | GWAS1196447_H | urinary albumin to creatinine ratio QTL GWAS1196447 (human) | | 1e-09 | urine albumin amount (VT:0002871) | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079885 | 93079886 | Human |
597378904 | GWAS1474978_H | Crohn's disease QTL GWAS1474978 (human) | | 3e-16 | intestine integrity trait (VT:0010554) | | 10 | 99531836 | 99531837 | Human |
597329747 | GWAS1425821_H | neuroticism measurement, cognitive function measurement QTL GWAS1425821 (human) | | 8e-11 | cognitive behavior trait (VT:0010450) | | 10 | 97229002 | 97229003 | Human |
597493591 | GWAS1589665_H | COVID-19 QTL GWAS1589665 (human) | | 0.000004 | COVID-19 | | 10 | 94607436 | 94607437 | Human |
597321552 | GWAS1417626_H | X-12822 measurement QTL GWAS1417626 (human) | | 9e-21 | X-12822 measurement | | 10 | 99849162 | 99849163 | Human |
597403479 | GWAS1499553_H | colorectal cancer QTL GWAS1499553 (human) | | 1e-09 | colorectal cancer | | 10 | 79059375 | 79059376 | Human |
597059418 | GWAS1155492_H | vital capacity QTL GWAS1155492 (human) | | 6e-16 | vital capacity | | 10 | 100687890 | 100687891 | Human |
597059416 | GWAS1155490_H | vital capacity QTL GWAS1155490 (human) | | 7e-15 | vital capacity | | 10 | 93176866 | 93176867 | Human |
597059417 | GWAS1155491_H | vital capacity QTL GWAS1155491 (human) | | 1e-09 | vital capacity | | 10 | 94004859 | 94004860 | Human |
596977477 | GWAS1096996_H | electrocardiography QTL GWAS1096996 (human) | | 4e-20 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597182280 | GWAS1278354_H | pyruvate measurement QTL GWAS1278354 (human) | | 1e-10 | pyruvate measurement | blood pyruvate level (CMO:0002422) | 10 | 98266968 | 98266969 | Human |
596977479 | GWAS1096998_H | electrocardiography QTL GWAS1096998 (human) | | 2e-16 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
596977478 | GWAS1096997_H | electrocardiography QTL GWAS1096997 (human) | | 1e-12 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597133123 | GWAS1229197_H | 2-O-methylascorbic acid measurement, sex interaction measurement QTL GWAS1229197 (human) | | 0.000003 | 2-O-methylascorbic acid measurement, sex interaction measurement | | 10 | 96247971 | 96247972 | Human |
596977485 | GWAS1097004_H | electrocardiography QTL GWAS1097004 (human) | | 4e-14 | functional brain measurement, language measurement | | 10 | 94278929 | 94278930 | Human |
596977484 | GWAS1097003_H | electrocardiography QTL GWAS1097003 (human) | | 3e-14 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597264192 | GWAS1360266_H | diastolic blood pressure QTL GWAS1360266 (human) | | 6e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 100315722 | 100315723 | Human |
596977481 | GWAS1097000_H | electrocardiography QTL GWAS1097000 (human) | | 1e-19 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597583682 | GWAS1640542_H | mean corpuscular hemoglobin concentration QTL GWAS1640542 (human) | | 2e-23 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 102869254 | 102869255 | Human |
596977480 | GWAS1096999_H | electrocardiography QTL GWAS1096999 (human) | | 2e-18 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
596977483 | GWAS1097002_H | electrocardiography QTL GWAS1097002 (human) | | 1e-16 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597190470 | GWAS1286544_H | hippocampal amigdala transition area volume QTL GWAS1286544 (human) | | 2e-09 | hippocampal amigdala transition area volume | | 10 | 102876519 | 102876520 | Human |
596977482 | GWAS1097001_H | electrocardiography QTL GWAS1097001 (human) | | 7e-19 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597583681 | GWAS1640541_H | mean corpuscular hemoglobin concentration QTL GWAS1640541 (human) | | 8e-36 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 99520522 | 99520523 | Human |
597034870 | GWAS1130944_H | type 2 diabetes mellitus QTL GWAS1130944 (human) | | 2e-29 | type 2 diabetes mellitus | | 10 | 79193069 | 79193070 | Human |
597034871 | GWAS1130945_H | type 2 diabetes mellitus QTL GWAS1130945 (human) | | 0.0000004 | type 2 diabetes mellitus | | 10 | 92164906 | 92164907 | Human |
597067637 | GWAS1163711_H | neutrophil count QTL GWAS1163711 (human) | | 7e-10 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 97218288 | 97218289 | Human |
597510009 | GWAS1606083_H | eosinophil count QTL GWAS1606083 (human) | | 1e-15 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 92669710 | 92669711 | Human |
597460856 | GWAS1556930_H | diastolic blood pressure QTL GWAS1556930 (human) | | 8e-09 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 101357896 | 101357897 | Human |
597460852 | GWAS1556926_H | diastolic blood pressure QTL GWAS1556926 (human) | | 8e-38 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 100793890 | 100793891 | Human |
597460853 | GWAS1556927_H | diastolic blood pressure QTL GWAS1556927 (human) | | 3e-08 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 100861657 | 100861658 | Human |
597026687 | GWAS1122761_H | body mass index QTL GWAS1122761 (human) | | 1e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 85731093 | 85731094 | Human |
597321584 | GWAS1417658_H | 3-hydroxy-2-ethylpropionate measurement QTL GWAS1417658 (human) | | 6e-31 | 3-hydroxy-2-ethylpropionate measurement | | 10 | 95177738 | 95177739 | Human |
597460854 | GWAS1556928_H | diastolic blood pressure QTL GWAS1556928 (human) | | 1e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 100883508 | 100883509 | Human |
597460855 | GWAS1556929_H | diastolic blood pressure QTL GWAS1556929 (human) | | 7e-11 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 100913306 | 100913307 | Human |
597460848 | GWAS1556922_H | diastolic blood pressure QTL GWAS1556922 (human) | | 3e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 94890571 | 94890572 | Human |
597460849 | GWAS1556923_H | diastolic blood pressure QTL GWAS1556923 (human) | | 6e-11 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 95262119 | 95262120 | Human |
597600112 | GWAS1656972_H | basophil measurement QTL GWAS1656972 (human) | | 8e-13 | basophil measurement | | 10 | 87938433 | 87938434 | Human |
597034872 | GWAS1130946_H | type 2 diabetes mellitus QTL GWAS1130946 (human) | | 1e-08 | type 2 diabetes mellitus | | 10 | 92702670 | 92702671 | Human |
597460850 | GWAS1556924_H | diastolic blood pressure QTL GWAS1556924 (human) | | 1e-08 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 100367735 | 100367736 | Human |
597034873 | GWAS1130947_H | type 2 diabetes mellitus QTL GWAS1130947 (human) | | 0.0000005 | type 2 diabetes mellitus | | 10 | 92719350 | 92719351 | Human |
597239670 | GWAS1335744_H | Myopia QTL GWAS1335744 (human) | | 0.000007 | Myopia | | 10 | 96243628 | 96243629 | Human |
597460851 | GWAS1556925_H | diastolic blood pressure QTL GWAS1556925 (human) | | 4e-11 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 100643925 | 100643926 | Human |
597460844 | GWAS1556918_H | diastolic blood pressure QTL GWAS1556918 (human) | | 2e-25 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 94140247 | 94140248 | Human |
597460845 | GWAS1556919_H | diastolic blood pressure QTL GWAS1556919 (human) | | 1e-12 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 94210790 | 94210791 | Human |
597477230 | GWAS1573304_H | testosterone measurement QTL GWAS1573304 (human) | | 2e-14 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 91887655 | 91887656 | Human |
597460846 | GWAS1556920_H | diastolic blood pressure QTL GWAS1556920 (human) | | 8e-13 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 94257826 | 94257827 | Human |
597460847 | GWAS1556921_H | diastolic blood pressure QTL GWAS1556921 (human) | | 9e-54 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 94278929 | 94278930 | Human |
597346158 | GWAS1442232_H | epilepsy QTL GWAS1442232 (human) | | 2e-12 | brain integrity trait (VT:0010579) | | 10 | 101806203 | 101806204 | Human |
597337966 | GWAS1434040_H | schizophrenia, gastroesophageal reflux disease QTL GWAS1434040 (human) | | 1e-11 | schizophrenia, gastroesophageal reflux disease | | 10 | 102866129 | 102866130 | Human |
597346159 | GWAS1442233_H | epilepsy QTL GWAS1442233 (human) | | 5e-08 | brain integrity trait (VT:0010579) | | 10 | 102279217 | 102279218 | Human |
597460842 | GWAS1556916_H | diastolic blood pressure QTL GWAS1556916 (human) | | 2e-08 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 80454830 | 80454831 | Human |
407092405 | GWAS741381_H | response to cisplatin, platinum measurement QTL GWAS741381 (human) | | 0.000002 | response to cisplatin, platinum measurement | | 10 | 84018619 | 84018620 | Human |
597460843 | GWAS1556917_H | diastolic blood pressure QTL GWAS1556917 (human) | | 3e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 93983330 | 93983331 | Human |
597591910 | GWAS1648770_H | seborrheic dermatitis QTL GWAS1648770 (human) | | 2e-18 | seborrheic dermatitis | | 10 | 79287626 | 79287627 | Human |
597403488 | GWAS1499562_H | prostate carcinoma QTL GWAS1499562 (human) | | 2e-10 | prostate carcinoma | | 10 | 79066140 | 79066141 | Human |
597075818 | GWAS1171892_H | heel bone mineral density QTL GWAS1171892 (human) | | 4e-08 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 77651982 | 77651983 | Human |
597075819 | GWAS1171893_H | heel bone mineral density QTL GWAS1171893 (human) | | 0.0000004 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 87796054 | 87796055 | Human |
407305403 | GWAS954379_H | asthma QTL GWAS954379 (human) | | 5e-08 | asthma | | 10 | 102753292 | 102753293 | Human |
597608093 | GWAS1664953_H | triglyceride measurement QTL GWAS1664953 (human) | | 3e-80 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079885 | 93079886 | Human |
407051591 | GWAS700567_H | urinary arsenic measurement QTL GWAS700567 (human) | | 3e-08 | urinary arsenic measurement | | 10 | 102939221 | 102939222 | Human |
597051024 | GWAS1147098_H | Parkinson disease QTL GWAS1147098 (human) | | 1e-09 | Parkinson disease | | 10 | 102255522 | 102255523 | Human |
597034641 | GWAS1130715_H | TPE interval measurement QTL GWAS1130715 (human) | | 2e-12 | TPE interval measurement | | 10 | 79111306 | 79111307 | Human |
407027013 | GWAS675989_H | serum IgG glycosylation measurement QTL GWAS675989 (human) | | 0.000006 | serum IgG glycosylation measurement | | 10 | 95541247 | 95541248 | Human |
597313170 | GWAS1409244_H | total cholesterol measurement QTL GWAS1409244 (human) | | 3e-12 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 86762651 | 86762652 | Human |
597411474 | GWAS1507548_H | age at menopause QTL GWAS1507548 (human) | | 2e-20 | age at menopause | | 10 | 96044240 | 96044241 | Human |
597206674 | GWAS1302748_H | birth weight QTL GWAS1302748 (human) | | 4e-23 | birth weight | neonatal body weight (CMO:0002079) | 10 | 92719350 | 92719351 | Human |
597206675 | GWAS1302749_H | birth weight QTL GWAS1302749 (human) | | 4e-10 | birth weight | neonatal body weight (CMO:0002079) | 10 | 94265734 | 94265735 | Human |
597419664 | GWAS1515738_H | sex hormone-binding globulin measurement QTL GWAS1515738 (human) | | 3e-08 | sex hormone-binding globulin measurement | | 10 | 101828101 | 101828102 | Human |
407059791 | GWAS708767_H | mean arterial pressure QTL GWAS708767 (human) | | 0.000001 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 102836092 | 102836093 | Human |
406920529 | GWAS569505_H | smoking behavior QTL GWAS569505 (human) | | 4e-08 | smoking behavior | | 10 | 101427081 | 101427082 | Human |
597108358 | GWAS1204432_H | C-reactive protein measurement QTL GWAS1204432 (human) | | 2e-09 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 89247603 | 89247604 | Human |
597304968 | GWAS1401042_H | metabolonic lactone sulfate measurement QTL GWAS1401042 (human) | | 6e-17 | metabolonic lactone sulfate measurement | | 10 | 94732786 | 94732787 | Human |
597411465 | GWAS1507539_H | age at menopause QTL GWAS1507539 (human) | | 3e-22 | age at menopause | | 10 | 96044240 | 96044241 | Human |
407059792 | GWAS708768_H | mean arterial pressure QTL GWAS708768 (human) | | 0.000001 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 103179458 | 103179459 | Human |
597395086 | GWAS1491160_H | total cholesterol measurement QTL GWAS1491160 (human) | | 3e-11 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 88045653 | 88045654 | Human |
597452425 | GWAS1548499_H | serum gamma-glutamyl transferase measurement QTL GWAS1548499 (human) | | 1e-11 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 100980303 | 100980304 | Human |
597501579 | GWAS1597653_H | severe acute respiratory syndrome, COVID-19 QTL GWAS1597653 (human) | | 2e-09 | severe acute respiratory syndrome, COVID-19 | | 10 | 79006250 | 79006251 | Human |
597395085 | GWAS1491159_H | total cholesterol measurement QTL GWAS1491159 (human) | | 2e-08 | total cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 10 | 80524756 | 80524757 | Human |
406920535 | GWAS569511_H | smoking behavior QTL GWAS569511 (human) | | 4e-08 | smoking behavior | | 10 | 85705377 | 85705378 | Human |
407051605 | GWAS700581_H | post-traumatic stress disorder QTL GWAS700581 (human) | | 0.000005 | post-traumatic stress disorder | | 10 | 85848703 | 85848704 | Human |
597395072 | GWAS1491146_H | total cholesterol measurement QTL GWAS1491146 (human) | | 1e-28 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 100244149 | 100244150 | Human |
597075593 | GWAS1171667_H | selective IgA deficiency disease QTL GWAS1171667 (human) | | 0.000007 | selective IgA deficiency disease | | 10 | 79379069 | 79379070 | Human |
597173944 | GWAS1270018_H | left ventricular mass index QTL GWAS1270018 (human) | | 0.0000001 | left ventricular mass index | heart left ventricle weight to body weight ratio (CMO:0000530) | 10 | 89819910 | 89819911 | Human |
597051063 | GWAS1147137_H | protein measurement QTL GWAS1147137 (human) | | 4e-12 | protein measurement | | 10 | 100045685 | 100045686 | Human |
407084390 | GWAS733366_H | cardioembolic stroke QTL GWAS733366 (human) | | 0.0000006 | cardioembolic stroke | | 10 | 103547967 | 103547968 | Human |
597034672 | GWAS1130746_H | TPE interval measurement QTL GWAS1130746 (human) | | 4e-09 | QT interval | QT interval (CMO:0000235) | 10 | 79114766 | 79114767 | Human |
597616312 | GWAS1673172_H | inflammatory bowel disease QTL GWAS1673172 (human) | | 1e-12 | inflammatory bowel disease | | 10 | 99524480 | 99524481 | Human |
406887783 | GWAS536759_H | dental caries QTL GWAS536759 (human) | | 0.000003 | dental caries | | 10 | 86183852 | 86183853 | Human |
406887786 | GWAS536762_H | dental caries QTL GWAS536762 (human) | | 0.000004 | dental caries | | 10 | 86183852 | 86183853 | Human |
597493430 | GWAS1589504_H | breast density QTL GWAS1589504 (human) | | 0.0000001 | breast density | | 10 | 91383678 | 91383679 | Human |
597378743 | GWAS1474817_H | neutrophil count QTL GWAS1474817 (human) | | 5e-16 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 102727686 | 102727687 | Human |
597378742 | GWAS1474816_H | neutrophil count QTL GWAS1474816 (human) | | 6e-104 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 97308981 | 97308982 | Human |
596969147 | GWAS1088666_H | triglyceride measurement, diet measurement QTL GWAS1088666 (human) | | 0.000003 | triglyceride measurement, diet measurement | | 10 | 95615511 | 95615512 | Human |
597206697 | GWAS1302771_H | protein measurement QTL GWAS1302771 (human) | | 4e-11 | protein measurement | | 10 | 95296494 | 95296495 | Human |
597608111 | GWAS1664971_H | creatine kinase measurement QTL GWAS1664971 (human) | | 3e-19 | creatine kinase measurement | blood creatine kinase activity level (CMO:0002242) | 10 | 100130207 | 100130208 | Human |
597509807 | GWAS1605881_H | sex hormone-binding globulin measurement QTL GWAS1605881 (human) | | 3e-08 | sex hormone-binding globulin measurement | | 10 | 79334368 | 79334369 | Human |
597501605 | GWAS1597679_H | high density lipoprotein cholesterol measurement QTL GWAS1597679 (human) | | 3e-12 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93063586 | 93063587 | Human |
597100205 | GWAS1196279_H | high density lipoprotein cholesterol measurement QTL GWAS1196279 (human) | | 2e-10 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93024020 | 93024021 | Human |
597157548 | GWAS1253622_H | high density lipoprotein cholesterol measurement QTL GWAS1253622 (human) | | 2e-08 | blood lipid amount (VT:0003949) | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 79347379 | 79347380 | Human |
597501606 | GWAS1597680_H | high density lipoprotein cholesterol measurement QTL GWAS1597680 (human) | | 1e-08 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93549265 | 93549266 | Human |
597501600 | GWAS1597674_H | severe acute respiratory syndrome, COVID-19 QTL GWAS1597674 (human) | | 0.000009 | severe acute respiratory syndrome, COVID-19 | | 10 | 79960935 | 79960936 | Human |
597599904 | GWAS1656764_H | mean corpuscular hemoglobin concentration QTL GWAS1656764 (human) | | 8e-16 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 89246195 | 89246196 | Human |
596952788 | GWAS1072307_H | hypertension QTL GWAS1072307 (human) | | 6e-14 | hypertension | | 10 | 103138144 | 103138145 | Human |
597133013 | GWAS1229087_H | pulse pressure measurement QTL GWAS1229087 (human) | | 5e-15 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 80455532 | 80455533 | Human |
407026945 | GWAS675921_H | serum IgG glycosylation measurement QTL GWAS675921 (human) | | 0.000005 | serum IgG glycosylation measurement | | 10 | 95535832 | 95535833 | Human |
406969605 | GWAS618581_H | parental longevity QTL GWAS618581 (human) | | 0.000009 | total life span (VT:0001661) | | 10 | 84319432 | 84319433 | Human |
597305054 | GWAS1401128_H | coronary artery disease QTL GWAS1401128 (human) | | 2e-13 | coronary artery disease | | 10 | 94269413 | 94269414 | Human |
597305055 | GWAS1401129_H | coronary artery disease QTL GWAS1401129 (human) | | 3e-09 | coronary artery disease | | 10 | 98164006 | 98164007 | Human |
597305052 | GWAS1401126_H | coronary artery disease QTL GWAS1401126 (human) | | 2e-10 | coronary artery disease | | 10 | 80491758 | 80491759 | Human |
597305053 | GWAS1401127_H | coronary artery disease QTL GWAS1401127 (human) | | 1e-28 | coronary artery disease | | 10 | 89247603 | 89247604 | Human |
407125261 | GWAS774237_H | attention deficit hyperactivity disorder QTL GWAS774237 (human) | | 0.000001 | attention deficit hyperactivity disorder | | 10 | 100145180 | 100145181 | Human |
597313239 | GWAS1409313_H | uric acid measurement QTL GWAS1409313 (human) | | 2e-27 | uric acid measurement | blood uric acid level (CMO:0000501) | 10 | 87085433 | 87085434 | Human |
597239510 | GWAS1335584_H | blood protein measurement QTL GWAS1335584 (human) | | 1e-25 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 102556824 | 102556825 | Human |
597247688 | GWAS1343762_H | serum alanine aminotransferase measurement QTL GWAS1343762 (human) | | 7e-28 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100006605 | 100006606 | Human |
597386953 | GWAS1483027_H | acute myeloid leukemia QTL GWAS1483027 (human) | | 1e-13 | leukocyte integrity trait (VT:0010898) | | 10 | 78074409 | 78074410 | Human |
597280459 | GWAS1376533_H | QT interval QTL GWAS1376533 (human) | | 3e-22 | QT interval | QT interval (CMO:0000235) | 10 | 102321592 | 102321593 | Human |
597452490 | GWAS1548564_H | platelet count QTL GWAS1548564 (human) | | 2e-12 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 95790983 | 95790984 | Human |
597247682 | GWAS1343756_H | serum alanine aminotransferase measurement QTL GWAS1343756 (human) | | 2e-35 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100312261 | 100312262 | Human |
597206726 | GWAS1302800_H | Agents acting on the renin-angiotensin system use measurement QTL GWAS1302800 (human) | | 2e-16 | Agents acting on the renin-angiotensin system use measurement | | 10 | 103034147 | 103034148 | Human |
597509826 | GWAS1605900_H | risk-taking behaviour QTL GWAS1605900 (human) | | 1e-11 | risk-taking behaviour | | 10 | 102653628 | 102653629 | Human |
597116663 | GWAS1212737_H | C-reactive protein measurement QTL GWAS1212737 (human) | | 2e-10 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 89222511 | 89222512 | Human |
597083895 | GWAS1179969_H | migraine disorder, diastolic blood pressure QTL GWAS1179969 (human) | | 7e-71 | migraine disorder, diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 94263320 | 94263321 | Human |
597083892 | GWAS1179966_H | migraine disorder, systolic blood pressure QTL GWAS1179966 (human) | | 2e-08 | migraine disorder, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 98900544 | 98900545 | Human |
597083889 | GWAS1179963_H | migraine disorder, systolic blood pressure QTL GWAS1179963 (human) | | 3e-60 | migraine disorder, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94263320 | 94263321 | Human |
406986026 | GWAS635002_H | lysophosphatidylcholine 18:1 measurement QTL GWAS635002 (human) | | 0.000007 | blood lipid amount (VT:0003949) | | 10 | 81335476 | 81335477 | Human |
597419761 | GWAS1515835_H | gout QTL GWAS1515835 (human) | | 5e-22 | gout | | 10 | 87199944 | 87199945 | Human |
597092093 | GWAS1188167_H | ulcerative colitis QTL GWAS1188167 (human) | | 0.000002 | ulcerative colitis | | 10 | 92704550 | 92704551 | Human |
597075706 | GWAS1171780_H | disposition index measurement QTL GWAS1171780 (human) | | 0.000003 | disposition index measurement | whole body insulin sensitivity index (CMO:0003001) | 10 | 92710223 | 92710224 | Human |
597386999 | GWAS1483073_H | mean arterial pressure QTL GWAS1483073 (human) | | 2e-11 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 102834750 | 102834751 | Human |
597386998 | GWAS1483072_H | mean arterial pressure QTL GWAS1483072 (human) | | 0.0000005 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 100344764 | 100344765 | Human |
597141240 | GWAS1237314_H | myristoleate 14:1n5 measurement QTL GWAS1237314 (human) | | 5e-14 | palmitoleoylcarnitine (C16:1) measurement | | 10 | 100315722 | 100315723 | Human |
597083878 | GWAS1179952_H | coronary artery disease QTL GWAS1179952 (human) | | 4e-29 | coronary artery disease | | 10 | 89243170 | 89243171 | Human |
597321450 | GWAS1417524_H | JT interval QTL GWAS1417524 (human) | | 4e-17 | heart electrical impulse conduction trait (VT:2000017) | heart electrical conduction measurement (CMO:0000230) | 10 | 89508037 | 89508038 | Human |
597321451 | GWAS1417525_H | orofacial cleft, sex interaction measurement QTL GWAS1417525 (human) | | 0.000002 | orofacial cleft, sex interaction measurement | | 10 | 94030306 | 94030307 | Human |
597321449 | GWAS1417523_H | JT interval QTL GWAS1417523 (human) | | 5e-09 | heart electrical impulse conduction trait (VT:2000017) | heart electrical conduction measurement (CMO:0000230) | 10 | 79113485 | 79113486 | Human |
597083877 | GWAS1179951_H | coronary artery disease QTL GWAS1179951 (human) | | 0.000003 | coronary artery disease | | 10 | 80482174 | 80482175 | Human |
597419758 | GWAS1515832_H | gout QTL GWAS1515832 (human) | | 3e-08 | gout | | 10 | 86753161 | 86753162 | Human |
597403373 | GWAS1499447_H | tea consumption measurement QTL GWAS1499447 (human) | | 0.0000008 | tea consumption measurement | drink intake measurement (CMO:0000771) | 10 | 85600966 | 85600967 | Human |
406961463 | GWAS610439_H | neutrophil count, eosinophil count QTL GWAS610439 (human) | | 6e-39 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 97314229 | 97314234 | Human |
406961462 | GWAS610438_H | neutrophil count, eosinophil count QTL GWAS610438 (human) | | 6e-09 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 89245159 | 89245160 | Human |
597305056 | GWAS1401130_H | coronary artery disease QTL GWAS1401130 (human) | | 3e-15 | coronary artery disease | | 10 | 103016448 | 103016449 | Human |
597460711 | GWAS1556785_H | triglyceride measurement QTL GWAS1556785 (human) | | 0.0000007 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 91584031 | 91584032 | Human |
597419751 | GWAS1515825_H | gout QTL GWAS1515825 (human) | | 4e-21 | gout | | 10 | 87180205 | 87180206 | Human |
597436129 | GWAS1532203_H | serum alanine aminotransferase measurement QTL GWAS1532203 (human) | | 5e-09 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 77786236 | 77786237 | Human |
597436130 | GWAS1532204_H | serum alanine aminotransferase measurement QTL GWAS1532204 (human) | | 1e-10 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 96700824 | 96700825 | Human |
406961600 | GWAS610576_H | response to vaccine QTL GWAS610576 (human) | | 0.0000005 | response to vaccine | | 10 | 95037713 | 95037714 | Human |
597206554 | GWAS1302628_H | type 2 diabetes mellitus QTL GWAS1302628 (human) | | 3e-11 | type 2 diabetes mellitus | | 10 | 79205218 | 79205219 | Human |
597206555 | GWAS1302629_H | type 2 diabetes mellitus QTL GWAS1302629 (human) | | 9e-40 | type 2 diabetes mellitus | | 10 | 92722319 | 92722320 | Human |
597206556 | GWAS1302630_H | type 2 diabetes mellitus QTL GWAS1302630 (human) | | 1e-09 | type 2 diabetes mellitus | | 10 | 100216744 | 100216745 | Human |
597075474 | GWAS1171548_H | body mass index QTL GWAS1171548 (human) | | 2e-15 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100635683 | 100635684 | Human |
597280284 | GWAS1376358_H | arginine measurement QTL GWAS1376358 (human) | | 1e-16 | arginine measurement | | 10 | 98386156 | 98386157 | Human |
597591577 | GWAS1648437_H | coronary atherosclerosis QTL GWAS1648437 (human) | | 9e-38 | coronary atherosclerosis | | 10 | 89243047 | 89243048 | Human |
597452308 | GWAS1548382_H | monocyte count QTL GWAS1548382 (human) | | 6e-11 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 99532633 | 99532634 | Human |
596968988 | GWAS1088507_H | Alzheimer disease QTL GWAS1088507 (human) | | 0.0000007 | Alzheimer disease | | 10 | 96266650 | 96266651 | Human |
597607954 | GWAS1664814_H | triglyceride measurement QTL GWAS1664814 (human) | | 1e-70 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079885 | 93079886 | Human |
597403158 | GWAS1499232_H | prostate carcinoma QTL GWAS1499232 (human) | | 7e-09 | prostate carcinoma | | 10 | 78501181 | 78501184 | Human |
597288470 | GWAS1384544_H | myocardial infarction QTL GWAS1384544 (human) | | 5e-08 | myocardial infarction | | 10 | 89246195 | 89246196 | Human |
597427731 | GWAS1523805_H | serum gamma-glutamyl transferase measurement QTL GWAS1523805 (human) | | 3e-15 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 100980303 | 100980304 | Human |
407027154 | GWAS676130_H | response to antineoplastic agent QTL GWAS676130 (human) | | 0.000007 | response to antineoplastic agent | | 10 | 80617834 | 80617835 | Human |
597140999 | GWAS1237073_H | X-17654 measurement QTL GWAS1237073 (human) | | 3e-13 | X-17654 measurement | | 10 | 94988738 | 94988739 | Human |
597091844 | GWAS1187918_H | balding measurement QTL GWAS1187918 (human) | | 4e-09 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 10 | 86233584 | 86233585 | Human |
597124609 | GWAS1220683_H | calcium measurement QTL GWAS1220683 (human) | | 3e-13 | brain measurement | blood calcium level (CMO:0000502) | 10 | 94279840 | 94279841 | Human |
597124608 | GWAS1220682_H | calcium measurement QTL GWAS1220682 (human) | | 1e-19 | calcium measurement | blood calcium level (CMO:0000502) | 10 | 79240172 | 79240174 | Human |
597206531 | GWAS1302605_H | protein measurement QTL GWAS1302605 (human) | | 2e-08 | protein measurement | | 10 | 89169204 | 89169205 | Human |
596968974 | GWAS1088493_H | rheumatoid arthritis, irritable bowel syndrome QTL GWAS1088493 (human) | | 3e-09 | rheumatoid arthritis, irritable bowel syndrome | | 10 | 99531836 | 99531837 | Human |
597313031 | GWAS1409105_H | uric acid measurement QTL GWAS1409105 (human) | | 1e-10 | uric acid measurement | blood uric acid level (CMO:0000501) | 10 | 79184390 | 79184391 | Human |
596960820 | GWAS1080339_H | QT interval QTL GWAS1080339 (human) | | 4e-09 | QT interval | | 10 | 79114766 | 79114767 | Human |
596977205 | GWAS1096724_H | calcium measurement QTL GWAS1096724 (human) | | 5e-16 | calcium measurement | | 10 | 94278929 | 94278930 | Human |
597157431 | GWAS1253505_H | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1253505 (human) | | 2e-10 | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 102331339 | 102331340 | Human |
597149234 | GWAS1245308_H | endometriosis QTL GWAS1245308 (human) | | 2e-10 | endometriosis | | 10 | 88423007 | 88423008 | Human |
406969832 | GWAS618808_H | triglyceride measurement, trait in response to hydrochlorothiazide QTL GWAS618808 (human) | | 0.000002 | triglyceride measurement, trait in response to hydrochlorothiazide | blood triglyceride level (CMO:0000118) | 10 | 100496440 | 100496441 | Human |
597018169 | GWAS1114243_H | intelligence QTL GWAS1114243 (human) | | 0.000001 | intelligence | | 10 | 91682483 | 91682484 | Human |
597419573 | GWAS1515647_H | adiponectin measurement QTL GWAS1515647 (human) | | 0.000003 | adiponectin measurement | blood adiponectin level (CMO:0000485) | 10 | 78440850 | 78440851 | Human |
597394984 | GWAS1491058_H | vaginal microbiome measurement QTL GWAS1491058 (human) | | 2e-08 | vaginal microbiome measurement | | 10 | 89401598 | 89401599 | Human |
597149218 | GWAS1245292_H | systolic blood pressure QTL GWAS1245292 (human) | | 3e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94371764 | 94371765 | Human |
597149217 | GWAS1245291_H | systolic blood pressure QTL GWAS1245291 (human) | | 2e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 93983330 | 93983331 | Human |
597050913 | GWAS1146987_H | prostate carcinoma QTL GWAS1146987 (human) | | 7e-09 | prostate carcinoma | | 10 | 88435392 | 88435393 | Human |
597394977 | GWAS1491051_H | vaginal microbiome measurement QTL GWAS1491051 (human) | | 4e-08 | vaginal microbiome measurement | | 10 | 89401598 | 89401599 | Human |
597091927 | GWAS1188001_H | inflammatory bowel disease QTL GWAS1188001 (human) | | 1e-15 | inflammatory bowel disease | | 10 | 80491075 | 80491076 | Human |
597149270 | GWAS1245344_H | plasma clozapine-to-N-desmethylclozapine ratio measurement QTL GWAS1245344 (human) | | 5e-22 | plasma clozapine-to-N-desmethylclozapine ratio measurement | | 10 | 94725020 | 94725021 | Human |
597182044 | GWAS1278118_H | body mass index QTL GWAS1278118 (human) | | 5e-18 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 85651147 | 85651148 | Human |
597182045 | GWAS1278119_H | body mass index QTL GWAS1278119 (human) | | 4e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 86249028 | 86249029 | Human |
597182046 | GWAS1278120_H | body mass index QTL GWAS1278120 (human) | | 3e-14 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 86359258 | 86359259 | Human |
597288543 | GWAS1384617_H | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1384617 (human) | | 2e-09 | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 102347434 | 102347435 | Human |
597182047 | GWAS1278121_H | body mass index QTL GWAS1278121 (human) | | 2e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 91273186 | 91273187 | Human |
597124703 | GWAS1220777_H | calcium measurement QTL GWAS1220777 (human) | | 4e-13 | calcium measurement | blood calcium level (CMO:0000502) | 10 | 92690476 | 92690477 | Human |
597280336 | GWAS1376410_H | androstenediol (3alpha, 17alpha) monosulfate (3) measurement QTL GWAS1376410 (human) | | 5e-20 | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | | 10 | 95064055 | 95064056 | Human |
597280339 | GWAS1376413_H | 16a-hydroxy DHEA 3-sulfate measurement QTL GWAS1376413 (human) | | 3e-17 | 16a-hydroxy DHEA 3-sulfate measurement | | 10 | 95001432 | 95001433 | Human |
597468755 | GWAS1564829_H | protein measurement QTL GWAS1564829 (human) | | 1e-14 | protein measurement | | 10 | 79293803 | 79293804 | Human |
596952667 | GWAS1072186_H | body mass index QTL GWAS1072186 (human) | | 6e-13 | body mass index | | 10 | 100687890 | 100687891 | Human |
597026373 | GWAS1122447_H | social interaction measurement QTL GWAS1122447 (human) | | 1e-08 | social interaction measurement | voluntary social interaction measurement (CMO:0002676) | 10 | 100866753 | 100866754 | Human |
597313099 | GWAS1409173_H | X-21258 measurement QTL GWAS1409173 (human) | | 5e-20 | X-21258 measurement | | 10 | 94797455 | 94797456 | Human |
597321289 | GWAS1417363_H | type 2 diabetes mellitus QTL GWAS1417363 (human) | | 7e-09 | type 2 diabetes mellitus | | 10 | 92664665 | 92664666 | Human |
597313100 | GWAS1409174_H | X-21258 measurement QTL GWAS1409174 (human) | | 5e-16 | X-21258 measurement | | 10 | 94797455 | 94797456 | Human |
597378626 | GWAS1474700_H | lung carcinoma QTL GWAS1474700 (human) | | 0.000001 | lung carcinoma | | 10 | 88967577 | 88967578 | Human |
407125405 | GWAS774381_H | response to anticoagulant QTL GWAS774381 (human) | | 0.0000003 | response to anticoagulant | | 10 | 94787706 | 94787707 | Human |
597296710 | GWAS1392784_H | neutrophil collagenase measurement QTL GWAS1392784 (human) | | 3e-11 | neutrophil collagenase measurement | | 10 | 100028551 | 100028552 | Human |
597190213 | GWAS1286287_H | sex hormone-binding globulin measurement QTL GWAS1286287 (human) | | 6e-17 | sex hormone-binding globulin measurement | | 10 | 91775436 | 91775437 | Human |
597280324 | GWAS1376398_H | cyclo(leu-pro) measurement QTL GWAS1376398 (human) | | 2e-23 | blood dipeptide amount (VT:0010987) | | 10 | 94748243 | 94748244 | Human |
597304900 | GWAS1400974_H | coronary artery disease QTL GWAS1400974 (human) | | 3e-15 | coronary artery disease | | 10 | 102938024 | 102938025 | Human |
597272185 | GWAS1368259_H | high density lipoprotein cholesterol measurement QTL GWAS1368259 (human) | | 1e-10 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 79194494 | 79194495 | Human |
596969077 | GWAS1088596_H | body height QTL GWAS1088596 (human) | | 6e-27 | body height | | 10 | 100899178 | 100899179 | Human |
596969076 | GWAS1088595_H | body height QTL GWAS1088595 (human) | | 2e-19 | body height | | 10 | 91167510 | 91167511 | Human |
407199143 | GWAS848119_H | gut microbiome measurement, bone density QTL GWAS848119 (human) | | 5e-09 | gut microbiome measurement, bone density | | 10 | 85698195 | 85698196 | Human |
597272187 | GWAS1368261_H | high density lipoprotein cholesterol measurement QTL GWAS1368261 (human) | | 7e-13 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93583015 | 93583016 | Human |
407199142 | GWAS848118_H | gut microbiome measurement, bone density QTL GWAS848118 (human) | | 2e-08 | gut microbiome measurement, bone density | | 10 | 85661057 | 85661058 | Human |
597272186 | GWAS1368260_H | high density lipoprotein cholesterol measurement QTL GWAS1368260 (human) | | 1e-09 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 92515052 | 92515053 | Human |
597395071 | GWAS1491145_H | total cholesterol measurement QTL GWAS1491145 (human) | | 3e-39 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 93079967 | 93079968 | Human |
597272188 | GWAS1368262_H | high density lipoprotein cholesterol measurement QTL GWAS1368262 (human) | | 6e-16 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 100152307 | 100152308 | Human |
597583478 | GWAS1640338_H | mean corpuscular hemoglobin concentration QTL GWAS1640338 (human) | | 4e-11 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 89249116 | 89249117 | Human |
597304944 | GWAS1401018_H | erythrocyte count QTL GWAS1401018 (human) | | 9e-09 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 102134967 | 102134968 | Human |
597091942 | GWAS1188016_H | Alzheimer disease, age at onset QTL GWAS1188016 (human) | | 0.0000003 | Alzheimer disease, age at onset | | 10 | 90679092 | 90679093 | Human |
597182056 | GWAS1278130_H | body mass index QTL GWAS1278130 (human) | | 3e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100796418 | 100796419 | Human |
597182057 | GWAS1278131_H | body mass index QTL GWAS1278131 (human) | | 4e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 101446358 | 101446359 | Human |
597296744 | GWAS1392818_H | acylcarnitine measurement QTL GWAS1392818 (human) | | 1e-19 | acylcarnitine measurement | | 10 | 100315722 | 100315723 | Human |
597075556 | GWAS1171630_H | intelligence QTL GWAS1171630 (human) | | 1e-17 | intelligence | | 10 | 101742008 | 101742009 | Human |
597263979 | GWAS1360053_H | triglyceride measurement QTL GWAS1360053 (human) | | 5e-14 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 102186723 | 102186724 | Human |
597263978 | GWAS1360052_H | triglyceride measurement QTL GWAS1360052 (human) | | 5e-09 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 94256036 | 94256037 | Human |
597419624 | GWAS1515698_H | colorectal cancer QTL GWAS1515698 (human) | | 1e-10 | colorectal cancer | | 10 | 99530544 | 99530545 | Human |
597075557 | GWAS1171631_H | intelligence QTL GWAS1171631 (human) | | 9e-10 | intelligence | | 10 | 102312216 | 102312217 | Human |
597075554 | GWAS1171628_H | intelligence QTL GWAS1171628 (human) | | 1e-09 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 10 | 102120361 | 102120362 | Human |
597026401 | GWAS1122475_H | hypertension QTL GWAS1122475 (human) | | 0.000005 | hypertension | | 10 | 102794772 | 102794773 | Human |
597075555 | GWAS1171629_H | intelligence QTL GWAS1171629 (human) | | 4e-08 | intelligence | | 10 | 102055738 | 102055739 | Human |
597091936 | GWAS1188010_H | inflammatory bowel disease QTL GWAS1188010 (human) | | 5e-20 | inflammatory bowel disease | | 10 | 79286696 | 79286697 | Human |
597075552 | GWAS1171626_H | intelligence QTL GWAS1171626 (human) | | 6e-09 | intelligence | | 10 | 102082608 | 102082609 | Human |
597124704 | GWAS1220778_H | calcium measurement QTL GWAS1220778 (human) | | 9e-12 | calcium measurement | blood calcium level (CMO:0000502) | 10 | 98420094 | 98420095 | Human |
597182048 | GWAS1278122_H | body mass index QTL GWAS1278122 (human) | | 3e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 95384069 | 95384070 | Human |
597182049 | GWAS1278123_H | body mass index QTL GWAS1278123 (human) | | 1e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 97215656 | 97215657 | Human |
597182051 | GWAS1278125_H | body mass index QTL GWAS1278125 (human) | | 5e-21 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98018469 | 98018470 | Human |
597182052 | GWAS1278126_H | body mass index QTL GWAS1278126 (human) | | 3e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98128586 | 98128587 | Human |
596969065 | GWAS1088584_H | body height QTL GWAS1088584 (human) | | 2e-15 | body height | | 10 | 102882480 | 102882481 | Human |
597182053 | GWAS1278127_H | body mass index QTL GWAS1278127 (human) | | 3e-18 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100635683 | 100635684 | Human |
597403237 | GWAS1499311_H | inflammatory bowel disease QTL GWAS1499311 (human) | | 2e-63 | inflammatory bowel disease | | 10 | 99523573 | 99523574 | Human |
597182054 | GWAS1278128_H | body mass index QTL GWAS1278128 (human) | | 8e-20 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100687890 | 100687891 | Human |
597059176 | GWAS1155250_H | reaction time measurement QTL GWAS1155250 (human) | | 0.000009 | cognitive behavior trait (VT:0010450) | | 10 | 102728114 | 102728115 | Human |
597182055 | GWAS1278129_H | body mass index QTL GWAS1278129 (human) | | 6e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100710675 | 100710676 | Human |
597075561 | GWAS1171635_H | intelligence QTL GWAS1171635 (human) | | 4e-09 | intelligence | | 10 | 102322931 | 102322932 | Human |
597493149 | GWAS1589223_H | wheezing QTL GWAS1589223 (human) | | 0.000001 | wheezing | | 10 | 89436645 | 89436646 | Human |
597312922 | GWAS1408996_H | diastolic blood pressure QTL GWAS1408996 (human) | | 7e-16 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 94136959 | 94136960 | Human |
597247385 | GWAS1343459_H | electrocardiography QTL GWAS1343459 (human) | | 7e-09 | electrocardiography | | 10 | 97215008 | 97215009 | Human |
407051843 | GWAS700819_H | triacylglycerol 58:9 measurement QTL GWAS700819 (human) | | 0.0000007 | blood triglyceride amount (VT:0002644) | | 10 | 102265653 | 102265654 | Human |
597247387 | GWAS1343461_H | electrocardiography QTL GWAS1343461 (human) | | 9e-09 | electrocardiography | | 10 | 97215008 | 97215009 | Human |
597247386 | GWAS1343460_H | electrocardiography QTL GWAS1343460 (human) | | 3e-08 | electrocardiography | | 10 | 97215008 | 97215009 | Human |
407051844 | GWAS700820_H | triacylglycerol 58:9 measurement QTL GWAS700820 (human) | | 0.0000009 | blood triglyceride amount (VT:0002644) | | 10 | 102383043 | 102383044 | Human |
597271953 | GWAS1368027_H | low density lipoprotein cholesterol measurement QTL GWAS1368027 (human) | | 6e-29 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 93079885 | 93079886 | Human |
597247379 | GWAS1343453_H | asthma QTL GWAS1343453 (human) | | 4e-08 | asthma | | 10 | 80486993 | 80486994 | Human |
597460374 | GWAS1556448_H | atrial fibrillation QTL GWAS1556448 (human) | | 5e-58 | atrial fibrillation | | 10 | 103582915 | 103582916 | Human |
597271954 | GWAS1368028_H | low density lipoprotein cholesterol measurement QTL GWAS1368028 (human) | | 1e-08 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 94341607 | 94341608 | Human |
596977049 | GWAS1096568_H | body height QTL GWAS1096568 (human) | | 2e-08 | body height | | 10 | 79406998 | 79406999 | Human |
597616016 | GWAS1672876_H | osteitis deformans QTL GWAS1672876 (human) | | 2e-12 | osteitis deformans | | 10 | 94173701 | 94173702 | Human |
597460371 | GWAS1556445_H | atrial fibrillation QTL GWAS1556445 (human) | | 2e-11 | atrial fibrillation | | 10 | 102230055 | 102230056 | Human |
597460367 | GWAS1556441_H | atrial fibrillation QTL GWAS1556441 (human) | | 1e-47 | atrial fibrillation | | 10 | 103582915 | 103582916 | Human |
407166545 | GWAS815521_H | unipolar depression QTL GWAS815521 (human) | | 2e-10 | unipolar depression | | 10 | 102660997 | 102660998 | Human |
407182930 | GWAS831906_H | lean body mass QTL GWAS831906 (human) | | 0.0000003 | lean body mass | | 10 | 94278929 | 94278930 | Human |
597607812 | GWAS1664672_H | multiple myeloma QTL GWAS1664672 (human) | | 8e-12 | multiple myeloma | | 10 | 82654167 | 82654168 | Human |
597075340 | GWAS1171414_H | mean arterial pressure QTL GWAS1171414 (human) | | 0.000001 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 94804000 | 94804001 | Human |
597091724 | GWAS1187798_H | white matter hyperintensity measurement QTL GWAS1187798 (human) | | 3e-08 | white matter hyperintensity measurement | | 10 | 103416422 | 103416423 | Human |
597607813 | GWAS1664673_H | multiple myeloma QTL GWAS1664673 (human) | | 2e-11 | multiple myeloma | | 10 | 87033831 | 87033832 | Human |
597067146 | GWAS1163220_H | susceptibility to Mycobacterium tuberculosis infection measurement QTL GWAS1163220 (human) | | 0.0000008 | response to bacterial infection trait (VT:0010435) | | 10 | 92458541 | 92458542 | Human |
597116298 | GWAS1212372_H | DNA methylation QTL GWAS1212372 (human) | | 7e-09 | DNA methylation | | 10 | 93676847 | 93676848 | Human |
597026231 | GWAS1122305_H | blood protein measurement QTL GWAS1122305 (human) | | 7e-09 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 93600270 | 93600271 | Human |
597091764 | GWAS1187838_H | white matter hyperintensity measurement QTL GWAS1187838 (human) | | 2e-09 | white matter hyperintensity measurement | | 10 | 103416422 | 103416423 | Human |
597337529 | GWAS1433603_H | sexual dimorphism measurement QTL GWAS1433603 (human) | | 5e-12 | sexual dimorphism measurement | | 10 | 79377944 | 79377947 | Human |
597517758 | GWAS1613832_H | urate measurement QTL GWAS1613832 (human) | | 7e-20 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 87090012 | 87090013 | Human |
597042610 | GWAS1138684_H | intraocular pressure measurement QTL GWAS1138684 (human) | | 2e-11 | intraocular pressure measurement | | 10 | 93016722 | 93016723 | Human |
597091763 | GWAS1187837_H | white matter hyperintensity measurement QTL GWAS1187837 (human) | | 6e-09 | white matter hyperintensity measurement | | 10 | 103559652 | 103559653 | Human |
597296562 | GWAS1392636_H | type 2 diabetes mellitus, coronary artery disease QTL GWAS1392636 (human) | | 5e-63 | type 2 diabetes mellitus, coronary artery disease | | 10 | 92704550 | 92704551 | Human |
597247408 | GWAS1343482_H | age at menopause QTL GWAS1343482 (human) | | 2e-10 | age at menopause | | 10 | 102889972 | 102889973 | Human |
596952510 | GWAS1072029_H | size QTL GWAS1072029 (human) | | 5e-10 | size | | 10 | 96897984 | 96897985 | Human |
406978157 | GWAS627133_H | hematocrit QTL GWAS627133 (human) | | 1e-13 | hematocrit | hematocrit (CMO:0000037) | 10 | 80381581 | 80381582 | Human |
597591472 | GWAS1648332_H | sleep apnea QTL GWAS1648332 (human) | | 3e-11 | sleep apnea | | 10 | 84156277 | 84156278 | Human |
406978159 | GWAS627135_H | hematocrit QTL GWAS627135 (human) | | 3e-11 | hematocrit | hematocrit (CMO:0000037) | 10 | 88536710 | 88536711 | Human |
406978158 | GWAS627134_H | hematocrit QTL GWAS627134 (human) | | 9e-12 | hematocrit | hematocrit (CMO:0000037) | 10 | 87107094 | 87107097 | Human |
407395943 | GWAS1044919_H | gut microbiome measurement, bone density QTL GWAS1044919 (human) | | 9e-09 | gut microbiome measurement, bone density | | 10 | 95674855 | 95674856 | Human |
406978161 | GWAS627137_H | hematocrit QTL GWAS627137 (human) | | 3e-10 | hematocrit | hematocrit (CMO:0000037) | 10 | 102804387 | 102804388 | Human |
596952485 | GWAS1072004_H | size QTL GWAS1072004 (human) | | 2e-10 | size | | 10 | 88058179 | 88058180 | Human |
406969968 | GWAS618944_H | cannabis dependence measurement QTL GWAS618944 (human) | | 1e-09 | response to addictive substance trait (VT:0010488) | | 10 | 93900201 | 93900202 | Human |
406978160 | GWAS627136_H | hematocrit QTL GWAS627136 (human) | | 1e-10 | hematocrit | hematocrit (CMO:0000037) | 10 | 95477870 | 95477871 | Human |
597140902 | GWAS1236976_H | 5-dodecenoate 12:1n7 measurement QTL GWAS1236976 (human) | | 9e-20 | 5-dodecenoate 12:1n7 measurement | | 10 | 100315722 | 100315723 | Human |
597140900 | GWAS1236974_H | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement QTL GWAS1236974 (human) | | 9e-08 | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement | | 10 | 85886585 | 85886586 | Human |
597288353 | GWAS1384427_H | apolipoprotein A 1 measurement, apolipoprotein B measurement QTL GWAS1384427 (human) | | 4e-15 | apolipoprotein A 1 measurement, apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 10 | 93083778 | 93083779 | Human |
597394855 | GWAS1490929_H | high density lipoprotein cholesterol measurement QTL GWAS1490929 (human) | | 3e-08 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 86751569 | 86751570 | Human |
597321126 | GWAS1417200_H | X-21467 measurement QTL GWAS1417200 (human) | | 3e-108 | X-21467 measurement | | 10 | 99844249 | 99844250 | Human |
597067178 | GWAS1163252_H | heart rate response to exercise QTL GWAS1163252 (human) | | 1e-08 | heart rate response to exercise | | 10 | 100792995 | 100792996 | Human |
597091753 | GWAS1187827_H | spine bone mineral density QTL GWAS1187827 (human) | | 0.0000004 | spine bone mineral density | bone mineral density (CMO:0001226) | 10 | 77670385 | 77670386 | Human |
597067177 | GWAS1163251_H | heart rate response to exercise QTL GWAS1163251 (human) | | 1e-11 | heart rate response to exercise | | 10 | 100792906 | 100792907 | Human |
407125510 | GWAS774486_H | multiple sclerosis QTL GWAS774486 (human) | | 0.0000004 | multiple sclerosis | | 10 | 79274913 | 79274914 | Human |
597599704 | GWAS1656564_H | mean corpuscular hemoglobin concentration QTL GWAS1656564 (human) | | 3e-57 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 99520522 | 99520523 | Human |
407068171 | GWAS717147_H | triglyceride measurement QTL GWAS717147 (human) | | 1e-09 | urinary albumin to creatinine ratio | | 10 | 93079885 | 93079886 | Human |
407027210 | GWAS676186_H | mean arterial pressure QTL GWAS676186 (human) | | 1e-15 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 103179458 | 103179459 | Human |
597042652 | GWAS1138726_H | refractive error QTL GWAS1138726 (human) | | 7e-27 | refractive error | | 10 | 84261268 | 84261269 | Human |
597607892 | GWAS1664752_H | creatine kinase measurement QTL GWAS1664752 (human) | | 3e-15 | creatine kinase measurement | blood creatine kinase activity level (CMO:0002242) | 10 | 100069757 | 100069758 | Human |
597099995 | GWAS1196069_H | sex hormone-binding globulin measurement QTL GWAS1196069 (human) | | 9e-09 | sex hormone-binding globulin measurement | | 10 | 87881465 | 87881466 | Human |
597411285 | GWAS1507359_H | colorectal cancer QTL GWAS1507359 (human) | | 6e-11 | colorectal cancer | | 10 | 99530544 | 99530545 | Human |
597206487 | GWAS1302561_H | inflammatory bowel disease QTL GWAS1302561 (human) | | 2e-08 | inflammatory bowel disease | | 10 | 89093116 | 89093117 | Human |
597173719 | GWAS1269793_H | intelligence QTL GWAS1269793 (human) | | 8e-11 | intelligence | | 10 | 102006021 | 102006022 | Human |
406920721 | GWAS569697_H | systolic blood pressure QTL GWAS569697 (human) | | 4e-15 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103146454 | 103146455 | Human |
597411274 | GWAS1507348_H | tumor necrosis factor receptor superfamily member 6 measurement QTL GWAS1507348 (human) | | 2e-28 | tumor necrosis factor receptor superfamily member 6 measurement | | 10 | 89010241 | 89010242 | Human |
596952512 | GWAS1072031_H | size QTL GWAS1072031 (human) | | 8e-09 | size | | 10 | 93965871 | 93965872 | Human |
597067214 | GWAS1163288_H | systolic blood pressure QTL GWAS1163288 (human) | | 3e-20 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103086421 | 103086422 | Human |
407141917 | GWAS790893_H | fatty acid measurement QTL GWAS790893 (human) | | 0.0000002 | fatty acid measurement | | 10 | 100315722 | 100315723 | Human |
597091787 | GWAS1187861_H | body mass index QTL GWAS1187861 (human) | | 1e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 85651147 | 85651148 | Human |
597108169 | GWAS1204243_H | urate measurement QTL GWAS1204243 (human) | | 2e-14 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 87120932 | 87120933 | Human |
597321157 | GWAS1417231_H | X-11787 measurement QTL GWAS1417231 (human) | | 7e-168 | X-11787 measurement | | 10 | 94972031 | 94972032 | Human |
407068194 | GWAS717170_H | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa QTL GWAS717170 (human) | | 2e-09 | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | | 10 | 102666420 | 102666421 | Human |
597116406 | GWAS1212480_H | reaction time measurement QTL GWAS1212480 (human) | | 0.0000002 | cognitive behavior trait (VT:0010450) | | 10 | 102711334 | 102711335 | Human |
597313022 | GWAS1409096_H | uric acid measurement QTL GWAS1409096 (human) | | 4e-13 | uric acid measurement | blood uric acid level (CMO:0000501) | 10 | 102940687 | 102940688 | Human |
597206527 | GWAS1302601_H | protein measurement QTL GWAS1302601 (human) | | 2e-11 | protein measurement | | 10 | 100742278 | 100742279 | Human |
597313010 | GWAS1409084_H | X-12112 measurement QTL GWAS1409084 (human) | | 6e-859 | X-12112 measurement | | 10 | 98399379 | 98399380 | Human |
597108222 | GWAS1204296_H | urate measurement QTL GWAS1204296 (human) | | 0.000005 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 87120932 | 87120933 | Human |
597607924 | GWAS1664784_H | nervous system cancer, brain cancer QTL GWAS1664784 (human) | | 1e-13 | nervous system cancer, brain cancer | | 10 | 92499682 | 92499683 | Human |
596952574 | GWAS1072093_H | body mass index QTL GWAS1072093 (human) | | 1e-12 | body mass index | | 10 | 98002936 | 98002937 | Human |
597313008 | GWAS1409082_H | N6,N6-dimethyllysine measurement QTL GWAS1409082 (human) | | 5e-2333 | N6,N6-dimethyllysine measurement | | 10 | 98388419 | 98388420 | Human |
597313009 | GWAS1409083_H | N6,N6-dimethyllysine measurement QTL GWAS1409083 (human) | | 2e-1449 | N6,N6-dimethyllysine measurement | | 10 | 98388419 | 98388420 | Human |
597386743 | GWAS1482817_H | acute myeloid leukemia QTL GWAS1482817 (human) | | 1e-16 | leukocyte integrity trait (VT:0010898) | | 10 | 78074409 | 78074410 | Human |
597476844 | GWAS1572918_H | intraocular pressure measurement QTL GWAS1572918 (human) | | 9e-27 | intraocular pressure measurement | | 10 | 93279640 | 93279641 | Human |
597288425 | GWAS1384499_H | cardioembolic stroke QTL GWAS1384499 (human) | | 0.0000006 | cardioembolic stroke | | 10 | 103547967 | 103547968 | Human |
597100003 | GWAS1196077_H | sex hormone-binding globulin measurement QTL GWAS1196077 (human) | | 3e-50 | sex hormone-binding globulin measurement | | 10 | 79314368 | 79314369 | Human |
597116387 | GWAS1212461_H | uric acid measurement QTL GWAS1212461 (human) | | 4e-12 | uric acid measurement | blood uric acid level (CMO:0000501) | 10 | 87149155 | 87149156 | Human |
597313006 | GWAS1409080_H | N6-methyllysine measurement QTL GWAS1409080 (human) | | 7e-403 | N6-methyllysine measurement | | 10 | 98392298 | 98392299 | Human |
597067234 | GWAS1163308_H | heart rate response to recovery post exercise QTL GWAS1163308 (human) | | 7e-15 | heart rate response to recovery post exercise | | 10 | 100799664 | 100799665 | Human |
597067235 | GWAS1163309_H | heart rate response to recovery post exercise QTL GWAS1163309 (human) | | 3e-09 | heart rate response to recovery post exercise | | 10 | 100792995 | 100792996 | Human |
597337581 | GWAS1433655_H | sexual dimorphism measurement QTL GWAS1433655 (human) | | 9e-12 | sexual dimorphism measurement | | 10 | 79165820 | 79165821 | Human |
597313005 | GWAS1409079_H | N6-methyllysine measurement QTL GWAS1409079 (human) | | 1e-2832 | N6-methyllysine measurement | | 10 | 98388419 | 98388420 | Human |
597067233 | GWAS1163307_H | heart rate response to recovery post exercise QTL GWAS1163307 (human) | | 0.0000002 | heart rate response to recovery post exercise | | 10 | 100792995 | 100792996 | Human |
406969913 | GWAS618889_H | trait in response to efavirenz, virologic response measurement QTL GWAS618889 (human) | | 0.000005 | trait in response to efavirenz, virologic response measurement | | 10 | 93717593 | 93717594 | Human |
596977135 | GWAS1096654_H | total cholesterol measurement QTL GWAS1096654 (human) | | 2e-13 | total cholesterol measurement | | 10 | 94278929 | 94278930 | Human |
597312794 | GWAS1408868_H | N-methylpipecolate measurement QTL GWAS1408868 (human) | | 1e-251 | N-methylpipecolate measurement | | 10 | 98388419 | 98388420 | Human |
597312792 | GWAS1408866_H | N-methylpipecolate measurement QTL GWAS1408866 (human) | | 2e-415 | N-methylpipecolate measurement | | 10 | 98392298 | 98392299 | Human |
597058837 | GWAS1154911_H | refractive error, age at onset, Myopia QTL GWAS1154911 (human) | | 3e-10 | refractive error, age at onset, Myopia | | 10 | 93193501 | 93193502 | Human |
407027393 | GWAS676369_H | Dengue Hemorrhagic Fever QTL GWAS676369 (human) | | 3e-10 | Dengue Hemorrhagic Fever | | 10 | 94298541 | 94298542 | Human |
596968726 | GWAS1088245_H | systolic blood pressure QTL GWAS1088245 (human) | | 4e-26 | systolic blood pressure | | 10 | 100792995 | 100792996 | Human |
597312798 | GWAS1408872_H | N2-acetyl,N6-methyllysine measurement QTL GWAS1408872 (human) | | 7e-935 | N2-acetyl,N6-methyllysine measurement | | 10 | 98388419 | 98388420 | Human |
597509401 | GWAS1605475_H | schizophrenia QTL GWAS1605475 (human) | | 0.000006 | schizophrenia | | 10 | 101701686 | 101701687 | Human |
597517593 | GWAS1613667_H | attention deficit hyperactivity disorder, risk-taking behaviour QTL GWAS1613667 (human) | | 5e-09 | attention deficit hyperactivity disorder, risk-taking behaviour | | 10 | 102449004 | 102449005 | Human |
597263646 | GWAS1359720_H | COVID-19 QTL GWAS1359720 (human) | | 0.0000005 | COVID-19 | | 10 | 79946568 | 79946569 | Human |
597058846 | GWAS1154920_H | FEV/FVC ratio QTL GWAS1154920 (human) | | 1e-08 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 94374928 | 94374929 | Human |
597058847 | GWAS1154921_H | FEV/FVC ratio QTL GWAS1154921 (human) | | 6e-12 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 100799664 | 100799665 | Human |
597026076 | GWAS1122150_H | mean arterial pressure QTL GWAS1122150 (human) | | 7e-15 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 103169157 | 103169158 | Human |
597058844 | GWAS1154918_H | FEV/FVC ratio QTL GWAS1154918 (human) | | 3e-09 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 84313903 | 84313904 | Human |
597263635 | GWAS1359709_H | mean corpuscular hemoglobin QTL GWAS1359709 (human) | | 1e-18 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 99536106 | 99536107 | Human |
597058845 | GWAS1154919_H | FEV/FVC ratio QTL GWAS1154919 (human) | | 8e-15 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 88067236 | 88067237 | Human |
597058842 | GWAS1154916_H | FEV/FVC ratio QTL GWAS1154916 (human) | | 4e-16 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 79612746 | 79612747 | Human |
597107995 | GWAS1204069_H | testosterone measurement QTL GWAS1204069 (human) | | 2e-09 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 91886511 | 91886512 | Human |
597468432 | GWAS1564506_H | erythrocyte count QTL GWAS1564506 (human) | | 3e-09 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 99562798 | 99562799 | Human |
597058843 | GWAS1154917_H | FEV/FVC ratio QTL GWAS1154917 (human) | | 6e-21 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 80449122 | 80449123 | Human |
597263636 | GWAS1359710_H | mean corpuscular hemoglobin QTL GWAS1359710 (human) | | 5e-14 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 102877845 | 102877846 | Human |
597615889 | GWAS1672749_H | arthritis QTL GWAS1672749 (human) | | 9e-12 | arthritis | | 10 | 97056235 | 97056236 | Human |
597493010 | GWAS1589084_H | pulse pressure measurement QTL GWAS1589084 (human) | | 1e-10 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 102868477 | 102868478 | Human |
597067014 | GWAS1163088_H | susceptibility to Mycobacterium tuberculosis infection measurement QTL GWAS1163088 (human) | | 0.0000007 | response to bacterial infection trait (VT:0010435) | | 10 | 92648450 | 92648451 | Human |
597468430 | GWAS1564504_H | erythrocyte count QTL GWAS1564504 (human) | | 9e-11 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 79040561 | 79040562 | Human |
597468431 | GWAS1564505_H | erythrocyte count QTL GWAS1564505 (human) | | 5e-09 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 89687662 | 89687663 | Human |
597583115 | GWAS1639975_H | mean corpuscular hemoglobin concentration QTL GWAS1639975 (human) | | 1e-13 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 89249116 | 89249117 | Human |
597116161 | GWAS1212235_H | electrocardiography QTL GWAS1212235 (human) | | 4e-08 | electrocardiography | | 10 | 86685984 | 86685985 | Human |
596968716 | GWAS1088235_H | systolic blood pressure QTL GWAS1088235 (human) | | 3e-10 | systolic blood pressure | | 10 | 80298232 | 80298233 | Human |
597591298 | GWAS1648158_H | Microscopic hematuria QTL GWAS1648158 (human) | | 1e-12 | Microscopic hematuria | | 10 | 92672243 | 92672244 | Human |
407092956 | GWAS741932_H | hair color QTL GWAS741932 (human) | | 2e-23 | hair color | | 10 | 79184390 | 79184391 | Human |
597378363 | GWAS1474437_H | xanthosine measurement QTL GWAS1474437 (human) | | 0.000005 | xanthosine measurement | | 10 | 90645019 | 90645020 | Human |
597034290 | GWAS1130364_H | glaucoma QTL GWAS1130364 (human) | | 0.000006 | glaucoma | | 10 | 94279840 | 94279841 | Human |
597394751 | GWAS1490825_H | adolescent idiopathic scoliosis QTL GWAS1490825 (human) | | 1e-36 | adolescent idiopathic scoliosis | | 10 | 101237824 | 101237825 | Human |
597607739 | GWAS1664599_H | creatine kinase measurement QTL GWAS1664599 (human) | | 7e-20 | creatine kinase measurement | blood creatine kinase activity level (CMO:0002242) | 10 | 100069757 | 100069758 | Human |
597140798 | GWAS1236872_H | X-21467 measurement QTL GWAS1236872 (human) | | 1e-38 | X-21467 measurement | | 10 | 99851537 | 99851538 | Human |
597140797 | GWAS1236871_H | X-21467 measurement QTL GWAS1236871 (human) | | 6e-18 | X-21467 measurement | | 10 | 99815503 | 99815504 | Human |
406961898 | GWAS610874_H | diastolic blood pressure, alcohol drinking QTL GWAS610874 (human) | | 0.000001 | diastolic blood pressure, alcohol drinking | diastolic blood pressure (CMO:0000005) | 10 | 97049946 | 97049947 | Human |
597140795 | GWAS1236869_H | X-21467 measurement QTL GWAS1236869 (human) | | 2e-38 | X-21467 measurement | | 10 | 99849162 | 99849163 | Human |
597304630 | GWAS1400704_H | neutrophil collagenase measurement QTL GWAS1400704 (human) | | 6e-20 | neutrophil collagenase measurement | | 10 | 100043668 | 100043669 | Human |
597288245 | GWAS1384319_H | fatty acid measurement QTL GWAS1384319 (human) | | 7e-41 | fatty acid measurement | | 10 | 100315722 | 100315723 | Human |
597271863 | GWAS1367937_H | diastolic blood pressure QTL GWAS1367937 (human) | | 1e-27 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 100793890 | 100793891 | Human |
597304629 | GWAS1400703_H | neutrophil collagenase measurement QTL GWAS1400703 (human) | | 3e-40 | neutrophil collagenase measurement | | 10 | 100069757 | 100069758 | Human |
597337386 | GWAS1433460_H | breast density QTL GWAS1433460 (human) | | 0.0000003 | breast density | | 10 | 80196878 | 80196879 | Human |
597108007 | GWAS1204081_H | sex hormone-binding globulin measurement QTL GWAS1204081 (human) | | 5e-18 | sex hormone-binding globulin measurement | | 10 | 91872199 | 91872200 | Human |
597329198 | GWAS1425272_H | response to angiotensin receptor blocker QTL GWAS1425272 (human) | | 0.0000004 | response to angiotensin receptor blocker | | 10 | 102877751 | 102877752 | Human |
597091619 | GWAS1187693_H | base metabolic rate measurement QTL GWAS1187693 (human) | | 0.0000008 | energy metabolism trait (VT:0010637) | | 10 | 81917730 | 81917731 | Human |
597099810 | GWAS1195884_H | protein measurement QTL GWAS1195884 (human) | | 6e-09 | protein measurement | | 10 | 103073291 | 103073292 | Human |
597058848 | GWAS1154922_H | FEV/FVC ratio QTL GWAS1154922 (human) | | 1e-10 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 102632823 | 102632824 | Human |
597271855 | GWAS1367929_H | diastolic blood pressure QTL GWAS1367929 (human) | | 6e-39 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103192742 | 103192743 | Human |
597165359 | GWAS1261433_H | fatty acid measurement QTL GWAS1261433 (human) | | 2e-21 | fatty acid measurement | | 10 | 100315722 | 100315723 | Human |
597615913 | GWAS1672773_H | prostate specific antigen amount QTL GWAS1672773 (human) | | 2e-11 | prostate specific antigen amount | | 10 | 102654464 | 102654465 | Human |
597411107 | GWAS1507181_H | urinary metabolite measurement QTL GWAS1507181 (human) | | 7e-81 | urinary metabolite measurement | | 10 | 98383436 | 98383437 | Human |
597312800 | GWAS1408874_H | metabolite measurement QTL GWAS1408874 (human) | | 3e-1709 | metabolite measurement | | 10 | 98388419 | 98388420 | Human |
596968750 | GWAS1088269_H | brain aneurysm QTL GWAS1088269 (human) | | 2e-08 | brain aneurysm | | 10 | 94278929 | 94278930 | Human |
407052024 | GWAS701000_H | asymmetric dimethylarginine measurement QTL GWAS701000 (human) | | 4e-33 | asymmetric dimethylarginine measurement | blood asymmetric dimethylarginine level (CMO:0003732) | 10 | 98392616 | 98392617 | Human |
597296422 | GWAS1392496_H | triacylglycerol 52:3 measurement QTL GWAS1392496 (human) | | 4e-10 | blood triglyceride amount (VT:0002644) | | 10 | 100315722 | 100315723 | Human |
597288228 | GWAS1384302_H | systolic blood pressure QTL GWAS1384302 (human) | | 1e-26 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94253193 | 94253194 | Human |
597493026 | GWAS1589100_H | alpha fetoprotein measurement QTL GWAS1589100 (human) | | 0.000009 | blood alpha-fetoprotein amount (VT:0010776) | | 10 | 87015953 | 87015954 | Human |
597075241 | GWAS1171315_H | endometriosis QTL GWAS1171315 (human) | | 0.0000001 | endometriosis | | 10 | 103473496 | 103473497 | Human |
597591386 | GWAS1648246_H | glaucoma QTL GWAS1648246 (human) | | 6e-24 | glaucoma | | 10 | 94278929 | 94278930 | Human |
597493078 | GWAS1589152_H | complex trait QTL GWAS1589152 (human) | | 1e-08 | complex trait | | 10 | 93127625 | 93127626 | Human |
597091674 | GWAS1187748_H | white matter hyperintensity measurement QTL GWAS1187748 (human) | | 3e-09 | white matter hyperintensity measurement | | 10 | 103559652 | 103559653 | Human |
597607760 | GWAS1664620_H | lymphoid leukemia QTL GWAS1664620 (human) | | 7e-15 | lymphoid leukemia | | 10 | 88991759 | 88991760 | Human |
597230921 | GWAS1326995_H | Hypermetropia QTL GWAS1326995 (human) | | 0.000003 | Hypermetropia | | 10 | 88272146 | 88272147 | Human |
597026119 | GWAS1122193_H | mean arterial pressure QTL GWAS1122193 (human) | | 1e-10 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 103086421 | 103086422 | Human |
407027350 | GWAS676326_H | pulse pressure measurement QTL GWAS676326 (human) | | 8e-11 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 103086421 | 103086422 | Human |
407027348 | GWAS676324_H | pulse pressure measurement QTL GWAS676324 (human) | | 5e-09 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 94135420 | 94135421 | Human |
597140814 | GWAS1236888_H | X-17654 measurement QTL GWAS1236888 (human) | | 3e-28 | X-17654 measurement | | 10 | 94876348 | 94876349 | Human |
597026127 | GWAS1122201_H | mean arterial pressure QTL GWAS1122201 (human) | | 8e-11 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 103179458 | 103179459 | Human |
597255492 | GWAS1351566_H | aspartate aminotransferase measurement QTL GWAS1351566 (human) | | 2e-19 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 100312261 | 100312262 | Human |
596952394 | GWAS1071913_H | major depressive disorder QTL GWAS1071913 (human) | | 0.000004 | major depressive disorder | | 10 | 86126629 | 86126630 | Human |
597026123 | GWAS1122197_H | mean arterial pressure QTL GWAS1122197 (human) | | 1e-10 | systolic blood pressure | | 10 | 103146454 | 103146455 | Human |
596977013 | GWAS1096532_H | body height QTL GWAS1096532 (human) | | 3e-22 | body height | | 10 | 98257696 | 98257697 | Human |
597116276 | GWAS1212350_H | response to selective serotonin reuptake inhibitor, openness measurement QTL GWAS1212350 (human) | | 0.0000009 | response to selective serotonin reuptake inhibitor, openness measurement | | 10 | 81128126 | 81128127 | Human |
597394808 | GWAS1490882_H | intelligence QTL GWAS1490882 (human) | | 8e-15 | intelligence | | 10 | 102230055 | 102230056 | Human |
596968816 | GWAS1088335_H | Alzheimer disease QTL GWAS1088335 (human) | | 1e-15 | Alzheimer disease | | 10 | 80503927 | 80503928 | Human |
597402995 | GWAS1499069_H | adolescent idiopathic scoliosis QTL GWAS1499069 (human) | | 5e-39 | adolescent idiopathic scoliosis | | 10 | 101219450 | 101219451 | Human |
597460341 | GWAS1556415_H | smoking initiation QTL GWAS1556415 (human) | | 2e-13 | smoking initiation | | 10 | 102858938 | 102858939 | Human |
597443958 | GWAS1540032_H | uric acid measurement QTL GWAS1540032 (human) | | 3e-09 | uric acid measurement | blood uric acid level (CMO:0000501) | 10 | 87193857 | 87193858 | Human |
597607796 | GWAS1664656_H | lymphoid leukemia QTL GWAS1664656 (human) | | 7e-17 | lymphoid leukemia | | 10 | 88991759 | 88991760 | Human |
597312886 | GWAS1408960_H | metabolite measurement QTL GWAS1408960 (human) | | 2e-13 | metabolite measurement | | 10 | 94959764 | 94959765 | Human |
597501299 | GWAS1597373_H | surfactant protein D measurement QTL GWAS1597373 (human) | | 2e-13 | surfactant protein D measurement | | 10 | 79951311 | 79951312 | Human |
597312885 | GWAS1408959_H | metabolite measurement QTL GWAS1408959 (human) | | 2e-18 | metabolite measurement | | 10 | 95032571 | 95032572 | Human |
597157223 | GWAS1253297_H | open-angle glaucoma QTL GWAS1253297 (human) | | 8e-10 | open-angle glaucoma | | 10 | 93011758 | 93011759 | Human |
597157222 | GWAS1253296_H | open-angle glaucoma QTL GWAS1253296 (human) | | 3e-08 | open-angle glaucoma | | 10 | 80265926 | 80265927 | Human |
597263722 | GWAS1359796_H | phospholipid measurement, high density lipoprotein cholesterol measurement QTL GWAS1359796 (human) | | 8e-09 | phospholipid measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 94741733 | 94741734 | Human |
406986417 | GWAS635393_H | intelligence QTL GWAS635393 (human) | | 1e-09 | intelligence | | 10 | 100080362 | 100080363 | Human |
597525864 | GWAS1621938_H | pulse pressure measurement QTL GWAS1621938 (human) | | 0.0000006 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 101283675 | 101283676 | Human |
597083489 | GWAS1179563_H | t-tau:beta-amyloid 1-42 ratio measurement QTL GWAS1179563 (human) | | 5e-09 | cerebral cortex integrity trait (VT:0010923) | | 10 | 100611084 | 100611085 | Human |
597525861 | GWAS1621935_H | pulse pressure measurement QTL GWAS1621935 (human) | | 6e-11 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 87844975 | 87844976 | Human |
597525863 | GWAS1621937_H | pulse pressure measurement QTL GWAS1621937 (human) | | 7e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 94311804 | 94311805 | Human |
597525862 | GWAS1621936_H | pulse pressure measurement QTL GWAS1621936 (human) | | 0.0000001 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 88958770 | 88958771 | Human |
597189987 | GWAS1286061_H | testosterone measurement QTL GWAS1286061 (human) | | 2e-12 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 91856146 | 91856147 | Human |
597443943 | GWAS1540017_H | serum gamma-glutamyl transferase measurement QTL GWAS1540017 (human) | | 2e-08 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 93071756 | 93071757 | Human |
597591394 | GWAS1648254_H | colon carcinoma QTL GWAS1648254 (human) | | 2e-13 | colon carcinoma | blood C-reactive protein level (CMO:0003160) | 10 | 79059375 | 79059376 | Human |
597157225 | GWAS1253299_H | open-angle glaucoma QTL GWAS1253299 (human) | | 2e-20 | open-angle glaucoma | | 10 | 94263320 | 94263321 | Human |
597157224 | GWAS1253298_H | open-angle glaucoma QTL GWAS1253298 (human) | | 3e-13 | open-angle glaucoma | | 10 | 93185106 | 93185107 | Human |
597468316 | GWAS1564390_H | diastolic blood pressure QTL GWAS1564390 (human) | | 0.000007 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103199143 | 103199144 | Human |
597591199 | GWAS1648059_H | neutrophil count QTL GWAS1648059 (human) | | 3e-14 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 97336188 | 97336189 | Human |
597525663 | GWAS1621737_H | coronary artery disease QTL GWAS1621737 (human) | | 0.000006 | coronary artery disease | | 10 | 88068397 | 88068398 | Human |
597386393 | GWAS1482467_H | coronary artery disease QTL GWAS1482467 (human) | | 6e-09 | coronary artery disease | | 10 | 102845159 | 102845160 | Human |
597451935 | GWAS1548009_H | apolipoprotein B measurement QTL GWAS1548009 (human) | | 2e-17 | apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 10 | 93072371 | 93072372 | Human |
597247132 | GWAS1343206_H | serum alanine aminotransferase measurement QTL GWAS1343206 (human) | | 6e-20 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100164546 | 100164547 | Human |
597279903 | GWAS1375977_H | high density lipoprotein cholesterol measurement QTL GWAS1375977 (human) | | 1e-11 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 79181660 | 79181661 | Human |
597099665 | GWAS1195739_H | sex hormone-binding globulin measurement QTL GWAS1195739 (human) | | 6e-27 | sex hormone-binding globulin measurement | | 10 | 79314368 | 79314369 | Human |
597312668 | GWAS1408742_H | X-16087 measurement QTL GWAS1408742 (human) | | 8e-25 | X-16087 measurement | | 10 | 95068566 | 95068567 | Human |
597157023 | GWAS1253097_H | triglyceride measurement, low density lipoprotein cholesterol measurement QTL GWAS1253097 (human) | | 7e-10 | triglyceride measurement, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 91882000 | 91882001 | Human |
597157021 | GWAS1253095_H | triglyceride measurement, low density lipoprotein cholesterol measurement QTL GWAS1253095 (human) | | 2e-09 | triglyceride measurement, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 98013128 | 98013129 | Human |
597312657 | GWAS1408731_H | metabolite measurement QTL GWAS1408731 (human) | | 4e-17 | metabolite measurement | | 10 | 94959764 | 94959765 | Human |
597075096 | GWAS1171170_H | diastolic blood pressure QTL GWAS1171170 (human) | | 0.0000003 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 94804000 | 94804001 | Human |
597337226 | GWAS1433300_H | breast density QTL GWAS1433300 (human) | | 0.0000002 | breast density | | 10 | 84540337 | 84540338 | Human |
597607567 | GWAS1664427_H | systolic blood pressure QTL GWAS1664427 (human) | | 9e-28 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94279840 | 94279841 | Human |
597263499 | GWAS1359573_H | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1359573 (human) | | 8e-10 | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93082456 | 93082457 | Human |
597410953 | GWAS1507027_H | metabolic syndrome QTL GWAS1507027 (human) | | 1e-20 | metabolic syndrome | | 10 | 98038477 | 98038478 | Human |
597410952 | GWAS1507026_H | metabolic syndrome QTL GWAS1507026 (human) | | 4e-09 | metabolic syndrome | | 10 | 87846680 | 87846681 | Human |
597156996 | GWAS1253070_H | fatty acid measurement QTL GWAS1253070 (human) | | 3e-12 | fatty acid measurement | | 10 | 94988735 | 94988736 | Human |
597501070 | GWAS1597144_H | self reported educational attainment QTL GWAS1597144 (human) | | 7e-09 | self reported educational attainment | | 10 | 103217846 | 103217847 | Human |
597296270 | GWAS1392344_H | electrocardiography QTL GWAS1392344 (human) | | 2e-08 | electrocardiography | | 10 | 79114766 | 79114767 | Human |
597042304 | GWAS1138378_H | appendicular lean mass QTL GWAS1138378 (human) | | 3e-13 | appendicular lean mass | | 10 | 94321383 | 94321384 | Human |
597296269 | GWAS1392343_H | electrocardiography QTL GWAS1392343 (human) | | 1e-08 | electrocardiography | | 10 | 79114766 | 79114767 | Human |
597410946 | GWAS1507020_H | metabolic syndrome QTL GWAS1507020 (human) | | 3e-08 | metabolic syndrome | | 10 | 100875718 | 100875719 | Human |
407183198 | GWAS832174_H | body height QTL GWAS832174 (human) | | 5e-08 | body height | | 10 | 87834823 | 87834824 | Human |
597410951 | GWAS1507025_H | metabolic syndrome QTL GWAS1507025 (human) | | 4e-08 | metabolic syndrome | | 10 | 78221056 | 78221057 | Human |
597271741 | GWAS1367815_H | low density lipoprotein cholesterol measurement QTL GWAS1367815 (human) | | 2e-08 | low density lipoprotein cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 80486993 | 80486994 | Human |
597435578 | GWAS1531652_H | prostate carcinoma QTL GWAS1531652 (human) | | 2e-10 | prostate carcinoma | | 10 | 79067875 | 79067876 | Human |
597157040 | GWAS1253114_H | fatty acid measurement QTL GWAS1253114 (human) | | 7e-10 | fatty acid measurement | | 10 | 98013128 | 98013129 | Human |
597107903 | GWAS1203977_H | breast carcinoma QTL GWAS1203977 (human) | | 4e-09 | mammary gland integrity trait (VT:0010552) | | 10 | 79085654 | 79085655 | Human |
597329074 | GWAS1425148_H | glycocholenate sulfate measurement QTL GWAS1425148 (human) | | 4e-26 | glycocholenate sulfate measurement | | 10 | 99832401 | 99832402 | Human |
407002986 | GWAS651962_H | intelligence QTL GWAS651962 (human) | | 0.0000006 | intelligence | | 10 | 100278884 | 100278885 | Human |
406953832 | GWAS602808_H | Cleft palate, cleft lip QTL GWAS602808 (human) | | 0.000005 | Cleft palate, cleft lip | | 10 | 97935437 | 97935438 | Human |
597329075 | GWAS1425149_H | glycocholenate sulfate measurement QTL GWAS1425149 (human) | | 2e-36 | glycocholenate sulfate measurement | | 10 | 99835096 | 99835097 | Human |
597157053 | GWAS1253127_H | total cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS1253127 (human) | | 1e-08 | total cholesterol measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 79346088 | 79346089 | Human |
597443767 | GWAS1539841_H | BMI-adjusted hip circumference QTL GWAS1539841 (human) | | 4e-11 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 94253948 | 94253949 | Human |
597058726 | GWAS1154800_H | refractive error, age at onset, Myopia QTL GWAS1154800 (human) | | 5e-12 | refractive error, age at onset, Myopia | | 10 | 88382446 | 88382447 | Human |
597378219 | GWAS1474293_H | hormone measurement QTL GWAS1474293 (human) | | 2e-08 | hormone measurement | blood hormone level (CMO:0001003) | 10 | 94991513 | 94991514 | Human |
597468333 | GWAS1564407_H | mean arterial pressure QTL GWAS1564407 (human) | | 3e-11 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 103199143 | 103199144 | Human |
597361832 | GWAS1457906_H | systolic blood pressure QTL GWAS1457906 (human) | | 6e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 102834750 | 102834751 | Human |
597157039 | GWAS1253113_H | fatty acid measurement QTL GWAS1253113 (human) | | 1e-09 | blood VLDL triglyceride amount (VT:0010700) | blood total cholesterol level (CMO:0000051) | 10 | 93038216 | 93038217 | Human |
597501093 | GWAS1597167_H | triglyceride measurement QTL GWAS1597167 (human) | | 6e-38 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079967 | 93079968 | Human |
597279905 | GWAS1375979_H | high density lipoprotein cholesterol measurement QTL GWAS1375979 (human) | | 4e-12 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 98012433 | 98012434 | Human |
597279904 | GWAS1375978_H | high density lipoprotein cholesterol measurement QTL GWAS1375978 (human) | | 1e-23 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93054953 | 93054954 | Human |
597484710 | GWAS1580784_H | mean arterial pressure QTL GWAS1580784 (human) | | 3e-29 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 94278929 | 94278930 | Human |
597468326 | GWAS1564400_H | pulse pressure measurement QTL GWAS1564400 (human) | | 2e-11 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 102856906 | 102856907 | Human |
597501094 | GWAS1597168_H | triglyceride measurement QTL GWAS1597168 (human) | | 1e-13 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93556280 | 93556281 | Human |
597116076 | GWAS1212150_H | DNA methylation QTL GWAS1212150 (human) | | 1e-08 | DNA methylation | | 10 | 94257517 | 94257518 | Human |
597468327 | GWAS1564401_H | pulse pressure measurement QTL GWAS1564401 (human) | | 2e-15 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 103199143 | 103199144 | Human |
597361831 | GWAS1457905_H | systolic blood pressure QTL GWAS1457905 (human) | | 6e-18 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 102834750 | 102834751 | Human |
597345447 | GWAS1441521_H | epilepsy QTL GWAS1441521 (human) | | 2e-09 | brain integrity trait (VT:0010579) | | 10 | 101806203 | 101806204 | Human |
597312676 | GWAS1408750_H | total blood protein measurement QTL GWAS1408750 (human) | | 3e-08 | total blood protein measurement | blood protein measurement (CMO:0000028) | 10 | 79439604 | 79439605 | Human |
597468323 | GWAS1564397_H | pulse pressure measurement QTL GWAS1564397 (human) | | 4e-10 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 102834750 | 102834751 | Human |
597419227 | GWAS1515301_H | upper aerodigestive tract neoplasm QTL GWAS1515301 (human) | | 0.000001 | upper aerodigestive tract neoplasm | | 10 | 97840610 | 97840611 | Human |
597222616 | GWAS1318690_H | serum gamma-glutamyl transferase measurement QTL GWAS1318690 (human) | | 5e-13 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 99575246 | 99575247 | Human |
597099734 | GWAS1195808_H | cardiac arrhythmia QTL GWAS1195808 (human) | | 1e-29 | cardiac arrhythmia | | 10 | 103571190 | 103571191 | Human |
597091536 | GWAS1187610_H | seasonal gut microbiome measurement QTL GWAS1187610 (human) | | 0.000009 | seasonal gut microbiome measurement | | 10 | 93312779 | 93312780 | Human |
407125763 | GWAS774739_H | type 2 diabetes mellitus QTL GWAS774739 (human) | | 7e-08 | type 2 diabetes mellitus | | 10 | 92705802 | 92705803 | Human |
597419228 | GWAS1515302_H | upper aerodigestive tract neoplasm QTL GWAS1515302 (human) | | 0.0000008 | upper aerodigestive tract neoplasm | | 10 | 100242351 | 100242352 | Human |
597615830 | GWAS1672690_H | systolic blood pressure QTL GWAS1672690 (human) | | 8e-40 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 102906240 | 102906241 | Human |
597320915 | GWAS1416989_H | X-21441 measurement QTL GWAS1416989 (human) | | 1e-141 | X-21441 measurement | | 10 | 99844249 | 99844250 | Human |
597615829 | GWAS1672689_H | systolic blood pressure QTL GWAS1672689 (human) | | 2e-18 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94279840 | 94279841 | Human |
597026014 | GWAS1122088_H | hypertension QTL GWAS1122088 (human) | | 1e-12 | hypertension | | 10 | 103171827 | 103171828 | Human |
597419216 | GWAS1515290_H | self reported educational attainment QTL GWAS1515290 (human) | | 4e-12 | self reported educational attainment | | 10 | 103199730 | 103199731 | Human |
597591250 | GWAS1648110_H | protozoa infectious disease QTL GWAS1648110 (human) | | 1e-11 | protozoa infectious disease | | 10 | 102807231 | 102807232 | Human |
407142155 | GWAS791131_H | fatty acid measurement QTL GWAS791131 (human) | | 6e-15 | fatty acid measurement | | 10 | 100315722 | 100315723 | Human |
597443788 | GWAS1539862_H | lipase member N measurement QTL GWAS1539862 (human) | | 7e-499 | lipase member N measurement | | 10 | 88766035 | 88766036 | Human |
597099719 | GWAS1195793_H | cardiac arrhythmia QTL GWAS1195793 (human) | | 1e-79 | cardiac arrhythmia | | 10 | 103575604 | 103575605 | Human |
597247178 | GWAS1343252_H | neutrophil-to-lymphocyte ratio QTL GWAS1343252 (human) | | 5e-08 | neutrophil quantity (VT:0000222) | | 10 | 92759940 | 92759941 | Human |
597189835 | GWAS1285909_H | testosterone measurement QTL GWAS1285909 (human) | | 1e-08 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 100152307 | 100152308 | Human |
597173452 | GWAS1269526_H | phospholipids:total lipids ratio QTL GWAS1269526 (human) | | 4e-10 | phospholipids:total lipids ratio | | 10 | 102406747 | 102406748 | Human |
597394638 | GWAS1490712_H | heel bone mineral density QTL GWAS1490712 (human) | | 4e-11 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 100108920 | 100108921 | Human |
597394637 | GWAS1490711_H | heel bone mineral density QTL GWAS1490711 (human) | | 3e-15 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 79379378 | 79379379 | Human |
597288142 | GWAS1384216_H | cholesterol in very small VLDL measurement QTL GWAS1384216 (human) | | 9e-10 | cholesterol in very small VLDL measurement | | 10 | 93083778 | 93083779 | Human |
597615817 | GWAS1672677_H | prostate specific antigen amount QTL GWAS1672677 (human) | | 3e-12 | prostate specific antigen amount | | 10 | 102654464 | 102654465 | Human |
597329090 | GWAS1425164_H | symmetrical dimethylarginine measurement QTL GWAS1425164 (human) | | 2e-20 | symmetrical dimethylarginine measurement | blood symmetric dimethylarginine level (CMO:0003733) | 10 | 98388419 | 98388420 | Human |
597402819 | GWAS1498893_H | coronary artery disease QTL GWAS1498893 (human) | | 9e-10 | coronary artery disease | | 10 | 102823638 | 102823639 | Human |
597075151 | GWAS1171225_H | coronary artery disease QTL GWAS1171225 (human) | | 4e-16 | coronary artery disease | | 10 | 89245129 | 89245130 | Human |
597058764 | GWAS1154838_H | respiratory system disease QTL GWAS1154838 (human) | | 0.0000001 | respiratory system disease | | 10 | 80473469 | 80473470 | Human |
597058765 | GWAS1154839_H | respiratory system disease QTL GWAS1154839 (human) | | 5e-13 | respiratory system disease | | 10 | 92672243 | 92672244 | Human |
597148872 | GWAS1244946_H | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS1244946 (human) | | 3e-11 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 10 | 93079885 | 93079886 | Human |
597452029 | GWAS1548103_H | brain aneurysm QTL GWAS1548103 (human) | | 0.0000002 | brain aneurysm | | 10 | 78406053 | 78406054 | Human |
407027491 | GWAS676467_H | coronary artery disease QTL GWAS676467 (human) | | 3e-13 | coronary artery disease | | 10 | 89243170 | 89243171 | Human |
597017847 | GWAS1113921_H | intelligence QTL GWAS1113921 (human) | | 2e-13 | intelligence | | 10 | 101760027 | 101760028 | Human |
407297829 | GWAS946805_H | functional brain measurement QTL GWAS946805 (human) | | 3e-41 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
407027492 | GWAS676468_H | coronary artery disease QTL GWAS676468 (human) | | 0.000004 | coronary artery disease | | 10 | 102959339 | 102959340 | Human |
407002920 | GWAS651896_H | FEV/FVC ratio QTL GWAS651896 (human) | | 2e-15 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 79946568 | 79946569 | Human |
597198066 | GWAS1294140_H | diastolic blood pressure QTL GWAS1294140 (human) | | 2e-08 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 94279840 | 94279841 | Human |
597198067 | GWAS1294141_H | diastolic blood pressure QTL GWAS1294141 (human) | | 9e-16 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103089359 | 103089360 | Human |
597091559 | GWAS1187633_H | BMI-adjusted waist circumference QTL GWAS1187633 (human) | | 2e-10 | body size trait (VT:0100005) | | 10 | 102567827 | 102567828 | Human |
597026020 | GWAS1122094_H | hypertension QTL GWAS1122094 (human) | | 2e-13 | hypertension | | 10 | 103146454 | 103146455 | Human |
406970163 | GWAS619139_H | trait in response to diclofenac, drug-induced liver injury QTL GWAS619139 (human) | | 0.0000006 | trait in response to diclofenac, drug-induced liver injury | | 10 | 92818147 | 92818148 | Human |
597026022 | GWAS1122096_H | hypertension QTL GWAS1122096 (human) | | 6e-13 | hypertension | | 10 | 103179458 | 103179459 | Human |
597394671 | GWAS1490745_H | gut microbiome measurement QTL GWAS1490745 (human) | | 0.000001 | gut microbiome measurement | | 10 | 101130337 | 101130338 | Human |
597026019 | GWAS1122093_H | hypertension QTL GWAS1122093 (human) | | 1e-12 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 103086421 | 103086422 | Human |
597050593 | GWAS1146667_H | vitamin D measurement QTL GWAS1146667 (human) | | 0.0000005 | vitamin D measurement | | 10 | 90693958 | 90693959 | Human |
597279982 | GWAS1376056_H | sex hormone-binding globulin measurement QTL GWAS1376056 (human) | | 3e-10 | sex hormone-binding globulin measurement | | 10 | 91856146 | 91856147 | Human |
597279971 | GWAS1376045_H | sex hormone-binding globulin measurement QTL GWAS1376045 (human) | | 5e-11 | sex hormone-binding globulin measurement | | 10 | 79314368 | 79314369 | Human |
597452000 | GWAS1548074_H | electrocardiography QTL GWAS1548074 (human) | | 4e-20 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597452001 | GWAS1548075_H | electrocardiography QTL GWAS1548075 (human) | | 1e-12 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597452002 | GWAS1548076_H | electrocardiography QTL GWAS1548076 (human) | | 2e-16 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597452003 | GWAS1548077_H | electrocardiography QTL GWAS1548077 (human) | | 2e-18 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597165080 | GWAS1261154_H | lipid measurement QTL GWAS1261154 (human) | | 0.000001 | lipid measurement | blood lipid measurement (CMO:0000050) | 10 | 88459801 | 88459802 | Human |
597296154 | GWAS1392228_H | lysophosphatidylcholine 19:0 measurement QTL GWAS1392228 (human) | | 2e-08 | lysophosphatidylcholine 19:0 measurement | | 10 | 100331167 | 100331168 | Human |
596960276 | GWAS1079795_H | glomerular filtration rate QTL GWAS1079795 (human) | | 2e-08 | glomerular filtration rate | | 10 | 100960997 | 100960998 | Human |
597427228 | GWAS1523302_H | gout QTL GWAS1523302 (human) | | 7e-11 | gout | | 10 | 102963863 | 102963864 | Human |
596960277 | GWAS1079796_H | glomerular filtration rate QTL GWAS1079796 (human) | | 7e-09 | glomerular filtration rate | | 10 | 102094023 | 102094024 | Human |
597402650 | GWAS1498724_H | ulcerative colitis QTL GWAS1498724 (human) | | 0.0000003 | ulcerative colitis | | 10 | 102472959 | 102472960 | Human |
597042196 | GWAS1138270_H | appendicular lean mass QTL GWAS1138270 (human) | | 3e-08 | appendicular lean mass | | 10 | 94372860 | 94372861 | Human |
407052225 | GWAS701201_H | systolic blood pressure QTL GWAS701201 (human) | | 7e-26 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103086421 | 103086422 | Human |
597296153 | GWAS1392227_H | lysophosphatidylcholine 19:0 measurement QTL GWAS1392227 (human) | | 5e-08 | lysophosphatidylcholine 19:0 measurement | | 10 | 100331167 | 100331168 | Human |
596960272 | GWAS1079791_H | glomerular filtration rate QTL GWAS1079791 (human) | | 0.0000003 | glomerular filtration rate | | 10 | 78285355 | 78285356 | Human |
597099539 | GWAS1195613_H | sex hormone-binding globulin measurement QTL GWAS1195613 (human) | | 1e-22 | sex hormone-binding globulin measurement | | 10 | 96097142 | 96097143 | Human |
597017617 | GWAS1113691_H | basophil count QTL GWAS1113691 (human) | | 4e-15 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 100343751 | 100343752 | Human |
596960273 | GWAS1079792_H | glomerular filtration rate QTL GWAS1079792 (human) | | 4e-09 | glomerular filtration rate | | 10 | 80434933 | 80434934 | Human |
597255196 | GWAS1351270_H | serum gamma-glutamyl transferase measurement QTL GWAS1351270 (human) | | 2e-10 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 97334679 | 97334680 | Human |
597369885 | GWAS1465959_H | major depressive disorder QTL GWAS1465959 (human) | | 0.000002 | major depressive disorder | | 10 | 78574404 | 78574405 | Human |
596960274 | GWAS1079793_H | glomerular filtration rate QTL GWAS1079793 (human) | | 1e-25 | glomerular filtration rate | | 10 | 93079885 | 93079886 | Human |
597468186 | GWAS1564260_H | adolescent idiopathic scoliosis QTL GWAS1564260 (human) | | 1e-14 | adolescent idiopathic scoliosis | | 10 | 101237824 | 101237825 | Human |
596960275 | GWAS1079794_H | glomerular filtration rate QTL GWAS1079794 (human) | | 9e-10 | glomerular filtration rate | | 10 | 95506844 | 95506845 | Human |
597337110 | GWAS1433184_H | pulse pressure measurement QTL GWAS1433184 (human) | | 2e-16 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 98257696 | 98257697 | Human |
597582864 | GWAS1639724_H | mean corpuscular hemoglobin concentration QTL GWAS1639724 (human) | | 6e-12 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 89246195 | 89246196 | Human |
597107736 | GWAS1203810_H | Drugs used in diabetes use measurement QTL GWAS1203810 (human) | | 9e-18 | Drugs used in diabetes use measurement | | 10 | 92719350 | 92719351 | Human |
597476364 | GWAS1572438_H | blood protein measurement QTL GWAS1572438 (human) | | 3e-45 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 100130207 | 100130208 | Human |
597476365 | GWAS1572439_H | blood protein measurement QTL GWAS1572439 (human) | | 1e-45 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 100039545 | 100039546 | Human |
597591055 | GWAS1647915_H | essential hypertension QTL GWAS1647915 (human) | | 3e-29 | essential hypertension | | 10 | 103086421 | 103086422 | Human |
597156865 | GWAS1252939_H | testosterone measurement QTL GWAS1252939 (human) | | 8e-12 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 102863296 | 102863297 | Human |
597402627 | GWAS1498701_H | aspartate aminotransferase measurement QTL GWAS1498701 (human) | | 6e-10 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 96700824 | 96700825 | Human |
597214209 | GWAS1310283_H | Alzheimer disease QTL GWAS1310283 (human) | | 0.000004 | Alzheimer disease | | 10 | 80513323 | 80513324 | Human |
597468166 | GWAS1564240_H | ulcerative colitis QTL GWAS1564240 (human) | | 2e-21 | ulcerative colitis | | 10 | 99524480 | 99524481 | Human |
597050381 | GWAS1146455_H | Eczematoid dermatitis QTL GWAS1146455 (human) | | 8e-17 | Eczematoid dermatitis | | 10 | 102581678 | 102581679 | Human |
597386245 | GWAS1482319_H | facial height measurement QTL GWAS1482319 (human) | | 0.000002 | facial morphology trait (VT:0003743) | | 10 | 85394782 | 85394783 | Human |
597443586 | GWAS1539660_H | glutamine measurement QTL GWAS1539660 (human) | | 9e-83 | glutamine measurement | blood amino acid measurement (CMO:0003730) | 10 | 97599655 | 97599656 | Human |
597214264 | GWAS1310338_H | mathematical ability QTL GWAS1310338 (human) | | 3e-08 | mathematical ability | | 10 | 86364502 | 86364503 | Human |
406962144 | GWAS611120_H | coronary artery disease QTL GWAS611120 (human) | | 4e-08 | coronary artery disease | | 10 | 89243170 | 89243171 | Human |
597214265 | GWAS1310339_H | mathematical ability QTL GWAS1310339 (human) | | 1e-08 | mathematical ability | | 10 | 89510130 | 89510131 | Human |
597214266 | GWAS1310340_H | mathematical ability QTL GWAS1310340 (human) | | 2e-10 | mathematical ability | | 10 | 89751225 | 89751226 | Human |
597058613 | GWAS1154687_H | age at menopause QTL GWAS1154687 (human) | | 2e-09 | age at menopause | | 10 | 100223656 | 100223657 | Human |
597435449 | GWAS1531523_H | BMI-adjusted waist-hip ratio QTL GWAS1531523 (human) | | 2e-10 | body size trait (VT:0100005) | | 10 | 102727686 | 102727687 | Human |
597615664 | GWAS1672524_H | glomerulonephritis QTL GWAS1672524 (human) | | 3e-13 | glomerulonephritis | | 10 | 99608580 | 99608581 | Human |
597156903 | GWAS1252977_H | sex hormone-binding globulin measurement QTL GWAS1252977 (human) | | 9e-22 | sex hormone-binding globulin measurement | | 10 | 79314368 | 79314369 | Human |
597083171 | GWAS1179245_H | protein measurement QTL GWAS1179245 (human) | | 1e-31 | protein measurement | | 10 | 100050547 | 100050548 | Human |
597107745 | GWAS1203819_H | Drugs used in diabetes use measurement QTL GWAS1203819 (human) | | 3e-20 | Drugs used in diabetes use measurement | | 10 | 79187911 | 79187912 | Human |
597312556 | GWAS1408630_H | arginine measurement QTL GWAS1408630 (human) | | 7e-13 | arginine measurement | | 10 | 98388551 | 98388552 | Human |
597066784 | GWAS1162858_H | fear of pain measurement QTL GWAS1162858 (human) | | 0.000002 | fear-related behavior trait (VT:0010715) | | 10 | 103564413 | 103564414 | Human |
597394471 | GWAS1490545_H | gut microbiome measurement QTL GWAS1490545 (human) | | 0.000004 | gut microbiome measurement | | 10 | 90318940 | 90318941 | Human |
597156907 | GWAS1252981_H | sex hormone-binding globulin measurement QTL GWAS1252981 (human) | | 6e-08 | sex hormone-binding globulin measurement | | 10 | 102232661 | 102232662 | Human |
597320743 | GWAS1416817_H | hypertension, pregnancy-induced QTL GWAS1416817 (human) | | 9e-09 | hypertension, pregnancy-induced | | 10 | 94133031 | 94133032 | Human |
597156906 | GWAS1252980_H | sex hormone-binding globulin measurement QTL GWAS1252980 (human) | | 3e-11 | sex hormone-binding globulin measurement | | 10 | 100164661 | 100164662 | Human |
597156905 | GWAS1252979_H | sex hormone-binding globulin measurement QTL GWAS1252979 (human) | | 6e-12 | sex hormone-binding globulin measurement | | 10 | 96097142 | 96097143 | Human |
597156904 | GWAS1252978_H | sex hormone-binding globulin measurement QTL GWAS1252978 (human) | | 1e-13 | sex hormone-binding globulin measurement | | 10 | 91872199 | 91872200 | Human |
597271640 | GWAS1367714_H | leprosy QTL GWAS1367714 (human) | | 9e-09 | leprosy | | 10 | 102467226 | 102467227 | Human |
597427295 | GWAS1523369_H | urate measurement QTL GWAS1523369 (human) | | 2e-08 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 100738251 | 100738252 | Human |
597361759 | GWAS1457833_H | forced expiratory volume, response to bronchodilator QTL GWAS1457833 (human) | | 0.000001 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 10 | 80541780 | 80541781 | Human |
597525592 | GWAS1621666_H | granulysin measurement QTL GWAS1621666 (human) | | 1e-28 | granulysin measurement | | 10 | 100130207 | 100130208 | Human |
407027592 | GWAS676568_H | fatty acid measurement QTL GWAS676568 (human) | | 6e-09 | fatty acid measurement | | 10 | 100542700 | 100542701 | Human |
597099610 | GWAS1195684_H | serum gamma-glutamyl transferase measurement QTL GWAS1195684 (human) | | 8e-28 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 77920756 | 77920757 | Human |
597222485 | GWAS1318559_H | COVID-19 QTL GWAS1318559 (human) | | 0.000002 | COVID-19 | | 10 | 93995054 | 93995055 | Human |
597386313 | GWAS1482387_H | colorectal cancer QTL GWAS1482387 (human) | | 8e-12 | colorectal cancer | | 10 | 102835491 | 102835492 | Human |
597386312 | GWAS1482386_H | colorectal cancer QTL GWAS1482386 (human) | | 0.0000004 | colorectal cancer | | 10 | 99529178 | 99529179 | Human |
596968518 | GWAS1088037_H | systolic blood pressure QTL GWAS1088037 (human) | | 2e-43 | systolic blood pressure | | 10 | 103141734 | 103141735 | Human |
597271628 | GWAS1367702_H | leprosy QTL GWAS1367702 (human) | | 0.000006 | leprosy | | 10 | 102473052 | 102473053 | Human |
597132367 | GWAS1228441_H | HbA1c measurement QTL GWAS1228441 (human) | | 1e-16 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 10 | 92600915 | 92600916 | Human |
407043994 | GWAS692970_H | amino acid measurement QTL GWAS692970 (human) | | 0.000006 | amino acid measurement | | 10 | 97040342 | 97040343 | Human |
597132366 | GWAS1228440_H | HbA1c measurement QTL GWAS1228440 (human) | | 8e-09 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 10 | 87995845 | 87995846 | Human |
597017676 | GWAS1113750_H | basophil count QTL GWAS1113750 (human) | | 3e-09 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 102824175 | 102824176 | Human |
597320768 | GWAS1416842_H | orofacial cleft, sex interaction measurement QTL GWAS1416842 (human) | | 0.0000005 | orofacial cleft, sex interaction measurement | | 10 | 94030306 | 94030307 | Human |
597279811 | GWAS1375885_H | N6,N6-dimethyllysine measurement QTL GWAS1375885 (human) | | 3e-1667 | N6,N6-dimethyllysine measurement | | 10 | 98391509 | 98391510 | Human |
597173317 | GWAS1269391_H | triglycerides in small VLDL measurement QTL GWAS1269391 (human) | | 2e-14 | triglycerides in small VLDL measurement | blood very low density lipoprotein triglyceride level (CMO:0002688) | 10 | 93083778 | 93083779 | Human |
597034056 | GWAS1130130_H | blood protein measurement QTL GWAS1130130 (human) | | 2e-08 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95803250 | 95803251 | Human |
597017675 | GWAS1113749_H | basophil count QTL GWAS1113749 (human) | | 1e-12 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 100336597 | 100336598 | Human |
597320773 | GWAS1416847_H | taurocholenate sulfate measurement QTL GWAS1416847 (human) | | 1e-22 | taurocholenate sulfate measurement | | 10 | 99850776 | 99850777 | Human |
407027618 | GWAS676594_H | body weight QTL GWAS676594 (human) | | 0.000007 | hip circumference | | 10 | 89058620 | 89058621 | Human |
597255291 | GWAS1351365_H | BMI-adjusted waist circumference QTL GWAS1351365 (human) | | 5e-08 | body size trait (VT:0100005) | | 10 | 97473193 | 97473194 | Human |
597255290 | GWAS1351364_H | BMI-adjusted waist circumference QTL GWAS1351364 (human) | | 3e-08 | body size trait (VT:0100005) | | 10 | 79164451 | 79164453 | Human |
597255292 | GWAS1351366_H | BMI-adjusted waist circumference QTL GWAS1351366 (human) | | 5e-08 | body size trait (VT:0100005) | | 10 | 102525837 | 102525838 | Human |
406962086 | GWAS611062_H | mean arterial pressure, alcohol drinking QTL GWAS611062 (human) | | 0.0000002 | mean arterial pressure, alcohol drinking | mean arterial blood pressure (CMO:0000009) | 10 | 97034302 | 97034303 | Human |
597345394 | GWAS1441468_H | color vision disorder QTL GWAS1441468 (human) | | 0.000001 | color vision disorder | | 10 | 80510005 | 80510006 | Human |
597042303 | GWAS1138377_H | appendicular lean mass QTL GWAS1138377 (human) | | 2e-12 | appendicular lean mass | | 10 | 94266818 | 94266819 | Human |
597165170 | GWAS1261244_H | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS1261244 (human) | | 1e-08 | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 102331339 | 102331340 | Human |
407388067 | GWAS1037043_H | daytime rest measurement QTL GWAS1037043 (human) | | 0.000006 | sleep behavior trait (VT:0001501) | | 10 | 81309114 | 81309115 | Human |
597107836 | GWAS1203910_H | testosterone measurement QTL GWAS1203910 (human) | | 2e-09 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 99987154 | 99987155 | Human |
597591155 | GWAS1648015_H | colorectal cancer QTL GWAS1648015 (human) | | 2e-12 | colorectal cancer | | 10 | 79059375 | 79059376 | Human |
597279860 | GWAS1375934_H | X-24588 measurement QTL GWAS1375934 (human) | | 8e-12 | X-24588 measurement | | 10 | 99814073 | 99814074 | Human |
597181558 | GWAS1277632_H | pulmonary surfactant-associated protein d measurement QTL GWAS1277632 (human) | | 3e-52 | pulmonary surfactant-associated protein d measurement | | 10 | 79854778 | 79854779 | Human |
597181559 | GWAS1277633_H | pulmonary surfactant-associated protein d measurement QTL GWAS1277633 (human) | | 7e-401 | pulmonary surfactant-associated protein d measurement | | 10 | 79990102 | 79990103 | Human |
597116024 | GWAS1212098_H | intraocular pressure measurement QTL GWAS1212098 (human) | | 1e-36 | intraocular pressure measurement | | 10 | 93285353 | 93285354 | Human |
597140600 | GWAS1236674_H | X-17654 measurement QTL GWAS1236674 (human) | | 1e-57 | X-17654 measurement | | 10 | 94988735 | 94988736 | Human |
597132391 | GWAS1228465_H | platelet count QTL GWAS1228465 (human) | | 2e-08 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 94269413 | 94269414 | Human |
597132390 | GWAS1228464_H | platelet count QTL GWAS1228464 (human) | | 4e-08 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 93079885 | 93079886 | Human |
597132389 | GWAS1228463_H | platelet count QTL GWAS1228463 (human) | | 1e-10 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 87879299 | 87879300 | Human |
597443694 | GWAS1539768_H | triglyceride:HDL cholesterol ratio QTL GWAS1539768 (human) | | 9e-19 | blood triglyceride amount (VT:0002644) | | 10 | 93549265 | 93549266 | Human |
597599340 | GWAS1656200_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1656200 (human) | | 3e-94 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 10 | 99397681 | 99397682 | Human |
597279852 | GWAS1375926_H | X-24546 measurement QTL GWAS1375926 (human) | | 3e-33 | X-24546 measurement | | 10 | 95070035 | 95070036 | Human |
597238881 | GWAS1334955_H | eosinophil count QTL GWAS1334955 (human) | | 4e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 87966988 | 87966989 | Human |
406945721 | GWAS594697_H | chronotype measurement QTL GWAS594697 (human) | | 0.000009 | sleep behavior trait (VT:0001501) | | 10 | 97889774 | 97889775 | Human |
597140589 | GWAS1236663_H | pulmonary surfactant-associated protein d measurement QTL GWAS1236663 (human) | | 2e-43 | pulmonary surfactant-associated protein d measurement | | 10 | 80002884 | 80002885 | Human |
597140588 | GWAS1236662_H | pulmonary surfactant-associated protein d measurement QTL GWAS1236662 (human) | | 1e-196 | pulmonary surfactant-associated protein d measurement | | 10 | 79946568 | 79946569 | Human |
597427296 | GWAS1523370_H | urate measurement QTL GWAS1523370 (human) | | 3e-12 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 102626552 | 102626553 | Human |
407224248 | GWAS873224_H | migraine disorder QTL GWAS873224 (human) | | 0.000009 | migraine disorder | | 10 | 78755324 | 78755325 | Human |
597427297 | GWAS1523371_H | urate measurement QTL GWAS1523371 (human) | | 2e-12 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 102940687 | 102940688 | Human |
597420955 | GWAS1517029_H | systolic blood pressure QTL GWAS1517029 (human) | | 2e-10 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 92708928 | 92708929 | Human |
597420954 | GWAS1517028_H | systolic blood pressure QTL GWAS1517028 (human) | | 2e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 87921931 | 87921932 | Human |
597420953 | GWAS1517027_H | systolic blood pressure QTL GWAS1517027 (human) | | 1e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 80454830 | 80454831 | Human |
597420958 | GWAS1517032_H | systolic blood pressure QTL GWAS1517032 (human) | | 6e-43 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94140247 | 94140248 | Human |
597420957 | GWAS1517031_H | systolic blood pressure QTL GWAS1517031 (human) | | 2e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94046799 | 94046800 | Human |
597461915 | GWAS1557989_H | triglyceride measurement QTL GWAS1557989 (human) | | 8e-19 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079967 | 93079968 | Human |
597420956 | GWAS1517030_H | systolic blood pressure QTL GWAS1517030 (human) | | 4e-13 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 93983330 | 93983331 | Human |
597019538 | GWAS1115612_H | smoking status measurement, diastolic blood pressure QTL GWAS1115612 (human) | | 1e-17 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103086421 | 103086422 | Human |
406999114 | GWAS648090_H | adolescent idiopathic scoliosis QTL GWAS648090 (human) | | 0.000004 | adolescent idiopathic scoliosis | | 10 | 96588838 | 96588839 | Human |
597584788 | GWAS1641648_H | mean corpuscular hemoglobin concentration QTL GWAS1641648 (human) | | 5e-41 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 99520522 | 99520523 | Human |
597379989 | GWAS1476063_H | lysophosphatidylethanolamine 18:1 measurement QTL GWAS1476063 (human) | | 0.000006 | blood lipid amount (VT:0003949) | | 10 | 78820033 | 78820034 | Human |
597289878 | GWAS1385952_H | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1385952 (human) | | 4e-11 | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 92690476 | 92690477 | Human |
407007318 | GWAS656294_H | creatine kinase measurement QTL GWAS656294 (human) | | 5e-11 | creatine kinase measurement | blood creatine kinase activity level (CMO:0002242) | 10 | 100069757 | 100069758 | Human |
597035907 | GWAS1131981_H | low density lipoprotein cholesterol measurement QTL GWAS1131981 (human) | | 5e-20 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 93079885 | 93079886 | Human |
596962188 | GWAS1081707_H | C-reactive protein measurement QTL GWAS1081707 (human) | | 3e-13 | C-reactive protein measurement | | 10 | 98009631 | 98009632 | Human |
597314439 | GWAS1410513_H | vaginal microbiome measurement QTL GWAS1410513 (human) | | 0.000005 | vaginal microbiome measurement | | 10 | 89419538 | 89419539 | Human |
597478333 | GWAS1574407_H | atrial fibrillation QTL GWAS1574407 (human) | | 4e-09 | atrial fibrillation | | 10 | 103517717 | 103517718 | Human |
597101491 | GWAS1197565_H | cognitive function measurement QTL GWAS1197565 (human) | | 0.0000005 | cognitive behavior trait (VT:0010450) | | 10 | 87580449 | 87580450 | Human |
597584824 | GWAS1641684_H | mean corpuscular hemoglobin concentration QTL GWAS1641684 (human) | | 3e-29 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 103031838 | 103031839 | Human |
597216176 | GWAS1312250_H | dickkopf‐related protein 1 measurement QTL GWAS1312250 (human) | | 3e-10 | dickkopf‐related protein 1 measurement | | 10 | 102632823 | 102632824 | Human |
597396402 | GWAS1492476_H | schizophrenia QTL GWAS1492476 (human) | | 0.0000002 | schizophrenia | | 10 | 89650815 | 89650816 | Human |
407081064 | GWAS730040_H | metabolic syndrome QTL GWAS730040 (human) | | 2e-10 | triglyceride measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 98012647 | 98012648 | Human |
597396407 | GWAS1492481_H | systolic blood pressure QTL GWAS1492481 (human) | | 1e-51 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 102845159 | 102845160 | Human |
597478320 | GWAS1574394_H | atrial fibrillation QTL GWAS1574394 (human) | | 9e-66 | atrial fibrillation | | 10 | 103582915 | 103582916 | Human |
597289896 | GWAS1385970_H | inflammatory bowel disease QTL GWAS1385970 (human) | | 5e-17 | inflammatory bowel disease | | 10 | 79286696 | 79286697 | Human |
597617581 | GWAS1674441_H | Abnormality of the liver QTL GWAS1674441 (human) | | 2e-37 | Abnormality of the liver | | 10 | 100152437 | 100152438 | Human |
597101474 | GWAS1197548_H | alkaline phosphatase measurement QTL GWAS1197548 (human) | | 2e-10 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 94675066 | 94675067 | Human |
597027746 | GWAS1123820_H | waist-hip ratio QTL GWAS1123820 (human) | | 3e-14 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 79147390 | 79147391 | Human |
596954028 | GWAS1073547_H | functional brain measurement QTL GWAS1073547 (human) | | 2e-36 | functional brain measurement | | 10 | 94279840 | 94279841 | Human |
406941817 | GWAS590793_H | insomnia measurement QTL GWAS590793 (human) | | 1e-09 | sleep behavior trait (VT:0001501) | body mass index (BMI) (CMO:0000105) | 10 | 103183291 | 103183292 | Human |
406941816 | GWAS590792_H | insomnia measurement QTL GWAS590792 (human) | | 4e-11 | sleep behavior trait (VT:0001501) | | 10 | 102481926 | 102481927 | Human |
597461920 | GWAS1557994_H | triglyceride measurement QTL GWAS1557994 (human) | | 1e-11 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079967 | 93079968 | Human |
597461923 | GWAS1557997_H | alcohol drinking, high density lipoprotein cholesterol measurement QTL GWAS1557997 (human) | | 6e-17 | alcohol drinking, high density lipoprotein cholesterol measurement | | 10 | 93079967 | 93079968 | Human |
596954027 | GWAS1073546_H | functional brain measurement QTL GWAS1073546 (human) | | 9e-53 | functional brain measurement | | 10 | 94279840 | 94279841 | Human |
597158824 | GWAS1254898_H | dementia QTL GWAS1254898 (human) | | 0.000006 | dementia | | 10 | 96359803 | 96359804 | Human |
597470174 | GWAS1566248_H | cognitive function measurement QTL GWAS1566248 (human) | | 6e-09 | cognitive behavior trait (VT:0010450) | | 10 | 101781259 | 101781260 | Human |
597593049 | GWAS1649909_H | platelet count QTL GWAS1649909 (human) | | 5e-30 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 93079967 | 93079968 | Human |
597126096 | GWAS1222170_H | lysophosphatidylcholine measurement QTL GWAS1222170 (human) | | 4e-11 | lysophosphatidylcholine measurement | blood phospholipid level (CMO:0001169) | 10 | 100315722 | 100315723 | Human |
597601238 | GWAS1658098_H | body mass index QTL GWAS1658098 (human) | | 3e-16 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100669361 | 100669362 | Human |
597601239 | GWAS1658099_H | body mass index QTL GWAS1658099 (human) | | 8e-21 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 103153896 | 103153897 | Human |
597363669 | GWAS1459743_H | adolescent idiopathic scoliosis QTL GWAS1459743 (human) | | 1e-62 | adolescent idiopathic scoliosis | | 10 | 101219450 | 101219451 | Human |
597445580 | GWAS1541654_H | serum gamma-glutamyl transferase measurement QTL GWAS1541654 (human) | | 3e-29 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 93079967 | 93079968 | Human |
597601228 | GWAS1658088_H | blood urea nitrogen measurement QTL GWAS1658088 (human) | | 1e-19 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 10 | 80391392 | 80391393 | Human |
596962246 | GWAS1081765_H | FEV/FVC ratio, peptic ulcer disease QTL GWAS1081765 (human) | | 2e-08 | FEV/FVC ratio, peptic ulcer disease | | 10 | 80448436 | 80448437 | Human |
597527496 | GWAS1623570_H | body mass index QTL GWAS1623570 (human) | | 7e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102660453 | 102660454 | Human |
597412801 | GWAS1508875_H | atopic asthma QTL GWAS1508875 (human) | | 9e-11 | atopic asthma | | 10 | 92669710 | 92669711 | Human |
597527495 | GWAS1623569_H | body mass index QTL GWAS1623569 (human) | | 1e-15 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100875718 | 100875719 | Human |
597183430 | GWAS1279504_H | multiple inositol polyphosphate phosphatase 1 measurement QTL GWAS1279504 (human) | | 3e-20 | multiple inositol polyphosphate phosphatase 1 measurement | | 10 | 87515300 | 87515301 | Human |
597052406 | GWAS1148480_H | HDL cholesterol change measurement QTL GWAS1148480 (human) | | 3e-08 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 86079952 | 86079953 | Human |
597027824 | GWAS1123898_H | atrial fibrillation QTL GWAS1123898 (human) | | 1e-09 | atrial fibrillation | | 10 | 101845957 | 101845958 | Human |
597601275 | GWAS1658135_H | body mass index QTL GWAS1658135 (human) | | 1e-22 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102897712 | 102897713 | Human |
597052400 | GWAS1148474_H | HDL cholesterol change measurement QTL GWAS1148474 (human) | | 5e-10 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 86079952 | 86079953 | Human |
596962291 | GWAS1081810_H | FEV/FVC ratio, inflammatory bowel disease QTL GWAS1081810 (human) | | 3e-10 | FEV/FVC ratio, inflammatory bowel disease | | 10 | 80520381 | 80520382 | Human |
597199871 | GWAS1295945_H | aspartate aminotransferase measurement QTL GWAS1295945 (human) | | 3e-14 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99372525 | 99372526 | Human |
596954108 | GWAS1073627_H | functional brain measurement QTL GWAS1073627 (human) | | 4e-42 | functional brain measurement | | 10 | 94279840 | 94279841 | Human |
597322738 | GWAS1418812_H | smoking initiation QTL GWAS1418812 (human) | | 7e-24 | smoking initiation | | 10 | 103015474 | 103015477 | Human |
596954109 | GWAS1073628_H | functional brain measurement QTL GWAS1073628 (human) | | 6e-36 | functional brain measurement | | 10 | 94279840 | 94279841 | Human |
597322739 | GWAS1418813_H | smoking initiation QTL GWAS1418813 (human) | | 2e-58 | smoking initiation | | 10 | 103065821 | 103065822 | Human |
597322736 | GWAS1418810_H | smoking initiation QTL GWAS1418810 (human) | | 2e-57 | smoking initiation | | 10 | 102924635 | 102924636 | Human |
597322737 | GWAS1418811_H | smoking initiation QTL GWAS1418811 (human) | | 5e-24 | smoking initiation | | 10 | 102947454 | 102947455 | Human |
597191669 | GWAS1287743_H | sex hormone-binding globulin measurement QTL GWAS1287743 (human) | | 9e-17 | sex hormone-binding globulin measurement | | 10 | 100152307 | 100152308 | Human |
597322728 | GWAS1418802_H | colorectal cancer QTL GWAS1418802 (human) | | 6e-09 | colorectal cancer | | 10 | 79288854 | 79288855 | Human |
596970471 | GWAS1089990_H | type 1 diabetes mellitus QTL GWAS1089990 (human) | | 0.0000004 | type 1 diabetes mellitus | | 10 | 88257039 | 88257040 | Human |
597322729 | GWAS1418803_H | colorectal cancer QTL GWAS1418803 (human) | | 0.000003 | colorectal cancer | | 10 | 89814867 | 89814868 | Human |
596986854 | GWAS1106373_H | systolic blood pressure QTL GWAS1106373 (human) | | 4e-15 | systolic blood pressure | | 10 | 94279951 | 94279952 | Human |
597322734 | GWAS1418808_H | smoking initiation QTL GWAS1418808 (human) | | 2e-64 | smoking initiation | | 10 | 102894626 | 102894627 | Human |
597322735 | GWAS1418809_H | smoking initiation QTL GWAS1418809 (human) | | 9e-24 | smoking initiation | | 10 | 102920700 | 102920701 | Human |
597322732 | GWAS1418806_H | smoking initiation QTL GWAS1418806 (human) | | 8e-44 | smoking initiation | | 10 | 102180872 | 102180873 | Human |
597322733 | GWAS1418807_H | smoking initiation QTL GWAS1418807 (human) | | 2e-29 | smoking initiation | | 10 | 102638825 | 102638826 | Human |
597117935 | GWAS1214009_H | response to trauma exposure, post-traumatic stress disorder symptom measurement QTL GWAS1214009 (human) | | 0.000001 | stress-related behavior trait (VT:0010451) | | 10 | 85866672 | 85866673 | Human |
597240801 | GWAS1336875_H | left atrial function QTL GWAS1336875 (human) | | 3e-09 | left atrial function | | 10 | 90932290 | 90932291 | Human |
597347299 | GWAS1443373_H | vitamin D measurement QTL GWAS1443373 (human) | | 2e-09 | vitamin D measurement | | 10 | 89735565 | 89735566 | Human |
597412832 | GWAS1508906_H | sleep apnea measurement QTL GWAS1508906 (human) | | 0.000003 | sleep behavior trait (VT:0001501) | | 10 | 91605258 | 91605259 | Human |
597224420 | GWAS1320494_H | alkaline phosphatase measurement QTL GWAS1320494 (human) | | 4e-35 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 100315722 | 100315723 | Human |
597347300 | GWAS1443374_H | vitamin D measurement QTL GWAS1443374 (human) | | 2e-09 | vitamin D measurement | | 10 | 86321681 | 86321682 | Human |
597404442 | GWAS1500516_H | 3-hydroxy-1-methylpropylmercapturic acid measurement QTL GWAS1500516 (human) | | 0.000002 | 3-hydroxy-1-methylpropylmercapturic acid measurement | | 10 | 90392443 | 90392444 | Human |
597084951 | GWAS1181025_H | autism spectrum disorder QTL GWAS1181025 (human) | | 0.000003 | autism spectrum disorder | | 10 | 95558200 | 95558201 | Human |
597183260 | GWAS1279334_H | sialate O-acetylesterase measurement QTL GWAS1279334 (human) | | 2e-19 | sialate O-acetylesterase measurement | | 10 | 98420094 | 98420095 | Human |
597084944 | GWAS1181018_H | platelet count QTL GWAS1181018 (human) | | 2e-25 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 99514668 | 99514669 | Human |
597084945 | GWAS1181019_H | platelet count QTL GWAS1181019 (human) | | 1e-22 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 102600127 | 102600128 | Human |
597314322 | GWAS1410396_H | triglyceride measurement QTL GWAS1410396 (human) | | 2e-53 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079885 | 93079886 | Human |
597158687 | GWAS1254761_H | BMI-adjusted waist-hip ratio QTL GWAS1254761 (human) | | 2e-09 | body size trait (VT:0100005) | | 10 | 102727217 | 102727218 | Human |
597314323 | GWAS1410397_H | triglyceride measurement QTL GWAS1410397 (human) | | 2e-13 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 98002936 | 98002937 | Human |
597158686 | GWAS1254760_H | BMI-adjusted waist-hip ratio QTL GWAS1254760 (human) | | 6e-13 | body size trait (VT:0100005) | | 10 | 102638825 | 102638826 | Human |
597158685 | GWAS1254759_H | BMI-adjusted waist-hip ratio QTL GWAS1254759 (human) | | 1e-14 | body size trait (VT:0100005) | | 10 | 93586310 | 93586311 | Human |
597158684 | GWAS1254758_H | BMI-adjusted waist-hip ratio QTL GWAS1254758 (human) | | 1e-10 | body size trait (VT:0100005) | | 10 | 93583015 | 93583016 | Human |
597158683 | GWAS1254757_H | BMI-adjusted waist-hip ratio QTL GWAS1254757 (human) | | 7e-11 | body size trait (VT:0100005) | | 10 | 93552378 | 93552379 | Human |
597322516 | GWAS1418590_H | palmitoleate 16:1n7 measurement QTL GWAS1418590 (human) | | 8e-22 | palmitoleate 16:1n7 measurement | | 10 | 100315722 | 100315723 | Human |
597314314 | GWAS1410388_H | triglyceride measurement QTL GWAS1410388 (human) | | 2e-08 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 100164661 | 100164662 | Human |
597314312 | GWAS1410386_H | triglyceride measurement QTL GWAS1410386 (human) | | 2e-09 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 102186723 | 102186724 | Human |
597109508 | GWAS1205582_H | BMI-adjusted waist-hip ratio QTL GWAS1205582 (human) | | 0.0000004 | body size trait (VT:0100005) | | 10 | 94171330 | 94171331 | Human |
407163089 | GWAS812065_H | serum metabolite measurement QTL GWAS812065 (human) | | 1e-11 | level of Phosphatidylcholine (16:1_18:1) in blood serum | | 10 | 100315722 | 100315723 | Human |
597510920 | GWAS1606994_H | protein measurement QTL GWAS1606994 (human) | | 1e-08 | protein measurement | | 10 | 100747709 | 100747710 | Human |
597084942 | GWAS1181016_H | platelet count QTL GWAS1181016 (human) | | 8e-13 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 87962505 | 87962506 | Human |
597084943 | GWAS1181017_H | platelet count QTL GWAS1181017 (human) | | 3e-35 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 93079885 | 93079886 | Human |
597084941 | GWAS1181015_H | platelet count QTL GWAS1181015 (human) | | 2e-23 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 79404390 | 79404391 | Human |
597273346 | GWAS1369420_H | granulysin measurement QTL GWAS1369420 (human) | | 4e-11 | granulysin measurement | | 10 | 100069757 | 100069758 | Human |
597592893 | GWAS1649753_H | platelet count QTL GWAS1649753 (human) | | 5e-23 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 93079967 | 93079968 | Human |
597461823 | GWAS1557897_H | systolic blood pressure QTL GWAS1557897 (human) | | 3e-16 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103199143 | 103199144 | Human |
597191484 | GWAS1287558_H | systemic lupus erythematosus QTL GWAS1287558 (human) | | 2e-11 | systemic lupus erythematosus | | 10 | 82770307 | 82770308 | Human |
597158706 | GWAS1254780_H | triglyceride:HDL cholesterol ratio QTL GWAS1254780 (human) | | 9e-09 | blood triglyceride amount (VT:0002644) | | 10 | 98012433 | 98012434 | Human |
597404478 | GWAS1500552_H | myocardial infarction QTL GWAS1500552 (human) | | 8e-08 | myocardial infarction | | 10 | 102834750 | 102834751 | Human |
597281598 | GWAS1377672_H | sex hormone-binding globulin measurement QTL GWAS1377672 (human) | | 1e-09 | sex hormone-binding globulin measurement | | 10 | 91775436 | 91775437 | Human |
597404476 | GWAS1500550_H | coronary artery disease QTL GWAS1500550 (human) | | 5e-09 | coronary artery disease | | 10 | 102845159 | 102845160 | Human |
597248817 | GWAS1344891_H | electrocardiography QTL GWAS1344891 (human) | | 2e-09 | electrocardiography | | 10 | 89518993 | 89518994 | Human |
597248819 | GWAS1344893_H | electrocardiography QTL GWAS1344893 (human) | | 8e-09 | electrocardiography | | 10 | 89518993 | 89518994 | Human |
597248818 | GWAS1344892_H | electrocardiography QTL GWAS1344892 (human) | | 2e-08 | electrocardiography | | 10 | 89518993 | 89518994 | Human |
597248820 | GWAS1344894_H | electrocardiography QTL GWAS1344894 (human) | | 4e-09 | electrocardiography | | 10 | 89518993 | 89518994 | Human |
407015663 | GWAS664639_H | neutrophil count QTL GWAS664639 (human) | | 1e-13 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 95265752 | 95265753 | Human |
597297975 | GWAS1394049_H | phosphatidylcholine measurement QTL GWAS1394049 (human) | | 9e-19 | glycerophosphocholine amount (VT:0011004) | | 10 | 100315722 | 100315723 | Human |
597134117 | GWAS1230191_H | body weight QTL GWAS1230191 (human) | | 5e-10 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 102876519 | 102876520 | Human |
597224236 | GWAS1320310_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1320310 (human) | | 5e-37 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 10 | 100057584 | 100057585 | Human |
597469988 | GWAS1566062_H | appendicular lean mass QTL GWAS1566062 (human) | | 7e-16 | appendicular lean mass | | 10 | 88063813 | 88063814 | Human |
597502758 | GWAS1598832_H | 5alpha-androstan-3beta,17beta-diol disulfate measurement QTL GWAS1598832 (human) | | 4e-16 | 5alpha-androstan-3beta,17beta-diol disulfate measurement | | 10 | 99769607 | 99769608 | Human |
597297959 | GWAS1394033_H | type 2 diabetes mellitus QTL GWAS1394033 (human) | | 2e-63 | type 2 diabetes mellitus | | 10 | 92706738 | 92706739 | Human |
597469986 | GWAS1566060_H | appendicular lean mass QTL GWAS1566060 (human) | | 2e-21 | appendicular lean mass | | 10 | 77783982 | 77783983 | Human |
597469987 | GWAS1566061_H | appendicular lean mass QTL GWAS1566061 (human) | | 5e-19 | appendicular lean mass | | 10 | 79358708 | 79358709 | Human |
597314392 | GWAS1410466_H | BMI-adjusted waist circumference QTL GWAS1410466 (human) | | 2e-14 | body size trait (VT:0100005) | | 10 | 102694943 | 102694944 | Human |
597478235 | GWAS1574309_H | bipolar disorder QTL GWAS1574309 (human) | | 2e-09 | bipolar disorder | | 10 | 102633732 | 102633733 | Human |
407113868 | GWAS762844_H | reading and spelling ability QTL GWAS762844 (human) | | 0.0000008 | reading and spelling ability | | 10 | 88657790 | 88657791 | Human |
597175120 | GWAS1271194_H | vital capacity QTL GWAS1271194 (human) | | 2e-18 | vital capacity | | 10 | 91284101 | 91284102 | Human |
597085022 | GWAS1181096_H | type 2 diabetes mellitus QTL GWAS1181096 (human) | | 6e-11 | type 2 diabetes mellitus | | 10 | 100152437 | 100152438 | Human |
597314386 | GWAS1410460_H | BMI-adjusted waist circumference QTL GWAS1410460 (human) | | 7e-19 | body size trait (VT:0100005) | | 10 | 102626552 | 102626553 | Human |
407294095 | GWAS943071_H | functional brain measurement QTL GWAS943071 (human) | | 4e-46 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
406966408 | GWAS615384_H | dental caries QTL GWAS615384 (human) | | 0.000006 | dental caries | | 10 | 99514608 | 99514609 | Human |
597314387 | GWAS1410461_H | BMI-adjusted waist circumference QTL GWAS1410461 (human) | | 1e-08 | body size trait (VT:0100005) | | 10 | 102518549 | 102518550 | Human |
597609303 | GWAS1666163_H | magnesium measurement QTL GWAS1666163 (human) | | 1e-13 | magnesium measurement | serum magnesium level (CMO:0000541) | 10 | 102938024 | 102938025 | Human |
407113870 | GWAS762846_H | reading and spelling ability QTL GWAS762846 (human) | | 4e-08 | reading and spelling ability | | 10 | 88623063 | 88623064 | Human |
597314384 | GWAS1410458_H | BMI-adjusted waist circumference QTL GWAS1410458 (human) | | 1e-10 | body size trait (VT:0100005) | | 10 | 102465559 | 102465560 | Human |
597314385 | GWAS1410459_H | BMI-adjusted waist circumference QTL GWAS1410459 (human) | | 3e-10 | body size trait (VT:0100005) | | 10 | 102631277 | 102631278 | Human |
597109595 | GWAS1205669_H | Inhalant adrenergic use measurement QTL GWAS1205669 (human) | | 6e-09 | Inhalant adrenergic use measurement | | 10 | 92672243 | 92672244 | Human |
596978521 | GWAS1098040_H | clonal hematopoiesis QTL GWAS1098040 (human) | | 5e-11 | clonal hematopoiesis | | 10 | 99512238 | 99512239 | Human |
597314390 | GWAS1410464_H | BMI-adjusted waist circumference QTL GWAS1410464 (human) | | 4e-09 | body size trait (VT:0100005) | | 10 | 102637512 | 102637514 | Human |
597314391 | GWAS1410465_H | BMI-adjusted waist circumference QTL GWAS1410465 (human) | | 1e-12 | body size trait (VT:0100005) | | 10 | 102781363 | 102781364 | Human |
597314388 | GWAS1410462_H | BMI-adjusted waist circumference QTL GWAS1410462 (human) | | 8e-11 | body size trait (VT:0100005) | | 10 | 102555910 | 102555911 | Human |
597314389 | GWAS1410463_H | BMI-adjusted waist circumference QTL GWAS1410463 (human) | | 5e-08 | body size trait (VT:0100005) | | 10 | 102559209 | 102559210 | Human |
597461836 | GWAS1557910_H | mean arterial pressure QTL GWAS1557910 (human) | | 6e-10 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 103199143 | 103199144 | Human |
597486413 | GWAS1582487_H | prostate carcinoma QTL GWAS1582487 (human) | | 2e-11 | prostate carcinoma | | 10 | 78492220 | 78492221 | Human |
407294103 | GWAS943079_H | functional brain measurement QTL GWAS943079 (human) | | 9e-47 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
597330763 | GWAS1426837_H | Tinnitus QTL GWAS1426837 (human) | | 0.0000002 | Tinnitus | | 10 | 102988697 | 102988698 | Human |
597019462 | GWAS1115536_H | white matter lesion progression measurement QTL GWAS1115536 (human) | | 0.000001 | central nervous system integrity trait (VT:0010772) | | 10 | 102995674 | 102995675 | Human |
597158723 | GWAS1254797_H | lipid measurement, high density lipoprotein cholesterol measurement QTL GWAS1254797 (human) | | 4e-08 | phospholipid measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 79345928 | 79345929 | Human |
597314382 | GWAS1410456_H | BMI-adjusted waist circumference QTL GWAS1410456 (human) | | 3e-08 | body size trait (VT:0100005) | | 10 | 91250626 | 91250627 | Human |
597314383 | GWAS1410457_H | BMI-adjusted waist circumference QTL GWAS1410457 (human) | | 2e-10 | body size trait (VT:0100005) | | 10 | 93586583 | 93586584 | Human |
407294099 | GWAS943075_H | functional brain measurement QTL GWAS943075 (human) | | 3e-39 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
407294096 | GWAS943072_H | functional brain measurement QTL GWAS943072 (human) | | 4e-58 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
597314381 | GWAS1410455_H | BMI-adjusted waist circumference QTL GWAS1410455 (human) | | 7e-09 | body size trait (VT:0100005) | | 10 | 86833189 | 86833190 | Human |
407294097 | GWAS943073_H | functional brain measurement QTL GWAS943073 (human) | | 3e-43 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
597322560 | GWAS1418634_H | systolic blood pressure QTL GWAS1418634 (human) | | 2e-30 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94140247 | 94140248 | Human |
597338945 | GWAS1435019_H | hearing loss QTL GWAS1435019 (human) | | 1e-08 | hearing loss | | 10 | 93017351 | 93017352 | Human |
407294106 | GWAS943082_H | functional brain measurement QTL GWAS943082 (human) | | 6e-62 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
407294107 | GWAS943083_H | functional brain measurement QTL GWAS943083 (human) | | 6e-53 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
407294116 | GWAS943092_H | calcium measurement QTL GWAS943092 (human) | | 5e-16 | calcium measurement | | 10 | 94278929 | 94278930 | Human |
597347192 | GWAS1443266_H | urate measurement QTL GWAS1443266 (human) | | 1e-14 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 102940687 | 102940688 | Human |
597412728 | GWAS1508802_H | erythrocyte count QTL GWAS1508802 (human) | | 2e-11 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 99525359 | 99525360 | Human |
597216125 | GWAS1312199_H | cigarettes per day measurement QTL GWAS1312199 (human) | | 9e-09 | cigarettes per day measurement | | 10 | 92026800 | 92026801 | Human |
597224317 | GWAS1320391_H | serum gamma-glutamyl transferase measurement QTL GWAS1320391 (human) | | 1e-20 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 99692460 | 99692461 | Human |
597076848 | GWAS1172922_H | intelligence QTL GWAS1172922 (human) | | 4e-09 | intelligence | | 10 | 102041222 | 102041223 | Human |
597216126 | GWAS1312200_H | cigarettes per day measurement QTL GWAS1312200 (human) | | 4e-09 | cigarettes per day measurement | | 10 | 102736841 | 102736842 | Human |
597166960 | GWAS1263034_H | free cholesterol in small VLDL measurement QTL GWAS1263034 (human) | | 5e-16 | blood VLDL cholesterol amount (VT:0005144) | | 10 | 93083778 | 93083779 | Human |
597592951 | GWAS1649811_H | platelet count QTL GWAS1649811 (human) | | 4e-36 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 93079967 | 93079968 | Human |
597347190 | GWAS1443264_H | urate measurement QTL GWAS1443264 (human) | | 4e-10 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 79187911 | 79187912 | Human |
597347191 | GWAS1443265_H | urate measurement QTL GWAS1443265 (human) | | 1e-40 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 87120932 | 87120933 | Human |
596953978 | GWAS1073497_H | waist-hip ratio QTL GWAS1073497 (human) | | 4e-12 | waist-hip ratio | | 10 | 87844975 | 87844976 | Human |
597101433 | GWAS1197507_H | protein measurement QTL GWAS1197507 (human) | | 3e-08 | protein measurement | | 10 | 95296494 | 95296495 | Human |
597248872 | GWAS1344946_H | serum alanine aminotransferase measurement QTL GWAS1344946 (human) | | 1e-09 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 99655076 | 99655077 | Human |
597363562 | GWAS1459636_H | adolescent idiopathic scoliosis QTL GWAS1459636 (human) | | 2e-82 | adolescent idiopathic scoliosis | | 10 | 101219450 | 101219451 | Human |
597093220 | GWAS1189294_H | inflammatory bowel disease QTL GWAS1189294 (human) | | 7e-09 | inflammatory bowel disease | | 10 | 102504350 | 102504351 | Human |
597437294 | GWAS1533368_H | body mass index QTL GWAS1533368 (human) | | 6e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102856906 | 102856907 | Human |
407015606 | GWAS664582_H | neutrophil count QTL GWAS664582 (human) | | 2e-25 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 89243170 | 89243171 | Human |
597207917 | GWAS1303991_H | vitamin D measurement QTL GWAS1303991 (human) | | 1e-08 | vitamin D measurement | | 10 | 86321681 | 86321682 | Human |
407015607 | GWAS664583_H | neutrophil count QTL GWAS664583 (human) | | 6e-19 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 94450643 | 94450644 | Human |
597060449 | GWAS1156523_H | chronic kidney disease QTL GWAS1156523 (human) | | 0.000003 | chronic kidney disease | | 10 | 88476640 | 88476641 | Human |
597134176 | GWAS1230250_H | memory performance QTL GWAS1230250 (human) | | 0.000004 | memory performance | | 10 | 99156866 | 99156867 | Human |
597019501 | GWAS1115575_H | smoking status measurement, systolic blood pressure QTL GWAS1115575 (human) | | 1e-45 | smoking status measurement, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103086421 | 103086422 | Human |
597363558 | GWAS1459632_H | triglyceride measurement, alcohol drinking QTL GWAS1459632 (human) | | 4e-13 | triglyceride measurement, alcohol drinking | blood triglyceride level (CMO:0000118) | 10 | 93079967 | 93079968 | Human |
407048382 | GWAS697358_H | orthostatic hypotension QTL GWAS697358 (human) | | 0.000005 | orthostatic hypotension | | 10 | 96658173 | 96658174 | Human |
597314404 | GWAS1410478_H | cortical thickness QTL GWAS1410478 (human) | | 2e-26 | cortical thickness | | 10 | 103053140 | 103053141 | Human |
407114052 | GWAS763028_H | reading and spelling ability QTL GWAS763028 (human) | | 0.000006 | reading and spelling ability | | 10 | 88623063 | 88623064 | Human |
597207705 | GWAS1303779_H | urate measurement QTL GWAS1303779 (human) | | 4e-08 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 79184390 | 79184391 | Human |
407114053 | GWAS763029_H | reading and spelling ability QTL GWAS763029 (human) | | 1e-09 | reading and spelling ability | | 10 | 88623063 | 88623064 | Human |
407032131 | GWAS681107_H | unipolar depression QTL GWAS681107 (human) | | 1e-08 | unipolar depression | | 10 | 102660997 | 102660998 | Human |
407114054 | GWAS763030_H | reading and spelling ability QTL GWAS763030 (human) | | 6e-08 | reading and spelling ability | | 10 | 88657790 | 88657791 | Human |
407114049 | GWAS763025_H | reading and spelling ability QTL GWAS763025 (human) | | 0.0000002 | reading and spelling ability | | 10 | 88623063 | 88623064 | Human |
406966598 | GWAS615574_H | amino acid measurement QTL GWAS615574 (human) | | 0.000007 | amino acid measurement | | 10 | 83110320 | 83110321 | Human |
407114051 | GWAS763027_H | reading and spelling ability QTL GWAS763027 (human) | | 0.000001 | reading and spelling ability | | 10 | 88657790 | 88657791 | Human |
597191327 | GWAS1287401_H | sex hormone-binding globulin measurement QTL GWAS1287401 (human) | | 3e-12 | sex hormone-binding globulin measurement | | 10 | 96102823 | 96102824 | Human |
597076625 | GWAS1172699_H | FEV change measurement, response to bronchodilator QTL GWAS1172699 (human) | | 0.0000007 | FEV change measurement, response to bronchodilator | respiratory system measurement (CMO:0000094) | 10 | 100296751 | 100296752 | Human |
597019282 | GWAS1115356_H | heart rate response to recovery post exercise QTL GWAS1115356 (human) | | 6e-17 | heart rate response to recovery post exercise | | 10 | 100798737 | 100798738 | Human |
597174921 | GWAS1270995_H | intraocular pressure measurement QTL GWAS1270995 (human) | | 2e-09 | intraocular pressure measurement | | 10 | 86687010 | 86687011 | Human |
597346952 | GWAS1443026_H | body fat percentage QTL GWAS1443026 (human) | | 5e-13 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 10 | 93079885 | 93079886 | Human |
597346953 | GWAS1443027_H | body fat percentage QTL GWAS1443027 (human) | | 1e-08 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 10 | 93562287 | 93562288 | Human |
596953735 | GWAS1073254_H | Vitiligo QTL GWAS1073254 (human) | | 6e-09 | Vitiligo | | 10 | 102618002 | 102618003 | Human |
597174926 | GWAS1271000_H | intraocular pressure measurement QTL GWAS1271000 (human) | | 7e-09 | intraocular pressure measurement | | 10 | 79349655 | 79349656 | Human |
596978307 | GWAS1097826_H | body height QTL GWAS1097826 (human) | | 3e-14 | body height | | 10 | 87846116 | 87846117 | Human |
597084814 | GWAS1180888_H | type 2 diabetes mellitus QTL GWAS1180888 (human) | | 6e-11 | type 2 diabetes mellitus | | 10 | 86357561 | 86357562 | Human |
597305986 | GWAS1402060_H | vaginal microbiome measurement QTL GWAS1402060 (human) | | 0.000002 | vaginal microbiome measurement | | 10 | 98340440 | 98340441 | Human |
407040347 | GWAS689323_H | unipolar depression, response to selective serotonin reuptake inhibitor QTL GWAS689323 (human) | | 2e-16 | unipolar depression, response to selective serotonin reuptake inhibitor | | 10 | 94922089 | 94922090 | Human |
597453445 | GWAS1549519_H | cataract QTL GWAS1549519 (human) | | 2e-08 | cataract | | 10 | 100341523 | 100341524 | Human |
597437062 | GWAS1533136_H | triglyceride:HDL cholesterol ratio QTL GWAS1533136 (human) | | 0.0000007 | blood triglyceride amount (VT:0002644) | | 10 | 93549265 | 93549266 | Human |
597224067 | GWAS1320141_H | BMI-adjusted waist circumference QTL GWAS1320141 (human) | | 7e-13 | body size trait (VT:0100005) | | 10 | 93586671 | 93586672 | Human |
597101195 | GWAS1197269_H | prostate carcinoma QTL GWAS1197269 (human) | | 8e-11 | prostate carcinoma | | 10 | 88435392 | 88435393 | Human |
596953736 | GWAS1073255_H | Vitiligo QTL GWAS1073255 (human) | | 2e-13 | Vitiligo | | 10 | 89860916 | 89860917 | Human |
597346951 | GWAS1443025_H | body fat percentage QTL GWAS1443025 (human) | | 8e-09 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 10 | 79339325 | 79339326 | Human |
597101193 | GWAS1197267_H | prostate carcinoma QTL GWAS1197267 (human) | | 7e-12 | prostate carcinoma | | 10 | 79076241 | 79076242 | Human |
407040348 | GWAS689324_H | unipolar depression, response to selective serotonin reuptake inhibitor QTL GWAS689324 (human) | | 4e-09 | unipolar depression, response to selective serotonin reuptake inhibitor | | 10 | 94922089 | 94922090 | Human |
597240454 | GWAS1336528_H | aging QTL GWAS1336528 (human) | | 9e-22 | aging | | 10 | 96287079 | 96287080 | Human |
597093046 | GWAS1189120_H | obsessive-compulsive symptom measurement QTL GWAS1189120 (human) | | 0.000009 | anxiety-related behavior trait (VT:0010716) | | 10 | 83360926 | 83360927 | Human |
597322426 | GWAS1418500_H | level of Phosphatidylcholine (O-18:0_16:1) in blood serum QTL GWAS1418500 (human) | | 5e-10 | level of Phosphatidylcholine (16:1_18:2) in blood serum | | 10 | 100315722 | 100315723 | Human |
597101238 | GWAS1197312_H | sex hormone-binding globulin measurement QTL GWAS1197312 (human) | | 1e-22 | sex hormone-binding globulin measurement | | 10 | 93050908 | 93050909 | Human |
597035700 | GWAS1131774_H | body mass index QTL GWAS1131774 (human) | | 5e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 86352566 | 86352567 | Human |
597101237 | GWAS1197311_H | sex hormone-binding globulin measurement QTL GWAS1197311 (human) | | 8e-28 | sex hormone-binding globulin measurement | | 10 | 91856146 | 91856147 | Human |
597101236 | GWAS1197310_H | sex hormone-binding globulin measurement QTL GWAS1197310 (human) | | 3e-28 | sex hormone-binding globulin measurement | | 10 | 79314368 | 79314369 | Human |
597150399 | GWAS1246473_H | prostate carcinoma QTL GWAS1246473 (human) | | 2e-09 | prostate carcinoma | | 10 | 88407308 | 88407309 | Human |
597387955 | GWAS1484029_H | intelligence QTL GWAS1484029 (human) | | 6e-19 | intelligence | | 10 | 102230055 | 102230056 | Human |
597387954 | GWAS1484028_H | intelligence QTL GWAS1484028 (human) | | 6e-10 | intelligence | | 10 | 91682483 | 91682484 | Human |
597338803 | GWAS1434877_H | pulse pressure measurement QTL GWAS1434877 (human) | | 1e-09 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 98257696 | 98257697 | Human |
597183145 | GWAS1279219_H | protein measurement QTL GWAS1279219 (human) | | 6e-14 | protein measurement | | 10 | 87727289 | 87727290 | Human |
597183146 | GWAS1279220_H | protein measurement QTL GWAS1279220 (human) | | 1e-22 | protein measurement | | 10 | 87695144 | 87695147 | Human |
596970150 | GWAS1089669_H | executive function measurement, cognitive function measurement, major depressive disorder QTL GWAS1089669 (human) | | 4e-08 | executive function measurement, cognitive function measurement, major depressive disorder | | 10 | 99548014 | 99548015 | Human |
597519017 | GWAS1615091_H | lean body mass QTL GWAS1615091 (human) | | 4e-21 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 94278929 | 94278930 | Human |
597191331 | GWAS1287405_H | sex hormone-binding globulin measurement QTL GWAS1287405 (human) | | 3e-10 | sex hormone-binding globulin measurement | | 10 | 100164661 | 100164662 | Human |
597428897 | GWAS1524971_H | protein measurement QTL GWAS1524971 (human) | | 6e-133 | protein measurement | | 10 | 88995152 | 88995153 | Human |
597207717 | GWAS1303791_H | age-related hearing impairment QTL GWAS1303791 (human) | | 4e-08 | age-related hearing impairment | | 10 | 93022978 | 93022979 | Human |
597183143 | GWAS1279217_H | protein measurement QTL GWAS1279217 (human) | | 2e-58 | protein measurement | | 10 | 87709196 | 87709197 | Human |
597600990 | GWAS1657850_H | blood urea nitrogen measurement QTL GWAS1657850 (human) | | 3e-11 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 10 | 88270362 | 88270363 | Human |
597600991 | GWAS1657851_H | blood urea nitrogen measurement QTL GWAS1657851 (human) | | 4e-13 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 10 | 94254865 | 94254866 | Human |
597600989 | GWAS1657849_H | blood urea nitrogen measurement QTL GWAS1657849 (human) | | 5e-21 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 10 | 80377705 | 80377706 | Human |
597027537 | GWAS1123611_H | mean arterial pressure QTL GWAS1123611 (human) | | 2e-09 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 102712218 | 102712219 | Human |
597281500 | GWAS1377574_H | phospholipids in VLDL measurement QTL GWAS1377574 (human) | | 2e-13 | phospholipids in VLDL measurement | | 10 | 93083778 | 93083779 | Human |
597428954 | GWAS1525028_H | inflammatory bowel disease QTL GWAS1525028 (human) | | 2e-11 | inflammatory bowel disease | | 10 | 99522847 | 99522849 | Human |
597117663 | GWAS1213737_H | intraocular pressure measurement QTL GWAS1213737 (human) | | 5e-09 | intraocular pressure measurement | | 10 | 103545244 | 103545245 | Human |
597043935 | GWAS1140009_H | smoking initiation QTL GWAS1140009 (human) | | 6e-16 | smoking initiation | | 10 | 102974866 | 102974867 | Human |
597199571 | GWAS1295645_H | restless legs syndrome QTL GWAS1295645 (human) | | 2e-08 | restless legs syndrome | | 10 | 98153050 | 98153051 | Human |
597060314 | GWAS1156388_H | refractive error, age at onset, Myopia QTL GWAS1156388 (human) | | 5e-08 | refractive error, age at onset, Myopia | | 10 | 101064592 | 101064593 | Human |
596978394 | GWAS1097913_H | body height QTL GWAS1097913 (human) | | 5e-11 | body height | | 10 | 101702932 | 101702933 | Human |
597322445 | GWAS1418519_H | tumor necrosis factor receptor superfamily member 6 measurement QTL GWAS1418519 (human) | | 2e-37 | tumor necrosis factor receptor superfamily member 6 measurement | | 10 | 89012010 | 89012011 | Human |
597256910 | GWAS1352984_H | total cholesterol measurement QTL GWAS1352984 (human) | | 3e-19 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 94263320 | 94263321 | Human |
406958361 | GWAS607337_H | migraine disorder QTL GWAS607337 (human) | | 1e-09 | migraine disorder | | 10 | 94278929 | 94278930 | Human |
596986572 | GWAS1106091_H | leukocyte count QTL GWAS1106091 (human) | | 4e-08 | leukocyte count | | 10 | 97243618 | 97243619 | Human |
597043916 | GWAS1139990_H | smoking initiation QTL GWAS1139990 (human) | | 2e-10 | smoking initiation | | 10 | 102200594 | 102200595 | Human |
597043915 | GWAS1139989_H | smoking initiation QTL GWAS1139989 (human) | | 2e-10 | smoking status measurement | | 10 | 101427081 | 101427082 | Human |
597084872 | GWAS1180946_H | response to ketamine QTL GWAS1180946 (human) | | 0.000008 | response to ketamine | | 10 | 91808653 | 91808654 | Human |
597396164 | GWAS1492238_H | vaginal microbiome measurement QTL GWAS1492238 (human) | | 0.000008 | vaginal microbiome measurement | | 10 | 96223272 | 96223273 | Human |
597166841 | GWAS1262915_H | body weight QTL GWAS1262915 (human) | | 6e-12 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 92707388 | 92707389 | Human |
597117685 | GWAS1213759_H | mathematical ability QTL GWAS1213759 (human) | | 8e-09 | mathematical ability | | 10 | 89497997 | 89497998 | Human |
597166842 | GWAS1262916_H | body weight QTL GWAS1262916 (human) | | 2e-09 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 96981536 | 96981537 | Human |
597510911 | GWAS1606985_H | Calcium channel blocker use measurement QTL GWAS1606985 (human) | | 6e-10 | Calcium channel blocker use measurement | | 10 | 102876898 | 102876899 | Human |
407048480 | GWAS697456_H | valine measurement QTL GWAS697456 (human) | | 0.000006 | valine measurement | blood amino acid measurement (CMO:0003730) | 10 | 79262084 | 79262085 | Human |
597117684 | GWAS1213758_H | mathematical ability QTL GWAS1213758 (human) | | 4e-08 | mathematical ability | | 10 | 86504258 | 86504259 | Human |
406901028 | GWAS550004_H | esophageal carcinoma QTL GWAS550004 (human) | | 4e-20 | esophageal carcinoma | | 10 | 94306584 | 94306585 | Human |
597330673 | GWAS1426747_H | colorectal cancer QTL GWAS1426747 (human) | | 0.000002 | colorectal cancer | | 10 | 82429991 | 82429992 | Human |
597355249 | GWAS1451323_H | systolic blood pressure QTL GWAS1451323 (human) | | 6e-17 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102856906 | 102856907 | Human |
597076730 | GWAS1172804_H | FEV change measurement, response to bronchodilator QTL GWAS1172804 (human) | | 2e-09 | FEV change measurement, response to bronchodilator | respiratory system measurement (CMO:0000094) | 10 | 100295789 | 100295790 | Human |
597617394 | GWAS1674254_H | biliary tract disease QTL GWAS1674254 (human) | | 6e-13 | biliary tract disease | | 10 | 100297481 | 100297482 | Human |
597355255 | GWAS1451329_H | diastolic blood pressure QTL GWAS1451329 (human) | | 6e-13 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 102856906 | 102856907 | Human |
597166837 | GWAS1262911_H | body weight QTL GWAS1262911 (human) | | 2e-16 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 102988252 | 102988253 | Human |
597601008 | GWAS1657868_H | glycerol measurement QTL GWAS1657868 (human) | | 0.000003 | glycerol measurement | blood glycerol level (CMO:0002679) | 10 | 84081676 | 84081677 | Human |
597183211 | GWAS1279285_H | membrane protein FAM174A measurement QTL GWAS1279285 (human) | | 5e-380 | membrane protein FAM174A measurement | | 10 | 88673588 | 88673589 | Human |
597428975 | GWAS1525049_H | diverticular disease QTL GWAS1525049 (human) | | 1e-11 | diverticular disease | | 10 | 99631412 | 99631413 | Human |
597453551 | GWAS1549625_H | thalamus volume QTL GWAS1549625 (human) | | 1e-09 | thalamus volume | | 10 | 103235738 | 103235739 | Human |
406950197 | GWAS599173_H | body mass index QTL GWAS599173 (human) | | 0.000002 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 85651147 | 85651148 | Human |
597388015 | GWAS1484089_H | physical activity measurement, body mass index QTL GWAS1484089 (human) | | 4e-08 | wellness/fitness trait (VT:1000152) | body mass index (BMI) (CMO:0000105) | 10 | 102641875 | 102641876 | Human |
597396206 | GWAS1492280_H | cup-to-disc ratio measurement QTL GWAS1492280 (human) | | 3e-13 | cup-to-disc ratio measurement | | 10 | 94311804 | 94311805 | Human |
597527274 | GWAS1623348_H | protein measurement QTL GWAS1623348 (human) | | 7e-79 | protein measurement | | 10 | 97865562 | 97865563 | Human |
597347042 | GWAS1443116_H | FEV/FVC ratio QTL GWAS1443116 (human) | | 7e-21 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 79946568 | 79946569 | Human |
597617382 | GWAS1674242_H | diverticular disease QTL GWAS1674242 (human) | | 3e-17 | diverticular disease | | 10 | 95688415 | 95688416 | Human |
406892857 | GWAS541833_H | lymphocyte percentage of leukocytes QTL GWAS541833 (human) | | 1e-11 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 10 | 79285450 | 79285451 | Human |
406892858 | GWAS541834_H | lymphocyte percentage of leukocytes QTL GWAS541834 (human) | | 6e-12 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 10 | 97206728 | 97206729 | Human |
597617380 | GWAS1674240_H | liver disease QTL GWAS1674240 (human) | | 2e-15 | liver disease | | 10 | 100164661 | 100164662 | Human |
597437153 | GWAS1533227_H | lipid measurement QTL GWAS1533227 (human) | | 0.000001 | lipid measurement | blood lipid measurement (CMO:0000050) | 10 | 92450730 | 92450731 | Human |
597207782 | GWAS1303856_H | birth weight QTL GWAS1303856 (human) | | 2e-08 | birth weight | neonatal body weight (CMO:0002079) | 10 | 80449122 | 80449123 | Human |
597355237 | GWAS1451311_H | hypertension QTL GWAS1451311 (human) | | 7e-13 | hypertension | | 10 | 102856906 | 102856907 | Human |
597617180 | GWAS1674040_H | soft tissue disease QTL GWAS1674040 (human) | | 3e-14 | soft tissue disease | | 10 | 100616262 | 100616263 | Human |
597436959 | GWAS1533033_H | aortic measurement QTL GWAS1533033 (human) | | 3e-09 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 93993019 | 93993020 | Human |
597346845 | GWAS1442919_H | body mass index QTL GWAS1442919 (human) | | 2e-19 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100687890 | 100687891 | Human |
597305872 | GWAS1401946_H | platelet count QTL GWAS1401946 (human) | | 2e-14 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 87893929 | 87893930 | Human |
597305873 | GWAS1401947_H | platelet count QTL GWAS1401947 (human) | | 1e-32 | platelet count | | 10 | 93079885 | 93079886 | Human |
407015886 | GWAS664862_H | neutrophil count QTL GWAS664862 (human) | | 1e-10 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 80489996 | 80489997 | Human |
597240340 | GWAS1336414_H | BMI-adjusted waist-hip ratio QTL GWAS1336414 (human) | | 3e-08 | body size trait (VT:0100005) | | 10 | 79169036 | 79169037 | Human |
597142023 | GWAS1238097_H | aspartate aminotransferase measurement QTL GWAS1238097 (human) | | 2e-184 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99397681 | 99397682 | Human |
597142022 | GWAS1238096_H | aspartate aminotransferase measurement QTL GWAS1238096 (human) | | 1e-12 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 94263320 | 94263321 | Human |
597142021 | GWAS1238095_H | aspartate aminotransferase measurement QTL GWAS1238095 (human) | | 1e-13 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 77911845 | 77911846 | Human |
597101061 | GWAS1197135_H | vitamin B6 measurement QTL GWAS1197135 (human) | | 4e-08 | vitamin B6 measurement | | 10 | 98393851 | 98393852 | Human |
597305871 | GWAS1401945_H | platelet count QTL GWAS1401945 (human) | | 2e-17 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 79404390 | 79404391 | Human |
597027331 | GWAS1123405_H | systolic blood pressure QTL GWAS1123405 (human) | | 4e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94253193 | 94253194 | Human |
597101056 | GWAS1197130_H | diverticular disease QTL GWAS1197130 (human) | | 0.000009 | diverticular disease | | 10 | 78086376 | 78086377 | Human |
597019138 | GWAS1115212_H | smoking status measurement, systolic blood pressure QTL GWAS1115212 (human) | | 5e-11 | smoking status measurement, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 97880706 | 97880707 | Human |
407138780 | GWAS787756_H | Alzheimer disease QTL GWAS787756 (human) | | 0.000001 | Alzheimer disease | | 10 | 80629227 | 80629228 | Human |
597256704 | GWAS1352778_H | vitamin D measurement QTL GWAS1352778 (human) | | 7e-10 | vitamin D measurement | | 10 | 80404898 | 80404899 | Human |
597297670 | GWAS1393744_H | lipase member N measurement QTL GWAS1393744 (human) | | 5e-436 | lipase member N measurement | | 10 | 88780569 | 88780570 | Human |
597248516 | GWAS1344590_H | corneal resistance factor QTL GWAS1344590 (human) | | 1e-08 | corneal resistance factor | | 10 | 93121531 | 93121532 | Human |
407294424 | GWAS943400_H | functional brain measurement QTL GWAS943400 (human) | | 1e-47 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
407294425 | GWAS943401_H | functional brain measurement QTL GWAS943401 (human) | | 2e-27 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
597166648 | GWAS1262722_H | serum alanine aminotransferase measurement QTL GWAS1262722 (human) | | 2e-09 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 94263320 | 94263321 | Human |
597420602 | GWAS1516676_H | aging QTL GWAS1516676 (human) | | 3e-08 | aging | | 10 | 99520522 | 99520523 | Human |
596953655 | GWAS1073174_H | waist-hip ratio QTL GWAS1073174 (human) | | 5e-08 | waist-hip ratio | | 10 | 79147390 | 79147391 | Human |
597223995 | GWAS1320069_H | serum gamma-glutamyl transferase measurement QTL GWAS1320069 (human) | | 1e-11 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 93082720 | 93082721 | Human |
597092926 | GWAS1189000_H | inflammatory bowel disease QTL GWAS1189000 (human) | | 2e-10 | inflammatory bowel disease | | 10 | 92742487 | 92742488 | Human |
597396018 | GWAS1492092_H | systolic blood pressure QTL GWAS1492092 (human) | | 3e-10 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 80298232 | 80298233 | Human |
597043775 | GWAS1139849_H | schizophrenia QTL GWAS1139849 (human) | | 2e-25 | schizophrenia | | 10 | 103033891 | 103033892 | Human |
597617202 | GWAS1674062_H | erythrocyte count QTL GWAS1674062 (human) | | 3e-11 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 79045259 | 79045260 | Human |
597617203 | GWAS1674063_H | erythrocyte count QTL GWAS1674063 (human) | | 1e-35 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 99528481 | 99528482 | Human |
597461553 | GWAS1557627_H | pulse pressure measurement QTL GWAS1557627 (human) | | 5e-17 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 103199143 | 103199144 | Human |
597166647 | GWAS1262721_H | serum alanine aminotransferase measurement QTL GWAS1262721 (human) | | 9e-33 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 77889895 | 77889896 | Human |
597158456 | GWAS1254530_H | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio QTL GWAS1254530 (human) | | 2e-08 | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 100315722 | 100315723 | Human |
597248553 | GWAS1344627_H | corneal resistance factor QTL GWAS1344627 (human) | | 3e-09 | corneal resistance factor | | 10 | 92763094 | 92763095 | Human |
597027364 | GWAS1123438_H | proliferative diabetic retinopathy QTL GWAS1123438 (human) | | 0.0000008 | proliferative diabetic retinopathy | | 10 | 85018443 | 85018444 | Human |
597240363 | GWAS1336437_H | retinal vasculature measurement QTL GWAS1336437 (human) | | 8e-08 | retina blood vessel morphology trait (VT:0002792) | | 10 | 84222045 | 84222046 | Human |
597445166 | GWAS1541240_H | citrate measurement QTL GWAS1541240 (human) | | 6e-10 | citrate measurement | | 10 | 93079967 | 93079968 | Human |
597101096 | GWAS1197170_H | major depressive episode, major depressive disorder QTL GWAS1197170 (human) | | 0.000005 | major depressive episode, major depressive disorder | | 10 | 101004334 | 101004335 | Human |
597166680 | GWAS1262754_H | aspartate aminotransferase measurement QTL GWAS1262754 (human) | | 4e-368 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99397621 | 99397622 | Human |
597305947 | GWAS1402021_H | metabolite measurement QTL GWAS1402021 (human) | | 6e-19 | metabolite measurement | | 10 | 95042172 | 95042173 | Human |
597109331 | GWAS1205405_H | mathematical ability QTL GWAS1205405 (human) | | 8e-14 | mathematical ability | | 10 | 102321592 | 102321593 | Human |
597109330 | GWAS1205404_H | mathematical ability QTL GWAS1205404 (human) | | 4e-12 | mathematical ability | | 10 | 102120361 | 102120362 | Human |
597494362 | GWAS1590436_H | COVID-19 QTL GWAS1590436 (human) | | 0.000009 | COVID-19 | | 10 | 79036076 | 79036077 | Human |
407073163 | GWAS722139_H | Crohn's disease QTL GWAS722139 (human) | | 0.0000003 | intestine integrity trait (VT:0010554) | | 10 | 79285450 | 79285451 | Human |
597051999 | GWAS1148073_H | intelligence QTL GWAS1148073 (human) | | 0.000002 | intelligence | | 10 | 101617239 | 101617240 | Human |
597248595 | GWAS1344669_H | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement QTL GWAS1344669 (human) | | 3e-28 | body fat mass (VT:0010482) | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 94279840 | 94279841 | Human |
597224020 | GWAS1320094_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1320094 (human) | | 2e-21 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 10 | 100006605 | 100006606 | Human |
597240407 | GWAS1336481_H | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement QTL GWAS1336481 (human) | | 7e-17 | body fat mass (VT:0010482) | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 98013128 | 98013129 | Human |
407081363 | GWAS730339_H | waist-hip ratio QTL GWAS730339 (human) | | 5e-08 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 93587048 | 93587049 | Human |
407056786 | GWAS705762_H | unipolar depression QTL GWAS705762 (human) | | 0.000004 | unipolar depression | | 10 | 86126629 | 86126630 | Human |
597158470 | GWAS1254544_H | sex hormone-binding globulin measurement QTL GWAS1254544 (human) | | 7e-08 | sex hormone-binding globulin measurement | | 10 | 102232661 | 102232662 | Human |
597314120 | GWAS1410194_H | glycine conjugate of C10H14O2 (1) measurement QTL GWAS1410194 (human) | | 2e-14 | glycine conjugate of C10H14O2 (1) measurement | | 10 | 94987449 | 94987450 | Human |
597158469 | GWAS1254543_H | sex hormone-binding globulin measurement QTL GWAS1254543 (human) | | 2e-11 | sex hormone-binding globulin measurement | | 10 | 100164661 | 100164662 | Human |
597314121 | GWAS1410195_H | glycine conjugate of C10H14O2 (1) measurement QTL GWAS1410195 (human) | | 5e-14 | glycine conjugate of C10H14O2 (1) measurement | | 10 | 94959764 | 94959765 | Human |
597158468 | GWAS1254542_H | sex hormone-binding globulin measurement QTL GWAS1254542 (human) | | 2e-12 | sex hormone-binding globulin measurement | | 10 | 96097142 | 96097143 | Human |
597158467 | GWAS1254541_H | sex hormone-binding globulin measurement QTL GWAS1254541 (human) | | 6e-21 | sex hormone-binding globulin measurement | | 10 | 93079885 | 93079886 | Human |
597158466 | GWAS1254540_H | sex hormone-binding globulin measurement QTL GWAS1254540 (human) | | 3e-13 | sex hormone-binding globulin measurement | | 10 | 91872199 | 91872200 | Human |
597494344 | GWAS1590418_H | serum alanine aminotransferase measurement QTL GWAS1590418 (human) | | 3e-14 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 96700824 | 96700825 | Human |
597174861 | GWAS1270935_H | intelligence QTL GWAS1270935 (human) | | 6e-14 | intelligence | | 10 | 101795854 | 101795855 | Human |
597158465 | GWAS1254539_H | sex hormone-binding globulin measurement QTL GWAS1254539 (human) | | 5e-21 | sex hormone-binding globulin measurement | | 10 | 79314368 | 79314369 | Human |
407155100 | GWAS804076_H | gut microbiome measurement QTL GWAS804076 (human) | | 0.000005 | gut microbiome measurement | | 10 | 79170941 | 79170942 | Human |
597445191 | GWAS1541265_H | lipid measurement QTL GWAS1541265 (human) | | 0.000009 | lipid measurement | blood lipid measurement (CMO:0000050) | 10 | 78541299 | 78541300 | Human |
407097758 | GWAS746734_H | reticulocyte count QTL GWAS746734 (human) | | 4e-11 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 102869116 | 102869117 | Human |
407040412 | GWAS689388_H | body mass index QTL GWAS689388 (human) | | 0.0000008 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102599593 | 102599594 | Human |
597371460 | GWAS1467534_H | urinary metabolite measurement QTL GWAS1467534 (human) | | 0.0000004 | urinary metabolite measurement | | 10 | 98410626 | 98410627 | Human |
597527165 | GWAS1623239_H | protein measurement QTL GWAS1623239 (human) | | 3e-19 | protein measurement | | 10 | 100130207 | 100130208 | Human |
597224056 | GWAS1320130_H | BMI-adjusted waist circumference QTL GWAS1320130 (human) | | 4e-08 | body size trait (VT:0100005) | | 10 | 100315722 | 100315723 | Human |
597109367 | GWAS1205441_H | mathematical ability QTL GWAS1205441 (human) | | 6e-10 | mathematical ability | | 10 | 102321592 | 102321593 | Human |
597142134 | GWAS1238208_H | insulin measurement QTL GWAS1238208 (human) | | 0.000002 | insulin measurement | pancreatic islet insulin release measurement (CMO:0001216) | 10 | 85558056 | 85558057 | Human |
597109366 | GWAS1205440_H | mathematical ability QTL GWAS1205440 (human) | | 8e-11 | mathematical ability | | 10 | 102120361 | 102120362 | Human |
597224057 | GWAS1320131_H | BMI-adjusted waist circumference QTL GWAS1320131 (human) | | 4e-10 | body size trait (VT:0100005) | | 10 | 102626552 | 102626553 | Human |
596986487 | GWAS1106006_H | myeloid white cell count QTL GWAS1106006 (human) | | 2e-27 | myeloid white cell count | | 10 | 94279840 | 94279841 | Human |
407155104 | GWAS804080_H | gut microbiome measurement QTL GWAS804080 (human) | | 0.000006 | gut microbiome measurement | | 10 | 98590050 | 98590051 | Human |
597142130 | GWAS1238204_H | Drugs used in diabetes use measurement QTL GWAS1238204 (human) | | 9e-30 | Drugs used in diabetes use measurement | | 10 | 92726006 | 92726007 | Human |
597142129 | GWAS1238203_H | Drugs used in diabetes use measurement QTL GWAS1238203 (human) | | 4e-19 | Drugs used in diabetes use measurement | | 10 | 79187681 | 79187682 | Human |
597428858 | GWAS1524932_H | protein measurement QTL GWAS1524932 (human) | | 2e-59 | protein measurement | | 10 | 79334494 | 79334495 | Human |
597224063 | GWAS1320137_H | BMI-adjusted waist circumference QTL GWAS1320137 (human) | | 1e-08 | body size trait (VT:0100005) | | 10 | 79147390 | 79147391 | Human |
597609078 | GWAS1665938_H | liver disease QTL GWAS1665938 (human) | | 2e-14 | liver disease | | 10 | 100152307 | 100152308 | Human |
597322353 | GWAS1418427_H | cup-to-disc ratio measurement QTL GWAS1418427 (human) | | 6e-17 | cup-to-disc ratio measurement | | 10 | 94253193 | 94253194 | Human |
597305974 | GWAS1402048_H | vaginal microbiome measurement QTL GWAS1402048 (human) | | 0.000002 | vaginal microbiome measurement | | 10 | 89422096 | 89422097 | Human |
597363319 | GWAS1459393_H | heel bone mineral density QTL GWAS1459393 (human) | | 9e-08 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 103217846 | 103217847 | Human |
597437041 | GWAS1533115_H | 3-hydroxyanthranilate 3,4-dioxygenase measurement QTL GWAS1533115 (human) | | 3e-41 | protein measurement | | 10 | 100130207 | 100130208 | Human |
597363318 | GWAS1459392_H | heel bone mineral density QTL GWAS1459392 (human) | | 4e-11 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 100130207 | 100130208 | Human |
597363317 | GWAS1459391_H | heel bone mineral density QTL GWAS1459391 (human) | | 3e-13 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 93191731 | 93191732 | Human |
597363316 | GWAS1459390_H | heel bone mineral density QTL GWAS1459390 (human) | | 3e-16 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 79379378 | 79379379 | Human |
597207657 | GWAS1303731_H | protein measurement QTL GWAS1303731 (human) | | 1e-08 | protein measurement | | 10 | 95296494 | 95296495 | Human |
597166689 | GWAS1262763_H | aspartate aminotransferase measurement QTL GWAS1262763 (human) | | 9e-21 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 77920756 | 77920757 | Human |
597027436 | GWAS1123510_H | blood protein measurement QTL GWAS1123510 (human) | | 9e-47 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 97882974 | 97882975 | Human |
597379681 | GWAS1475755_H | sporadic amyotrophic lateral sclerosis QTL GWAS1475755 (human) | | 0.000003 | sporadic amyotrophic lateral sclerosis | | 10 | 86402481 | 86402482 | Human |
597166690 | GWAS1262764_H | aspartate aminotransferase measurement QTL GWAS1262764 (human) | | 3e-08 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 89315587 | 89315588 | Human |
597166691 | GWAS1262765_H | aspartate aminotransferase measurement QTL GWAS1262765 (human) | | 4e-11 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 94254865 | 94254866 | Human |
597289573 | GWAS1385647_H | body weight QTL GWAS1385647 (human) | | 5e-11 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 85731093 | 85731094 | Human |
597445217 | GWAS1541291_H | triglyceride:HDL cholesterol ratio QTL GWAS1541291 (human) | | 1e-08 | blood triglyceride amount (VT:0002644) | | 10 | 93182170 | 93182171 | Human |
597215847 | GWAS1311921_H | heel bone mineral density QTL GWAS1311921 (human) | | 2e-31 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 77651982 | 77651983 | Human |
597363300 | GWAS1459374_H | triglyceride measurement, alcohol drinking QTL GWAS1459374 (human) | | 7e-27 | triglyceride measurement, alcohol drinking | blood triglyceride level (CMO:0000118) | 10 | 93079967 | 93079968 | Human |
597289574 | GWAS1385648_H | body weight QTL GWAS1385648 (human) | | 1e-15 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 98002936 | 98002937 | Human |
597076585 | GWAS1172659_H | Parkinson disease QTL GWAS1172659 (human) | | 0.0000002 | Parkinson disease | | 10 | 102245653 | 102245654 | Human |
596986260 | GWAS1105779_H | diastolic blood pressure QTL GWAS1105779 (human) | | 2e-08 | diastolic blood pressure | | 10 | 94279840 | 94279841 | Human |
597223835 | GWAS1319909_H | bipolar disorder QTL GWAS1319909 (human) | | 6e-14 | bipolar disorder | | 10 | 102861311 | 102861312 | Human |
597232028 | GWAS1328102_H | smoking cessation QTL GWAS1328102 (human) | | 4e-12 | smoking cessation | | 10 | 102804051 | 102804052 | Human |
597035408 | GWAS1131482_H | high density lipoprotein cholesterol measurement QTL GWAS1131482 (human) | | 5e-16 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 79194494 | 79194495 | Human |
597518747 | GWAS1614821_H | colorectal cancer QTL GWAS1614821 (human) | | 9e-08 | colorectal cancer | | 10 | 90091324 | 90091325 | Human |
597445012 | GWAS1541086_H | triglycerides:total lipids ratio, intermediate density lipoprotein measurement QTL GWAS1541086 (human) | | 4e-08 | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | blood intermediate density lipoprotein cholesterol level (CMO:0001562) | 10 | 93549265 | 93549266 | Human |
597035422 | GWAS1131496_H | high density lipoprotein cholesterol measurement QTL GWAS1131496 (human) | | 1e-14 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 100152307 | 100152308 | Human |
597019037 | GWAS1115111_H | body mass index QTL GWAS1115111 (human) | | 8e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100635683 | 100635684 | Human |
597223827 | GWAS1319901_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1319901 (human) | | 7e-23 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 10 | 100312261 | 100312262 | Human |
597207444 | GWAS1303518_H | grip strength measurement QTL GWAS1303518 (human) | | 3e-12 | grip strength measurement | | 10 | 98012647 | 98012648 | Human |
407048783 | GWAS697759_H | urinary metabolite measurement QTL GWAS697759 (human) | | 6e-19 | urinary metabolite measurement | | 10 | 98388419 | 98388420 | Human |
597068185 | GWAS1164259_H | peripheral arterial disease, traffic air pollution measurement QTL GWAS1164259 (human) | | 0.000001 | peripheral arterial disease, traffic air pollution measurement | | 10 | 86655778 | 86655779 | Human |
597477779 | GWAS1573853_H | blood protein measurement QTL GWAS1573853 (human) | | 4e-17 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 97841299 | 97841300 | Human |
597272969 | GWAS1369043_H | type 2 diabetes mellitus QTL GWAS1369043 (human) | | 1e-14 | type 2 diabetes mellitus | | 10 | 92700893 | 92700894 | Human |
407048787 | GWAS697763_H | urinary metabolite measurement QTL GWAS697763 (human) | | 4e-34 | urinary metabolite measurement | | 10 | 98388419 | 98388420 | Human |
597174664 | GWAS1270738_H | intelligence QTL GWAS1270738 (human) | | 4e-09 | intelligence | | 10 | 101966771 | 101966772 | Human |
597272968 | GWAS1369042_H | type 2 diabetes mellitus QTL GWAS1369042 (human) | | 3e-36 | type 2 diabetes mellitus | | 10 | 79184084 | 79184085 | Human |
597526924 | GWAS1622998_H | lipase member N measurement QTL GWAS1622998 (human) | | 1e-764 | lipase member N measurement | | 10 | 88766035 | 88766036 | Human |
597379466 | GWAS1475540_H | platelet count QTL GWAS1475540 (human) | | 1e-18 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 95764023 | 95764024 | Human |
407048786 | GWAS697762_H | urinary metabolite measurement QTL GWAS697762 (human) | | 2e-20 | urinary metabolite measurement | | 10 | 98388301 | 98388302 | Human |
597272971 | GWAS1369045_H | type 2 diabetes mellitus QTL GWAS1369045 (human) | | 8e-08 | type 2 diabetes mellitus | | 10 | 92719350 | 92719351 | Human |
407048785 | GWAS697761_H | urinary metabolite measurement QTL GWAS697761 (human) | | 4e-12 | urinary metabolite measurement | | 10 | 98387303 | 98387304 | Human |
597076356 | GWAS1172430_H | dermatomyositis QTL GWAS1172430 (human) | | 0.0000009 | dermatomyositis | | 10 | 100057106 | 100057107 | Human |
597272970 | GWAS1369044_H | type 2 diabetes mellitus QTL GWAS1369044 (human) | | 1e-09 | type 2 diabetes mellitus | | 10 | 92708490 | 92708491 | Human |
407048784 | GWAS697760_H | urinary metabolite measurement QTL GWAS697760 (human) | | 2e-19 | urinary metabolite measurement | | 10 | 98387303 | 98387304 | Human |
597272972 | GWAS1369046_H | type 2 diabetes mellitus QTL GWAS1369046 (human) | | 5e-15 | type 2 diabetes mellitus | | 10 | 97296433 | 97296434 | Human |
597526923 | GWAS1622997_H | lipase member N measurement QTL GWAS1622997 (human) | | 7e-24 | lipase member N measurement | | 10 | 88767075 | 88767076 | Human |
597084554 | GWAS1180628_H | response to clopidogrel, cardiovascular event measurement QTL GWAS1180628 (human) | | 0.000001 | response to clopidogrel, cardiovascular event measurement | cardiovascular measurement (CMO:0000001) | 10 | 98071581 | 98071582 | Human |
597395898 | GWAS1491972_H | cup-to-disc ratio measurement QTL GWAS1491972 (human) | | 7e-09 | cup-to-disc ratio measurement | | 10 | 93191324 | 93191325 | Human |
597019062 | GWAS1115136_H | heart rate response to recovery post exercise QTL GWAS1115136 (human) | | 1e-17 | heart rate response to recovery post exercise | | 10 | 100796418 | 100796419 | Human |
597109172 | GWAS1205246_H | protein measurement QTL GWAS1205246 (human) | | 1e-09 | protein measurement | | 10 | 102984468 | 102984469 | Human |
597092786 | GWAS1188860_H | type 2 diabetes mellitus QTL GWAS1188860 (human) | | 2e-14 | type 2 diabetes mellitus | | 10 | 93052497 | 93052498 | Human |
597092787 | GWAS1188861_H | type 2 diabetes mellitus QTL GWAS1188861 (human) | | 2e-14 | type 2 diabetes mellitus | | 10 | 92898450 | 92898451 | Human |
597289407 | GWAS1385481_H | blood urea nitrogen measurement, major depressive disorder QTL GWAS1385481 (human) | | 2e-12 | blood urea nitrogen measurement, major depressive disorder | blood urea nitrogen level (CMO:0000049) | 10 | 102559209 | 102559210 | Human |
596978108 | GWAS1097627_H | hypertension QTL GWAS1097627 (human) | | 1e-20 | hypertension | | 10 | 103186066 | 103186067 | Human |
596978110 | GWAS1097629_H | hypertension QTL GWAS1097629 (human) | | 2e-18 | hypertension | | 10 | 94140247 | 94140248 | Human |
597019064 | GWAS1115138_H | heart rate response to exercise QTL GWAS1115138 (human) | | 1e-14 | heart rate response to exercise | | 10 | 100796418 | 100796419 | Human |
407294568 | GWAS943544_H | mean arterial pressure QTL GWAS943544 (human) | | 3e-29 | mean arterial pressure | | 10 | 94278929 | 94278930 | Human |
597019045 | GWAS1115119_H | heart rate response to recovery post exercise QTL GWAS1115119 (human) | | 2e-09 | heart rate response to recovery post exercise | | 10 | 100798737 | 100798738 | Human |
597289389 | GWAS1385463_H | total cholesterol in small VLDL QTL GWAS1385463 (human) | | 1e-15 | total cholesterol in small VLDL | | 10 | 93083778 | 93083779 | Human |
597223840 | GWAS1319914_H | major depressive disorder QTL GWAS1319914 (human) | | 8e-11 | major depressive disorder | | 10 | 102963863 | 102963864 | Human |
597436837 | GWAS1532911_H | N6,N6-dimethyllysine measurement QTL GWAS1532911 (human) | | 4e-253 | N6,N6-dimethyllysine measurement | | 10 | 98391432 | 98391433 | Human |
597445031 | GWAS1541105_H | fatty acid measurement QTL GWAS1541105 (human) | | 2e-11 | fatty acid measurement | | 10 | 100600003 | 100600004 | Human |
597461410 | GWAS1557484_H | retinal vasculature measurement QTL GWAS1557484 (human) | | 0.000003 | retina blood vessel morphology trait (VT:0002792) | | 10 | 94278929 | 94278930 | Human |
597117352 | GWAS1213426_H | electrocardiography QTL GWAS1213426 (human) | | 4e-08 | electrocardiography | | 10 | 102625375 | 102625376 | Human |
597289432 | GWAS1385506_H | triglycerides in small HDL measurement QTL GWAS1385506 (human) | | 6e-12 | triglycerides in small HDL measurement | blood high density lipoprotein triglyceride level (CMO:0002686) | 10 | 93083778 | 93083779 | Human |
597027280 | GWAS1123354_H | systolic blood pressure QTL GWAS1123354 (human) | | 3e-15 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103179458 | 103179459 | Human |
597223888 | GWAS1319962_H | cystatin C measurement QTL GWAS1319962 (human) | | 2e-09 | cystatin C measurement | blood cystatin C level (CMO:0002777) | 10 | 80266060 | 80266061 | Human |
596978141 | GWAS1097660_H | ulcerative colitis QTL GWAS1097660 (human) | | 3e-11 | ulcerative colitis | | 10 | 96860106 | 96860107 | Human |
597608918 | GWAS1665778_H | Abnormality of the liver QTL GWAS1665778 (human) | | 1e-39 | Abnormality of the liver | | 10 | 100152437 | 100152438 | Human |
596978140 | GWAS1097659_H | ulcerative colitis QTL GWAS1097659 (human) | | 1e-09 | ulcerative colitis | | 10 | 92669710 | 92669711 | Human |
597223889 | GWAS1319963_H | cystatin C measurement QTL GWAS1319963 (human) | | 2e-09 | cystatin C measurement | blood cystatin C level (CMO:0002777) | 10 | 93082720 | 93082721 | Human |
596978143 | GWAS1097662_H | ulcerative colitis QTL GWAS1097662 (human) | | 2e-08 | ulcerative colitis | | 10 | 101436625 | 101436626 | Human |
596978142 | GWAS1097661_H | ulcerative colitis QTL GWAS1097661 (human) | | 3e-40 | ulcerative colitis | | 10 | 99524480 | 99524481 | Human |
597068250 | GWAS1164324_H | mean corpuscular hemoglobin QTL GWAS1164324 (human) | | 7e-11 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 102948555 | 102948556 | Human |
597395926 | GWAS1492000_H | white matter lesion progression measurement QTL GWAS1492000 (human) | | 0.00001 | central nervous system integrity trait (VT:0010772) | | 10 | 81841708 | 81841709 | Human |
407040527 | GWAS689503_H | self reported educational attainment QTL GWAS689503 (human) | | 0.0000006 | self reported educational attainment | | 10 | 102042651 | 102042652 | Human |
596978139 | GWAS1097658_H | ulcerative colitis QTL GWAS1097658 (human) | | 3e-12 | ulcerative colitis | | 10 | 89146767 | 89146768 | Human |
597387733 | GWAS1483807_H | intelligence QTL GWAS1483807 (human) | | 4e-11 | intelligence | | 10 | 101781259 | 101781260 | Human |
596978138 | GWAS1097657_H | ulcerative colitis QTL GWAS1097657 (human) | | 8e-08 | ulcerative colitis | | 10 | 79286696 | 79286697 | Human |
597297621 | GWAS1393695_H | low density lipoprotein cholesterol measurement QTL GWAS1393695 (human) | | 4e-18 | low density lipoprotein cholesterol measurement | | 10 | 93079885 | 93079886 | Human |
597158360 | GWAS1254434_H | triglyceride:HDL cholesterol ratio QTL GWAS1254434 (human) | | 2e-39 | blood triglyceride amount (VT:0002644) | | 10 | 93079885 | 93079886 | Human |
597092806 | GWAS1188880_H | manic episode measurement, depressive episode measurement QTL GWAS1188880 (human) | | 0.0000001 | depression-related behavior trait (VT:0015015) | | 10 | 88570726 | 88570727 | Human |
597395915 | GWAS1491989_H | Calcium channel blocker use measurement QTL GWAS1491989 (human) | | 6e-15 | Calcium channel blocker use measurement | pulse pressure (CMO:0000292) | 10 | 94278929 | 94278930 | Human |
597313994 | GWAS1410068_H | glycocholenate sulfate measurement QTL GWAS1410068 (human) | | 2e-14 | glycocholenate sulfate measurement | | 10 | 99865792 | 99865793 | Human |
597428684 | GWAS1524758_H | depressive symptom measurement QTL GWAS1524758 (human) | | 3e-08 | depressive symptom measurement | | 10 | 103199431 | 103199432 | Human |
596978116 | GWAS1097635_H | hypertension QTL GWAS1097635 (human) | | 5e-09 | hypertension | | 10 | 80439507 | 80439508 | Human |
597191114 | GWAS1287188_H | testosterone measurement QTL GWAS1287188 (human) | | 1e-10 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 95050911 | 95050912 | Human |
596978118 | GWAS1097637_H | hypertension QTL GWAS1097637 (human) | | 1e-08 | hypertension | | 10 | 93983330 | 93983331 | Human |
597313993 | GWAS1410067_H | glycocholenate sulfate measurement QTL GWAS1410067 (human) | | 3e-25 | glycocholenate sulfate measurement | | 10 | 99848144 | 99848145 | Human |
596978113 | GWAS1097632_H | hypertension QTL GWAS1097632 (human) | | 2e-12 | hypertension | | 10 | 94546848 | 94546849 | Human |
597060034 | GWAS1156108_H | age at menarche QTL GWAS1156108 (human) | | 1e-09 | age at menarche | | 10 | 100880906 | 100880907 | Human |
597068225 | GWAS1164299_H | androstenedione measurement QTL GWAS1164299 (human) | | 0.0000006 | blood hormone amount (VT:0005418) | | 10 | 86667452 | 86667453 | Human |
597060033 | GWAS1156107_H | age at menarche QTL GWAS1156107 (human) | | 6e-33 | age at menarche | | 10 | 96117563 | 96117564 | Human |
597428683 | GWAS1524757_H | depressive symptom measurement QTL GWAS1524757 (human) | | 2e-08 | depressive symptom measurement | | 10 | 102834750 | 102834751 | Human |
597453252 | GWAS1549326_H | alkaline phosphatase measurement QTL GWAS1549326 (human) | | 1e-10 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 100910439 | 100910440 | Human |
597191104 | GWAS1287178_H | Parkinson disease QTL GWAS1287178 (human) | | 0.000003 | Parkinson disease | | 10 | 102255522 | 102255523 | Human |
597510596 | GWAS1606670_H | insomnia QTL GWAS1606670 (human) | | 1e-08 | insomnia | | 10 | 101576645 | 101576646 | Human |
597150157 | GWAS1246231_H | triglyceride measurement, low density lipoprotein cholesterol measurement QTL GWAS1246231 (human) | | 2e-08 | very low density lipoprotein cholesterol measurement, lipid measurement | blood lipid measurement (CMO:0000050) | 10 | 98013128 | 98013129 | Human |
597035468 | GWAS1131542_H | triglyceride measurement QTL GWAS1131542 (human) | | 1e-10 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 102186723 | 102186724 | Human |
597191106 | GWAS1287180_H | testosterone measurement QTL GWAS1287180 (human) | | 7e-21 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 102863296 | 102863297 | Human |
597027279 | GWAS1123353_H | systolic blood pressure QTL GWAS1123353 (human) | | 7e-15 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103146454 | 103146455 | Human |
597150156 | GWAS1246230_H | triglyceride measurement, low density lipoprotein cholesterol measurement QTL GWAS1246230 (human) | | 2e-11 | triglyceride measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 93079885 | 93079886 | Human |
597027278 | GWAS1123352_H | systolic blood pressure QTL GWAS1123352 (human) | | 8e-15 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103086421 | 103086422 | Human |
597150155 | GWAS1246229_H | triglyceride measurement, low density lipoprotein cholesterol measurement QTL GWAS1246229 (human) | | 2e-11 | triglyceride measurement, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 91882000 | 91882001 | Human |
597207492 | GWAS1303566_H | protein measurement QTL GWAS1303566 (human) | | 3e-08 | protein measurement | | 10 | 100742278 | 100742279 | Human |
597019083 | GWAS1115157_H | heart rate response to recovery post exercise QTL GWAS1115157 (human) | | 3e-15 | heart rate response to recovery post exercise | | 10 | 100796418 | 100796419 | Human |
596969930 | GWAS1089449_H | major depressive disorder QTL GWAS1089449 (human) | | 2e-10 | major depressive disorder | | 10 | 102660997 | 102660998 | Human |
597428732 | GWAS1524806_H | Red cell distribution width QTL GWAS1524806 (human) | | 4e-18 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 79040331 | 79040332 | Human |
597076470 | GWAS1172544_H | sarcoidosis QTL GWAS1172544 (human) | | 0.000004 | sarcoidosis | | 10 | 80382420 | 80382421 | Human |
597428733 | GWAS1524807_H | Red cell distribution width QTL GWAS1524807 (human) | | 2e-09 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 99494751 | 99494752 | Human |
597428734 | GWAS1524808_H | Red cell distribution width QTL GWAS1524808 (human) | | 2e-10 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 102875346 | 102875347 | Human |
597101045 | GWAS1197119_H | protein measurement QTL GWAS1197119 (human) | | 1e-10 | protein measurement | | 10 | 103073291 | 103073292 | Human |
407147041 | GWAS796017_H | obsolete_red blood cell distribution width QTL GWAS796017 (human) | | 9e-16 | obsolete_red blood cell distribution width | | 10 | 100315722 | 100315723 | Human |
597510650 | GWAS1606724_H | facial height measurement QTL GWAS1606724 (human) | | 7e-08 | facial morphology trait (VT:0003743) | | 10 | 90541950 | 90541951 | Human |
597371388 | GWAS1467462_H | scoliosis QTL GWAS1467462 (human) | | 1e-19 | scoliosis | | 10 | 101219450 | 101219451 | Human |
597289457 | GWAS1385531_H | inflammatory bowel disease QTL GWAS1385531 (human) | | 5e-09 | inflammatory bowel disease | | 10 | 80511585 | 80511586 | Human |
597510645 | GWAS1606719_H | facial width measurement QTL GWAS1606719 (human) | | 0.000005 | facial morphology trait (VT:0003743) | | 10 | 84292391 | 84292392 | Human |
597289456 | GWAS1385530_H | inflammatory bowel disease QTL GWAS1385530 (human) | | 1e-28 | inflammatory bowel disease | | 10 | 79286696 | 79286697 | Human |
597289459 | GWAS1385533_H | inflammatory bowel disease QTL GWAS1385533 (human) | | 9e-08 | inflammatory bowel disease | | 10 | 101436625 | 101436626 | Human |
597289458 | GWAS1385532_H | inflammatory bowel disease QTL GWAS1385532 (human) | | 3e-10 | inflammatory bowel disease | | 10 | 89146767 | 89146768 | Human |
597289460 | GWAS1385534_H | inflammatory bowel disease QTL GWAS1385534 (human) | | 8e-11 | inflammatory bowel disease | | 10 | 102465559 | 102465560 | Human |
597289448 | GWAS1385522_H | body mass index QTL GWAS1385522 (human) | | 7e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 94254865 | 94254866 | Human |
597019104 | GWAS1115178_H | heart rate response to recovery post exercise QTL GWAS1115178 (human) | | 2e-15 | heart rate response to recovery post exercise | | 10 | 100798737 | 100798738 | Human |
596978144 | GWAS1097663_H | ulcerative colitis QTL GWAS1097663 (human) | | 5e-09 | ulcerative colitis | | 10 | 102465559 | 102465560 | Human |
597084640 | GWAS1180714_H | serum metabolite measurement QTL GWAS1180714 (human) | | 2e-14 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 100315722 | 100315723 | Human |
597281248 | GWAS1377322_H | X-11787 measurement QTL GWAS1377322 (human) | | 5e-64 | X-11787 measurement | | 10 | 94960088 | 94960089 | Human |
597297635 | GWAS1393709_H | phosphatidylcholine measurement QTL GWAS1393709 (human) | | 9e-12 | glycerophosphocholine amount (VT:0011004) | | 10 | 100315722 | 100315723 | Human |
597297632 | GWAS1393706_H | lysophosphatidylcholine 16:1 measurement QTL GWAS1393706 (human) | | 7e-20 | glycerophosphocholine amount (VT:0011004) | | 10 | 100315722 | 100315723 | Human |
597363175 | GWAS1459249_H | monocyte count QTL GWAS1459249 (human) | | 3e-36 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 99532633 | 99532634 | Human |
597281254 | GWAS1377328_H | X-12112 measurement QTL GWAS1377328 (human) | | 5e-1181 | X-12112 measurement | | 10 | 98386156 | 98386157 | Human |
596977944 | GWAS1097463_H | body height QTL GWAS1097463 (human) | | 4e-45 | body height | | 10 | 91255322 | 91255323 | Human |
597158168 | GWAS1254242_H | fatty acid measurement QTL GWAS1254242 (human) | | 1e-12 | fatty acid measurement | | 10 | 94990179 | 94990180 | Human |
597264649 | GWAS1360723_H | schizophrenia QTL GWAS1360723 (human) | | 0.00001 | schizophrenia | | 10 | 100900524 | 100900525 | Human |
597248265 | GWAS1344339_H | lymphocyte:monocyte ratio QTL GWAS1344339 (human) | | 5e-08 | leukocyte quantity (VT:0000217) | | 10 | 102793809 | 102793810 | Human |
597248264 | GWAS1344338_H | lymphocyte:monocyte ratio QTL GWAS1344338 (human) | | 5e-08 | platelet quantity (VT:0003179) | | 10 | 96620380 | 96620381 | Human |
597018884 | GWAS1114958_H | intelligence QTL GWAS1114958 (human) | | 2e-10 | intelligence | | 10 | 101781259 | 101781260 | Human |
406975187 | GWAS624163_H | allergic disease QTL GWAS624163 (human) | | 0.000009 | allergic disease | | 10 | 83493925 | 83493926 | Human |
597395713 | GWAS1491787_H | cardioembolic stroke QTL GWAS1491787 (human) | | 8e-41 | cardioembolic stroke | | 10 | 103582915 | 103582916 | Human |
597305606 | GWAS1401680_H | platelet count QTL GWAS1401680 (human) | | 4e-17 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 102556824 | 102556825 | Human |
597305605 | GWAS1401679_H | platelet count QTL GWAS1401679 (human) | | 2e-15 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 99515392 | 99515393 | Human |
597387579 | GWAS1483653_H | high density lipoprotein cholesterol measurement QTL GWAS1483653 (human) | | 0.0000009 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 100267650 | 100267651 | Human |
597092663 | GWAS1188737_H | FEV/FVC ratio, response to bronchodilator QTL GWAS1188737 (human) | | 0.000002 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 97512247 | 97512248 | Human |
407048928 | GWAS697904_H | serum metabolite measurement QTL GWAS697904 (human) | | 7e-21 | serum metabolite measurement | | 10 | 94989424 | 94989425 | Human |
597092659 | GWAS1188733_H | FEV/FVC ratio, response to bronchodilator QTL GWAS1188733 (human) | | 0.000002 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 87572949 | 87572950 | Human |
597305660 | GWAS1401734_H | breast cancer, lung cancer QTL GWAS1401734 (human) | | 7e-22 | breast cancer, lung cancer | | 10 | 79129101 | 79129102 | Human |
597264691 | GWAS1360765_H | cup-to-disc ratio measurement QTL GWAS1360765 (human) | | 3e-09 | cup-to-disc ratio measurement | | 10 | 97207839 | 97207840 | Human |
407048937 | GWAS697913_H | serum metabolite measurement QTL GWAS697913 (human) | | 2e-281 | serum metabolite measurement | | 10 | 98399379 | 98399380 | Human |
597027129 | GWAS1123203_H | pulse pressure measurement QTL GWAS1123203 (human) | | 4e-13 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 103179458 | 103179459 | Human |
407048940 | GWAS697916_H | serum metabolite measurement QTL GWAS697916 (human) | | 1e-27 | serum metabolite measurement | | 10 | 98399379 | 98399380 | Human |
597027105 | GWAS1123179_H | pulse pressure measurement QTL GWAS1123179 (human) | | 9e-13 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 103146454 | 103146455 | Human |
597469482 | GWAS1565556_H | Myopia QTL GWAS1565556 (human) | | 9e-08 | Myopia | | 10 | 89946673 | 89946674 | Human |
597289251 | GWAS1385325_H | fatty acid measurement QTL GWAS1385325 (human) | | 8e-62 | fatty acid measurement | | 10 | 100315722 | 100315723 | Human |
597248293 | GWAS1344367_H | serum alanine aminotransferase measurement QTL GWAS1344367 (human) | | 8e-12 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 77921372 | 77921373 | Human |
596977963 | GWAS1097482_H | body height QTL GWAS1097482 (human) | | 3e-29 | body height | | 10 | 77812829 | 77812830 | Human |
597174566 | GWAS1270640_H | preeclampsia, hypertension, pregnancy-induced QTL GWAS1270640 (human) | | 2e-13 | preeclampsia, hypertension, pregnancy-induced | | 10 | 94133031 | 94133032 | Human |
597248294 | GWAS1344368_H | serum alanine aminotransferase measurement QTL GWAS1344368 (human) | | 7e-12 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 96711108 | 96711109 | Human |
406966912 | GWAS615888_H | forced expiratory volume, response to bronchodilator QTL GWAS615888 (human) | | 0.0000004 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 10 | 80462422 | 80462423 | Human |
597092692 | GWAS1188766_H | type 2 diabetes mellitus QTL GWAS1188766 (human) | | 3e-08 | type 2 diabetes mellitus | | 10 | 79184084 | 79184085 | Human |
597313887 | GWAS1409961_H | X-24588 measurement QTL GWAS1409961 (human) | | 2e-11 | X-24588 measurement | | 10 | 99835096 | 99835097 | Human |
597608793 | GWAS1665653_H | liver disease QTL GWAS1665653 (human) | | 3e-15 | liver disease | | 10 | 100152437 | 100152438 | Human |
597043551 | GWAS1139625_H | hemoglobin measurement QTL GWAS1139625 (human) | | 3e-10 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 87170492 | 87170493 | Human |
597027164 | GWAS1123238_H | pulse pressure measurement QTL GWAS1123238 (human) | | 4e-22 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 103034329 | 103034330 | Human |
406893197 | GWAS542173_H | systolic blood pressure QTL GWAS542173 (human) | | 1e-14 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94136183 | 94136184 | Human |
597117252 | GWAS1213326_H | intraocular pressure measurement QTL GWAS1213326 (human) | | 1e-08 | intraocular pressure measurement | | 10 | 103603532 | 103603533 | Human |
406942357 | GWAS591333_H | white matter microstructure measurement QTL GWAS591333 (human) | | 3e-10 | white matter microstructure measurement | | 10 | 90833199 | 90833200 | Human |
597395790 | GWAS1491864_H | body mass index QTL GWAS1491864 (human) | | 2e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102460544 | 102460545 | Human |
597158223 | GWAS1254297_H | IGA glomerulonephritis QTL GWAS1254297 (human) | | 2e-10 | IGA glomerulonephritis | | 10 | 79283986 | 79283987 | Human |
597018957 | GWAS1115031_H | basophil percentage of leukocytes QTL GWAS1115031 (human) | | 4e-16 | basophil quantity (VT:0002607) | blood basophil count to total leukocyte count ratio (CMO:0000368) | 10 | 100343751 | 100343752 | Human |
597027148 | GWAS1123222_H | systolic blood pressure QTL GWAS1123222 (human) | | 2e-22 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103186066 | 103186067 | Human |
597305671 | GWAS1401745_H | thymol sulfate measurement QTL GWAS1401745 (human) | | 3e-19 | thymol sulfate measurement | | 10 | 94990494 | 94990495 | Human |
597281145 | GWAS1377219_H | sex hormone-binding globulin measurement QTL GWAS1377219 (human) | | 1e-09 | sex hormone-binding globulin measurement | | 10 | 91883203 | 91883204 | Human |
597150068 | GWAS1246142_H | smoking status measurement QTL GWAS1246142 (human) | | 7e-09 | smoking status measurement | | 10 | 102813260 | 102813261 | Human |
597068157 | GWAS1164231_H | peripheral arterial disease, traffic air pollution measurement QTL GWAS1164231 (human) | | 0.000001 | peripheral arterial disease, traffic air pollution measurement | | 10 | 99418299 | 99418300 | Human |
597068135 | GWAS1164209_H | peripheral arterial disease, traffic air pollution measurement QTL GWAS1164209 (human) | | 9e-08 | peripheral arterial disease, traffic air pollution measurement | | 10 | 99361961 | 99361962 | Human |
597592431 | GWAS1649291_H | high density lipoprotein cholesterol measurement QTL GWAS1649291 (human) | | 2e-29 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 100152307 | 100152308 | Human |
597109092 | GWAS1205166_H | mathematical ability QTL GWAS1205166 (human) | | 2e-10 | mathematical ability | | 10 | 89783381 | 89783382 | Human |
597100900 | GWAS1196974_H | diverticular disease QTL GWAS1196974 (human) | | 0.000009 | diverticular disease | | 10 | 95930862 | 95930863 | Human |
597510510 | GWAS1606584_H | uric acid measurement QTL GWAS1606584 (human) | | 5e-09 | uric acid measurement | blood uric acid level (CMO:0000501) | 10 | 102727686 | 102727687 | Human |
407007926 | GWAS656902_H | neutrophil count QTL GWAS656902 (human) | | 3e-25 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 89243047 | 89243048 | Human |
597109091 | GWAS1205165_H | mathematical ability QTL GWAS1205165 (human) | | 3e-09 | mathematical ability | | 10 | 89497997 | 89497998 | Human |
407040695 | GWAS689671_H | chronic obstructive pulmonary disease, surfactant protein D measurement QTL GWAS689671 (human) | | 7e-11 | lung integrity trait (VT:0010906) | | 10 | 80028348 | 80028349 | Human |
597109090 | GWAS1205164_H | mathematical ability QTL GWAS1205164 (human) | | 7e-09 | mathematical ability | | 10 | 86504258 | 86504259 | Human |
407270067 | GWAS919043_H | neutrophil count QTL GWAS919043 (human) | | 2e-12 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 91873092 | 91873093 | Human |
407007924 | GWAS656900_H | neutrophil count QTL GWAS656900 (human) | | 7e-12 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 79287818 | 79287819 | Human |
597428586 | GWAS1524660_H | gout QTL GWAS1524660 (human) | | 5e-27 | gout | | 10 | 87162875 | 87162876 | Human |
407040693 | GWAS689669_H | chronic obstructive pulmonary disease, surfactant protein D measurement QTL GWAS689669 (human) | | 2e-12 | lung integrity trait (VT:0010906) | | 10 | 80088158 | 80088159 | Human |
407007925 | GWAS656901_H | neutrophil count QTL GWAS656901 (human) | | 5e-11 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 80489996 | 80489997 | Human |
597248353 | GWAS1344427_H | neuroblastoma QTL GWAS1344427 (human) | | 0.000002 | neuroblastoma | | 10 | 86357936 | 86357937 | Human |
597051758 | GWAS1147832_H | hematocrit QTL GWAS1147832 (human) | | 4e-12 | hematocrit | hematocrit (CMO:0000037) | 10 | 91277652 | 91277653 | Human |
597051759 | GWAS1147833_H | hematocrit QTL GWAS1147833 (human) | | 8e-12 | hematocrit | hematocrit (CMO:0000037) | 10 | 95500358 | 95500359 | Human |
407040696 | GWAS689672_H | chronic obstructive pulmonary disease, surfactant protein D measurement QTL GWAS689672 (human) | | 1e-10 | lung integrity trait (VT:0010906) | | 10 | 80173992 | 80173993 | Human |
597051756 | GWAS1147830_H | hematocrit QTL GWAS1147830 (human) | | 6e-12 | hematocrit | hematocrit (CMO:0000037) | 10 | 88536710 | 88536711 | Human |
597592420 | GWAS1649280_H | high density lipoprotein cholesterol measurement QTL GWAS1649280 (human) | | 1e-32 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 93079885 | 93079886 | Human |
597051757 | GWAS1147831_H | hematocrit QTL GWAS1147831 (human) | | 1e-11 | hematocrit | hematocrit (CMO:0000037) | 10 | 89635671 | 89635672 | Human |
597051755 | GWAS1147829_H | hematocrit QTL GWAS1147829 (human) | | 9e-17 | hematocrit | hematocrit (CMO:0000037) | 10 | 80394740 | 80394741 | Human |
597608803 | GWAS1665663_H | digestive system disease QTL GWAS1665663 (human) | | 6e-13 | digestive system disease | | 10 | 98058846 | 98058847 | Human |
597084521 | GWAS1180595_H | PR interval QTL GWAS1180595 (human) | | 1e-15 | PR interval | PR interval (CMO:0000233) | 10 | 86749331 | 86749332 | Human |
597141864 | GWAS1237938_H | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement QTL GWAS1237938 (human) | | 9e-14 | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | | 10 | 95035530 | 95035531 | Human |
597600415 | GWAS1657275_H | basophil measurement QTL GWAS1657275 (human) | | 6e-14 | basophil measurement | | 10 | 87938433 | 87938434 | Human |
407073600 | GWAS722576_H | BMI-adjusted waist-hip ratio QTL GWAS722576 (human) | | 4e-09 | body size trait (VT:0100005) | | 10 | 92237938 | 92237939 | Human |
407073606 | GWAS722582_H | BMI-adjusted waist-hip ratio QTL GWAS722582 (human) | | 3e-12 | body size trait (VT:0100005) | | 10 | 93587048 | 93587049 | Human |
597297308 | GWAS1393382_H | membrane protein FAM174A measurement QTL GWAS1393382 (human) | | 1e-107 | membrane protein FAM174A measurement | | 10 | 88673588 | 88673589 | Human |
597076112 | GWAS1172186_H | late-onset Alzheimers disease QTL GWAS1172186 (human) | | 0.000004 | late-onset Alzheimers disease | | 10 | 88850285 | 88850286 | Human |
597371026 | GWAS1467100_H | parental emotion expression measurmement, conduct disorder QTL GWAS1467100 (human) | | 0.000006 | parental emotion expression measurmement, conduct disorder | | 10 | 78341104 | 78341105 | Human |
597321867 | GWAS1417941_H | mean arterial pressure QTL GWAS1417941 (human) | | 0.000005 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 102678808 | 102678809 | Human |
597207182 | GWAS1303256_H | urate measurement QTL GWAS1303256 (human) | | 1e-10 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 87149044 | 87149045 | Human |
597461124 | GWAS1557198_H | diastolic blood pressure QTL GWAS1557198 (human) | | 9e-56 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103146454 | 103146455 | Human |
597461125 | GWAS1557199_H | diastolic blood pressure QTL GWAS1557199 (human) | | 3e-52 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103192742 | 103192743 | Human |
597461126 | GWAS1557200_H | diastolic blood pressure QTL GWAS1557200 (human) | | 2e-08 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103533760 | 103533761 | Human |
597461127 | GWAS1557201_H | diastolic blood pressure QTL GWAS1557201 (human) | | 6e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103564413 | 103564414 | Human |
597223556 | GWAS1319630_H | serum gamma-glutamyl transferase measurement QTL GWAS1319630 (human) | | 5e-43 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 77921372 | 77921373 | Human |
597305478 | GWAS1401552_H | vaginal microbiome measurement QTL GWAS1401552 (human) | | 0.0000009 | vaginal microbiome measurement | | 10 | 89419538 | 89419539 | Human |
597387399 | GWAS1483473_H | acute myeloid leukemia QTL GWAS1483473 (human) | | 0.000004 | leukocyte integrity trait (VT:0010898) | | 10 | 92411094 | 92411095 | Human |
597461120 | GWAS1557194_H | diastolic blood pressure QTL GWAS1557194 (human) | | 7e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 102076050 | 102076051 | Human |
597461121 | GWAS1557195_H | diastolic blood pressure QTL GWAS1557195 (human) | | 5e-22 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 102727686 | 102727687 | Human |
597461122 | GWAS1557196_H | diastolic blood pressure QTL GWAS1557196 (human) | | 4e-16 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103026556 | 103026557 | Human |
597461123 | GWAS1557197_H | diastolic blood pressure QTL GWAS1557197 (human) | | 2e-09 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103086555 | 103086556 | Human |
407335780 | GWAS984756_H | eosinophil count QTL GWAS984756 (human) | | 5e-08 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 92804854 | 92804855 | Human |
597239999 | GWAS1336073_H | diet measurement, body mass index QTL GWAS1336073 (human) | | 0.000006 | eating behavior trait (VT:0001431) | body mass index (BMI) (CMO:0000105) | 10 | 93755758 | 93755759 | Human |
597199038 | GWAS1295112_H | body mass index QTL GWAS1295112 (human) | | 1e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102875591 | 102875592 | Human |
407122796 | GWAS771772_H | mean corpuscular hemoglobin QTL GWAS771772 (human) | | 5e-10 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 99863999 | 99864000 | Human |
407122797 | GWAS771773_H | mean corpuscular hemoglobin QTL GWAS771773 (human) | | 4e-16 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 101503499 | 101503500 | Human |
597412016 | GWAS1508090_H | triglyceride measurement QTL GWAS1508090 (human) | | 1e-32 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079967 | 93079968 | Human |
596953272 | GWAS1072791_H | smoking behaviour measurement, risk-taking behaviour QTL GWAS1072791 (human) | | 1e-17 | smoking behaviour measurement, risk-taking behaviour | | 10 | 102880295 | 102880296 | Human |
596977848 | GWAS1097367_H | ulcerative colitis QTL GWAS1097367 (human) | | 8e-10 | ulcerative colitis | | 10 | 96837270 | 96837271 | Human |
407122794 | GWAS771770_H | mean corpuscular hemoglobin QTL GWAS771770 (human) | | 2e-10 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 94386376 | 94386377 | Human |
597362863 | GWAS1458937_H | bone mineral content measurement QTL GWAS1458937 (human) | | 0.000007 | bone mineral content measurement | | 10 | 89934979 | 89934980 | Human |
597321902 | GWAS1417976_H | 16a-hydroxy DHEA 3-sulfate measurement QTL GWAS1417976 (human) | | 9e-48 | 16a-hydroxy DHEA 3-sulfate measurement | | 10 | 95081567 | 95081568 | Human |
597608618 | GWAS1665478_H | morbid obesity QTL GWAS1665478 (human) | | 6e-12 | morbid obesity | | 10 | 102870655 | 102870656 | Human |
597231791 | GWAS1327865_H | BMI-adjusted waist-hip ratio QTL GWAS1327865 (human) | | 4e-11 | body size trait (VT:0100005) | | 10 | 94171330 | 94171331 | Human |
597043360 | GWAS1139434_H | schizophrenia QTL GWAS1139434 (human) | | 9e-19 | schizophrenia | | 10 | 102889618 | 102889619 | Human |
597616807 | GWAS1673667_H | mean corpuscular hemoglobin concentration QTL GWAS1673667 (human) | | 8e-19 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 89246195 | 89246196 | Human |
597493921 | GWAS1589995_H | COVID-19 QTL GWAS1589995 (human) | | 0.000007 | COVID-19 | | 10 | 79041650 | 79041651 | Human |
597330085 | GWAS1426159_H | sexual dimorphism measurement QTL GWAS1426159 (human) | | 5e-10 | sexual dimorphism measurement | | 10 | 102489866 | 102489867 | Human |
407147271 | GWAS796247_H | migraine disorder QTL GWAS796247 (human) | | 0.0000006 | migraine disorder | | 10 | 86456645 | 86456646 | Human |
597371102 | GWAS1467176_H | low density lipoprotein cholesterol measurement QTL GWAS1467176 (human) | | 0.000006 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 99732646 | 99732647 | Human |
597371101 | GWAS1467175_H | physical activity QTL GWAS1467175 (human) | | 0.000004 | physical activity | | 10 | 77781077 | 77781078 | Human |
597272789 | GWAS1368863_H | total cholesterol measurement QTL GWAS1368863 (human) | | 2e-11 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 89250556 | 89250557 | Human |
407147272 | GWAS796248_H | migraine disorder QTL GWAS796248 (human) | | 0.000002 | migraine disorder | | 10 | 98886424 | 98886425 | Human |
597018841 | GWAS1114915_H | basophil count QTL GWAS1114915 (human) | | 3e-14 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 100336597 | 100336598 | Human |
597272788 | GWAS1368862_H | total cholesterol measurement QTL GWAS1368862 (human) | | 8e-11 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 79316720 | 79316721 | Human |
597018840 | GWAS1114914_H | basophil count QTL GWAS1114914 (human) | | 5e-11 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 94311804 | 94311805 | Human |
597403862 | GWAS1499936_H | schizophrenia QTL GWAS1499936 (human) | | 0.000005 | schizophrenia | | 10 | 100146576 | 100146577 | Human |
597272790 | GWAS1368864_H | total cholesterol measurement QTL GWAS1368864 (human) | | 1e-29 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 93079885 | 93079886 | Human |
597018842 | GWAS1114916_H | basophil count QTL GWAS1114916 (human) | | 1e-10 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 102824175 | 102824176 | Human |
597084359 | GWAS1180433_H | reticulocyte measurement QTL GWAS1180433 (human) | | 4e-14 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 10 | 79357419 | 79357420 | Human |
597518540 | GWAS1614614_H | omega-3 polyunsaturated fatty acid measurement QTL GWAS1614614 (human) | | 9e-10 | omega-3 polyunsaturated fatty acid measurement | | 10 | 93079967 | 93079968 | Human |
597018823 | GWAS1114897_H | eosinophil count QTL GWAS1114897 (human) | | 7e-39 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 92669710 | 92669711 | Human |
597149890 | GWAS1245964_H | smoking status measurement QTL GWAS1245964 (human) | | 0.000005 | smoking status measurement | | 10 | 102813260 | 102813261 | Human |
597280961 | GWAS1377035_H | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement QTL GWAS1377035 (human) | | 5e-19 | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | | 10 | 95059456 | 95059457 | Human |
597166273 | GWAS1262347_H | ulcerative colitis QTL GWAS1262347 (human) | | 6e-09 | ulcerative colitis | | 10 | 97048848 | 97048849 | Human |
597084360 | GWAS1180434_H | reticulocyte measurement QTL GWAS1180434 (human) | | 4e-11 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 10 | 99514668 | 99514669 | Human |
597084361 | GWAS1180435_H | reticulocyte measurement QTL GWAS1180435 (human) | | 8e-31 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 10 | 103148603 | 103148604 | Human |
597592319 | GWAS1649179_H | high density lipoprotein cholesterol measurement QTL GWAS1649179 (human) | | 4e-20 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 100152307 | 100152308 | Human |
597027062 | GWAS1123136_H | serum metabolite measurement QTL GWAS1123136 (human) | | 3e-13 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 100315722 | 100315723 | Human |
406950693 | GWAS599669_H | neuroticism measurement QTL GWAS599669 (human) | | 0.000009 | neuroticism measurement | | 10 | 98911149 | 98911150 | Human |
597043440 | GWAS1139514_H | serum metabolite measurement QTL GWAS1139514 (human) | | 7e-11 | serum metabolite measurement | | 10 | 100315722 | 100315723 | Human |
597027071 | GWAS1123145_H | mean arterial pressure QTL GWAS1123145 (human) | | 0.0000007 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 102794772 | 102794773 | Human |
597371126 | GWAS1467200_H | migraine disorder QTL GWAS1467200 (human) | | 0.000009 | migraine disorder | | 10 | 103273258 | 103273259 | Human |
597485804 | GWAS1581878_H | lysophosphatidylcholine 16:1 measurement QTL GWAS1581878 (human) | | 2e-08 | glycerophosphocholine amount (VT:0011004) | | 10 | 100335312 | 100335313 | Human |
407049011 | GWAS697987_H | coronary artery calcification QTL GWAS697987 (human) | | 0.000004 | coronary artery calcification | | 10 | 101938948 | 101938949 | Human |
597485805 | GWAS1581879_H | lysophosphatidylcholine 16:1 measurement QTL GWAS1581879 (human) | | 6e-10 | glycerophosphocholine amount (VT:0011004) | | 10 | 100454822 | 100454823 | Human |
406967090 | GWAS616066_H | retinopathy QTL GWAS616066 (human) | | 0.000008 | retinopathy | | 10 | 81429197 | 81429198 | Human |
597051618 | GWAS1147692_H | white matter microstructure measurement QTL GWAS1147692 (human) | | 4e-08 | white matter microstructure measurement | | 10 | 102559209 | 102559210 | Human |
597592299 | GWAS1649159_H | high density lipoprotein cholesterol measurement QTL GWAS1649159 (human) | | 7e-36 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079885 | 93079886 | Human |
597510374 | GWAS1606448_H | systolic blood pressure QTL GWAS1606448 (human) | | 2e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103459415 | 103459416 | Human |
597461020 | GWAS1557094_H | body mass index QTL GWAS1557094 (human) | | 8e-14 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100875096 | 100875097 | Human |
597379098 | GWAS1475172_H | coffee consumption measurement, tea consumption measurement QTL GWAS1475172 (human) | | 7e-10 | coffee consumption measurement, tea consumption measurement | drink intake measurement (CMO:0000771) | 10 | 93079967 | 93079968 | Human |
597592095 | GWAS1648955_H | coronary artery disease QTL GWAS1648955 (human) | | 1e-13 | coronary artery disease | | 10 | 98257696 | 98257697 | Human |
597592093 | GWAS1648953_H | coronary artery disease QTL GWAS1648953 (human) | | 9e-16 | coronary artery disease | | 10 | 103069712 | 103069713 | Human |
596953118 | GWAS1072637_H | body mass index QTL GWAS1072637 (human) | | 7e-09 | body mass index | | 10 | 94254865 | 94254866 | Human |
597280787 | GWAS1376861_H | X-11308 measurement QTL GWAS1376861 (human) | | 7e-18 | X-11308 measurement | | 10 | 94936798 | 94936799 | Human |
597108765 | GWAS1204839_H | self reported educational attainment QTL GWAS1204839 (human) | | 4e-11 | self reported educational attainment | | 10 | 100164661 | 100164662 | Human |
597157917 | GWAS1253991_H | fatty acid measurement QTL GWAS1253991 (human) | | 2e-10 | lymphocyte measurement, neutrophil measurement | systolic blood pressure (CMO:0000004) | 10 | 100315722 | 100315723 | Human |
597157916 | GWAS1253990_H | fatty acid measurement QTL GWAS1253990 (human) | | 1e-08 | fatty acid measurement | | 10 | 98012647 | 98012648 | Human |
597510166 | GWAS1606240_H | aspartate aminotransferase measurement QTL GWAS1606240 (human) | | 8e-17 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99483886 | 99483887 | Human |
597592082 | GWAS1648942_H | coronary artery disease QTL GWAS1648942 (human) | | 5e-33 | coronary artery disease | | 10 | 89243047 | 89243048 | Human |
597305365 | GWAS1401439_H | platelet count QTL GWAS1401439 (human) | | 2e-12 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 95814898 | 95814899 | Human |
597280776 | GWAS1376850_H | Takayasu arteritis QTL GWAS1376850 (human) | | 0.0000001 | Takayasu arteritis | | 10 | 96397528 | 96397529 | Human |
597493775 | GWAS1589849_H | neuroticism measurement, cognitive function measurement QTL GWAS1589849 (human) | | 5e-08 | cognitive behavior trait (VT:0010450) | | 10 | 91307387 | 91307388 | Human |
597157893 | GWAS1253967_H | triglyceride:HDL cholesterol ratio QTL GWAS1253967 (human) | | 9e-21 | blood triglyceride amount (VT:0002644) | | 10 | 93079885 | 93079886 | Human |
596961280 | GWAS1080799_H | metabolic syndrome QTL GWAS1080799 (human) | | 2e-20 | metabolic syndrome | | 10 | 86359258 | 86359259 | Human |
597329934 | GWAS1426008_H | treatment-resistant hypertension QTL GWAS1426008 (human) | | 0.000009 | treatment-resistant hypertension | | 10 | 103005737 | 103005738 | Human |
596961281 | GWAS1080800_H | metabolic syndrome QTL GWAS1080800 (human) | | 4e-09 | metabolic syndrome | | 10 | 87846680 | 87846681 | Human |
597379086 | GWAS1475160_H | neutrophil count QTL GWAS1475160 (human) | | 4e-16 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 102727686 | 102727687 | Human |
597379085 | GWAS1475159_H | neutrophil count QTL GWAS1475159 (human) | | 5e-112 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 97308981 | 97308982 | Human |
597313539 | GWAS1409613_H | metabolite measurement QTL GWAS1409613 (human) | | 7e-33 | metabolite measurement | | 10 | 95227255 | 95227256 | Human |
597026827 | GWAS1122901_H | body mass index QTL GWAS1122901 (human) | | 2e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102224303 | 102224304 | Human |
597108789 | GWAS1204863_H | C-reactive protein measurement QTL GWAS1204863 (human) | | 3e-08 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 89251701 | 89251702 | Human |
597166129 | GWAS1262203_H | triglyceride measurement QTL GWAS1262203 (human) | | 8e-11 | familial hyperlipidemia | blood triglyceride level (CMO:0000118) | 10 | 93079885 | 93079886 | Human |
597166130 | GWAS1262204_H | triglyceride measurement QTL GWAS1262204 (human) | | 1e-10 | very low density lipoprotein cholesterol measurement, phospholipid measurement | blood triglyceride level (CMO:0000118) | 10 | 98013128 | 98013129 | Human |
406950891 | GWAS599867_H | trait in response to escitalopram, unipolar depression, trait in response to citalopram, mood disorder QTL GWAS599867 (human) | | 0.000002 | trait in response to escitalopram, unipolar depression, trait in response to citalopram, mood disorder | | 10 | 103161907 | 103161908 | Human |
597518385 | GWAS1614459_H | asthma QTL GWAS1614459 (human) | | 9e-16 | asthma | | 10 | 92669710 | 92669711 | Human |
596953144 | GWAS1072663_H | respiratory system disease QTL GWAS1072663 (human) | | 2e-11 | respiratory system disease | | 10 | 92682235 | 92682237 | Human |
597026872 | GWAS1122946_H | body mass index QTL GWAS1122946 (human) | | 2e-18 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 85651147 | 85651148 | Human |
406950895 | GWAS599871_H | trait in response to escitalopram, trait in response to citalopram QTL GWAS599871 (human) | | 0.0000004 | trait in response to escitalopram, trait in response to citalopram | | 10 | 103390184 | 103390185 | Human |
407081971 | GWAS730947_H | parental longevity QTL GWAS730947 (human) | | 0.0000004 | total life span (VT:0001661) | | 10 | 80446592 | 80446593 | Human |
597239849 | GWAS1335923_H | depressive symptom measurement QTL GWAS1335923 (human) | | 3e-09 | depressive symptom measurement | | 10 | 80766367 | 80766368 | Human |
597108775 | GWAS1204849_H | self reported educational attainment QTL GWAS1204849 (human) | | 1e-10 | self reported educational attainment | | 10 | 88331783 | 88331784 | Human |
597108774 | GWAS1204848_H | self reported educational attainment QTL GWAS1204848 (human) | | 5e-08 | self reported educational attainment | | 10 | 102614365 | 102614366 | Human |
597313576 | GWAS1409650_H | total blood protein measurement QTL GWAS1409650 (human) | | 3e-16 | total blood protein measurement | blood protein measurement (CMO:0000028) | 10 | 93079885 | 93079886 | Human |
597305384 | GWAS1401458_H | coronary artery disease QTL GWAS1401458 (human) | | 0.000009 | coronary artery disease | | 10 | 100315722 | 100315723 | Human |
597108773 | GWAS1204847_H | self reported educational attainment QTL GWAS1204847 (human) | | 1e-08 | self reported educational attainment | | 10 | 102406709 | 102406710 | Human |
597108772 | GWAS1204846_H | self reported educational attainment QTL GWAS1204846 (human) | | 4e-11 | self reported educational attainment | | 10 | 85225094 | 85225095 | Human |
596985894 | GWAS1105413_H | monocyte count QTL GWAS1105413 (human) | | 1e-15 | monocyte count | | 10 | 94279840 | 94279841 | Human |
597092386 | GWAS1188460_H | Crohn's disease QTL GWAS1188460 (human) | | 4e-18 | intestine integrity trait (VT:0010554) | | 10 | 80491075 | 80491076 | Human |
597280813 | GWAS1376887_H | andro steroid monosulfate C19H28O6S (1) measurement QTL GWAS1376887 (human) | | 5e-22 | andro steroid monosulfate C19H28O6S (1) measurement | | 10 | 95001432 | 95001433 | Human |
597108771 | GWAS1204845_H | self reported educational attainment QTL GWAS1204845 (human) | | 7e-33 | self reported educational attainment | | 10 | 102261328 | 102261329 | Human |
596969504 | GWAS1089023_H | triglyceride change measurement, intermediate density lipoprotein measurement QTL GWAS1089023 (human) | | 5e-08 | triglyceride change measurement, intermediate density lipoprotein measurement | | 10 | 86906307 | 86906308 | Human |
597108770 | GWAS1204844_H | self reported educational attainment QTL GWAS1204844 (human) | | 1e-37 | self reported educational attainment | | 10 | 102057071 | 102057072 | Human |
597108768 | GWAS1204842_H | self reported educational attainment QTL GWAS1204842 (human) | | 2e-08 | self reported educational attainment | | 10 | 101851434 | 101851435 | Human |
597444644 | GWAS1540718_H | fatty acid measurement QTL GWAS1540718 (human) | | 6e-09 | fatty acid measurement | | 10 | 92748298 | 92748299 | Human |
597264416 | GWAS1360490_H | diastolic blood pressure QTL GWAS1360490 (human) | | 1e-09 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 95008010 | 95008011 | Human |
597501991 | GWAS1598065_H | short sleep QTL GWAS1598065 (human) | | 0.0000003 | short sleep | | 10 | 102818158 | 102818159 | Human |
597313574 | GWAS1409648_H | total blood protein measurement QTL GWAS1409648 (human) | | 1e-08 | total blood protein measurement | blood protein measurement (CMO:0000028) | 10 | 88105577 | 88105578 | Human |
597157931 | GWAS1254005_H | fatty acid measurement QTL GWAS1254005 (human) | | 2e-09 | fatty acid measurement | | 10 | 100582811 | 100582815 | Human |
597313575 | GWAS1409649_H | total blood protein measurement QTL GWAS1409649 (human) | | 9e-12 | total blood protein measurement | blood protein measurement (CMO:0000028) | 10 | 89139865 | 89139866 | Human |
597305383 | GWAS1401457_H | coronary artery disease QTL GWAS1401457 (human) | | 3e-28 | coronary artery disease | | 10 | 89243170 | 89243171 | Human |
597157930 | GWAS1254004_H | fatty acid measurement QTL GWAS1254004 (human) | | 5e-21 | fatty acid measurement | | 10 | 100315722 | 100315723 | Human |
597157929 | GWAS1254003_H | fatty acid measurement QTL GWAS1254003 (human) | | 1e-09 | fatty acid measurement | | 10 | 98012647 | 98012648 | Human |
597108777 | GWAS1204851_H | self reported educational attainment QTL GWAS1204851 (human) | | 2e-08 | self reported educational attainment | | 10 | 103469963 | 103469964 | Human |
597108776 | GWAS1204850_H | self reported educational attainment QTL GWAS1204850 (human) | | 3e-11 | self reported educational attainment | | 10 | 97952377 | 97952378 | Human |
407147515 | GWAS796491_H | migraine without aura, susceptibility to, 4 QTL GWAS796491 (human) | | 0.000003 | migraine without aura, susceptibility to, 4 | | 10 | 98820366 | 98820367 | Human |
597428316 | GWAS1524390_H | depressive symptom measurement, stressful life event measurement QTL GWAS1524390 (human) | | 0.000006 | depressive symptom measurement, stressful life event measurement | | 10 | 86613201 | 86613202 | Human |
596961365 | GWAS1080884_H | metabolic syndrome QTL GWAS1080884 (human) | | 3e-08 | metabolic syndrome | | 10 | 89815975 | 89815976 | Human |
596961366 | GWAS1080885_H | metabolic syndrome QTL GWAS1080885 (human) | | 2e-22 | metabolic syndrome | | 10 | 92184143 | 92184144 | Human |
597076052 | GWAS1172126_H | heel bone mineral density QTL GWAS1172126 (human) | | 3e-09 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 100315722 | 100315723 | Human |
596961367 | GWAS1080886_H | metabolic syndrome QTL GWAS1080886 (human) | | 8e-09 | metabolic syndrome | | 10 | 92264888 | 92264889 | Human |
597076051 | GWAS1172125_H | heel bone mineral density QTL GWAS1172125 (human) | | 1e-08 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 77651982 | 77651983 | Human |
596961372 | GWAS1080891_H | metabolic syndrome QTL GWAS1080891 (human) | | 8e-10 | metabolic syndrome | | 10 | 97265854 | 97265855 | Human |
597166163 | GWAS1262237_H | asthma exacerbation measurement QTL GWAS1262237 (human) | | 0.000007 | asthma exacerbation measurement | | 10 | 81359454 | 81359455 | Human |
597264466 | GWAS1360540_H | level of Sterol ester (27:1/16:1) in blood serum QTL GWAS1360540 (human) | | 2e-09 | ceramide measurement | | 10 | 100315722 | 100315723 | Human |
596961368 | GWAS1080887_H | metabolic syndrome QTL GWAS1080887 (human) | | 1e-20 | metabolic syndrome | | 10 | 92704188 | 92704189 | Human |
596961369 | GWAS1080888_H | metabolic syndrome QTL GWAS1080888 (human) | | 4e-17 | metabolic syndrome | | 10 | 93045908 | 93045909 | Human |
596961370 | GWAS1080889_H | metabolic syndrome QTL GWAS1080889 (human) | | 2e-08 | metabolic syndrome | | 10 | 94292990 | 94292991 | Human |
597616720 | GWAS1673580_H | platelet count QTL GWAS1673580 (human) | | 4e-14 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 102572229 | 102572230 | Human |
596961371 | GWAS1080890_H | metabolic syndrome QTL GWAS1080890 (human) | | 3e-08 | metabolic syndrome | | 10 | 95468581 | 95468582 | Human |
407098252 | GWAS747228_H | schizophrenia QTL GWAS747228 (human) | | 2e-16 | schizophrenia | | 10 | 102869116 | 102869117 | Human |
597616718 | GWAS1673578_H | platelet count QTL GWAS1673578 (human) | | 6e-14 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 95738465 | 95738466 | Human |
597616719 | GWAS1673579_H | platelet count QTL GWAS1673579 (human) | | 2e-21 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 99520522 | 99520523 | Human |
597616716 | GWAS1673576_H | platelet count QTL GWAS1673576 (human) | | 5e-19 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 93079967 | 93079968 | Human |
597190730 | GWAS1286804_H | anthropometric measurement QTL GWAS1286804 (human) | | 2e-08 | anthropometric measurement | body morphological measurement (CMO:0000021) | 10 | 102626552 | 102626553 | Human |
597616717 | GWAS1673577_H | platelet count QTL GWAS1673577 (human) | | 6e-16 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 94518638 | 94518639 | Human |
407147408 | GWAS796384_H | maleate measurement, Alpha ketoglutarate measurement, fumarate measurement QTL GWAS796384 (human) | | 0.000006 | urine keto acid amount (VT:0002893) | | 10 | 84129749 | 84129750 | Human |
597616715 | GWAS1673575_H | platelet count QTL GWAS1673575 (human) | | 2e-15 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 79404390 | 79404391 | Human |
596985920 | GWAS1105439_H | brain connectivity measurement QTL GWAS1105439 (human) | | 2e-17 | brain connectivity measurement | | 10 | 94279840 | 94279841 | Human |
597264449 | GWAS1360523_H | diastolic blood pressure QTL GWAS1360523 (human) | | 3e-39 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 94279840 | 94279841 | Human |
407024539 | GWAS673515_H | exercise QTL GWAS673515 (human) | | 0.000004 | exercise | | 10 | 87683553 | 87683554 | Human |
597395522 | GWAS1491596_H | Thyroid preparation use measurement QTL GWAS1491596 (human) | | 2e-10 | Thyroid preparation use measurement | | 10 | 99523573 | 99523574 | Human |
597411904 | GWAS1507978_H | schizophrenia QTL GWAS1507978 (human) | | 5e-15 | schizophrenia | | 10 | 102454510 | 102454511 | Human |
597280837 | GWAS1376911_H | serum gamma-glutamyl transferase measurement QTL GWAS1376911 (human) | | 7e-154 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 77920676 | 77920677 | Human |
597190724 | GWAS1286798_H | anthropometric measurement QTL GWAS1286798 (human) | | 7e-10 | anthropometric measurement | body morphological measurement (CMO:0000021) | 10 | 79139212 | 79139213 | Human |
597420101 | GWAS1516175_H | progesterone measurement QTL GWAS1516175 (human) | | 2e-11 | progesterone measurement | | 10 | 102838849 | 102838850 | Human |
597280838 | GWAS1376912_H | serum gamma-glutamyl transferase measurement QTL GWAS1376912 (human) | | 5e-10 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 79337509 | 79337510 | Human |
596977780 | GWAS1097299_H | electrocardiography QTL GWAS1097299 (human) | | 4e-15 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597444734 | GWAS1540808_H | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1540808 (human) | | 9e-11 | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079967 | 93079968 | Human |
596977783 | GWAS1097302_H | neuroimaging measurement QTL GWAS1097302 (human) | | 1e-08 | neuroimaging measurement | | 10 | 94278929 | 94278930 | Human |
596977777 | GWAS1097296_H | electrocardiography QTL GWAS1097296 (human) | | 9e-15 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
596977776 | GWAS1097295_H | electrocardiography QTL GWAS1097295 (human) | | 5e-14 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
596977779 | GWAS1097298_H | electrocardiography QTL GWAS1097298 (human) | | 2e-15 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597215359 | GWAS1311433_H | self reported educational attainment QTL GWAS1311433 (human) | | 3e-12 | self reported educational attainment | | 10 | 85263825 | 85263826 | Human |
596977778 | GWAS1097297_H | electrocardiography QTL GWAS1097297 (human) | | 1e-15 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597297265 | GWAS1393339_H | type 2 diabetes mellitus QTL GWAS1393339 (human) | | 2e-13 | type 2 diabetes mellitus | | 10 | 100152307 | 100152308 | Human |
597117050 | GWAS1213124_H | mathematical ability QTL GWAS1213124 (human) | | 4e-10 | mathematical ability | | 10 | 89638692 | 89638693 | Human |
407147444 | GWAS796420_H | urinary arsenic measurement QTL GWAS796420 (human) | | 3e-09 | urinary arsenic measurement | | 10 | 102863821 | 102863822 | Human |
597256296 | GWAS1352370_H | urate measurement QTL GWAS1352370 (human) | | 2e-14 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 87171980 | 87171981 | Human |
597469293 | GWAS1565367_H | juvenile idiopathic arthritis QTL GWAS1565367 (human) | | 0.0000001 | juvenile idiopathic arthritis | | 10 | 88982292 | 88982293 | Human |
597338216 | GWAS1434290_H | sexual dimorphism measurement QTL GWAS1434290 (human) | | 7e-11 | sexual dimorphism measurement | | 10 | 100886253 | 100886254 | Human |
597092453 | GWAS1188527_H | antipsychotic drug use measurement QTL GWAS1188527 (human) | | 0.000004 | antipsychotic drug use measurement | | 10 | 81908569 | 81908570 | Human |
407147440 | GWAS796416_H | type 1 diabetes mellitus QTL GWAS796416 (human) | | 0.0000008 | type 1 diabetes mellitus | | 10 | 98540425 | 98540426 | Human |
597141615 | GWAS1237689_H | neuroimaging measurement QTL GWAS1237689 (human) | | 2e-08 | neuroimaging measurement | | 10 | 88444143 | 88444144 | Human |
596961388 | GWAS1080907_H | metabolic syndrome QTL GWAS1080907 (human) | | 2e-09 | metabolic syndrome | | 10 | 100652186 | 100652187 | Human |
407098298 | GWAS747274_H | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa QTL GWAS747274 (human) | | 3e-16 | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | | 10 | 102869116 | 102869117 | Human |
597387360 | GWAS1483434_H | peripheral arterial disease, traffic air pollution measurement QTL GWAS1483434 (human) | | 0.000007 | peripheral arterial disease, traffic air pollution measurement | | 10 | 90100843 | 90100844 | Human |
406999998 | GWAS648974_H | diastolic blood pressure QTL GWAS648974 (human) | | 1e-11 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 100796696 | 100796697 | Human |
596961385 | GWAS1080904_H | metabolic syndrome QTL GWAS1080904 (human) | | 1e-20 | metabolic syndrome | | 10 | 98038477 | 98038478 | Human |
596961386 | GWAS1080905_H | metabolic syndrome QTL GWAS1080905 (human) | | 4e-10 | metabolic syndrome | | 10 | 98267034 | 98267035 | Human |
596985962 | GWAS1105481_H | Antihypertensive use measurement QTL GWAS1105481 (human) | | 1e-12 | Antihypertensive use measurement | | 10 | 94279840 | 94279841 | Human |
596961387 | GWAS1080906_H | metabolic syndrome QTL GWAS1080906 (human) | | 9e-16 | metabolic syndrome | | 10 | 100635683 | 100635684 | Human |
406975553 | GWAS624529_H | heart failure QTL GWAS624529 (human) | | 0.000008 | heart failure | | 10 | 89204857 | 89204858 | Human |
597528477 | GWAS1624551_H | body mass index QTL GWAS1624551 (human) | | 6e-22 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98038477 | 98038478 | Human |
597299096 | GWAS1395170_H | triglyceride measurement QTL GWAS1395170 (human) | | 3e-14 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079885 | 93079886 | Human |
597290909 | GWAS1386983_H | body mass index QTL GWAS1386983 (human) | | 7e-17 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 103032493 | 103032496 | Human |
597208989 | GWAS1305063_H | blood protein measurement QTL GWAS1305063 (human) | | 6e-17 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95625601 | 95625602 | Human |
597159839 | GWAS1255913_H | lipid measurement QTL GWAS1255913 (human) | | 0.000009 | lipid measurement | blood lipid measurement (CMO:0000050) | 10 | 86434772 | 86434773 | Human |
407041098 | GWAS690074_H | metabolite measurement QTL GWAS690074 (human) | | 2e-91 | metabolite measurement | | 10 | 98387303 | 98387304 | Human |
597168017 | GWAS1264091_H | total lipids in small VLDL QTL GWAS1264091 (human) | | 8e-17 | total lipids in small VLDL | | 10 | 93083778 | 93083779 | Human |
597503889 | GWAS1599963_H | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence QTL GWAS1599963 (human) | | 6e-10 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 10 | 101781259 | 101781260 | Human |
597503888 | GWAS1599962_H | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence QTL GWAS1599962 (human) | | 7e-14 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 10 | 101760027 | 101760028 | Human |
597282710 | GWAS1378784_H | COVID-19 QTL GWAS1378784 (human) | | 0.000008 | COVID-19 | | 10 | 95515777 | 95515778 | Human |
597487501 | GWAS1583575_H | revision of total knee arthroplasty QTL GWAS1583575 (human) | | 5e-08 | revision of total knee arthroplasty | | 10 | 85422984 | 85422985 | Human |
597471119 | GWAS1567193_H | smoking status measurement QTL GWAS1567193 (human) | | 5e-10 | smoking status measurement | | 10 | 85597981 | 85597982 | Human |
597462921 | GWAS1558995_H | blood protein measurement QTL GWAS1558995 (human) | | 4e-08 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 93079967 | 93079968 | Human |
597233537 | GWAS1329611_H | appendicular lean mass QTL GWAS1329611 (human) | | 2e-14 | appendicular lean mass | | 10 | 102127036 | 102127037 | Human |
597495684 | GWAS1591758_H | ectonucleoside triphosphate diphosphohydrolase 1 measurement QTL GWAS1591758 (human) | | 4e-27 | ectonucleoside triphosphate diphosphohydrolase 1 measurement | | 10 | 95861509 | 95861510 | Human |
597233536 | GWAS1329610_H | appendicular lean mass QTL GWAS1329610 (human) | | 2e-10 | appendicular lean mass | | 10 | 96801112 | 96801113 | Human |
596987791 | GWAS1107310_H | memory performance, sex interaction measurement QTL GWAS1107310 (human) | | 0.000003 | memory performance, sex interaction measurement | | 10 | 97103183 | 97103184 | Human |
597020555 | GWAS1116629_H | forced expiratory volume, response to bronchodilator QTL GWAS1116629 (human) | | 0.0000009 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 10 | 86671535 | 86671536 | Human |
597266365 | GWAS1362439_H | high density lipoprotein cholesterol measurement QTL GWAS1362439 (human) | | 2e-12 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 79194494 | 79194495 | Human |
597266367 | GWAS1362441_H | high density lipoprotein cholesterol measurement QTL GWAS1362441 (human) | | 7e-11 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 92515052 | 92515053 | Human |
597266366 | GWAS1362440_H | high density lipoprotein cholesterol measurement QTL GWAS1362440 (human) | | 8e-09 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 91816074 | 91816075 | Human |
597422002 | GWAS1518076_H | alkaline phosphatase measurement QTL GWAS1518076 (human) | | 3e-32 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 101822816 | 101822817 | Human |
406967403 | GWAS616379_H | vital capacity QTL GWAS616379 (human) | | 0.0000003 | vital capacity | | 10 | 79170941 | 79170942 | Human |
597127100 | GWAS1223174_H | metabolite measurement QTL GWAS1223174 (human) | | 3e-198 | metabolite measurement | | 10 | 98388419 | 98388420 | Human |
596979646 | GWAS1099165_H | body height QTL GWAS1099165 (human) | | 2e-55 | body height | | 10 | 102525837 | 102525838 | Human |
597594035 | GWAS1650895_H | hypertension, Antihypertensive use measurement QTL GWAS1650895 (human) | | 4e-19 | hypertension, Antihypertensive use measurement | | 10 | 103153896 | 103153897 | Human |
407139434 | GWAS788410_H | serum gamma-glutamyl transferase measurement QTL GWAS788410 (human) | | 6e-10 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 77920676 | 77920677 | Human |
597282731 | GWAS1378805_H | total cholesterol change measurement, high density lipoprotein cholesterol measurement QTL GWAS1378805 (human) | | 1e-11 | blood cholesterol amount (VT:0000180) | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93083778 | 93083779 | Human |
597094307 | GWAS1190381_H | schizophrenia QTL GWAS1190381 (human) | | 1e-08 | schizophrenia | | 10 | 102981826 | 102981827 | Human |
597421987 | GWAS1518061_H | serum alanine aminotransferase measurement QTL GWAS1518061 (human) | | 8e-10 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100193518 | 100193519 | Human |
406967419 | GWAS616395_H | appendicular lean mass QTL GWAS616395 (human) | | 7e-26 | appendicular lean mass | | 10 | 94278929 | 94278930 | Human |
407123071 | GWAS772047_H | mean corpuscular hemoglobin QTL GWAS772047 (human) | | 5e-31 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 102125800 | 102125801 | Human |
597290919 | GWAS1386993_H | body mass index QTL GWAS1386993 (human) | | 6e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100687890 | 100687891 | Human |
597036969 | GWAS1133043_H | rheumatoid arthritis QTL GWAS1133043 (human) | | 0.000001 | rheumatoid arthritis | | 10 | 79947217 | 79947218 | Human |
597503965 | GWAS1600039_H | low density lipoprotein cholesterol measurement QTL GWAS1600039 (human) | | 8e-24 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 93079967 | 93079968 | Human |
597250011 | GWAS1346085_H | corneal resistance factor QTL GWAS1346085 (human) | | 2e-29 | corneal resistance factor | | 10 | 93292662 | 93292663 | Human |
597250012 | GWAS1346086_H | corneal resistance factor QTL GWAS1346086 (human) | | 2e-08 | corneal resistance factor | | 10 | 103545244 | 103545245 | Human |
597397470 | GWAS1493544_H | atrial fibrillation QTL GWAS1493544 (human) | | 7e-63 | atrial fibrillation | | 10 | 103582915 | 103582916 | Human |
597618648 | GWAS1675508_H | coronary atherosclerosis QTL GWAS1675508 (human) | | 4e-21 | coronary atherosclerosis | | 10 | 89243170 | 89243171 | Human |
597168094 | GWAS1264168_H | body mass index QTL GWAS1264168 (human) | | 2e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 101471884 | 101471885 | Human |
597618649 | GWAS1675509_H | coronary atherosclerosis QTL GWAS1675509 (human) | | 5e-15 | coronary atherosclerosis | | 10 | 103179458 | 103179459 | Human |
597315542 | GWAS1411616_H | refractive error QTL GWAS1411616 (human) | | 1e-09 | refractive error | | 10 | 101064592 | 101064593 | Human |
597315541 | GWAS1411615_H | refractive error QTL GWAS1411615 (human) | | 7e-08 | refractive error | | 10 | 84222045 | 84222046 | Human |
407147540 | GWAS796516_H | schizophrenia QTL GWAS796516 (human) | | 2e-08 | schizophrenia | | 10 | 103016151 | 103016152 | Human |
597348299 | GWAS1444373_H | Abdominal Aortic Aneurysm QTL GWAS1444373 (human) | | 5e-11 | Abdominal Aortic Aneurysm | | 10 | 80478647 | 80478648 | Human |
597446607 | GWAS1542681_H | colorectal cancer QTL GWAS1542681 (human) | | 3e-21 | colorectal cancer | | 10 | 79059375 | 79059376 | Human |
596971462 | GWAS1090981_H | systolic blood pressure QTL GWAS1090981 (human) | | 1e-26 | systolic blood pressure | | 10 | 94253193 | 94253194 | Human |
597348300 | GWAS1444374_H | Abdominal Aortic Aneurysm QTL GWAS1444374 (human) | | 9e-19 | Abdominal Aortic Aneurysm | | 10 | 89243170 | 89243171 | Human |
597446603 | GWAS1542677_H | colorectal cancer QTL GWAS1542677 (human) | | 6e-09 | colorectal cancer | | 10 | 79050586 | 79050587 | Human |
407041055 | GWAS690031_H | BMI-adjusted waist circumference QTL GWAS690031 (human) | | 6e-10 | body size trait (VT:0100005) | | 10 | 102567827 | 102567828 | Human |
597422021 | GWAS1518095_H | alkaline phosphatase measurement QTL GWAS1518095 (human) | | 5e-11 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 100414960 | 100414961 | Human |
597389252 | GWAS1485326_H | total cholesterol measurement QTL GWAS1485326 (human) | | 0.000003 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 100267650 | 100267651 | Human |
597463037 | GWAS1559111_H | low density lipoprotein cholesterol measurement QTL GWAS1559111 (human) | | 0.000007 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 93079967 | 93079968 | Human |
597381113 | GWAS1477187_H | hypothyroidism QTL GWAS1477187 (human) | | 9e-12 | hypothyroidism | | 10 | 99523573 | 99523574 | Human |
596979696 | GWAS1099215_H | body height QTL GWAS1099215 (human) | | 8e-16 | body height | | 10 | 88014821 | 88014822 | Human |
597463035 | GWAS1559109_H | body mass index QTL GWAS1559109 (human) | | 6e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 78220750 | 78220751 | Human |
597290993 | GWAS1387067_H | inflammatory biomarker measurement, diet measurement QTL GWAS1387067 (human) | | 5e-09 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 102160718 | 102160719 | Human |
597241843 | GWAS1337917_H | serum metabolite measurement QTL GWAS1337917 (human) | | 4e-67 | serum metabolite measurement | | 10 | 98388301 | 98388302 | Human |
597618677 | GWAS1675537_H | heart disease QTL GWAS1675537 (human) | | 4e-17 | heart disease | | 10 | 89243047 | 89243048 | Human |
597209076 | GWAS1305150_H | lymphocyte count QTL GWAS1305150 (human) | | 1e-17 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95806026 | 95806027 | Human |
597209077 | GWAS1305151_H | lymphocyte count QTL GWAS1305151 (human) | | 1e-897 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95835288 | 95835289 | Human |
597209078 | GWAS1305152_H | lymphocyte count QTL GWAS1305152 (human) | | 3e-45 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95790039 | 95790040 | Human |
597209079 | GWAS1305153_H | lymphocyte count QTL GWAS1305153 (human) | | 5e-22 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95723042 | 95723043 | Human |
597028839 | GWAS1124913_H | rheumatoid arthritis QTL GWAS1124913 (human) | | 8e-08 | rheumatoid arthritis | | 10 | 79947217 | 79947218 | Human |
597348335 | GWAS1444409_H | migraine disorder QTL GWAS1444409 (human) | | 3e-08 | migraine disorder | | 10 | 102940687 | 102940688 | Human |
597602280 | GWAS1659140_H | drug use measurement, myocardial infarction QTL GWAS1659140 (human) | | 2e-13 | drug use measurement, myocardial infarction | | 10 | 89243170 | 89243171 | Human |
597463012 | GWAS1559086_H | beta-amyloid 1-42 measurement QTL GWAS1559086 (human) | | 0.0000003 | beta-amyloid 1-42 measurement | | 10 | 93703269 | 93703270 | Human |
597168097 | GWAS1264171_H | body mass index QTL GWAS1264171 (human) | | 2e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 92707388 | 92707389 | Human |
596979476 | GWAS1098995_H | body height QTL GWAS1098995 (human) | | 2e-09 | body height | | 10 | 86261778 | 86261779 | Human |
597241627 | GWAS1337701_H | C-reactive protein measurement QTL GWAS1337701 (human) | | 3e-10 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 98024795 | 98024796 | Human |
597618461 | GWAS1675321_H | myocardial infarction QTL GWAS1675321 (human) | | 7e-16 | myocardial infarction | | 10 | 89243047 | 89243048 | Human |
597315358 | GWAS1411432_H | metabolite measurement QTL GWAS1411432 (human) | | 3e-28 | metabolite measurement | | 10 | 95049129 | 95049130 | Human |
597618459 | GWAS1675319_H | triglyceride measurement QTL GWAS1675319 (human) | | 4e-36 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079885 | 93079886 | Human |
597487386 | GWAS1583460_H | serum alanine aminotransferase measurement QTL GWAS1583460 (human) | | 2e-09 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 88027354 | 88027355 | Human |
597487387 | GWAS1583461_H | serum alanine aminotransferase measurement QTL GWAS1583461 (human) | | 2e-20 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 96700824 | 96700825 | Human |
597258014 | GWAS1354088_H | type 2 diabetes mellitus QTL GWAS1354088 (human) | | 0.000003 | type 2 diabetes mellitus | | 10 | 100726389 | 100726390 | Human |
597372691 | GWAS1468765_H | mean corpuscular hemoglobin QTL GWAS1468765 (human) | | 8e-13 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 79044959 | 79044960 | Human |
597069598 | GWAS1165672_H | smoking behavior, BMI-adjusted waist circumference QTL GWAS1165672 (human) | | 0.000002 | body size trait (VT:0100005) | | 10 | 102567827 | 102567828 | Human |
597348112 | GWAS1444186_H | migraine disorder QTL GWAS1444186 (human) | | 7e-13 | migraine disorder | | 10 | 98942980 | 98942981 | Human |
597372692 | GWAS1468766_H | mean corpuscular hemoglobin QTL GWAS1468766 (human) | | 2e-36 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 99562798 | 99562799 | Human |
597528338 | GWAS1624412_H | pregnenolone sulfate measurement QTL GWAS1624412 (human) | | 3e-14 | pregnenolone sulfate measurement | | 10 | 102882383 | 102882384 | Human |
597167882 | GWAS1263956_H | myocardial infarction QTL GWAS1263956 (human) | | 1e-11 | myocardial infarction | | 10 | 89243088 | 89243089 | Human |
597307144 | GWAS1403218_H | pulse pressure measurement QTL GWAS1403218 (human) | | 8e-09 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 98267034 | 98267035 | Human |
597438223 | GWAS1534297_H | peptide measurement QTL GWAS1534297 (human) | | 0.000004 | peptide metabolism trait (VT:0010634) | | 10 | 92811903 | 92811904 | Human |
597307145 | GWAS1403219_H | pulse pressure measurement QTL GWAS1403219 (human) | | 3e-12 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 100792995 | 100792996 | Human |
597593866 | GWAS1650726_H | potassium measurement QTL GWAS1650726 (human) | | 5e-25 | potassium measurement | blood potassium level (CMO:0000496) | 10 | 92725454 | 92725455 | Human |
597348111 | GWAS1444185_H | migraine disorder QTL GWAS1444185 (human) | | 6e-19 | migraine disorder | | 10 | 94254865 | 94254866 | Human |
597479179 | GWAS1575253_H | testosterone measurement QTL GWAS1575253 (human) | | 4e-13 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 102832492 | 102832493 | Human |
406910167 | GWAS559143_H | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia QTL GWAS559143 (human) | | 2e-09 | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | | 10 | 103016151 | 103016152 | Human |
597339904 | GWAS1435978_H | N6-methyllysine measurement QTL GWAS1435978 (human) | | 4e-21 | N6-methyllysine measurement | | 10 | 98388551 | 98388552 | Human |
597479168 | GWAS1575242_H | blood protein measurement QTL GWAS1575242 (human) | | 5e-178 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 88766035 | 88766036 | Human |
596954889 | GWAS1074408_H | body mass index QTL GWAS1074408 (human) | | 7e-17 | body mass index | | 10 | 103032493 | 103032496 | Human |
597151497 | GWAS1247571_H | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1247571 (human) | | 1e-10 | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93550782 | 93550783 | Human |
406910175 | GWAS559151_H | bipolar disorder QTL GWAS559151 (human) | | 0.000008 | bipolar disorder | | 10 | 79195310 | 79195311 | Human |
597102389 | GWAS1198463_H | alkaline phosphatase measurement QTL GWAS1198463 (human) | | 2e-16 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 77897947 | 77897948 | Human |
597110581 | GWAS1206655_H | gastric carcinoma QTL GWAS1206655 (human) | | 3e-12 | stomach integrity trait (VT:0010603) | | 10 | 94309297 | 94309298 | Human |
597528377 | GWAS1624451_H | electrocardiography QTL GWAS1624451 (human) | | 8e-10 | electrocardiography | | 10 | 95767330 | 95767331 | Human |
597528376 | GWAS1624450_H | electrocardiography QTL GWAS1624450 (human) | | 1e-10 | electrocardiography | | 10 | 95767330 | 95767331 | Human |
597143345 | GWAS1239419_H | triglyceride measurement QTL GWAS1239419 (human) | | 9e-09 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079885 | 93079886 | Human |
597618488 | GWAS1675348_H | triglyceride measurement QTL GWAS1675348 (human) | | 2e-11 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 102127596 | 102127597 | Human |
597528378 | GWAS1624452_H | electrocardiography QTL GWAS1624452 (human) | | 3e-08 | electrocardiography | | 10 | 95767330 | 95767331 | Human |
597053233 | GWAS1149307_H | intelligence QTL GWAS1149307 (human) | | 5e-10 | intelligence | | 10 | 102120361 | 102120362 | Human |
597143359 | GWAS1239433_H | high density lipoprotein cholesterol measurement QTL GWAS1239433 (human) | | 0.000007 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 92837771 | 92837772 | Human |
597528373 | GWAS1624447_H | electrocardiography QTL GWAS1624447 (human) | | 7e-14 | electrocardiography | | 10 | 95767330 | 95767331 | Human |
597528372 | GWAS1624446_H | electrocardiography QTL GWAS1624446 (human) | | 3e-14 | electrocardiography | | 10 | 95767330 | 95767331 | Human |
597528375 | GWAS1624449_H | electrocardiography QTL GWAS1624449 (human) | | 6e-11 | electrocardiography | | 10 | 95767330 | 95767331 | Human |
597331761 | GWAS1427835_H | able to hear with hearing aids QTL GWAS1427835 (human) | | 0.0000005 | able to hear with hearing aids | | 10 | 93022978 | 93022979 | Human |
597528374 | GWAS1624448_H | electrocardiography QTL GWAS1624448 (human) | | 4e-12 | electrocardiography | | 10 | 95767330 | 95767331 | Human |
407041262 | GWAS690238_H | body mass index QTL GWAS690238 (human) | | 8e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 103109281 | 103109282 | Human |
597045048 | GWAS1141122_H | lifestyle measurement QTL GWAS1141122 (human) | | 5e-11 | lifestyle measurement | | 10 | 101977436 | 101977437 | Human |
597110561 | GWAS1206635_H | viral load QTL GWAS1206635 (human) | | 8e-16 | viral load | | 10 | 85322237 | 85322238 | Human |
597503787 | GWAS1599861_H | N-acetylarginine measurement QTL GWAS1599861 (human) | | 1e-21 | N-acetylarginine measurement | | 10 | 89648999 | 89649000 | Human |
407295217 | GWAS944193_H | systolic blood pressure QTL GWAS944193 (human) | | 3e-31 | systolic blood pressure | | 10 | 94278929 | 94278930 | Human |
406959353 | GWAS608329_H | reticulocyte count QTL GWAS608329 (human) | | 4e-11 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 79354304 | 79354305 | Human |
597528356 | GWAS1624430_H | Pregn steroid monosulfate measurement QTL GWAS1624430 (human) | | 3e-16 | Pregn steroid monosulfate measurement | | 10 | 102882480 | 102882481 | Human |
406959354 | GWAS608330_H | reticulocyte count QTL GWAS608330 (human) | | 1e-40 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 103107201 | 103107202 | Human |
597618464 | GWAS1675324_H | hypertension QTL GWAS1675324 (human) | | 7e-22 | hypertension | | 10 | 103086421 | 103086422 | Human |
597208922 | GWAS1304996_H | lymphocyte count QTL GWAS1304996 (human) | | 4e-26 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95701449 | 95701450 | Human |
597208924 | GWAS1304998_H | lymphocyte count QTL GWAS1304998 (human) | | 4e-294 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95803181 | 95803182 | Human |
407123072 | GWAS772048_H | mean corpuscular hemoglobin QTL GWAS772048 (human) | | 3e-15 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 102284277 | 102284278 | Human |
407123073 | GWAS772049_H | mean corpuscular hemoglobin QTL GWAS772049 (human) | | 2e-16 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 102801321 | 102801322 | Human |
407123074 | GWAS772050_H | mean corpuscular hemoglobin QTL GWAS772050 (human) | | 2e-41 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 103078059 | 103078060 | Human |
407057546 | GWAS706522_H | blood protein measurement QTL GWAS706522 (human) | | 1e-12 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 87539952 | 87539953 | Human |
597331792 | GWAS1427866_H | uterine fibroid, age at menarche QTL GWAS1427866 (human) | | 1e-10 | uterine fibroid, age at menarche | | 10 | 88426366 | 88426367 | Human |
407024777 | GWAS673753_H | brain aneurysm QTL GWAS673753 (human) | | 1e-09 | coronary artery disease | | 10 | 102959339 | 102959340 | Human |
597454674 | GWAS1550748_H | age at first sexual intercourse measurement QTL GWAS1550748 (human) | | 6e-13 | age at first sexual intercourse measurement | | 10 | 96181266 | 96181267 | Human |
597610320 | GWAS1667180_H | monocyte count QTL GWAS1667180 (human) | | 8e-42 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 99522443 | 99522444 | Human |
597061465 | GWAS1157539_H | basophil count QTL GWAS1157539 (human) | | 1e-09 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 99513789 | 99513790 | Human |
597454675 | GWAS1550749_H | age at first sexual intercourse measurement QTL GWAS1550749 (human) | | 6e-10 | age at first sexual intercourse measurement | | 10 | 102880295 | 102880296 | Human |
597610318 | GWAS1667178_H | monocyte count QTL GWAS1667178 (human) | | 1e-14 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 96700912 | 96700913 | Human |
597610319 | GWAS1667179_H | monocyte count QTL GWAS1667179 (human) | | 3e-19 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 97389039 | 97389040 | Human |
597503823 | GWAS1599897_H | body mass index QTL GWAS1599897 (human) | | 4e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 91300592 | 91300593 | Human |
597348174 | GWAS1444248_H | body fat percentage QTL GWAS1444248 (human) | | 5e-08 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 10 | 100652147 | 100652148 | Human |
597249870 | GWAS1345944_H | Epstein-Barr virus seropositivity QTL GWAS1345944 (human) | | 2e-08 | Epstein-Barr virus seropositivity | serum anti-Epstein-Barr virus (EBV) antibody level (CMO:0003143) | 10 | 83404030 | 83404031 | Human |
597618503 | GWAS1675363_H | essential hypertension QTL GWAS1675363 (human) | | 3e-22 | essential hypertension | | 10 | 103029718 | 103029719 | Human |
597495622 | GWAS1591696_H | prostate carcinoma QTL GWAS1591696 (human) | | 8e-09 | prostate carcinoma | | 10 | 102662289 | 102662290 | Human |
597192517 | GWAS1288591_H | COVID-19 QTL GWAS1288591 (human) | | 2e-10 | COVID-19 | | 10 | 79946568 | 79946569 | Human |
597069684 | GWAS1165758_H | body weight QTL GWAS1165758 (human) | | 0.000009 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 100898742 | 100898743 | Human |
597233533 | GWAS1329607_H | appendicular lean mass QTL GWAS1329607 (human) | | 1e-11 | appendicular lean mass | | 10 | 79468622 | 79468623 | Human |
597077875 | GWAS1173949_H | osteoarthritis QTL GWAS1173949 (human) | | 0.000008 | osteoarthritis | | 10 | 83556502 | 83556503 | Human |
407319714 | GWAS968690_H | unipolar depression, systolic blood pressure QTL GWAS968690 (human) | | 7e-09 | unipolar depression, systolic blood pressure | | 10 | 103199143 | 103199144 | Human |
597233535 | GWAS1329609_H | appendicular lean mass QTL GWAS1329609 (human) | | 5e-33 | appendicular lean mass | | 10 | 94831527 | 94831528 | Human |
597233534 | GWAS1329608_H | appendicular lean mass QTL GWAS1329608 (human) | | 8e-13 | appendicular lean mass | | 10 | 91255322 | 91255323 | Human |
406967465 | GWAS616441_H | reticulocyte count QTL GWAS616441 (human) | | 6e-11 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 79357481 | 79357482 | Human |
597512053 | GWAS1608127_H | color vision disorder QTL GWAS1608127 (human) | | 0.000004 | color vision disorder | | 10 | 93851341 | 93851342 | Human |
597225328 | GWAS1321402_H | self reported educational attainment QTL GWAS1321402 (human) | | 3e-09 | self reported educational attainment | | 10 | 100223656 | 100223657 | Human |
597225329 | GWAS1321403_H | self reported educational attainment QTL GWAS1321403 (human) | | 2e-08 | self reported educational attainment | | 10 | 101352408 | 101352409 | Human |
597159805 | GWAS1255879_H | lipid measurement QTL GWAS1255879 (human) | | 0.000009 | lipid measurement | blood lipid measurement (CMO:0000050) | 10 | 93618790 | 93618791 | Human |
597225330 | GWAS1321404_H | self reported educational attainment QTL GWAS1321404 (human) | | 2e-08 | self reported educational attainment | | 10 | 101846365 | 101846366 | Human |
597053309 | GWAS1149383_H | eosinophil count QTL GWAS1149383 (human) | | 4e-11 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 102578181 | 102578182 | Human |
597315446 | GWAS1411520_H | Inhalant adrenergic use measurement QTL GWAS1411520 (human) | | 7e-10 | Inhalant adrenergic use measurement | | 10 | 92672243 | 92672244 | Human |
597241706 | GWAS1337780_H | bilirubin measurement QTL GWAS1337780 (human) | | 4e-10 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 10 | 92742487 | 92742488 | Human |
407024817 | GWAS673793_H | attention deficit hyperactivity disorder QTL GWAS673793 (human) | | 0.000002 | attention deficit hyperactivity disorder | | 10 | 96375748 | 96375749 | Human |
597225325 | GWAS1321399_H | self reported educational attainment QTL GWAS1321399 (human) | | 5e-12 | self reported educational attainment | | 10 | 85279495 | 85279496 | Human |
597225326 | GWAS1321400_H | self reported educational attainment QTL GWAS1321400 (human) | | 1e-11 | self reported educational attainment | | 10 | 88331783 | 88331784 | Human |
597495659 | GWAS1591733_H | smoking initiation QTL GWAS1591733 (human) | | 2e-66 | smoking initiation | | 10 | 102883839 | 102883840 | Human |
597495658 | GWAS1591732_H | smoking initiation QTL GWAS1591732 (human) | | 2e-11 | smoking initiation | | 10 | 81836383 | 81836384 | Human |
597225327 | GWAS1321401_H | self reported educational attainment QTL GWAS1321401 (human) | | 2e-11 | self reported educational attainment | | 10 | 98007267 | 98007268 | Human |
407303358 | GWAS952334_H | lymphocyte count QTL GWAS952334 (human) | | 3e-12 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 97324669 | 97324670 | Human |
597413730 | GWAS1509804_H | mean corpuscular hemoglobin QTL GWAS1509804 (human) | | 2e-13 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 99529104 | 99529105 | Human |
407303356 | GWAS952332_H | lymphocyte count QTL GWAS952332 (human) | | 1e-15 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 94764638 | 94764639 | Human |
597471078 | GWAS1567152_H | major depressive disorder QTL GWAS1567152 (human) | | 0.0000005 | major depressive disorder | | 10 | 102660997 | 102660998 | Human |
407303357 | GWAS952333_H | lymphocyte count QTL GWAS952333 (human) | | 1e-13 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 96609998 | 96609999 | Human |
597340006 | GWAS1436080_H | serum alanine aminotransferase measurement QTL GWAS1436080 (human) | | 8e-12 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 88047609 | 88047610 | Human |
597340007 | GWAS1436081_H | serum alanine aminotransferase measurement QTL GWAS1436081 (human) | | 3e-10 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 89250556 | 89250557 | Human |
407303355 | GWAS952331_H | lymphocyte count QTL GWAS952331 (human) | | 2e-15 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 92755446 | 92755447 | Human |
597340004 | GWAS1436078_H | serum alanine aminotransferase measurement QTL GWAS1436078 (human) | | 6e-40 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 77900367 | 77900368 | Human |
597340005 | GWAS1436079_H | serum alanine aminotransferase measurement QTL GWAS1436079 (human) | | 2e-08 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 79170235 | 79170236 | Human |
597495450 | GWAS1591524_H | pulse pressure measurement QTL GWAS1591524 (human) | | 7e-10 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 102641875 | 102641876 | Human |
597413523 | GWAS1509597_H | hypertension QTL GWAS1509597 (human) | | 4e-16 | hypertension | | 10 | 102834750 | 102834751 | Human |
597380758 | GWAS1476832_H | monocyte count QTL GWAS1476832 (human) | | 2e-55 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 99532633 | 99532634 | Human |
597380757 | GWAS1476831_H | monocyte count QTL GWAS1476831 (human) | | 3e-50 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 97365965 | 97365966 | Human |
407016786 | GWAS665762_H | maximal midexpiratory flow rate QTL GWAS665762 (human) | | 0.000006 | maximal midexpiratory flow rate | maximum mid-expiratory flow (MMEF) (CMO:0000253) | 10 | 84961425 | 84961426 | Human |
597380744 | GWAS1476818_H | type 2 diabetes mellitus QTL GWAS1476818 (human) | | 8e-16 | type 2 diabetes mellitus | | 10 | 97331612 | 97331613 | Human |
597167747 | GWAS1263821_H | type 1 diabetes mellitus QTL GWAS1263821 (human) | | 2e-08 | type 1 diabetes mellitus | | 10 | 88257039 | 88257040 | Human |
597315207 | GWAS1411281_H | X-17654 measurement QTL GWAS1411281 (human) | | 4e-19 | X-17654 measurement | | 10 | 94959764 | 94959765 | Human |
597135031 | GWAS1231105_H | memory performance, sex interaction measurement QTL GWAS1231105 (human) | | 0.000009 | memory performance, sex interaction measurement | | 10 | 78168055 | 78168056 | Human |
597044918 | GWAS1140992_H | bipolar disorder, major depressive disorder QTL GWAS1140992 (human) | | 3e-08 | bipolar disorder, major depressive disorder | | 10 | 102924787 | 102924788 | Human |
597372601 | GWAS1468675_H | mean corpuscular hemoglobin concentration QTL GWAS1468675 (human) | | 7e-12 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 79032176 | 79032177 | Human |
597315256 | GWAS1411330_H | language measurement QTL GWAS1411330 (human) | | 0.000007 | language measurement | | 10 | 80103364 | 80103365 | Human |
597413561 | GWAS1509635_H | prostate carcinoma QTL GWAS1509635 (human) | | 6e-16 | prostate carcinoma | | 10 | 102654464 | 102654465 | Human |
597028529 | GWAS1124603_H | self reported educational attainment QTL GWAS1124603 (human) | | 7e-08 | self reported educational attainment | | 10 | 102224633 | 102224634 | Human |
597028528 | GWAS1124602_H | self reported educational attainment QTL GWAS1124602 (human) | | 4e-09 | self reported educational attainment | | 10 | 85352411 | 85352412 | Human |
597085886 | GWAS1181960_H | monocyte count QTL GWAS1181960 (human) | | 3e-10 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 97351994 | 97351995 | Human |
597618357 | GWAS1675217_H | polyp QTL GWAS1675217 (human) | | 2e-29 | polyp | | 10 | 81061489 | 81061490 | Human |
597102244 | GWAS1198318_H | neutrophil count QTL GWAS1198318 (human) | | 3e-21 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 89243047 | 89243048 | Human |
597102243 | GWAS1198317_H | neutrophil count QTL GWAS1198317 (human) | | 7e-21 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 87921701 | 87921702 | Human |
597593770 | GWAS1650630_H | potassium measurement QTL GWAS1650630 (human) | | 6e-33 | potassium measurement | blood potassium level (CMO:0000496) | 10 | 92725454 | 92725455 | Human |
597102242 | GWAS1198316_H | neutrophil count QTL GWAS1198316 (human) | | 1e-09 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 79287818 | 79287819 | Human |
597511850 | GWAS1607924_H | COVID-19 QTL GWAS1607924 (human) | | 0.000003 | COVID-19 | | 10 | 79958042 | 79958043 | Human |
597159598 | GWAS1255672_H | Drugs used in diabetes use measurement QTL GWAS1255672 (human) | | 2e-34 | Drugs used in diabetes use measurement | | 10 | 92707388 | 92707389 | Human |
597159597 | GWAS1255671_H | Drugs used in diabetes use measurement QTL GWAS1255671 (human) | | 1e-10 | Drugs used in diabetes use measurement | | 10 | 79183098 | 79183099 | Human |
597610146 | GWAS1667006_H | monocyte count QTL GWAS1667006 (human) | | 9e-28 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 99522443 | 99522444 | Human |
597077672 | GWAS1173746_H | asthma QTL GWAS1173746 (human) | | 0.0000002 | asthma | | 10 | 86305355 | 86305356 | Human |
597610144 | GWAS1667004_H | monocyte count QTL GWAS1667004 (human) | | 5e-12 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 96695003 | 96695004 | Human |
597610145 | GWAS1667005_H | monocyte count QTL GWAS1667005 (human) | | 5e-16 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 97353972 | 97353973 | Human |
597618398 | GWAS1675258_H | atrial fibrillation QTL GWAS1675258 (human) | | 7e-47 | atrial fibrillation | | 10 | 103565017 | 103565018 | Human |
596979415 | GWAS1098934_H | thyroid stimulating hormone measurement QTL GWAS1098934 (human) | | 5e-44 | thyroid stimulating hormone measurement | | 10 | 99523573 | 99523574 | Human |
597077716 | GWAS1173790_H | blood protein measurement QTL GWAS1173790 (human) | | 4e-19 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 102722573 | 102722574 | Human |
596979414 | GWAS1098933_H | thyroid stimulating hormone measurement QTL GWAS1098933 (human) | | 3e-12 | thyroid stimulating hormone measurement | | 10 | 88089762 | 88089763 | Human |
597454559 | GWAS1550633_H | executive function measurement, cognitive function measurement, major depressive disorder QTL GWAS1550633 (human) | | 4e-08 | cognitive behavior trait (VT:0010450) | | 10 | 99548014 | 99548015 | Human |
406959362 | GWAS608338_H | diastolic blood pressure QTL GWAS608338 (human) | | 2e-08 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 102794772 | 102794773 | Human |
597356249 | GWAS1452323_H | schizophrenia QTL GWAS1452323 (human) | | 6e-19 | schizophrenia | | 10 | 102852578 | 102852579 | Human |
406959365 | GWAS608341_H | mean arterial pressure QTL GWAS608341 (human) | | 5e-11 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 102794772 | 102794773 | Human |
406959364 | GWAS608340_H | mean arterial pressure QTL GWAS608340 (human) | | 3e-08 | mean arterial pressure | systolic blood pressure (CMO:0000004) | 10 | 102712218 | 102712219 | Human |
597389021 | GWAS1485095_H | body mass index QTL GWAS1485095 (human) | | 7e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 97336919 | 97336920 | Human |
597094096 | GWAS1190170_H | autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis QTL GWAS1190170 (human) | | 9e-11 | intestine integrity trait (VT:0010554) | | 10 | 99538694 | 99538695 | Human |
597593817 | GWAS1650677_H | eosinophil count QTL GWAS1650677 (human) | | 4e-24 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 92669710 | 92669711 | Human |
597077724 | GWAS1173798_H | asthma QTL GWAS1173798 (human) | | 0.000008 | asthma | | 10 | 86305355 | 86305356 | Human |
597429975 | GWAS1526049_H | erythrocyte count QTL GWAS1526049 (human) | | 2e-16 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 79028089 | 79028090 | Human |
407147785 | GWAS796761_H | malate measurement QTL GWAS796761 (human) | | 0.000003 | malate measurement | | 10 | 84102811 | 84102812 | Human |
596979416 | GWAS1098935_H | thyroid stimulating hormone measurement QTL GWAS1098935 (human) | | 4e-08 | thyroid stimulating hormone measurement | | 10 | 99935839 | 99935840 | Human |
597184200 | GWAS1280274_H | migraine disorder, Headache QTL GWAS1280274 (human) | | 4e-09 | migraine disorder, Headache | | 10 | 94256036 | 94256037 | Human |
597159621 | GWAS1255695_H | lipid measurement QTL GWAS1255695 (human) | | 0.000007 | lipid measurement | blood lipid measurement (CMO:0000050) | 10 | 86762838 | 86762839 | Human |
597266122 | GWAS1362196_H | type 2 diabetes mellitus QTL GWAS1362196 (human) | | 0.0000005 | type 2 diabetes mellitus | | 10 | 97296433 | 97296434 | Human |
597495497 | GWAS1591571_H | memory performance QTL GWAS1591571 (human) | | 0.000004 | memory performance | | 10 | 85405544 | 85405545 | Human |
407221520 | GWAS870496_H | pimelic acid measurement, 3-methyladipic acid measurement QTL GWAS870496 (human) | | 0.000004 | pimelic acid measurement, 3-methyladipic acid measurement | | 10 | 83484845 | 83484846 | Human |
597618374 | GWAS1675234_H | liver disease QTL GWAS1675234 (human) | | 3e-15 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 100164661 | 100164662 | Human |
597094095 | GWAS1190169_H | autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis QTL GWAS1190169 (human) | | 1e-08 | intestine integrity trait (VT:0010554) | | 10 | 79287626 | 79287627 | Human |
597356227 | GWAS1452301_H | autism spectrum disorder symptom QTL GWAS1452301 (human) | | 0.000003 | autism spectrum disorder symptom | | 10 | 102448042 | 102448043 | Human |
596954830 | GWAS1074349_H | functional brain measurement QTL GWAS1074349 (human) | | 2e-28 | functional brain measurement | | 10 | 94279840 | 94279841 | Human |
596954831 | GWAS1074350_H | functional brain measurement QTL GWAS1074350 (human) | | 2e-30 | functional brain measurement | | 10 | 94279840 | 94279841 | Human |
407024925 | GWAS673901_H | response to anticoagulant QTL GWAS673901 (human) | | 8e-12 | response to anticoagulant | | 10 | 94645572 | 94645573 | Human |
597110472 | GWAS1206546_H | chronotype measurement QTL GWAS1206546 (human) | | 3e-08 | sleep behavior trait (VT:0001501) | | 10 | 103184236 | 103184237 | Human |
597077749 | GWAS1173823_H | blood protein measurement QTL GWAS1173823 (human) | | 0.000002 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 79440478 | 79440479 | Human |
407139623 | GWAS788599_H | type 2 diabetes mellitus QTL GWAS788599 (human) | | 3e-19 | type 2 diabetes mellitus | | 10 | 92703125 | 92703126 | Human |
597339902 | GWAS1435976_H | N6-methyllysine measurement QTL GWAS1435976 (human) | | 2e-17 | N6-methyllysine measurement | | 10 | 98397611 | 98397612 | Human |
597339903 | GWAS1435977_H | N6-methyllysine measurement QTL GWAS1435977 (human) | | 6e-22 | N6-methyllysine measurement | | 10 | 98395539 | 98395540 | Human |
597339900 | GWAS1435974_H | N6,N6-dimethyllysine measurement QTL GWAS1435974 (human) | | 2e-11 | N6,N6-dimethyllysine measurement | | 10 | 98388301 | 98388302 | Human |
597339901 | GWAS1435975_H | N6,N6-dimethyllysine measurement QTL GWAS1435975 (human) | | 1e-09 | N6,N6-dimethyllysine measurement | | 10 | 98392616 | 98392617 | Human |
597044990 | GWAS1141064_H | Abnormality of refraction QTL GWAS1141064 (human) | | 2e-08 | Abnormality of refraction | | 10 | 90952495 | 90952496 | Human |
407229740 | GWAS878716_H | type 2 diabetes mellitus QTL GWAS878716 (human) | | 2e-10 | type 2 diabetes mellitus | | 10 | 79182874 | 79182875 | Human |
597044991 | GWAS1141065_H | Abnormality of refraction QTL GWAS1141065 (human) | | 3e-22 | Abnormality of refraction | | 10 | 101064592 | 101064593 | Human |
597044988 | GWAS1141062_H | Abnormality of refraction QTL GWAS1141062 (human) | | 1e-70 | Abnormality of refraction | | 10 | 84261268 | 84261269 | Human |
597044989 | GWAS1141063_H | Abnormality of refraction QTL GWAS1141063 (human) | | 5e-32 | Abnormality of refraction | | 10 | 88282397 | 88282398 | Human |
407377187 | GWAS1026163_H | obsolete_red blood cell distribution width QTL GWAS1026163 (human) | | 6e-13 | obsolete_red blood cell distribution width | | 10 | 94486139 | 94486140 | Human |
407049518 | GWAS698494_H | lysophosphatidylcholine 16:1 measurement QTL GWAS698494 (human) | | 0.0000004 | glycerophosphocholine amount (VT:0011004) | | 10 | 100327281 | 100327282 | Human |
597413621 | GWAS1509695_H | gout QTL GWAS1509695 (human) | | 4e-11 | gout | | 10 | 87189288 | 87189289 | Human |
597151461 | GWAS1247535_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1247535 (human) | | 3e-09 | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 98012433 | 98012434 | Human |
597151460 | GWAS1247534_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1247534 (human) | | 9e-10 | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079885 | 93079886 | Human |
407024949 | GWAS673925_H | breast carcinoma QTL GWAS673925 (human) | | 4e-09 | mammary gland integrity trait (VT:0010552) | | 10 | 79081391 | 79081392 | Human |
406992181 | GWAS641157_H | mean corpuscular hemoglobin concentration QTL GWAS641157 (human) | | 4e-14 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 102727625 | 102727626 | Human |
597077740 | GWAS1173814_H | blood protein measurement QTL GWAS1173814 (human) | | 0.000006 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 97533899 | 97533900 | Human |
597503712 | GWAS1599786_H | X-17653 measurement QTL GWAS1599786 (human) | | 4e-12 | X-17653 measurement | | 10 | 94630027 | 94630028 | Human |
407065917 | GWAS714893_H | apolipoprotein B measurement QTL GWAS714893 (human) | | 7e-31 | apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 10 | 93079885 | 93079886 | Human |
597208600 | GWAS1304674_H | lymphocyte count QTL GWAS1304674 (human) | | 7e-33 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95701449 | 95701450 | Human |
597208601 | GWAS1304675_H | lymphocyte count QTL GWAS1304675 (human) | | 9e-57 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95643459 | 95643460 | Human |
597208602 | GWAS1304676_H | lymphocyte count QTL GWAS1304676 (human) | | 2e-574 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95841946 | 95841947 | Human |
597462559 | GWAS1558633_H | coronary artery disease QTL GWAS1558633 (human) | | 2e-13 | coronary artery disease | | 10 | 89243170 | 89243171 | Human |
597208603 | GWAS1304677_H | lymphocyte count QTL GWAS1304677 (human) | | 2e-31 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95701449 | 95701450 | Human |
597208604 | GWAS1304678_H | lymphocyte count QTL GWAS1304678 (human) | | 2e-50 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95643459 | 95643460 | Human |
597282320 | GWAS1378394_H | COVID-19 QTL GWAS1378394 (human) | | 0.000008 | COVID-19 | | 10 | 80555977 | 80555978 | Human |
597397014 | GWAS1493088_H | cognitive function measurement QTL GWAS1493088 (human) | | 0.000009 | cognitive behavior trait (VT:0010450) | | 10 | 93070061 | 93070062 | Human |
597208597 | GWAS1304671_H | lymphocyte count QTL GWAS1304671 (human) | | 7e-31 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95701449 | 95701450 | Human |
597397013 | GWAS1493087_H | cognitive function measurement QTL GWAS1493087 (human) | | 0.000004 | cognitive behavior trait (VT:0010450) | | 10 | 90282644 | 90282645 | Human |
597208598 | GWAS1304672_H | lymphocyte count QTL GWAS1304672 (human) | | 1e-66 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95643459 | 95643460 | Human |
597405204 | GWAS1501278_H | pulse pressure measurement QTL GWAS1501278 (human) | | 3e-09 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 87844975 | 87844976 | Human |
597208599 | GWAS1304673_H | lymphocyte count QTL GWAS1304673 (human) | | 1e-583 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95832540 | 95832541 | Human |
597388820 | GWAS1484894_H | body mass index QTL GWAS1484894 (human) | | 5e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102856906 | 102856907 | Human |
597208584 | GWAS1304658_H | neuroimaging measurement QTL GWAS1304658 (human) | | 9e-09 | neuroimaging measurement | | 10 | 94253193 | 94253194 | Human |
597110279 | GWAS1206353_H | Calcium channel blocker use measurement QTL GWAS1206353 (human) | | 2e-10 | Calcium channel blocker use measurement | | 10 | 94263320 | 94263321 | Human |
596962822 | GWAS1082341_H | type 2 diabetes mellitus, coronary artery disease QTL GWAS1082341 (human) | | 5e-63 | type 2 diabetes mellitus, coronary artery disease | | 10 | 92704550 | 92704551 | Human |
597454350 | GWAS1550424_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1550424 (human) | | 2e-09 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 10 | 100329906 | 100329907 | Human |
597323272 | GWAS1419346_H | schizophrenia QTL GWAS1419346 (human) | | 7e-09 | schizophrenia | | 10 | 102703919 | 102703920 | Human |
596979200 | GWAS1098719_H | pulse pressure measurement QTL GWAS1098719 (human) | | 3e-09 | pulse pressure measurement | | 10 | 87844975 | 87844976 | Human |
597413390 | GWAS1509464_H | monocyte count QTL GWAS1509464 (human) | | 1e-09 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 99530544 | 99530545 | Human |
597618185 | GWAS1675045_H | body weight QTL GWAS1675045 (human) | | 3e-22 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 103092132 | 103092133 | Human |
406967769 | GWAS616745_H | eosinophil percentage of granulocytes QTL GWAS616745 (human) | | 9e-11 | eosinophil quantity (VT:0002602) | | 10 | 92693718 | 92693719 | Human |
596962830 | GWAS1082349_H | COVID-19 symptoms measurement QTL GWAS1082349 (human) | | 8e-08 | COVID-19 symptoms measurement | | 10 | 97878459 | 97878460 | Human |
597208581 | GWAS1304655_H | blood protein measurement QTL GWAS1304655 (human) | | 3e-14 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95562166 | 95562167 | Human |
597175813 | GWAS1271887_H | Tinnitus QTL GWAS1271887 (human) | | 0.000007 | Tinnitus | | 10 | 101453251 | 101453252 | Human |
597323323 | GWAS1419397_H | non-high density lipoprotein cholesterol measurement QTL GWAS1419397 (human) | | 1e-39 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 10 | 93079885 | 93079886 | Human |
597274168 | GWAS1370242_H | BMI-adjusted hip circumference QTL GWAS1370242 (human) | | 5e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 102756042 | 102756043 | Human |
597339710 | GWAS1435784_H | N6,N6-dimethyllysine measurement QTL GWAS1435784 (human) | | 1e-16 | N6,N6-dimethyllysine measurement | | 10 | 98395539 | 98395540 | Human |
596971057 | GWAS1090576_H | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa, major depressive disorder QTL GWAS1090576 (human) | | 3e-16 | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa, major depressive disorder | | 10 | 102869116 | 102869117 | Human |
407033319 | GWAS682295_H | psoriasis vulgaris QTL GWAS682295 (human) | | 0.0000001 | psoriasis vulgaris | | 10 | 79273128 | 79273129 | Human |
597339711 | GWAS1435785_H | N6,N6-dimethyllysine measurement QTL GWAS1435785 (human) | | 7e-17 | N6,N6-dimethyllysine measurement | | 10 | 98388551 | 98388552 | Human |
597323324 | GWAS1419398_H | non-high density lipoprotein cholesterol measurement QTL GWAS1419398 (human) | | 2e-08 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 10 | 94263320 | 94263321 | Human |
597339708 | GWAS1435782_H | metabolite measurement QTL GWAS1435782 (human) | | 9e-19 | metabolite measurement | | 10 | 98408103 | 98408104 | Human |
597339709 | GWAS1435783_H | N6,N6-dimethyllysine measurement QTL GWAS1435783 (human) | | 2e-13 | N6,N6-dimethyllysine measurement | | 10 | 98397611 | 98397612 | Human |
597159487 | GWAS1255561_H | testosterone measurement QTL GWAS1255561 (human) | | 9e-10 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 92682235 | 92682237 | Human |
597036606 | GWAS1132680_H | body mass index QTL GWAS1132680 (human) | | 4e-19 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100687890 | 100687891 | Human |
597503540 | GWAS1599614_H | hypothyroidism QTL GWAS1599614 (human) | | 5e-15 | hypothyroidism | | 10 | 99523573 | 99523574 | Human |
597397047 | GWAS1493121_H | low density lipoprotein cholesterol measurement QTL GWAS1493121 (human) | | 1e-08 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 88045653 | 88045654 | Human |
597274165 | GWAS1370239_H | BMI-adjusted hip circumference QTL GWAS1370239 (human) | | 4e-11 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 102485191 | 102485192 | Human |
597290548 | GWAS1386622_H | lymphocyte measurement, neutrophil measurement QTL GWAS1386622 (human) | | 8e-14 | lymphocyte measurement, neutrophil measurement | | 10 | 97229697 | 97229698 | Human |
597446193 | GWAS1542267_H | Parkinson's disease symptom measurement QTL GWAS1542267 (human) | | 0.0000008 | Parkinson's disease symptom measurement | | 10 | 101289238 | 101289239 | Human |
597274155 | GWAS1370229_H | BMI-adjusted hip circumference QTL GWAS1370229 (human) | | 1e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 102665714 | 102665715 | Human |
597274157 | GWAS1370231_H | BMI-adjusted hip circumference QTL GWAS1370231 (human) | | 5e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 102786426 | 102786427 | Human |
597274156 | GWAS1370230_H | BMI-adjusted hip circumference QTL GWAS1370230 (human) | | 1e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 102694943 | 102694944 | Human |
597478948 | GWAS1575022_H | protein measurement QTL GWAS1575022 (human) | | 5e-09 | protein measurement | | 10 | 95295396 | 95295397 | Human |
407066106 | GWAS715082_H | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa QTL GWAS715082 (human) | | 3e-14 | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | | 10 | 103111522 | 103111523 | Human |
597462560 | GWAS1558634_H | coronary artery disease QTL GWAS1558634 (human) | | 5e-10 | coronary artery disease | | 10 | 102845159 | 102845160 | Human |
407025151 | GWAS674127_H | cardiovascular measurement QTL GWAS674127 (human) | | 0.0000007 | cardiovascular measurement | cardiovascular measurement (CMO:0000001) | 10 | 86087202 | 86087203 | Human |
597249575 | GWAS1345649_H | age at menopause QTL GWAS1345649 (human) | | 2e-08 | age at menopause | | 10 | 102889972 | 102889973 | Human |
597143080 | GWAS1239154_H | high density lipoprotein cholesterol measurement QTL GWAS1239154 (human) | | 3e-08 | vitamin D measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079885 | 93079886 | Human |
596954667 | GWAS1074186_H | size QTL GWAS1074186 (human) | | 7e-10 | size | | 10 | 93186366 | 93186367 | Human |
597454429 | GWAS1550503_H | androgenetic alopecia QTL GWAS1550503 (human) | | 0.000009 | androgenetic alopecia | | 10 | 89671541 | 89671542 | Human |
597241435 | GWAS1337509_H | BMI-adjusted hip circumference QTL GWAS1337509 (human) | | 8e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 94321383 | 94321384 | Human |
597167708 | GWAS1263782_H | alkaline phosphatase measurement QTL GWAS1263782 (human) | | 6e-22 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 77921469 | 77921470 | Human |
597167709 | GWAS1263783_H | alkaline phosphatase measurement QTL GWAS1263783 (human) | | 3e-13 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 91882000 | 91882001 | Human |
596954706 | GWAS1074225_H | size QTL GWAS1074225 (human) | | 2e-08 | size | | 10 | 94814191 | 94814192 | Human |
597069392 | GWAS1165466_H | lung carcinoma QTL GWAS1165466 (human) | | 9e-08 | lung carcinoma | | 10 | 97913426 | 97913427 | Human |
597585497 | GWAS1642357_H | high density lipoprotein cholesterol measurement QTL GWAS1642357 (human) | | 7e-14 | high density lipoprotein cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 93079885 | 93079886 | Human |
597044817 | GWAS1140891_H | refractive error QTL GWAS1140891 (human) | | 3e-10 | refractive error | | 10 | 101064592 | 101064593 | Human |
597339730 | GWAS1435804_H | N6,N6-dimethyllysine measurement QTL GWAS1435804 (human) | | 2e-11 | N6,N6-dimethyllysine measurement | | 10 | 98388419 | 98388420 | Human |
597339731 | GWAS1435805_H | N6,N6-dimethyllysine measurement QTL GWAS1435805 (human) | | 4e-09 | N6,N6-dimethyllysine measurement | | 10 | 98388247 | 98388248 | Human |
597339728 | GWAS1435802_H | N6,N6-dimethyllysine measurement QTL GWAS1435802 (human) | | 1e-09 | N6,N6-dimethyllysine measurement | | 10 | 98395539 | 98395540 | Human |
597028447 | GWAS1124521_H | body mass index QTL GWAS1124521 (human) | | 4e-18 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100635683 | 100635684 | Human |
597339729 | GWAS1435803_H | N6,N6-dimethyllysine measurement QTL GWAS1435803 (human) | | 2e-09 | N6,N6-dimethyllysine measurement | | 10 | 98388551 | 98388552 | Human |
597339732 | GWAS1435806_H | N6,N6-dimethyllysine measurement QTL GWAS1435806 (human) | | 1e-09 | N6,N6-dimethyllysine measurement | | 10 | 98387303 | 98387304 | Human |
406943118 | GWAS592094_H | chronic obstructive pulmonary disease QTL GWAS592094 (human) | | 4e-08 | lung integrity trait (VT:0010906) | | 10 | 80458350 | 80458351 | Human |
597339722 | GWAS1435796_H | metabolite measurement QTL GWAS1435796 (human) | | 0.0000001 | metabolite measurement | | 10 | 98388247 | 98388248 | Human |
597339723 | GWAS1435797_H | metabolite measurement QTL GWAS1435797 (human) | | 2e-08 | metabolite measurement | | 10 | 98387303 | 98387304 | Human |
597339720 | GWAS1435794_H | metabolite measurement QTL GWAS1435794 (human) | | 2e-08 | metabolite measurement | | 10 | 98388551 | 98388552 | Human |
597339721 | GWAS1435795_H | metabolite measurement QTL GWAS1435795 (human) | | 4e-10 | metabolite measurement | | 10 | 98388419 | 98388420 | Human |
597143107 | GWAS1239181_H | chronic obstructive pulmonary disease QTL GWAS1239181 (human) | | 6e-14 | lung integrity trait (VT:0010906) | | 10 | 79946568 | 79946569 | Human |
597339726 | GWAS1435800_H | metabolite measurement QTL GWAS1435800 (human) | | 0.0000001 | N6,N6-dimethyllysine measurement | | 10 | 98408103 | 98408104 | Human |
597102147 | GWAS1198221_H | alkaline phosphatase measurement QTL GWAS1198221 (human) | | 7e-24 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 102646093 | 102646094 | Human |
597339727 | GWAS1435801_H | N6,N6-dimethyllysine measurement QTL GWAS1435801 (human) | | 7e-09 | N6,N6-dimethyllysine measurement | | 10 | 98397611 | 98397612 | Human |
597102146 | GWAS1198220_H | alkaline phosphatase measurement QTL GWAS1198220 (human) | | 4e-16 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 100315722 | 100315723 | Human |
597290575 | GWAS1386649_H | age at menarche QTL GWAS1386649 (human) | | 3e-08 | age at menarche | | 10 | 91223151 | 91223152 | Human |
597339724 | GWAS1435798_H | metabolite measurement QTL GWAS1435798 (human) | | 4e-10 | metabolite measurement | | 10 | 98388301 | 98388302 | Human |
597159489 | GWAS1255563_H | testosterone measurement QTL GWAS1255563 (human) | | 6e-19 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 102863296 | 102863297 | Human |
597159488 | GWAS1255562_H | testosterone measurement QTL GWAS1255562 (human) | | 0.0000001 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 95064055 | 95064056 | Human |
597339725 | GWAS1435799_H | metabolite measurement QTL GWAS1435799 (human) | | 2e-08 | metabolite measurement | | 10 | 98392616 | 98392617 | Human |
597339714 | GWAS1435788_H | N6,N6-dimethyllysine measurement QTL GWAS1435788 (human) | | 4e-17 | N6,N6-dimethyllysine measurement | | 10 | 98387303 | 98387304 | Human |
407369118 | GWAS1018094_H | eosinophil count QTL GWAS1018094 (human) | | 2e-15 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 87895485 | 87895486 | Human |
596971087 | GWAS1090606_H | pulse pressure measurement QTL GWAS1090606 (human) | | 7e-17 | pulse pressure measurement | | 10 | 94253193 | 94253194 | Human |
597339712 | GWAS1435786_H | N6,N6-dimethyllysine measurement QTL GWAS1435786 (human) | | 2e-17 | N6,N6-dimethyllysine measurement | | 10 | 98388419 | 98388420 | Human |
596971086 | GWAS1090605_H | pulse pressure measurement QTL GWAS1090605 (human) | | 4e-08 | pulse pressure measurement | | 10 | 87962505 | 87962506 | Human |
407377299 | GWAS1026275_H | urinary albumin to creatinine ratio QTL GWAS1026275 (human) | | 3e-10 | platelet count | | 10 | 93079885 | 93079886 | Human |
597339713 | GWAS1435787_H | N6,N6-dimethyllysine measurement QTL GWAS1435787 (human) | | 3e-16 | N6,N6-dimethyllysine measurement | | 10 | 98388247 | 98388248 | Human |
597339718 | GWAS1435792_H | metabolite measurement QTL GWAS1435792 (human) | | 9e-09 | metabolite measurement | | 10 | 98397611 | 98397612 | Human |
597339719 | GWAS1435793_H | metabolite measurement QTL GWAS1435793 (human) | | 2e-08 | metabolite measurement | | 10 | 98395539 | 98395540 | Human |
597266041 | GWAS1362115_H | triglyceride measurement QTL GWAS1362115 (human) | | 9e-13 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 94256036 | 94256037 | Human |
597266040 | GWAS1362114_H | triglyceride measurement QTL GWAS1362114 (human) | | 5e-14 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93583015 | 93583016 | Human |
406975907 | GWAS624883_H | mean corpuscular hemoglobin QTL GWAS624883 (human) | | 8e-13 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 102142301 | 102142306 | Human |
406910371 | GWAS559347_H | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia QTL GWAS559347 (human) | | 0.000005 | gamma-glutamyltyrosine measurement | | 10 | 79193379 | 79193380 | Human |
406975906 | GWAS624882_H | mean corpuscular hemoglobin QTL GWAS624882 (human) | | 3e-16 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 99541336 | 99541337 | Human |
597266042 | GWAS1362116_H | triglyceride measurement QTL GWAS1362116 (human) | | 3e-11 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 100152437 | 100152438 | Human |
406992294 | GWAS641270_H | intelligence QTL GWAS641270 (human) | | 1e-08 | intelligence | | 10 | 102120361 | 102120362 | Human |
596971121 | GWAS1090640_H | diastolic blood pressure QTL GWAS1090640 (human) | | 3e-43 | diastolic blood pressure | | 10 | 102900247 | 102900248 | Human |
597020272 | GWAS1116346_H | forced expiratory volume, response to bronchodilator QTL GWAS1116346 (human) | | 0.0000005 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 10 | 86435202 | 86435203 | Human |
596971120 | GWAS1090639_H | diastolic blood pressure QTL GWAS1090639 (human) | | 3e-20 | diastolic blood pressure | | 10 | 94242603 | 94242604 | Human |
406975908 | GWAS624884_H | mean corpuscular hemoglobin QTL GWAS624884 (human) | | 2e-21 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 103031837 | 103031838 | Human |
597225072 | GWAS1321146_H | response to mitochondrial complex I inhibitor QTL GWAS1321146 (human) | | 0.000005 | response to xenobiotic stimulus trait (VT:0010487) | | 10 | 79439329 | 79439330 | Human |
597290610 | GWAS1386684_H | gastroesophageal reflux disease, vital capacity QTL GWAS1386684 (human) | | 9e-09 | gastroesophageal reflux disease, vital capacity | | 10 | 79172541 | 79172542 | Human |
407000495 | GWAS649471_H | mean corpuscular hemoglobin QTL GWAS649471 (human) | | 1e-10 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 99522443 | 99522444 | Human |
597446258 | GWAS1542332_H | sex hormone-binding globulin measurement QTL GWAS1542332 (human) | | 9e-10 | sex hormone-binding globulin measurement | | 10 | 79318008 | 79318009 | Human |
597102176 | GWAS1198250_H | cognitive function measurement QTL GWAS1198250 (human) | | 0.0000002 | cognitive behavior trait (VT:0010450) | | 10 | 87580449 | 87580450 | Human |
597167714 | GWAS1263788_H | radiation-induced disorder QTL GWAS1263788 (human) | | 0.000006 | radiation-induced disorder | | 10 | 80138357 | 80138358 | Human |
597618276 | GWAS1675136_H | digestive system disease QTL GWAS1675136 (human) | | 2e-11 | digestive system disease | | 10 | 102313277 | 102313278 | Human |
597241240 | GWAS1337314_H | high density lipoprotein cholesterol measurement QTL GWAS1337314 (human) | | 5e-09 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 98002936 | 98002937 | Human |
597388698 | GWAS1484772_H | squamous cell lung carcinoma QTL GWAS1484772 (human) | | 0.0000005 | squamous cell lung carcinoma | | 10 | 100186276 | 100186277 | Human |
597044626 | GWAS1140700_H | birth weight QTL GWAS1140700 (human) | | 8e-13 | birth weight | neonatal body weight (CMO:0002079) | 10 | 92732959 | 92732960 | Human |
597339551 | GWAS1435625_H | metabolite measurement QTL GWAS1435625 (human) | | 8e-23 | metabolite measurement | | 10 | 98397611 | 98397612 | Human |
597044627 | GWAS1140701_H | birth weight QTL GWAS1140701 (human) | | 3e-08 | birth weight | neonatal body weight (CMO:0002079) | 10 | 103141734 | 103141735 | Human |
597609878 | GWAS1666738_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1666738 (human) | | 2e-66 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 10 | 100164661 | 100164662 | Human |
597257616 | GWAS1353690_H | BMI-adjusted waist-hip ratio QTL GWAS1353690 (human) | | 8e-15 | body size trait (VT:0100005) | | 10 | 93586583 | 93586584 | Human |
597257619 | GWAS1353693_H | BMI-adjusted waist-hip ratio QTL GWAS1353693 (human) | | 1e-08 | body size trait (VT:0100005) | | 10 | 102727217 | 102727218 | Human |
597298577 | GWAS1394651_H | diglyceride measurement QTL GWAS1394651 (human) | | 2e-08 | diglyceride measurement | | 10 | 92159370 | 92159371 | Human |
596979102 | GWAS1098621_H | body height QTL GWAS1098621 (human) | | 3e-11 | body height | | 10 | 100143201 | 100143202 | Human |
597257618 | GWAS1353692_H | BMI-adjusted waist-hip ratio QTL GWAS1353692 (human) | | 3e-11 | body size trait (VT:0100005) | | 10 | 102638825 | 102638826 | Human |
597241239 | GWAS1337313_H | high density lipoprotein cholesterol measurement QTL GWAS1337313 (human) | | 2e-09 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93012138 | 93012139 | Human |
597323157 | GWAS1419231_H | smoking initiation QTL GWAS1419231 (human) | | 9e-11 | smoking initiation | | 10 | 98034108 | 98034109 | Human |
597429651 | GWAS1525725_H | erythrocyte count QTL GWAS1525725 (human) | | 5e-16 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 102854593 | 102854594 | Human |
597519757 | GWAS1615831_H | serum gamma-glutamyl transferase measurement QTL GWAS1615831 (human) | | 8e-46 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 99843765 | 99843766 | Human |
597519756 | GWAS1615830_H | serum gamma-glutamyl transferase measurement QTL GWAS1615830 (human) | | 4e-12 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 94647595 | 94647596 | Human |
596962694 | GWAS1082213_H | forced expiratory volume, gastroesophageal reflux disease QTL GWAS1082213 (human) | | 4e-08 | forced expiratory volume, gastroesophageal reflux disease | | 10 | 79172541 | 79172542 | Human |
597519758 | GWAS1615832_H | serum gamma-glutamyl transferase measurement QTL GWAS1615832 (human) | | 1e-15 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 100910439 | 100910440 | Human |
597298574 | GWAS1394648_H | diglyceride measurement QTL GWAS1394648 (human) | | 5e-09 | diglyceride measurement | | 10 | 100315722 | 100315723 | Human |
597224845 | GWAS1320919_H | alkaline phosphatase measurement QTL GWAS1320919 (human) | | 7e-34 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 77897947 | 77897948 | Human |
597323151 | GWAS1419225_H | smoking initiation QTL GWAS1419225 (human) | | 8e-22 | smoking initiation | | 10 | 91983415 | 91983416 | Human |
597519755 | GWAS1615829_H | serum gamma-glutamyl transferase measurement QTL GWAS1615829 (human) | | 1e-29 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 93079967 | 93079968 | Human |
597257615 | GWAS1353689_H | BMI-adjusted waist-hip ratio QTL GWAS1353689 (human) | | 1e-09 | body size trait (VT:0100005) | | 10 | 93578182 | 93578183 | Human |
597101952 | GWAS1198026_H | aspartate aminotransferase measurement QTL GWAS1198026 (human) | | 3e-73 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 100152307 | 100152308 | Human |
597200256 | GWAS1296330_H | lean body mass QTL GWAS1296330 (human) | | 3e-15 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 102748445 | 102748446 | Human |
597208449 | GWAS1304523_H | protein measurement QTL GWAS1304523 (human) | | 3e-12 | protein measurement | | 10 | 88109713 | 88109714 | Human |
597208450 | GWAS1304524_H | protein measurement QTL GWAS1304524 (human) | | 5e-12 | protein measurement | | 10 | 79349702 | 79349703 | Human |
407041630 | GWAS690606_H | sitting height ratio QTL GWAS690606 (human) | | 0.0000002 | sitting height ratio | | 10 | 79165820 | 79165821 | Human |
597175686 | GWAS1271760_H | non-alcoholic fatty liver disease, type 2 diabetes mellitus QTL GWAS1271760 (human) | | 2e-08 | non-alcoholic fatty liver disease, type 2 diabetes mellitus | | 10 | 100925284 | 100925285 | Human |
597454271 | GWAS1550345_H | blood urea nitrogen measurement QTL GWAS1550345 (human) | | 2e-15 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 10 | 89063382 | 89063383 | Human |
597241277 | GWAS1337351_H | eye disease QTL GWAS1337351 (human) | | 2e-08 | eye disease | | 10 | 84249415 | 84249416 | Human |
597077424 | GWAS1173498_H | heel bone mineral density QTL GWAS1173498 (human) | | 3e-12 | 5-dodecenoylcarnitine (C12:1) measurement | bone mineral density (CMO:0001226) | 10 | 100315722 | 100315723 | Human |
406959718 | GWAS608694_H | palmitoleic acid measurement QTL GWAS608694 (human) | | 8e-11 | fatty acid amount (VT:0010046) | | 10 | 100539650 | 100539651 | Human |
597110192 | GWAS1206266_H | diastolic blood pressure QTL GWAS1206266 (human) | | 3e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 101355588 | 101355589 | Human |
407049834 | GWAS698810_H | oxalate measurement QTL GWAS698810 (human) | | 0.000002 | oxalate measurement | | 10 | 95466753 | 95466754 | Human |
597380530 | GWAS1476604_H | monocyte count QTL GWAS1476604 (human) | | 4e-113 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 99532633 | 99532634 | Human |
597167539 | GWAS1263613_H | type 1 diabetes mellitus QTL GWAS1263613 (human) | | 0.0000004 | type 1 diabetes mellitus | | 10 | 88257039 | 88257040 | Human |
597101991 | GWAS1198065_H | corneal topography QTL GWAS1198065 (human) | | 2e-10 | corneal topography | | 10 | 88264842 | 88264843 | Human |
597142950 | GWAS1239024_H | low density lipoprotein cholesterol measurement QTL GWAS1239024 (human) | | 3e-15 | low density lipoprotein cholesterol measurement | | 10 | 100164661 | 100164662 | Human |
597142949 | GWAS1239023_H | low density lipoprotein cholesterol measurement QTL GWAS1239023 (human) | | 6e-10 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 93152041 | 93152042 | Human |
597347752 | GWAS1443826_H | myocardial infarction QTL GWAS1443826 (human) | | 1e-08 | myocardial infarction | | 10 | 103016770 | 103016771 | Human |
597347753 | GWAS1443827_H | myocardial infarction QTL GWAS1443827 (human) | | 1e-08 | coronary artery disease | | 10 | 103192742 | 103192743 | Human |
597077422 | GWAS1173496_H | heel bone mineral density QTL GWAS1173496 (human) | | 2e-15 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 77651982 | 77651983 | Human |
597339554 | GWAS1435628_H | metabolite measurement QTL GWAS1435628 (human) | | 3e-25 | metabolite measurement | | 10 | 98388419 | 98388420 | Human |
597077423 | GWAS1173497_H | heel bone mineral density QTL GWAS1173497 (human) | | 1e-10 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 87796054 | 87796055 | Human |
597446053 | GWAS1542127_H | total cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS1542127 (human) | | 2e-14 | blood HDL triglyceride amount (VT:0010698) | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079967 | 93079968 | Human |
597339555 | GWAS1435629_H | metabolite measurement QTL GWAS1435629 (human) | | 2e-23 | metabolite measurement | | 10 | 98388247 | 98388248 | Human |
597339552 | GWAS1435626_H | metabolite measurement QTL GWAS1435626 (human) | | 1e-25 | metabolite measurement | | 10 | 98395539 | 98395540 | Human |
597339553 | GWAS1435627_H | metabolite measurement QTL GWAS1435627 (human) | | 2e-24 | metabolite measurement | | 10 | 98388551 | 98388552 | Human |
597282213 | GWAS1378287_H | triglycerides in IDL measurement QTL GWAS1378287 (human) | | 2e-12 | total lipids in very large VLDL measurement | | 10 | 93083778 | 93083779 | Human |
597339558 | GWAS1435632_H | metabolite measurement QTL GWAS1435632 (human) | | 1e-25 | metabolite measurement | | 10 | 98392616 | 98392617 | Human |
597175717 | GWAS1271791_H | vital capacity QTL GWAS1271791 (human) | | 2e-16 | vital capacity | | 10 | 93203634 | 93203635 | Human |
597339556 | GWAS1435630_H | metabolite measurement QTL GWAS1435630 (human) | | 4e-25 | metabolite measurement | | 10 | 98387303 | 98387304 | Human |
597462434 | GWAS1558508_H | colorectal cancer, colorectal adenoma QTL GWAS1558508 (human) | | 0.000004 | colorectal cancer, colorectal adenoma | | 10 | 99555409 | 99555410 | Human |
597618081 | GWAS1674941_H | eye injury QTL GWAS1674941 (human) | | 1e-11 | eye injury | | 10 | 86181267 | 86181268 | Human |
597339557 | GWAS1435631_H | metabolite measurement QTL GWAS1435631 (human) | | 3e-25 | metabolite measurement | | 10 | 98388301 | 98388302 | Human |
597315034 | GWAS1411108_H | cognitive function measurement QTL GWAS1411108 (human) | | 0.000007 | cognitive behavior trait (VT:0010450) | | 10 | 98318201 | 98318202 | Human |
597347806 | GWAS1443880_H | nephrolithiasis QTL GWAS1443880 (human) | | 1e-08 | nephrolithiasis | | 10 | 88382446 | 88382447 | Human |
597061074 | GWAS1157148_H | colorectal mucinous adenocarcinoma QTL GWAS1157148 (human) | | 0.000006 | colorectal mucinous adenocarcinoma | | 10 | 88820573 | 88820574 | Human |
597159379 | GWAS1255453_H | triglyceride:HDL cholesterol ratio QTL GWAS1255453 (human) | | 0.0000005 | blood triglyceride amount (VT:0002644) | | 10 | 92995002 | 92995003 | Human |
597470681 | GWAS1566755_H | ovarian carcinoma QTL GWAS1566755 (human) | | 0.000007 | ovarian carcinoma | | 10 | 80653667 | 80653668 | Human |
597183966 | GWAS1280040_H | cholesterol in large HDL measurement QTL GWAS1280040 (human) | | 9e-11 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 10 | 93079885 | 93079886 | Human |
597241311 | GWAS1337385_H | aging QTL GWAS1337385 (human) | | 4e-10 | aging | | 10 | 99512225 | 99512226 | Human |
597585369 | GWAS1642229_H | diabetes mellitus, Drugs used in diabetes use measurement QTL GWAS1642229 (human) | | 2e-22 | pancreas integrity trait (VT:0010560) | | 10 | 79193694 | 79193695 | Human |
597380563 | GWAS1476637_H | body mass index QTL GWAS1476637 (human) | | 1e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102460544 | 102460545 | Human |
597372371 | GWAS1468445_H | schizophrenia QTL GWAS1468445 (human) | | 0.0000003 | schizophrenia | | 10 | 102902701 | 102902702 | Human |
597257680 | GWAS1353754_H | triglyceride measurement QTL GWAS1353754 (human) | | 3e-14 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93082720 | 93082721 | Human |
407041554 | GWAS690530_H | central nervous system cancer QTL GWAS690530 (human) | | 0.000004 | central nervous system integrity trait (VT:0010772) | | 10 | 99096696 | 99096697 | Human |
597585356 | GWAS1642216_H | eosinophil count QTL GWAS1642216 (human) | | 2e-16 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 92672243 | 92672244 | Human |
597077445 | GWAS1173519_H | psoriasis QTL GWAS1173519 (human) | | 0.000001 | psoriasis | | 10 | 79256139 | 79256140 | Human |
407082519 | GWAS731495_H | obsolete_red blood cell distribution width QTL GWAS731495 (human) | | 4e-18 | obsolete_red blood cell distribution width | | 10 | 79040331 | 79040332 | Human |
407123472 | GWAS772448_H | periodontitis QTL GWAS772448 (human) | | 0.000003 | periodontitis | | 10 | 87992454 | 87992455 | Human |
597585355 | GWAS1642215_H | eosinophil count QTL GWAS1642215 (human) | | 7e-13 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 87938433 | 87938434 | Human |
597290433 | GWAS1386507_H | body mass index QTL GWAS1386507 (human) | | 1e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98002936 | 98002937 | Human |
407082522 | GWAS731498_H | obsolete_red blood cell distribution width QTL GWAS731498 (human) | | 2e-09 | obsolete_red blood cell distribution width | | 10 | 99494751 | 99494752 | Human |
597110221 | GWAS1206295_H | chronotype measurement QTL GWAS1206295 (human) | | 2e-08 | sleep behavior trait (VT:0001501) | | 10 | 91267239 | 91267240 | Human |
407082521 | GWAS731497_H | obsolete_red blood cell distribution width QTL GWAS731497 (human) | | 1e-09 | obsolete_red blood cell distribution width | | 10 | 94687805 | 94687806 | Human |
407082520 | GWAS731496_H | obsolete_red blood cell distribution width QTL GWAS731496 (human) | | 2e-29 | obsolete_red blood cell distribution width | | 10 | 94546848 | 94546849 | Human |
596987337 | GWAS1106856_H | triglyceride measurement QTL GWAS1106856 (human) | | 3e-14 | triglyceride measurement | | 10 | 93079885 | 93079886 | Human |
596979145 | GWAS1098664_H | body height QTL GWAS1098664 (human) | | 7e-17 | body height | | 10 | 93146154 | 93146155 | Human |
597036489 | GWAS1132563_H | triglyceride measurement QTL GWAS1132563 (human) | | 6e-16 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 98012647 | 98012648 | Human |
597306876 | GWAS1402950_H | pulse pressure measurement QTL GWAS1402950 (human) | | 1e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 80354129 | 80354130 | Human |
597020146 | GWAS1116220_H | eating disorder, bipolar disorder QTL GWAS1116220 (human) | | 0.000003 | eating disorder, bipolar disorder | | 10 | 81895974 | 81895975 | Human |
407000618 | GWAS649594_H | intelligence QTL GWAS649594 (human) | | 0.000009 | intelligence | | 10 | 98388773 | 98388774 | Human |
597593591 | GWAS1650451_H | potassium measurement QTL GWAS1650451 (human) | | 6e-15 | potassium measurement | blood potassium level (CMO:0000496) | 10 | 92672243 | 92672244 | Human |
597405170 | GWAS1501244_H | retinal vasculature measurement QTL GWAS1501244 (human) | | 3e-08 | retina blood vessel morphology trait (VT:0002792) | | 10 | 92730417 | 92730418 | Human |
597290482 | GWAS1386556_H | size QTL GWAS1386556 (human) | | 5e-10 | size | | 10 | 96897984 | 96897985 | Human |
597208553 | GWAS1304627_H | birth weight, parental genotype effect measurement QTL GWAS1304627 (human) | | 6e-21 | birth weight, parental genotype effect measurement | neonatal body weight (CMO:0002079) | 10 | 94265734 | 94265735 | Human |
597208554 | GWAS1304628_H | birth weight, parental genotype effect measurement QTL GWAS1304628 (human) | | 1e-08 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 10 | 94279840 | 94279841 | Human |
597388783 | GWAS1484857_H | acute myeloid leukemia QTL GWAS1484857 (human) | | 0.000001 | leukocyte integrity trait (VT:0010898) | | 10 | 98379226 | 98379227 | Human |
597102050 | GWAS1198124_H | low density lipoprotein cholesterol measurement QTL GWAS1198124 (human) | | 2e-46 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 93079885 | 93079886 | Human |
597437924 | GWAS1533998_H | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement QTL GWAS1533998 (human) | | 2e-08 | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 93549265 | 93549266 | Human |
596970989 | GWAS1090508_H | dry eye syndrome QTL GWAS1090508 (human) | | 0.000004 | dry eye syndrome | | 10 | 98041174 | 98041175 | Human |
597339619 | GWAS1435693_H | pulse pressure measurement QTL GWAS1435693 (human) | | 0.000002 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 86288454 | 86288455 | Human |
597110254 | GWAS1206328_H | ankylosing spondylitis QTL GWAS1206328 (human) | | 0.000005 | ankylosing spondylitis | | 10 | 88994730 | 88994731 | Human |
597093871 | GWAS1189945_H | coronary artery disease QTL GWAS1189945 (human) | | 5e-12 | coronary artery disease | | 10 | 89243170 | 89243171 | Human |
597290464 | GWAS1386538_H | HbA1c measurement QTL GWAS1386538 (human) | | 4e-11 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 10 | 92704550 | 92704551 | Human |
596978967 | GWAS1098486_H | Red cell distribution width QTL GWAS1098486 (human) | | 2e-29 | Red cell distribution width | | 10 | 94546848 | 94546849 | Human |
597077268 | GWAS1173342_H | intelligence QTL GWAS1173342 (human) | | 2e-13 | intelligence | | 10 | 102364848 | 102364849 | Human |
596978966 | GWAS1098485_H | Red cell distribution width QTL GWAS1098485 (human) | | 4e-18 | Red cell distribution width | | 10 | 79040331 | 79040332 | Human |
597077269 | GWAS1173343_H | intelligence QTL GWAS1173343 (human) | | 5e-09 | intelligence | | 10 | 102053377 | 102053378 | Human |
597077267 | GWAS1173341_H | intelligence QTL GWAS1173341 (human) | | 2e-09 | intelligence | | 10 | 102071841 | 102071842 | Human |
597191966 | GWAS1288040_H | anthropometric measurement QTL GWAS1288040 (human) | | 2e-10 | anthropometric measurement | body morphological measurement (CMO:0000021) | 10 | 79158760 | 79158761 | Human |
596970783 | GWAS1090302_H | pulse pressure measurement QTL GWAS1090302 (human) | | 1e-15 | pulse pressure measurement | | 10 | 94253193 | 94253194 | Human |
407393988 | GWAS1042964_H | BMI-adjusted hip circumference QTL GWAS1042964 (human) | | 1e-08 | BMI-adjusted hip circumference | | 10 | 87834823 | 87834824 | Human |
596978969 | GWAS1098488_H | Red cell distribution width QTL GWAS1098488 (human) | | 2e-09 | Red cell distribution width | | 10 | 99494751 | 99494752 | Human |
596978968 | GWAS1098487_H | Red cell distribution width QTL GWAS1098487 (human) | | 1e-09 | Red cell distribution width | | 10 | 94687805 | 94687806 | Human |
596978971 | GWAS1098490_H | Red cell distribution width QTL GWAS1098490 (human) | | 2e-10 | Red cell distribution width | | 10 | 102875346 | 102875347 | Human |
596978970 | GWAS1098489_H | Red cell distribution width QTL GWAS1098489 (human) | | 1e-15 | Red cell distribution width | | 10 | 101404997 | 101404998 | Human |
597060868 | GWAS1156942_H | metabolic syndrome QTL GWAS1156942 (human) | | 5e-24 | metabolic syndrome | | 10 | 79182179 | 79182180 | Human |
407418588 | GWAS1067564_H | systolic blood pressure QTL GWAS1067564 (human) | | 6e-10 | systolic blood pressure | | 10 | 87844975 | 87844976 | Human |
597421326 | GWAS1517400_H | bilirubin measurement QTL GWAS1517400 (human) | | 1e-14 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 10 | 93072371 | 93072372 | Human |
407148241 | GWAS797217_H | migraine disorder QTL GWAS797217 (human) | | 0.000007 | migraine disorder | | 10 | 95437221 | 95437222 | Human |
597069056 | GWAS1165130_H | smoking behavior, BMI-adjusted waist circumference QTL GWAS1165130 (human) | | 2e-08 | body size trait (VT:0100005) | | 10 | 102567827 | 102567828 | Human |
597314821 | GWAS1410895_H | vaginal microbiome measurement QTL GWAS1410895 (human) | | 0.000001 | vaginal microbiome measurement | | 10 | 89419538 | 89419539 | Human |
597060918 | GWAS1156992_H | metabolic syndrome QTL GWAS1156992 (human) | | 2e-22 | metabolic syndrome | | 10 | 92184143 | 92184144 | Human |
597060919 | GWAS1156993_H | metabolic syndrome QTL GWAS1156993 (human) | | 8e-09 | metabolic syndrome | | 10 | 92264888 | 92264889 | Human |
597060916 | GWAS1156990_H | metabolic syndrome QTL GWAS1156990 (human) | | 2e-20 | metabolic syndrome | | 10 | 86359258 | 86359259 | Human |
597060917 | GWAS1156991_H | metabolic syndrome QTL GWAS1156991 (human) | | 3e-08 | metabolic syndrome | | 10 | 89815975 | 89815976 | Human |
596954423 | GWAS1073942_H | hypertension QTL GWAS1073942 (human) | | 7e-24 | hypertension | | 10 | 94256036 | 94256037 | Human |
597060914 | GWAS1156988_H | metabolic syndrome QTL GWAS1156988 (human) | | 7e-13 | metabolic syndrome | | 10 | 79299578 | 79299579 | Human |
597224765 | GWAS1320839_H | serum gamma-glutamyl transferase measurement QTL GWAS1320839 (human) | | 2e-14 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 77902342 | 77902343 | Human |
597060915 | GWAS1156989_H | metabolic syndrome QTL GWAS1156989 (human) | | 3e-14 | metabolic syndrome | | 10 | 85651147 | 85651148 | Human |
597060913 | GWAS1156987_H | metabolic syndrome QTL GWAS1156987 (human) | | 9e-11 | metabolic syndrome | | 10 | 79230979 | 79230980 | Human |
597437755 | GWAS1533829_H | body mass index QTL GWAS1533829 (human) | | 0.000004 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102641875 | 102641876 | Human |
597191984 | GWAS1288058_H | free androgen index QTL GWAS1288058 (human) | | 1e-10 | free androgen index | | 10 | 100001413 | 100001414 | Human |
597060926 | GWAS1157000_H | metabolic syndrome QTL GWAS1157000 (human) | | 9e-16 | metabolic syndrome | | 10 | 100635683 | 100635684 | Human |
597388594 | GWAS1484668_H | spine bone mineral density QTL GWAS1484668 (human) | | 5e-09 | spine bone mineral density | bone mineral density (CMO:0001226) | 10 | 77641558 | 77641559 | Human |
597191985 | GWAS1288059_H | free androgen index QTL GWAS1288059 (human) | | 3e-10 | free androgen index | | 10 | 93279507 | 93279508 | Human |
596954429 | GWAS1073948_H | functional brain measurement QTL GWAS1073948 (human) | | 2e-42 | functional brain measurement | | 10 | 94279840 | 94279841 | Human |
597060927 | GWAS1157001_H | metabolic syndrome QTL GWAS1157001 (human) | | 2e-09 | metabolic syndrome | | 10 | 100652186 | 100652187 | Human |
597060924 | GWAS1156998_H | metabolic syndrome QTL GWAS1156998 (human) | | 8e-10 | metabolic syndrome | | 10 | 97265854 | 97265855 | Human |
597060925 | GWAS1156999_H | metabolic syndrome QTL GWAS1156999 (human) | | 4e-10 | metabolic syndrome | | 10 | 98267034 | 98267035 | Human |
597060922 | GWAS1156996_H | metabolic syndrome QTL GWAS1156996 (human) | | 2e-08 | metabolic syndrome | | 10 | 94292990 | 94292991 | Human |
597060923 | GWAS1156997_H | metabolic syndrome QTL GWAS1156997 (human) | | 3e-08 | metabolic syndrome | | 10 | 95468581 | 95468582 | Human |
597404982 | GWAS1501056_H | total cholesterol measurement QTL GWAS1501056 (human) | | 2e-16 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 100233804 | 100233805 | Human |
597191989 | GWAS1288063_H | free androgen index QTL GWAS1288063 (human) | | 2e-12 | free androgen index | | 10 | 102786426 | 102786427 | Human |
597060920 | GWAS1156994_H | metabolic syndrome QTL GWAS1156994 (human) | | 1e-20 | metabolic syndrome | | 10 | 92704188 | 92704189 | Human |
597060921 | GWAS1156995_H | metabolic syndrome QTL GWAS1156995 (human) | | 4e-17 | metabolic syndrome | | 10 | 93045908 | 93045909 | Human |
407385848 | GWAS1034824_H | obsolete_red blood cell distribution width QTL GWAS1034824 (human) | | 1e-08 | obsolete_red blood cell distribution width | | 10 | 89250722 | 89250723 | Human |
407385849 | GWAS1034825_H | obsolete_red blood cell distribution width QTL GWAS1034825 (human) | | 3e-31 | obsolete_red blood cell distribution width | | 10 | 94596424 | 94596425 | Human |
597110053 | GWAS1206127_H | urate measurement QTL GWAS1206127 (human) | | 1e-11 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 87120932 | 87120933 | Human |
407049969 | GWAS698945_H | multiple myeloma QTL GWAS698945 (human) | | 0.0000009 | multiple myeloma | | 10 | 96880089 | 96880090 | Human |
407385850 | GWAS1034826_H | obsolete_red blood cell distribution width QTL GWAS1034826 (human) | | 1e-12 | obsolete_red blood cell distribution width | | 10 | 99496351 | 99496352 | Human |
407385851 | GWAS1034827_H | obsolete_red blood cell distribution width QTL GWAS1034827 (human) | | 6e-15 | obsolete_red blood cell distribution width | | 10 | 101438198 | 101438199 | Human |
407385852 | GWAS1034828_H | obsolete_red blood cell distribution width QTL GWAS1034828 (human) | | 9e-08 | obsolete_red blood cell distribution width | | 10 | 102875346 | 102875347 | Human |
597077281 | GWAS1173355_H | intelligence QTL GWAS1173355 (human) | | 1e-16 | intelligence | | 10 | 101845957 | 101845958 | Human |
597290275 | GWAS1386349_H | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1386349 (human) | | 5e-11 | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93083778 | 93083779 | Human |
596962606 | GWAS1082125_H | anxiety disorder QTL GWAS1082125 (human) | | 8e-09 | anxiety disorder | | 10 | 102831636 | 102831637 | Human |
407385847 | GWAS1034823_H | obsolete_red blood cell distribution width QTL GWAS1034823 (human) | | 3e-21 | obsolete_red blood cell distribution width | | 10 | 79041217 | 79041218 | Human |
597618014 | GWAS1674874_H | glaucoma QTL GWAS1674874 (human) | | 4e-19 | glaucoma | | 10 | 94279840 | 94279841 | Human |
597339482 | GWAS1435556_H | N6-methyllysine measurement QTL GWAS1435556 (human) | | 5e-25 | N6-methyllysine measurement | | 10 | 98388301 | 98388302 | Human |
597347674 | GWAS1443748_H | urate measurement QTL GWAS1443748 (human) | | 2e-08 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 102940687 | 102940688 | Human |
596954453 | GWAS1073972_H | functional brain measurement QTL GWAS1073972 (human) | | 1e-37 | functional brain measurement | | 10 | 94279840 | 94279841 | Human |
597339483 | GWAS1435557_H | N6-methyllysine measurement QTL GWAS1435557 (human) | | 6e-22 | N6-methyllysine measurement | | 10 | 98392616 | 98392617 | Human |
597224794 | GWAS1320868_H | total cholesterol measurement QTL GWAS1320868 (human) | | 3e-12 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 93082720 | 93082721 | Human |
596954454 | GWAS1073973_H | functional brain measurement QTL GWAS1073973 (human) | | 1e-20 | functional brain measurement | | 10 | 94279840 | 94279841 | Human |
597339480 | GWAS1435554_H | N6-methyllysine measurement QTL GWAS1435554 (human) | | 1e-21 | N6-methyllysine measurement | | 10 | 98388247 | 98388248 | Human |
597347673 | GWAS1443747_H | urate measurement QTL GWAS1443747 (human) | | 4e-19 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 87120932 | 87120933 | Human |
597077333 | GWAS1173407_H | sporadic amyotrophic lateral sclerosis, survival time QTL GWAS1173407 (human) | | 2e-09 | sporadic amyotrophic lateral sclerosis, survival time | | 10 | 92524312 | 92524313 | Human |
597339481 | GWAS1435555_H | N6-methyllysine measurement QTL GWAS1435555 (human) | | 6e-22 | N6-methyllysine measurement | | 10 | 98387303 | 98387304 | Human |
597224795 | GWAS1320869_H | total cholesterol measurement QTL GWAS1320869 (human) | | 1e-12 | level of oxylipin in blood plasma | blood total cholesterol level (CMO:0000051) | 10 | 100315722 | 100315723 | Human |
596962640 | GWAS1082159_H | gastroesophageal reflux disease, vital capacity QTL GWAS1082159 (human) | | 9e-09 | gastroesophageal reflux disease, vital capacity | | 10 | 79172541 | 79172542 | Human |
597339484 | GWAS1435558_H | N6-methyllysine measurement QTL GWAS1435558 (human) | | 2e-11 | N6-methyllysine measurement | | 10 | 98408103 | 98408104 | Human |
597208415 | GWAS1304489_H | serum alanine aminotransferase measurement QTL GWAS1304489 (human) | | 3e-08 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100080295 | 100080296 | Human |
597339479 | GWAS1435553_H | N6-methyllysine measurement QTL GWAS1435553 (human) | | 5e-25 | N6-methyllysine measurement | | 10 | 98388419 | 98388420 | Human |
597192009 | GWAS1288083_H | sex hormone-binding globulin measurement QTL GWAS1288083 (human) | | 2e-24 | sex hormone-binding globulin measurement | | 10 | 79314368 | 79314369 | Human |
597314888 | GWAS1410962_H | bilirubin measurement QTL GWAS1410962 (human) | | 2e-47 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 10 | 93079885 | 93079886 | Human |
597290315 | GWAS1386389_H | hypertension QTL GWAS1386389 (human) | | 7e-24 | hypertension | | 10 | 94256036 | 94256037 | Human |
597314889 | GWAS1410963_H | bilirubin measurement QTL GWAS1410963 (human) | | 3e-14 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 10 | 94735111 | 94735114 | Human |
596954432 | GWAS1073951_H | hypertension QTL GWAS1073951 (human) | | 2e-08 | hypertension | | 10 | 100655852 | 100655853 | Human |
597273932 | GWAS1370006_H | BMI-adjusted hip circumference QTL GWAS1370006 (human) | | 1e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 79355057 | 79355058 | Human |
406967956 | GWAS616932_H | reticulocyte count QTL GWAS616932 (human) | | 4e-42 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 103107201 | 103107202 | Human |
597503300 | GWAS1599374_H | triglyceride measurement QTL GWAS1599374 (human) | | 7e-20 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 102382537 | 102382538 | Human |
406959768 | GWAS608744_H | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia QTL GWAS608744 (human) | | 1e-08 | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | | 10 | 102900247 | 102900248 | Human |
597593413 | GWAS1650273_H | platelet count QTL GWAS1650273 (human) | | 3e-21 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 79404390 | 79404391 | Human |
597314886 | GWAS1410960_H | X-12112 measurement QTL GWAS1410960 (human) | | 2e-1614 | X-12112 measurement | | 10 | 98388419 | 98388420 | Human |
597503296 | GWAS1599370_H | triglyceride measurement QTL GWAS1599370 (human) | | 2e-09 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 79334494 | 79334495 | Human |
597314887 | GWAS1410961_H | bilirubin measurement QTL GWAS1410961 (human) | | 3e-08 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 10 | 79384941 | 79384942 | Human |
597462337 | GWAS1558411_H | prostate cancer QTL GWAS1558411 (human) | | 0.000002 | prostate cancer | | 10 | 96991404 | 96991405 | Human |
597019979 | GWAS1116053_H | frontotemporal dementia QTL GWAS1116053 (human) | | 0.000005 | frontotemporal dementia | | 10 | 79434463 | 79434464 | Human |
597503299 | GWAS1599373_H | triglyceride measurement QTL GWAS1599373 (human) | | 5e-105 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079967 | 93079968 | Human |
597503298 | GWAS1599372_H | triglyceride measurement QTL GWAS1599372 (human) | | 3e-22 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 92455257 | 92455262 | Human |
597601662 | GWAS1658522_H | calcium measurement QTL GWAS1658522 (human) | | 2e-14 | calcium measurement | blood calcium level (CMO:0000502) | 10 | 79240220 | 79240221 | Human |
597159284 | GWAS1255358_H | triglyceride:HDL cholesterol ratio QTL GWAS1255358 (human) | | 5e-14 | blood triglyceride amount (VT:0002644) | | 10 | 98012433 | 98012434 | Human |
597454201 | GWAS1550275_H | serum gamma-glutamyl transferase measurement QTL GWAS1550275 (human) | | 9e-11 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 94647595 | 94647596 | Human |
597249407 | GWAS1345481_H | complement factor H-related protein 3 measurement QTL GWAS1345481 (human) | | 0.000006 | complement factor H-related protein 3 measurement | | 10 | 80940049 | 80940050 | Human |
597486964 | GWAS1583038_H | triacylglycerol 50:3 measurement QTL GWAS1583038 (human) | | 1e-08 | blood triglyceride amount (VT:0002644) | | 10 | 100377376 | 100377377 | Human |
407385761 | GWAS1034737_H | mean corpuscular hemoglobin concentration QTL GWAS1034737 (human) | | 8e-17 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 87879299 | 87879301 | Human |
597486965 | GWAS1583039_H | triacylglycerol 52:3 measurement QTL GWAS1583039 (human) | | 5e-08 | blood triglyceride amount (VT:0002644) | | 10 | 100389282 | 100389283 | Human |
597396854 | GWAS1492928_H | vaginal microbiome measurement QTL GWAS1492928 (human) | | 0.0000005 | vaginal microbiome measurement | | 10 | 89401598 | 89401599 | Human |
597298551 | GWAS1394625_H | blood rubidium measurement QTL GWAS1394625 (human) | | 0.000006 | blood rubidium measurement | | 10 | 100605297 | 100605298 | Human |
597265769 | GWAS1361843_H | triglyceride measurement QTL GWAS1361843 (human) | | 5e-18 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 92515052 | 92515053 | Human |
597265768 | GWAS1361842_H | triglyceride measurement QTL GWAS1361842 (human) | | 1e-12 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 91816074 | 91816075 | Human |
597306731 | GWAS1402805_H | monocyte count QTL GWAS1402805 (human) | | 2e-11 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 102801599 | 102801600 | Human |
597208426 | GWAS1304500_H | venous thromboembolism QTL GWAS1304500 (human) | | 2e-24 | venous thromboembolism | | 10 | 82209365 | 82209366 | Human |
597028199 | GWAS1124273_H | blood urea nitrogen measurement QTL GWAS1124273 (human) | | 3e-09 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 10 | 93082289 | 93082290 | Human |
597265771 | GWAS1361845_H | triglyceride measurement QTL GWAS1361845 (human) | | 5e-11 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93583015 | 93583016 | Human |
597265770 | GWAS1361844_H | triglyceride measurement QTL GWAS1361844 (human) | | 8e-65 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079885 | 93079886 | Human |
597060973 | GWAS1157047_H | refractive error QTL GWAS1157047 (human) | | 7e-09 | refractive error | | 10 | 93200318 | 93200319 | Human |
597421408 | GWAS1517482_H | alkaline phosphatase measurement QTL GWAS1517482 (human) | | 1e-13 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 100345873 | 100345874 | Human |
597249176 | GWAS1345250_H | low density lipoprotein cholesterol measurement QTL GWAS1345250 (human) | | 7e-14 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 100315722 | 100315723 | Human |
597429407 | GWAS1525481_H | sex hormone-binding globulin measurement QTL GWAS1525481 (human) | | 7e-39 | sex hormone-binding globulin measurement | | 10 | 91869742 | 91869743 | Human |
597060755 | GWAS1156829_H | refractive error QTL GWAS1156829 (human) | | 4e-09 | refractive error | | 10 | 93184133 | 93184134 | Human |
597437594 | GWAS1533668_H | urolithiasis QTL GWAS1533668 (human) | | 8e-10 | urolithiasis | | 10 | 87194125 | 87194126 | Human |
597052560 | GWAS1148634_H | anxiety QTL GWAS1148634 (human) | | 2e-13 | anxiety | | 10 | 102988702 | 102988703 | Human |
597191824 | GWAS1287898_H | systemic lupus erythematosus QTL GWAS1287898 (human) | | 4e-10 | systemic lupus erythematosus | | 10 | 84224688 | 84224689 | Human |
597314706 | GWAS1410780_H | X-11787 measurement QTL GWAS1410780 (human) | | 1e-38 | X-11787 measurement | | 10 | 94988735 | 94988736 | Human |
597175446 | GWAS1271520_H | protein measurement QTL GWAS1271520 (human) | | 8e-12 | protein measurement | | 10 | 79139212 | 79139213 | Human |
597249175 | GWAS1345249_H | low density lipoprotein cholesterol measurement QTL GWAS1345249 (human) | | 2e-14 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 93082720 | 93082721 | Human |
597175447 | GWAS1271521_H | protein measurement QTL GWAS1271521 (human) | | 1e-25 | protein measurement | | 10 | 102576669 | 102576670 | Human |
596970629 | GWAS1090148_H | progression free survival, response to tyrosine kinase inhibitor QTL GWAS1090148 (human) | | 0.0000001 | progression free survival, response to tyrosine kinase inhibitor | | 10 | 96724017 | 96724018 | Human |
597372042 | GWAS1468116_H | ulcerative colitis QTL GWAS1468116 (human) | | 0.0000002 | ulcerative colitis | | 10 | 99530544 | 99530545 | Human |
597273741 | GWAS1369815_H | systolic blood pressure QTL GWAS1369815 (human) | | 5e-15 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 102582449 | 102582450 | Human |
597404813 | GWAS1500887_H | fatty acid measurement QTL GWAS1500887 (human) | | 1e-09 | vitamin D measurement | | 10 | 93079967 | 93079968 | Human |
597281921 | GWAS1377995_H | thymol sulfate measurement QTL GWAS1377995 (human) | | 3e-14 | thymol sulfate measurement | | 10 | 94970329 | 94970330 | Human |
407131996 | GWAS780972_H | body mass index QTL GWAS780972 (human) | | 2e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100635683 | 100635684 | Human |
597290115 | GWAS1386189_H | triglycerides in very small VLDL measurement QTL GWAS1386189 (human) | | 4e-16 | triglycerides in very small VLDL measurement | blood very low density lipoprotein triglyceride level (CMO:0002688) | 10 | 93083778 | 93083779 | Human |
597027976 | GWAS1124050_H | waist-hip ratio QTL GWAS1124050 (human) | | 2e-10 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 93587048 | 93587049 | Human |
597617793 | GWAS1674653_H | glaucoma QTL GWAS1674653 (human) | | 2e-14 | glaucoma | | 10 | 93201869 | 93201870 | Human |
597052553 | GWAS1148627_H | anxiety QTL GWAS1148627 (human) | | 2e-12 | anxiety | | 10 | 102875591 | 102875592 | Human |
597150903 | GWAS1246977_H | systolic blood pressure QTL GWAS1246977 (human) | | 1e-12 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 100799664 | 100799665 | Human |
597593279 | GWAS1650139_H | platelet count QTL GWAS1650139 (human) | | 2e-27 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 79404390 | 79404391 | Human |
597241016 | GWAS1337090_H | educational attainment QTL GWAS1337090 (human) | | 2e-16 | educational attainment | | 10 | 101999764 | 101999765 | Human |
597462206 | GWAS1558280_H | triglyceride measurement QTL GWAS1558280 (human) | | 0.0000008 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079967 | 93079968 | Human |
597077172 | GWAS1173246_H | nicotine dependence symptom count QTL GWAS1173246 (human) | | 0.000003 | nicotine dependence symptom count | | 10 | 98050158 | 98050159 | Human |
597617850 | GWAS1674710_H | Phenotypic abnormality QTL GWAS1674710 (human) | | 2e-11 | Phenotypic abnormality | | 10 | 83395837 | 83395838 | Human |
597290172 | GWAS1386246_H | blood urea nitrogen measurement QTL GWAS1386246 (human) | | 4e-11 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 10 | 80290294 | 80290295 | Human |
597322943 | GWAS1419017_H | smoking initiation QTL GWAS1419017 (human) | | 6e-13 | smoking initiation | | 10 | 81070042 | 81070043 | Human |
597109937 | GWAS1206011_H | urate measurement QTL GWAS1206011 (human) | | 1e-20 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 87120932 | 87120933 | Human |
597077169 | GWAS1173243_H | nicotine dependence symptom count QTL GWAS1173243 (human) | | 0.000008 | nicotine dependence symptom count | | 10 | 79998263 | 79998264 | Human |
597290174 | GWAS1386248_H | blood urea nitrogen measurement QTL GWAS1386248 (human) | | 4e-09 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 10 | 94151004 | 94151005 | Human |
597167295 | GWAS1263369_H | serum alanine aminotransferase measurement QTL GWAS1263369 (human) | | 5e-155 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100152307 | 100152308 | Human |
597224627 | GWAS1320701_H | alkaline phosphatase measurement QTL GWAS1320701 (human) | | 3e-83 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 102186723 | 102186724 | Human |
407279466 | GWAS928442_H | cognitive decline measurement QTL GWAS928442 (human) | | 0.000007 | cognitive behavior trait (VT:0010450) | | 10 | 92777733 | 92777734 | Human |
597085371 | GWAS1181445_H | type 2 diabetes mellitus QTL GWAS1181445 (human) | | 7e-13 | type 2 diabetes mellitus | | 10 | 87962974 | 87962975 | Human |
597241015 | GWAS1337089_H | educational attainment QTL GWAS1337089 (human) | | 1e-08 | educational attainment | | 10 | 91148075 | 91148076 | Human |
597241014 | GWAS1337088_H | educational attainment QTL GWAS1337088 (human) | | 5e-10 | educational attainment | | 10 | 89821726 | 89821727 | Human |
597093542 | GWAS1189616_H | schizophrenia QTL GWAS1189616 (human) | | 2e-16 | schizophrenia | | 10 | 103111522 | 103111523 | Human |
597224617 | GWAS1320691_H | alkaline phosphatase measurement QTL GWAS1320691 (human) | | 4e-18 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 91882000 | 91882001 | Human |
407074673 | GWAS723649_H | memory performance QTL GWAS723649 (human) | | 0.000002 | memory performance | | 10 | 78079816 | 78079817 | Human |
597249195 | GWAS1345269_H | platelet-to-lymphocyte ratio QTL GWAS1345269 (human) | | 5e-08 | platelet quantity (VT:0003179) | | 10 | 101931242 | 101931243 | Human |
597388463 | GWAS1484537_H | body weight QTL GWAS1484537 (human) | | 0.000008 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 79022044 | 79022045 | Human |
597208236 | GWAS1304310_H | mitochondrial DNA measurement QTL GWAS1304310 (human) | | 0.0000005 | mitochondrial DNA measurement | | 10 | 93261609 | 93261610 | Human |
597453990 | GWAS1550064_H | COVID-19 QTL GWAS1550064 (human) | | 0.000003 | COVID-19 | | 10 | 103481851 | 103481852 | Human |
597372064 | GWAS1468138_H | glycoprotein measurement QTL GWAS1468138 (human) | | 0.000002 | glycoprotein measurement | | 10 | 99605556 | 99605557 | Human |
597380263 | GWAS1476337_H | Parkinson disease QTL GWAS1476337 (human) | | 7e-08 | Parkinson disease | | 10 | 102831636 | 102831637 | Human |
597200038 | GWAS1296112_H | attention deficit hyperactivity disorder, risk-taking behaviour QTL GWAS1296112 (human) | | 2e-08 | attention deficit hyperactivity disorder, risk-taking behaviour | | 10 | 97209210 | 97209211 | Human |
597429468 | GWAS1525542_H | protein measurement QTL GWAS1525542 (human) | | 4e-16 | protein measurement | | 10 | 84199939 | 84199940 | Human |
597257433 | GWAS1353507_H | triglyceride measurement QTL GWAS1353507 (human) | | 3e-09 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 100164661 | 100164662 | Human |
407000835 | GWAS649811_H | diastolic blood pressure QTL GWAS649811 (human) | | 0.000002 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 94890571 | 94890572 | Human |
597257437 | GWAS1353511_H | triglyceride measurement QTL GWAS1353511 (human) | | 2e-09 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93332122 | 93332123 | Human |
597421279 | GWAS1517353_H | systolic blood pressure QTL GWAS1517353 (human) | | 2e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94349017 | 94349018 | Human |
597421278 | GWAS1517352_H | systolic blood pressure QTL GWAS1517352 (human) | | 7e-48 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94263320 | 94263321 | Human |
597421277 | GWAS1517351_H | systolic blood pressure QTL GWAS1517351 (human) | | 5e-13 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94257826 | 94257827 | Human |
597347538 | GWAS1443612_H | myocardial infarction QTL GWAS1443612 (human) | | 4e-20 | myocardial infarction | | 10 | 89243047 | 89243048 | Human |
597347539 | GWAS1443613_H | myocardial infarction QTL GWAS1443613 (human) | | 0.000006 | myocardial infarction | | 10 | 98103792 | 98103793 | Human |
597347536 | GWAS1443610_H | myocardial infarction QTL GWAS1443610 (human) | | 0.0000005 | myocardial infarction | | 10 | 80491758 | 80491759 | Human |
597339344 | GWAS1435418_H | axial length measurement QTL GWAS1435418 (human) | | 5e-08 | axial length measurement | | 10 | 102980453 | 102980454 | Human |
597347537 | GWAS1443611_H | myocardial infarction QTL GWAS1443611 (human) | | 0.000006 | myocardial infarction | | 10 | 86723770 | 86723771 | Human |
597077213 | GWAS1173287_H | trait in response to thiopurine, alopecia QTL GWAS1173287 (human) | | 0.000001 | trait in response to thiopurine, alopecia | | 10 | 94662973 | 94662974 | Human |
597347540 | GWAS1443614_H | myocardial infarction QTL GWAS1443614 (human) | | 0.000005 | myocardial infarction | | 10 | 98251320 | 98251321 | Human |
597421257 | GWAS1517331_H | aging QTL GWAS1517331 (human) | | 2e-17 | aging | | 10 | 96298598 | 96298599 | Human |
597036229 | GWAS1132303_H | triglyceride measurement QTL GWAS1132303 (human) | | 4e-57 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079885 | 93079886 | Human |
597404879 | GWAS1500953_H | 3-methylcytidine measurement QTL GWAS1500953 (human) | | 3e-14 | 3-methylcytidine measurement | | 10 | 98383436 | 98383437 | Human |
597044419 | GWAS1140493_H | myelodysplastic syndrome QTL GWAS1140493 (human) | | 0.000009 | myelodysplastic syndrome | | 10 | 85873038 | 85873039 | Human |
597601480 | GWAS1658340_H | body mass index QTL GWAS1658340 (human) | | 2e-22 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 103153896 | 103153897 | Human |
407369488 | GWAS1018464_H | eosinophil percentage of granulocytes QTL GWAS1018464 (human) | | 7e-12 | eosinophil quantity (VT:0002602) | | 10 | 87939452 | 87939453 | Human |
596978893 | GWAS1098412_H | body height QTL GWAS1098412 (human) | | 5e-38 | body height | | 10 | 79384941 | 79384942 | Human |
597322946 | GWAS1419020_H | smoking initiation QTL GWAS1419020 (human) | | 5e-12 | smoking initiation | | 10 | 88446781 | 88446782 | Human |
597322947 | GWAS1419021_H | smoking initiation QTL GWAS1419021 (human) | | 6e-10 | smoking initiation | | 10 | 89510130 | 89510131 | Human |
597322944 | GWAS1419018_H | smoking initiation QTL GWAS1419018 (human) | | 1e-11 | smoking initiation | | 10 | 84795417 | 84795418 | Human |
597322945 | GWAS1419019_H | smoking initiation QTL GWAS1419019 (human) | | 2e-16 | smoking initiation | | 10 | 85641640 | 85641641 | Human |
597609667 | GWAS1666527_H | magnesium measurement QTL GWAS1666527 (human) | | 3e-13 | magnesium measurement | serum magnesium level (CMO:0000541) | 10 | 102981357 | 102981358 | Human |
597322948 | GWAS1419022_H | smoking initiation QTL GWAS1419022 (human) | | 1e-16 | smoking initiation | | 10 | 91668529 | 91668530 | Human |
597093577 | GWAS1189651_H | persistent Staphylococcus aureus carrier status QTL GWAS1189651 (human) | | 0.000002 | response to bacterial infection trait (VT:0010435) | | 10 | 95534155 | 95534156 | Human |
597019893 | GWAS1115967_H | body mass index QTL GWAS1115967 (human) | | 3e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 85651147 | 85651148 | Human |
597413114 | GWAS1509188_H | cup-to-disc ratio measurement QTL GWAS1509188 (human) | | 4e-11 | cup-to-disc ratio measurement | | 10 | 94278645 | 94278646 | Human |
597265656 | GWAS1361730_H | type 2 diabetes mellitus QTL GWAS1361730 (human) | | 3e-09 | type 2 diabetes mellitus | | 10 | 97296433 | 97296434 | Human |
407082786 | GWAS731762_H | obsolete_red blood cell distribution width QTL GWAS731762 (human) | | 2e-10 | obsolete_red blood cell distribution width | | 10 | 102875346 | 102875347 | Human |
407082785 | GWAS731761_H | obsolete_red blood cell distribution width QTL GWAS731761 (human) | | 1e-15 | obsolete_red blood cell distribution width | | 10 | 101404997 | 101404998 | Human |
597019895 | GWAS1115969_H | body mass index QTL GWAS1115969 (human) | | 3e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 103013607 | 103013608 | Human |
597019894 | GWAS1115968_H | body mass index QTL GWAS1115968 (human) | | 1e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100635683 | 100635684 | Human |
597093618 | GWAS1189692_H | 3-hydroxypropylmercapturic acid measurement QTL GWAS1189692 (human) | | 0.000001 | 3-hydroxypropylmercapturic acid measurement | | 10 | 92804854 | 92804855 | Human |
597052656 | GWAS1148730_H | anxiety QTL GWAS1148730 (human) | | 2e-12 | anxiety | | 10 | 103186066 | 103186067 | Human |
597093617 | GWAS1189691_H | 3-hydroxypropylmercapturic acid measurement QTL GWAS1189691 (human) | | 0.000008 | 3-hydroxypropylmercapturic acid measurement | | 10 | 85725660 | 85725661 | Human |
597495034 | GWAS1591108_H | S-7-hydroxywarfarin to S-warfarin ratio measurement QTL GWAS1591108 (human) | | 0.000004 | S-7-hydroxywarfarin to S-warfarin ratio measurement | | 10 | 90986737 | 90986738 | Human |
597617911 | GWAS1674771_H | prostate specific antigen amount QTL GWAS1674771 (human) | | 6e-14 | prostate specific antigen amount | | 10 | 102654464 | 102654465 | Human |
596978942 | GWAS1098461_H | body mass index QTL GWAS1098461 (human) | | 1e-19 | body mass index | | 10 | 98012647 | 98012648 | Human |
597363959 | GWAS1460033_H | FEV/FVC ratio, response to bronchodilator QTL GWAS1460033 (human) | | 0.0000006 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 78627927 | 78627928 | Human |
597380342 | GWAS1476416_H | response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy QTL GWAS1476416 (human) | | 0.0000004 | response to viral infection trait (VT:0010439) | | 10 | 89981680 | 89981681 | Human |
597511408 | GWAS1607482_H | diastolic blood pressure QTL GWAS1607482 (human) | | 1e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 102846003 | 102846004 | Human |
597019896 | GWAS1115970_H | body mass index QTL GWAS1115970 (human) | | 2e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 103146454 | 103146455 | Human |
406943535 | GWAS592511_H | hematocrit QTL GWAS592511 (human) | | 3e-13 | hematocrit | hematocrit (CMO:0000037) | 10 | 87169895 | 87169896 | Human |
406943534 | GWAS592510_H | hematocrit QTL GWAS592510 (human) | | 2e-16 | hematocrit | hematocrit (CMO:0000037) | 10 | 80290890 | 80290891 | Human |
406943537 | GWAS592513_H | hematocrit QTL GWAS592513 (human) | | 2e-10 | hematocrit | hematocrit (CMO:0000037) | 10 | 89635671 | 89635672 | Human |
597019877 | GWAS1115951_H | cup-to-disc ratio measurement, open-angle glaucoma QTL GWAS1115951 (human) | | 6e-10 | cup-to-disc ratio measurement, open-angle glaucoma | | 10 | 93203634 | 93203635 | Human |
597421291 | GWAS1517365_H | systolic blood pressure QTL GWAS1517365 (human) | | 8e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 102535686 | 102535687 | Human |
406943536 | GWAS592512_H | hematocrit QTL GWAS592512 (human) | | 1e-10 | hematocrit | hematocrit (CMO:0000037) | 10 | 88536710 | 88536711 | Human |
597421290 | GWAS1517364_H | systolic blood pressure QTL GWAS1517364 (human) | | 5e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 102307476 | 102307477 | Human |
406943539 | GWAS592515_H | hematocrit QTL GWAS592515 (human) | | 1e-10 | hematocrit | hematocrit (CMO:0000037) | 10 | 95500358 | 95500359 | Human |
597421289 | GWAS1517363_H | systolic blood pressure QTL GWAS1517363 (human) | | 2e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 101627018 | 101627019 | Human |
406943538 | GWAS592514_H | hematocrit QTL GWAS592514 (human) | | 7e-11 | hematocrit | hematocrit (CMO:0000037) | 10 | 91277652 | 91277653 | Human |
597019878 | GWAS1115952_H | open-angle glaucoma QTL GWAS1115952 (human) | | 0.000002 | open-angle glaucoma | | 10 | 93183256 | 93183257 | Human |
597421288 | GWAS1517362_H | systolic blood pressure QTL GWAS1517362 (human) | | 1e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 100898267 | 100898268 | Human |
597339375 | GWAS1435449_H | sexual dimorphism measurement QTL GWAS1435449 (human) | | 1e-11 | sexual dimorphism measurement | | 10 | 100900917 | 100900918 | Human |
597421294 | GWAS1517368_H | systolic blood pressure QTL GWAS1517368 (human) | | 4e-78 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103192742 | 103192743 | Human |
597421293 | GWAS1517367_H | systolic blood pressure QTL GWAS1517367 (human) | | 4e-83 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103146454 | 103146455 | Human |
597421292 | GWAS1517366_H | systolic blood pressure QTL GWAS1517366 (human) | | 2e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 102727686 | 102727687 | Human |
597478628 | GWAS1574702_H | protein measurement QTL GWAS1574702 (human) | | 1e-08 | protein measurement | | 10 | 84654691 | 84654692 | Human |
597421283 | GWAS1517357_H | systolic blood pressure QTL GWAS1517357 (human) | | 3e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 95566568 | 95566569 | Human |
597421282 | GWAS1517356_H | systolic blood pressure QTL GWAS1517356 (human) | | 1e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 95262119 | 95262120 | Human |
597421281 | GWAS1517355_H | systolic blood pressure QTL GWAS1517355 (human) | | 2e-18 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94423594 | 94423595 | Human |
597478631 | GWAS1574705_H | protein measurement QTL GWAS1574705 (human) | | 4e-10 | protein measurement | | 10 | 84927640 | 84927641 | Human |
596962543 | GWAS1082062_H | age at menarche QTL GWAS1082062 (human) | | 3e-08 | age at menarche | | 10 | 91223151 | 91223152 | Human |
596978926 | GWAS1098445_H | retinal vasculature measurement QTL GWAS1098445 (human) | | 0.000003 | retinal vasculature measurement | | 10 | 94278929 | 94278930 | Human |
597421280 | GWAS1517354_H | systolic blood pressure QTL GWAS1517354 (human) | | 8e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94371764 | 94371765 | Human |
597421287 | GWAS1517361_H | systolic blood pressure QTL GWAS1517361 (human) | | 8e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 100861657 | 100861658 | Human |
597421286 | GWAS1517360_H | systolic blood pressure QTL GWAS1517360 (human) | | 3e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 100849249 | 100849250 | Human |
597421285 | GWAS1517359_H | systolic blood pressure QTL GWAS1517359 (human) | | 8e-44 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 100793890 | 100793891 | Human |
597421284 | GWAS1517358_H | systolic blood pressure QTL GWAS1517358 (human) | | 1e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 100643925 | 100643926 | Human |
597150743 | GWAS1246817_H | endometriosis QTL GWAS1246817 (human) | | 5e-09 | endometriosis | | 10 | 88423281 | 88423282 | Human |
597158934 | GWAS1255008_H | dementia QTL GWAS1255008 (human) | | 0.000007 | dementia | | 10 | 95945574 | 95945575 | Human |
597527580 | GWAS1623654_H | protein measurement QTL GWAS1623654 (human) | | 4e-15 | protein measurement | | 10 | 102882480 | 102882481 | Human |
597437470 | GWAS1533544_H | hypothyroidism QTL GWAS1533544 (human) | | 7e-09 | Thyroid preparation use measurement | | 10 | 99523573 | 99523574 | Human |
597290011 | GWAS1386085_H | blood urea nitrogen measurement QTL GWAS1386085 (human) | | 1e-08 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 10 | 100960997 | 100960998 | Human |
407025601 | GWAS674577_H | celiac disease QTL GWAS674577 (human) | | 9e-10 | celiac disease | | 10 | 79298270 | 79298271 | Human |
597601302 | GWAS1658162_H | blood urea nitrogen measurement QTL GWAS1658162 (human) | | 7e-16 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 10 | 80338390 | 80338391 | Human |
597052446 | GWAS1148520_H | cardiovascular disease QTL GWAS1148520 (human) | | 7e-22 | cardiovascular disease | | 10 | 94254865 | 94254866 | Human |
597052447 | GWAS1148521_H | cardiovascular disease QTL GWAS1148521 (human) | | 6e-08 | cardiovascular disease | | 10 | 95494548 | 95494549 | Human |
597093404 | GWAS1189478_H | Alzheimer disease, age at onset QTL GWAS1189478 (human) | | 5e-08 | Alzheimer disease, age at onset | | 10 | 83190139 | 83190140 | Human |
597281811 | GWAS1377885_H | QT interval QTL GWAS1377885 (human) | | 3e-09 | QT interval | QT interval (CMO:0000235) | 10 | 90922303 | 90922304 | Human |
597396496 | GWAS1492570_H | vaginal microbiome measurement QTL GWAS1492570 (human) | | 0.0000001 | vaginal microbiome measurement | | 10 | 89401598 | 89401599 | Human |
597281810 | GWAS1377884_H | QT interval QTL GWAS1377884 (human) | | 2e-11 | QT interval | QT interval (CMO:0000235) | 10 | 89518993 | 89518994 | Human |
597052445 | GWAS1148519_H | cardiovascular disease QTL GWAS1148519 (human) | | 2e-11 | cardiovascular disease | | 10 | 94132902 | 94132903 | Human |
597363728 | GWAS1459802_H | schizophrenia QTL GWAS1459802 (human) | | 8e-10 | schizophrenia | | 10 | 102894820 | 102894821 | Human |
597593106 | GWAS1649966_H | retinal degeneration QTL GWAS1649966 (human) | | 9e-13 | retinal degeneration | | 10 | 94278929 | 94278930 | Human |
407099345 | GWAS748321_H | schizophrenia QTL GWAS748321 (human) | | 4e-13 | schizophrenia | | 10 | 102869116 | 102869117 | Human |
597371912 | GWAS1467986_H | mean corpuscular hemoglobin concentration QTL GWAS1467986 (human) | | 2e-12 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 79045499 | 79045500 | Human |
407386078 | GWAS1035054_H | mean corpuscular hemoglobin concentration QTL GWAS1035054 (human) | | 2e-16 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 99514276 | 99514277 | Human |
597486602 | GWAS1582676_H | phosphatidylcholine measurement QTL GWAS1582676 (human) | | 4e-10 | phosphatidylcholine measurement | | 10 | 100339336 | 100339337 | Human |
597208066 | GWAS1304140_H | complement factor D measurement QTL GWAS1304140 (human) | | 2e-08 | complement protein amount (VT:0010033) | | 10 | 87709326 | 87709327 | Human |
597347328 | GWAS1443402_H | body mass index QTL GWAS1443402 (human) | | 1e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102973517 | 102973518 | Human |
596954127 | GWAS1073646_H | systolic blood pressure QTL GWAS1073646 (human) | | 8e-45 | systolic blood pressure | | 10 | 94278929 | 94278930 | Human |
597609477 | GWAS1666337_H | magnesium measurement QTL GWAS1666337 (human) | | 5e-19 | magnesium measurement | serum magnesium level (CMO:0000541) | 10 | 102968859 | 102968860 | Human |
597208068 | GWAS1304142_H | vitamin D measurement QTL GWAS1304142 (human) | | 3e-10 | vitamin D measurement | | 10 | 89764255 | 89764256 | Human |
407386070 | GWAS1035046_H | eosinophil count QTL GWAS1035046 (human) | | 7e-37 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 87938433 | 87938434 | Human |
407386071 | GWAS1035047_H | eosinophil count QTL GWAS1035047 (human) | | 6e-15 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 89084129 | 89084130 | Human |
597470269 | GWAS1566343_H | body mass index QTL GWAS1566343 (human) | | 2e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102856906 | 102856907 | Human |
597036084 | GWAS1132158_H | triglyceride measurement QTL GWAS1132158 (human) | | 3e-10 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 92499423 | 92499424 | Human |
596962359 | GWAS1081878_H | age at menarche QTL GWAS1081878 (human) | | 2e-08 | age at menarche | | 10 | 91223151 | 91223152 | Human |
597396543 | GWAS1492617_H | cup-to-disc ratio measurement QTL GWAS1492617 (human) | | 5e-15 | cup-to-disc ratio measurement | | 10 | 93190956 | 93190957 | Human |
597363774 | GWAS1459848_H | waist-hip ratio QTL GWAS1459848 (human) | | 5e-08 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 87843667 | 87843668 | Human |
597019696 | GWAS1115770_H | smoking status measurement, systolic blood pressure QTL GWAS1115770 (human) | | 0.000007 | smoking status measurement, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 97880706 | 97880707 | Human |
597593140 | GWAS1650000_H | platelet count QTL GWAS1650000 (human) | | 6e-20 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 79404390 | 79404391 | Human |
596978751 | GWAS1098270_H | Crohn's disease QTL GWAS1098270 (human) | | 4e-50 | Crohn's disease | | 10 | 99524480 | 99524481 | Human |
597077050 | GWAS1173124_H | Epstein-Barr virus infection QTL GWAS1173124 (human) | | 0.0000007 | Epstein-Barr virus infection | | 10 | 82625296 | 82625297 | Human |
597339181 | GWAS1435255_H | puberty onset measurement QTL GWAS1435255 (human) | | 2e-09 | puberty onset measurement | | 10 | 100914880 | 100914881 | Human |
597380131 | GWAS1476205_H | smoking status measurement QTL GWAS1476205 (human) | | 2e-11 | smoking status measurement | | 10 | 102880295 | 102880296 | Human |
597503071 | GWAS1599145_H | 5alpha-androstan-3alpha,17beta-diol disulfate measurement QTL GWAS1599145 (human) | | 4e-12 | 5alpha-androstan-3alpha,17beta-diol disulfate measurement | | 10 | 99763315 | 99763316 | Human |
597052499 | GWAS1148573_H | cardiovascular disease QTL GWAS1148573 (human) | | 7e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 100315722 | 100315723 | Human |
597175390 | GWAS1271464_H | omega-3 polyunsaturated fatty acid measurement QTL GWAS1271464 (human) | | 2e-10 | omega-3 polyunsaturated fatty acid measurement | | 10 | 94935323 | 94935324 | Human |
597118047 | GWAS1214121_H | cerebral amyloid deposition measurement QTL GWAS1214121 (human) | | 0.0000008 | cerebral cortex integrity trait (VT:0010923) | | 10 | 88306867 | 88306868 | Human |
597208144 | GWAS1304218_H | protein measurement QTL GWAS1304218 (human) | | 5e-09 | protein measurement | | 10 | 90681387 | 90681388 | Human |
597159007 | GWAS1255081_H | triglyceride:HDL cholesterol ratio QTL GWAS1255081 (human) | | 3e-24 | blood triglyceride amount (VT:0002644) | | 10 | 93079885 | 93079886 | Human |
597052510 | GWAS1148584_H | cardiovascular disease QTL GWAS1148584 (human) | | 2e-19 | cardiovascular disease | | 10 | 103146454 | 103146455 | Human |
597584981 | GWAS1641841_H | diabetes mellitus, Drugs used in diabetes use measurement QTL GWAS1641841 (human) | | 5e-32 | pancreas integrity trait (VT:0010560) | | 10 | 92700524 | 92700525 | Human |
597486679 | GWAS1582753_H | triacylglycerol 50:3 measurement QTL GWAS1582753 (human) | | 5e-08 | blood triglyceride amount (VT:0002644) | | 10 | 100377376 | 100377377 | Human |
597396560 | GWAS1492634_H | body mass index QTL GWAS1492634 (human) | | 1e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102875346 | 102875347 | Human |
597159003 | GWAS1255077_H | triglyceride:HDL cholesterol ratio QTL GWAS1255077 (human) | | 0.0000001 | blood triglyceride amount (VT:0002644) | | 10 | 98012433 | 98012434 | Human |
597052506 | GWAS1148580_H | cardiovascular disease QTL GWAS1148580 (human) | | 5e-09 | cardiovascular disease | | 10 | 100794914 | 100794915 | Human |
597363797 | GWAS1459871_H | chronic lymphocytic leukemia QTL GWAS1459871 (human) | | 1e-15 | leukocyte integrity trait (VT:0010898) | | 10 | 88992261 | 88992262 | Human |
597101637 | GWAS1197711_H | type 2 diabetes mellitus QTL GWAS1197711 (human) | | 3e-14 | type 2 diabetes mellitus | | 10 | 79191373 | 79191374 | Human |
597101635 | GWAS1197709_H | type 2 diabetes mellitus QTL GWAS1197709 (human) | | 5e-39 | type 2 diabetes mellitus | | 10 | 92706682 | 92706683 | Human |
597290061 | GWAS1386135_H | body weight QTL GWAS1386135 (human) | | 1e-19 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 100900524 | 100900525 | Human |
597453897 | GWAS1549971_H | serum gamma-glutamyl transferase measurement QTL GWAS1549971 (human) | | 6e-47 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 99843765 | 99843766 | Human |
597290062 | GWAS1386136_H | body weight QTL GWAS1386136 (human) | | 9e-25 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 102988252 | 102988253 | Human |
597249089 | GWAS1345163_H | breast carcinoma QTL GWAS1345163 (human) | | 0.0000002 | mammary gland integrity trait (VT:0010552) | | 10 | 79081391 | 79081392 | Human |
597052494 | GWAS1148568_H | anxiety QTL GWAS1148568 (human) | | 4e-09 | brain connectivity measurement | | 10 | 102981357 | 102981358 | Human |
406960024 | GWAS609000_H | systolic blood pressure QTL GWAS609000 (human) | | 5e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103126864 | 103126865 | Human |
597052492 | GWAS1148566_H | anxiety QTL GWAS1148566 (human) | | 4e-08 | anxiety | | 10 | 103279484 | 103279485 | Human |
597412934 | GWAS1509008_H | childhood onset asthma QTL GWAS1509008 (human) | | 8e-12 | childhood onset asthma | | 10 | 92669710 | 92669711 | Human |
597052491 | GWAS1148565_H | anxiety QTL GWAS1148565 (human) | | 5e-08 | anxiety | | 10 | 102767194 | 102767195 | Human |
596954186 | GWAS1073705_H | lean body mass QTL GWAS1073705 (human) | | 0.000002 | lean body mass | | 10 | 94278929 | 94278930 | Human |
597494909 | GWAS1590983_H | Back pain QTL GWAS1590983 (human) | | 4e-09 | Back pain | | 10 | 102868477 | 102868478 | Human |
597306488 | GWAS1402562_H | monocyte count QTL GWAS1402562 (human) | | 7e-74 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 97349165 | 97349166 | Human |
407304098 | GWAS953074_H | reticulocyte measurement QTL GWAS953074 (human) | | 3e-09 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 10 | 79397838 | 79397839 | Human |
597462138 | GWAS1558212_H | body mass index QTL GWAS1558212 (human) | | 4e-15 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102851169 | 102851170 | Human |
597273726 | GWAS1369800_H | systolic blood pressure QTL GWAS1369800 (human) | | 2e-17 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103369141 | 103369142 | Human |
597380211 | GWAS1476285_H | monocyte count QTL GWAS1476285 (human) | | 1e-15 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 88118577 | 88118578 | Human |
597347443 | GWAS1443517_H | body mass index QTL GWAS1443517 (human) | | 2e-15 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98002936 | 98002937 | Human |
597306486 | GWAS1402560_H | monocyte count QTL GWAS1402560 (human) | | 2e-08 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 92415715 | 92415716 | Human |
597306487 | GWAS1402561_H | monocyte count QTL GWAS1402561 (human) | | 4e-16 | monocyte count | | 10 | 94279840 | 94279841 | Human |
597273716 | GWAS1369790_H | systolic blood pressure QTL GWAS1369790 (human) | | 1e-15 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94916135 | 94916136 | Human |
597380212 | GWAS1476286_H | monocyte count QTL GWAS1476286 (human) | | 9e-16 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 94311804 | 94311805 | Human |
597216375 | GWAS1312449_H | protein measurement QTL GWAS1312449 (human) | | 2e-101 | protein measurement | | 10 | 100045685 | 100045686 | Human |
597494898 | GWAS1590972_H | Back pain QTL GWAS1590972 (human) | | 0.0000001 | Back pain | | 10 | 102868477 | 102868478 | Human |
597118054 | GWAS1214128_H | cerebral amyloid deposition measurement QTL GWAS1214128 (human) | | 0.0000007 | cerebral cortex integrity trait (VT:0010923) | | 10 | 88431443 | 88431444 | Human |
597019748 | GWAS1115822_H | smoking status measurement, diastolic blood pressure QTL GWAS1115822 (human) | | 0.0000003 | smoking status measurement, diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 97880706 | 97880707 | Human |
407222198 | GWAS871174_H | plasma betaine measurement QTL GWAS871174 (human) | | 0.000005 | plasma betaine measurement | | 10 | 81254023 | 81254024 | Human |
597240941 | GWAS1337015_H | electrocardiography QTL GWAS1337015 (human) | | 3e-08 | electrocardiography | | 10 | 93066890 | 93066891 | Human |
407132082 | GWAS781058_H | clopidogrel metabolite measurement QTL GWAS781058 (human) | | 3e-14 | clopidogrel metabolite measurement | | 10 | 94839753 | 94839754 | Human |
597273710 | GWAS1369784_H | systolic blood pressure QTL GWAS1369784 (human) | | 7e-16 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94565920 | 94565921 | Human |
597216367 | GWAS1312441_H | body mass index QTL GWAS1312441 (human) | | 9e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102813206 | 102813207 | Human |
597404775 | GWAS1500849_H | diabetic nephropathy QTL GWAS1500849 (human) | | 0.0000009 | kidney integrity trait (VT:0010580) | | 10 | 80253378 | 80253379 | Human |
406988866 | GWAS637842_H | mean corpuscular hemoglobin concentration QTL GWAS637842 (human) | | 1e-44 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 99541336 | 99541337 | Human |
406988867 | GWAS637843_H | mean corpuscular hemoglobin concentration QTL GWAS637843 (human) | | 4e-51 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 103126776 | 103126777 | Human |
597119891 | GWAS1215965_H | aspartate aminotransferase measurement QTL GWAS1215965 (human) | | 2e-12 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99420626 | 99420627 | Human |
597119890 | GWAS1215964_H | aspartate aminotransferase measurement QTL GWAS1215964 (human) | | 3e-14 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99406138 | 99406139 | Human |
597291935 | GWAS1388009_H | body mass index QTL GWAS1388009 (human) | | 1e-14 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 85651147 | 85651148 | Human |
597119889 | GWAS1215963_H | aspartate aminotransferase measurement QTL GWAS1215963 (human) | | 1e-46 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99403870 | 99403871 | Human |
597119888 | GWAS1215962_H | aspartate aminotransferase measurement QTL GWAS1215962 (human) | | 1e-609 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99397621 | 99397622 | Human |
597529493 | GWAS1625567_H | smoking initiation QTL GWAS1625567 (human) | | 9e-10 | smoking initiation | | 10 | 102662289 | 102662290 | Human |
597095327 | GWAS1191401_H | influenza A (H1N1) QTL GWAS1191401 (human) | | 4e-09 | influenza A (H1N1) | | 10 | 83884859 | 83884860 | Human |
597529492 | GWAS1625566_H | smoking initiation QTL GWAS1625566 (human) | | 9e-12 | smoking initiation | | 10 | 102208790 | 102208791 | Human |
597439376 | GWAS1535450_H | BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment QTL GWAS1535450 (human) | | 0.0000006 | body size trait (VT:0100005) | | 10 | 102727686 | 102727687 | Human |
597054360 | GWAS1150434_H | multiple sclerosis QTL GWAS1150434 (human) | | 2e-17 | multiple sclerosis | | 10 | 92719350 | 92719351 | Human |
597177228 | GWAS1273302_H | tuberculosis QTL GWAS1273302 (human) | | 0.000004 | tuberculosis | | 10 | 89348283 | 89348284 | Human |
597398403 | GWAS1494477_H | erythrocyte count QTL GWAS1494477 (human) | | 3e-15 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 79028089 | 79028090 | Human |
597341058 | GWAS1437132_H | serum gamma-glutamyl transferase measurement QTL GWAS1437132 (human) | | 6e-11 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 87997883 | 87997884 | Human |
597119887 | GWAS1215961_H | aspartate aminotransferase measurement QTL GWAS1215961 (human) | | 4e-16 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99330450 | 99330451 | Human |
597341059 | GWAS1437133_H | serum gamma-glutamyl transferase measurement QTL GWAS1437133 (human) | | 1e-10 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 89513997 | 89513998 | Human |
597341057 | GWAS1437131_H | serum gamma-glutamyl transferase measurement QTL GWAS1437131 (human) | | 5e-200 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 77920676 | 77920677 | Human |
597095304 | GWAS1191378_H | schizophrenia QTL GWAS1191378 (human) | | 0.000005 | schizophrenia | | 10 | 86353182 | 86353183 | Human |
597341060 | GWAS1437134_H | serum gamma-glutamyl transferase measurement QTL GWAS1437134 (human) | | 6e-15 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 96709936 | 96709937 | Human |
597431230 | GWAS1527304_H | protein measurement QTL GWAS1527304 (human) | | 4e-13 | protein measurement | | 10 | 97653734 | 97653735 | Human |
597365688 | GWAS1461762_H | hemoglobin measurement QTL GWAS1461762 (human) | | 4e-11 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 102911075 | 102911076 | Human |
407062628 | GWAS711604_H | cup-to-disc ratio measurement QTL GWAS711604 (human) | | 9e-16 | cup-to-disc ratio measurement | | 10 | 93203634 | 93203635 | Human |
597095345 | GWAS1191419_H | FEV/FVC ratio, response to bronchodilator QTL GWAS1191419 (human) | | 0.000003 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 93557637 | 93557638 | Human |
597595062 | GWAS1651922_H | eosinophil count QTL GWAS1651922 (human) | | 2e-17 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 92669710 | 92669711 | Human |
406923368 | GWAS572344_H | systolic blood pressure QTL GWAS572344 (human) | | 8e-45 | systolic blood pressure | | 10 | 94278929 | 94278930 | Human |
597242803 | GWAS1338877_H | aspartate aminotransferase measurement QTL GWAS1338877 (human) | | 9e-86 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 100152307 | 100152308 | Human |
596972475 | GWAS1091994_H | systolic blood pressure QTL GWAS1091994 (human) | | 3e-23 | systolic blood pressure | | 10 | 94253193 | 94253194 | Human |
597193654 | GWAS1289728_H | response to radiation, hearing loss, response to antineoplastic agent QTL GWAS1289728 (human) | | 0.000003 | response to radiation, hearing loss, response to antineoplastic agent | | 10 | 99409129 | 99409131 | Human |
597480371 | GWAS1576445_H | PR interval QTL GWAS1576445 (human) | | 4e-16 | PR interval | PR interval (CMO:0000233) | 10 | 95605406 | 95605407 | Human |
597382058 | GWAS1478132_H | platelet count QTL GWAS1478132 (human) | | 1e-17 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 95764023 | 95764024 | Human |
597382057 | GWAS1478131_H | platelet count QTL GWAS1478131 (human) | | 5e-13 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 94278929 | 94278930 | Human |
597054372 | GWAS1150446_H | smoking status measurement QTL GWAS1150446 (human) | | 2e-22 | smoking status measurement | | 10 | 103095899 | 103095900 | Human |
597373864 | GWAS1469938_H | prostate carcinoma QTL GWAS1469938 (human) | | 5e-10 | prostate carcinoma | | 10 | 102654464 | 102654465 | Human |
597054371 | GWAS1150445_H | smoking status measurement QTL GWAS1150445 (human) | | 6e-09 | smoking status measurement | | 10 | 101427081 | 101427082 | Human |
597267374 | GWAS1363448_H | pulse pressure measurement QTL GWAS1363448 (human) | | 3e-10 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 94450643 | 94450644 | Human |
597291937 | GWAS1388011_H | body mass index QTL GWAS1388011 (human) | | 6e-19 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98013128 | 98013129 | Human |
407226492 | GWAS875468_H | chronic obstructive pulmonary disease, surfactant protein D measurement QTL GWAS875468 (human) | | 5e-09 | lung integrity trait (VT:0010906) | | 10 | 79945677 | 79945678 | Human |
597291936 | GWAS1388010_H | body mass index QTL GWAS1388010 (human) | | 1e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 86336290 | 86336291 | Human |
597095340 | GWAS1191414_H | FEV/FVC ratio, response to bronchodilator QTL GWAS1191414 (human) | | 0.000003 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 86671535 | 86671536 | Human |
597291939 | GWAS1388013_H | body mass index QTL GWAS1388013 (human) | | 2e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102224303 | 102224304 | Human |
597291938 | GWAS1388012_H | body mass index QTL GWAS1388012 (human) | | 8e-18 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100635683 | 100635684 | Human |
597291940 | GWAS1388014_H | body mass index QTL GWAS1388014 (human) | | 3e-17 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102959339 | 102959340 | Human |
597480354 | GWAS1576428_H | birth weight QTL GWAS1576428 (human) | | 1e-10 | birth weight | neonatal body weight (CMO:0002079) | 10 | 103198487 | 103198488 | Human |
597038038 | GWAS1134112_H | diastolic blood pressure QTL GWAS1134112 (human) | | 0.000005 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103146454 | 103146455 | Human |
597038036 | GWAS1134110_H | diastolic blood pressure QTL GWAS1134110 (human) | | 0.000005 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103086421 | 103086422 | Human |
597038037 | GWAS1134111_H | diastolic blood pressure QTL GWAS1134111 (human) | | 0.000002 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 102712218 | 102712219 | Human |
597038034 | GWAS1134108_H | diastolic blood pressure QTL GWAS1134108 (human) | | 0.000004 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103179458 | 103179459 | Human |
597332957 | GWAS1429031_H | S-6-hydroxywarfarin measurement QTL GWAS1429031 (human) | | 0.0000002 | S-6-hydroxywarfarin measurement | | 10 | 88751379 | 88751380 | Human |
597160912 | GWAS1256986_H | triglyceride measurement QTL GWAS1256986 (human) | | 1e-16 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93023917 | 93023918 | Human |
597136351 | GWAS1232425_H | neuroimaging measurement QTL GWAS1232425 (human) | | 7e-13 | neuroimaging measurement | | 10 | 100564926 | 100564927 | Human |
597521364 | GWAS1617438_H | myocardial infarction QTL GWAS1617438 (human) | | 7e-09 | myocardial infarction | | 10 | 102831636 | 102831637 | Human |
596956123 | GWAS1075642_H | size QTL GWAS1075642 (human) | | 8e-16 | size | | 10 | 77897947 | 77897948 | Human |
597480396 | GWAS1576470_H | Hypermetropia QTL GWAS1576470 (human) | | 0.000004 | Hypermetropia | | 10 | 78925301 | 78925302 | Human |
597480397 | GWAS1576471_H | Hypermetropia QTL GWAS1576471 (human) | | 0.0000007 | Hypermetropia | | 10 | 84244482 | 84244483 | Human |
597586892 | GWAS1643752_H | eosinophil count QTL GWAS1643752 (human) | | 4e-12 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 92669710 | 92669711 | Human |
407218193 | GWAS867169_H | lymphocyte count QTL GWAS867169 (human) | | 4e-15 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 94253193 | 94253194 | Human |
597586891 | GWAS1643751_H | eosinophil count QTL GWAS1643751 (human) | | 1e-12 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 88016317 | 88016318 | Human |
407218192 | GWAS867168_H | lymphocyte count QTL GWAS867168 (human) | | 2e-13 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 92761658 | 92761659 | Human |
407218195 | GWAS867171_H | lymphocyte count QTL GWAS867171 (human) | | 1e-10 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 97324669 | 97324670 | Human |
407218194 | GWAS867170_H | lymphocyte count QTL GWAS867170 (human) | | 6e-13 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 96609998 | 96609999 | Human |
596956099 | GWAS1075618_H | lymphocyte measurement, neutrophil measurement QTL GWAS1075618 (human) | | 8e-14 | lymphocyte measurement, neutrophil measurement | | 10 | 97229697 | 97229698 | Human |
597406657 | GWAS1502731_H | BMI-adjusted waist circumference QTL GWAS1502731 (human) | | 9e-09 | body size trait (VT:0100005) | | 10 | 102660759 | 102660760 | Human |
597210051 | GWAS1306125_H | neuroimaging measurement QTL GWAS1306125 (human) | | 3e-16 | neuroimaging measurement | | 10 | 94253193 | 94253194 | Human |
597406656 | GWAS1502730_H | BMI-adjusted waist circumference QTL GWAS1502730 (human) | | 3e-08 | body size trait (VT:0100005) | | 10 | 102845764 | 102845765 | Human |
597259205 | GWAS1355279_H | aortic measurement QTL GWAS1355279 (human) | | 1e-15 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 94356663 | 94356664 | Human |
597160907 | GWAS1256981_H | monocyte count QTL GWAS1256981 (human) | | 4e-11 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 99518059 | 99518060 | Human |
597087176 | GWAS1183250_H | type 2 diabetes mellitus QTL GWAS1183250 (human) | | 5e-54 | type 2 diabetes mellitus | | 10 | 79187681 | 79187682 | Human |
597259206 | GWAS1355280_H | aortic measurement QTL GWAS1355280 (human) | | 9e-09 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 95814898 | 95814899 | Human |
597234630 | GWAS1330704_H | anxiety measurement QTL GWAS1330704 (human) | | 0.000004 | anxiety measurement | | 10 | 102877751 | 102877752 | Human |
597169145 | GWAS1265219_H | radiation-induced disorder QTL GWAS1265219 (human) | | 0.000007 | radiation-induced disorder | | 10 | 88018209 | 88018210 | Human |
597398522 | GWAS1494596_H | vaginal microbiome measurement QTL GWAS1494596 (human) | | 0.000005 | vaginal microbiome measurement | | 10 | 89401598 | 89401599 | Human |
597455869 | GWAS1551943_H | smoking status measurement QTL GWAS1551943 (human) | | 1e-08 | smoking status measurement | | 10 | 102878235 | 102878236 | Human |
597128179 | GWAS1224253_H | lysophosphatidylcholine measurement QTL GWAS1224253 (human) | | 1e-42 | lysophosphatidylcholine measurement | blood phospholipid level (CMO:0001169) | 10 | 100315722 | 100315723 | Human |
597505016 | GWAS1601090_H | oral microbiome measurement QTL GWAS1601090 (human) | | 0.0000001 | mouth morphology trait (VT:0000452) | | 10 | 78561950 | 78561951 | Human |
597029874 | GWAS1125948_H | BMI-adjusted waist-hip ratio QTL GWAS1125948 (human) | | 2e-15 | body size trait (VT:0100005) | | 10 | 93587048 | 93587049 | Human |
597603316 | GWAS1660176_H | neutrophil count QTL GWAS1660176 (human) | | 5e-25 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 97334679 | 97334680 | Human |
406997033 | GWAS646009_H | mean corpuscular hemoglobin concentration QTL GWAS646009 (human) | | 8e-10 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 102938452 | 102938453 | Human |
597390327 | GWAS1486401_H | appendicular lean mass QTL GWAS1486401 (human) | | 2e-08 | appendicular lean mass | | 10 | 77940313 | 77940314 | Human |
597349366 | GWAS1445440_H | restless legs syndrome QTL GWAS1445440 (human) | | 4e-10 | restless legs syndrome | | 10 | 102126344 | 102126345 | Human |
597349364 | GWAS1445438_H | restless legs syndrome QTL GWAS1445438 (human) | | 6e-08 | restless legs syndrome | | 10 | 92953298 | 92953299 | Human |
597349365 | GWAS1445439_H | restless legs syndrome QTL GWAS1445439 (human) | | 3e-13 | restless legs syndrome | | 10 | 98187757 | 98187758 | Human |
597062630 | GWAS1158704_H | pulse pressure measurement QTL GWAS1158704 (human) | | 9e-12 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 103086421 | 103086422 | Human |
597062629 | GWAS1158703_H | pulse pressure measurement QTL GWAS1158703 (human) | | 6e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 94136183 | 94136184 | Human |
597152736 | GWAS1248810_H | triglyceride measurement, low density lipoprotein cholesterol measurement QTL GWAS1248810 (human) | | 4e-09 | triglyceride measurement, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 98013128 | 98013129 | Human |
597496810 | GWAS1592884_H | phosphoglycerate mutase 1 measurement QTL GWAS1592884 (human) | | 2e-17 | enzyme/coenzyme activity trait (VT:0005584) | | 10 | 100130207 | 100130208 | Human |
597136367 | GWAS1232441_H | 3-hydroxy-2-ethylpropionate measurement QTL GWAS1232441 (human) | | 1e-12 | 3-hydroxy-2-ethylpropionate measurement | | 10 | 95112854 | 95112855 | Human |
597275617 | GWAS1371691_H | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence QTL GWAS1371691 (human) | | 3e-13 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 10 | 102274330 | 102274331 | Human |
597136366 | GWAS1232440_H | 3-hydroxy-2-ethylpropionate measurement QTL GWAS1232440 (human) | | 7e-14 | 3-hydroxy-2-ethylpropionate measurement | | 10 | 95200558 | 95200562 | Human |
597332960 | GWAS1429034_H | S-6-hydroxywarfarin measurement QTL GWAS1429034 (human) | | 0.000001 | S-6-hydroxywarfarin measurement | | 10 | 87716273 | 87716274 | Human |
597275619 | GWAS1371693_H | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence QTL GWAS1371693 (human) | | 2e-09 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 10 | 102322931 | 102322932 | Human |
597332961 | GWAS1429035_H | S-6-hydroxywarfarin measurement QTL GWAS1429035 (human) | | 0.000009 | S-6-hydroxywarfarin measurement | | 10 | 88635563 | 88635564 | Human |
597316577 | GWAS1412651_H | body mass index QTL GWAS1412651 (human) | | 0.000001 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 94259744 | 94259745 | Human |
597275618 | GWAS1371692_H | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence QTL GWAS1371692 (human) | | 2e-08 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 10 | 102312216 | 102312217 | Human |
597136363 | GWAS1232437_H | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement QTL GWAS1232437 (human) | | 5e-18 | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | | 10 | 95064649 | 95064650 | Human |
597275620 | GWAS1371694_H | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence QTL GWAS1371694 (human) | | 1e-10 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 10 | 102364848 | 102364849 | Human |
597578720 | GWAS1635580_H | metabolic disease QTL GWAS1635580 (human) | | 7e-22 | metabolic disease | | 10 | 93079885 | 93079886 | Human |
597062420 | GWAS1158494_H | atrial fibrillation QTL GWAS1158494 (human) | | 0.0000003 | atrial fibrillation | | 10 | 103539854 | 103539855 | Human |
597422872 | GWAS1518946_H | atrial fibrillation QTL GWAS1518946 (human) | | 4e-08 | atrial fibrillation | | 10 | 103578969 | 103578970 | Human |
597054226 | GWAS1150300_H | multiple sclerosis QTL GWAS1150300 (human) | | 0.0000001 | multiple sclerosis | | 10 | 88067364 | 88067365 | Human |
597381919 | GWAS1477993_H | autoimmune disease QTL GWAS1477993 (human) | | 9e-08 | autoimmune disease | | 10 | 99523573 | 99523574 | Human |
597390109 | GWAS1486183_H | body fat distribution QTL GWAS1486183 (human) | | 1e-10 | body fat distribution | body fat morphological measurement (CMO:0000089) | 10 | 94266427 | 94266428 | Human |
597603092 | GWAS1659952_H | drug use measurement, coronary artery disease QTL GWAS1659952 (human) | | 2e-16 | drug use measurement, coronary artery disease | | 10 | 89243170 | 89243171 | Human |
596964120 | GWAS1083639_H | trait in response to escitalopram, trait in response to citalopram, mood disorder, major depressive disorder QTL GWAS1083639 (human) | | 0.000002 | trait in response to escitalopram, trait in response to citalopram, mood disorder, major depressive disorder | | 10 | 103161907 | 103161908 | Human |
597422871 | GWAS1518945_H | atrial fibrillation QTL GWAS1518945 (human) | | 1e-30 | atrial fibrillation | | 10 | 103575399 | 103575400 | Human |
597422870 | GWAS1518944_H | atrial fibrillation QTL GWAS1518944 (human) | | 1e-08 | atrial fibrillation | | 10 | 103538219 | 103538220 | Human |
597390101 | GWAS1486175_H | body fat distribution QTL GWAS1486175 (human) | | 9e-09 | body fat distribution | body fat morphological measurement (CMO:0000089) | 10 | 94266427 | 94266428 | Human |
597422869 | GWAS1518943_H | atrial fibrillation QTL GWAS1518943 (human) | | 2e-08 | atrial fibrillation | | 10 | 102626337 | 102626338 | Human |
597422868 | GWAS1518942_H | atrial fibrillation QTL GWAS1518942 (human) | | 1e-12 | atrial fibrillation | | 10 | 102380845 | 102380846 | Human |
597226248 | GWAS1322322_H | stroke outcome severity measurement QTL GWAS1322322 (human) | | 0.000003 | stroke outcome severity measurement | | 10 | 84732025 | 84732026 | Human |
597070596 | GWAS1166670_H | total cholesterol measurement QTL GWAS1166670 (human) | | 0.000001 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 93079885 | 93079886 | Human |
596964103 | GWAS1083622_H | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder QTL GWAS1083622 (human) | | 1e-08 | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | | 10 | 103146454 | 103146455 | Human |
597463817 | GWAS1559891_H | colorectal cancer, colorectal adenoma QTL GWAS1559891 (human) | | 5e-18 | colorectal cancer, colorectal adenoma | | 10 | 79059375 | 79059376 | Human |
597291791 | GWAS1387865_H | asthma, endometriosis QTL GWAS1387865 (human) | | 2e-09 | asthma, endometriosis | | 10 | 88022133 | 88022134 | Human |
597324556 | GWAS1420630_H | X-12092 measurement QTL GWAS1420630 (human) | | 4e-191 | X-12092 measurement | | 10 | 98388419 | 98388420 | Human |
407128274 | GWAS777250_H | Alzheimer disease QTL GWAS777250 (human) | | 0.000006 | Alzheimer disease | | 10 | 100741814 | 100741815 | Human |
597259022 | GWAS1355096_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1355096 (human) | | 8e-11 | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 98012433 | 98012434 | Human |
597046031 | GWAS1142105_H | omega-6:omega-3 polyunsaturated fatty acid ratio QTL GWAS1142105 (human) | | 0.000004 | milk omega-6 fatty acid amount (VT:0010323) | milk omega-6 to omega-3 fatty acid ratio (CMO:0001392) | 10 | 82013458 | 82013459 | Human |
597431045 | GWAS1527119_H | systolic blood pressure change measurement QTL GWAS1527119 (human) | | 5e-08 | systolic blood pressure change measurement | change in systolic blood pressure (CMO:0000746) | 10 | 90062580 | 90062581 | Human |
597340929 | GWAS1437003_H | sexual dimorphism measurement QTL GWAS1437003 (human) | | 3e-10 | sexual dimorphism measurement | | 10 | 102553638 | 102553639 | Human |
596972299 | GWAS1091818_H | radiation-induced disorder QTL GWAS1091818 (human) | | 0.000006 | radiation-induced disorder | | 10 | 80138357 | 80138358 | Human |
597103368 | GWAS1199442_H | myocardial infarction QTL GWAS1199442 (human) | | 0.0000001 | myocardial infarction | | 10 | 80491758 | 80491759 | Human |
407046364 | GWAS695340_H | Abnormality of refraction QTL GWAS695340 (human) | | 1e-11 | Abnormality of refraction | | 10 | 93164567 | 93164568 | Human |
597414660 | GWAS1510734_H | coronary artery disease QTL GWAS1510734 (human) | | 5e-15 | coronary artery disease | | 10 | 102878723 | 102878724 | Human |
597373755 | GWAS1469829_H | breast carcinoma QTL GWAS1469829 (human) | | 0.000006 | mammary gland integrity trait (VT:0010552) | | 10 | 79295869 | 79295870 | Human |
597177145 | GWAS1273219_H | apolipoprotein L1 measurement QTL GWAS1273219 (human) | | 1e-35 | apolipoprotein L1 measurement | | 10 | 100044357 | 100044358 | Human |
597226303 | GWAS1322377_H | smoking status measurement QTL GWAS1322377 (human) | | 7e-20 | smoking status measurement | | 10 | 102200594 | 102200595 | Human |
597283633 | GWAS1379707_H | hemoglobin A1 measurement QTL GWAS1379707 (human) | | 3e-13 | hemoglobin A1 measurement | | 10 | 77845657 | 77845658 | Human |
597316402 | GWAS1412476_H | body mass index QTL GWAS1412476 (human) | | 0.0000001 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 94259744 | 94259745 | Human |
597365552 | GWAS1461626_H | nicotine dependence symptom count QTL GWAS1461626 (human) | | 0.000002 | nicotine dependence symptom count | | 10 | 101117883 | 101117884 | Human |
597103419 | GWAS1199493_H | aspartate aminotransferase measurement QTL GWAS1199493 (human) | | 1e-12 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99052093 | 99052094 | Human |
597316407 | GWAS1412481_H | body mass index QTL GWAS1412481 (human) | | 1e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 94259744 | 94259745 | Human |
597513010 | GWAS1609084_H | diverticular disease QTL GWAS1609084 (human) | | 0.0000005 | diverticular disease | | 10 | 99583948 | 99583949 | Human |
597611308 | GWAS1668168_H | neutrophil count QTL GWAS1668168 (human) | | 9e-14 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 89243047 | 89243048 | Human |
597611309 | GWAS1668169_H | neutrophil count QTL GWAS1668169 (human) | | 1e-25 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 97334679 | 97334680 | Human |
597496619 | GWAS1592693_H | lean body mass QTL GWAS1592693 (human) | | 2e-13 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 77783982 | 77783983 | Human |
597431078 | GWAS1527152_H | wellbeing measurement QTL GWAS1527152 (human) | | 2e-08 | wellness/fitness trait (VT:1000152) | | 10 | 102856906 | 102856907 | Human |
597390116 | GWAS1486190_H | body fat distribution QTL GWAS1486190 (human) | | 2e-09 | body fat distribution | body fat morphological measurement (CMO:0000089) | 10 | 94266427 | 94266428 | Human |
597283622 | GWAS1379696_H | hemoglobin A1 measurement QTL GWAS1379696 (human) | | 2e-08 | hemoglobin A1 measurement | | 10 | 103057952 | 103057953 | Human |
597054290 | GWAS1150364_H | eosinophil count QTL GWAS1150364 (human) | | 1e-11 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 102556824 | 102556825 | Human |
597144402 | GWAS1240476_H | X-11469 measurement QTL GWAS1240476 (human) | | 4e-14 | X-11469 measurement | | 10 | 95068566 | 95068567 | Human |
597037907 | GWAS1133981_H | body mass index QTL GWAS1133981 (human) | | 9e-22 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98012647 | 98012648 | Human |
597054288 | GWAS1150362_H | eosinophil count QTL GWAS1150362 (human) | | 1e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 92782530 | 92782531 | Human |
597603160 | GWAS1660020_H | type 2 diabetes mellitus QTL GWAS1660020 (human) | | 2e-12 | type 2 diabetes mellitus | | 10 | 103273985 | 103273986 | Human |
597054289 | GWAS1150363_H | eosinophil count QTL GWAS1150363 (human) | | 1e-13 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 97314229 | 97314234 | Human |
597087070 | GWAS1183144_H | type 2 diabetes mellitus QTL GWAS1183144 (human) | | 1e-71 | type 2 diabetes mellitus | | 10 | 92675916 | 92675917 | Human |
597021533 | GWAS1117607_H | multiple system atrophy QTL GWAS1117607 (human) | | 0.000004 | multiple system atrophy | | 10 | 98289722 | 98289723 | Human |
597603158 | GWAS1660018_H | type 2 diabetes mellitus QTL GWAS1660018 (human) | | 1e-12 | type 2 diabetes mellitus | | 10 | 100660841 | 100660842 | Human |
597390163 | GWAS1486237_H | BMI-adjusted waist circumference QTL GWAS1486237 (human) | | 4e-08 | body size trait (VT:0100005) | | 10 | 102819499 | 102819500 | Human |
597463893 | GWAS1559967_H | alcohol drinking, high density lipoprotein cholesterol measurement QTL GWAS1559967 (human) | | 0.000002 | alcohol drinking, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079967 | 93079968 | Human |
597087071 | GWAS1183145_H | type 2 diabetes mellitus QTL GWAS1183145 (human) | | 6e-19 | type 2 diabetes mellitus | | 10 | 93249423 | 93249424 | Human |
597603159 | GWAS1660019_H | type 2 diabetes mellitus QTL GWAS1660019 (human) | | 2e-08 | type 2 diabetes mellitus | | 10 | 101233892 | 101233893 | Human |
597087068 | GWAS1183142_H | type 2 diabetes mellitus QTL GWAS1183142 (human) | | 4e-10 | type 2 diabetes mellitus | | 10 | 87924457 | 87924458 | Human |
597603156 | GWAS1660016_H | type 2 diabetes mellitus QTL GWAS1660016 (human) | | 3e-26 | type 2 diabetes mellitus | | 10 | 97296433 | 97296434 | Human |
597087069 | GWAS1183143_H | type 2 diabetes mellitus QTL GWAS1183143 (human) | | 1e-27 | type 2 diabetes mellitus | | 10 | 91832946 | 91832947 | Human |
597603157 | GWAS1660017_H | type 2 diabetes mellitus QTL GWAS1660017 (human) | | 1e-13 | type 2 diabetes mellitus | | 10 | 100152307 | 100152308 | Human |
597529425 | GWAS1625499_H | vitamin D measurement QTL GWAS1625499 (human) | | 5e-09 | vitamin D measurement | | 10 | 80282868 | 80282869 | Human |
597594962 | GWAS1651822_H | eosinophil count QTL GWAS1651822 (human) | | 5e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 92669710 | 92669711 | Human |
596955992 | GWAS1075511_H | lymphocyte measurement, neutrophil measurement QTL GWAS1075511 (human) | | 2e-10 | lymphocyte count | | 10 | 100315722 | 100315723 | Human |
597087067 | GWAS1183141_H | type 2 diabetes mellitus QTL GWAS1183141 (human) | | 5e-19 | type 2 diabetes mellitus | | 10 | 79191373 | 79191374 | Human |
596988760 | GWAS1108279_H | diastolic blood pressure QTL GWAS1108279 (human) | | 3e-39 | diastolic blood pressure | | 10 | 94279840 | 94279841 | Human |
597439313 | GWAS1535387_H | autism spectrum disorder, schizophrenia QTL GWAS1535387 (human) | | 1e-16 | autism spectrum disorder, schizophrenia | | 10 | 102852578 | 102852579 | Human |
597390165 | GWAS1486239_H | BMI-adjusted waist circumference QTL GWAS1486239 (human) | | 2e-08 | body size trait (VT:0100005) | | 10 | 102845764 | 102845765 | Human |
597128024 | GWAS1224098_H | carotid artery disease QTL GWAS1224098 (human) | | 2e-11 | carotid artery disease | | 10 | 85500575 | 85500576 | Human |
597529426 | GWAS1625500_H | vitamin D measurement QTL GWAS1625500 (human) | | 3e-08 | vitamin D measurement | | 10 | 86321681 | 86321682 | Human |
597390164 | GWAS1486238_H | BMI-adjusted waist circumference QTL GWAS1486238 (human) | | 8e-11 | body size trait (VT:0100005) | | 10 | 102660759 | 102660760 | Human |
597619530 | GWAS1676390_H | Abdominal Aortic Aneurysm QTL GWAS1676390 (human) | | 2e-13 | Abdominal Aortic Aneurysm | | 10 | 94140176 | 94140177 | Human |
406997140 | GWAS646116_H | intelligence QTL GWAS646116 (human) | | 0.000007 | intelligence | | 10 | 87119939 | 87119940 | Human |
597095232 | GWAS1191306_H | schizophrenia QTL GWAS1191306 (human) | | 5e-09 | schizophrenia | | 10 | 102540881 | 102540882 | Human |
597496650 | GWAS1592724_H | hip geometry QTL GWAS1592724 (human) | | 2e-23 | hip geometry | hip circumference (CMO:0000014) | 10 | 102594667 | 102594668 | Human |
597054286 | GWAS1150360_H | eosinophil count QTL GWAS1150360 (human) | | 2e-30 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 87938433 | 87938434 | Human |
597226304 | GWAS1322378_H | smoking status measurement QTL GWAS1322378 (human) | | 2e-12 | smoking status measurement | | 10 | 103092364 | 103092365 | Human |
597054287 | GWAS1150361_H | eosinophil count QTL GWAS1150361 (human) | | 6e-12 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 89089947 | 89089948 | Human |
597054285 | GWAS1150359_H | eosinophil count QTL GWAS1150359 (human) | | 7e-12 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 87921701 | 87921702 | Human |
597373760 | GWAS1469834_H | metabolite measurement QTL GWAS1469834 (human) | | 1e-12 | metabolite measurement | | 10 | 97599982 | 97599983 | Human |
596980555 | GWAS1100074_H | memory performance, sex interaction measurement QTL GWAS1100074 (human) | | 0.000009 | memory performance, sex interaction measurement | | 10 | 78168055 | 78168056 | Human |
596956020 | GWAS1075539_H | lymphocyte measurement, neutrophil measurement QTL GWAS1075539 (human) | | 1e-15 | lymphocyte measurement, neutrophil measurement | | 10 | 79283986 | 79283987 | Human |
597062516 | GWAS1158590_H | Borderline personality disorder QTL GWAS1158590 (human) | | 0.000005 | Borderline personality disorder | | 10 | 80431578 | 80431579 | Human |
597496703 | GWAS1592777_H | insomnia QTL GWAS1592777 (human) | | 3e-09 | insomnia | | 10 | 102459375 | 102459376 | Human |
597185405 | GWAS1281479_H | mitochondrial DNA measurement QTL GWAS1281479 (human) | | 7e-37 | mitochondrial DNA measurement | | 10 | 100992588 | 100992589 | Human |
597439354 | GWAS1535428_H | coronary artery calcification QTL GWAS1535428 (human) | | 0.000007 | coronary artery calcification | | 10 | 90012421 | 90012422 | Human |
597185406 | GWAS1281480_H | mitochondrial DNA measurement QTL GWAS1281480 (human) | | 1e-21 | mitochondrial DNA measurement | | 10 | 102598421 | 102598422 | Human |
596988797 | GWAS1108316_H | monocyte count QTL GWAS1108316 (human) | | 6e-11 | monocyte count | | 10 | 99532633 | 99532634 | Human |
597201776 | GWAS1297850_H | lean body mass QTL GWAS1297850 (human) | | 2e-12 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 102546403 | 102546404 | Human |
407046312 | GWAS695288_H | body mass index QTL GWAS695288 (human) | | 0.000005 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 89058620 | 89058621 | Human |
597586802 | GWAS1643662_H | bipolar disorder, family history QTL GWAS1643662 (human) | | 7e-12 | bipolar disorder, family history | | 10 | 77930341 | 77930342 | Human |
597169012 | GWAS1265086_H | basophil count QTL GWAS1265086 (human) | | 9e-17 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 87896399 | 87896400 | Human |
597128059 | GWAS1224133_H | fatty acid measurement QTL GWAS1224133 (human) | | 5e-11 | glycerophosphocholine amount (VT:0011004) | | 10 | 100315722 | 100315723 | Human |
597054330 | GWAS1150404_H | household income QTL GWAS1150404 (human) | | 1e-08 | household income | | 10 | 101797901 | 101797902 | Human |
597291895 | GWAS1387969_H | Progressive visual loss QTL GWAS1387969 (human) | | 2e-16 | Progressive visual loss | | 10 | 84261142 | 84261143 | Human |
597144423 | GWAS1240497_H | X-12092 measurement QTL GWAS1240497 (human) | | 3e-860 | X-12092 measurement | | 10 | 98399379 | 98399380 | Human |
597144421 | GWAS1240495_H | palmitoleate 16:1n7 measurement QTL GWAS1240495 (human) | | 1e-14 | palmitoleate 16:1n7 measurement | | 10 | 100315722 | 100315723 | Human |
597103460 | GWAS1199534_H | diastolic blood pressure, systolic blood pressure QTL GWAS1199534 (human) | | 0.000008 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 87926752 | 87926753 | Human |
597291884 | GWAS1387958_H | lymphocyte measurement, neutrophil measurement QTL GWAS1387958 (human) | | 1e-15 | lymphocyte measurement, neutrophil measurement | | 10 | 79283986 | 79283987 | Human |
597087072 | GWAS1183146_H | type 2 diabetes mellitus QTL GWAS1183146 (human) | | 9e-11 | type 2 diabetes mellitus | | 10 | 97297164 | 97297165 | Human |
597144416 | GWAS1240490_H | X-11247 measurement QTL GWAS1240490 (human) | | 1e-12 | X-11247 measurement | | 10 | 94906180 | 94906181 | Human |
597480292 | GWAS1576366_H | liver fibrosis measurement QTL GWAS1576366 (human) | | 0.000002 | liver integrity trait (VT:0010547) | liver fibrotic lesion measurement (CMO:0001088) | 10 | 90514725 | 90514726 | Human |
597144431 | GWAS1240505_H | N6-methyllysine measurement QTL GWAS1240505 (human) | | 4e-81 | N6-methyllysine measurement | | 10 | 98392298 | 98392299 | Human |
597226339 | GWAS1322413_H | heel bone mineral density QTL GWAS1322413 (human) | | 3e-32 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 77657143 | 77657144 | Human |
597226340 | GWAS1322414_H | heel bone mineral density QTL GWAS1322414 (human) | | 4e-11 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 80439507 | 80439508 | Human |
597521248 | GWAS1617322_H | triglyceride measurement QTL GWAS1617322 (human) | | 1e-09 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93063586 | 93063587 | Human |
407005372 | GWAS654348_H | platelet count QTL GWAS654348 (human) | | 5e-13 | platelet count | | 10 | 94278929 | 94278930 | Human |
597480291 | GWAS1576365_H | liver fibrosis measurement QTL GWAS1576365 (human) | | 0.000002 | liver integrity trait (VT:0010547) | liver fibrotic lesion measurement (CMO:0001088) | 10 | 90488252 | 90488253 | Human |
407046332 | GWAS695308_H | amino acid measurement QTL GWAS695308 (human) | | 0.000007 | amino acid measurement | | 10 | 97535040 | 97535041 | Human |
597176984 | GWAS1273058_H | complement C1q subcomponent subunit C measurement QTL GWAS1273058 (human) | | 1e-19 | complement C1q subcomponent subunit C measurement | | 10 | 89307681 | 89307682 | Human |
597398175 | GWAS1494249_H | vaginal microbiome measurement QTL GWAS1494249 (human) | | 0.0000009 | vaginal microbiome measurement | | 10 | 89401598 | 89401599 | Human |
597275295 | GWAS1371369_H | testosterone measurement QTL GWAS1371369 (human) | | 2e-08 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 100001413 | 100001414 | Human |
597021330 | GWAS1117404_H | Crohn's disease QTL GWAS1117404 (human) | | 7e-08 | intestine integrity trait (VT:0010554) | | 10 | 80494291 | 80494292 | Human |
2314551 | GLUCO52_H | Glucose level QTL 52 (human) | 1.4 | | Glucose level | | 10 | 77605006 | 103605006 | Human |
597619336 | GWAS1676196_H | tympanic membrane perforation QTL GWAS1676196 (human) | | 9e-13 | tympanic membrane perforation | | 10 | 81372753 | 81372754 | Human |
597054093 | GWAS1150167_H | multiple sclerosis QTL GWAS1150167 (human) | | 2e-23 | multiple sclerosis | | 10 | 79299578 | 79299579 | Human |
597291655 | GWAS1387729_H | size QTL GWAS1387729 (human) | | 4e-22 | size | | 10 | 100900524 | 100900525 | Human |
597455550 | GWAS1551624_H | hypertension QTL GWAS1551624 (human) | | 2e-08 | hypertension | | 10 | 100655852 | 100655853 | Human |
597324473 | GWAS1420547_H | diastolic blood pressure QTL GWAS1420547 (human) | | 2e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 94276939 | 94276940 | Human |
597611194 | GWAS1668054_H | neutrophil count QTL GWAS1668054 (human) | | 6e-17 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 97334679 | 97334680 | Human |
597242557 | GWAS1338631_H | body fat percentage QTL GWAS1338631 (human) | | 9e-19 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 10 | 98013128 | 98013129 | Human |
597602999 | GWAS1659859_H | monocyte count QTL GWAS1659859 (human) | | 5e-13 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 89243047 | 89243048 | Human |
597152445 | GWAS1248519_H | triglyceride measurement, low density lipoprotein cholesterol measurement QTL GWAS1248519 (human) | | 1e-10 | triglyceride measurement, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 91882112 | 91882113 | Human |
597422769 | GWAS1518843_H | systolic blood pressure QTL GWAS1518843 (human) | | 3e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103487319 | 103487320 | Human |
597422768 | GWAS1518842_H | systolic blood pressure QTL GWAS1518842 (human) | | 1e-14 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103248169 | 103248170 | Human |
597209769 | GWAS1305843_H | blood protein measurement QTL GWAS1305843 (human) | | 3e-16 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95750947 | 95750948 | Human |
597185196 | GWAS1281270_H | vascular endothelial function measurement QTL GWAS1281270 (human) | | 0.000005 | vascular endothelial function measurement | | 10 | 97594662 | 97594663 | Human |
406980983 | GWAS629959_H | hemoglobin measurement QTL GWAS629959 (human) | | 2e-09 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 80381581 | 80381582 | Human |
597144226 | GWAS1240300_H | X-02249 measurement QTL GWAS1240300 (human) | | 3e-16 | X-02249 measurement | | 10 | 95028804 | 95028805 | Human |
597594792 | GWAS1651652_H | eosinophil count QTL GWAS1651652 (human) | | 4e-11 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 102148323 | 102148324 | Human |
597291694 | GWAS1387768_H | asthma, endometriosis QTL GWAS1387768 (human) | | 0.000004 | asthma, endometriosis | | 10 | 81666211 | 81666212 | Human |
597619369 | GWAS1676229_H | lagophthalmos QTL GWAS1676229 (human) | | 4e-11 | lagophthalmos | | 10 | 84320073 | 84320074 | Human |
597152430 | GWAS1248504_H | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1248504 (human) | | 1e-12 | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079885 | 93079886 | Human |
406980984 | GWAS629960_H | hemoglobin measurement QTL GWAS629960 (human) | | 6e-12 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 87165772 | 87165773 | Human |
406980985 | GWAS629961_H | hemoglobin measurement QTL GWAS629961 (human) | | 1e-11 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 88536710 | 88536711 | Human |
597234340 | GWAS1330414_H | appendicular lean mass QTL GWAS1330414 (human) | | 2e-14 | appendicular lean mass | | 10 | 103431639 | 103431640 | Human |
597062312 | GWAS1158386_H | BMI-adjusted waist-hip ratio, physical activity measurement QTL GWAS1158386 (human) | | 1e-08 | wellness/fitness trait (VT:1000152) | voluntary body mobility/immobility measurement (CMO:0000954) | 10 | 94133757 | 94133758 | Human |
407144826 | GWAS793802_H | migraine disorder QTL GWAS793802 (human) | | 0.000004 | migraine disorder | | 10 | 98531419 | 98531420 | Human |
597299876 | GWAS1395950_H | serum alanine aminotransferase measurement QTL GWAS1395950 (human) | | 3e-112 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100164661 | 100164662 | Human |
597414564 | GWAS1510638_H | blood protein measurement QTL GWAS1510638 (human) | | 0.0000001 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 93597029 | 93597030 | Human |
597349029 | GWAS1445103_H | body mass index QTL GWAS1445103 (human) | | 7e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98257696 | 98257697 | Human |
407144827 | GWAS793803_H | migraine disorder QTL GWAS793803 (human) | | 0.0000004 | migraine disorder | | 10 | 102988961 | 102988962 | Human |
596964052 | GWAS1083571_H | platelet crit QTL GWAS1083571 (human) | | 2e-22 | platelet crit | | 10 | 94278929 | 94278930 | Human |
406923523 | GWAS572499_H | apolipoprotein B measurement QTL GWAS572499 (human) | | 1e-08 | apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 10 | 93292264 | 93292265 | Human |
597258971 | GWAS1355045_H | aortic measurement QTL GWAS1355045 (human) | | 3e-10 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 94133031 | 94133032 | Human |
597291738 | GWAS1387812_H | size QTL GWAS1387812 (human) | | 1e-21 | size | | 10 | 79355057 | 79355058 | Human |
597258970 | GWAS1355044_H | aortic measurement QTL GWAS1355044 (human) | | 2e-09 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 93985644 | 93985645 | Human |
597619418 | GWAS1676278_H | Abdominal Aortic Aneurysm QTL GWAS1676278 (human) | | 3e-11 | Abdominal Aortic Aneurysm | | 10 | 89243170 | 89243171 | Human |
597258973 | GWAS1355047_H | aortic measurement QTL GWAS1355047 (human) | | 4e-17 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 94356663 | 94356664 | Human |
597258972 | GWAS1355046_H | aortic measurement QTL GWAS1355046 (human) | | 9e-09 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 94255912 | 94255913 | Human |
597086931 | GWAS1183005_H | allergic disease, age at onset QTL GWAS1183005 (human) | | 8e-15 | allergic disease, age at onset | | 10 | 102525837 | 102525838 | Human |
597258974 | GWAS1355048_H | aortic measurement QTL GWAS1355048 (human) | | 2e-10 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 95814898 | 95814899 | Human |
596955868 | GWAS1075387_H | lymphocyte measurement, neutrophil measurement QTL GWAS1075387 (human) | | 5e-12 | lymphocyte measurement, neutrophil measurement | | 10 | 92759940 | 92759941 | Human |
597324497 | GWAS1420571_H | 1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) measurement QTL GWAS1420571 (human) | | 4e-50 | glycerophosphocholine amount (VT:0011004) | | 10 | 100315722 | 100315723 | Human |
597406423 | GWAS1502497_H | dry eye syndrome QTL GWAS1502497 (human) | | 0.000004 | dry eye syndrome | | 10 | 98041174 | 98041175 | Human |
597365460 | GWAS1461534_H | low density lipoprotein cholesterol measurement, alcohol drinking QTL GWAS1461534 (human) | | 5e-08 | low density lipoprotein cholesterol measurement, alcohol drinking | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 93079967 | 93079968 | Human |
597185239 | GWAS1281313_H | mitochondrial DNA measurement QTL GWAS1281313 (human) | | 6e-09 | mitochondrial DNA measurement | | 10 | 100853859 | 100853860 | Human |
597332680 | GWAS1428754_H | atrial fibrillation QTL GWAS1428754 (human) | | 3e-141 | atrial fibrillation | | 10 | 103574950 | 103574951 | Human |
597463752 | GWAS1559826_H | sodium measurement QTL GWAS1559826 (human) | | 6e-15 | sodium measurement | blood sodium level (CMO:0000499) | 10 | 102825368 | 102825369 | Human |
597144256 | GWAS1240330_H | X-11787 measurement QTL GWAS1240330 (human) | | 9e-65 | X-11787 measurement | | 10 | 94974919 | 94974920 | Human |
406948120 | GWAS597096_H | PR interval QTL GWAS597096 (human) | | 4e-11 | PR interval | PR interval (CMO:0000233) | 10 | 79139212 | 79139213 | Human |
597267143 | GWAS1363217_H | pulse pressure measurement QTL GWAS1363217 (human) | | 1e-11 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 94279840 | 94279841 | Human |
597160695 | GWAS1256769_H | factor VIII measurement, coronary artery disease QTL GWAS1256769 (human) | | 9e-10 | factor VIII measurement, coronary artery disease | | 10 | 80482174 | 80482175 | Human |
597308155 | GWAS1404229_H | metabolite measurement QTL GWAS1404229 (human) | | 3e-13 | metabolite measurement | | 10 | 99872116 | 99872117 | Human |
597308153 | GWAS1404227_H | metabolite measurement QTL GWAS1404227 (human) | | 3e-23 | metabolite measurement | | 10 | 94909603 | 94909604 | Human |
597316348 | GWAS1412422_H | X-21258 measurement QTL GWAS1412422 (human) | | 2e-26 | X-21258 measurement | | 10 | 94931264 | 94931265 | Human |
407152942 | GWAS801918_H | birth weight QTL GWAS801918 (human) | | 3e-15 | birth weight | neonatal body weight (CMO:0002079) | 10 | 92710223 | 92710224 | Human |
597275379 | GWAS1371453_H | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence QTL GWAS1371453 (human) | | 6e-09 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 10 | 101797338 | 101797339 | Human |
597275378 | GWAS1371452_H | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence QTL GWAS1371452 (human) | | 5e-09 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 10 | 100164661 | 100164662 | Human |
596964095 | GWAS1083614_H | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder QTL GWAS1083614 (human) | | 2e-09 | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | | 10 | 103016151 | 103016152 | Human |
597168887 | GWAS1264961_H | high density lipoprotein cholesterol measurement QTL GWAS1264961 (human) | | 9e-11 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93027199 | 93027200 | Human |
597160696 | GWAS1256770_H | factor VIII measurement, coronary artery disease QTL GWAS1256770 (human) | | 1e-09 | factor XI measurement, coronary artery disease | | 10 | 103009635 | 103009636 | Human |
597308138 | GWAS1404212_H | Alzheimer's disease biomarker measurement QTL GWAS1404212 (human) | | 4e-08 | Alzheimer's disease biomarker measurement | | 10 | 82863970 | 82863971 | Human |
597242601 | GWAS1338675_H | small vessel stroke QTL GWAS1338675 (human) | | 0.00001 | small vessel stroke | | 10 | 88829111 | 88829112 | Human |
597291753 | GWAS1387827_H | size QTL GWAS1387827 (human) | | 8e-09 | size | | 10 | 93965871 | 93965872 | Human |
597439215 | GWAS1535289_H | peripheral arterial disease, traffic air pollution measurement QTL GWAS1535289 (human) | | 0.000009 | peripheral arterial disease, traffic air pollution measurement | | 10 | 86985503 | 86985504 | Human |
597095151 | GWAS1191225_H | schizophrenia QTL GWAS1191225 (human) | | 0.000001 | schizophrenia | | 10 | 103559284 | 103559285 | Human |
597619429 | GWAS1676289_H | aneurysm QTL GWAS1676289 (human) | | 3e-14 | aneurysm | | 10 | 94133295 | 94133296 | Human |
597062381 | GWAS1158455_H | smoking behavior, BMI-adjusted waist circumference QTL GWAS1158455 (human) | | 0.000001 | body size trait (VT:0100005) | | 10 | 102567827 | 102567828 | Human |
596988651 | GWAS1108170_H | HbA1c measurement QTL GWAS1108170 (human) | | 4e-11 | HbA1c measurement | | 10 | 92704550 | 92704551 | Human |
597291544 | GWAS1387618_H | size QTL GWAS1387618 (human) | | 3e-19 | size | | 10 | 91255322 | 91255323 | Human |
406890946 | GWAS539922_H | neutrophil percentage of leukocytes QTL GWAS539922 (human) | | 2e-09 | neutrophil quantity (VT:0000222) | blood neutrophil count to total leukocyte count ratio (CMO:0000370) | 10 | 79285450 | 79285451 | Human |
406890947 | GWAS539923_H | neutrophil percentage of leukocytes QTL GWAS539923 (human) | | 5e-10 | neutrophil quantity (VT:0000222) | blood neutrophil count to total leukocyte count ratio (CMO:0000370) | 10 | 97209210 | 97209211 | Human |
596955678 | GWAS1075197_H | Progressive visual loss QTL GWAS1075197 (human) | | 2e-16 | Progressive visual loss | | 10 | 84261142 | 84261143 | Human |
597348885 | GWAS1444959_H | BMI-adjusted waist-hip ratio QTL GWAS1444959 (human) | | 6e-09 | body size trait (VT:0100005) | | 10 | 102727686 | 102727687 | Human |
597594638 | GWAS1651498_H | glucose measurement QTL GWAS1651498 (human) | | 2e-69 | glucose measurement | blood glucose level (CMO:0000046) | 10 | 92700524 | 92700525 | Human |
597455373 | GWAS1551447_H | serum gamma-glutamyl transferase measurement QTL GWAS1551447 (human) | | 1e-31 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079967 | 93079968 | Human |
597463565 | GWAS1559639_H | pulse pressure measurement, alcohol drinking QTL GWAS1559639 (human) | | 4e-23 | pulse pressure measurement, alcohol drinking | pulse pressure (CMO:0000292) | 10 | 102899261 | 102899262 | Human |
597455374 | GWAS1551448_H | serum gamma-glutamyl transferase measurement QTL GWAS1551448 (human) | | 1e-13 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 94311804 | 94311805 | Human |
597455375 | GWAS1551449_H | serum gamma-glutamyl transferase measurement QTL GWAS1551449 (human) | | 5e-13 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 96700824 | 96700825 | Human |
597324303 | GWAS1420377_H | systolic blood pressure QTL GWAS1420377 (human) | | 2e-15 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94276939 | 94276940 | Human |
597094913 | GWAS1190987_H | mean arterial pressure QTL GWAS1190987 (human) | | 0.000002 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 103179458 | 103179459 | Human |
597324290 | GWAS1420364_H | diastolic blood pressure QTL GWAS1420364 (human) | | 7e-14 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 102720118 | 102720119 | Human |
597021196 | GWAS1117270_H | Crohn's disease QTL GWAS1117270 (human) | | 9e-15 | intestine integrity trait (VT:0010554) | | 10 | 79300560 | 79300561 | Human |
597086733 | GWAS1182807_H | Self-injurious behavior QTL GWAS1182807 (human) | | 0.000003 | Self-injurious behavior | | 10 | 84603883 | 84603884 | Human |
597242373 | GWAS1338447_H | aspartate aminotransferase measurement QTL GWAS1338447 (human) | | 1e-09 | neuroimaging measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 94279840 | 94279841 | Human |
597054006 | GWAS1150080_H | household income QTL GWAS1150080 (human) | | 2e-14 | household income | | 10 | 101742008 | 101742009 | Human |
407226855 | GWAS875831_H | asthma, response to diisocyanate QTL GWAS875831 (human) | | 0.000001 | asthma, response to diisocyanate | | 10 | 103597080 | 103597081 | Human |
597594681 | GWAS1651541_H | glucose measurement QTL GWAS1651541 (human) | | 2e-14 | glucose measurement | blood glucose level (CMO:0000046) | 10 | 100152437 | 100152438 | Human |
596988477 | GWAS1107996_H | functional brain measurement QTL GWAS1107996 (human) | | 1e-08 | functional brain measurement | | 10 | 94279840 | 94279841 | Human |
597619253 | GWAS1676113_H | aortic aneurysm QTL GWAS1676113 (human) | | 5e-16 | aortic aneurysm | | 10 | 94133295 | 94133296 | Human |
596963903 | GWAS1083422_H | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder QTL GWAS1083422 (human) | | 1e-08 | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | | 10 | 102900247 | 102900248 | Human |
597119545 | GWAS1215619_H | blood protein measurement QTL GWAS1215619 (human) | | 4e-36 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 102689687 | 102689688 | Human |
407398887 | GWAS1047863_H | pulse pressure measurement QTL GWAS1047863 (human) | | 6e-11 | pulse pressure measurement | | 10 | 87844975 | 87844976 | Human |
597242422 | GWAS1338496_H | triglyceride measurement QTL GWAS1338496 (human) | | 4e-10 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93012138 | 93012139 | Human |
597185064 | GWAS1281138_H | metabolite measurement QTL GWAS1281138 (human) | | 4e-12 | blood triglyceride amount (VT:0002644) | | 10 | 100315722 | 100315723 | Human |
597291561 | GWAS1387635_H | hypertension QTL GWAS1387635 (human) | | 6e-14 | hypertension | | 10 | 103138144 | 103138145 | Human |
407128567 | GWAS777543_H | type 2 diabetes mellitus QTL GWAS777543 (human) | | 7e-12 | type 2 diabetes mellitus | | 10 | 92703125 | 92703126 | Human |
597463592 | GWAS1559666_H | schizophrenia QTL GWAS1559666 (human) | | 2e-18 | schizophrenia | | 10 | 102880295 | 102880296 | Human |
597185069 | GWAS1281143_H | X-24736 measurement QTL GWAS1281143 (human) | | 3e-13 | X-24736 measurement | | 10 | 98400642 | 98400643 | Human |
407161330 | GWAS810306_H | FEV/FVC ratio, response to bronchodilator QTL GWAS810306 (human) | | 0.0000008 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 86435202 | 86435203 | Human |
596963874 | GWAS1083393_H | monocyte count QTL GWAS1083393 (human) | | 4e-16 | monocyte count | | 10 | 94279840 | 94279841 | Human |
597275183 | GWAS1371257_H | systolic blood pressure, major depressive disorder QTL GWAS1371257 (human) | | 6e-09 | systolic blood pressure, major depressive disorder | systolic blood pressure (CMO:0000004) | 10 | 103051446 | 103051447 | Human |
406890999 | GWAS539975_H | gout QTL GWAS539975 (human) | | 0.0000001 | gout | | 10 | 95042841 | 95042842 | Human |
597439019 | GWAS1535093_H | lung carcinoma QTL GWAS1535093 (human) | | 0.0000006 | lung carcinoma | | 10 | 100912491 | 100912492 | Human |
597275182 | GWAS1371256_H | systolic blood pressure, major depressive disorder QTL GWAS1371256 (human) | | 8e-10 | systolic blood pressure, major depressive disorder | systolic blood pressure (CMO:0000004) | 10 | 102937759 | 102937760 | Human |
597340706 | GWAS1436780_H | neuroticism measurement, cognitive function measurement QTL GWAS1436780 (human) | | 1e-21 | cognitive behavior trait (VT:0010450) | | 10 | 101795854 | 101795855 | Human |
597496357 | GWAS1592431_H | systolic blood pressure QTL GWAS1592431 (human) | | 2e-16 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 102831636 | 102831637 | Human |
597160493 | GWAS1256567_H | lipid measurement QTL GWAS1256567 (human) | | 0.000005 | lipid measurement | blood lipid measurement (CMO:0000050) | 10 | 91846926 | 91846927 | Human |
597373477 | GWAS1469551_H | gastric carcinoma QTL GWAS1469551 (human) | | 4e-09 | stomach integrity trait (VT:0010603) | | 10 | 94310618 | 94310619 | Human |
597594719 | GWAS1651579_H | glucose measurement QTL GWAS1651579 (human) | | 2e-12 | glucose measurement | blood glucose level (CMO:0000046) | 10 | 100164661 | 100164662 | Human |
597291611 | GWAS1387685_H | size QTL GWAS1387685 (human) | | 7e-10 | size | | 10 | 93186366 | 93186367 | Human |
407079297 | GWAS728273_H | gut microbiome measurement QTL GWAS728273 (human) | | 0.000005 | gut microbiome measurement | | 10 | 95168945 | 95168946 | Human |
597037652 | GWAS1133726_H | pulse pressure measurement QTL GWAS1133726 (human) | | 7e-12 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 102794772 | 102794773 | Human |
597242461 | GWAS1338535_H | retinal vasculature measurement QTL GWAS1338535 (human) | | 0.000009 | retina blood vessel morphology trait (VT:0002792) | | 10 | 93376856 | 93376857 | Human |
597176926 | GWAS1273000_H | ADP-ribosylation factor-like protein 3 measurement QTL GWAS1273000 (human) | | 9e-75 | ADP-ribosylation factor-like protein 3 measurement | | 10 | 102714289 | 102714290 | Human |
597176927 | GWAS1273001_H | ADP-ribosylation factor-like protein 3 measurement QTL GWAS1273001 (human) | | 1e-57 | ADP-ribosylation factor-like protein 3 measurement | | 10 | 102689687 | 102689688 | Human |
597430864 | GWAS1526938_H | squamous cell lung carcinoma QTL GWAS1526938 (human) | | 6e-11 | squamous cell lung carcinoma | | 10 | 100231378 | 100231379 | Human |
596963904 | GWAS1083423_H | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder QTL GWAS1083423 (human) | | 0.000007 | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | | 10 | 103538013 | 103538014 | Human |
596955726 | GWAS1075245_H | intraocular pressure measurement QTL GWAS1075245 (human) | | 8e-21 | intraocular pressure measurement | | 10 | 93285032 | 93285033 | Human |
597135944 | GWAS1232018_H | protein-glutamine gamma-glutamyltransferase e measurement QTL GWAS1232018 (human) | | 9e-26 | enzyme/coenzyme activity trait (VT:0005584) | | 10 | 77923160 | 77923161 | Human |
597348933 | GWAS1445007_H | body mass index QTL GWAS1445007 (human) | | 2e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 103129109 | 103129110 | Human |
597086838 | GWAS1182912_H | lymphocyte count QTL GWAS1182912 (human) | | 1e-12 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 92755446 | 92755447 | Human |
597086836 | GWAS1182910_H | lymphocyte count QTL GWAS1182910 (human) | | 4e-11 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 79283986 | 79283987 | Human |
597168762 | GWAS1264836_H | age of onset of type 1 diabetes mellitus QTL GWAS1264836 (human) | | 0.0000001 | age of onset of type 1 diabetes mellitus | | 10 | 88287593 | 88287594 | Human |
597209722 | GWAS1305796_H | body mass index, coronary artery disease QTL GWAS1305796 (human) | | 9e-16 | body mass index, coronary artery disease | body mass index (BMI) (CMO:0000105) | 10 | 103111522 | 103111523 | Human |
597086837 | GWAS1182911_H | lymphocyte count QTL GWAS1182911 (human) | | 4e-11 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 80520381 | 80520382 | Human |
597037682 | GWAS1133756_H | pulse pressure measurement QTL GWAS1133756 (human) | | 0.0000002 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 102712218 | 102712219 | Human |
597406321 | GWAS1502395_H | type 2 diabetes mellitus QTL GWAS1502395 (human) | | 1e-10 | type 2 diabetes mellitus | | 10 | 88006611 | 88006612 | Human |
597496439 | GWAS1592513_H | 3-hydroxyanthranilate 3,4-dioxygenase measurement QTL GWAS1592513 (human) | | 1e-94 | 3-hydroxyanthranilate 3,4-dioxygenase measurement | | 10 | 100130207 | 100130208 | Human |
597086844 | GWAS1182918_H | lymphocyte count QTL GWAS1182918 (human) | | 4e-14 | glycerophosphocholine amount (VT:0011004) | blood lymphocyte count (CMO:0000031) | 10 | 100315722 | 100315723 | Human |
597496438 | GWAS1592512_H | 3-hydroxyanthranilate 3,4-dioxygenase measurement QTL GWAS1592512 (human) | | 2e-95 | 3-hydroxyanthranilate 3,4-dioxygenase measurement | | 10 | 100039545 | 100039546 | Human |
597086845 | GWAS1182919_H | lymphocyte count QTL GWAS1182919 (human) | | 9e-10 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 102301461 | 102301462 | Human |
407071151 | GWAS720127_H | serum gamma-glutamyl transferase measurement QTL GWAS720127 (human) | | 0.000001 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 85123642 | 85123643 | Human |
597086843 | GWAS1182917_H | lymphocyte count QTL GWAS1182917 (human) | | 2e-12 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 97324669 | 97324670 | Human |
597086840 | GWAS1182914_H | lymphocyte count QTL GWAS1182914 (human) | | 3e-12 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 94914437 | 94914438 | Human |
597086841 | GWAS1182915_H | lymphocyte count QTL GWAS1182915 (human) | | 4e-11 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 96609998 | 96609999 | Human |
597316202 | GWAS1412276_H | body mass index QTL GWAS1412276 (human) | | 0.000004 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 94259744 | 94259745 | Human |
406931891 | GWAS580867_H | pulse pressure measurement QTL GWAS580867 (human) | | 7e-29 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 100771850 | 100771851 | Human |
597430895 | GWAS1526969_H | rheumatoid arthritis, ulcerative colitis QTL GWAS1526969 (human) | | 3e-10 | rheumatoid arthritis, ulcerative colitis | | 10 | 99530544 | 99530545 | Human |
597430889 | GWAS1526963_H | autism spectrum disorder, schizophrenia QTL GWAS1526963 (human) | | 3e-12 | autism spectrum disorder, schizophrenia | | 10 | 102875346 | 102875347 | Human |
596972128 | GWAS1091647_H | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa, major depressive disorder QTL GWAS1091647 (human) | | 3e-14 | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa, major depressive disorder | | 10 | 103111522 | 103111523 | Human |
597439082 | GWAS1535156_H | grip strength measurement QTL GWAS1535156 (human) | | 1e-09 | grip strength measurement | | 10 | 102367414 | 102367415 | Human |
597111392 | GWAS1207466_H | pulse pressure measurement QTL GWAS1207466 (human) | | 3e-13 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 101943006 | 101943007 | Human |
597193313 | GWAS1289387_H | executive function measurement QTL GWAS1289387 (human) | | 0.0000008 | executive function measurement | | 10 | 83812741 | 83812742 | Human |
406981048 | GWAS630024_H | hemoglobin measurement QTL GWAS630024 (human) | | 3e-10 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 95240116 | 95240117 | Human |
597594722 | GWAS1651582_H | glucose measurement QTL GWAS1651582 (human) | | 2e-62 | glucose measurement | blood glucose level (CMO:0000046) | 10 | 92700524 | 92700525 | Human |
597602914 | GWAS1659774_H | monocyte count QTL GWAS1659774 (human) | | 8e-27 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 97353972 | 97353973 | Human |
597168536 | GWAS1264610_H | alkaline phosphatase measurement QTL GWAS1264610 (human) | | 2e-58 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 102232661 | 102232662 | Human |
597365146 | GWAS1461220_H | blood protein measurement QTL GWAS1461220 (human) | | 2e-37 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 79955982 | 79955983 | Human |
597496220 | GWAS1592294_H | memory performance, sex interaction measurement QTL GWAS1592294 (human) | | 0.000001 | memory performance, sex interaction measurement | | 10 | 87641149 | 87641150 | Human |
597143957 | GWAS1240031_H | citrulline measurement QTL GWAS1240031 (human) | | 8e-11 | citrulline measurement | blood amino acid measurement (CMO:0003730) | 10 | 95636205 | 95636206 | Human |
597619100 | GWAS1675960_H | body weight QTL GWAS1675960 (human) | | 7e-24 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 102897491 | 102897492 | Human |
596963735 | GWAS1083254_H | urinary albumin to creatinine ratio QTL GWAS1083254 (human) | | 5e-10 | urinary albumin to creatinine ratio | | 10 | 93079885 | 93079886 | Human |
597479832 | GWAS1575906_H | mean corpuscular hemoglobin QTL GWAS1575906 (human) | | 2e-10 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 88060413 | 88060414 | Human |
597193116 | GWAS1289190_H | testosterone measurement QTL GWAS1289190 (human) | | 2e-08 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 91885784 | 91885785 | Human |
597619099 | GWAS1675959_H | body weight QTL GWAS1675959 (human) | | 3e-11 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 85868436 | 85868437 | Human |
597102994 | GWAS1199068_H | platelet crit QTL GWAS1199068 (human) | | 8e-26 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 10 | 93079885 | 93079886 | Human |
597102993 | GWAS1199067_H | platelet crit QTL GWAS1199067 (human) | | 6e-10 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 10 | 89611572 | 89611573 | Human |
597102992 | GWAS1199066_H | platelet crit QTL GWAS1199066 (human) | | 3e-09 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 10 | 87926409 | 87926410 | Human |
597365138 | GWAS1461212_H | adolescent idiopathic scoliosis QTL GWAS1461212 (human) | | 0.0000006 | adolescent idiopathic scoliosis | | 10 | 78383945 | 78383946 | Human |
597479831 | GWAS1575905_H | mean corpuscular hemoglobin QTL GWAS1575905 (human) | | 1e-08 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 79028089 | 79028090 | Human |
597143961 | GWAS1240035_H | X-12093 measurement QTL GWAS1240035 (human) | | 1e-48 | X-12093 measurement | | 10 | 98399379 | 98399380 | Human |
596955525 | GWAS1075044_H | physical activity measurement QTL GWAS1075044 (human) | | 1e-10 | physical activity measurement | | 10 | 102120361 | 102120362 | Human |
597021062 | GWAS1117136_H | inflammatory bowel disease QTL GWAS1117136 (human) | | 4e-12 | inflammatory bowel disease | | 10 | 79300560 | 79300561 | Human |
597119363 | GWAS1215437_H | blood protein measurement QTL GWAS1215437 (human) | | 6e-74 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 88672181 | 88672182 | Human |
597143939 | GWAS1240013_H | serum alanine aminotransferase measurement QTL GWAS1240013 (human) | | 4e-10 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 99798989 | 99798990 | Human |
597143938 | GWAS1240012_H | serum alanine aminotransferase measurement QTL GWAS1240012 (human) | | 4e-09 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 94263320 | 94263321 | Human |
597143937 | GWAS1240011_H | serum alanine aminotransferase measurement QTL GWAS1240011 (human) | | 4e-13 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 77911845 | 77911846 | Human |
406899287 | GWAS548263_H | chronic kidney disease, diabetic nephropathy QTL GWAS548263 (human) | | 0.000007 | kidney integrity trait (VT:0010580) | | 10 | 81531934 | 81531935 | Human |
597102991 | GWAS1199065_H | platelet crit QTL GWAS1199065 (human) | | 3e-16 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 10 | 79404390 | 79404391 | Human |
596955532 | GWAS1075051_H | schizophrenia QTL GWAS1075051 (human) | | 2e-18 | schizophrenia | | 10 | 102880295 | 102880296 | Human |
597414274 | GWAS1510348_H | idiopathic pulmonary fibrosis QTL GWAS1510348 (human) | | 0.0000006 | idiopathic pulmonary fibrosis | | 10 | 91511259 | 91511260 | Human |
597143950 | GWAS1240024_H | stearate 18:0 measurement QTL GWAS1240024 (human) | | 6e-21 | stearate 18:0 measurement | | 10 | 100315722 | 100315723 | Human |
597479814 | GWAS1575888_H | monocyte count QTL GWAS1575888 (human) | | 8e-14 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 88118577 | 88118578 | Human |
597619073 | GWAS1675933_H | atrial flutter QTL GWAS1675933 (human) | | 7e-19 | atrial flutter | | 10 | 103578237 | 103578238 | Human |
597119415 | GWAS1215489_H | cognitive function measurement, self reported educational attainment QTL GWAS1215489 (human) | | 4e-10 | cognitive behavior trait (VT:0010450) | | 10 | 102057071 | 102057072 | Human |
597119414 | GWAS1215488_H | cognitive function measurement, self reported educational attainment QTL GWAS1215488 (human) | | 3e-17 | cognitive behavior trait (VT:0010450) | | 10 | 101806203 | 101806204 | Human |
597119413 | GWAS1215487_H | cognitive function measurement, self reported educational attainment QTL GWAS1215487 (human) | | 2e-08 | cognitive behavior trait (VT:0010450) | | 10 | 91960387 | 91960388 | Human |
597209530 | GWAS1305604_H | lymphocyte count QTL GWAS1305604 (human) | | 2e-258 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95810241 | 95810242 | Human |
407071328 | GWAS720304_H | BMI-adjusted waist-hip ratio QTL GWAS720304 (human) | | 3e-24 | body size trait (VT:0100005) | | 10 | 79147390 | 79147391 | Human |
597430712 | GWAS1526786_H | neuroticism measurement QTL GWAS1526786 (human) | | 2e-08 | neuroticism measurement | | 10 | 103199431 | 103199432 | Human |
597021104 | GWAS1117178_H | inflammatory bowel disease QTL GWAS1117178 (human) | | 0.0000005 | inflammatory bowel disease | | 10 | 92677094 | 92677095 | Human |
597143985 | GWAS1240059_H | N6-methyllysine measurement QTL GWAS1240059 (human) | | 3e-300 | N6-methyllysine measurement | | 10 | 98384252 | 98384254 | Human |
597135807 | GWAS1231881_H | diastolic blood pressure QTL GWAS1231881 (human) | | 2e-24 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 94136183 | 94136184 | Human |
597242289 | GWAS1338363_H | serum metabolite measurement QTL GWAS1338363 (human) | | 6e-12 | serum metabolite measurement | | 10 | 99851537 | 99851538 | Human |
597135806 | GWAS1231880_H | diastolic blood pressure QTL GWAS1231880 (human) | | 2e-08 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 89357033 | 89357034 | Human |
596955582 | GWAS1075101_H | diabetes mellitus QTL GWAS1075101 (human) | | 6e-09 | diabetes mellitus | | 10 | 79195032 | 79195033 | Human |
597135805 | GWAS1231879_H | diastolic blood pressure QTL GWAS1231879 (human) | | 0.000001 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 87921931 | 87921932 | Human |
597430711 | GWAS1526785_H | neuroticism measurement QTL GWAS1526785 (human) | | 1e-08 | systolic blood pressure, major depressive disorder | systolic blood pressure (CMO:0000004) | 10 | 102834750 | 102834751 | Human |
597176756 | GWAS1272830_H | obstructive sleep apnea QTL GWAS1272830 (human) | | 2e-08 | obstructive sleep apnea | | 10 | 103076162 | 103076163 | Human |
597389739 | GWAS1485813_H | glucagon measurement QTL GWAS1485813 (human) | | 0.000002 | blood glucagon amount (VT:0002695) | blood glucagon level (CMO:0001294) | 10 | 86931800 | 86931801 | Human |
597103011 | GWAS1199085_H | myocardial infarction QTL GWAS1199085 (human) | | 2e-09 | myocardial infarction | | 10 | 89243170 | 89243171 | Human |
597037474 | GWAS1133548_H | body mass index QTL GWAS1133548 (human) | | 1e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102875591 | 102875592 | Human |
597062051 | GWAS1158125_H | squamous cell lung carcinoma QTL GWAS1158125 (human) | | 0.000001 | squamous cell lung carcinoma | | 10 | 100289222 | 100289223 | Human |
597242286 | GWAS1338360_H | serum metabolite measurement QTL GWAS1338360 (human) | | 3e-12 | serum metabolite measurement | | 10 | 98388301 | 98388302 | Human |
597463467 | GWAS1559541_H | aspartate aminotransferase measurement QTL GWAS1559541 (human) | | 2e-09 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99761184 | 99761185 | Human |
597209565 | GWAS1305639_H | systolic blood pressure, body mass index QTL GWAS1305639 (human) | | 3e-24 | systolic blood pressure, body mass index | body mass index (BMI) (CMO:0000105) | 10 | 103111522 | 103111523 | Human |
597422557 | GWAS1518631_H | atrial fibrillation QTL GWAS1518631 (human) | | 8e-09 | atrial fibrillation | | 10 | 101899844 | 101899845 | Human |
407153160 | GWAS802136_H | gut microbiome measurement QTL GWAS802136 (human) | | 0.000005 | gut microbiome measurement | | 10 | 98590050 | 98590051 | Human |
597135815 | GWAS1231889_H | diastolic blood pressure QTL GWAS1231889 (human) | | 2e-55 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103146454 | 103146455 | Human |
597135814 | GWAS1231888_H | diastolic blood pressure QTL GWAS1231888 (human) | | 8e-09 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 102535625 | 102535626 | Human |
597160389 | GWAS1256463_H | lipid measurement QTL GWAS1256463 (human) | | 0.000005 | lipid measurement | blood lipid measurement (CMO:0000050) | 10 | 97864909 | 97864910 | Human |
597135813 | GWAS1231887_H | diastolic blood pressure QTL GWAS1231887 (human) | | 3e-09 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 101355588 | 101355589 | Human |
597135812 | GWAS1231886_H | diastolic blood pressure QTL GWAS1231886 (human) | | 5e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 100882640 | 100882641 | Human |
596955584 | GWAS1075103_H | size QTL GWAS1075103 (human) | | 3e-19 | size | | 10 | 91255322 | 91255323 | Human |
597135811 | GWAS1231885_H | diastolic blood pressure QTL GWAS1231885 (human) | | 3e-36 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 100792906 | 100792907 | Human |
597135810 | GWAS1231884_H | diastolic blood pressure QTL GWAS1231884 (human) | | 0.000001 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 98257696 | 98257697 | Human |
597594568 | GWAS1651428_H | hypertension QTL GWAS1651428 (human) | | 2e-14 | hypertension | | 10 | 94278929 | 94278930 | Human |
597135809 | GWAS1231883_H | diastolic blood pressure QTL GWAS1231883 (human) | | 0.000004 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 95560648 | 95560649 | Human |
597160384 | GWAS1256458_H | caffeine measurement QTL GWAS1256458 (human) | | 0.000006 | caffeine measurement | | 10 | 84127298 | 84127299 | Human |
597135808 | GWAS1231882_H | diastolic blood pressure QTL GWAS1231882 (human) | | 2e-62 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 94279840 | 94279841 | Human |
597488075 | GWAS1584149_H | glutamine measurement QTL GWAS1584149 (human) | | 2e-39 | glutamine measurement | blood amino acid measurement (CMO:0003730) | 10 | 97599655 | 97599656 | Human |
597594569 | GWAS1651429_H | hypertension QTL GWAS1651429 (human) | | 1e-20 | hypertension | | 10 | 103153896 | 103153897 | Human |
407079449 | GWAS728425_H | waist-hip ratio QTL GWAS728425 (human) | | 5e-08 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 92237938 | 92237939 | Human |
407226910 | GWAS875886_H | pulse pressure measurement QTL GWAS875886 (human) | | 0.0000003 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 97802815 | 97802816 | Human |
597242308 | GWAS1338382_H | HbA1c measurement QTL GWAS1338382 (human) | | 3e-12 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 10 | 87895485 | 87895486 | Human |
597135816 | GWAS1231890_H | diastolic blood pressure QTL GWAS1231890 (human) | | 5e-18 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103389888 | 103389889 | Human |
597602812 | GWAS1659672_H | hypertension QTL GWAS1659672 (human) | | 6e-19 | hypertension | | 10 | 103153896 | 103153897 | Human |
597602811 | GWAS1659671_H | hypertension QTL GWAS1659671 (human) | | 1e-12 | hypertension | | 10 | 94278929 | 94278930 | Human |
596955634 | GWAS1075153_H | inflammatory biomarker measurement, diet measurement QTL GWAS1075153 (human) | | 5e-09 | inflammatory biomarker measurement, diet measurement | | 10 | 102160718 | 102160719 | Human |
597094911 | GWAS1190985_H | systolic blood pressure QTL GWAS1190985 (human) | | 0.0000001 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103086421 | 103086422 | Human |
597225971 | GWAS1322045_H | childhood onset asthma QTL GWAS1322045 (human) | | 3e-20 | childhood onset asthma | | 10 | 92624756 | 92624761 | Human |
597045757 | GWAS1141831_H | hemoglobin measurement QTL GWAS1141831 (human) | | 1e-08 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 102813206 | 102813207 | Human |
597094909 | GWAS1190983_H | systolic blood pressure QTL GWAS1190983 (human) | | 3e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103086421 | 103086422 | Human |
596963833 | GWAS1083352_H | type 2 diabetes mellitus QTL GWAS1083352 (human) | | 2e-13 | type 2 diabetes mellitus | | 10 | 100152307 | 100152308 | Human |
597078521 | GWAS1174595_H | nicotine withdrawal symptom count QTL GWAS1174595 (human) | | 0.000002 | nicotine withdrawal symptom count | | 10 | 82116264 | 82116265 | Human |
597070310 | GWAS1166384_H | smoking behavior, body mass index QTL GWAS1166384 (human) | | 0.000002 | smoking behavior, body mass index | body mass index (BMI) (CMO:0000105) | 10 | 103109281 | 103109282 | Human |
597488110 | GWAS1584184_H | inflammatory bowel disease QTL GWAS1584184 (human) | | 2e-12 | inflammatory bowel disease | | 10 | 92669710 | 92669711 | Human |
597307881 | GWAS1403955_H | Alzheimer's disease biomarker measurement QTL GWAS1403955 (human) | | 5e-09 | Alzheimer's disease biomarker measurement | | 10 | 82863970 | 82863971 | Human |
597488111 | GWAS1584185_H | inflammatory bowel disease QTL GWAS1584185 (human) | | 3e-72 | inflammatory bowel disease | | 10 | 99524480 | 99524481 | Human |
597070309 | GWAS1166383_H | smoking behavior, body mass index QTL GWAS1166383 (human) | | 0.0000001 | smoking behavior, body mass index | body mass index (BMI) (CMO:0000105) | 10 | 103109281 | 103109282 | Human |
597168621 | GWAS1264695_H | aspartate aminotransferase measurement QTL GWAS1264695 (human) | | 3e-240 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99397681 | 99397682 | Human |
597275119 | GWAS1371193_H | age-related hearing impairment QTL GWAS1371193 (human) | | 7e-13 | age-related hearing impairment | | 10 | 93017351 | 93017352 | Human |
597275118 | GWAS1371192_H | age-related hearing impairment QTL GWAS1371192 (human) | | 7e-12 | age-related hearing impairment | | 10 | 78760556 | 78760557 | Human |
407079476 | GWAS728452_H | gut microbiome measurement QTL GWAS728452 (human) | | 4e-08 | gut microbiome measurement | | 10 | 93082720 | 93082721 | Human |
407292479 | GWAS941455_H | brain aneurysm QTL GWAS941455 (human) | | 2e-08 | brain aneurysm | | 10 | 94278929 | 94278930 | Human |
597266915 | GWAS1362989_H | diastolic blood pressure QTL GWAS1362989 (human) | | 8e-11 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 101355588 | 101355589 | Human |
596963823 | GWAS1083342_H | migraine disorder QTL GWAS1083342 (human) | | 3e-26 | migraine disorder | | 10 | 94279840 | 94279841 | Human |
407013950 | GWAS662926_H | alpha-linolenic acid measurement QTL GWAS662926 (human) | | 4e-08 | fatty acid amount (VT:0010046) | blood free fatty acids level (CMO:0000117) | 10 | 97799964 | 97799965 | Human |
597357029 | GWAS1453103_H | personality trait QTL GWAS1453103 (human) | | 4e-08 | personality trait | | 10 | 94253948 | 94253949 | Human |
597430755 | GWAS1526829_H | metabolic syndrome QTL GWAS1526829 (human) | | 4e-08 | metabolic syndrome | | 10 | 103200707 | 103200708 | Human |
407079619 | GWAS728595_H | atopic eczema, psoriasis QTL GWAS728595 (human) | | 0.000007 | atopic eczema, psoriasis | | 10 | 98153375 | 98153376 | Human |
597070103 | GWAS1166177_H | smoking behavior, body mass index QTL GWAS1166177 (human) | | 0.000002 | smoking behavior, body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100635683 | 100635684 | Human |
597274909 | GWAS1370983_H | systolic blood pressure QTL GWAS1370983 (human) | | 2e-34 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94279840 | 94279841 | Human |
597258524 | GWAS1354598_H | schizophrenia QTL GWAS1354598 (human) | | 0.0000005 | schizophrenia | | 10 | 102755312 | 102755313 | Human |
597463322 | GWAS1559396_H | alcohol drinking, high density lipoprotein cholesterol measurement QTL GWAS1559396 (human) | | 0.000003 | alcohol drinking, high density lipoprotein cholesterol measurement | systolic blood pressure (CMO:0000004) | 10 | 93079967 | 93079968 | Human |
597373201 | GWAS1469275_H | response to vaccine QTL GWAS1469275 (human) | | 0.0000002 | response to vaccine | | 10 | 95007177 | 95007178 | Human |
597528848 | GWAS1624922_H | FEV/FVC ratio QTL GWAS1624922 (human) | | 2e-15 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 88064490 | 88064491 | Human |
597250324 | GWAS1346398_H | familial hyperlipidemia QTL GWAS1346398 (human) | | 9e-18 | familial hyperlipidemia | | 10 | 93079885 | 93079886 | Human |
597446929 | GWAS1543003_H | phospholipid measurement, high density lipoprotein cholesterol measurement QTL GWAS1543003 (human) | | 1e-10 | phospholipid measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079967 | 93079968 | Human |
597520659 | GWAS1616733_H | body mass index QTL GWAS1616733 (human) | | 2e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102839238 | 102839239 | Human |
596955419 | GWAS1074938_H | inflammatory biomarker measurement, diet measurement QTL GWAS1074938 (human) | | 1e-10 | inflammatory biomarker measurement, diet measurement | | 10 | 97334679 | 97334680 | Human |
597340427 | GWAS1436501_H | level of endocrine disruptor in urine QTL GWAS1436501 (human) | | 5e-25 | level of endocrine disruptor in urine | | 10 | 94357060 | 94357061 | Human |
597594380 | GWAS1651240_H | calcium measurement QTL GWAS1651240 (human) | | 2e-15 | calcium measurement | blood calcium level (CMO:0000502) | 10 | 79243389 | 79243390 | Human |
596955398 | GWAS1074917_H | size QTL GWAS1074917 (human) | | 1e-21 | size | | 10 | 79355057 | 79355058 | Human |
597070085 | GWAS1166159_H | smoking behavior, body mass index QTL GWAS1166159 (human) | | 0.000005 | smoking behavior, body mass index | body mass index (BMI) (CMO:0000105) | 10 | 103109281 | 103109282 | Human |
597340430 | GWAS1436504_H | level of endocrine disruptor in urine QTL GWAS1436504 (human) | | 1e-15 | level of endocrine disruptor in urine | | 10 | 94898752 | 94898753 | Human |
596955393 | GWAS1074912_H | size QTL GWAS1074912 (human) | | 4e-22 | size | | 10 | 100900524 | 100900525 | Human |
597340428 | GWAS1436502_H | level of endocrine disruptor in urine QTL GWAS1436502 (human) | | 2e-19 | level of endocrine disruptor in urine | | 10 | 94502573 | 94502574 | Human |
596971778 | GWAS1091297_H | mean arterial pressure QTL GWAS1091297 (human) | | 1e-25 | mean arterial pressure | | 10 | 94242603 | 94242604 | Human |
597340429 | GWAS1436503_H | level of endocrine disruptor in urine QTL GWAS1436503 (human) | | 4e-71 | level of endocrine disruptor in urine | | 10 | 94990786 | 94990787 | Human |
597291278 | GWAS1387352_H | inflammatory biomarker measurement, diet measurement QTL GWAS1387352 (human) | | 1e-10 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 97334679 | 97334680 | Human |
597291265 | GWAS1387339_H | hypertension QTL GWAS1387339 (human) | | 8e-09 | hypertension | | 10 | 95502784 | 95502785 | Human |
597053710 | GWAS1149784_H | intelligence QTL GWAS1149784 (human) | | 0.000002 | intelligence | | 10 | 96238564 | 96238565 | Human |
597496068 | GWAS1592142_H | protein FAM163B measurement QTL GWAS1592142 (human) | | 7e-68 | protein FAM163B measurement | | 10 | 100130207 | 100130208 | Human |
597397761 | GWAS1493835_H | schizophrenia QTL GWAS1493835 (human) | | 9e-08 | schizophrenia | | 10 | 103241568 | 103241569 | Human |
407022303 | GWAS671279_H | serum IgG glycosylation measurement QTL GWAS671279 (human) | | 0.000002 | serum IgG glycosylation measurement | | 10 | 97148976 | 97148977 | Human |
597070091 | GWAS1166165_H | smoking behavior, body mass index QTL GWAS1166165 (human) | | 0.0000005 | smoking behavior, body mass index | body mass index (BMI) (CMO:0000105) | 10 | 103109281 | 103109282 | Human |
597094665 | GWAS1190739_H | response to anticoagulant QTL GWAS1190739 (human) | | 2e-13 | response to anticoagulant | | 10 | 94990786 | 94990787 | Human |
597463299 | GWAS1559373_H | systolic blood pressure, alcohol drinking QTL GWAS1559373 (human) | | 6e-13 | systolic blood pressure, alcohol drinking | systolic blood pressure (CMO:0000004) | 10 | 102899261 | 102899262 | Human |
597250361 | GWAS1346435_H | corneal resistance factor QTL GWAS1346435 (human) | | 2e-08 | corneal resistance factor | | 10 | 101064592 | 101064593 | Human |
597070135 | GWAS1166209_H | psoriasis QTL GWAS1166209 (human) | | 2e-09 | psoriasis | | 10 | 100278884 | 100278885 | Human |
597045557 | GWAS1141631_H | intraocular pressure measurement QTL GWAS1141631 (human) | | 3e-09 | intraocular pressure measurement | | 10 | 80486993 | 80486994 | Human |
597086515 | GWAS1182589_H | colorectal cancer QTL GWAS1182589 (human) | | 8e-09 | colorectal cancer | | 10 | 89814867 | 89814868 | Human |
597586235 | GWAS1643095_H | eosinophil count QTL GWAS1643095 (human) | | 2e-12 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 92669710 | 92669711 | Human |
407104230 | GWAS753206_H | urinary arsenic measurement QTL GWAS753206 (human) | | 2e-38 | urinary arsenic measurement | | 10 | 102874717 | 102874718 | Human |
406948583 | GWAS597559_H | body mass index QTL GWAS597559 (human) | | 2e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 103109281 | 103109282 | Human |
597250353 | GWAS1346427_H | corneal resistance factor QTL GWAS1346427 (human) | | 8e-09 | corneal resistance factor | | 10 | 103545244 | 103545245 | Human |
597594423 | GWAS1651283_H | calcium measurement QTL GWAS1651283 (human) | | 6e-16 | calcium measurement | blood calcium level (CMO:0000502) | 10 | 79243389 | 79243390 | Human |
597250352 | GWAS1346426_H | corneal resistance factor QTL GWAS1346426 (human) | | 1e-09 | corneal resistance factor | | 10 | 93121531 | 93121532 | Human |
597274928 | GWAS1371002_H | systolic blood pressure QTL GWAS1371002 (human) | | 3e-63 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103096405 | 103096406 | Human |
597086524 | GWAS1182598_H | colorectal cancer QTL GWAS1182598 (human) | | 0.000001 | colorectal cancer | | 10 | 89814867 | 89814868 | Human |
597053752 | GWAS1149826_H | household income QTL GWAS1149826 (human) | | 1e-09 | household income | | 10 | 102060796 | 102060797 | Human |
597610799 | GWAS1667659_H | neutrophil count QTL GWAS1667659 (human) | | 4e-13 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 97336188 | 97336189 | Human |
597053732 | GWAS1149806_H | sunburn QTL GWAS1149806 (human) | | 1e-08 | sunburn | | 10 | 80441547 | 80441548 | Human |
597274922 | GWAS1370996_H | systolic blood pressure QTL GWAS1370996 (human) | | 3e-26 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94140247 | 94140248 | Human |
597340462 | GWAS1436536_H | Alzheimer disease QTL GWAS1436536 (human) | | 4e-14 | Alzheimer disease | | 10 | 80494228 | 80494229 | Human |
597176620 | GWAS1272694_H | noggin measurement QTL GWAS1272694 (human) | | 2e-45 | noggin measurement | | 10 | 102600127 | 102600128 | Human |
597340463 | GWAS1436537_H | Alzheimer disease QTL GWAS1436537 (human) | | 0.0000002 | Alzheimer disease | | 10 | 96266650 | 96266651 | Human |
597586216 | GWAS1643076_H | eosinophil count QTL GWAS1643076 (human) | | 3e-11 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 87844975 | 87844976 | Human |
597274913 | GWAS1370987_H | systolic blood pressure QTL GWAS1370987 (human) | | 9e-31 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 100793890 | 100793891 | Human |
597610788 | GWAS1667648_H | neutrophil count QTL GWAS1667648 (human) | | 1e-16 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 89243047 | 89243048 | Human |
597610789 | GWAS1667649_H | neutrophil count QTL GWAS1667649 (human) | | 3e-30 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 97335451 | 97335452 | Human |
597242149 | GWAS1338223_H | Myopia QTL GWAS1338223 (human) | | 2e-10 | Myopia | | 10 | 84219476 | 84219477 | Human |
597184858 | GWAS1280932_H | X-24588 measurement QTL GWAS1280932 (human) | | 5e-29 | X-24588 measurement | | 10 | 99861975 | 99861976 | Human |
597438809 | GWAS1534883_H | smoking behavior, BMI-adjusted waist-hip ratio QTL GWAS1534883 (human) | | 0.000007 | body size trait (VT:0100005) | | 10 | 102727686 | 102727687 | Human |
597438810 | GWAS1534884_H | smoking behavior, BMI-adjusted waist-hip ratio QTL GWAS1534884 (human) | | 5e-08 | body size trait (VT:0100005) | | 10 | 102727686 | 102727687 | Human |
597029202 | GWAS1125276_H | BMI-adjusted waist-hip ratio QTL GWAS1125276 (human) | | 3e-20 | body size trait (VT:0100005) | | 10 | 79147390 | 79147391 | Human |
597487957 | GWAS1584031_H | calcium/calmodulin-dependent protein kinase type 1 measurement QTL GWAS1584031 (human) | | 5e-11 | calcium/calmodulin-dependent protein kinase type 1 measurement | | 10 | 99569401 | 99569402 | Human |
596963677 | GWAS1083196_H | cardiovascular measurement QTL GWAS1083196 (human) | | 8e-08 | cardiovascular measurement | | 10 | 99587221 | 99587222 | Human |
597315920 | GWAS1411994_H | attention function measurement QTL GWAS1411994 (human) | | 5e-08 | attention function measurement | | 10 | 90705279 | 90705280 | Human |
596963678 | GWAS1083197_H | cardiovascular measurement QTL GWAS1083197 (human) | | 0.0000004 | cardiovascular measurement | | 10 | 99586708 | 99586709 | Human |
597315921 | GWAS1411995_H | attention function measurement QTL GWAS1411995 (human) | | 2e-08 | attention function measurement | | 10 | 90828533 | 90828534 | Human |
597111111 | GWAS1207185_H | body mass index QTL GWAS1207185 (human) | | 0.000001 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 96349685 | 96349686 | Human |
597389642 | GWAS1485716_H | appendicular lean mass QTL GWAS1485716 (human) | | 1e-34 | appendicular lean mass | | 10 | 94278929 | 94278930 | Human |
597021004 | GWAS1117078_H | inflammatory bowel disease QTL GWAS1117078 (human) | | 5e-08 | inflammatory bowel disease | | 10 | 80494291 | 80494292 | Human |
597053772 | GWAS1149846_H | eosinophil count QTL GWAS1149846 (human) | | 2e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 97297164 | 97297165 | Human |
597070154 | GWAS1166228_H | smoking behavior, body mass index QTL GWAS1166228 (human) | | 0.000005 | smoking behavior, body mass index | body mass index (BMI) (CMO:0000105) | 10 | 85651147 | 85651148 | Human |
597053770 | GWAS1149844_H | eosinophil count QTL GWAS1149844 (human) | | 4e-43 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 87938433 | 87938434 | Human |
597168452 | GWAS1264526_H | myocardial infarction QTL GWAS1264526 (human) | | 2e-13 | myocardial infarction | | 10 | 102892566 | 102892567 | Human |
597053771 | GWAS1149845_H | eosinophil count QTL GWAS1149845 (human) | | 4e-15 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 89089947 | 89089948 | Human |
597406022 | GWAS1502096_H | non-high density lipoprotein cholesterol measurement QTL GWAS1502096 (human) | | 2e-12 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 10 | 100244149 | 100244150 | Human |
597406021 | GWAS1502095_H | non-high density lipoprotein cholesterol measurement QTL GWAS1502095 (human) | | 9e-11 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 10 | 88045653 | 88045654 | Human |
597381445 | GWAS1477519_H | monocyte count QTL GWAS1477519 (human) | | 4e-13 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 88118577 | 88118578 | Human |
597455226 | GWAS1551300_H | size QTL GWAS1551300 (human) | | 2e-10 | size | | 10 | 88058179 | 88058180 | Human |
597414259 | GWAS1510333_H | Abnormality of refraction QTL GWAS1510333 (human) | | 3e-08 | Abnormality of refraction | | 10 | 86751480 | 86751481 | Human |
597414260 | GWAS1510334_H | Abnormality of refraction QTL GWAS1510334 (human) | | 3e-23 | Abnormality of refraction | | 10 | 93190516 | 93190517 | Human |
597602670 | GWAS1659530_H | type 2 diabetes mellitus QTL GWAS1659530 (human) | | 1e-08 | type 2 diabetes mellitus | | 10 | 79173103 | 79173104 | Human |
597193066 | GWAS1289140_H | memory performance QTL GWAS1289140 (human) | | 0.000008 | memory performance | | 10 | 88455681 | 88455682 | Human |
597602669 | GWAS1659529_H | type 2 diabetes mellitus QTL GWAS1659529 (human) | | 1e-08 | type 2 diabetes mellitus | | 10 | 78687790 | 78687791 | Human |
597348713 | GWAS1444787_H | lean body mass QTL GWAS1444787 (human) | | 7e-26 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 100943376 | 100943377 | Human |
407104181 | GWAS753157_H | eosinophil percentage of leukocytes QTL GWAS753157 (human) | | 4e-13 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 10 | 89089947 | 89089948 | Human |
597045600 | GWAS1141674_H | intraocular pressure measurement QTL GWAS1141674 (human) | | 7e-09 | intraocular pressure measurement | | 10 | 93285353 | 93285354 | Human |
597168483 | GWAS1264557_H | serum gamma-glutamyl transferase measurement QTL GWAS1264557 (human) | | 2e-30 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 77897947 | 77897948 | Human |
597479783 | GWAS1575857_H | pulmonary surfactant-associated protein d measurement QTL GWAS1575857 (human) | | 1e-15 | pulmonary surfactant-associated protein d measurement | | 10 | 79949523 | 79949524 | Human |
597184869 | GWAS1280943_H | X-24947 measurement QTL GWAS1280943 (human) | | 3e-17 | X-24947 measurement | | 10 | 95050911 | 95050912 | Human |
596963690 | GWAS1083209_H | type 2 diabetes mellitus QTL GWAS1083209 (human) | | 3e-23 | type 2 diabetes mellitus | | 10 | 79182874 | 79182875 | Human |
597070184 | GWAS1166258_H | mosquito bite reaction size measurement QTL GWAS1166258 (human) | | 0.000002 | mosquito bite reaction size measurement | | 10 | 88996406 | 88996407 | Human |
597135721 | GWAS1231795_H | trait in response to apixaban QTL GWAS1231795 (human) | | 4e-08 | trait in response to apixaban | | 10 | 93529697 | 93529698 | Human |
597070185 | GWAS1166259_H | mosquito bite reaction size measurement QTL GWAS1166259 (human) | | 0.000002 | mosquito bite reaction size measurement | | 10 | 93189177 | 93189178 | Human |
597151895 | GWAS1247969_H | triglyceride measurement, high density lipoprotein cholesterol measurement QTL GWAS1247969 (human) | | 2e-08 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 102331339 | 102331340 | Human |
597037204 | GWAS1133278_H | body mass index QTL GWAS1133278 (human) | | 1e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102876519 | 102876520 | Human |
596955282 | GWAS1074801_H | diabetes mellitus QTL GWAS1074801 (human) | | 1e-12 | diabetes mellitus | | 10 | 92706738 | 92706739 | Human |
597463194 | GWAS1559268_H | serum alanine aminotransferase measurement QTL GWAS1559268 (human) | | 8e-09 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 96700824 | 96700825 | Human |
597045407 | GWAS1141481_H | high density lipoprotein cholesterol measurement QTL GWAS1141481 (human) | | 6e-09 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 79195310 | 79195311 | Human |
597143706 | GWAS1239780_H | X-14473 measurement QTL GWAS1239780 (human) | | 6e-12 | X-14473 measurement | | 10 | 94762608 | 94762609 | Human |
596988059 | GWAS1107578_H | memory performance, sex interaction measurement QTL GWAS1107578 (human) | | 0.000001 | memory performance, sex interaction measurement | | 10 | 87641149 | 87641150 | Human |
407128907 | GWAS777883_H | multiple sclerosis QTL GWAS777883 (human) | | 0.000002 | multiple sclerosis | | 10 | 79276250 | 79276251 | Human |
597201032 | GWAS1297106_H | lean body mass QTL GWAS1297106 (human) | | 5e-14 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 103069345 | 103069346 | Human |
597143686 | GWAS1239760_H | myristoleate 14:1n5 measurement QTL GWAS1239760 (human) | | 7e-16 | myristoleate 14:1n5 measurement | | 10 | 100315722 | 100315723 | Human |
407161686 | GWAS810662_H | systolic blood pressure QTL GWAS810662 (human) | | 7e-16 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94136183 | 94136184 | Human |
597463183 | GWAS1559257_H | triglyceride measurement QTL GWAS1559257 (human) | | 4e-16 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93071756 | 93071757 | Human |
407161681 | GWAS810657_H | hypertension QTL GWAS810657 (human) | | 9e-09 | hypertension | | 10 | 94136183 | 94136184 | Human |
596955266 | GWAS1074785_H | Progressive visual loss QTL GWAS1074785 (human) | | 8e-10 | Progressive visual loss | | 10 | 88270362 | 88270363 | Human |
597299341 | GWAS1395415_H | type 2 diabetes mellitus QTL GWAS1395415 (human) | | 3e-23 | type 2 diabetes mellitus | | 10 | 79182874 | 79182875 | Human |
597323908 | GWAS1419982_H | non-high density lipoprotein cholesterol measurement QTL GWAS1419982 (human) | | 6e-10 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 10 | 89250400 | 89250401 | Human |
597094536 | GWAS1190610_H | response to anticoagulant QTL GWAS1190610 (human) | | 0.0000009 | response to anticoagulant | | 10 | 99583184 | 99583185 | Human |
597209273 | GWAS1305347_H | blood protein measurement QTL GWAS1305347 (human) | | 2e-21 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95806295 | 95806296 | Human |
597209276 | GWAS1305350_H | blood protein measurement QTL GWAS1305350 (human) | | 1e-20 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95806295 | 95806296 | Human |
597127357 | GWAS1223431_H | urate measurement QTL GWAS1223431 (human) | | 2e-11 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 103179475 | 103179476 | Human |
597495990 | GWAS1592064_H | prostate carcinoma QTL GWAS1592064 (human) | | 4e-14 | prostate carcinoma | | 10 | 78478258 | 78478259 | Human |
597127356 | GWAS1223430_H | urate measurement QTL GWAS1223430 (human) | | 7e-19 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 87180205 | 87180206 | Human |
597127355 | GWAS1223429_H | urate measurement QTL GWAS1223429 (human) | | 4e-08 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 80392882 | 80392883 | Human |
407055219 | GWAS704195_H | unipolar depression QTL GWAS704195 (human) | | 0.000006 | unipolar depression | | 10 | 84826084 | 84826085 | Human |
407145333 | GWAS794309_H | type 2 diabetes mellitus QTL GWAS794309 (human) | | 0.000003 | type 2 diabetes mellitus | | 10 | 92703125 | 92703126 | Human |
597086375 | GWAS1182449_H | type 2 diabetes mellitus QTL GWAS1182449 (human) | | 2e-10 | type 2 diabetes mellitus | | 10 | 98662084 | 98662085 | Human |
597495983 | GWAS1592057_H | prostate carcinoma QTL GWAS1592057 (human) | | 7e-29 | prostate carcinoma | | 10 | 102662289 | 102662290 | Human |
597348520 | GWAS1444594_H | lean body mass QTL GWAS1444594 (human) | | 8e-16 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 102728114 | 102728115 | Human |
597495982 | GWAS1592056_H | prostate carcinoma QTL GWAS1592056 (human) | | 0.0000009 | prostate carcinoma | | 10 | 78478258 | 78478259 | Human |
597151906 | GWAS1247980_H | triglyceride measurement, diet measurement QTL GWAS1247980 (human) | | 0.000003 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 95615511 | 95615512 | Human |
407055220 | GWAS704196_H | unipolar depression QTL GWAS704196 (human) | | 0.000002 | unipolar depression | | 10 | 78574404 | 78574405 | Human |
407128957 | GWAS777933_H | type 2 diabetes mellitus, metabolic syndrome QTL GWAS777933 (human) | | 0.000009 | type 2 diabetes mellitus, metabolic syndrome | | 10 | 97877821 | 97877822 | Human |
597282979 | GWAS1379053_H | COVID-19 QTL GWAS1379053 (human) | | 0.000009 | COVID-19 | | 10 | 79468285 | 79468286 | Human |
597282980 | GWAS1379054_H | COVID-19 QTL GWAS1379054 (human) | | 0.000003 | COVID-19 | | 10 | 79645176 | 79645177 | Human |
597323943 | GWAS1420017_H | paraxanthine measurement QTL GWAS1420017 (human) | | 0.0000005 | paraxanthine measurement | | 10 | 82682402 | 82682403 | Human |
407022463 | GWAS671439_H | osteonecrosis QTL GWAS671439 (human) | | 0.000001 | osteonecrosis | | 10 | 95038791 | 95038792 | Human |
597225688 | GWAS1321762_H | smoking status measurement QTL GWAS1321762 (human) | | 5e-10 | smoking status measurement | | 10 | 81055918 | 81055919 | Human |
406915841 | GWAS564817_H | systolic blood pressure QTL GWAS564817 (human) | | 8e-16 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 102527602 | 102527603 | Human |
597225689 | GWAS1321763_H | smoking status measurement QTL GWAS1321763 (human) | | 4e-10 | smoking status measurement | | 10 | 85605340 | 85605341 | Human |
597225690 | GWAS1321764_H | smoking status measurement QTL GWAS1321764 (human) | | 2e-08 | smoking status measurement | | 10 | 96137995 | 96137996 | Human |
597225691 | GWAS1321765_H | smoking status measurement QTL GWAS1321765 (human) | | 4e-08 | smoking status measurement | | 10 | 101009953 | 101009954 | Human |
597225692 | GWAS1321766_H | smoking status measurement QTL GWAS1321766 (human) | | 1e-08 | smoking status measurement | | 10 | 101456133 | 101456134 | Human |
597225693 | GWAS1321767_H | smoking status measurement QTL GWAS1321767 (human) | | 9e-21 | smoking status measurement | | 10 | 102200594 | 102200595 | Human |
597151967 | GWAS1248041_H | colorectal cancer QTL GWAS1248041 (human) | | 3e-10 | colorectal cancer | | 10 | 89639807 | 89639808 | Human |
597086428 | GWAS1182502_H | serum clozapine-to-N-desmethylclozapine ratio measurement QTL GWAS1182502 (human) | | 1e-16 | serum clozapine-to-N-desmethylclozapine ratio measurement | | 10 | 94787706 | 94787707 | Human |
597405905 | GWAS1501979_H | erythrocyte count QTL GWAS1501979 (human) | | 1e-27 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 99525359 | 99525360 | Human |
597078237 | GWAS1174311_H | nicotine dependence QTL GWAS1174311 (human) | | 0.000002 | nicotine dependence | | 10 | 98030641 | 98030642 | Human |
597315798 | GWAS1411872_H | JT interval QTL GWAS1411872 (human) | | 6e-17 | heart electrical impulse conduction trait (VT:2000017) | heart electrical conduction measurement (CMO:0000230) | 10 | 89518701 | 89518702 | Human |
597315797 | GWAS1411871_H | JT interval QTL GWAS1411871 (human) | | 4e-10 | heart electrical impulse conduction trait (VT:2000017) | heart electrical conduction measurement (CMO:0000230) | 10 | 79114766 | 79114767 | Human |
597225687 | GWAS1321761_H | Abdominal Aortic Aneurysm QTL GWAS1321761 (human) | | 1e-10 | Abdominal Aortic Aneurysm | | 10 | 89243047 | 89243048 | Human |
597242070 | GWAS1338144_H | serum metabolite measurement QTL GWAS1338144 (human) | | 8e-59 | serum metabolite measurement | | 10 | 98388301 | 98388302 | Human |
597430483 | GWAS1526557_H | protein measurement QTL GWAS1526557 (human) | | 2e-10 | protein measurement | | 10 | 102659708 | 102659709 | Human |
597086402 | GWAS1182476_H | type 2 diabetes mellitus QTL GWAS1182476 (human) | | 2e-11 | type 2 diabetes mellitus | | 10 | 97299888 | 97299889 | Human |
597086403 | GWAS1182477_H | type 2 diabetes mellitus QTL GWAS1182477 (human) | | 1e-09 | type 2 diabetes mellitus | | 10 | 102788636 | 102788637 | Human |
597479626 | GWAS1575700_H | mathematical ability QTL GWAS1575700 (human) | | 7e-11 | mathematical ability | | 10 | 101781259 | 101781260 | Human |
597086401 | GWAS1182475_H | type 2 diabetes mellitus QTL GWAS1182475 (human) | | 1e-08 | type 2 diabetes mellitus | | 10 | 86364744 | 86364745 | Human |
597160143 | GWAS1256217_H | cholate measurement QTL GWAS1256217 (human) | | 0.000006 | cholate measurement | | 10 | 81995805 | 81995806 | Human |
597053646 | GWAS1149720_H | household income QTL GWAS1149720 (human) | | 2e-08 | household income | | 10 | 102297931 | 102297932 | Human |
597045451 | GWAS1141525_H | triglyceride measurement QTL GWAS1141525 (human) | | 0.000009 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 92608110 | 92608111 | Human |
597143798 | GWAS1239872_H | serum gamma-glutamyl transferase measurement QTL GWAS1239872 (human) | | 1e-09 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 99798989 | 99798990 | Human |
596979959 | GWAS1099478_H | body height QTL GWAS1099478 (human) | | 9e-52 | body height | | 10 | 79164501 | 79164502 | Human |
597143797 | GWAS1239871_H | serum gamma-glutamyl transferase measurement QTL GWAS1239871 (human) | | 1e-11 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 94373327 | 94373328 | Human |
407022368 | GWAS671344_H | mental or behavioural disorder, attempted suicide QTL GWAS671344 (human) | | 0.000003 | mental or behavioural disorder, attempted suicide | | 10 | 95362484 | 95362485 | Human |
597143796 | GWAS1239870_H | serum gamma-glutamyl transferase measurement QTL GWAS1239870 (human) | | 2e-15 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 93079885 | 93079886 | Human |
597143795 | GWAS1239869_H | serum gamma-glutamyl transferase measurement QTL GWAS1239869 (human) | | 6e-57 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 77900176 | 77900177 | Human |
597487864 | GWAS1583938_H | COVID-19 QTL GWAS1583938 (human) | | 2e-11 | COVID-19 | | 10 | 79963939 | 79963940 | Human |
597143807 | GWAS1239881_H | X-02269 measurement QTL GWAS1239881 (human) | | 7e-14 | X-02269 measurement | | 10 | 95068566 | 95068567 | Human |
597266674 | GWAS1362748_H | diastolic blood pressure QTL GWAS1362748 (human) | | 5e-11 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103155261 | 103155262 | Human |
597479665 | GWAS1575739_H | intraocular pressure measurement QTL GWAS1575739 (human) | | 8e-09 | intraocular pressure measurement | | 10 | 93282147 | 93282148 | Human |
597160186 | GWAS1256260_H | amino acid measurement QTL GWAS1256260 (human) | | 0.000002 | amino acid measurement | | 10 | 97538719 | 97538720 | Human |
407227178 | GWAS876154_H | body mass index QTL GWAS876154 (human) | | 6e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100635683 | 100635684 | Human |
597291241 | GWAS1387315_H | diabetes mellitus QTL GWAS1387315 (human) | | 1e-12 | pancreas integrity trait (VT:0010560) | | 10 | 92706738 | 92706739 | Human |
597291240 | GWAS1387314_H | diabetes mellitus QTL GWAS1387314 (human) | | 6e-09 | pancreas integrity trait (VT:0010560) | | 10 | 79195032 | 79195033 | Human |
597266667 | GWAS1362741_H | diastolic blood pressure QTL GWAS1362741 (human) | | 1e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 102076050 | 102076051 | Human |
597266666 | GWAS1362740_H | diastolic blood pressure QTL GWAS1362740 (human) | | 1e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103466781 | 103466782 | Human |
597045486 | GWAS1141560_H | refractive error QTL GWAS1141560 (human) | | 3e-09 | refractive error | | 10 | 91069149 | 91069150 | Human |
597070063 | GWAS1166137_H | bone quantitative ultrasound measurement QTL GWAS1166137 (human) | | 0.0000004 | bone quantitative ultrasound measurement | | 10 | 79390041 | 79390042 | Human |
597471462 | GWAS1567536_H | schizophrenia, intelligence, self reported educational attainment QTL GWAS1567536 (human) | | 3e-20 | schizophrenia, intelligence, self reported educational attainment | | 10 | 102875346 | 102875347 | Human |
407046968 | GWAS695944_H | breast carcinoma QTL GWAS695944 (human) | | 7e-22 | mammary gland integrity trait (VT:0010552) | | 10 | 79081391 | 79081392 | Human |
597119211 | GWAS1215285_H | blood protein measurement QTL GWAS1215285 (human) | | 1e-51 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 91906592 | 91906593 | Human |
597258468 | GWAS1354542_H | amino acid measurement QTL GWAS1354542 (human) | | 8e-10 | amino acid measurement | | 10 | 87060835 | 87060836 | Human |
597119210 | GWAS1215284_H | blood protein measurement QTL GWAS1215284 (human) | | 5e-14 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 100069757 | 100069758 | Human |
597618913 | GWAS1675773_H | creatine kinase measurement QTL GWAS1675773 (human) | | 9e-18 | creatine kinase measurement | blood creatine kinase activity level (CMO:0002242) | 10 | 100069757 | 100069758 | Human |
597184536 | GWAS1280610_H | metabolite measurement QTL GWAS1280610 (human) | | 4e-11 | metabolite measurement | | 10 | 98391509 | 98391510 | Human |
597282843 | GWAS1378917_H | BMI-adjusted hip circumference QTL GWAS1378917 (human) | | 2e-10 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 79350551 | 79350552 | Human |
597282842 | GWAS1378916_H | BMI-adjusted hip circumference QTL GWAS1378916 (human) | | 7e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 79317360 | 79317361 | Human |
597282845 | GWAS1378919_H | BMI-adjusted hip circumference QTL GWAS1378919 (human) | | 5e-13 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 91273186 | 91273187 | Human |
597282844 | GWAS1378918_H | BMI-adjusted hip circumference QTL GWAS1378918 (human) | | 2e-17 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 79351280 | 79351281 | Human |
597282847 | GWAS1378921_H | BMI-adjusted hip circumference QTL GWAS1378921 (human) | | 8e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 91230846 | 91230847 | Human |
597037073 | GWAS1133147_H | lung adenocarcinoma, family history of lung cancer QTL GWAS1133147 (human) | | 0.0000001 | lung adenocarcinoma, family history of lung cancer | | 10 | 88340394 | 88340395 | Human |
597282846 | GWAS1378920_H | BMI-adjusted hip circumference QTL GWAS1378920 (human) | | 4e-13 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 91251984 | 91251985 | Human |
597102623 | GWAS1198697_H | neutrophil percentage of leukocytes QTL GWAS1198697 (human) | | 6e-09 | neutrophil quantity (VT:0000222) | blood neutrophil count to total leukocyte count ratio (CMO:0000370) | 10 | 87921701 | 87921702 | Human |
597389331 | GWAS1485405_H | total cholesterol measurement QTL GWAS1485405 (human) | | 2e-09 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 100267650 | 100267651 | Human |
597102622 | GWAS1198696_H | neutrophil percentage of leukocytes QTL GWAS1198696 (human) | | 1e-14 | neutrophil quantity (VT:0000222) | blood neutrophil count to total leukocyte count ratio (CMO:0000370) | 10 | 79287818 | 79287819 | Human |
597602327 | GWAS1659187_H | myocardial infarction QTL GWAS1659187 (human) | | 1e-14 | myocardial infarction | | 10 | 89243170 | 89243171 | Human |
597512214 | GWAS1608288_H | major depressive disorder QTL GWAS1608288 (human) | | 1e-08 | major depressive disorder | | 10 | 102660997 | 102660998 | Human |
597504017 | GWAS1600091_H | colorectal cancer QTL GWAS1600091 (human) | | 4e-28 | colorectal cancer | | 10 | 99584506 | 99584507 | Human |
597454864 | GWAS1550938_H | schizophrenia QTL GWAS1550938 (human) | | 2e-08 | schizophrenia | | 10 | 102882480 | 102882481 | Human |
597504016 | GWAS1600090_H | colorectal cancer QTL GWAS1600090 (human) | | 1e-08 | colorectal cancer | | 10 | 99530544 | 99530545 | Human |
596955162 | GWAS1074681_H | hypertension QTL GWAS1074681 (human) | | 1e-09 | hypertension | | 10 | 86412952 | 86412953 | Human |
597528594 | GWAS1624668_H | lean body mass QTL GWAS1624668 (human) | | 3e-08 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 88059229 | 88059230 | Human |
597094425 | GWAS1190499_H | urinary metabolite measurement QTL GWAS1190499 (human) | | 1e-307 | urinary metabolite measurement | | 10 | 98386327 | 98386328 | Human |
596955140 | GWAS1074659_H | body mass index QTL GWAS1074659 (human) | | 2e-10 | body mass index | | 10 | 102224303 | 102224304 | Human |
597504015 | GWAS1600089_H | colorectal cancer QTL GWAS1600089 (human) | | 2e-38 | colorectal cancer | | 10 | 79059375 | 79059376 | Human |
597028871 | GWAS1124945_H | attempted suicide QTL GWAS1124945 (human) | | 0.000008 | attempted suicide | | 10 | 92422486 | 92422487 | Human |
597241867 | GWAS1337941_H | body fat percentage QTL GWAS1337941 (human) | | 7e-29 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 10 | 94279840 | 94279841 | Human |
597102597 | GWAS1198671_H | schizophrenia, intelligence, self reported educational attainment QTL GWAS1198671 (human) | | 2e-08 | schizophrenia, intelligence, self reported educational attainment | | 10 | 100152437 | 100152438 | Human |
597430287 | GWAS1526361_H | protein measurement QTL GWAS1526361 (human) | | 6e-124 | protein measurement | | 10 | 89006839 | 89006840 | Human |
596979712 | GWAS1099231_H | body height QTL GWAS1099231 (human) | | 5e-13 | body height | | 10 | 91612369 | 91612370 | Human |
596955138 | GWAS1074657_H | body mass index QTL GWAS1074657 (human) | | 3e-10 | body mass index | | 10 | 102460544 | 102460545 | Human |
406948822 | GWAS597798_H | body mass index QTL GWAS597798 (human) | | 3e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 85651147 | 85651148 | Human |
596955139 | GWAS1074658_H | body mass index QTL GWAS1074658 (human) | | 3e-17 | body mass index | | 10 | 102959339 | 102959340 | Human |
597209088 | GWAS1305162_H | lymphocyte count QTL GWAS1305162 (human) | | 2e-488 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95806026 | 95806027 | Human |
597209089 | GWAS1305163_H | lymphocyte count QTL GWAS1305163 (human) | | 2e-28 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95790039 | 95790040 | Human |
597159948 | GWAS1256022_H | IGA glomerulonephritis QTL GWAS1256022 (human) | | 0.000006 | IGA glomerulonephritis | | 10 | 79283986 | 79283987 | Human |
597192707 | GWAS1288781_H | testosterone measurement QTL GWAS1288781 (human) | | 1e-18 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 102863296 | 102863297 | Human |
597061645 | GWAS1157719_H | schizophrenia QTL GWAS1157719 (human) | | 3e-14 | schizophrenia | | 10 | 103192742 | 103192743 | Human |
597045258 | GWAS1141332_H | soluble triggering receptor expressed on myeloid cells 2 measurement QTL GWAS1141332 (human) | | 0.000006 | soluble triggering receptor expressed on myeloid cells 2 measurement | | 10 | 102604785 | 102604786 | Human |
597504000 | GWAS1600074_H | pulse pressure measurement QTL GWAS1600074 (human) | | 4e-11 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 103264621 | 103264622 | Human |
597233671 | GWAS1329745_H | gut microbiome measurement QTL GWAS1329745 (human) | | 0.000003 | gut microbiome measurement | | 10 | 101336336 | 101336337 | Human |
597282873 | GWAS1378947_H | hemoglobin A1 measurement QTL GWAS1378947 (human) | | 4e-42 | hemoglobin A1 measurement | | 10 | 92700524 | 92700525 | Human |
597225528 | GWAS1321602_H | self reported educational attainment QTL GWAS1321602 (human) | | 1e-32 | self reported educational attainment | | 10 | 102057071 | 102057072 | Human |
597282872 | GWAS1378946_H | hemoglobin A1 measurement QTL GWAS1378946 (human) | | 4e-13 | hemoglobin A1 measurement | | 10 | 87895485 | 87895486 | Human |
407145445 | GWAS794421_H | ejection fraction measurement QTL GWAS794421 (human) | | 0.0000004 | ejection fraction measurement | ejection fraction (CMO:0000180) | 10 | 101004290 | 101004291 | Human |
597225529 | GWAS1321603_H | self reported educational attainment QTL GWAS1321603 (human) | | 2e-08 | self reported educational attainment | | 10 | 102190030 | 102190031 | Human |
597397561 | GWAS1493635_H | vaginal microbiome measurement QTL GWAS1493635 (human) | | 0.0000003 | vaginal microbiome measurement | | 10 | 89401598 | 89401599 | Human |
597225530 | GWAS1321604_H | self reported educational attainment QTL GWAS1321604 (human) | | 7e-28 | self reported educational attainment | | 10 | 102261328 | 102261329 | Human |
597282874 | GWAS1378948_H | hemoglobin A1 measurement QTL GWAS1378948 (human) | | 2e-09 | hemoglobin A1 measurement | | 10 | 94849429 | 94849430 | Human |
597225532 | GWAS1321606_H | self reported educational attainment QTL GWAS1321606 (human) | | 4e-08 | self reported educational attainment | | 10 | 102466184 | 102466185 | Human |
597291068 | GWAS1387142_H | forced expiratory volume, gastroesophageal reflux disease QTL GWAS1387142 (human) | | 4e-08 | forced expiratory volume, gastroesophageal reflux disease | forced expiratory volume (CMO:0000254) | 10 | 79172541 | 79172542 | Human |
597315647 | GWAS1411721_H | body mass index QTL GWAS1411721 (human) | | 1e-19 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98012647 | 98012648 | Human |
597159985 | GWAS1256059_H | chenodeoxycholate measurement QTL GWAS1256059 (human) | | 0.000009 | chenodeoxycholate measurement | | 10 | 95068403 | 95068404 | Human |
597381171 | GWAS1477245_H | ceramide measurement QTL GWAS1477245 (human) | | 0.000005 | ceramide measurement | | 10 | 79318745 | 79318746 | Human |
406981610 | GWAS630586_H | hemoglobin measurement QTL GWAS630586 (human) | | 3e-10 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 95499232 | 95499233 | Human |
596955197 | GWAS1074716_H | body mass index QTL GWAS1074716 (human) | | 1e-11 | body mass index | | 10 | 86336290 | 86336291 | Human |
596955199 | GWAS1074718_H | body mass index QTL GWAS1074718 (human) | | 1e-14 | body mass index | | 10 | 85651147 | 85651148 | Human |
597225524 | GWAS1321598_H | self reported educational attainment QTL GWAS1321598 (human) | | 1e-09 | self reported educational attainment | | 10 | 101984548 | 101984549 | Human |
597200949 | GWAS1297023_H | smoking status measurement, pancreatic carcinoma QTL GWAS1297023 (human) | | 0.000001 | smoking status measurement, pancreatic carcinoma | | 10 | 78074044 | 78074045 | Human |
597504045 | GWAS1600119_H | response to cranial radiation therapy, short-term memory QTL GWAS1600119 (human) | | 0.000008 | response to cranial radiation therapy, short-term memory | | 10 | 91046512 | 91046513 | Human |
407178230 | GWAS827206_H | type 2 diabetes mellitus QTL GWAS827206 (human) | | 2e-09 | uric acid measurement | | 10 | 79184390 | 79184391 | Human |
597479464 | GWAS1575538_H | blood protein measurement QTL GWAS1575538 (human) | | 4e-13 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 100130207 | 100130208 | Human |
597102626 | GWAS1198700_H | neutrophil percentage of leukocytes QTL GWAS1198700 (human) | | 5e-19 | neutrophil quantity (VT:0000222) | blood neutrophil count to total leukocyte count ratio (CMO:0000370) | 10 | 97314229 | 97314234 | Human |
407178227 | GWAS827203_H | type 2 diabetes mellitus QTL GWAS827203 (human) | | 1e-09 | type 2 diabetes mellitus | | 10 | 92664316 | 92664317 | Human |
597102625 | GWAS1198699_H | neutrophil percentage of leukocytes QTL GWAS1198699 (human) | | 2e-16 | neutrophil quantity (VT:0000222) | blood neutrophil count to total leukocyte count ratio (CMO:0000370) | 10 | 92759940 | 92759941 | Human |
597102624 | GWAS1198698_H | neutrophil percentage of leukocytes QTL GWAS1198698 (human) | | 2e-11 | neutrophil percentage of leukocytes | | 10 | 89243047 | 89243048 | Human |
597045281 | GWAS1141355_H | glucose measurement QTL GWAS1141355 (human) | | 0.000007 | glucose measurement | blood glucose level (CMO:0000046) | 10 | 92608110 | 92608111 | Human |
597618729 | GWAS1675589_H | atrial fibrillation QTL GWAS1675589 (human) | | 9e-46 | atrial fibrillation | | 10 | 103582915 | 103582916 | Human |
406899709 | GWAS548685_H | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia QTL GWAS548685 (human) | | 0.000007 | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | | 10 | 103538013 | 103538014 | Human |
597397595 | GWAS1493669_H | vaginal microbiome measurement QTL GWAS1493669 (human) | | 0.000003 | vaginal microbiome measurement | | 10 | 89401598 | 89401599 | Human |
597332062 | GWAS1428136_H | atrial fibrillation QTL GWAS1428136 (human) | | 9e-77 | atrial fibrillation | | 10 | 103556539 | 103556540 | Human |
597397596 | GWAS1493670_H | vaginal microbiome measurement QTL GWAS1493670 (human) | | 0.000006 | vaginal microbiome measurement | | 10 | 89401598 | 89401599 | Human |
597020765 | GWAS1116839_H | colorectal cancer QTL GWAS1116839 (human) | | 4e-08 | colorectal cancer | | 10 | 99591947 | 99591948 | Human |
597176401 | GWAS1272475_H | noggin measurement QTL GWAS1272475 (human) | | 2e-13 | noggin measurement | | 10 | 92670768 | 92670769 | Human |
597299281 | GWAS1395355_H | lysophosphatidylcholine measurement QTL GWAS1395355 (human) | | 5e-36 | lysophosphatidylcholine measurement | blood phospholipid level (CMO:0001169) | 10 | 100315722 | 100315723 | Human |
597594190 | GWAS1651050_H | glucose measurement QTL GWAS1651050 (human) | | 3e-12 | glucose measurement | blood glucose level (CMO:0000046) | 10 | 79184390 | 79184391 | Human |
597028935 | GWAS1125009_H | Red cell distribution width QTL GWAS1125009 (human) | | 6e-13 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 94486139 | 94486140 | Human |
597528649 | GWAS1624723_H | triacylglycerol 46:1 measurement QTL GWAS1624723 (human) | | 1e-08 | blood triglyceride amount (VT:0002644) | | 10 | 91032631 | 91032632 | Human |
597291085 | GWAS1387159_H | size QTL GWAS1387159 (human) | | 2e-08 | size | | 10 | 94814191 | 94814192 | Human |
596955200 | GWAS1074719_H | body mass index QTL GWAS1074719 (human) | | 6e-19 | body mass index | | 10 | 98013128 | 98013129 | Human |
596955201 | GWAS1074720_H | body mass index QTL GWAS1074720 (human) | | 8e-18 | body mass index | | 10 | 100635683 | 100635684 | Human |
597020739 | GWAS1116813_H | colorectal cancer QTL GWAS1116813 (human) | | 0.0000008 | colorectal cancer | | 10 | 99591947 | 99591948 | Human |
596955202 | GWAS1074721_H | body mass index QTL GWAS1074721 (human) | | 7e-11 | body mass index | | 10 | 100875718 | 100875719 | Human |
597528650 | GWAS1624724_H | triacylglycerol 48:2 measurement QTL GWAS1624724 (human) | | 2e-08 | blood triglyceride amount (VT:0002644) | | 10 | 91032631 | 91032632 | Human |
597340226 | GWAS1436300_H | serum alanine aminotransferase measurement QTL GWAS1436300 (human) | | 9e-09 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 98667875 | 98667876 | Human |
597340227 | GWAS1436301_H | serum alanine aminotransferase measurement QTL GWAS1436301 (human) | | 7e-245 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100152307 | 100152308 | Human |
406932379 | GWAS581355_H | apolipoprotein B measurement QTL GWAS581355 (human) | | 2e-10 | apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 10 | 102415892 | 102415893 | Human |
597340225 | GWAS1436299_H | serum alanine aminotransferase measurement QTL GWAS1436299 (human) | | 2e-16 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 96706525 | 96706526 | Human |
596963402 | GWAS1082921_H | type 2 diabetes mellitus QTL GWAS1082921 (human) | | 2e-63 | type 2 diabetes mellitus | | 10 | 92706738 | 92706739 | Human |
597192825 | GWAS1288899_H | sexual dimorphism measurement QTL GWAS1288899 (human) | | 2e-17 | sexual dimorphism measurement | | 10 | 79165820 | 79165821 | Human |
597201019 | GWAS1297093_H | gestational diabetes QTL GWAS1297093 (human) | | 0.000002 | gestational diabetes | | 10 | 98847250 | 98847251 | Human |
597454971 | GWAS1551045_H | platelet count QTL GWAS1551045 (human) | | 2e-15 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 95795537 | 95795538 | Human |
597528689 | GWAS1624763_H | pyroglutamine measurement QTL GWAS1624763 (human) | | 2e-09 | pyroglutamine measurement | | 10 | 89463238 | 89463239 | Human |
597586032 | GWAS1642892_H | diastolic blood pressure change measurement QTL GWAS1642892 (human) | | 2e-14 | diastolic blood pressure change measurement | change in diastolic blood pressure (CMO:0001016) | 10 | 94253193 | 94253194 | Human |
597405812 | GWAS1501886_H | alanine measurement QTL GWAS1501886 (human) | | 1e-09 | alanine measurement | blood amino acid measurement (CMO:0003730) | 10 | 97599655 | 97599656 | Human |
597586033 | GWAS1642893_H | diastolic blood pressure change measurement QTL GWAS1642893 (human) | | 3e-11 | diastolic blood pressure change measurement | change in diastolic blood pressure (CMO:0001016) | 10 | 103084254 | 103084255 | Human |
597586031 | GWAS1642891_H | diastolic blood pressure change measurement QTL GWAS1642891 (human) | | 4e-15 | diastolic blood pressure change measurement | change in diastolic blood pressure (CMO:0001016) | 10 | 92672243 | 92672244 | Human |
596971622 | GWAS1091141_H | blood urea nitrogen measurement, major depressive disorder QTL GWAS1091141 (human) | | 2e-12 | blood urea nitrogen measurement, major depressive disorder | | 10 | 102559209 | 102559210 | Human |
597274733 | GWAS1370807_H | calpastatin measurement QTL GWAS1370807 (human) | | 6e-41 | calpastatin measurement | | 10 | 100069757 | 100069758 | Human |
596988000 | GWAS1107519_H | non-high density lipoprotein cholesterol measurement QTL GWAS1107519 (human) | | 3e-13 | non-high density lipoprotein cholesterol measurement | | 10 | 93079885 | 93079886 | Human |
597618790 | GWAS1675650_H | creatine kinase measurement QTL GWAS1675650 (human) | | 7e-22 | creatine kinase measurement | blood creatine kinase activity level (CMO:0002242) | 10 | 100069757 | 100069758 | Human |
597233767 | GWAS1329841_H | schizophrenia QTL GWAS1329841 (human) | | 0.000006 | schizophrenia | | 10 | 78744513 | 78744514 | Human |
597192806 | GWAS1288880_H | sexual dimorphism measurement QTL GWAS1288880 (human) | | 8e-13 | sexual dimorphism measurement | | 10 | 79166000 | 79166001 | Human |
597096342 | GWAS1192416_H | serum alanine aminotransferase measurement QTL GWAS1192416 (human) | | 2e-09 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 77920756 | 77920757 | Human |
597096343 | GWAS1192417_H | serum alanine aminotransferase measurement QTL GWAS1192417 (human) | | 1e-16 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100152437 | 100152438 | Human |
597530524 | GWAS1626598_H | level of oxylipin in blood plasma QTL GWAS1626598 (human) | | 1e-22 | level of oxylipin in blood plasma | | 10 | 100315722 | 100315723 | Human |
597530526 | GWAS1626600_H | palmitoleic acid measurement QTL GWAS1626600 (human) | | 2e-64 | fatty acid amount (VT:0010046) | | 10 | 100315722 | 100315723 | Human |
597120915 | GWAS1216989_H | blood protein measurement QTL GWAS1216989 (human) | | 4e-62 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 97882974 | 97882975 | Human |
597186461 | GWAS1282535_H | cholesteryl ester measurement QTL GWAS1282535 (human) | | 6e-10 | blood lipid amount (VT:0003949) | | 10 | 93083778 | 93083779 | Human |
597333919 | GWAS1429993_H | S-6-hydroxywarfarin to S-warfarin ratio measurement QTL GWAS1429993 (human) | | 5e-09 | S-6-hydroxywarfarin to S-warfarin ratio measurement | | 10 | 94729240 | 94729241 | Human |
407006279 | GWAS655255_H | lymphocyte count QTL GWAS655255 (human) | | 3e-16 | blood carnitine amount (VT:0003977) | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 100315722 | 100315723 | Human |
406965319 | GWAS614295_H | Child Behaviour Checklist assessment QTL GWAS614295 (human) | | 0.0000005 | Child Behaviour Checklist assessment | | 10 | 93632828 | 93632829 | Human |
597481370 | GWAS1577444_H | neutrophil count QTL GWAS1577444 (human) | | 2e-67 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 97241501 | 97241502 | Human |
597333917 | GWAS1429991_H | S-6-hydroxywarfarin to S-warfarin ratio measurement QTL GWAS1429991 (human) | | 2e-09 | S-6-hydroxywarfarin to S-warfarin ratio measurement | | 10 | 94998551 | 94998552 | Human |
407145551 | GWAS794527_H | serum metabolite measurement QTL GWAS794527 (human) | | 4e-11 | serum metabolite measurement | | 10 | 83694164 | 83694165 | Human |
407145544 | GWAS794520_H | serum metabolite measurement QTL GWAS794520 (human) | | 4e-26 | serum metabolite measurement | | 10 | 94704973 | 94704974 | Human |
597587855 | GWAS1644715_H | diabetic neuropathy QTL GWAS1644715 (human) | | 8e-23 | diabetic neuropathy | | 10 | 79187681 | 79187682 | Human |
597170057 | GWAS1266131_H | valine measurement QTL GWAS1266131 (human) | | 4e-11 | valine measurement | blood amino acid measurement (CMO:0003730) | 10 | 87060835 | 87060836 | Human |
597268411 | GWAS1364485_H | aortic measurement QTL GWAS1364485 (human) | | 0.0000005 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 94356663 | 94356664 | Human |
597407673 | GWAS1503747_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1503747 (human) | | 2e-09 | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 102358877 | 102358878 | Human |
597268410 | GWAS1364484_H | aortic measurement QTL GWAS1364484 (human) | | 5e-13 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 94143431 | 94143432 | Human |
406916199 | GWAS565175_H | bipolar disorder QTL GWAS565175 (human) | | 0.0000007 | bipolar disorder | | 10 | 97119904 | 97119905 | Human |
407047269 | GWAS696245_H | urinary metabolite measurement QTL GWAS696245 (human) | | 0.000009 | urinary metabolite measurement | | 10 | 98824158 | 98824159 | Human |
597432251 | GWAS1528325_H | protein measurement QTL GWAS1528325 (human) | | 2e-161 | protein measurement | | 10 | 88996308 | 88996309 | Human |
597022653 | GWAS1118727_H | acute myeloid leukemia QTL GWAS1118727 (human) | | 0.000007 | leukocyte integrity trait (VT:0010898) | | 10 | 81908154 | 81908155 | Human |
597022652 | GWAS1118726_H | acute myeloid leukemia QTL GWAS1118726 (human) | | 0.000008 | leukocyte integrity trait (VT:0010898) | | 10 | 80421678 | 80421679 | Human |
597465014 | GWAS1561088_H | waist-hip ratio QTL GWAS1561088 (human) | | 4e-12 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 87844975 | 87844976 | Human |
597350320 | GWAS1446394_H | lean body mass QTL GWAS1446394 (human) | | 2e-14 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 103016770 | 103016771 | Human |
597407664 | GWAS1503738_H | angina pectoris QTL GWAS1503738 (human) | | 3e-10 | angina pectoris | | 10 | 102856906 | 102856907 | Human |
597039034 | GWAS1135108_H | apolipoprotein A 1 measurement QTL GWAS1135108 (human) | | 6e-09 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 10 | 98002936 | 98002937 | Human |
597424054 | GWAS1520128_H | eosinophil count QTL GWAS1520128 (human) | | 4e-21 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 92669710 | 92669711 | Human |
597022651 | GWAS1118725_H | acute myeloid leukemia QTL GWAS1118725 (human) | | 0.0000001 | leukocyte integrity trait (VT:0010898) | | 10 | 80421678 | 80421679 | Human |
407022706 | GWAS671682_H | serum IgG glycosylation measurement QTL GWAS671682 (human) | | 0.000004 | serum IgG glycosylation measurement | | 10 | 82659654 | 82659655 | Human |
597292968 | GWAS1389042_H | monocyte count QTL GWAS1389042 (human) | | 1e-13 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 97354207 | 97354208 | Human |
597465006 | GWAS1561080_H | waist-hip ratio QTL GWAS1561080 (human) | | 2e-11 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 92354876 | 92354877 | Human |
597276586 | GWAS1372660_H | X-21467 measurement QTL GWAS1372660 (human) | | 3e-39 | X-21467 measurement | | 10 | 99811603 | 99811604 | Human |
597530537 | GWAS1626611_H | level of oxylipin in blood plasma QTL GWAS1626611 (human) | | 2e-20 | level of oxylipin in blood plasma | | 10 | 100315722 | 100315723 | Human |
597096352 | GWAS1192426_H | bipolar disorder QTL GWAS1192426 (human) | | 9e-13 | bipolar disorder | | 10 | 103153896 | 103153897 | Human |
597333921 | GWAS1429995_H | S-6-hydroxywarfarin to S-warfarin ratio measurement QTL GWAS1429995 (human) | | 1e-08 | S-6-hydroxywarfarin to S-warfarin ratio measurement | | 10 | 94445558 | 94445559 | Human |
407022719 | GWAS671695_H | pulmonary function measurement QTL GWAS671695 (human) | | 0.000003 | pulmonary function measurement | | 10 | 92409040 | 92409041 | Human |
597276583 | GWAS1372657_H | X-21441 measurement QTL GWAS1372657 (human) | | 5e-12 | X-21441 measurement | | 10 | 99920364 | 99920365 | Human |
597604256 | GWAS1661116_H | erythrocyte count QTL GWAS1661116 (human) | | 5e-22 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 101578251 | 101578252 | Human |
597333925 | GWAS1429999_H | S-6-hydroxywarfarin to S-warfarin ratio measurement QTL GWAS1429999 (human) | | 0.000001 | S-6-hydroxywarfarin to S-warfarin ratio measurement | | 10 | 95123591 | 95123592 | Human |
597276582 | GWAS1372656_H | X-21441 measurement QTL GWAS1372656 (human) | | 1e-57 | X-21441 measurement | | 10 | 99811603 | 99811604 | Human |
597391323 | GWAS1487397_H | leptin measurement, type 2 diabetes mellitus QTL GWAS1487397 (human) | | 2e-15 | leptin measurement, type 2 diabetes mellitus | blood leptin level (CMO:0000779) | 10 | 92730417 | 92730418 | Human |
597325786 | GWAS1421860_H | FEV/FVC ratio QTL GWAS1421860 (human) | | 4e-11 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 102632823 | 102632824 | Human |
597022679 | GWAS1118753_H | acute myeloid leukemia QTL GWAS1118753 (human) | | 1e-09 | leukocyte integrity trait (VT:0010898) | | 10 | 86305399 | 86305400 | Human |
597407708 | GWAS1503782_H | COVID-19 symptoms measurement QTL GWAS1503782 (human) | | 8e-08 | response to Coronaviridae infection (VT:0010997) | | 10 | 97878459 | 97878460 | Human |
597137373 | GWAS1233447_H | 4-ethylphenylsulfate measurement QTL GWAS1233447 (human) | | 0.000003 | 4-ethylphenylsulfate measurement | | 10 | 82636218 | 82636219 | Human |
597309392 | GWAS1405466_H | body mass index QTL GWAS1405466 (human) | | 2e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 91278773 | 91278774 | Human |
597071834 | GWAS1167908_H | breast carcinoma QTL GWAS1167908 (human) | | 3e-23 | mammary gland integrity trait (VT:0010552) | | 10 | 79081391 | 79081392 | Human |
597022681 | GWAS1118755_H | acute myeloid leukemia QTL GWAS1118755 (human) | | 0.000005 | leukocyte integrity trait (VT:0010898) | | 10 | 91629586 | 91629587 | Human |
597022680 | GWAS1118754_H | acute myeloid leukemia QTL GWAS1118754 (human) | | 5e-08 | leukocyte integrity trait (VT:0010898) | | 10 | 86305399 | 86305400 | Human |
597022682 | GWAS1118756_H | acute myeloid leukemia QTL GWAS1118756 (human) | | 6e-21 | leukocyte integrity trait (VT:0010898) | | 10 | 95456597 | 95456598 | Human |
596957124 | GWAS1076643_H | brain measurement QTL GWAS1076643 (human) | | 2e-11 | brain measurement | | 10 | 94254865 | 94254866 | Human |
597186505 | GWAS1282579_H | arginine measurement QTL GWAS1282579 (human) | | 1e-17 | arginine measurement | | 10 | 98388596 | 98388597 | Human |
597022662 | GWAS1118736_H | acute myeloid leukemia QTL GWAS1118736 (human) | | 0.000001 | leukocyte integrity trait (VT:0010898) | | 10 | 81996346 | 81996347 | Human |
597022657 | GWAS1118731_H | acute myeloid leukemia QTL GWAS1118731 (human) | | 0.000004 | leukocyte integrity trait (VT:0010898) | | 10 | 81936006 | 81936007 | Human |
597022656 | GWAS1118730_H | acute myeloid leukemia QTL GWAS1118730 (human) | | 5e-08 | leukocyte integrity trait (VT:0010898) | | 10 | 81936006 | 81936007 | Human |
597579713 | GWAS1636573_H | high density lipoprotein cholesterol measurement QTL GWAS1636573 (human) | | 3e-12 | high density lipoprotein cholesterol measurement | blood triglyceride level (CMO:0000118) | 10 | 93079885 | 93079886 | Human |
597465027 | GWAS1561101_H | mean arterial pressure QTL GWAS1561101 (human) | | 0.0000001 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 93079967 | 93079968 | Human |
597350395 | GWAS1446469_H | BMI-adjusted waist-hip ratio QTL GWAS1446469 (human) | | 2e-08 | body size trait (VT:0100005) | | 10 | 102727686 | 102727687 | Human |
597309433 | GWAS1405507_H | vaginal microbiome measurement QTL GWAS1405507 (human) | | 0.000003 | vaginal microbiome measurement | | 10 | 89422096 | 89422097 | Human |
407047207 | GWAS696183_H | waist-hip ratio QTL GWAS696183 (human) | | 4e-12 | waist-hip ratio | | 10 | 87844975 | 87844976 | Human |
597391344 | GWAS1487418_H | triglyceride measurement QTL GWAS1487418 (human) | | 2e-23 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93556280 | 93556281 | Human |
597407734 | GWAS1503808_H | non-alcoholic fatty liver disease QTL GWAS1503808 (human) | | 1e-09 | non-alcoholic fatty liver disease | | 10 | 100133661 | 100133662 | Human |
597407733 | GWAS1503807_H | non-alcoholic fatty liver disease QTL GWAS1503807 (human) | | 8e-10 | non-alcoholic fatty liver disease | | 10 | 100038589 | 100038590 | Human |
597407732 | GWAS1503806_H | non-alcoholic fatty liver disease QTL GWAS1503806 (human) | | 4e-08 | non-alcoholic fatty liver disease | | 10 | 92588073 | 92588074 | Human |
596957179 | GWAS1076698_H | age at first sexual intercourse measurement QTL GWAS1076698 (human) | | 6e-10 | age at first sexual intercourse measurement | | 10 | 102880295 | 102880296 | Human |
597047266 | GWAS1143340_H | Red cell distribution width QTL GWAS1143340 (human) | | 1e-08 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 89250722 | 89250723 | Human |
597211116 | GWAS1307190_H | lymphocyte count QTL GWAS1307190 (human) | | 4e-33 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95618281 | 95618282 | Human |
597374958 | GWAS1471032_H | trauma exposure measurement QTL GWAS1471032 (human) | | 0.000003 | trauma exposure measurement | | 10 | 78574404 | 78574405 | Human |
597211117 | GWAS1307191_H | lymphocyte count QTL GWAS1307191 (human) | | 2e-38 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95618281 | 95618282 | Human |
597137378 | GWAS1233452_H | dimethylglycine measurement QTL GWAS1233452 (human) | | 1e-22 | dimethylglycine measurement | | 10 | 102727625 | 102727626 | Human |
597432298 | GWAS1528372_H | protein measurement QTL GWAS1528372 (human) | | 5e-41 | protein measurement | | 10 | 91817867 | 91817868 | Human |
597587944 | GWAS1644804_H | eosinophil count QTL GWAS1644804 (human) | | 2e-16 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 92669710 | 92669711 | Human |
597506027 | GWAS1602101_H | neuroimaging measurement QTL GWAS1602101 (human) | | 1e-08 | neuroimaging measurement | | 10 | 94278929 | 94278930 | Human |
597211118 | GWAS1307192_H | lymphocyte count QTL GWAS1307192 (human) | | 2e-32 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95704290 | 95704291 | Human |
597243873 | GWAS1339947_H | progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1339947 (human) | | 0.000005 | progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel | survival measurement (CMO:0001021) | 10 | 86171880 | 86171881 | Human |
597481444 | GWAS1577518_H | monocyte count QTL GWAS1577518 (human) | | 9e-69 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 99532633 | 99532634 | Human |
597587943 | GWAS1644803_H | eosinophil count QTL GWAS1644803 (human) | | 2e-13 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 87844975 | 87844976 | Human |
597465061 | GWAS1561135_H | blood protein measurement QTL GWAS1561135 (human) | | 3e-21 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 89010241 | 89010242 | Human |
597309408 | GWAS1405482_H | vaginal microbiome measurement QTL GWAS1405482 (human) | | 0.0000009 | vaginal microbiome measurement | | 10 | 84435104 | 84435105 | Human |
597211107 | GWAS1307181_H | neuroimaging measurement QTL GWAS1307181 (human) | | 2e-13 | neuroimaging measurement | | 10 | 94254865 | 94254866 | Human |
407211067 | GWAS860043_H | mean corpuscular hemoglobin QTL GWAS860043 (human) | | 5e-08 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 79377440 | 79377441 | Human |
597186328 | GWAS1282402_H | X-12112 measurement QTL GWAS1282402 (human) | | 3e-226 | X-12112 measurement | | 10 | 98399616 | 98399617 | Human |
597382938 | GWAS1479012_H | serum metabolite measurement QTL GWAS1479012 (human) | | 4e-62 | serum metabolite measurement | | 10 | 98363855 | 98363856 | Human |
597104405 | GWAS1200479_H | corneal topography QTL GWAS1200479 (human) | | 1e-10 | corneal topography | | 10 | 88264842 | 88264843 | Human |
597104403 | GWAS1200477_H | corneal topography QTL GWAS1200477 (human) | | 6e-11 | corneal topography | | 10 | 101064592 | 101064593 | Human |
597432083 | GWAS1528157_H | protein measurement QTL GWAS1528157 (human) | | 1e-190 | protein measurement | | 10 | 88676583 | 88676584 | Human |
597186327 | GWAS1282401_H | X-12112 measurement QTL GWAS1282401 (human) | | 2e-2804 | X-12112 measurement | | 10 | 98388419 | 98388420 | Human |
597391113 | GWAS1487187_H | schizophrenia QTL GWAS1487187 (human) | | 0.000001 | schizophrenia | | 10 | 101719305 | 101719306 | Human |
597161743 | GWAS1257817_H | monocyte count QTL GWAS1257817 (human) | | 1e-08 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 97399708 | 97399709 | Human |
597391107 | GWAS1487181_H | schizophrenia QTL GWAS1487181 (human) | | 3e-18 | schizophrenia | | 10 | 102852578 | 102852579 | Human |
597333760 | GWAS1429834_H | smoking cessation QTL GWAS1429834 (human) | | 7e-12 | smoking cessation | | 10 | 85314808 | 85314809 | Human |
597161738 | GWAS1257812_H | neutrophil count QTL GWAS1257812 (human) | | 2e-12 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 97301629 | 97301630 | Human |
597309188 | GWAS1405262_H | vaginal microbiome measurement QTL GWAS1405262 (human) | | 0.000007 | vaginal microbiome measurement | | 10 | 98953678 | 98953679 | Human |
597595905 | GWAS1652765_H | diastolic blood pressure QTL GWAS1652765 (human) | | 3e-12 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103089359 | 103089360 | Human |
597038903 | GWAS1134977_H | gut microbiome measurement QTL GWAS1134977 (human) | | 0.000005 | gut microbiome measurement | | 10 | 80665633 | 80665634 | Human |
597186365 | GWAS1282439_H | metabolonic lactone sulfate measurement QTL GWAS1282439 (human) | | 2e-19 | metabolonic lactone sulfate measurement | | 10 | 94909603 | 94909604 | Human |
596956988 | GWAS1076507_H | triglyceride:HDL cholesterol ratio QTL GWAS1076507 (human) | | 5e-27 | triglyceride:HDL cholesterol ratio | | 10 | 93085789 | 93085790 | Human |
597178161 | GWAS1274235_H | total lipids in large VLDL QTL GWAS1274235 (human) | | 7e-10 | blood VLDL cholesterol amount (VT:0005144) | | 10 | 93038216 | 93038217 | Human |
597227315 | GWAS1323389_H | serum gamma-glutamyl transferase measurement QTL GWAS1323389 (human) | | 1e-09 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 96711108 | 96711109 | Human |
597227316 | GWAS1323390_H | serum gamma-glutamyl transferase measurement QTL GWAS1323390 (human) | | 1e-09 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 99830729 | 99830730 | Human |
597210920 | GWAS1306994_H | blood protein measurement QTL GWAS1306994 (human) | | 2e-27 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95682419 | 95682420 | Human |
597333800 | GWAS1429874_H | opioid use disorder QTL GWAS1429874 (human) | | 4e-08 | conditioned place preference behavior trait (VT:0010723) | | 10 | 101655128 | 101655129 | Human |
597088046 | GWAS1184120_H | monocyte count QTL GWAS1184120 (human) | | 1e-09 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 79165568 | 79165569 | Human |
597088047 | GWAS1184121_H | monocyte count QTL GWAS1184121 (human) | | 4e-13 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 80511585 | 80511586 | Human |
407162104 | GWAS811080_H | diastolic blood pressure QTL GWAS811080 (human) | | 0.0000008 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 94136183 | 94136184 | Human |
597161770 | GWAS1257844_H | gamma-glutamyltyrosine measurement QTL GWAS1257844 (human) | | 0.000005 | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | | 10 | 79193379 | 79193380 | Human |
597374810 | GWAS1470884_H | economic and social preference QTL GWAS1470884 (human) | | 0.000002 | economic and social preference | | 10 | 90202913 | 90202914 | Human |
597186394 | GWAS1282468_H | peak expiratory flow QTL GWAS1282468 (human) | | 3e-08 | peak expiratory flow | maximum mid-expiratory flow (MMEF) (CMO:0000253) | 10 | 85950617 | 85950618 | Human |
597374809 | GWAS1470883_H | economic and social preference QTL GWAS1470883 (human) | | 0.000001 | economic and social preference | | 10 | 90203706 | 90203707 | Human |
597399384 | GWAS1495458_H | uric acid measurement QTL GWAS1495458 (human) | | 7e-09 | uric acid measurement | blood uric acid level (CMO:0000501) | 10 | 80325364 | 80325365 | Human |
597129044 | GWAS1225118_H | maximal oxygen uptake measurement QTL GWAS1225118 (human) | | 4e-10 | maximal oxygen uptake measurement | maximal oxygen consumption (CMO:0000135) | 10 | 100792906 | 100792907 | Human |
407039111 | GWAS688087_H | QT interval QTL GWAS688087 (human) | | 3e-08 | QT interval | QT interval (CMO:0000235) | 10 | 102290249 | 102290250 | Human |
406965383 | GWAS614359_H | chronic lymphocytic leukemia QTL GWAS614359 (human) | | 1e-14 | leukocyte integrity trait (VT:0010898) | | 10 | 88999967 | 88999968 | Human |
597129051 | GWAS1225125_H | maximal oxygen uptake measurement QTL GWAS1225125 (human) | | 4e-08 | maximal oxygen uptake measurement | maximal oxygen consumption (CMO:0000135) | 10 | 100793890 | 100793891 | Human |
597350211 | GWAS1446285_H | lean body mass QTL GWAS1446285 (human) | | 4e-11 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 77900176 | 77900177 | Human |
597448512 | GWAS1544586_H | hypertension QTL GWAS1544586 (human) | | 0.000002 | hypertension | | 10 | 78583197 | 78583198 | Human |
597489532 | GWAS1585606_H | high density lipoprotein cholesterol measurement QTL GWAS1585606 (human) | | 7e-23 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079967 | 93079968 | Human |
597170040 | GWAS1266114_H | body mass index QTL GWAS1266114 (human) | | 2e-17 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102988252 | 102988253 | Human |
597104499 | GWAS1200573_H | serum alanine aminotransferase measurement QTL GWAS1200573 (human) | | 1e-14 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 96706525 | 96706526 | Human |
597145458 | GWAS1241532_H | body mass index QTL GWAS1241532 (human) | | 0.000008 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 97935213 | 97935214 | Human |
597170047 | GWAS1266121_H | body mass index QTL GWAS1266121 (human) | | 2e-14 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100687890 | 100687891 | Human |
597391219 | GWAS1487293_H | apolipoprotein A 1 measurement QTL GWAS1487293 (human) | | 2e-09 | apolipoprotein A 1 measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 86751546 | 86751547 | Human |
597366646 | GWAS1462720_H | lean body mass QTL GWAS1462720 (human) | | 0.000002 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 94278929 | 94278930 | Human |
406981811 | GWAS630787_H | hemoglobin measurement QTL GWAS630787 (human) | | 2e-14 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 87169895 | 87169896 | Human |
596981601 | GWAS1101120_H | telomere length QTL GWAS1101120 (human) | | 2e-20 | telomere length | | 10 | 99608442 | 99608443 | Human |
406981812 | GWAS630788_H | hemoglobin measurement QTL GWAS630788 (human) | | 2e-10 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 88536710 | 88536711 | Human |
406981813 | GWAS630789_H | hemoglobin measurement QTL GWAS630789 (human) | | 2e-10 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 91277652 | 91277653 | Human |
596957035 | GWAS1076554_H | gamma-glutamyltyrosine measurement QTL GWAS1076554 (human) | | 0.000005 | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | | 10 | 79193379 | 79193380 | Human |
597456739 | GWAS1552813_H | Crohn's disease QTL GWAS1552813 (human) | | 4e-50 | intestine integrity trait (VT:0010554) | | 10 | 99524480 | 99524481 | Human |
597071508 | GWAS1167582_H | psoriasis QTL GWAS1167582 (human) | | 0.0000007 | psoriasis | | 10 | 79272775 | 79272776 | Human |
597481112 | GWAS1577186_H | BMI-adjusted hip circumference QTL GWAS1577186 (human) | | 6e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 91296075 | 91296076 | Human |
597186205 | GWAS1282279_H | smoking cessation QTL GWAS1282279 (human) | | 2e-12 | smoking cessation | | 10 | 85314808 | 85314809 | Human |
597481113 | GWAS1577187_H | BMI-adjusted hip circumference QTL GWAS1577187 (human) | | 2e-10 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 91291987 | 91291988 | Human |
597186206 | GWAS1282280_H | smoking cessation QTL GWAS1282280 (human) | | 2e-10 | smoking cessation | | 10 | 85322767 | 85322768 | Human |
597481114 | GWAS1577188_H | BMI-adjusted hip circumference QTL GWAS1577188 (human) | | 3e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 91302094 | 91302095 | Human |
597481115 | GWAS1577189_H | BMI-adjusted hip circumference QTL GWAS1577189 (human) | | 8e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 94253948 | 94253949 | Human |
597333661 | GWAS1429735_H | opioid use disorder QTL GWAS1429735 (human) | | 3e-08 | conditioned place preference behavior trait (VT:0010723) | | 10 | 101655128 | 101655129 | Human |
597186207 | GWAS1282281_H | smoking cessation QTL GWAS1282281 (human) | | 1e-09 | smoking cessation | | 10 | 102999434 | 102999435 | Human |
597440148 | GWAS1536222_H | susceptibility to measles measurement QTL GWAS1536222 (human) | | 0.000008 | response to viral infection trait (VT:0010439) | | 10 | 85386263 | 85386264 | Human |
407080267 | GWAS729243_H | unipolar depression, neuroticism measurement QTL GWAS729243 (human) | | 0.000006 | unipolar depression, neuroticism measurement | | 10 | 96376493 | 96376494 | Human |
597038751 | GWAS1134825_H | gut microbiome measurement QTL GWAS1134825 (human) | | 0.000002 | gut microbiome measurement | | 10 | 77806607 | 77806608 | Human |
597309075 | GWAS1405149_H | blood urea nitrogen measurement QTL GWAS1405149 (human) | | 0.0000003 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 10 | 80441547 | 80441548 | Human |
597481111 | GWAS1577185_H | BMI-adjusted hip circumference QTL GWAS1577185 (human) | | 6e-14 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 79329405 | 79329406 | Human |
597489298 | GWAS1585372_H | urolithiasis QTL GWAS1585372 (human) | | 7e-11 | urolithiasis | | 10 | 87194263 | 87194264 | Human |
597137048 | GWAS1233122_H | andro steroid monosulfate C19H28O6S (1) measurement QTL GWAS1233122 (human) | | 9e-13 | andro steroid monosulfate C19H28O6S (1) measurement | | 10 | 95243244 | 95243245 | Human |
597104261 | GWAS1200335_H | serum alanine aminotransferase measurement QTL GWAS1200335 (human) | | 3e-114 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100152307 | 100152308 | Human |
597284493 | GWAS1380567_H | hemoglobin measurement QTL GWAS1380567 (human) | | 9e-09 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 88536710 | 88536711 | Human |
597522057 | GWAS1618131_H | Abdominal Aortic Aneurysm QTL GWAS1618131 (human) | | 5e-18 | Abdominal Aortic Aneurysm | | 10 | 94310118 | 94310119 | Human |
597390991 | GWAS1487065_H | appendicular lean mass QTL GWAS1487065 (human) | | 6e-13 | appendicular lean mass | | 10 | 94942795 | 94942796 | Human |
597169804 | GWAS1265878_H | angina pectoris QTL GWAS1265878 (human) | | 1e-09 | angina pectoris | | 10 | 102876519 | 102876520 | Human |
597284492 | GWAS1380566_H | hemoglobin measurement QTL GWAS1380566 (human) | | 1e-10 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 87165772 | 87165773 | Human |
597284495 | GWAS1380569_H | hemoglobin measurement QTL GWAS1380569 (human) | | 3e-09 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 95499232 | 95499233 | Human |
597440139 | GWAS1536213_H | forced expiratory volume, response to bronchodilator QTL GWAS1536213 (human) | | 0.0000006 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 10 | 89931743 | 89931744 | Human |
597284494 | GWAS1380568_H | hemoglobin measurement QTL GWAS1380568 (human) | | 3e-09 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 91277652 | 91277653 | Human |
597202575 | GWAS1298649_H | lean body mass QTL GWAS1298649 (human) | | 6e-13 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 102520216 | 102520217 | Human |
597415555 | GWAS1511629_H | smoking status measurement QTL GWAS1511629 (human) | | 9e-29 | smoking status measurement | | 10 | 102880295 | 102880296 | Human |
597415554 | GWAS1511628_H | smoking status measurement QTL GWAS1511628 (human) | | 2e-14 | smoking status measurement | | 10 | 102643553 | 102643554 | Human |
597096077 | GWAS1192151_H | low density lipoprotein cholesterol measurement QTL GWAS1192151 (human) | | 2e-08 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 95172943 | 95172944 | Human |
597374592 | GWAS1470666_H | intelligence QTL GWAS1470666 (human) | | 2e-08 | intelligence | | 10 | 102438771 | 102438772 | Human |
597104265 | GWAS1200339_H | serum alanine aminotransferase measurement QTL GWAS1200339 (human) | | 6e-09 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 88047609 | 88047610 | Human |
597251719 | GWAS1347793_H | serum alanine aminotransferase measurement QTL GWAS1347793 (human) | | 3e-61 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100057584 | 100057585 | Human |
597104264 | GWAS1200338_H | serum alanine aminotransferase measurement QTL GWAS1200338 (human) | | 5e-27 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 77900367 | 77900368 | Human |
597243526 | GWAS1339600_H | HbA1c measurement QTL GWAS1339600 (human) | | 6e-10 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 10 | 79205218 | 79205219 | Human |
597104311 | GWAS1200385_H | type 2 diabetes mellitus QTL GWAS1200385 (human) | | 5e-38 | type 2 diabetes mellitus | | 10 | 92716841 | 92716842 | Human |
597415611 | GWAS1511685_H | triglyceride:HDL cholesterol ratio QTL GWAS1511685 (human) | | 5e-27 | blood triglyceride amount (VT:0002644) | | 10 | 93085789 | 93085790 | Human |
597079735 | GWAS1175809_H | diabetes mellitus biomarker QTL GWAS1175809 (human) | | 0.0000003 | diabetes mellitus biomarker | | 10 | 92622283 | 92622284 | Human |
597112500 | GWAS1208574_H | systolic blood pressure QTL GWAS1208574 (human) | | 3e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 92708928 | 92708929 | Human |
596956849 | GWAS1076368_H | major depressive disorder QTL GWAS1076368 (human) | | 0.000006 | major depressive disorder | | 10 | 84826084 | 84826085 | Human |
597276348 | GWAS1372422_H | X-16087 measurement QTL GWAS1372422 (human) | | 5e-17 | X-16087 measurement | | 10 | 95059456 | 95059457 | Human |
597120700 | GWAS1216774_H | blood protein measurement QTL GWAS1216774 (human) | | 9e-144 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 88780569 | 88780570 | Human |
597268148 | GWAS1364222_H | aortic measurement QTL GWAS1364222 (human) | | 9e-19 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 94356663 | 94356664 | Human |
407268712 | GWAS917688_H | neutrophil count QTL GWAS917688 (human) | | 8e-12 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 79285523 | 79285524 | Human |
597079736 | GWAS1175810_H | diabetes mellitus biomarker QTL GWAS1175810 (human) | | 0.0000009 | diabetes mellitus biomarker | | 10 | 92732959 | 92732960 | Human |
596965028 | GWAS1084547_H | serum albumin measurement, diet measurement QTL GWAS1084547 (human) | | 0.000006 | serum albumin measurement, diet measurement | | 10 | 82063533 | 82063534 | Human |
597530285 | GWAS1626359_H | neutrophil measurement QTL GWAS1626359 (human) | | 1e-33 | neutrophil measurement | | 10 | 99485473 | 99485474 | Human |
597087910 | GWAS1183984_H | monocyte count QTL GWAS1183984 (human) | | 5e-10 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 99560855 | 99560856 | Human |
597087911 | GWAS1183985_H | monocyte count QTL GWAS1183985 (human) | | 4e-12 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 102799204 | 102799205 | Human |
597030567 | GWAS1126641_H | physical activity measurement QTL GWAS1126641 (human) | | 5e-09 | wellness/fitness trait (VT:1000152) | voluntary body mobility/immobility measurement (CMO:0000954) | 10 | 88823948 | 88823949 | Human |
597268139 | GWAS1364213_H | aortic measurement QTL GWAS1364213 (human) | | 4e-14 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 94356663 | 94356664 | Human |
597087908 | GWAS1183982_H | monocyte count QTL GWAS1183982 (human) | | 1e-14 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 96682319 | 96682320 | Human |
597087909 | GWAS1183983_H | monocyte count QTL GWAS1183983 (human) | | 2e-35 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 97334679 | 97334680 | Human |
597087907 | GWAS1183981_H | monocyte count QTL GWAS1183981 (human) | | 1e-15 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 94279840 | 94279841 | Human |
597358243 | GWAS1454317_H | chronic obstructive pulmonary disease, surfactant protein D measurement QTL GWAS1454317 (human) | | 5e-09 | lung integrity trait (VT:0010906) | | 10 | 79935194 | 79935195 | Human |
407039355 | GWAS688331_H | pancreatic carcinoma QTL GWAS688331 (human) | | 0.000003 | pancreatic carcinoma | | 10 | 85980996 | 85980997 | Human |
597505697 | GWAS1601771_H | BMI-adjusted hip circumference QTL GWAS1601771 (human) | | 1e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 87834823 | 87834824 | Human |
597505696 | GWAS1601770_H | BMI-adjusted hip circumference QTL GWAS1601770 (human) | | 4e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 79333309 | 79333310 | Human |
597259940 | GWAS1356014_H | schizophrenia QTL GWAS1356014 (human) | | 0.0000007 | schizophrenia | | 10 | 86244013 | 86244014 | Human |
596965033 | GWAS1084552_H | diet measurement, vitamin D measurement QTL GWAS1084552 (human) | | 0.000006 | diet measurement, vitamin D measurement | | 10 | 86536484 | 86536485 | Human |
597407398 | GWAS1503472_H | hypertension QTL GWAS1503472 (human) | | 2e-17 | hypertension | | 10 | 94278929 | 94278930 | Human |
597309146 | GWAS1405220_H | systolic blood pressure QTL GWAS1405220 (human) | | 2e-16 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 100792995 | 100792996 | Human |
406965504 | GWAS614480_H | type 2 diabetes mellitus QTL GWAS614480 (human) | | 0.000009 | type 2 diabetes mellitus | | 10 | 88008827 | 88008828 | Human |
597432029 | GWAS1528103_H | attention deficit hyperactivity disorder, schizophrenia QTL GWAS1528103 (human) | | 4e-08 | attention deficit hyperactivity disorder, schizophrenia | | 10 | 102880295 | 102880296 | Human |
597309147 | GWAS1405221_H | systolic blood pressure QTL GWAS1405221 (human) | | 9e-47 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103151202 | 103151203 | Human |
597604061 | GWAS1660921_H | total cholesterol measurement QTL GWAS1660921 (human) | | 1e-14 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 89243047 | 89243048 | Human |
597595867 | GWAS1652727_H | diastolic blood pressure QTL GWAS1652727 (human) | | 9e-16 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 94279840 | 94279841 | Human |
597268191 | GWAS1364265_H | facial width measurement QTL GWAS1364265 (human) | | 0.000004 | facial morphology trait (VT:0003743) | | 10 | 84694716 | 84694717 | Human |
597407453 | GWAS1503527_H | systolic blood pressure QTL GWAS1503527 (human) | | 3e-31 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94278929 | 94278930 | Human |
597137117 | GWAS1233191_H | 21-hydroxypregnenolone disulfate measurement QTL GWAS1233191 (human) | | 2e-10 | 21-hydroxypregnenolone disulfate measurement | | 10 | 100064544 | 100064545 | Human |
597407446 | GWAS1503520_H | non-alcoholic fatty liver disease QTL GWAS1503520 (human) | | 4e-17 | non-alcoholic fatty liver disease | | 10 | 77940296 | 77940297 | Human |
597317322 | GWAS1413396_H | vaginal microbiome measurement QTL GWAS1413396 (human) | | 0.000007 | vaginal microbiome measurement | | 10 | 83859967 | 83859968 | Human |
407039248 | GWAS688224_H | gamma-linolenic acid measurement QTL GWAS688224 (human) | | 0.000004 | fatty acid amount (VT:0010046) | blood free fatty acids level (CMO:0000117) | 10 | 84030720 | 84030721 | Human |
597210826 | GWAS1306900_H | lymphocyte count QTL GWAS1306900 (human) | | 1e-32 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95763038 | 95763039 | Human |
597513935 | GWAS1610009_H | 4-hydroxyglutamate measurement QTL GWAS1610009 (human) | | 3e-14 | 4-hydroxyglutamate measurement | | 10 | 97599655 | 97599656 | Human |
597104325 | GWAS1200399_H | neutrophil count QTL GWAS1200399 (human) | | 3e-12 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 102476052 | 102476053 | Human |
597210827 | GWAS1306901_H | lymphocyte count QTL GWAS1306901 (human) | | 3e-14 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95902897 | 95902898 | Human |
597104324 | GWAS1200398_H | neutrophil count QTL GWAS1200398 (human) | | 5e-12 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 97355926 | 97355927 | Human |
597587658 | GWAS1644518_H | benign colon neoplasm QTL GWAS1644518 (human) | | 9e-25 | benign colon neoplasm | | 10 | 79059375 | 79059376 | Human |
597104323 | GWAS1200397_H | neutrophil count QTL GWAS1200397 (human) | | 3e-72 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 97314229 | 97314234 | Human |
597104322 | GWAS1200396_H | neutrophil count QTL GWAS1200396 (human) | | 3e-18 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 94450643 | 94450644 | Human |
597505736 | GWAS1601810_H | smoking initiation QTL GWAS1601810 (human) | | 1e-24 | smoking initiation | | 10 | 102890176 | 102890177 | Human |
597489354 | GWAS1585428_H | prostate carcinoma QTL GWAS1585428 (human) | | 1e-19 | prostate carcinoma | | 10 | 78478258 | 78478259 | Human |
597104321 | GWAS1200395_H | neutrophil count QTL GWAS1200395 (human) | | 3e-11 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 91873094 | 91873095 | Human |
597489355 | GWAS1585429_H | prostate carcinoma QTL GWAS1585429 (human) | | 1e-41 | prostate carcinoma | | 10 | 102662289 | 102662290 | Human |
407145758 | GWAS794734_H | type 2 diabetes mellitus QTL GWAS794734 (human) | | 2e-08 | type 2 diabetes mellitus | | 10 | 92703125 | 92703126 | Human |
597399233 | GWAS1495307_H | vaginal microbiome measurement QTL GWAS1495307 (human) | | 0.000006 | vaginal microbiome measurement | | 10 | 99523587 | 99523588 | Human |
597309178 | GWAS1405252_H | vaginal microbiome measurement QTL GWAS1405252 (human) | | 0.0000002 | vaginal microbiome measurement | | 10 | 89419538 | 89419539 | Human |
597309179 | GWAS1405253_H | vaginal microbiome measurement QTL GWAS1405253 (human) | | 0.000008 | vaginal microbiome measurement | | 10 | 89422096 | 89422097 | Human |
597300988 | GWAS1397062_H | complement C1q subcomponent subunit C measurement QTL GWAS1397062 (human) | | 2e-14 | complement C1q subcomponent subunit C measurement | | 10 | 89307681 | 89307682 | Human |
597284593 | GWAS1380667_H | triglyceride measurement, low density lipoprotein cholesterol measurement QTL GWAS1380667 (human) | | 4e-11 | triglyceride measurement, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 93083778 | 93083779 | Human |
406940971 | GWAS589947_H | insomnia measurement QTL GWAS589947 (human) | | 2e-09 | sleep behavior trait (VT:0001501) | | 10 | 103183291 | 103183292 | Human |
406940970 | GWAS589946_H | insomnia measurement QTL GWAS589946 (human) | | 5e-08 | sleep behavior trait (VT:0001501) | | 10 | 102481926 | 102481927 | Human |
597178100 | GWAS1274174_H | protein measurement QTL GWAS1274174 (human) | | 8e-16 | protein measurement | | 10 | 95294018 | 95294019 | Human |
407047479 | GWAS696455_H | plasma betaine measurement QTL GWAS696455 (human) | | 0.000004 | plasma betaine measurement | | 10 | 102179548 | 102179549 | Human |
597268195 | GWAS1364269_H | facial width measurement QTL GWAS1364269 (human) | | 0.000006 | facial morphology trait (VT:0003743) | | 10 | 84687741 | 84687742 | Human |
407022904 | GWAS671880_H | serum IgG glycosylation measurement QTL GWAS671880 (human) | | 0.000005 | serum IgG glycosylation measurement | | 10 | 96672946 | 96672947 | Human |
597423847 | GWAS1519921_H | response to anticonvulsant QTL GWAS1519921 (human) | | 0.000004 | response to anticonvulsant | | 10 | 98332004 | 98332005 | Human |
597079574 | GWAS1175648_H | Red cell distribution width QTL GWAS1175648 (human) | | 3e-14 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 101427425 | 101427426 | Human |
597079575 | GWAS1175649_H | Red cell distribution width QTL GWAS1175649 (human) | | 6e-15 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 102875591 | 102875592 | Human |
597366297 | GWAS1462371_H | gut microbiome measurement QTL GWAS1462371 (human) | | 0.000006 | gut microbiome measurement | | 10 | 88988979 | 88988980 | Human |
597079572 | GWAS1175646_H | Red cell distribution width QTL GWAS1175646 (human) | | 3e-36 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 94593444 | 94593445 | Human |
597079573 | GWAS1175647_H | Red cell distribution width QTL GWAS1175647 (human) | | 9e-16 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 100315722 | 100315723 | Human |
597292572 | GWAS1388646_H | intraocular pressure measurement QTL GWAS1388646 (human) | | 8e-21 | intraocular pressure measurement | | 10 | 93285032 | 93285033 | Human |
597054995 | GWAS1151069_H | intelligence QTL GWAS1151069 (human) | | 1e-11 | intelligence | | 10 | 100152437 | 100152438 | Human |
597071377 | GWAS1167451_H | serum alanine aminotransferase measurement QTL GWAS1167451 (human) | | 1e-08 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 77920756 | 77920757 | Human |
597161502 | GWAS1257576_H | glutamine measurement QTL GWAS1257576 (human) | | 1e-08 | glutamine measurement | blood amino acid measurement (CMO:0003730) | 10 | 97600168 | 97600169 | Human |
597161501 | GWAS1257575_H | glutamine measurement QTL GWAS1257575 (human) | | 2e-08 | glutamine measurement | blood amino acid measurement (CMO:0003730) | 10 | 87060835 | 87060836 | Human |
597612053 | GWAS1668913_H | temporomandibular joint disorder QTL GWAS1668913 (human) | | 1e-11 | temporomandibular joint disorder | | 10 | 88672563 | 88672564 | Human |
406965709 | GWAS614685_H | sarcoidosis QTL GWAS614685 (human) | | 0.000001 | sarcoidosis | | 10 | 80151969 | 80151970 | Human |
597292565 | GWAS1388639_H | FEV/FVC ratio, peptic ulcer disease QTL GWAS1388639 (human) | | 2e-08 | FEV/FVC ratio, peptic ulcer disease | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 80448436 | 80448437 | Human |
597104153 | GWAS1200227_H | corneal topography QTL GWAS1200227 (human) | | 2e-19 | corneal topography | | 10 | 97315202 | 97315203 | Human |
597030426 | GWAS1126500_H | waist-hip ratio QTL GWAS1126500 (human) | | 4e-14 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 79181660 | 79181661 | Human |
597055001 | GWAS1151075_H | intelligence QTL GWAS1151075 (human) | | 2e-11 | intelligence | | 10 | 102364848 | 102364849 | Human |
597300745 | GWAS1396819_H | protocadherin alpha-7 measurement QTL GWAS1396819 (human) | | 2e-52 | protocadherin alpha-7 measurement | | 10 | 100069757 | 100069758 | Human |
597333518 | GWAS1429592_H | R-6-hydroxywarfarin to R-warfarin ratio measurement QTL GWAS1429592 (human) | | 0.000003 | R-6-hydroxywarfarin to R-warfarin ratio measurement | | 10 | 94998551 | 94998552 | Human |
597308943 | GWAS1405017_H | triglyceride measurement QTL GWAS1405017 (human) | | 0.000007 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079885 | 93079886 | Human |
597104129 | GWAS1200203_H | myocardial infarction QTL GWAS1200203 (human) | | 1e-20 | myocardial infarction | | 10 | 89243047 | 89243048 | Human |
597407235 | GWAS1503309_H | vaginal microbiome measurement QTL GWAS1503309 (human) | | 0.000006 | vaginal microbiome measurement | | 10 | 99484770 | 99484771 | Human |
596964877 | GWAS1084396_H | diet measurement, alanine aminotransferase 1 measurement QTL GWAS1084396 (human) | | 0.000002 | diet measurement, alanine aminotransferase 1 measurement | | 10 | 98711875 | 98711876 | Human |
597407234 | GWAS1503308_H | vaginal microbiome measurement QTL GWAS1503308 (human) | | 0.000008 | vaginal microbiome measurement | | 10 | 99469977 | 99469978 | Human |
597612036 | GWAS1668896_H | erythrocyte count QTL GWAS1668896 (human) | | 3e-29 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 99528481 | 99528482 | Human |
597317120 | GWAS1413194_H | systolic blood pressure QTL GWAS1413194 (human) | | 2e-43 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103141734 | 103141735 | Human |
597612037 | GWAS1668897_H | erythrocyte count QTL GWAS1668897 (human) | | 1e-11 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 101578251 | 101578252 | Human |
597284357 | GWAS1380431_H | pulmonary surfactant-associated protein d measurement QTL GWAS1380431 (human) | | 5e-25 | pulmonary surfactant-associated protein d measurement | | 10 | 79946568 | 79946569 | Human |
597112329 | GWAS1208403_H | diastolic blood pressure QTL GWAS1208403 (human) | | 2e-17 | eicosanoid amount (VT:0010787) | diastolic blood pressure (CMO:0000005) | 10 | 100315722 | 100315723 | Human |
597284358 | GWAS1380432_H | pulmonary surfactant-associated protein d measurement QTL GWAS1380432 (human) | | 5e-13 | pulmonary surfactant-associated protein d measurement | | 10 | 79614701 | 79614702 | Human |
597595711 | GWAS1652571_H | blood urea nitrogen measurement QTL GWAS1652571 (human) | | 7e-13 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 10 | 94279840 | 94279841 | Human |
597440063 | GWAS1536137_H | susceptibility to vaginal yeast infection measurement QTL GWAS1536137 (human) | | 0.000001 | response to fungal infection trait (VT:0010436) | | 10 | 91540556 | 91540557 | Human |
597186108 | GWAS1282182_H | 3-hydroxy-2-ethylpropionate measurement QTL GWAS1282182 (human) | | 5e-17 | 3-hydroxy-2-ethylpropionate measurement | | 10 | 95096253 | 95096254 | Human |
597481012 | GWAS1577086_H | protein measurement QTL GWAS1577086 (human) | | 6e-10 | protein measurement | | 10 | 78212702 | 78212703 | Human |
597521973 | GWAS1618047_H | B-cell acute lymphoblastic leukemia, inflammatory bowel disease QTL GWAS1618047 (human) | | 3e-08 | leukocyte integrity trait (VT:0010898) | | 10 | 99444757 | 99444758 | Human |
597071423 | GWAS1167497_H | ankylosing spondylitis QTL GWAS1167497 (human) | | 2e-09 | ankylosing spondylitis | | 10 | 79300560 | 79300561 | Human |
597071420 | GWAS1167494_H | HbA1c measurement QTL GWAS1167494 (human) | | 2e-11 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 10 | 92706682 | 92706683 | Human |
597464626 | GWAS1560700_H | response to antidepressant QTL GWAS1560700 (human) | | 0.000004 | response to antidepressant | | 10 | 103515993 | 103515994 | Human |
597071398 | GWAS1167472_H | platelet count QTL GWAS1167472 (human) | | 1e-11 | platelet quantity (VT:0003179) | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 93079885 | 93079886 | Human |
597104166 | GWAS1200240_H | corneal topography QTL GWAS1200240 (human) | | 0.0000002 | corneal topography | | 10 | 101064592 | 101064593 | Human |
597308968 | GWAS1405042_H | HMG CoA reductase inhibitor use measurement QTL GWAS1405042 (human) | | 7e-18 | HMG CoA reductase inhibitor use measurement | | 10 | 93079885 | 93079886 | Human |
597063204 | GWAS1159278_H | autism spectrum disorder, schizophrenia QTL GWAS1159278 (human) | | 4e-14 | autism spectrum disorder, schizophrenia | | 10 | 103153896 | 103153897 | Human |
597284441 | GWAS1380515_H | triglycerides in large LDL measurement QTL GWAS1380515 (human) | | 8e-11 | blood LDL triglyceride amount (VT:0010699) | | 10 | 93083778 | 93083779 | Human |
597390939 | GWAS1487013_H | refractive error QTL GWAS1487013 (human) | | 1e-08 | refractive error | | 10 | 100889103 | 100889104 | Human |
597587548 | GWAS1644408_H | eosinophil count QTL GWAS1644408 (human) | | 3e-13 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 92725454 | 92725455 | Human |
597071454 | GWAS1167528_H | aspartate aminotransferase measurement QTL GWAS1167528 (human) | | 1e-25 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99372525 | 99372526 | Human |
597333590 | GWAS1429664_H | S-6-hydroxywarfarin measurement QTL GWAS1429664 (human) | | 0.0000003 | S-6-hydroxywarfarin measurement | | 10 | 92778602 | 92778603 | Human |
597333588 | GWAS1429662_H | S-6-hydroxywarfarin measurement QTL GWAS1429662 (human) | | 0.000007 | S-6-hydroxywarfarin measurement | | 10 | 91911530 | 91911531 | Human |
597620304 | GWAS1677164_H | triglyceride measurement QTL GWAS1677164 (human) | | 1e-42 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079885 | 93079886 | Human |
597292630 | GWAS1388704_H | non-high density lipoprotein cholesterol measurement QTL GWAS1388704 (human) | | 3e-13 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 10 | 93079885 | 93079886 | Human |
597620305 | GWAS1677165_H | triglyceride measurement QTL GWAS1677165 (human) | | 3e-13 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 102127596 | 102127597 | Human |
406941070 | GWAS590046_H | insomnia measurement QTL GWAS590046 (human) | | 7e-10 | sleep behavior trait (VT:0001501) | | 10 | 102925542 | 102925543 | Human |
597268041 | GWAS1364115_H | Alzheimer disease QTL GWAS1364115 (human) | | 0.0000007 | Alzheimer disease | | 10 | 96266650 | 96266651 | Human |
597390921 | GWAS1486995_H | apolipoprotein A 1 measurement QTL GWAS1486995 (human) | | 6e-12 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 10 | 93063586 | 93063587 | Human |
597399112 | GWAS1495186_H | cup-to-disc ratio measurement QTL GWAS1495186 (human) | | 4e-10 | cup-to-disc ratio measurement | | 10 | 94311804 | 94311805 | Human |
597595725 | GWAS1652585_H | chloride measurement QTL GWAS1652585 (human) | | 1e-15 | chloride measurement | blood chloride level (CMO:0000497) | 10 | 102716535 | 102716536 | Human |
597038659 | GWAS1134733_H | high density lipoprotein cholesterol measurement QTL GWAS1134733 (human) | | 1e-23 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 93079885 | 93079886 | Human |
597349964 | GWAS1446038_H | urate measurement QTL GWAS1446038 (human) | | 3e-09 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 79184390 | 79184391 | Human |
407252381 | GWAS901357_H | adolescent idiopathic scoliosis QTL GWAS901357 (human) | | 0.000007 | adolescent idiopathic scoliosis | | 10 | 80757710 | 80757711 | Human |
597620293 | GWAS1677153_H | total cholesterol measurement QTL GWAS1677153 (human) | | 8e-12 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 89243047 | 89243048 | Human |
597579333 | GWAS1636193_H | eosinophil count QTL GWAS1636193 (human) | | 2e-11 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 92725454 | 92725455 | Human |
407170456 | GWAS819432_H | FEV/FVC ratio QTL GWAS819432 (human) | | 8e-08 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 79558486 | 79558487 | Human |
597374535 | GWAS1470609_H | Crohn's disease QTL GWAS1470609 (human) | | 0.0000005 | intestine integrity trait (VT:0010554) | | 10 | 99532633 | 99532634 | Human |
597038664 | GWAS1134738_H | body mass index QTL GWAS1134738 (human) | | 0.0000001 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102924787 | 102924788 | Human |
597399161 | GWAS1495235_H | vaginal microbiome measurement QTL GWAS1495235 (human) | | 0.000002 | vaginal microbiome measurement | | 10 | 89401598 | 89401599 | Human |
597186171 | GWAS1282245_H | triglycerides in IDL measurement QTL GWAS1282245 (human) | | 8e-10 | triglycerides in IDL measurement | blood lipoprotein triglyceride level (CMO:0002685) | 10 | 91882151 | 91882152 | Human |
406957474 | GWAS606450_H | granulocyte percentage of myeloid white cells QTL GWAS606450 (human) | | 3e-10 | granulocyte quantity (VT:0000334) | | 10 | 97395225 | 97395226 | Human |
597497470 | GWAS1593544_H | protein measurement QTL GWAS1593544 (human) | | 1e-72 | protein measurement | | 10 | 100130207 | 100130208 | Human |
597472888 | GWAS1568962_H | tumor necrosis factor receptor superfamily member 6 measurement QTL GWAS1568962 (human) | | 8e-11 | tumor necrosis factor receptor superfamily member 6 measurement | | 10 | 88970454 | 88970455 | Human |
407367072 | GWAS1016048_H | p-tau measurement QTL GWAS1016048 (human) | | 0.000005 | p-tau measurement | | 10 | 84858274 | 84858275 | Human |
597071486 | GWAS1167560_H | aspartate aminotransferase measurement QTL GWAS1167560 (human) | | 3e-10 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 98480617 | 98480618 | Human |
597472886 | GWAS1568960_H | tumor necrosis factor receptor superfamily member 6 measurement QTL GWAS1568960 (human) | | 2e-185 | tumor necrosis factor receptor superfamily member 6 measurement | | 10 | 89010241 | 89010242 | Human |
597472887 | GWAS1568961_H | tumor necrosis factor receptor superfamily member 6 measurement QTL GWAS1568961 (human) | | 4e-47 | tumor necrosis factor receptor superfamily member 6 measurement | | 10 | 89023563 | 89023564 | Human |
597202537 | GWAS1298611_H | lean body mass QTL GWAS1298611 (human) | | 3e-12 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 79376373 | 79376374 | Human |
406973877 | GWAS622853_H | forced expiratory volume, response to bronchodilator QTL GWAS622853 (human) | | 0.0000008 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 10 | 80460841 | 80460842 | Human |
597603944 | GWAS1660804_H | Red cell distribution width QTL GWAS1660804 (human) | | 1e-11 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 89243170 | 89243171 | Human |
597071468 | GWAS1167542_H | ankylosing spondylitis QTL GWAS1167542 (human) | | 5e-14 | ankylosing spondylitis | | 10 | 99518968 | 99518969 | Human |
597309025 | GWAS1405099_H | vaginal microbiome measurement QTL GWAS1405099 (human) | | 0.000008 | vaginal microbiome measurement | | 10 | 79183214 | 79183215 | Human |
597522019 | GWAS1618093_H | Abdominal Aortic Aneurysm QTL GWAS1618093 (human) | | 3e-30 | Abdominal Aortic Aneurysm | | 10 | 94138924 | 94138925 | Human |
596989547 | GWAS1109066_H | neuroimaging measurement QTL GWAS1109066 (human) | | 5e-17 | neuroimaging measurement | | 10 | 94279840 | 94279841 | Human |
597611934 | GWAS1668794_H | platelet count QTL GWAS1668794 (human) | | 2e-12 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 95738465 | 95738466 | Human |
597136791 | GWAS1232865_H | 9-hydroxystearate measurement QTL GWAS1232865 (human) | | 3e-14 | glycerophosphocholine amount (VT:0011004) | | 10 | 100315722 | 100315723 | Human |
597611935 | GWAS1668795_H | platelet count QTL GWAS1668795 (human) | | 2e-17 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 99520522 | 99520523 | Human |
597218714 | GWAS1314788_H | BMI-adjusted waist-hip ratio QTL GWAS1314788 (human) | | 2e-13 | body size trait (VT:0100005) | | 10 | 79158760 | 79158761 | Human |
407129670 | GWAS778646_H | hormone measurement QTL GWAS778646 (human) | | 5e-09 | hormone measurement | blood hormone level (CMO:0001003) | 10 | 92725454 | 92725455 | Human |
597398937 | GWAS1495011_H | calpastatin measurement QTL GWAS1495011 (human) | | 2e-17 | calpastatin measurement | | 10 | 100038589 | 100038590 | Human |
597300633 | GWAS1396707_H | response to methotrexate, neurotoxicity QTL GWAS1396707 (human) | | 0.000004 | response to methotrexate, neurotoxicity | | 10 | 101085484 | 101085485 | Human |
407047749 | GWAS696725_H | aspartate aminotransferase measurement QTL GWAS696725 (human) | | 0.0000009 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99397681 | 99397682 | Human |
597603737 | GWAS1660597_H | neutrophil count QTL GWAS1660597 (human) | | 2e-19 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 97336188 | 97336189 | Human |
597030301 | GWAS1126375_H | waist-hip ratio QTL GWAS1126375 (human) | | 0.0000002 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 94186763 | 94186764 | Human |
406974027 | GWAS623003_H | forced expiratory volume, response to bronchodilator QTL GWAS623003 (human) | | 0.000005 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 10 | 80492013 | 80492014 | Human |
597333392 | GWAS1429466_H | neuroimaging measurement QTL GWAS1429466 (human) | | 5e-08 | neuroimaging measurement | | 10 | 94263320 | 94263321 | Human |
597136797 | GWAS1232871_H | andro steroid monosulfate C19H28O6S (1) measurement QTL GWAS1232871 (human) | | 2e-20 | andro steroid monosulfate C19H28O6S (1) measurement | | 10 | 95064981 | 95064982 | Human |
597595541 | GWAS1652401_H | myocardial infarction QTL GWAS1652401 (human) | | 1e-20 | myocardial infarction | | 10 | 89243170 | 89243171 | Human |
406908491 | GWAS557467_H | unipolar depression, bipolar disorder QTL GWAS557467 (human) | | 3e-08 | unipolar depression, bipolar disorder | | 10 | 102924787 | 102924788 | Human |
597587346 | GWAS1644206_H | colorectal cancer QTL GWAS1644206 (human) | | 9e-12 | colorectal cancer | | 10 | 79059375 | 79059376 | Human |
597308822 | GWAS1404896_H | vaginal microbiome measurement QTL GWAS1404896 (human) | | 0.000001 | vaginal microbiome measurement | | 10 | 89422096 | 89422097 | Human |
597046681 | GWAS1142755_H | vitamin D measurement QTL GWAS1142755 (human) | | 1e-10 | vitamin D measurement | | 10 | 80282868 | 80282869 | Human |
597333386 | GWAS1429460_H | neuroimaging measurement QTL GWAS1429460 (human) | | 5e-09 | neuroimaging measurement | | 10 | 94263320 | 94263321 | Human |
597333387 | GWAS1429461_H | neuroimaging measurement QTL GWAS1429461 (human) | | 3e-09 | neuroimaging measurement | | 10 | 94263320 | 94263321 | Human |
597226891 | GWAS1322965_H | asthma, age at onset QTL GWAS1322965 (human) | | 0.0000008 | asthma, age at onset | | 10 | 92624756 | 92624761 | Human |
597333385 | GWAS1429459_H | neuroimaging measurement QTL GWAS1429459 (human) | | 5e-08 | neuroimaging measurement | | 10 | 94253193 | 94253194 | Human |
597153156 | GWAS1249230_H | triglyceride measurement, high density lipoprotein cholesterol measurement QTL GWAS1249230 (human) | | 5e-08 | triglyceride measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 100152437 | 100152438 | Human |
597333390 | GWAS1429464_H | neuroimaging measurement QTL GWAS1429464 (human) | | 7e-09 | neuroimaging measurement | | 10 | 94253193 | 94253194 | Human |
597087619 | GWAS1183693_H | type 2 diabetes mellitus QTL GWAS1183693 (human) | | 1e-128 | type 2 diabetes mellitus | | 10 | 92703125 | 92703126 | Human |
597333388 | GWAS1429462_H | neuroimaging measurement QTL GWAS1429462 (human) | | 6e-09 | neuroimaging measurement | | 10 | 94263320 | 94263321 | Human |
597333389 | GWAS1429463_H | neuroimaging measurement QTL GWAS1429463 (human) | | 5e-17 | neuroimaging measurement | | 10 | 94279840 | 94279841 | Human |
597349762 | GWAS1445836_H | body mass index QTL GWAS1445836 (human) | | 3e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100687890 | 100687891 | Human |
597194114 | GWAS1290188_H | COVID-19 QTL GWAS1290188 (human) | | 8e-09 | COVID-19 | | 10 | 79946568 | 79946569 | Human |
597112203 | GWAS1208277_H | protein measurement QTL GWAS1208277 (human) | | 1e-09 | protein measurement | | 10 | 95296494 | 95296495 | Human |
597464451 | GWAS1560525_H | alcohol drinking, high density lipoprotein cholesterol measurement QTL GWAS1560525 (human) | | 6e-09 | alcohol drinking, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079967 | 93079968 | Human |
597439932 | GWAS1536006_H | granulocyte colony-stimulating factor measurement QTL GWAS1536006 (human) | | 0.000002 | cytokine amount (VT:0008713) | | 10 | 90320085 | 90320086 | Human |
597603774 | GWAS1660634_H | neutrophil count QTL GWAS1660634 (human) | | 2e-43 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 97334679 | 97334680 | Human |
597243320 | GWAS1339394_H | glucose measurement QTL GWAS1339394 (human) | | 2e-10 | glucose measurement | blood glucose level (CMO:0000046) | 10 | 92707153 | 92707154 | Human |
597292477 | GWAS1388551_H | respiratory system disease QTL GWAS1388551 (human) | | 2e-11 | respiratory system disease | | 10 | 92682235 | 92682237 | Human |
597292479 | GWAS1388553_H | age at menarche QTL GWAS1388553 (human) | | 2e-08 | age at menarche | | 10 | 91223151 | 91223152 | Human |
597489083 | GWAS1585157_H | phosphatidylethanolamine measurement QTL GWAS1585157 (human) | | 2e-08 | phosphatidylethanolamine measurement | | 10 | 101245795 | 101245796 | Human |
597358002 | GWAS1454076_H | chronic obstructive pulmonary disease, surfactant protein D measurement QTL GWAS1454076 (human) | | 2e-27 | lung integrity trait (VT:0010906) | | 10 | 79976225 | 79976226 | Human |
597358003 | GWAS1454077_H | chronic obstructive pulmonary disease, surfactant protein D measurement QTL GWAS1454077 (human) | | 1e-11 | lung integrity trait (VT:0010906) | | 10 | 80122614 | 80122615 | Human |
597243315 | GWAS1339389_H | serum gamma-glutamyl transferase measurement QTL GWAS1339389 (human) | | 5e-82 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 77920676 | 77920677 | Human |
597595572 | GWAS1652432_H | drug use measurement, coronary artery disease QTL GWAS1652432 (human) | | 9e-23 | drug use measurement, coronary artery disease | | 10 | 89243170 | 89243171 | Human |
597267891 | GWAS1363965_H | aortic measurement QTL GWAS1363965 (human) | | 2e-30 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 94140176 | 94140177 | Human |
597112253 | GWAS1208327_H | protein measurement QTL GWAS1208327 (human) | | 3e-10 | protein measurement | | 10 | 100742278 | 100742279 | Human |
406965866 | GWAS614842_H | response to radiation, prostate carcinoma QTL GWAS614842 (human) | | 0.000002 | response to radiation, prostate carcinoma | | 10 | 100170652 | 100170653 | Human |
597218741 | GWAS1314815_H | glucose measurement QTL GWAS1314815 (human) | | 2e-09 | glucose measurement | blood glucose level (CMO:0000046) | 10 | 93624395 | 93624396 | Human |
597317044 | GWAS1413118_H | diastolic blood pressure, systolic blood pressure QTL GWAS1413118 (human) | | 1e-13 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 98254058 | 98254059 | Human |
597317033 | GWAS1413107_H | Pregn steroid monosulfate measurement QTL GWAS1413107 (human) | | 4e-12 | Pregn steroid monosulfate measurement | | 10 | 92607104 | 92607105 | Human |
406965879 | GWAS614855_H | autism spectrum disorder QTL GWAS614855 (human) | | 0.0000004 | autism spectrum disorder | | 10 | 102431844 | 102431845 | Human |
597325218 | GWAS1421292_H | N2-acetyl,N6-methyllysine measurement QTL GWAS1421292 (human) | | 5e-219 | N2-acetyl,N6-methyllysine measurement | | 10 | 98386556 | 98386557 | Human |
597325219 | GWAS1421293_H | N2-acetyl,N6,N6-dimethyllysine measurement QTL GWAS1421293 (human) | | 4e-248 | N2-acetyl,N6,N6-dimethyllysine measurement | | 10 | 98386556 | 98386557 | Human |
597439909 | GWAS1535983_H | intelligence QTL GWAS1535983 (human) | | 0.000003 | intelligence | | 10 | 102230055 | 102230056 | Human |
597521824 | GWAS1617898_H | urate measurement QTL GWAS1617898 (human) | | 4e-09 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 80377705 | 80377706 | Human |
597423525 | GWAS1519599_H | testosterone measurement QTL GWAS1519599 (human) | | 5e-09 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 79007449 | 79007450 | Human |
597325220 | GWAS1421294_H | N6-methyllysine measurement QTL GWAS1421294 (human) | | 5e-303 | N6-methyllysine measurement | | 10 | 98388419 | 98388420 | Human |
597611936 | GWAS1668796_H | platelet count QTL GWAS1668796 (human) | | 2e-12 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 102618377 | 102618378 | Human |
597489059 | GWAS1585133_H | aspartate aminotransferase measurement QTL GWAS1585133 (human) | | 8e-11 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 96700824 | 96700825 | Human |
597439907 | GWAS1535981_H | intelligence, self reported educational attainment QTL GWAS1535981 (human) | | 3e-13 | intelligence, self reported educational attainment | | 10 | 102230055 | 102230056 | Human |
597325275 | GWAS1421349_H | Abnormality of the genital system QTL GWAS1421349 (human) | | 0.000001 | Abnormality of the genital system | | 10 | 93215254 | 93215255 | Human |
597259739 | GWAS1355813_H | triglyceride measurement, phospholipid measurement QTL GWAS1355813 (human) | | 5e-10 | triglyceride measurement, phospholipid measurement | blood triglyceride level (CMO:0000118) | 10 | 98013128 | 98013129 | Human |
406973954 | GWAS622930_H | forced expiratory volume, response to bronchodilator QTL GWAS622930 (human) | | 0.000002 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 10 | 80470390 | 80470391 | Human |
597407198 | GWAS1503272_H | total blood protein measurement QTL GWAS1503272 (human) | | 8e-09 | total blood protein measurement | blood protein measurement (CMO:0000028) | 10 | 94264600 | 94264601 | Human |
596964831 | GWAS1084350_H | colorectal cancer QTL GWAS1084350 (human) | | 3e-09 | colorectal cancer | | 10 | 89745536 | 89745537 | Human |
597398998 | GWAS1495072_H | glutamine measurement QTL GWAS1495072 (human) | | 3e-10 | glutamine measurement | blood amino acid measurement (CMO:0003730) | 10 | 97599655 | 97599656 | Human |
597587408 | GWAS1644268_H | hypothyroidism QTL GWAS1644268 (human) | | 8e-18 | hypothyroidism | | 10 | 88089762 | 88089763 | Human |
597095896 | GWAS1191970_H | schizophrenia QTL GWAS1191970 (human) | | 3e-17 | schizophrenia | | 10 | 103153896 | 103153897 | Human |
597177800 | GWAS1273874_H | Hodgkins lymphoma, multiple myeloma, non-Hodgkins lymphoma QTL GWAS1273874 (human) | | 1e-09 | Hodgkins lymphoma, multiple myeloma, non-Hodgkins lymphoma | | 10 | 80696232 | 80696233 | Human |
597333451 | GWAS1429525_H | S-6-hydroxywarfarin measurement QTL GWAS1429525 (human) | | 0.000001 | S-6-hydroxywarfarin measurement | | 10 | 97892335 | 97892336 | Human |
597251531 | GWAS1347605_H | serum alanine aminotransferase measurement QTL GWAS1347605 (human) | | 2e-10 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 99955492 | 99955493 | Human |
597251530 | GWAS1347604_H | serum alanine aminotransferase measurement QTL GWAS1347604 (human) | | 1e-10 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 99913702 | 99913703 | Human |
597390796 | GWAS1486870_H | Crohn's disease QTL GWAS1486870 (human) | | 1e-36 | intestine integrity trait (VT:0010554) | | 10 | 99523571 | 99523574 | Human |
597251523 | GWAS1347597_H | serum alanine aminotransferase measurement QTL GWAS1347597 (human) | | 4e-13 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 99575246 | 99575247 | Human |
597366208 | GWAS1462282_H | eosinophil percentage of leukocytes QTL GWAS1462282 (human) | | 3e-32 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 10 | 92669710 | 92669711 | Human |
597251524 | GWAS1347598_H | serum alanine aminotransferase measurement QTL GWAS1347598 (human) | | 1e-13 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 99816570 | 99816571 | Human |
597063112 | GWAS1159186_H | BMI-adjusted waist circumference QTL GWAS1159186 (human) | | 0.000004 | body size trait (VT:0100005) | | 10 | 84569594 | 84569595 | Human |
597169657 | GWAS1265731_H | type 2 diabetes mellitus QTL GWAS1265731 (human) | | 3e-44 | type 2 diabetes mellitus | | 10 | 92706682 | 92706683 | Human |
597587451 | GWAS1644311_H | hypothyroidism QTL GWAS1644311 (human) | | 2e-24 | hypothyroidism | | 10 | 99523573 | 99523574 | Human |
597046769 | GWAS1142843_H | response to interferon QTL GWAS1142843 (human) | | 0.000001 | immune response trait (VT:0010139) | | 10 | 94012060 | 94012061 | Human |
597325302 | GWAS1421376_H | color vision disorder QTL GWAS1421376 (human) | | 0.0000005 | color vision disorder | | 10 | 79439689 | 79439690 | Human |
597243380 | GWAS1339454_H | bilirubin measurement QTL GWAS1339454 (human) | | 8e-15 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 10 | 93082720 | 93082721 | Human |
597169654 | GWAS1265728_H | type 2 diabetes mellitus QTL GWAS1265728 (human) | | 1e-14 | type 2 diabetes mellitus | | 10 | 79184473 | 79184474 | Human |
597325300 | GWAS1421374_H | color vision disorder QTL GWAS1421374 (human) | | 0.0000003 | color vision disorder | | 10 | 88435044 | 88435045 | Human |
597169655 | GWAS1265729_H | type 2 diabetes mellitus QTL GWAS1265729 (human) | | 4e-09 | type 2 diabetes mellitus | | 10 | 88009583 | 88009584 | Human |
597112312 | GWAS1208386_H | systolic blood pressure QTL GWAS1208386 (human) | | 0.000002 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103086421 | 103086422 | Human |
407227956 | GWAS876932_H | colorectal cancer QTL GWAS876932 (human) | | 5e-11 | colorectal cancer | | 10 | 99585609 | 99585610 | Human |
597145059 | GWAS1241133_H | COVID-19 QTL GWAS1241133 (human) | | 0.0000001 | COVID-19 | | 10 | 80588198 | 80588199 | Human |
597390831 | GWAS1486905_H | hematocrit QTL GWAS1486905 (human) | | 2e-14 | hematocrit | hematocrit (CMO:0000037) | 10 | 87191905 | 87191906 | Human |
597046754 | GWAS1142828_H | alcoholic liver disease QTL GWAS1142828 (human) | | 0.0000001 | alcoholic liver disease | | 10 | 95282006 | 95282007 | Human |
597046753 | GWAS1142827_H | alcoholic liver disease QTL GWAS1142827 (human) | | 0.0000001 | alcoholic liver disease | | 10 | 77897947 | 77897948 | Human |
597349857 | GWAS1445931_H | electrocardiography QTL GWAS1445931 (human) | | 3e-11 | electrocardiography | | 10 | 86685984 | 86685985 | Human |
597464551 | GWAS1560625_H | hypothyroidism QTL GWAS1560625 (human) | | 1e-10 | hypothyroidism | | 10 | 99555409 | 99555410 | Human |
597136872 | GWAS1232946_H | 1-stearyl-GPC (O-18:0) measurement QTL GWAS1232946 (human) | | 8e-08 | 1-stearyl-GPC (O-18:0) measurement | | 10 | 100315722 | 100315723 | Human |
407383752 | GWAS1032728_H | obsolete_red blood cell distribution width QTL GWAS1032728 (human) | | 1e-18 | obsolete_red blood cell distribution width | | 10 | 79040331 | 79040332 | Human |
597316890 | GWAS1412964_H | vaginal microbiome measurement QTL GWAS1412964 (human) | | 0.000003 | vaginal microbiome measurement | | 10 | 89419538 | 89419539 | Human |
597087510 | GWAS1183584_H | mean corpuscular hemoglobin concentration QTL GWAS1183584 (human) | | 3e-10 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 103042109 | 103042110 | Human |
597316891 | GWAS1412965_H | vaginal microbiome measurement QTL GWAS1412965 (human) | | 0.0000004 | vaginal microbiome measurement | | 10 | 89422096 | 89422097 | Human |
597603615 | GWAS1660475_H | type 2 diabetes mellitus QTL GWAS1660475 (human) | | 8e-10 | type 2 diabetes mellitus | | 10 | 92734703 | 92734704 | Human |
407383753 | GWAS1032729_H | obsolete_red blood cell distribution width QTL GWAS1032729 (human) | | 3e-36 | obsolete_red blood cell distribution width | | 10 | 94593444 | 94593445 | Human |
407383754 | GWAS1032730_H | obsolete_red blood cell distribution width QTL GWAS1032730 (human) | | 9e-14 | obsolete_red blood cell distribution width | | 10 | 99499704 | 99499705 | Human |
597112083 | GWAS1208157_H | emphysema imaging measurement QTL GWAS1208157 (human) | | 0.000006 | emphysema imaging measurement | | 10 | 98294124 | 98294125 | Human |
407383756 | GWAS1032732_H | obsolete_red blood cell distribution width QTL GWAS1032732 (human) | | 3e-14 | obsolete_red blood cell distribution width | | 10 | 101427425 | 101427426 | Human |
407154380 | GWAS803356_H | type 2 diabetes mellitus QTL GWAS803356 (human) | | 5e-08 | type 2 diabetes mellitus | | 10 | 88009583 | 88009584 | Human |
597136670 | GWAS1232744_H | neuroimaging measurement QTL GWAS1232744 (human) | | 5e-09 | neuroimaging measurement | | 10 | 89760164 | 89760165 | Human |
597103898 | GWAS1199972_H | corneal topography QTL GWAS1199972 (human) | | 7e-54 | corneal topography | | 10 | 101064592 | 101064593 | Human |
597611793 | GWAS1668653_H | platelet count QTL GWAS1668653 (human) | | 9e-13 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 79404390 | 79404391 | Human |
597579025 | GWAS1635885_H | drug use measurement, Blindness QTL GWAS1635885 (human) | | 3e-12 | drug use measurement, Blindness | | 10 | 83248050 | 83248051 | Human |
597333259 | GWAS1429333_H | atrial fibrillation QTL GWAS1429333 (human) | | 2e-58 | atrial fibrillation | | 10 | 103575604 | 103575605 | Human |
597071105 | GWAS1167179_H | chloride measurement QTL GWAS1167179 (human) | | 3e-10 | chloride measurement | blood chloride level (CMO:0000497) | 10 | 102810527 | 102810528 | Human |
597316867 | GWAS1412941_H | X-17612 measurement QTL GWAS1412941 (human) | | 4e-18 | X-17612 measurement | | 10 | 99833993 | 99833994 | Human |
597513476 | GWAS1609550_H | complement factor H-related protein 1 measurement QTL GWAS1609550 (human) | | 2e-160 | complement factor H-related protein 1 measurement | | 10 | 100130207 | 100130208 | Human |
597316870 | GWAS1412944_H | X-17653 measurement QTL GWAS1412944 (human) | | 7e-18 | X-17653 measurement | | 10 | 94990179 | 94990180 | Human |
596964616 | GWAS1084135_H | serum alanine aminotransferase measurement QTL GWAS1084135 (human) | | 1e-14 | serum alanine aminotransferase measurement | | 10 | 100207653 | 100207654 | Human |
596964617 | GWAS1084136_H | serum alanine aminotransferase measurement QTL GWAS1084136 (human) | | 1e-12 | serum alanine aminotransferase measurement | | 10 | 100101865 | 100101866 | Human |
597095688 | GWAS1191762_H | sex hormone-binding globulin measurement QTL GWAS1191762 (human) | | 7e-19 | sex hormone-binding globulin measurement | | 10 | 93050908 | 93050909 | Human |
597587262 | GWAS1644122_H | diabetes mellitus QTL GWAS1644122 (human) | | 5e-37 | pancreas integrity trait (VT:0010560) | | 10 | 92700524 | 92700525 | Human |
597587261 | GWAS1644121_H | diabetes mellitus QTL GWAS1644121 (human) | | 3e-23 | pancreas integrity trait (VT:0010560) | | 10 | 79184473 | 79184474 | Human |
597464376 | GWAS1560450_H | lung carcinoma, family history of lung cancer QTL GWAS1560450 (human) | | 0.000005 | lung carcinoma, family history of lung cancer | | 10 | 85156391 | 85156392 | Human |
407375596 | GWAS1024572_H | treatment-resistant hypertension QTL GWAS1024572 (human) | | 0.000002 | treatment-resistant hypertension | | 10 | 85230610 | 85230611 | Human |
597333311 | GWAS1429385_H | R-6-hydroxywarfarin measurement QTL GWAS1429385 (human) | | 0.0000005 | R-6-hydroxywarfarin measurement | | 10 | 80677149 | 80677150 | Human |
597316925 | GWAS1412999_H | hippocampal volume QTL GWAS1412999 (human) | | 0.000006 | hippocampal volume | | 10 | 97933552 | 97933553 | Human |
597267760 | GWAS1363834_H | N6,N6-dimethyllysine measurement QTL GWAS1363834 (human) | | 1e-13 | N6,N6-dimethyllysine measurement | | 10 | 102142301 | 102142306 | Human |
407023340 | GWAS672316_H | serum IgG glycosylation measurement QTL GWAS672316 (human) | | 0.000003 | serum IgG glycosylation measurement | | 10 | 95541247 | 95541248 | Human |
407162603 | GWAS811579_H | serum metabolite measurement QTL GWAS811579 (human) | | 7e-23 | serum metabolite measurement | | 10 | 94880139 | 94880140 | Human |
596964644 | GWAS1084163_H | serum alanine aminotransferase measurement QTL GWAS1084163 (human) | | 5e-10 | serum alanine aminotransferase measurement | | 10 | 99811236 | 99811237 | Human |
597062951 | GWAS1159025_H | autism spectrum disorder, schizophrenia QTL GWAS1159025 (human) | | 9e-10 | autism spectrum disorder, schizophrenia | | 10 | 102664043 | 102664044 | Human |
597284138 | GWAS1380212_H | eosinophil count QTL GWAS1380212 (human) | | 1e-28 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 92708886 | 92708887 | Human |
597595435 | GWAS1652295_H | body mass index QTL GWAS1652295 (human) | | 3e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 92670740 | 92670741 | Human |
597382445 | GWAS1478519_H | type 2 diabetes mellitus QTL GWAS1478519 (human) | | 2e-12 | type 2 diabetes mellitus | | 10 | 102803986 | 102803987 | Human |
597595433 | GWAS1652293_H | body mass index QTL GWAS1652293 (human) | | 1e-15 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98257696 | 98257697 | Human |
597374240 | GWAS1470314_H | lymphocyte count QTL GWAS1470314 (human) | | 2e-10 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 99532633 | 99532634 | Human |
597603616 | GWAS1660476_H | type 2 diabetes mellitus QTL GWAS1660476 (human) | | 4e-15 | type 2 diabetes mellitus | | 10 | 92782853 | 92782854 | Human |
597284134 | GWAS1380208_H | eosinophil count QTL GWAS1380208 (human) | | 2e-09 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 89083362 | 89083363 | Human |
597284185 | GWAS1380259_H | electrocardiography QTL GWAS1380259 (human) | | 4e-08 | electrocardiography | | 10 | 79139212 | 79139213 | Human |
597611869 | GWAS1668729_H | jaw disease QTL GWAS1668729 (human) | | 1e-11 | jaw disease | | 10 | 81890243 | 81890244 | Human |
597366104 | GWAS1462178_H | triglyceride measurement, alcohol drinking QTL GWAS1462178 (human) | | 2e-12 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079967 | 93079968 | Human |
597448025 | GWAS1544099_H | cholesteryl ester measurement, high density lipoprotein cholesterol measurement QTL GWAS1544099 (human) | | 7e-15 | blood lipid amount (VT:0003949) | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079967 | 93079968 | Human |
597595476 | GWAS1652336_H | body mass index QTL GWAS1652336 (human) | | 2e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 92670740 | 92670741 | Human |
597275987 | GWAS1372061_H | Uterine leiomyoma QTL GWAS1372061 (human) | | 2e-16 | Uterine leiomyoma | | 10 | 102788270 | 102788271 | Human |
597267796 | GWAS1363870_H | aortic measurement QTL GWAS1363870 (human) | | 2e-19 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 94356663 | 94356664 | Human |
597595475 | GWAS1652335_H | body mass index QTL GWAS1652335 (human) | | 4e-16 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98257696 | 98257697 | Human |
597529936 | GWAS1626010_H | neutrophil measurement QTL GWAS1626010 (human) | | 6e-16 | neutrophil measurement | | 10 | 99492777 | 99492778 | Human |
597349704 | GWAS1445778_H | body mass index QTL GWAS1445778 (human) | | 4e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 97938999 | 97939000 | Human |
597030209 | GWAS1126283_H | balding measurement QTL GWAS1126283 (human) | | 3e-10 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 10 | 78749143 | 78749144 | Human |
597374287 | GWAS1470361_H | reticulocyte count QTL GWAS1470361 (human) | | 7e-09 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 79045259 | 79045260 | Human |
597235021 | GWAS1331095_H | Ischemic stroke QTL GWAS1331095 (human) | | 8e-08 | Ischemic stroke | | 10 | 98108273 | 98108274 | Human |
597144898 | GWAS1240972_H | age of onset of childhood onset asthma QTL GWAS1240972 (human) | | 7e-13 | age of onset of childhood onset asthma | | 10 | 92682235 | 92682236 | Human |
597366094 | GWAS1462168_H | low density lipoprotein cholesterol measurement, alcohol drinking QTL GWAS1462168 (human) | | 6e-11 | low density lipoprotein cholesterol measurement, alcohol drinking | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 93079967 | 93079968 | Human |
597235020 | GWAS1331094_H | Ischemic stroke QTL GWAS1331094 (human) | | 0.0000008 | Ischemic stroke | | 10 | 97963866 | 97963867 | Human |
597030211 | GWAS1126285_H | balding measurement QTL GWAS1126285 (human) | | 1e-15 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 10 | 88336158 | 88336159 | Human |
597030210 | GWAS1126284_H | balding measurement QTL GWAS1126284 (human) | | 4e-08 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 10 | 79198831 | 79198832 | Human |
597464395 | GWAS1560469_H | body mass index QTL GWAS1560469 (human) | | 4e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 91302354 | 91302355 | Human |
597267790 | GWAS1363864_H | aortic measurement QTL GWAS1363864 (human) | | 3e-10 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 94137431 | 94137432 | Human |
597611846 | GWAS1668706_H | platelet count QTL GWAS1668706 (human) | | 5e-15 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 93079967 | 93079968 | Human |
597267777 | GWAS1363851_H | aortic measurement QTL GWAS1363851 (human) | | 2e-10 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 94142296 | 94142297 | Human |
597046606 | GWAS1142680_H | body fat distribution QTL GWAS1142680 (human) | | 0.0000004 | body fat distribution | body fat morphological measurement (CMO:0000089) | 10 | 100687890 | 100687891 | Human |
597341507 | GWAS1437581_H | sexual dimorphism measurement QTL GWAS1437581 (human) | | 2e-10 | sexual dimorphism measurement | | 10 | 79381768 | 79381769 | Human |
597611847 | GWAS1668707_H | platelet count QTL GWAS1668707 (human) | | 7e-13 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 94518638 | 94518639 | Human |
407367324 | GWAS1016300_H | parental longevity QTL GWAS1016300 (human) | | 0.000001 | total life span (VT:0001661) | | 10 | 89169204 | 89169205 | Human |
597529923 | GWAS1625997_H | neutrophil measurement QTL GWAS1625997 (human) | | 3e-15 | neutrophil measurement | | 10 | 97337434 | 97337435 | Human |
597464446 | GWAS1560520_H | high density lipoprotein cholesterol measurement QTL GWAS1560520 (human) | | 9e-09 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079967 | 93079968 | Human |
597095797 | GWAS1191871_H | sex hormone-binding globulin measurement QTL GWAS1191871 (human) | | 0.000001 | sex hormone-binding globulin measurement | | 10 | 77781881 | 77781882 | Human |
597038463 | GWAS1134537_H | gut microbiome measurement QTL GWAS1134537 (human) | | 0.000006 | gut microbiome measurement | | 10 | 86170040 | 86170041 | Human |
597366129 | GWAS1462203_H | Crohn's disease QTL GWAS1462203 (human) | | 8e-08 | intestine integrity trait (VT:0010554) | | 10 | 99524480 | 99524481 | Human |
597456247 | GWAS1552321_H | asthma, endometriosis QTL GWAS1552321 (human) | | 0.0000004 | asthma, endometriosis | | 10 | 88026131 | 88026132 | Human |
406974122 | GWAS623098_H | response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy QTL GWAS623098 (human) | | 0.000007 | response to viral infection trait (VT:0010439) | | 10 | 98922691 | 98922692 | Human |
597489010 | GWAS1585084_H | calcium measurement QTL GWAS1585084 (human) | | 5e-16 | calcium measurement | blood calcium level (CMO:0000502) | 10 | 94278929 | 94278930 | Human |
597292393 | GWAS1388467_H | size QTL GWAS1388467 (human) | | 8e-16 | size | | 10 | 77897947 | 77897948 | Human |
597128551 | GWAS1224625_H | systolic blood pressure QTL GWAS1224625 (human) | | 0.0000003 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 102119174 | 102119175 | Human |
597325166 | GWAS1421240_H | color vision disorder QTL GWAS1421240 (human) | | 0.000009 | color vision disorder | | 10 | 86376415 | 86376416 | Human |
597325167 | GWAS1421241_H | color vision disorder QTL GWAS1421241 (human) | | 0.000009 | color vision disorder | | 10 | 81079248 | 81079249 | Human |
597366126 | GWAS1462200_H | BMI-adjusted waist-hip ratio QTL GWAS1462200 (human) | | 8e-11 | body size trait (VT:0100005) | | 10 | 87843667 | 87843668 | Human |
597505384 | GWAS1601458_H | systolic blood pressure, major depressive disorder QTL GWAS1601458 (human) | | 7e-09 | systolic blood pressure, major depressive disorder | systolic blood pressure (CMO:0000004) | 10 | 103199143 | 103199144 | Human |
597316972 | GWAS1413046_H | diastolic blood pressure QTL GWAS1413046 (human) | | 1e-18 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 100792995 | 100792996 | Human |
597112160 | GWAS1208234_H | cognitive function measurement QTL GWAS1208234 (human) | | 1e-17 | cognitive behavior trait (VT:0010450) | | 10 | 101806203 | 101806204 | Human |
597464421 | GWAS1560495_H | pulse pressure measurement, alcohol drinking QTL GWAS1560495 (human) | | 1e-29 | pulse pressure measurement, alcohol drinking | pulse pressure (CMO:0000292) | 10 | 102899261 | 102899262 | Human |
597177700 | GWAS1273774_H | triglycerides in very large VLDL measurement QTL GWAS1273774 (human) | | 8e-10 | blood VLDL triglyceride amount (VT:0010700) | | 10 | 93038216 | 93038217 | Human |
597325156 | GWAS1421230_H | inflammatory bowel disease QTL GWAS1421230 (human) | | 6e-09 | inflammatory bowel disease | | 10 | 99568261 | 99568262 | Human |
597128553 | GWAS1224627_H | systolic blood pressure QTL GWAS1224627 (human) | | 1e-111 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103146454 | 103146455 | Human |
597128552 | GWAS1224626_H | systolic blood pressure QTL GWAS1224626 (human) | | 8e-19 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103138228 | 103138229 | Human |
597357723 | GWAS1453797_H | magnesium measurement QTL GWAS1453797 (human) | | 0.000002 | magnesium measurement | serum magnesium level (CMO:0000541) | 10 | 87652818 | 87652819 | Human |
597283992 | GWAS1380066_H | C-reactive protein measurement QTL GWAS1380066 (human) | | 1e-24 | C-reactive protein measurement | | 10 | 89243170 | 89243171 | Human |
596964501 | GWAS1084020_H | birth weight QTL GWAS1084020 (human) | | 8e-13 | birth weight | neonatal body weight (CMO:0002079) | 10 | 94279840 | 94279841 | Human |
597357720 | GWAS1453794_H | magnesium measurement QTL GWAS1453794 (human) | | 0.0000004 | magnesium measurement | serum magnesium level (CMO:0000541) | 10 | 87652818 | 87652819 | Human |
597603484 | GWAS1660344_H | type 2 diabetes mellitus QTL GWAS1660344 (human) | | 8e-10 | type 2 diabetes mellitus | | 10 | 92518928 | 92518929 | Human |
597603485 | GWAS1660345_H | type 2 diabetes mellitus QTL GWAS1660345 (human) | | 9e-10 | type 2 diabetes mellitus | | 10 | 92576828 | 92576829 | Human |
597603482 | GWAS1660342_H | type 2 diabetes mellitus QTL GWAS1660342 (human) | | 9e-33 | type 2 diabetes mellitus | | 10 | 92395742 | 92395743 | Human |
597603483 | GWAS1660343_H | type 2 diabetes mellitus QTL GWAS1660343 (human) | | 2e-12 | type 2 diabetes mellitus | | 10 | 92449024 | 92449025 | Human |
597603480 | GWAS1660340_H | type 2 diabetes mellitus QTL GWAS1660340 (human) | | 9e-09 | type 2 diabetes mellitus | | 10 | 89683526 | 89683527 | Human |
597095569 | GWAS1191643_H | sex hormone-binding globulin measurement QTL GWAS1191643 (human) | | 4e-08 | sex hormone-binding globulin measurement | | 10 | 87881465 | 87881466 | Human |
597603481 | GWAS1660341_H | type 2 diabetes mellitus QTL GWAS1660341 (human) | | 1e-11 | type 2 diabetes mellitus | | 10 | 91685918 | 91685919 | Human |
597603478 | GWAS1660338_H | type 2 diabetes mellitus QTL GWAS1660338 (human) | | 1e-19 | type 2 diabetes mellitus | | 10 | 86353858 | 86353859 | Human |
597603479 | GWAS1660339_H | type 2 diabetes mellitus QTL GWAS1660339 (human) | | 8e-20 | type 2 diabetes mellitus | | 10 | 87961655 | 87961656 | Human |
597603476 | GWAS1660336_H | type 2 diabetes mellitus QTL GWAS1660336 (human) | | 1e-13 | type 2 diabetes mellitus | | 10 | 79251832 | 79251833 | Human |
597054620 | GWAS1150694_H | systolic blood pressure QTL GWAS1150694 (human) | | 5e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 87921931 | 87921932 | Human |
597603477 | GWAS1660337_H | type 2 diabetes mellitus QTL GWAS1660337 (human) | | 6e-11 | type 2 diabetes mellitus | | 10 | 79299578 | 79299579 | Human |
597054621 | GWAS1150695_H | systolic blood pressure QTL GWAS1150695 (human) | | 2e-31 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94132902 | 94132903 | Human |
597603475 | GWAS1660335_H | type 2 diabetes mellitus QTL GWAS1660335 (human) | | 1e-78 | type 2 diabetes mellitus | | 10 | 79187681 | 79187682 | Human |
597226645 | GWAS1322719_H | type 1 diabetes mellitus QTL GWAS1322719 (human) | | 0.000001 | type 1 diabetes mellitus | | 10 | 88428167 | 88428168 | Human |
597439633 | GWAS1535707_H | BMI-adjusted waist-hip ratio QTL GWAS1535707 (human) | | 0.000008 | body size trait (VT:0100005) | | 10 | 102727686 | 102727687 | Human |
597111961 | GWAS1208035_H | non-alcoholic fatty liver disease severity measurement QTL GWAS1208035 (human) | | 0.000002 | liver integrity trait (VT:0010547) | liver disease severity measurement (CMO:0002155) | 10 | 82309646 | 82309647 | Human |
597038233 | GWAS1134307_H | urinary metabolite measurement QTL GWAS1134307 (human) | | 3e-917 | urinary metabolite measurement | | 10 | 98388419 | 98388420 | Human |
597619852 | GWAS1676712_H | total cholesterol measurement QTL GWAS1676712 (human) | | 5e-12 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 89243047 | 89243048 | Human |
406957909 | GWAS606885_H | forced expiratory volume, response to bronchodilator QTL GWAS606885 (human) | | 0.000003 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 10 | 80454830 | 80454831 | Human |
597243008 | GWAS1339082_H | aspartate aminotransferase measurement QTL GWAS1339082 (human) | | 2e-18 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 77897947 | 77897948 | Human |
597390465 | GWAS1486539_H | Crohn's disease QTL GWAS1486539 (human) | | 6e-47 | intestine integrity trait (VT:0010554) | | 10 | 99524480 | 99524481 | Human |
597210243 | GWAS1306317_H | blood protein measurement QTL GWAS1306317 (human) | | 2e-09 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 92762681 | 92762682 | Human |
597439623 | GWAS1535697_H | BMI-adjusted waist-hip ratio QTL GWAS1535697 (human) | | 0.000004 | body size trait (VT:0100005) | | 10 | 102727686 | 102727687 | Human |
597595266 | GWAS1652126_H | coronary artery disease QTL GWAS1652126 (human) | | 5e-23 | coronary artery disease | | 10 | 89243047 | 89243048 | Human |
597054603 | GWAS1150677_H | household income QTL GWAS1150677 (human) | | 5e-11 | household income | | 10 | 101853341 | 101853342 | Human |
597324984 | GWAS1421058_H | color vision disorder QTL GWAS1421058 (human) | | 0.000004 | color vision disorder | | 10 | 82219894 | 82219895 | Human |
597374131 | GWAS1470205_H | fatty acid measurement QTL GWAS1470205 (human) | | 0.0000004 | fatty acid measurement | | 10 | 85193571 | 85193572 | Human |
597038271 | GWAS1134345_H | urinary metabolite measurement QTL GWAS1134345 (human) | | 1e-12 | urinary metabolite measurement | | 10 | 95227255 | 95227256 | Human |
597300403 | GWAS1396477_H | apolipoprotein L1 measurement QTL GWAS1396477 (human) | | 3e-33 | apolipoprotein L1 measurement | | 10 | 100045685 | 100045686 | Human |
406957933 | GWAS606909_H | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis QTL GWAS606909 (human) | | 1e-13 | intestine integrity trait (VT:0010554) | | 10 | 80491075 | 80491076 | Human |
597210292 | GWAS1306366_H | neuroimaging measurement QTL GWAS1306366 (human) | | 8e-10 | neuroimaging measurement | | 10 | 94253193 | 94253194 | Human |
597054650 | GWAS1150724_H | systolic blood pressure QTL GWAS1150724 (human) | | 2e-38 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 100792995 | 100792996 | Human |
597054651 | GWAS1150725_H | systolic blood pressure QTL GWAS1150725 (human) | | 4e-57 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103146454 | 103146455 | Human |
597054648 | GWAS1150722_H | systolic blood pressure QTL GWAS1150722 (human) | | 9e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 95502784 | 95502785 | Human |
597054649 | GWAS1150723_H | systolic blood pressure QTL GWAS1150723 (human) | | 2e-12 | heptadecanoic acid measurement | systolic blood pressure (CMO:0000004) | 10 | 100315722 | 100315723 | Human |
406957940 | GWAS606916_H | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis QTL GWAS606916 (human) | | 3e-11 | intestine integrity trait (VT:0010554) | | 10 | 92672243 | 92672244 | Human |
597202095 | GWAS1298169_H | lean body mass QTL GWAS1298169 (human) | | 1e-09 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 88013232 | 88013233 | Human |
597071022 | GWAS1167096_H | bilirubin measurement QTL GWAS1167096 (human) | | 1e-09 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 10 | 93050042 | 93050043 | Human |
597161134 | GWAS1257208_H | gut microbiome measurement QTL GWAS1257208 (human) | | 7e-09 | gut microbiome measurement | | 10 | 96390553 | 96390554 | Human |
597284004 | GWAS1380078_H | electrocardiography QTL GWAS1380078 (human) | | 1e-08 | electrocardiography | | 10 | 79139212 | 79139213 | Human |
597447841 | GWAS1543915_H | omega-3 polyunsaturated fatty acid measurement QTL GWAS1543915 (human) | | 4e-10 | omega-3 polyunsaturated fatty acid measurement | | 10 | 93079967 | 93079968 | Human |
597333159 | GWAS1429233_H | S-7-hydroxywarfarin measurement QTL GWAS1429233 (human) | | 0.000002 | S-7-hydroxywarfarin measurement | | 10 | 101352877 | 101352878 | Human |
597578913 | GWAS1635773_H | hyperlipidemia QTL GWAS1635773 (human) | | 3e-22 | hyperlipidemia | | 10 | 93079885 | 93079886 | Human |
597423322 | GWAS1519396_H | colorectal cancer QTL GWAS1519396 (human) | | 7e-10 | colorectal cancer | | 10 | 79059375 | 79059376 | Human |
597169370 | GWAS1265444_H | basophil count QTL GWAS1265444 (human) | | 3e-16 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 87878379 | 87878380 | Human |
597218523 | GWAS1314597_H | COVID-19 QTL GWAS1314597 (human) | | 0.0000009 | COVID-19 | | 10 | 78069803 | 78069804 | Human |
597071061 | GWAS1167135_H | uric acid measurement QTL GWAS1167135 (human) | | 4e-11 | uric acid measurement | blood uric acid level (CMO:0000501) | 10 | 87149155 | 87149156 | Human |
597587162 | GWAS1644022_H | colon carcinoma QTL GWAS1644022 (human) | | 4e-12 | colon carcinoma | | 10 | 79059375 | 79059376 | Human |
597218524 | GWAS1314598_H | COVID-19 QTL GWAS1314598 (human) | | 0.000003 | COVID-19 | | 10 | 98895915 | 98895916 | Human |
597529816 | GWAS1625890_H | level of gamma-synuclein in blood serum QTL GWAS1625890 (human) | | 3e-403 | level of gamma-synuclein in blood serum | | 10 | 86945549 | 86945550 | Human |
597079249 | GWAS1175323_H | PR interval QTL GWAS1175323 (human) | | 6e-17 | PR interval | PR interval (CMO:0000233) | 10 | 86749331 | 86749332 | Human |
407056139 | GWAS705115_H | waist-hip ratio QTL GWAS705115 (human) | | 1e-09 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 92707153 | 92707154 | Human |
597267665 | GWAS1363739_H | metabolite measurement QTL GWAS1363739 (human) | | 2e-124 | metabolite measurement | | 10 | 98386156 | 98386157 | Human |
597267667 | GWAS1363741_H | metabolite measurement QTL GWAS1363741 (human) | | 6e-13 | metabolite measurement | | 10 | 91192083 | 91192084 | Human |
597267666 | GWAS1363740_H | metabolite measurement QTL GWAS1363740 (human) | | 5e-12 | metabolite measurement | | 10 | 93725340 | 93725341 | Human |
597472465 | GWAS1568539_H | pulmonary function measurement QTL GWAS1568539 (human) | | 0.000007 | pulmonary function measurement | | 10 | 100530633 | 100530634 | Human |
597365972 | GWAS1462046_H | gut microbiome measurement QTL GWAS1462046 (human) | | 0.000006 | gut microbiome measurement | | 10 | 90398991 | 90398992 | Human |
597267670 | GWAS1363744_H | metabolite measurement QTL GWAS1363744 (human) | | 5e-11 | metabolite measurement | | 10 | 98400642 | 98400643 | Human |
597071047 | GWAS1167121_H | ankylosing spondylitis QTL GWAS1167121 (human) | | 0.0000006 | ankylosing spondylitis | | 10 | 79300560 | 79300561 | Human |
597333195 | GWAS1429269_H | S-6-hydroxywarfarin to S-warfarin ratio measurement QTL GWAS1429269 (human) | | 4e-08 | S-6-hydroxywarfarin to S-warfarin ratio measurement | | 10 | 94829819 | 94829820 | Human |
597136582 | GWAS1232656_H | 5-dodecenoate 12:1n7 measurement QTL GWAS1232656 (human) | | 9e-13 | 5-dodecenoate 12:1n7 measurement | | 10 | 100315722 | 100315723 | Human |
597603532 | GWAS1660392_H | type 2 diabetes mellitus QTL GWAS1660392 (human) | | 4e-08 | type 2 diabetes mellitus | | 10 | 92725503 | 92725504 | Human |
597136581 | GWAS1232655_H | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement QTL GWAS1232655 (human) | | 1e-13 | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | | 10 | 95272855 | 95272856 | Human |
597603533 | GWAS1660393_H | type 2 diabetes mellitus QTL GWAS1660393 (human) | | 4e-12 | type 2 diabetes mellitus | | 10 | 92728938 | 92728939 | Human |
597603530 | GWAS1660390_H | type 2 diabetes mellitus QTL GWAS1660390 (human) | | 4e-50 | type 2 diabetes mellitus | | 10 | 92679284 | 92679285 | Human |
597603531 | GWAS1660391_H | type 2 diabetes mellitus QTL GWAS1660391 (human) | | 3e-223 | type 2 diabetes mellitus | | 10 | 92704188 | 92704189 | Human |
597136578 | GWAS1232652_H | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement QTL GWAS1232652 (human) | | 1e-28 | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | | 10 | 95002841 | 95002842 | Human |
596964557 | GWAS1084076_H | hypertension QTL GWAS1084076 (human) | | 5e-14 | hypertension | | 10 | 94279840 | 94279841 | Human |
597071048 | GWAS1167122_H | ankylosing spondylitis QTL GWAS1167122 (human) | | 2e-14 | ankylosing spondylitis | | 10 | 99518968 | 99518969 | Human |
597406971 | GWAS1503045_H | rheumatoid arthritis, irritable bowel syndrome QTL GWAS1503045 (human) | | 3e-09 | rheumatoid arthritis, irritable bowel syndrome | | 10 | 99531836 | 99531837 | Human |
407072545 | GWAS721521_H | balding measurement QTL GWAS721521 (human) | | 3e-12 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 10 | 78749590 | 78749591 | Human |
597177594 | GWAS1273668_H | diffuse large B-cell lymphoma, marginal zone B-cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia QTL GWAS1273668 (human) | | 3e-09 | leukocyte integrity trait (VT:0010898) | | 10 | 92742487 | 92742488 | Human |
597284093 | GWAS1380167_H | diastolic blood pressure QTL GWAS1380167 (human) | | 6e-24 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 94249436 | 94249438 | Human |
597316863 | GWAS1412937_H | metabolite measurement QTL GWAS1412937 (human) | | 2e-13 | metabolite measurement | | 10 | 99802499 | 99802500 | Human |
407146274 | GWAS795250_H | rheumatoid arthritis QTL GWAS795250 (human) | | 9e-09 | rheumatoid arthritis | | 10 | 79947217 | 79947218 | Human |
597439739 | GWAS1535813_H | systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis QTL GWAS1535813 (human) | | 3e-08 | systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis | | 10 | 89002619 | 89002620 | Human |
597619958 | GWAS1676818_H | creatine kinase measurement QTL GWAS1676818 (human) | | 1e-20 | creatine kinase measurement | blood creatine kinase activity level (CMO:0002242) | 10 | 100130207 | 100130208 | Human |
597619954 | GWAS1676814_H | triglyceride measurement QTL GWAS1676814 (human) | | 2e-12 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 102127596 | 102127597 | Human |
597619953 | GWAS1676813_H | triglyceride measurement QTL GWAS1676813 (human) | | 1e-40 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079885 | 93079886 | Human |
597619950 | GWAS1676810_H | body weight QTL GWAS1676810 (human) | | 1e-21 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 103069712 | 103069713 | Human |
597619949 | GWAS1676809_H | body weight QTL GWAS1676809 (human) | | 2e-12 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 100672953 | 100672954 | Human |
597103843 | GWAS1199917_H | response to simvastatin, myopathy QTL GWAS1199917 (human) | | 0.000006 | response to simvastatin, myopathy | | 10 | 96947432 | 96947433 | Human |
597038307 | GWAS1134381_H | gut microbiome measurement QTL GWAS1134381 (human) | | 0.000003 | gut microbiome measurement | | 10 | 82092565 | 82092566 | Human |
406957879 | GWAS606855_H | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis QTL GWAS606855 (human) | | 2e-22 | intestine integrity trait (VT:0010554) | | 10 | 79282718 | 79282719 | Human |
597234926 | GWAS1331000_H | major depressive disorder QTL GWAS1331000 (human) | | 4e-09 | major depressive disorder | | 10 | 103033891 | 103033892 | Human |
597423329 | GWAS1519403_H | polyp of large intestine, colorectal cancer QTL GWAS1519403 (human) | | 3e-09 | polyp of large intestine, colorectal cancer | | 10 | 79059375 | 79059376 | Human |
597595364 | GWAS1652224_H | blood urea nitrogen measurement QTL GWAS1652224 (human) | | 7e-16 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 10 | 94279840 | 94279841 | Human |
597325024 | GWAS1421098_H | 5-dodecenoate 12:1n7 measurement QTL GWAS1421098 (human) | | 5e-30 | 5-dodecenoate 12:1n7 measurement | | 10 | 100315722 | 100315723 | Human |
597406948 | GWAS1503022_H | pulse pressure measurement QTL GWAS1503022 (human) | | 4e-39 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 103199143 | 103199144 | Human |
597316634 | GWAS1412708_H | body mass index QTL GWAS1412708 (human) | | 2e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 92670150 | 92670151 | Human |
597087250 | GWAS1183324_H | adult onset asthma, type 2 diabetes mellitus QTL GWAS1183324 (human) | | 1e-08 | adult onset asthma, type 2 diabetes mellitus | | 10 | 92738679 | 92738680 | Human |
597316639 | GWAS1412713_H | body mass index QTL GWAS1412713 (human) | | 0.000009 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 94259744 | 94259745 | Human |
597160991 | GWAS1257065_H | IGA glomerulonephritis QTL GWAS1257065 (human) | | 0.000007 | IGA glomerulonephritis | | 10 | 79283986 | 79283987 | Human |
407048139 | GWAS697115_H | urinary metabolite measurement QTL GWAS697115 (human) | | 2e-55 | urinary metabolite measurement | | 10 | 98388419 | 98388420 | Human |
597103646 | GWAS1199720_H | corneal topography QTL GWAS1199720 (human) | | 4e-44 | corneal topography | | 10 | 88264842 | 88264843 | Human |
407048138 | GWAS697114_H | urinary metabolite measurement QTL GWAS697114 (human) | | 8e-30 | urinary metabolite measurement | | 10 | 98388419 | 98388420 | Human |
407048137 | GWAS697113_H | urinary metabolite measurement QTL GWAS697113 (human) | | 3e-164 | urinary metabolite measurement | | 10 | 98388419 | 98388420 | Human |
407154633 | GWAS803609_H | gut microbiome measurement QTL GWAS803609 (human) | | 0.0000007 | gut microbiome measurement | | 10 | 86007287 | 86007288 | Human |
407048142 | GWAS697118_H | uric acid measurement QTL GWAS697118 (human) | | 0.0000009 | uric acid measurement | blood uric acid level (CMO:0000501) | 10 | 93317865 | 93317866 | Human |
597619728 | GWAS1676588_H | cardiac transplant QTL GWAS1676588 (human) | | 4e-11 | cardiac transplant | | 10 | 89759477 | 89759478 | Human |
407048140 | GWAS697116_H | urinary metabolite measurement QTL GWAS697116 (human) | | 3e-22 | urinary metabolite measurement | | 10 | 98406240 | 98406241 | Human |
596972549 | GWAS1092068_H | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa, major depressive disorder QTL GWAS1092068 (human) | | 2e-09 | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa, major depressive disorder | | 10 | 102666420 | 102666421 | Human |
597390351 | GWAS1486425_H | heel bone mineral density QTL GWAS1486425 (human) | | 2e-09 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 103217846 | 103217847 | Human |
597390350 | GWAS1486424_H | heel bone mineral density QTL GWAS1486424 (human) | | 6e-17 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 100130207 | 100130208 | Human |
597054467 | GWAS1150541_H | household income QTL GWAS1150541 (human) | | 9e-13 | household income | | 10 | 102042651 | 102042652 | Human |
597398541 | GWAS1494615_H | vaginal microbiome measurement QTL GWAS1494615 (human) | | 0.000002 | vaginal microbiome measurement | | 10 | 83952513 | 83952514 | Human |
597193742 | GWAS1289816_H | language measurement QTL GWAS1289816 (human) | | 0.0000002 | language measurement | | 10 | 92928196 | 92928197 | Human |
406958039 | GWAS607015_H | monocyte percentage of leukocytes QTL GWAS607015 (human) | | 4e-16 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 10 | 97376646 | 97376647 | Human |
597496843 | GWAS1592917_H | hip geometry QTL GWAS1592917 (human) | | 4e-21 | hip geometry | hip circumference (CMO:0000014) | 10 | 102614896 | 102614897 | Human |
406958038 | GWAS607014_H | monocyte percentage of leukocytes QTL GWAS607014 (human) | | 3e-09 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 10 | 96710584 | 96710585 | Human |
597431307 | GWAS1527381_H | mitochondrial DNA measurement QTL GWAS1527381 (human) | | 2e-19 | mitochondrial DNA measurement | | 10 | 100889008 | 100889009 | Human |
597021709 | GWAS1117783_H | diet measurement QTL GWAS1117783 (human) | | 0.000004 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 81982939 | 81982940 | Human |
597226496 | GWAS1322570_H | aspartate aminotransferase measurement QTL GWAS1322570 (human) | | 9e-10 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99397681 | 99397682 | Human |
597316611 | GWAS1412685_H | vaginal microbiome measurement QTL GWAS1412685 (human) | | 0.0000004 | vaginal microbiome measurement | | 10 | 89419538 | 89419539 | Human |
597087242 | GWAS1183316_H | asthma, type 2 diabetes mellitus QTL GWAS1183316 (human) | | 4e-08 | asthma, type 2 diabetes mellitus | | 10 | 92499423 | 92499424 | Human |
596988937 | GWAS1108456_H | ulcerative colitis QTL GWAS1108456 (human) | | 0.0000006 | ulcerative colitis | | 10 | 99524480 | 99524481 | Human |
597054472 | GWAS1150546_H | intelligence QTL GWAS1150546 (human) | | 7e-13 | cognitive behavior trait (VT:0010450) | | 10 | 101845957 | 101845958 | Human |
597464067 | GWAS1560141_H | blood protein measurement QTL GWAS1560141 (human) | | 2e-24 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 89010241 | 89010242 | Human |
597087241 | GWAS1183315_H | adult onset asthma, type 2 diabetes mellitus QTL GWAS1183315 (human) | | 3e-29 | adult onset asthma, type 2 diabetes mellitus | | 10 | 92670740 | 92670741 | Human |
597587007 | GWAS1643867_H | diastolic blood pressure QTL GWAS1643867 (human) | | 6e-14 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103089359 | 103089360 | Human |
597333048 | GWAS1429122_H | cigarettes per day measurement QTL GWAS1429122 (human) | | 6e-12 | cigarettes per day measurement | | 10 | 92056728 | 92056729 | Human |
597267514 | GWAS1363588_H | uric acid measurement QTL GWAS1363588 (human) | | 7e-09 | uric acid measurement | blood uric acid level (CMO:0000501) | 10 | 102162217 | 102162218 | Human |
597201982 | GWAS1298056_H | restless legs syndrome QTL GWAS1298056 (human) | | 1e-08 | restless legs syndrome | | 10 | 101361540 | 101361541 | Human |
597095473 | GWAS1191547_H | influenza A (H1N1) QTL GWAS1191547 (human) | | 3e-10 | influenza A (H1N1) | | 10 | 83884859 | 83884860 | Human |
406958057 | GWAS607033_H | response to xenobiotic stimulus QTL GWAS607033 (human) | | 0.000007 | response to xenobiotic stimulus | | 10 | 95092933 | 95092934 | Human |
597275697 | GWAS1371771_H | insomnia QTL GWAS1371771 (human) | | 7e-12 | insomnia | | 10 | 103338267 | 103338268 | Human |
597275696 | GWAS1371770_H | insomnia QTL GWAS1371770 (human) | | 4e-11 | insomnia | | 10 | 102934897 | 102934898 | Human |
597324851 | GWAS1420925_H | mean arterial pressure QTL GWAS1420925 (human) | | 6e-17 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 103092132 | 103092133 | Human |
597324848 | GWAS1420922_H | pulse pressure measurement QTL GWAS1420922 (human) | | 7e-10 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 94250635 | 94250636 | Human |
597242931 | GWAS1339005_H | smoking status measurement QTL GWAS1339005 (human) | | 5e-11 | smoking status measurement | | 10 | 102993203 | 102993204 | Human |
407384035 | GWAS1033011_H | reticulocyte measurement QTL GWAS1033011 (human) | | 8e-09 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 10 | 88237738 | 88237739 | Human |
597103675 | GWAS1199749_H | aspartate aminotransferase measurement QTL GWAS1199749 (human) | | 1e-16 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 77814320 | 77814321 | Human |
407384036 | GWAS1033012_H | reticulocyte measurement QTL GWAS1033012 (human) | | 4e-16 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 10 | 99514668 | 99514669 | Human |
597300278 | GWAS1396352_H | apolipoprotein L1 measurement QTL GWAS1396352 (human) | | 4e-127 | apolipoprotein L1 measurement | | 10 | 100069757 | 100069758 | Human |
597234741 | GWAS1330815_H | blood protein measurement QTL GWAS1330815 (human) | | 9e-20 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 102556824 | 102556825 | Human |
597324852 | GWAS1420926_H | mean arterial pressure QTL GWAS1420926 (human) | | 4e-14 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 94276939 | 94276940 | Human |
597586991 | GWAS1643851_H | diastolic blood pressure QTL GWAS1643851 (human) | | 8e-12 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 94279840 | 94279841 | Human |
407072753 | GWAS721729_H | hyperopia QTL GWAS721729 (human) | | 0.0000002 | hyperopia | | 10 | 86030323 | 86030324 | Human |
596964384 | GWAS1083903_H | gut microbiome measurement, bone density QTL GWAS1083903 (human) | | 2e-08 | gut microbiome measurement, bone density | | 10 | 85661057 | 85661058 | Human |
597226540 | GWAS1322614_H | protein measurement QTL GWAS1322614 (human) | | 2e-08 | protein measurement | | 10 | 95296494 | 95296495 | Human |
597054498 | GWAS1150572_H | household income QTL GWAS1150572 (human) | | 1e-12 | household income | | 10 | 102364848 | 102364849 | Human |
596964385 | GWAS1083904_H | gut microbiome measurement, bone density QTL GWAS1083904 (human) | | 5e-09 | gut microbiome measurement, bone density | | 10 | 85698195 | 85698196 | Human |
596964386 | GWAS1083905_H | gut microbiome measurement, bone density QTL GWAS1083905 (human) | | 9e-09 | gut microbiome measurement, bone density | | 10 | 95674855 | 95674856 | Human |
597275695 | GWAS1371769_H | insomnia QTL GWAS1371769 (human) | | 1e-08 | insomnia | | 10 | 96496194 | 96496195 | Human |
596956206 | GWAS1075725_H | risk-taking behaviour QTL GWAS1075725 (human) | | 1e-15 | risk-taking behaviour | | 10 | 102880295 | 102880296 | Human |
596956207 | GWAS1075726_H | smoking behaviour measurement QTL GWAS1075726 (human) | | 1e-19 | smoking behaviour measurement | | 10 | 102880295 | 102880296 | Human |
597136424 | GWAS1232498_H | dimethylglycine measurement QTL GWAS1232498 (human) | | 7e-11 | dimethylglycine measurement | | 10 | 102727625 | 102727626 | Human |
407056380 | GWAS705356_H | intracranial volume measurement QTL GWAS705356 (human) | | 1e-09 | insomnia | | 10 | 103410892 | 103410893 | Human |
597398619 | GWAS1494693_H | tumor necrosis factor receptor superfamily member 6 measurement QTL GWAS1494693 (human) | | 6e-29 | tumor necrosis factor receptor superfamily member 6 measurement | | 10 | 89020457 | 89020458 | Human |
406957953 | GWAS606929_H | carotid plaque build QTL GWAS606929 (human) | | 2e-08 | carotid plaque build | | 10 | 102727625 | 102727626 | Human |
597161046 | GWAS1257120_H | uric acid measurement QTL GWAS1257120 (human) | | 2e-09 | type 2 diabetes mellitus | blood uric acid level (CMO:0000501) | 10 | 79184390 | 79184391 | Human |
597136469 | GWAS1232543_H | 1-palmitoleoyl-GPC (16:1) measurement QTL GWAS1232543 (human) | | 8e-43 | glycerophosphocholine amount (VT:0011004) | | 10 | 100315722 | 100315723 | Human |
406957955 | GWAS606931_H | carotid plaque build QTL GWAS606931 (human) | | 0.0000005 | carotid plaque build | | 10 | 102787871 | 102787872 | Human |
407146368 | GWAS795344_H | type 2 diabetes mellitus QTL GWAS795344 (human) | | 2e-09 | type 2 diabetes mellitus | | 10 | 92705802 | 92705803 | Human |
597136466 | GWAS1232540_H | 1-palmitoleoylglycerol (16:1) measurement QTL GWAS1232540 (human) | | 9e-10 | milk monoacylglycerol amount (VT:0010386) | | 10 | 100315722 | 100315723 | Human |
597423197 | GWAS1519271_H | sex hormone-binding globulin measurement QTL GWAS1519271 (human) | | 1e-09 | sex hormone-binding globulin measurement | | 10 | 91894624 | 91894625 | Human |
597226591 | GWAS1322665_H | chronotype measurement QTL GWAS1322665 (human) | | 2e-09 | sleep behavior trait (VT:0001501) | | 10 | 92129053 | 92129054 | Human |
597169233 | GWAS1265307_H | hemoglobin A1 measurement QTL GWAS1265307 (human) | | 2e-11 | hemoglobin A1 measurement | | 10 | 92700893 | 92700894 | Human |
596989020 | GWAS1108539_H | systolic blood pressure QTL GWAS1108539 (human) | | 5e-50 | systolic blood pressure | | 10 | 94279840 | 94279841 | Human |
597218385 | GWAS1314459_H | serum gamma-glutamyl transferase measurement QTL GWAS1314459 (human) | | 4e-12 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 100994481 | 100994482 | Human |
597283923 | GWAS1379997_H | diastolic blood pressure QTL GWAS1379997 (human) | | 3e-18 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103186066 | 103186067 | Human |
596989022 | GWAS1108541_H | pulse pressure measurement QTL GWAS1108541 (human) | | 9e-15 | pulse pressure measurement | | 10 | 94279840 | 94279841 | Human |
597283922 | GWAS1379996_H | diastolic blood pressure QTL GWAS1379996 (human) | | 1e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 100857962 | 100857963 | Human |
596989019 | GWAS1108538_H | diastolic blood pressure QTL GWAS1108538 (human) | | 2e-62 | diastolic blood pressure | | 10 | 94279840 | 94279841 | Human |
597267531 | GWAS1363605_H | N6-methyllysine measurement QTL GWAS1363605 (human) | | 2e-23 | N6-methyllysine measurement | | 10 | 91194742 | 91194743 | Human |
597095492 | GWAS1191566_H | FEV/FVC ratio, response to bronchodilator QTL GWAS1191566 (human) | | 0.000003 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 93715597 | 93715598 | Human |
597472334 | GWAS1568408_H | triglyceride measurement QTL GWAS1568408 (human) | | 3e-10 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 102168617 | 102168618 | Human |
596988998 | GWAS1108517_H | pulse pressure measurement QTL GWAS1108517 (human) | | 1e-11 | pulse pressure measurement | | 10 | 94279840 | 94279841 | Human |
597431369 | GWAS1527443_H | protein measurement QTL GWAS1527443 (human) | | 1e-98 | protein measurement | | 10 | 88995196 | 88995197 | Human |
597267532 | GWAS1363606_H | N6,N6-dimethyllysine measurement QTL GWAS1363606 (human) | | 1e-16 | N6,N6-dimethyllysine measurement | | 10 | 91194742 | 91194743 | Human |
597136450 | GWAS1232524_H | neuroimaging measurement QTL GWAS1232524 (human) | | 9e-09 | neuroimaging measurement | | 10 | 92910803 | 92910804 | Human |
597267534 | GWAS1363608_H | N6,N6-dimethyllysine measurement QTL GWAS1363608 (human) | | 1e-13 | N6,N6-dimethyllysine measurement | | 10 | 93725340 | 93725341 | Human |
407179164 | GWAS828140_H | lean body mass QTL GWAS828140 (human) | | 0.000002 | lean body mass | | 10 | 94278929 | 94278930 | Human |
597341249 | GWAS1437323_H | gout QTL GWAS1437323 (human) | | 2e-12 | gout | | 10 | 87183510 | 87183511 | Human |
597349446 | GWAS1445520_H | body mass index QTL GWAS1445520 (human) | | 2e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98084934 | 98084935 | Human |
597529727 | GWAS1625801_H | body surface area QTL GWAS1625801 (human) | | 0.000006 | body surface area | | 10 | 100655852 | 100655853 | Human |
407039910 | GWAS688886_H | response to methotrexate, juvenile idiopathic arthritis QTL GWAS688886 (human) | | 0.000007 | response to methotrexate, juvenile idiopathic arthritis | | 10 | 79201071 | 79201072 | Human |
597488760 | GWAS1584834_H | ulcerative colitis QTL GWAS1584834 (human) | | 5e-10 | ulcerative colitis | | 10 | 99523573 | 99523574 | Human |
407039909 | GWAS688885_H | response to methotrexate, juvenile idiopathic arthritis QTL GWAS688885 (human) | | 0.000001 | response to methotrexate, juvenile idiopathic arthritis | | 10 | 79200216 | 79200217 | Human |
597595254 | GWAS1652114_H | body mass index QTL GWAS1652114 (human) | | 4e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 92670740 | 92670741 | Human |
597152895 | GWAS1248969_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1248969 (human) | | 2e-09 | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 98012433 | 98012434 | Human |
597283952 | GWAS1380026_H | eosinophil count QTL GWAS1380026 (human) | | 7e-26 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 87938433 | 87938434 | Human |
597390448 | GWAS1486522_H | body fat distribution QTL GWAS1486522 (human) | | 1e-22 | body fat distribution | body fat morphological measurement (CMO:0000089) | 10 | 94266427 | 94266428 | Human |
597267573 | GWAS1363647_H | Alzheimer disease QTL GWAS1363647 (human) | | 1e-15 | Alzheimer disease | | 10 | 80503927 | 80503928 | Human |
597595251 | GWAS1652111_H | body mass index QTL GWAS1652111 (human) | | 2e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98257696 | 98257697 | Human |
597324917 | GWAS1420991_H | cup-to-disc ratio measurement QTL GWAS1420991 (human) | | 2e-11 | cup-to-disc ratio measurement | | 10 | 93214372 | 93214373 | Human |
596964448 | GWAS1083967_H | body fat percentage QTL GWAS1083967 (human) | | 0.000004 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 10 | 94279840 | 94279841 | Human |
596964449 | GWAS1083968_H | body fat percentage QTL GWAS1083968 (human) | | 4e-11 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 10 | 94279840 | 94279841 | Human |
407375805 | GWAS1024781_H | systolic blood pressure QTL GWAS1024781 (human) | | 4e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 101768487 | 101768488 | Human |
596964451 | GWAS1083970_H | body fat percentage QTL GWAS1083970 (human) | | 4e-15 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 10 | 94279840 | 94279841 | Human |
596989036 | GWAS1108555_H | monocyte count QTL GWAS1108555 (human) | | 1e-13 | monocyte count | | 10 | 97354207 | 97354208 | Human |
597333091 | GWAS1429165_H | atrial fibrillation QTL GWAS1429165 (human) | | 3e-85 | atrial fibrillation | | 10 | 103574950 | 103574951 | Human |
597267555 | GWAS1363629_H | aortic measurement QTL GWAS1363629 (human) | | 3e-29 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 94140176 | 94140177 | Human |
597046381 | GWAS1142455_H | alcoholic liver disease QTL GWAS1142455 (human) | | 0.0000004 | alcoholic liver disease | | 10 | 77900176 | 77900177 | Human |
596964463 | GWAS1083982_H | glaucoma QTL GWAS1083982 (human) | | 0.000006 | glaucoma | | 10 | 94279840 | 94279841 | Human |
597152875 | GWAS1248949_H | lifestyle measurement, anxiety disorder measurement QTL GWAS1248949 (human) | | 1e-10 | anxiety-related behavior trait (VT:0010716) | | 10 | 101991483 | 101991484 | Human |
597464161 | GWAS1560235_H | beta-amyloid 1-42 measurement QTL GWAS1560235 (human) | | 0.000007 | beta-amyloid 1-42 measurement | | 10 | 93703269 | 93703270 | Human |
597080983 | GWAS1177057_H | gut microbiome measurement QTL GWAS1177057 (human) | | 6e-08 | gut microbiome measurement | | 10 | 83180902 | 83180903 | Human |
597080979 | GWAS1177053_H | gut microbiome measurement QTL GWAS1177053 (human) | | 4e-08 | gut microbiome measurement | | 10 | 82864691 | 82864692 | Human |
597179293 | GWAS1275367_H | omega-6:omega-3 polyunsaturated fatty acid ratio QTL GWAS1275367 (human) | | 8e-10 | milk omega-6 fatty acid amount (VT:0010323) | milk omega-6 to omega-3 fatty acid ratio (CMO:0001392) | 10 | 94909603 | 94909604 | Human |
597146525 | GWAS1242599_H | prostate carcinoma QTL GWAS1242599 (human) | | 4e-12 | prostate carcinoma | | 10 | 88407308 | 88407309 | Human |
597474198 | GWAS1570272_H | blood protein measurement QTL GWAS1570272 (human) | | 5e-215 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 100130207 | 100130208 | Human |
597146524 | GWAS1242598_H | prostate carcinoma QTL GWAS1242598 (human) | | 1e-20 | prostate carcinoma | | 10 | 79076241 | 79076242 | Human |
597080985 | GWAS1177059_H | gut microbiome measurement QTL GWAS1177059 (human) | | 0.000007 | gut microbiome measurement | | 10 | 94527501 | 94527502 | Human |
597080966 | GWAS1177040_H | lymphocyte percentage of leukocytes QTL GWAS1177040 (human) | | 2e-09 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 10 | 102301461 | 102301462 | Human |
597040007 | GWAS1136081_H | urinary metabolite measurement QTL GWAS1136081 (human) | | 4e-574 | urinary metabolite measurement | | 10 | 98388419 | 98388420 | Human |
597605260 | GWAS1662120_H | neutrophil count QTL GWAS1662120 (human) | | 5e-20 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 89243047 | 89243048 | Human |
597080964 | GWAS1177038_H | lymphocyte percentage of leukocytes QTL GWAS1177038 (human) | | 3e-11 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 10 | 96620380 | 96620381 | Human |
597326728 | GWAS1422802_H | N6,N6-dimethyllysine measurement QTL GWAS1422802 (human) | | 8e-234 | N6,N6-dimethyllysine measurement | | 10 | 98413823 | 98413824 | Human |
597597069 | GWAS1653929_H | low density lipoprotein cholesterol measurement QTL GWAS1653929 (human) | | 2e-12 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 89243047 | 89243048 | Human |
597080965 | GWAS1177039_H | lymphocyte percentage of leukocytes QTL GWAS1177039 (human) | | 2e-26 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 10 | 97314229 | 97314234 | Human |
597080962 | GWAS1177036_H | lymphocyte percentage of leukocytes QTL GWAS1177036 (human) | | 7e-09 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 10 | 89243047 | 89243048 | Human |
597080963 | GWAS1177037_H | lymphocyte percentage of leukocytes QTL GWAS1177037 (human) | | 1e-21 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 10 | 92759940 | 92759941 | Human |
597080960 | GWAS1177034_H | lymphocyte percentage of leukocytes QTL GWAS1177034 (human) | | 4e-21 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 10 | 79287818 | 79287819 | Human |
596958082 | GWAS1077601_H | systolic blood pressure QTL GWAS1077601 (human) | | 1e-10 | systolic blood pressure | | 10 | 103146454 | 103146455 | Human |
597080961 | GWAS1177035_H | lymphocyte percentage of leukocytes QTL GWAS1177035 (human) | | 1e-10 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 10 | 87872090 | 87872091 | Human |
597343117 | GWAS1439191_H | open-angle glaucoma QTL GWAS1439191 (human) | | 3e-10 | open-angle glaucoma | | 10 | 94256036 | 94256037 | Human |
597064577 | GWAS1160651_H | body mass index QTL GWAS1160651 (human) | | 0.000007 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 103109281 | 103109282 | Human |
597474180 | GWAS1570254_H | blood protein measurement QTL GWAS1570254 (human) | | 2e-34 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 89009208 | 89009209 | Human |
597269378 | GWAS1365452_H | BMI-adjusted waist circumference QTL GWAS1365452 (human) | | 1e-10 | body size trait (VT:0100005) | | 10 | 79164105 | 79164106 | Human |
406929501 | GWAS578477_H | pulse pressure measurement QTL GWAS578477 (human) | | 1e-12 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 94296872 | 94296873 | Human |
597474178 | GWAS1570252_H | blood protein measurement QTL GWAS1570252 (human) | | 5e-30 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 89009208 | 89009209 | Human |
597040008 | GWAS1136082_H | urinary metabolite measurement QTL GWAS1136082 (human) | | 3e-520 | urinary metabolite measurement | | 10 | 98388419 | 98388420 | Human |
406929503 | GWAS578479_H | pulse pressure measurement QTL GWAS578479 (human) | | 6e-42 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 103169157 | 103169158 | Human |
597498754 | GWAS1594828_H | low density lipoprotein cholesterol measurement QTL GWAS1594828 (human) | | 1e-09 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 88045653 | 88045654 | Human |
597474179 | GWAS1570253_H | blood protein measurement QTL GWAS1570253 (human) | | 4e-29 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 89009208 | 89009209 | Human |
597449662 | GWAS1545736_H | triglyceride measurement QTL GWAS1545736 (human) | | 3e-15 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93072371 | 93072372 | Human |
597048245 | GWAS1144319_H | BMI-adjusted waist-hip ratio QTL GWAS1144319 (human) | | 2e-09 | body size trait (VT:0100005) | | 10 | 87995844 | 87995845 | Human |
597326777 | GWAS1422851_H | sex interaction measurement, inflammatory bowel disease QTL GWAS1422851 (human) | | 9e-09 | sex interaction measurement, inflammatory bowel disease | | 10 | 99568261 | 99568262 | Human |
597212092 | GWAS1308166_H | metastasis measurement, disease progression measurement QTL GWAS1308166 (human) | | 4e-08 | metastasis measurement, disease progression measurement | disease progression measurement (CMO:0001110) | 10 | 96663139 | 96663140 | Human |
597375932 | GWAS1472006_H | Crohn's disease QTL GWAS1472006 (human) | | 6e-08 | intestine integrity trait (VT:0010554) | | 10 | 99528007 | 99528008 | Human |
596974514 | GWAS1094033_H | major depressive disorder QTL GWAS1094033 (human) | | 1e-08 | major depressive disorder | | 10 | 102660997 | 102660998 | Human |
407175266 | GWAS824242_H | obsolete_red blood cell distribution width QTL GWAS824242 (human) | | 2e-15 | obsolete_red blood cell distribution width | | 10 | 102875591 | 102875592 | Human |
597236657 | GWAS1332731_H | lymphocyte:monocyte ratio QTL GWAS1332731 (human) | | 2e-24 | leukocyte quantity (VT:0000217) | | 10 | 97353029 | 97353030 | Human |
597121980 | GWAS1218054_H | rheumatoid arthritis, Crohn's disease QTL GWAS1218054 (human) | | 5e-10 | intestine integrity trait (VT:0010554) | | 10 | 99538694 | 99538695 | Human |
597253045 | GWAS1349119_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1349119 (human) | | 3e-09 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 10 | 99816570 | 99816571 | Human |
597253044 | GWAS1349118_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1349118 (human) | | 5e-09 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 10 | 89243088 | 89243089 | Human |
597048248 | GWAS1144322_H | BMI-adjusted waist-hip ratio QTL GWAS1144322 (human) | | 2e-12 | body size trait (VT:0100005) | | 10 | 93586671 | 93586672 | Human |
597326773 | GWAS1422847_H | inflammatory bowel disease QTL GWAS1422847 (human) | | 4e-08 | inflammatory bowel disease | | 10 | 99568261 | 99568262 | Human |
597253046 | GWAS1349120_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1349120 (human) | | 2e-09 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 10 | 102193181 | 102193182 | Human |
407027825 | GWAS676801_H | esophageal carcinoma QTL GWAS676801 (human) | | 2e-09 | esophageal carcinoma | | 10 | 94298541 | 94298542 | Human |
597097388 | GWAS1193462_H | testosterone measurement QTL GWAS1193462 (human) | | 6e-09 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 100152307 | 100152308 | Human |
597335002 | GWAS1431076_H | educational attainment QTL GWAS1431076 (human) | | 0.0000001 | educational attainment | | 10 | 93649911 | 93649912 | Human |
597482460 | GWAS1578534_H | blood protein measurement QTL GWAS1578534 (human) | | 5e-95 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95759888 | 95759889 | Human |
407019523 | GWAS668499_H | sudden cardiac arrest QTL GWAS668499 (human) | | 0.0000004 | sudden cardiac arrest | | 10 | 94276223 | 94276224 | Human |
597482462 | GWAS1578536_H | blood protein measurement QTL GWAS1578536 (human) | | 2e-18 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95848357 | 95848358 | Human |
597179358 | GWAS1275432_H | N6-Acetyl-L-lysine measurement QTL GWAS1275432 (human) | | 4e-63 | N6-Acetyl-L-lysine measurement | | 10 | 98388301 | 98388302 | Human |
597162975 | GWAS1259049_H | oxalate measurement QTL GWAS1259049 (human) | | 0.000004 | oxalate measurement | | 10 | 84895809 | 84895810 | Human |
597433296 | GWAS1529370_H | interleukin-1 beta measurement, response to stimulus QTL GWAS1529370 (human) | | 0.0000005 | interleukin-1 beta measurement, response to stimulus | | 10 | 78282203 | 78282204 | Human |
597072859 | GWAS1168933_H | creatine kinase measurement QTL GWAS1168933 (human) | | 6e-17 | creatine kinase measurement | blood creatine kinase activity level (CMO:0002242) | 10 | 100069757 | 100069758 | Human |
597343189 | GWAS1439263_H | diet measurement QTL GWAS1439263 (human) | | 0.000002 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 85549138 | 85549139 | Human |
597482451 | GWAS1578525_H | blood protein measurement QTL GWAS1578525 (human) | | 5e-12 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95792195 | 95792196 | Human |
597523410 | GWAS1619484_H | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement QTL GWAS1619484 (human) | | 8e-11 | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | | 10 | 99860022 | 99860023 | Human |
597089222 | GWAS1185296_H | PR interval QTL GWAS1185296 (human) | | 1e-11 | PR interval | PR interval (CMO:0000233) | 10 | 79139212 | 79139213 | Human |
597334987 | GWAS1431061_H | educational attainment QTL GWAS1431061 (human) | | 2e-08 | educational attainment | | 10 | 93667524 | 93667525 | Human |
597310408 | GWAS1406482_H | body mass index QTL GWAS1406482 (human) | | 1e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 85731093 | 85731094 | Human |
597334990 | GWAS1431064_H | educational attainment QTL GWAS1431064 (human) | | 3e-08 | educational attainment | | 10 | 96633582 | 96633583 | Human |
597334988 | GWAS1431062_H | educational attainment QTL GWAS1431062 (human) | | 6e-09 | educational attainment | | 10 | 94385489 | 94385490 | Human |
597154752 | GWAS1250826_H | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1250826 (human) | | 2e-08 | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93550782 | 93550783 | Human |
597334989 | GWAS1431063_H | educational attainment QTL GWAS1431063 (human) | | 8e-10 | educational attainment | | 10 | 96490434 | 96490435 | Human |
596949964 | GWAS1069483_H | calcium measurement QTL GWAS1069483 (human) | | 3e-13 | brain measurement | | 10 | 94279840 | 94279841 | Human |
597318595 | GWAS1414669_H | triglyceride measurement QTL GWAS1414669 (human) | | 5e-11 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 102186723 | 102186724 | Human |
597121997 | GWAS1218071_H | blood protein measurement QTL GWAS1218071 (human) | | 2e-20 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 102583047 | 102583048 | Human |
597285829 | GWAS1381903_H | systolic blood pressure QTL GWAS1381903 (human) | | 3e-23 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94253193 | 94253194 | Human |
406954013 | GWAS602989_H | self reported educational attainment QTL GWAS602989 (human) | | 2e-08 | self reported educational attainment | | 10 | 102364298 | 102364299 | Human |
597031883 | GWAS1127957_H | colorectal cancer, colorectal adenoma QTL GWAS1127957 (human) | | 7e-15 | colorectal cancer, colorectal adenoma | | 10 | 99591947 | 99591948 | Human |
597105609 | GWAS1201683_H | sex hormone-binding globulin measurement QTL GWAS1201683 (human) | | 1e-11 | sex hormone-binding globulin measurement | | 10 | 102232661 | 102232662 | Human |
597105608 | GWAS1201682_H | sex hormone-binding globulin measurement QTL GWAS1201682 (human) | | 8e-11 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 100164661 | 100164662 | Human |
407298084 | GWAS947060_H | functional brain measurement QTL GWAS947060 (human) | | 1e-43 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
597146613 | GWAS1242687_H | nephrotic syndrome QTL GWAS1242687 (human) | | 0.0000002 | nephrotic syndrome | | 10 | 97412169 | 97412170 | Human |
597040117 | GWAS1136191_H | diet measurement QTL GWAS1136191 (human) | | 3e-08 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 102042651 | 102042652 | Human |
407298082 | GWAS947058_H | functional brain measurement QTL GWAS947058 (human) | | 1e-48 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
597269500 | GWAS1365574_H | aortic measurement QTL GWAS1365574 (human) | | 1e-21 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 94143431 | 94143432 | Human |
407298083 | GWAS947059_H | functional brain measurement QTL GWAS947059 (human) | | 4e-44 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
407298080 | GWAS947056_H | functional brain measurement QTL GWAS947056 (human) | | 2e-17 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
407298081 | GWAS947057_H | functional brain measurement QTL GWAS947057 (human) | | 1e-57 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
597212147 | GWAS1308221_H | schizophrenia QTL GWAS1308221 (human) | | 3e-16 | schizophrenia | | 10 | 102866129 | 102866130 | Human |
597212148 | GWAS1308222_H | schizophrenia QTL GWAS1308222 (human) | | 8e-12 | schizophrenia | | 10 | 103089359 | 103089360 | Human |
597326837 | GWAS1422911_H | color vision disorder QTL GWAS1422911 (human) | | 6e-08 | color vision disorder | | 10 | 80643748 | 80643749 | Human |
597433321 | GWAS1529395_H | protein measurement QTL GWAS1529395 (human) | | 1e-16 | protein measurement | | 10 | 100211240 | 100211241 | Human |
406921271 | GWAS570247_H | pulse pressure measurement QTL GWAS570247 (human) | | 0.000005 | pulse pressure measurement | | 10 | 87844975 | 87844976 | Human |
597425123 | GWAS1521197_H | type 2 diabetes mellitus QTL GWAS1521197 (human) | | 0.000008 | type 2 diabetes mellitus | | 10 | 97878426 | 97878427 | Human |
597113838 | GWAS1209912_H | QT interval QTL GWAS1209912 (human) | | 0.000006 | QT interval | QT interval (CMO:0000235) | 10 | 102290249 | 102290250 | Human |
597031913 | GWAS1127987_H | BMI-adjusted waist-hip ratio QTL GWAS1127987 (human) | | 3e-10 | body size trait (VT:0100005) | | 10 | 102626552 | 102626553 | Human |
597285860 | GWAS1381934_H | total lipids in medium VLDL QTL GWAS1381934 (human) | | 7e-14 | total lipids in medium VLDL | | 10 | 93083778 | 93083779 | Human |
597531619 | GWAS1627693_H | body mass index QTL GWAS1627693 (human) | | 2e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 103197872 | 103197873 | Human |
597531618 | GWAS1627692_H | body mass index QTL GWAS1627692 (human) | | 4e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102478801 | 102478802 | Human |
597318427 | GWAS1414501_H | interstitial lung disease QTL GWAS1414501 (human) | | 0.000004 | interstitial lung disease | | 10 | 81723143 | 81723144 | Human |
597531417 | GWAS1627491_H | schizophrenia, type 2 diabetes mellitus QTL GWAS1627491 (human) | | 2e-09 | schizophrenia, type 2 diabetes mellitus | | 10 | 103198487 | 103198488 | Human |
597228304 | GWAS1324378_H | body mass index QTL GWAS1324378 (human) | | 6e-15 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100635683 | 100635684 | Human |
597211921 | GWAS1307995_H | intraocular pressure measurement QTL GWAS1307995 (human) | | 1e-08 | intraocular pressure measurement | | 10 | 92670768 | 92670769 | Human |
597228305 | GWAS1324379_H | body mass index QTL GWAS1324379 (human) | | 8e-15 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 103109281 | 103109282 | Human |
407371970 | GWAS1020946_H | parental longevity QTL GWAS1020946 (human) | | 0.000003 | total life span (VT:0001661) | | 10 | 86555424 | 86555425 | Human |
597211922 | GWAS1307996_H | intraocular pressure measurement QTL GWAS1307996 (human) | | 8e-12 | intraocular pressure measurement | | 10 | 93016722 | 93016723 | Human |
597613326 | GWAS1670186_H | erythematosquamous dermatosis QTL GWAS1670186 (human) | | 3e-16 | erythematosquamous dermatosis | | 10 | 79287626 | 79287627 | Human |
597261064 | GWAS1357138_H | total cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS1357138 (human) | | 8e-13 | total cholesterol measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079885 | 93079886 | Human |
596957958 | GWAS1077477_H | Red cell distribution width QTL GWAS1077477 (human) | | 3e-21 | Red cell distribution width | | 10 | 79041217 | 79041218 | Human |
596957959 | GWAS1077478_H | Red cell distribution width QTL GWAS1077478 (human) | | 1e-08 | Red cell distribution width | | 10 | 89250722 | 89250723 | Human |
597031680 | GWAS1127754_H | sugar consumption measurement QTL GWAS1127754 (human) | | 0.000004 | sugar consumption measurement | sucrose drink intake volume (CMO:0002200) | 10 | 88698733 | 88698734 | Human |
597252876 | GWAS1348950_H | C-reactive protein measurement QTL GWAS1348950 (human) | | 1e-09 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 89229352 | 89229353 | Human |
597228303 | GWAS1324377_H | body mass index QTL GWAS1324377 (human) | | 6e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98209811 | 98209812 | Human |
597408515 | GWAS1504589_H | non-high density lipoprotein cholesterol measurement QTL GWAS1504589 (human) | | 6e-13 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 10 | 100244149 | 100244150 | Human |
596957964 | GWAS1077483_H | Red cell distribution width QTL GWAS1077483 (human) | | 9e-08 | Red cell distribution width | | 10 | 102875346 | 102875347 | Human |
597195520 | GWAS1291594_H | systolic blood pressure QTL GWAS1291594 (human) | | 2e-24 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103091078 | 103091079 | Human |
597408514 | GWAS1504588_H | non-high density lipoprotein cholesterol measurement QTL GWAS1504588 (human) | | 4e-10 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 10 | 94278929 | 94278930 | Human |
597383938 | GWAS1480012_H | Red cell distribution width QTL GWAS1480012 (human) | | 9e-14 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 99499704 | 99499705 | Human |
597383937 | GWAS1480011_H | Red cell distribution width QTL GWAS1480011 (human) | | 1e-18 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 79040331 | 79040332 | Human |
597613316 | GWAS1670176_H | seborrheic dermatitis QTL GWAS1670176 (human) | | 2e-15 | seborrheic dermatitis | | 10 | 79283950 | 79283951 | Human |
597408513 | GWAS1504587_H | non-high density lipoprotein cholesterol measurement QTL GWAS1504587 (human) | | 2e-53 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 10 | 93079967 | 93079968 | Human |
596949775 | GWAS1069294_H | pulse pressure measurement QTL GWAS1069294 (human) | | 0.000005 | pulse pressure measurement | | 10 | 87844975 | 87844976 | Human |
597408512 | GWAS1504586_H | non-high density lipoprotein cholesterol measurement QTL GWAS1504586 (human) | | 3e-13 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 10 | 88045653 | 88045654 | Human |
597310209 | GWAS1406283_H | vaginal microbiome measurement QTL GWAS1406283 (human) | | 0.000007 | vaginal microbiome measurement | | 10 | 89419538 | 89419539 | Human |
596957960 | GWAS1077479_H | Red cell distribution width QTL GWAS1077479 (human) | | 3e-31 | Red cell distribution width | | 10 | 94596424 | 94596425 | Human |
597482240 | GWAS1578314_H | lymphocyte count QTL GWAS1578314 (human) | | 1e-605 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95847887 | 95847888 | Human |
596957961 | GWAS1077480_H | Red cell distribution width QTL GWAS1077480 (human) | | 1e-12 | Red cell distribution width | | 10 | 99496351 | 99496352 | Human |
596957962 | GWAS1077481_H | Red cell distribution width QTL GWAS1077481 (human) | | 1e-18 | 1-palmitoleoyl-GPC (16:1) measurement | | 10 | 100315722 | 100315723 | Human |
406962398 | GWAS611374_H | anorexia nervosa QTL GWAS611374 (human) | | 0.000002 | anorexia nervosa | | 10 | 85934535 | 85934536 | Human |
596957963 | GWAS1077482_H | Red cell distribution width QTL GWAS1077482 (human) | | 6e-15 | Red cell distribution width | | 10 | 101438198 | 101438199 | Human |
406954209 | GWAS603185_H | forced expiratory volume, response to bronchodilator QTL GWAS603185 (human) | | 0.000005 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 10 | 80544406 | 80544407 | Human |
597334842 | GWAS1430916_H | educational attainment QTL GWAS1430916 (human) | | 3e-15 | educational attainment | | 10 | 91756347 | 91756348 | Human |
597334843 | GWAS1430917_H | educational attainment QTL GWAS1430917 (human) | | 4e-08 | educational attainment | | 10 | 92649100 | 92649101 | Human |
597334840 | GWAS1430914_H | educational attainment QTL GWAS1430914 (human) | | 8e-09 | educational attainment | | 10 | 89510130 | 89510131 | Human |
597334841 | GWAS1430915_H | educational attainment QTL GWAS1430915 (human) | | 0.0000002 | educational attainment | | 10 | 91133185 | 91133186 | Human |
407060704 | GWAS709680_H | vitamin A measurement QTL GWAS709680 (human) | | 7e-15 | vitamin A measurement | | 10 | 93588425 | 93588426 | Human |
597318462 | GWAS1414536_H | type 2 diabetes mellitus QTL GWAS1414536 (human) | | 6e-10 | type 2 diabetes mellitus | | 10 | 92700524 | 92700525 | Human |
597334844 | GWAS1430918_H | educational attainment QTL GWAS1430918 (human) | | 2e-10 | educational attainment | | 10 | 93022810 | 93022811 | Human |
597334834 | GWAS1430908_H | educational attainment QTL GWAS1430908 (human) | | 5e-27 | educational attainment | | 10 | 85257141 | 85257142 | Human |
597334835 | GWAS1430909_H | educational attainment QTL GWAS1430909 (human) | | 3e-10 | educational attainment | | 10 | 86040379 | 86040380 | Human |
597334832 | GWAS1430906_H | educational attainment QTL GWAS1430906 (human) | | 2e-10 | educational attainment | | 10 | 83185756 | 83185757 | Human |
597105469 | GWAS1201543_H | cervical carcinoma QTL GWAS1201543 (human) | | 0.0000004 | cervical carcinoma | | 10 | 102040002 | 102040003 | Human |
597334833 | GWAS1430907_H | educational attainment QTL GWAS1430907 (human) | | 3e-08 | educational attainment | | 10 | 83583540 | 83583541 | Human |
597334838 | GWAS1430912_H | educational attainment QTL GWAS1430912 (human) | | 3e-08 | educational attainment | | 10 | 86383715 | 86383716 | Human |
597334839 | GWAS1430913_H | educational attainment QTL GWAS1430913 (human) | | 5e-12 | educational attainment | | 10 | 88414445 | 88414446 | Human |
597277492 | GWAS1373566_H | diet measurement QTL GWAS1373566 (human) | | 2e-09 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 98970451 | 98970452 | Human |
597334836 | GWAS1430910_H | educational attainment QTL GWAS1430910 (human) | | 0.000009 | educational attainment | | 10 | 86181868 | 86181869 | Human |
597334837 | GWAS1430911_H | educational attainment QTL GWAS1430911 (human) | | 2e-08 | educational attainment | | 10 | 86260826 | 86260827 | Human |
407388391 | GWAS1037367_H | neutrophil percentage of granulocytes QTL GWAS1037367 (human) | | 5e-09 | neutrophil quantity (VT:0000222) | | 10 | 87939452 | 87939453 | Human |
597252904 | GWAS1348978_H | platelet count QTL GWAS1348978 (human) | | 3e-09 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 79404390 | 79404391 | Human |
597334830 | GWAS1430904_H | educational attainment QTL GWAS1430904 (human) | | 2e-10 | educational attainment | | 10 | 81037827 | 81037828 | Human |
597334831 | GWAS1430905_H | educational attainment QTL GWAS1430905 (human) | | 6e-08 | educational attainment | | 10 | 81643653 | 81643654 | Human |
597474090 | GWAS1570164_H | prostate carcinoma QTL GWAS1570164 (human) | | 5e-22 | prostate carcinoma | | 10 | 102668959 | 102668960 | Human |
596974381 | GWAS1093900_H | vitamin D measurement QTL GWAS1093900 (human) | | 2e-09 | vitamin D measurement | | 10 | 89735565 | 89735566 | Human |
597269281 | GWAS1365355_H | aortic measurement QTL GWAS1365355 (human) | | 6e-11 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 94524717 | 94524718 | Human |
597310242 | GWAS1406316_H | body mass index QTL GWAS1406316 (human) | | 1e-17 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100687890 | 100687891 | Human |
597596965 | GWAS1653825_H | low density lipoprotein cholesterol measurement QTL GWAS1653825 (human) | | 3e-13 | low density lipoprotein cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 89243047 | 89243048 | Human |
597269282 | GWAS1365356_H | aortic measurement QTL GWAS1365356 (human) | | 8e-10 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 94567912 | 94567913 | Human |
597097302 | GWAS1193376_H | sex hormone-binding globulin measurement QTL GWAS1193376 (human) | | 1e-08 | sex hormone-binding globulin measurement | | 10 | 100164661 | 100164662 | Human |
597130071 | GWAS1226145_H | mitochondrial DNA measurement QTL GWAS1226145 (human) | | 9e-41 | mitochondrial DNA measurement | | 10 | 100992588 | 100992589 | Human |
597105489 | GWAS1201563_H | cytokine measurement QTL GWAS1201563 (human) | | 0.000002 | cytokine measurement | blood cytokine measurement (CMO:0001924) | 10 | 82274230 | 82274231 | Human |
597441370 | GWAS1537444_H | tetradecanedioate measurement QTL GWAS1537444 (human) | | 0.000008 | tetradecanedioate measurement | | 10 | 93771588 | 93771589 | Human |
597424989 | GWAS1521063_H | cortical thickness QTL GWAS1521063 (human) | | 1e-17 | cortical thickness | | 10 | 102876898 | 102876899 | Human |
597285712 | GWAS1381786_H | ulcerative colitis QTL GWAS1381786 (human) | | 5e-09 | ulcerative colitis | | 10 | 102465559 | 102465560 | Human |
596966238 | GWAS1085757_H | body height QTL GWAS1085757 (human) | | 2e-66 | body height | | 10 | 79351280 | 79351281 | Human |
597097309 | GWAS1193383_H | Takayasu arteritis QTL GWAS1193383 (human) | | 0.000009 | Takayasu arteritis | | 10 | 79286696 | 79286697 | Human |
597490512 | GWAS1586586_H | migraine disorder, glucose measurement QTL GWAS1586586 (human) | | 4e-09 | migraine disorder, glucose measurement | blood glucose level (CMO:0000046) | 10 | 87619975 | 87619976 | Human |
597359446 | GWAS1455520_H | carotid plaque build QTL GWAS1455520 (human) | | 0.000003 | carotid plaque build | | 10 | 89898952 | 89898953 | Human |
596982619 | GWAS1102138_H | memory performance QTL GWAS1102138 (human) | | 0.000004 | memory performance | | 10 | 85405544 | 85405545 | Human |
597097304 | GWAS1193378_H | sex hormone-binding globulin measurement QTL GWAS1193378 (human) | | 1e-08 | sex hormone-binding globulin measurement | | 10 | 102232661 | 102232662 | Human |
597130072 | GWAS1226146_H | mitochondrial DNA measurement QTL GWAS1226146 (human) | | 2e-15 | mitochondrial DNA measurement | | 10 | 102589091 | 102589092 | Human |
406962318 | GWAS611294_H | mean arterial pressure QTL GWAS611294 (human) | | 4e-09 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 102869254 | 102869255 | Human |
597203784 | GWAS1299858_H | pain measurement, response to gamma-aminobutyric acid receptor agonists QTL GWAS1299858 (human) | | 0.000003 | nociception system physiology trait (VT:0015100) | | 10 | 89097441 | 89097442 | Human |
597400394 | GWAS1496468_H | systolic blood pressure QTL GWAS1496468 (human) | | 0.000009 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 102856906 | 102856907 | Human |
597187402 | GWAS1283476_H | X-11308 measurement QTL GWAS1283476 (human) | | 4e-31 | X-11308 measurement | | 10 | 94997876 | 94997877 | Human |
407019670 | GWAS668646_H | inflammatory bowel disease QTL GWAS668646 (human) | | 6e-09 | multiple sclerosis | | 10 | 79300560 | 79300561 | Human |
597285709 | GWAS1381783_H | ulcerative colitis QTL GWAS1381783 (human) | | 3e-12 | ulcerative colitis | | 10 | 89146767 | 89146768 | Human |
407060631 | GWAS709607_H | neutrophil count QTL GWAS709607 (human) | | 2e-21 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 94542150 | 94542151 | Human |
597285708 | GWAS1381782_H | ulcerative colitis QTL GWAS1381782 (human) | | 8e-08 | ulcerative colitis | | 10 | 79286696 | 79286697 | Human |
407060629 | GWAS709605_H | neutrophil count QTL GWAS709605 (human) | | 8e-25 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 87879230 | 87879231 | Human |
597285711 | GWAS1381785_H | ulcerative colitis QTL GWAS1381785 (human) | | 2e-08 | ulcerative colitis | | 10 | 101436625 | 101436626 | Human |
597285710 | GWAS1381784_H | ulcerative colitis QTL GWAS1381784 (human) | | 3e-11 | ulcerative colitis | | 10 | 96860106 | 96860107 | Human |
597138255 | GWAS1234329_H | 1-(1-enyl-stearoyl)-2-arachidonoyl-GPC (P-18:0/20:4) measurement QTL GWAS1234329 (human) | | 6e-11 | blood triglyceride amount (VT:0002644) | | 10 | 100315722 | 100315723 | Human |
406954139 | GWAS603115_H | forced expiratory volume, response to bronchodilator QTL GWAS603115 (human) | | 0.000003 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 10 | 80544541 | 80544542 | Human |
597097292 | GWAS1193366_H | comparative body size at age 10, self-reported QTL GWAS1193366 (human) | | 1e-18 | comparative body size at age 10, self-reported | | 10 | 100687890 | 100687891 | Human |
597334854 | GWAS1430928_H | COVID-19, mortality QTL GWAS1430928 (human) | | 0.000003 | COVID-19, mortality | ratio of deaths to total study population during a period of time (CMO:0001023) | 10 | 77718029 | 77718030 | Human |
597097290 | GWAS1193364_H | comparative body size at age 10, self-reported QTL GWAS1193364 (human) | | 4e-14 | comparative body size at age 10, self-reported | | 10 | 85731093 | 85731094 | Human |
597285701 | GWAS1381775_H | free cholesterol in medium VLDL measurement QTL GWAS1381775 (human) | | 3e-14 | blood VLDL cholesterol amount (VT:0005144) | | 10 | 93083778 | 93083779 | Human |
407126168 | GWAS775144_H | systolic blood pressure QTL GWAS775144 (human) | | 7e-17 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94136183 | 94136184 | Human |
597187396 | GWAS1283470_H | X-11787 measurement QTL GWAS1283470 (human) | | 1e-52 | X-11787 measurement | | 10 | 94628908 | 94628909 | Human |
597523265 | GWAS1619339_H | intelligence QTL GWAS1619339 (human) | | 5e-09 | intelligence | | 10 | 102230055 | 102230056 | Human |
597097291 | GWAS1193365_H | comparative body size at age 10, self-reported QTL GWAS1193365 (human) | | 2e-08 | comparative body size at age 10, self-reported | | 10 | 86270684 | 86270685 | Human |
597326661 | GWAS1422735_H | color vision disorder QTL GWAS1422735 (human) | | 0.000003 | color vision disorder | | 10 | 77766435 | 77766436 | Human |
597449539 | GWAS1545613_H | diet measurement, vitamin D measurement QTL GWAS1545613 (human) | | 0.000005 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 86536484 | 86536485 | Human |
597506882 | GWAS1602956_H | aortic measurement QTL GWAS1602956 (human) | | 1e-08 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 94311455 | 94311456 | Human |
406986914 | GWAS635890_H | diet measurement, HOMA-IR QTL GWAS635890 (human) | | 4e-08 | eating behavior trait (VT:0001431) | Homeostatic Model Assessment of Insulin Resistance (CMO:0003002) | 10 | 81806930 | 81806931 | Human |
597146487 | GWAS1242561_H | photoreceptor cell layer thickness measurement QTL GWAS1242561 (human) | | 2e-26 | photoreceptor cell layer thickness measurement | | 10 | 84202002 | 84202003 | Human |
596958064 | GWAS1077583_H | serum metabolite measurement QTL GWAS1077583 (human) | | 4e-63 | serum metabolite measurement | | 10 | 98388301 | 98388302 | Human |
597392243 | GWAS1488317_H | type 2 diabetes mellitus QTL GWAS1488317 (human) | | 0.000002 | type 2 diabetes mellitus | | 10 | 79336832 | 79336833 | Human |
597212016 | GWAS1308090_H | blood protein measurement QTL GWAS1308090 (human) | | 3e-143 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95726520 | 95726521 | Human |
597187442 | GWAS1283516_H | X-21441 measurement QTL GWAS1283516 (human) | | 3e-10 | X-21441 measurement | | 10 | 99817203 | 99817204 | Human |
597187444 | GWAS1283518_H | X-21441 measurement QTL GWAS1283518 (human) | | 5e-75 | X-21441 measurement | | 10 | 99848144 | 99848145 | Human |
597089146 | GWAS1185220_H | coronary artery disease QTL GWAS1185220 (human) | | 7e-15 | coronary artery disease | | 10 | 103069712 | 103069713 | Human |
597089145 | GWAS1185219_H | coronary artery disease QTL GWAS1185219 (human) | | 1e-09 | coronary artery disease | | 10 | 89243047 | 89243048 | Human |
597334901 | GWAS1430975_H | COVID-19 QTL GWAS1430975 (human) | | 0.000007 | COVID-19 | | 10 | 97145811 | 97145812 | Human |
597457779 | GWAS1553853_H | Crohn's disease QTL GWAS1553853 (human) | | 1e-12 | intestine integrity trait (VT:0010554) | | 10 | 99555409 | 99555410 | Human |
597146488 | GWAS1242562_H | photoreceptor cell layer thickness measurement QTL GWAS1242562 (human) | | 3e-08 | photoreceptor cell layer thickness measurement | | 10 | 102274793 | 102274794 | Human |
597416820 | GWAS1512894_H | testosterone measurement QTL GWAS1512894 (human) | | 1e-26 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 102859535 | 102859536 | Human |
597449580 | GWAS1545654_H | diet measurement, vitamin D measurement QTL GWAS1545654 (human) | | 0.000006 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 86536484 | 86536485 | Human |
406978736 | GWAS627712_H | intelligence QTL GWAS627712 (human) | | 0.000003 | intelligence | | 10 | 91166943 | 91166944 | Human |
597269355 | GWAS1365429_H | metabolite measurement QTL GWAS1365429 (human) | | 8e-96 | metabolite measurement | | 10 | 98386156 | 98386157 | Human |
597359465 | GWAS1455539_H | diastolic blood pressure QTL GWAS1455539 (human) | | 6e-17 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 102834750 | 102834751 | Human |
597244781 | GWAS1340855_H | high density lipoprotein cholesterol measurement QTL GWAS1340855 (human) | | 3e-14 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 98013128 | 98013129 | Human |
597031776 | GWAS1127850_H | colorectal cancer, colorectal adenoma QTL GWAS1127850 (human) | | 3e-08 | colorectal cancer, colorectal adenoma | | 10 | 79286508 | 79286509 | Human |
597212014 | GWAS1308088_H | blood protein measurement QTL GWAS1308088 (human) | | 1e-700 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95712813 | 95712814 | Human |
597212015 | GWAS1308089_H | blood protein measurement QTL GWAS1308089 (human) | | 2e-45 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95905626 | 95905627 | Human |
597048172 | GWAS1144246_H | BMI-adjusted waist-hip ratio QTL GWAS1144246 (human) | | 8e-12 | body size trait (VT:0100005) | | 10 | 79193069 | 79193070 | Human |
597048173 | GWAS1144247_H | BMI-adjusted waist-hip ratio QTL GWAS1144247 (human) | | 1e-08 | body size trait (VT:0100005) | | 10 | 79134804 | 79134805 | Human |
407060664 | GWAS709640_H | platelet count QTL GWAS709640 (human) | | 2e-26 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 99514668 | 99514669 | Human |
597048171 | GWAS1144245_H | BMI-adjusted waist-hip ratio QTL GWAS1144245 (human) | | 4e-17 | body size trait (VT:0100005) | | 10 | 79147390 | 79147391 | Human |
597580643 | GWAS1637503_H | lymphocyte count QTL GWAS1637503 (human) | | 1e-17 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 97335930 | 97335931 | Human |
597138281 | GWAS1234355_H | protein-glutamine gamma-glutamyltransferase e measurement QTL GWAS1234355 (human) | | 2e-13 | enzyme/coenzyme activity trait (VT:0005584) | | 10 | 77896074 | 77896075 | Human |
406896830 | GWAS545806_H | atrial fibrillation QTL GWAS545806 (human) | | 2e-08 | atrial fibrillation | | 10 | 103562124 | 103562125 | Human |
597195417 | GWAS1291491_H | memory performance QTL GWAS1291491 (human) | | 0.000005 | memory performance | | 10 | 86567650 | 86567651 | Human |
597613212 | GWAS1670072_H | platelet count QTL GWAS1670072 (human) | | 4e-12 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 95747555 | 95747556 | Human |
407011648 | GWAS660624_H | mean corpuscular hemoglobin QTL GWAS660624 (human) | | 3e-11 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 103031837 | 103031838 | Human |
597457560 | GWAS1553634_H | pulmonary surfactant-associated protein d measurement QTL GWAS1553634 (human) | | 3e-19 | pulmonary surfactant-associated protein d measurement | | 10 | 79956537 | 79956538 | Human |
597613210 | GWAS1670070_H | platelet count QTL GWAS1670070 (human) | | 6e-17 | platelet quantity (VT:0003179) | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079967 | 93079968 | Human |
597613211 | GWAS1670071_H | platelet count QTL GWAS1670071 (human) | | 5e-14 | platelet count | | 10 | 94518638 | 94518639 | Human |
597613209 | GWAS1670069_H | platelet count QTL GWAS1670069 (human) | | 1e-12 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 79404390 | 79404391 | Human |
597187216 | GWAS1283290_H | X-21258 measurement QTL GWAS1283290 (human) | | 6e-29 | X-21258 measurement | | 10 | 94735990 | 94735991 | Human |
597482133 | GWAS1578207_H | blood protein measurement QTL GWAS1578207 (human) | | 2e-12 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95909039 | 95909040 | Human |
597252745 | GWAS1348819_H | schizophrenia QTL GWAS1348819 (human) | | 2e-18 | schizophrenia | | 10 | 102869116 | 102869117 | Human |
597187209 | GWAS1283283_H | X-17653 measurement QTL GWAS1283283 (human) | | 5e-10 | X-17653 measurement | | 10 | 94814498 | 94814499 | Human |
597482125 | GWAS1578199_H | blood protein measurement QTL GWAS1578199 (human) | | 8e-170 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95814932 | 95814933 | Human |
597129862 | GWAS1225936_H | cortical thickness QTL GWAS1225936 (human) | | 4e-13 | cortical thickness | | 10 | 100564926 | 100564927 | Human |
597129861 | GWAS1225935_H | cortical thickness QTL GWAS1225935 (human) | | 5e-14 | cortical thickness | | 10 | 94256036 | 94256037 | Human |
597129860 | GWAS1225934_H | cortical thickness QTL GWAS1225934 (human) | | 3e-12 | cortical thickness | | 10 | 89788681 | 89788682 | Human |
597252746 | GWAS1348820_H | schizophrenia QTL GWAS1348820 (human) | | 4e-08 | schizophrenia | | 10 | 103095504 | 103095505 | Human |
597129859 | GWAS1225933_H | cortical thickness QTL GWAS1225933 (human) | | 5e-10 | cortical thickness | | 10 | 88445442 | 88445443 | Human |
597088898 | GWAS1184972_H | gastric carcinoma QTL GWAS1184972 (human) | | 2e-22 | stomach integrity trait (VT:0010603) | | 10 | 94308190 | 94308191 | Human |
597490308 | GWAS1586382_H | electrocardiography QTL GWAS1586382 (human) | | 3e-15 | electrocardiography | | 10 | 95767330 | 95767331 | Human |
407265629 | GWAS914605_H | neuroimaging measurement QTL GWAS914605 (human) | | 1e-08 | neuroimaging measurement | | 10 | 94278929 | 94278930 | Human |
406921565 | GWAS570541_H | balding measurement QTL GWAS570541 (human) | | 1e-20 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 10 | 88331568 | 88331569 | Human |
407085407 | GWAS734383_H | systolic blood pressure QTL GWAS734383 (human) | | 8e-21 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94263320 | 94263321 | Human |
597187206 | GWAS1283280_H | X-17654 measurement QTL GWAS1283280 (human) | | 3e-55 | X-17654 measurement | | 10 | 94897643 | 94897644 | Human |
597113481 | GWAS1209555_H | erythrocyte count QTL GWAS1209555 (human) | | 2e-09 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 102801321 | 102801322 | Human |
597113480 | GWAS1209554_H | erythrocyte count QTL GWAS1209554 (human) | | 2e-13 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 102177487 | 102177488 | Human |
407290214 | GWAS939190_H | electrocardiography QTL GWAS939190 (human) | | 1e-12 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
407290215 | GWAS939191_H | electrocardiography QTL GWAS939191 (human) | | 2e-16 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597220025 | GWAS1316099_H | alkaline phosphatase measurement QTL GWAS1316099 (human) | | 5e-10 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 102193181 | 102193182 | Human |
597170873 | GWAS1266947_H | grip strength measurement QTL GWAS1266947 (human) | | 0.000002 | grip strength measurement | | 10 | 102812519 | 102812520 | Human |
407290213 | GWAS939189_H | electrocardiography QTL GWAS939189 (human) | | 4e-20 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597138099 | GWAS1234173_H | 1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) measurement QTL GWAS1234173 (human) | | 2e-25 | glycerophosphocholine amount (VT:0011004) | | 10 | 100315722 | 100315723 | Human |
597596859 | GWAS1653719_H | diastolic blood pressure change measurement QTL GWAS1653719 (human) | | 9e-20 | diastolic blood pressure change measurement | change in diastolic blood pressure (CMO:0001016) | 10 | 94279840 | 94279841 | Human |
597301949 | GWAS1398023_H | adseverin measurement QTL GWAS1398023 (human) | | 3e-13 | adseverin measurement | | 10 | 100037758 | 100037759 | Human |
597392051 | GWAS1488125_H | pulse pressure measurement QTL GWAS1488125 (human) | | 4e-09 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 88958770 | 88958771 | Human |
597301938 | GWAS1398012_H | cell growth regulator with EF hand domain protein 1 measurement QTL GWAS1398012 (human) | | 5e-20 | cell growth regulator with EF hand domain protein 1 measurement | | 10 | 100069757 | 100069758 | Human |
407011688 | GWAS660664_H | mean corpuscular hemoglobin QTL GWAS660664 (human) | | 6e-10 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 103179475 | 103179476 | Human |
597072570 | GWAS1168644_H | worry measurement QTL GWAS1168644 (human) | | 8e-13 | worry measurement | | 10 | 103185994 | 103185995 | Human |
597588656 | GWAS1645516_H | glucose measurement QTL GWAS1645516 (human) | | 3e-35 | glucose measurement | blood glucose level (CMO:0000046) | 10 | 92664665 | 92664666 | Human |
407290216 | GWAS939192_H | electrocardiography QTL GWAS939192 (human) | | 2e-18 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597162680 | GWAS1258754_H | coronary artery disease, plasminogen activator inhibitor 1 measurement QTL GWAS1258754 (human) | | 1e-09 | tissue plasminogen activator measurement, coronary artery disease | blood plasminogen activator inhibitor 1 level (CMO:0003034) | 10 | 80482174 | 80482175 | Human |
407290217 | GWAS939193_H | electrocardiography QTL GWAS939193 (human) | | 1e-19 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
407019885 | GWAS668861_H | response to anticoagulant QTL GWAS668861 (human) | | 0.0000004 | response to anticoagulant | | 10 | 94974582 | 94974583 | Human |
597220023 | GWAS1316097_H | alkaline phosphatase measurement QTL GWAS1316097 (human) | | 3e-10 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 100602786 | 100602787 | Human |
597072569 | GWAS1168643_H | worry measurement QTL GWAS1168643 (human) | | 8e-13 | worry measurement | | 10 | 103079395 | 103079396 | Human |
597154471 | GWAS1250545_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1250545 (human) | | 3e-10 | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93082456 | 93082457 | Human |
597146279 | GWAS1242353_H | Antihypertensive use measurement QTL GWAS1242353 (human) | | 1e-12 | Antihypertensive use measurement | | 10 | 94279840 | 94279841 | Human |
597588655 | GWAS1645515_H | glucose measurement QTL GWAS1645515 (human) | | 5e-23 | glucose measurement | blood glucose level (CMO:0000046) | 10 | 79184390 | 79184391 | Human |
597326507 | GWAS1422581_H | pain QTL GWAS1422581 (human) | | 0.000004 | pain | | 10 | 99063404 | 99063405 | Human |
597375658 | GWAS1471732_H | ulcerative colitis QTL GWAS1471732 (human) | | 8e-21 | ulcerative colitis | | 10 | 99530544 | 99530545 | Human |
597465774 | GWAS1561848_H | mean arterial pressure QTL GWAS1561848 (human) | | 3e-08 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 102856906 | 102856907 | Human |
596966055 | GWAS1085574_H | systolic blood pressure QTL GWAS1085574 (human) | | 2e-30 | systolic blood pressure | | 10 | 94140247 | 94140248 | Human |
597441199 | GWAS1537273_H | tyrosine-protein kinase JAK2 measurement QTL GWAS1537273 (human) | | 6e-14 | tyrosine-protein kinase JAK2 measurement | | 10 | 100130207 | 100130208 | Human |
597334703 | GWAS1430777_H | R-warfarin measurement QTL GWAS1430777 (human) | | 0.0000003 | R-warfarin measurement | | 10 | 93615624 | 93615625 | Human |
597400237 | GWAS1496311_H | Alzheimer disease, age at onset QTL GWAS1496311 (human) | | 0.0000007 | Alzheimer disease, age at onset | | 10 | 90473719 | 90473720 | Human |
597211808 | GWAS1307882_H | blood protein measurement QTL GWAS1307882 (human) | | 1e-700 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95714614 | 95714615 | Human |
597211809 | GWAS1307883_H | blood protein measurement QTL GWAS1307883 (human) | | 7e-30 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95905626 | 95905627 | Human |
597211810 | GWAS1307884_H | blood protein measurement QTL GWAS1307884 (human) | | 5e-47 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95905626 | 95905627 | Human |
597613220 | GWAS1670080_H | Red cell distribution width QTL GWAS1670080 (human) | | 3e-13 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 99479225 | 99479226 | Human |
597432999 | GWAS1529073_H | protein measurement QTL GWAS1529073 (human) | | 2e-716 | protein measurement | | 10 | 79946568 | 79946569 | Human |
597211811 | GWAS1307885_H | blood protein measurement QTL GWAS1307885 (human) | | 2e-09 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95709352 | 95709353 | Human |
597613219 | GWAS1670079_H | Red cell distribution width QTL GWAS1670079 (human) | | 3e-11 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 94414215 | 94414216 | Human |
597277350 | GWAS1373424_H | age-related macular degeneration, COVID-19 QTL GWAS1373424 (human) | | 2e-08 | age-related macular degeneration, COVID-19 | | 10 | 100049236 | 100049237 | Human |
597097174 | GWAS1193248_H | testosterone measurement QTL GWAS1193248 (human) | | 7e-22 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 92682235 | 92682237 | Human |
407109892 | GWAS758868_H | waist-hip ratio QTL GWAS758868 (human) | | 2e-08 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 93966124 | 93966125 | Human |
597039830 | GWAS1135904_H | urinary metabolite measurement QTL GWAS1135904 (human) | | 2e-209 | urinary metabolite measurement | | 10 | 98399379 | 98399380 | Human |
407290118 | GWAS939094_H | unipolar depression, systolic blood pressure QTL GWAS939094 (human) | | 6e-09 | unipolar depression, systolic blood pressure | | 10 | 103051446 | 103051447 | Human |
597097175 | GWAS1193249_H | testosterone measurement QTL GWAS1193249 (human) | | 2e-14 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 95064055 | 95064056 | Human |
596974292 | GWAS1093811_H | neurofilament light chain measurement QTL GWAS1093811 (human) | | 9e-08 | neurofilament light chain measurement | | 10 | 97999883 | 97999884 | Human |
597097173 | GWAS1193247_H | testosterone measurement QTL GWAS1193247 (human) | | 2e-09 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 89000159 | 89000160 | Human |
407290117 | GWAS939093_H | unipolar depression, systolic blood pressure QTL GWAS939093 (human) | | 8e-10 | unipolar depression, systolic blood pressure | | 10 | 102937759 | 102937760 | Human |
407109888 | GWAS758864_H | waist-hip ratio QTL GWAS758864 (human) | | 1e-18 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 79158760 | 79158761 | Human |
597244639 | GWAS1340713_H | sex hormone-binding globulin measurement QTL GWAS1340713 (human) | | 0.0000001 | sex hormone-binding globulin measurement | | 10 | 98013128 | 98013129 | Human |
597383901 | GWAS1479975_H | body mass index QTL GWAS1479975 (human) | | 4e-17 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98101555 | 98101556 | Human |
407142658 | GWAS791634_H | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia QTL GWAS791634 (human) | | 1e-08 | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | | 10 | 103146454 | 103146455 | Human |
597383900 | GWAS1479974_H | body mass index QTL GWAS1479974 (human) | | 1e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 91300592 | 91300593 | Human |
407109891 | GWAS758867_H | waist-hip ratio QTL GWAS758867 (human) | | 8e-11 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 93586671 | 93586672 | Human |
407298319 | GWAS947295_H | functional brain measurement QTL GWAS947295 (human) | | 9e-29 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
597097176 | GWAS1193250_H | testosterone measurement QTL GWAS1193250 (human) | | 4e-31 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 102863296 | 102863297 | Human |
597138136 | GWAS1234210_H | decadienedioic acid (C10:2-DC) measurement QTL GWAS1234210 (human) | | 8e-20 | decadienedioic acid (C10:2-DC) measurement | | 10 | 100315722 | 100315723 | Human |
597375689 | GWAS1471763_H | Crohn's disease QTL GWAS1471763 (human) | | 2e-20 | intestine integrity trait (VT:0010554) | | 10 | 99524480 | 99524481 | Human |
597285578 | GWAS1381652_H | cholesterol esters in medium VLDL measurement QTL GWAS1381652 (human) | | 4e-14 | cholesterol esters in medium VLDL measurement | | 10 | 93083778 | 93083779 | Human |
597244618 | GWAS1340692_H | serum gamma-glutamyl transferase measurement QTL GWAS1340692 (human) | | 1e-10 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 99825683 | 99825685 | Human |
597613261 | GWAS1670121_H | Red cell distribution width QTL GWAS1670121 (human) | | 4e-12 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 101558619 | 101558620 | Human |
407298322 | GWAS947298_H | functional brain measurement QTL GWAS947298 (human) | | 3e-56 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
407298323 | GWAS947299_H | functional brain measurement QTL GWAS947299 (human) | | 2e-37 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
407298320 | GWAS947296_H | functional brain measurement QTL GWAS947296 (human) | | 9e-55 | functional brain measurement | | 10 | 94278929 | 94278930 | Human |
597359298 | GWAS1455372_H | FEV/FVC ratio, response to bronchodilator QTL GWAS1455372 (human) | | 0.0000006 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 78630510 | 78630511 | Human |
597326529 | GWAS1422603_H | N6,N6-dimethyllysine measurement QTL GWAS1422603 (human) | | 7e-223 | N6,N6-dimethyllysine measurement | | 10 | 98382311 | 98382312 | Human |
597613250 | GWAS1670110_H | platelet count QTL GWAS1670110 (human) | | 5e-12 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 102614896 | 102614897 | Human |
597596867 | GWAS1653727_H | eosinophil count QTL GWAS1653727 (human) | | 2e-22 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 92672243 | 92672244 | Human |
597392069 | GWAS1488143_H | risk-taking behaviour QTL GWAS1488143 (human) | | 4e-08 | risk-taking behaviour | | 10 | 102883839 | 102883840 | Human |
597613249 | GWAS1670109_H | platelet count QTL GWAS1670109 (human) | | 4e-18 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 99520522 | 99520523 | Human |
597121783 | GWAS1217857_H | rheumatoid arthritis, Crohn's disease QTL GWAS1217857 (human) | | 7e-08 | intestine integrity trait (VT:0010554) | | 10 | 80462422 | 80462423 | Human |
596949748 | GWAS1069267_H | migraine disorder QTL GWAS1069267 (human) | | 1e-09 | migraine disorder | | 10 | 94278929 | 94278930 | Human |
597048054 | GWAS1144128_H | neuroticism measurement QTL GWAS1144128 (human) | | 5e-09 | neuroticism measurement | | 10 | 102876519 | 102876520 | Human |
597121782 | GWAS1217856_H | rheumatoid arthritis, Crohn's disease QTL GWAS1217856 (human) | | 0.000001 | intestine integrity trait (VT:0010554) | | 10 | 79282718 | 79282719 | Human |
407019808 | GWAS668784_H | Crohn's disease QTL GWAS668784 (human) | | 1e-30 | intestine integrity trait (VT:0010554) | | 10 | 79300560 | 79300561 | Human |
597482238 | GWAS1578312_H | lymphocyte count QTL GWAS1578312 (human) | | 5e-712 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95810558 | 95810559 | Human |
597482239 | GWAS1578313_H | lymphocyte count QTL GWAS1578313 (human) | | 7e-738 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95810558 | 95810559 | Human |
406970661 | GWAS619637_H | diastolic blood pressure QTL GWAS619637 (human) | | 4e-14 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103076162 | 103076163 | Human |
597031664 | GWAS1127738_H | body mass index QTL GWAS1127738 (human) | | 7e-22 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98018469 | 98018470 | Human |
597285630 | GWAS1381704_H | cholesterol esters in large HDL measurement QTL GWAS1381704 (human) | | 2e-11 | cholesterol esters in large HDL measurement | | 10 | 93083778 | 93083779 | Human |
597359346 | GWAS1455420_H | pulse pressure measurement QTL GWAS1455420 (human) | | 0.000005 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 87844975 | 87844976 | Human |
597318387 | GWAS1414461_H | triglyceride measurement QTL GWAS1414461 (human) | | 3e-51 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079885 | 93079886 | Human |
597170930 | GWAS1267004_H | pulse pressure measurement QTL GWAS1267004 (human) | | 2e-09 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 103178833 | 103178834 | Human |
597367543 | GWAS1463617_H | smoking behavior QTL GWAS1463617 (human) | | 6e-12 | smoking behavior | | 10 | 102653628 | 102653629 | Human |
597244660 | GWAS1340734_H | aortic measurement QTL GWAS1340734 (human) | | 2e-10 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 94356663 | 94356664 | Human |
597318388 | GWAS1414462_H | triglyceride measurement QTL GWAS1414462 (human) | | 9e-15 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 98012647 | 98012648 | Human |
597367532 | GWAS1463606_H | systolic blood pressure QTL GWAS1463606 (human) | | 1e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 87844975 | 87844976 | Human |
597301986 | GWAS1398060_H | neutrophil count QTL GWAS1398060 (human) | | 1e-13 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 87921701 | 87921702 | Human |
597301985 | GWAS1398059_H | neutrophil count QTL GWAS1398059 (human) | | 5e-12 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 79285450 | 79285451 | Human |
597465831 | GWAS1561905_H | nicotine withdrawal measurement QTL GWAS1561905 (human) | | 0.0000001 | nicotine withdrawal measurement | | 10 | 84599521 | 84599522 | Human |
597310182 | GWAS1406256_H | Drugs used in diabetes use measurement QTL GWAS1406256 (human) | | 5e-08 | Drugs used in diabetes use measurement | | 10 | 100152307 | 100152308 | Human |
407011646 | GWAS660622_H | mean corpuscular hemoglobin QTL GWAS660622 (human) | | 7e-28 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 102148323 | 102148324 | Human |
597465825 | GWAS1561899_H | nicotine withdrawal symptom count QTL GWAS1561899 (human) | | 0.000003 | nicotine withdrawal symptom count | | 10 | 84599521 | 84599522 | Human |
597392102 | GWAS1488176_H | body fat distribution QTL GWAS1488176 (human) | | 0.0000003 | body fat distribution | body fat morphological measurement (CMO:0000089) | 10 | 94266427 | 94266428 | Human |
407011647 | GWAS660623_H | mean corpuscular hemoglobin QTL GWAS660623 (human) | | 1e-12 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 102134967 | 102134968 | Human |
407011645 | GWAS660621_H | mean corpuscular hemoglobin QTL GWAS660621 (human) | | 1e-36 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 99545585 | 99545586 | Human |
597375516 | GWAS1471590_H | bipolar disorder QTL GWAS1471590 (human) | | 1e-12 | bipolar disorder | | 10 | 102868477 | 102868478 | Human |
597522967 | GWAS1619041_H | calcium/calmodulin-dependent protein kinase type 1 measurement QTL GWAS1619041 (human) | | 8e-26 | calcium/calmodulin-dependent protein kinase type 1 measurement | | 10 | 100130207 | 100130208 | Human |
597064218 | GWAS1160292_H | BMI-adjusted waist-hip ratio QTL GWAS1160292 (human) | | 0.000008 | body size trait (VT:0100005) | | 10 | 92490284 | 92490285 | Human |
596957722 | GWAS1077241_H | major depressive disorder QTL GWAS1077241 (human) | | 1e-09 | major depressive disorder | | 10 | 103004514 | 103004515 | Human |
597170696 | GWAS1266770_H | aortic measurement QTL GWAS1266770 (human) | | 7e-10 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 94151004 | 94151005 | Human |
597613070 | GWAS1669930_H | erythrocyte count QTL GWAS1669930 (human) | | 9e-19 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 99531610 | 99531611 | Human |
597187073 | GWAS1283147_H | mitochondrial DNA measurement QTL GWAS1283147 (human) | | 4e-15 | mitochondrial DNA measurement | | 10 | 97314215 | 97314230 | Human |
597096969 | GWAS1193043_H | sex hormone-binding globulin measurement QTL GWAS1193043 (human) | | 2e-22 | sex hormone-binding globulin measurement | | 10 | 93079885 | 93079886 | Human |
597293630 | GWAS1389704_H | cardiac troponin I measurement QTL GWAS1389704 (human) | | 0.000003 | cardiac troponin I measurement | blood troponin level (CMO:0001283) | 10 | 86064761 | 86064762 | Human |
597252670 | GWAS1348744_H | platelet count QTL GWAS1348744 (human) | | 3e-10 | urine albumin amount (VT:0002871) | urine albumin level to urine creatinine level ratio (CMO:0000384) | 10 | 93079885 | 93079886 | Human |
597211711 | GWAS1307785_H | glaucoma QTL GWAS1307785 (human) | | 3e-09 | glaucoma | | 10 | 93182666 | 93182667 | Human |
406954477 | GWAS603453_H | forced expiratory volume, response to bronchodilator QTL GWAS603453 (human) | | 0.0000006 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 10 | 80462942 | 80462943 | Human |
597056038 | GWAS1152112_H | adolescent idiopathic scoliosis QTL GWAS1152112 (human) | | 3e-20 | adolescent idiopathic scoliosis | | 10 | 100578375 | 100578376 | Human |
597056039 | GWAS1152113_H | adolescent idiopathic scoliosis QTL GWAS1152113 (human) | | 2e-17 | adolescent idiopathic scoliosis | | 10 | 99934728 | 99934729 | Human |
596949536 | GWAS1069055_H | triglyceride measurement QTL GWAS1069055 (human) | | 2e-08 | blood urea nitrogen measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 93079885 | 93079886 | Human |
597498407 | GWAS1594481_H | Uterine leiomyoma QTL GWAS1594481 (human) | | 3e-10 | Uterine leiomyoma | | 10 | 101726828 | 101726829 | Human |
597170726 | GWAS1266800_H | phospholipids in VLDL measurement QTL GWAS1266800 (human) | | 2e-16 | blood VLDL phospholipid amount (VT:0010507) | | 10 | 93083778 | 93083779 | Human |
597506653 | GWAS1602727_H | C-reactive protein measurement QTL GWAS1602727 (human) | | 2e-13 | C-reactive protein measurement | | 10 | 79059375 | 79059376 | Human |
597383771 | GWAS1479845_H | serum metabolite measurement QTL GWAS1479845 (human) | | 2e-11 | serum metabolite measurement | | 10 | 87658807 | 87658808 | Human |
597047894 | GWAS1143968_H | C-reactive protein measurement QTL GWAS1143968 (human) | | 6e-12 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 98002936 | 98002937 | Human |
597432924 | GWAS1528998_H | sex hormone-binding globulin measurement QTL GWAS1528998 (human) | | 0.0000007 | sex hormone-binding globulin measurement | | 10 | 101828101 | 101828102 | Human |
597047895 | GWAS1143969_H | C-reactive protein measurement QTL GWAS1143969 (human) | | 2e-10 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 103524831 | 103524832 | Human |
597228122 | GWAS1324196_H | serum gamma-glutamyl transferase measurement QTL GWAS1324196 (human) | | 9e-10 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 77797644 | 77797645 | Human |
597047892 | GWAS1143966_H | C-reactive protein measurement QTL GWAS1143966 (human) | | 1e-35 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 89243170 | 89243171 | Human |
597506655 | GWAS1602729_H | C-reactive protein measurement QTL GWAS1602729 (human) | | 3e-19 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 93063586 | 93063587 | Human |
597506654 | GWAS1602728_H | C-reactive protein measurement QTL GWAS1602728 (human) | | 1e-09 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 91796740 | 91796741 | Human |
597047893 | GWAS1143967_H | C-reactive protein measurement QTL GWAS1143967 (human) | | 5e-17 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 93079885 | 93079886 | Human |
597047891 | GWAS1143965_H | C-reactive protein measurement QTL GWAS1143965 (human) | | 2e-10 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 79328300 | 79328301 | Human |
597162578 | GWAS1258652_H | lipid measurement QTL GWAS1258652 (human) | | 0.000007 | lipid measurement | blood lipid measurement (CMO:0000050) | 10 | 92155896 | 92155897 | Human |
597072467 | GWAS1168541_H | worry measurement QTL GWAS1168541 (human) | | 2e-13 | worry measurement | | 10 | 102944260 | 102944261 | Human |
597039696 | GWAS1135770_H | apolipoprotein A 1 measurement QTL GWAS1135770 (human) | | 5e-08 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 10 | 79392512 | 79392513 | Human |
597383772 | GWAS1479846_H | serum metabolite measurement QTL GWAS1479846 (human) | | 1e-10 | serum metabolite measurement | | 10 | 95144300 | 95144301 | Human |
597056095 | GWAS1152169_H | adolescent idiopathic scoliosis QTL GWAS1152169 (human) | | 6e-12 | adolescent idiopathic scoliosis | | 10 | 85762211 | 85762212 | Human |
597310032 | GWAS1406106_H | vaginal microbiome measurement QTL GWAS1406106 (human) | | 0.000001 | vaginal microbiome measurement | | 10 | 97116393 | 97116394 | Human |
597056090 | GWAS1152164_H | adolescent idiopathic scoliosis QTL GWAS1152164 (human) | | 9e-14 | adolescent idiopathic scoliosis | | 10 | 82112793 | 82112794 | Human |
596982361 | GWAS1101880_H | memory performance QTL GWAS1101880 (human) | | 0.000008 | memory performance | | 10 | 88455681 | 88455682 | Human |
597056088 | GWAS1152162_H | adolescent idiopathic scoliosis QTL GWAS1152162 (human) | | 2e-14 | adolescent idiopathic scoliosis | | 10 | 85607609 | 85607610 | Human |
407159179 | GWAS808155_H | gut microbiome measurement QTL GWAS808155 (human) | | 0.000003 | gut microbiome measurement | | 10 | 100309578 | 100309579 | Human |
597580366 | GWAS1637226_H | lymphocyte count QTL GWAS1637226 (human) | | 2e-22 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 97335930 | 97335931 | Human |
597318216 | GWAS1414290_H | X-11308 measurement QTL GWAS1414290 (human) | | 5e-68 | X-11308 measurement | | 10 | 94940223 | 94940224 | Human |
597310031 | GWAS1406105_H | vaginal microbiome measurement QTL GWAS1406105 (human) | | 0.000001 | vaginal microbiome measurement | | 10 | 96970388 | 96970389 | Human |
597318210 | GWAS1414284_H | X-02269 measurement QTL GWAS1414284 (human) | | 9e-41 | X-02269 measurement | | 10 | 95064649 | 95064650 | Human |
597621318 | GWAS1678178_H | body weight QTL GWAS1678178 (human) | | 2e-23 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 102897491 | 102897492 | Human |
597318208 | GWAS1414282_H | X-02249 measurement QTL GWAS1414282 (human) | | 3e-56 | X-02249 measurement | | 10 | 95086085 | 95086086 | Human |
406954403 | GWAS603379_H | forced expiratory volume, response to bronchodilator QTL GWAS603379 (human) | | 0.000002 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 10 | 80505515 | 80505516 | Human |
597154418 | GWAS1250492_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1250492 (human) | | 3e-12 | triglyceride measurement | | 10 | 93079885 | 93079886 | Human |
597326460 | GWAS1422534_H | FEV/FVC ratio QTL GWAS1422534 (human) | | 2e-12 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 80513323 | 80513324 | Human |
597334642 | GWAS1430716_H | educational attainment QTL GWAS1430716 (human) | | 8e-26 | educational attainment | | 10 | 103394332 | 103394333 | Human |
597588599 | GWAS1645459_H | glucose measurement QTL GWAS1645459 (human) | | 1e-35 | glucose measurement | blood glucose level (CMO:0000046) | 10 | 92709177 | 92709178 | Human |
597211761 | GWAS1307835_H | schizophrenia QTL GWAS1307835 (human) | | 2e-11 | schizophrenia | | 10 | 102664043 | 102664044 | Human |
597334643 | GWAS1430717_H | educational attainment QTL GWAS1430717 (human) | | 4e-12 | educational attainment | | 10 | 103458495 | 103458496 | Human |
597334640 | GWAS1430714_H | educational attainment QTL GWAS1430714 (human) | | 2e-11 | educational attainment | | 10 | 103189977 | 103189978 | Human |
597334641 | GWAS1430715_H | educational attainment QTL GWAS1430715 (human) | | 9e-15 | educational attainment | | 10 | 103315979 | 103315980 | Human |
597236340 | GWAS1332414_H | asparaginase hypersensitivity QTL GWAS1332414 (human) | | 0.000003 | asparaginase hypersensitivity | | 10 | 79263945 | 79263946 | Human |
597326455 | GWAS1422529_H | color vision disorder QTL GWAS1422529 (human) | | 0.000004 | color vision disorder | | 10 | 92125252 | 92125253 | Human |
597334634 | GWAS1430708_H | educational attainment QTL GWAS1430708 (human) | | 2e-09 | educational attainment | | 10 | 102045319 | 102045320 | Human |
596974181 | GWAS1093700_H | systolic blood pressure, major depressive disorder QTL GWAS1093700 (human) | | 7e-09 | systolic blood pressure, major depressive disorder | | 10 | 103199143 | 103199144 | Human |
597334635 | GWAS1430709_H | educational attainment QTL GWAS1430709 (human) | | 7e-20 | educational attainment | | 10 | 102224633 | 102224634 | Human |
597334632 | GWAS1430706_H | educational attainment QTL GWAS1430706 (human) | | 0.000002 | educational attainment | | 10 | 101903032 | 101903033 | Human |
597228139 | GWAS1324213_H | body mass index QTL GWAS1324213 (human) | | 3e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 85651147 | 85651148 | Human |
597056101 | GWAS1152175_H | adolescent idiopathic scoliosis QTL GWAS1152175 (human) | | 4e-10 | adolescent idiopathic scoliosis | | 10 | 86207323 | 86207324 | Human |
597334633 | GWAS1430707_H | educational attainment QTL GWAS1430707 (human) | | 1e-49 | educational attainment | | 10 | 102042651 | 102042652 | Human |
597318254 | GWAS1414328_H | risk-taking behaviour QTL GWAS1414328 (human) | | 2e-12 | risk-taking behaviour | | 10 | 81402102 | 81402103 | Human |
597326446 | GWAS1422520_H | color vision disorder QTL GWAS1422520 (human) | | 0.0000007 | color vision disorder | | 10 | 85884308 | 85884309 | Human |
597334638 | GWAS1430712_H | educational attainment QTL GWAS1430712 (human) | | 9e-12 | educational attainment | | 10 | 102571233 | 102571234 | Human |
597310063 | GWAS1406137_H | vaginal microbiome measurement QTL GWAS1406137 (human) | | 0.000002 | vaginal microbiome measurement | | 10 | 96970388 | 96970389 | Human |
597318255 | GWAS1414329_H | risk-taking behaviour QTL GWAS1414329 (human) | | 5e-09 | risk-taking behaviour | | 10 | 102466184 | 102466185 | Human |
597334639 | GWAS1430713_H | educational attainment QTL GWAS1430713 (human) | | 2e-08 | educational attainment | | 10 | 102632740 | 102632741 | Human |
597334636 | GWAS1430710_H | educational attainment QTL GWAS1430710 (human) | | 5e-09 | educational attainment | | 10 | 102265959 | 102265960 | Human |
597334637 | GWAS1430711_H | educational attainment QTL GWAS1430711 (human) | | 1e-28 | educational attainment | | 10 | 102427647 | 102427648 | Human |
597310051 | GWAS1406125_H | systolic blood pressure QTL GWAS1406125 (human) | | 4e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 80279560 | 80279561 | Human |
597293666 | GWAS1389740_H | triacylglycerol 50:1 measurement QTL GWAS1389740 (human) | | 8e-09 | blood triglyceride amount (VT:0002644) | | 10 | 100315722 | 100315723 | Human |
597498465 | GWAS1594539_H | memory performance, sex interaction measurement QTL GWAS1594539 (human) | | 0.000003 | memory performance, sex interaction measurement | | 10 | 97103183 | 97103184 | Human |
597334630 | GWAS1430704_H | educational attainment QTL GWAS1430704 (human) | | 2e-17 | educational attainment | | 10 | 100987606 | 100987607 | Human |
597195365 | GWAS1291439_H | lean body mass QTL GWAS1291439 (human) | | 3e-09 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 94238422 | 94238423 | Human |
597334631 | GWAS1430705_H | educational attainment QTL GWAS1430705 (human) | | 4e-10 | educational attainment | | 10 | 101352408 | 101352409 | Human |
597064299 | GWAS1160373_H | body mass index QTL GWAS1160373 (human) | | 0.000004 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 103109281 | 103109282 | Human |
597310052 | GWAS1406126_H | systolic blood pressure QTL GWAS1406126 (human) | | 4e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 87855059 | 87855060 | Human |
596957589 | GWAS1077108_H | hypothyroidism QTL GWAS1077108 (human) | | 1e-10 | hypothyroidism | | 10 | 99555409 | 99555410 | Human |
597326235 | GWAS1422309_H | FEV/FVC ratio QTL GWAS1422309 (human) | | 6e-14 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 103588736 | 103588737 | Human |
596965782 | GWAS1085301_H | colorectal cancer QTL GWAS1085301 (human) | | 3e-10 | colorectal cancer | | 10 | 89639807 | 89639808 | Human |
597219742 | GWAS1315816_H | corneal resistance factor QTL GWAS1315816 (human) | | 2e-35 | corneal resistance factor | | 10 | 93299095 | 93299096 | Human |
407020111 | GWAS669087_H | insulin measurement QTL GWAS669087 (human) | | 0.0000003 | insulin measurement | pancreatic islet insulin release measurement (CMO:0001216) | 10 | 89612776 | 89612777 | Human |
597293460 | GWAS1389534_H | lymphocyte measurement, neutrophil measurement QTL GWAS1389534 (human) | | 5e-12 | lymphocyte measurement, neutrophil measurement | | 10 | 92759940 | 92759941 | Human |
597358996 | GWAS1455070_H | platelet crit QTL GWAS1455070 (human) | | 9e-12 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 10 | 94266427 | 94266428 | Human |
597064071 | GWAS1160145_H | smoking behavior, body mass index QTL GWAS1160145 (human) | | 0.000003 | smoking behavior, body mass index | body mass index (BMI) (CMO:0000105) | 10 | 85651147 | 85651148 | Human |
597309835 | GWAS1405909_H | vaginal microbiome measurement QTL GWAS1405909 (human) | | 7e-08 | vaginal microbiome measurement | | 10 | 97057038 | 97057039 | Human |
597326223 | GWAS1422297_H | vital capacity QTL GWAS1422297 (human) | | 1e-13 | vital capacity | | 10 | 79169036 | 79169037 | Human |
597498248 | GWAS1594322_H | protein measurement QTL GWAS1594322 (human) | | 5e-14 | protein measurement | | 10 | 100130207 | 100130208 | Human |
597277056 | GWAS1373130_H | X-17654 measurement QTL GWAS1373130 (human) | | 3e-45 | X-17654 measurement | | 10 | 94936798 | 94936799 | Human |
597596548 | GWAS1653408_H | diabetes mellitus QTL GWAS1653408 (human) | | 5e-38 | pancreas integrity trait (VT:0010560) | | 10 | 79184390 | 79184391 | Human |
597490109 | GWAS1586183_H | diabetes mellitus QTL GWAS1586183 (human) | | 2e-08 | pancreas integrity trait (VT:0010560) | | 10 | 92585402 | 92585403 | Human |
597088695 | GWAS1184769_H | monocyte percentage of leukocytes QTL GWAS1184769 (human) | | 2e-10 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 10 | 96620380 | 96620381 | Human |
597088692 | GWAS1184766_H | monocyte percentage of leukocytes QTL GWAS1184766 (human) | | 9e-10 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 10 | 92250021 | 92250022 | Human |
597326264 | GWAS1422338_H | coronary artery disease QTL GWAS1422338 (human) | | 4e-08 | coronary artery disease | | 10 | 93996743 | 93996744 | Human |
597301688 | GWAS1397762_H | calcium/calmodulin-dependent protein kinase type 1 measurement QTL GWAS1397762 (human) | | 2e-28 | calcium/calmodulin-dependent protein kinase type 1 measurement | | 10 | 100069757 | 100069758 | Human |
597088693 | GWAS1184767_H | monocyte percentage of leukocytes QTL GWAS1184767 (human) | | 2e-09 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 10 | 93079885 | 93079886 | Human |
597326265 | GWAS1422339_H | coronary artery disease QTL GWAS1422339 (human) | | 1e-09 | coronary artery disease | | 10 | 98033255 | 98033256 | Human |
597490107 | GWAS1586181_H | type 2 diabetes mellitus QTL GWAS1586181 (human) | | 1e-09 | type 2 diabetes mellitus | | 10 | 92454823 | 92454824 | Human |
597162431 | GWAS1258505_H | docosahexaenoic acid measurement QTL GWAS1258505 (human) | | 1e-10 | fatty acid amount (VT:0010046) | blood free fatty acids level (CMO:0000117) | 10 | 94968412 | 94968413 | Human |
597465527 | GWAS1561601_H | hypertension QTL GWAS1561601 (human) | | 9e-13 | hypertension | | 10 | 103199143 | 103199144 | Human |
597088699 | GWAS1184773_H | monocyte percentage of leukocytes QTL GWAS1184773 (human) | | 2e-10 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 10 | 102793809 | 102793810 | Human |
597088696 | GWAS1184770_H | monocyte percentage of leukocytes QTL GWAS1184770 (human) | | 5e-15 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 10 | 96711129 | 96711130 | Human |
597088697 | GWAS1184771_H | monocyte percentage of leukocytes QTL GWAS1184771 (human) | | 6e-33 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 10 | 97399913 | 97399914 | Human |
407290486 | GWAS939462_H | electrocardiography QTL GWAS939462 (human) | | 3e-14 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
407290487 | GWAS939463_H | electrocardiography QTL GWAS939463 (human) | | 4e-14 | functional brain measurement, language measurement | | 10 | 94278929 | 94278930 | Human |
407290484 | GWAS939460_H | electrocardiography QTL GWAS939460 (human) | | 1e-16 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
407290485 | GWAS939461_H | electrocardiography QTL GWAS939461 (human) | | 1e-14 | migraine disorder | | 10 | 94278929 | 94278930 | Human |
597580205 | GWAS1637065_H | gout QTL GWAS1637065 (human) | | 1e-11 | gout | | 10 | 103086421 | 103086422 | Human |
407290483 | GWAS939459_H | electrocardiography QTL GWAS939459 (human) | | 7e-19 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
407290492 | GWAS939468_H | electrocardiography QTL GWAS939468 (human) | | 4e-15 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597064106 | GWAS1160180_H | birth weight QTL GWAS1160180 (human) | | 1e-14 | birth weight | neonatal body weight (CMO:0002079) | 10 | 92708886 | 92708887 | Human |
407290490 | GWAS939466_H | electrocardiography QTL GWAS939466 (human) | | 1e-15 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
407290491 | GWAS939467_H | electrocardiography QTL GWAS939467 (human) | | 2e-15 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
407290488 | GWAS939464_H | electrocardiography QTL GWAS939464 (human) | | 5e-14 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
596965803 | GWAS1085322_H | colorectal cancer QTL GWAS1085322 (human) | | 3e-21 | colorectal cancer | | 10 | 79059375 | 79059376 | Human |
407290489 | GWAS939465_H | electrocardiography QTL GWAS939465 (human) | | 9e-15 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
407233146 | GWAS882122_H | allergic disease QTL GWAS882122 (human) | | 1e-10 | allergic disease | | 10 | 102518504 | 102518505 | Human |
597113303 | GWAS1209377_H | erythrocyte count QTL GWAS1209377 (human) | | 2e-09 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 92656472 | 92656473 | Human |
597113302 | GWAS1209376_H | erythrocyte count QTL GWAS1209376 (human) | | 1e-12 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 89730330 | 89730331 | Human |
596974033 | GWAS1093552_H | neuroticism measurement, major depressive disorder QTL GWAS1093552 (human) | | 0.000006 | neuroticism measurement, major depressive disorder | | 10 | 96376493 | 96376494 | Human |
597309919 | GWAS1405993_H | vaginal microbiome measurement QTL GWAS1405993 (human) | | 2e-08 | vaginal microbiome measurement | | 10 | 96970388 | 96970389 | Human |
597023196 | GWAS1119270_H | low density lipoprotein cholesterol measurement QTL GWAS1119270 (human) | | 0.000002 | familial hyperlipidemia | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 93079885 | 93079886 | Human |
597268944 | GWAS1365018_H | metabolite measurement QTL GWAS1365018 (human) | | 6e-14 | metabolite measurement | | 10 | 99840980 | 99840981 | Human |
597514710 | GWAS1610784_H | testosterone measurement QTL GWAS1610784 (human) | | 3e-08 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 102889600 | 102889601 | Human |
597187029 | GWAS1283103_H | X-16087 measurement QTL GWAS1283103 (human) | | 3e-23 | X-16087 measurement | | 10 | 95060813 | 95060814 | Human |
597113306 | GWAS1209380_H | erythrocyte count QTL GWAS1209380 (human) | | 4e-17 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 99549133 | 99549134 | Human |
597318100 | GWAS1414174_H | HbA1c measurement QTL GWAS1414174 (human) | | 4e-13 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 10 | 92664665 | 92664666 | Human |
597113305 | GWAS1209379_H | erythrocyte count QTL GWAS1209379 (human) | | 5e-11 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 95477870 | 95477871 | Human |
597113304 | GWAS1209378_H | erythrocyte count QTL GWAS1209378 (human) | | 2e-11 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 94403655 | 94403662 | Human |
597383626 | GWAS1479700_H | cardiovascular disease QTL GWAS1479700 (human) | | 5e-08 | cardiovascular disease | | 10 | 86412952 | 86412953 | Human |
597334475 | GWAS1430549_H | educational attainment QTL GWAS1430549 (human) | | 4e-10 | educational attainment | | 10 | 97361940 | 97361941 | Human |
597268936 | GWAS1365010_H | stearic acid measurement QTL GWAS1365010 (human) | | 4e-18 | milk saturated fatty acid amount (VT:0010304) | | 10 | 100315722 | 100315723 | Human |
407208465 | GWAS857441_H | platelet count QTL GWAS857441 (human) | | 2e-25 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 79404390 | 79404391 | Human |
597334476 | GWAS1430550_H | educational attainment QTL GWAS1430550 (human) | | 7e-19 | educational attainment | | 10 | 97952377 | 97952378 | Human |
597457348 | GWAS1553422_H | Crohn's disease QTL GWAS1553422 (human) | | 0.000003 | intestine integrity trait (VT:0010554) | | 10 | 92669710 | 92669711 | Human |
597064143 | GWAS1160217_H | birth weight QTL GWAS1160217 (human) | | 2e-09 | birth weight | neonatal body weight (CMO:0002079) | 10 | 103154183 | 103154184 | Human |
597244355 | GWAS1340429_H | blood protein measurement QTL GWAS1340429 (human) | | 7e-11 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 89139865 | 89139866 | Human |
597211586 | GWAS1307660_H | blood protein measurement QTL GWAS1307660 (human) | | 1e-10 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95571440 | 95571441 | Human |
597211588 | GWAS1307662_H | blood protein measurement QTL GWAS1307662 (human) | | 8e-28 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95714614 | 95714615 | Human |
597465536 | GWAS1561610_H | mean arterial pressure QTL GWAS1561610 (human) | | 0.0000005 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 102834750 | 102834751 | Human |
597375430 | GWAS1471504_H | sphingomyelin 16:0 measurement QTL GWAS1471504 (human) | | 0.000008 | blood phospholipid amount (VT:0006084) | | 10 | 101303323 | 101303324 | Human |
597227974 | GWAS1324048_H | BMI-adjusted waist-hip ratio QTL GWAS1324048 (human) | | 0.0000003 | body size trait (VT:0100005) | | 10 | 94171330 | 94171331 | Human |
597432770 | GWAS1528844_H | platelet count QTL GWAS1528844 (human) | | 1e-12 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 95875759 | 95875760 | Human |
407134752 | GWAS783728_H | marginal zone B-cell lymphoma, multiple sclerosis QTL GWAS783728 (human) | | 9e-08 | marginal zone B-cell lymphoma, multiple sclerosis | | 10 | 79300560 | 79300561 | Human |
407061031 | GWAS710007_H | coronary artery disease QTL GWAS710007 (human) | | 0.000001 | coronary artery disease | | 10 | 102959339 | 102959340 | Human |
597113331 | GWAS1209405_H | protein measurement QTL GWAS1209405 (human) | | 3e-11 | protein measurement | | 10 | 103073291 | 103073292 | Human |
597252607 | GWAS1348681_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1348681 (human) | | 6e-11 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 10 | 100164546 | 100164547 | Human |
597031411 | GWAS1127485_H | smoking initiation QTL GWAS1127485 (human) | | 1e-14 | smoking initiation | | 10 | 102883484 | 102883485 | Human |
597441019 | GWAS1537093_H | uric acid measurement QTL GWAS1537093 (human) | | 4e-12 | uric acid measurement | blood uric acid level (CMO:0000501) | 10 | 87193857 | 87193858 | Human |
597252606 | GWAS1348680_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1348680 (human) | | 9e-11 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 10 | 99830729 | 99830730 | Human |
597096957 | GWAS1193031_H | total cholesterol measurement QTL GWAS1193031 (human) | | 8e-09 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 95172943 | 95172944 | Human |
597301745 | GWAS1397819_H | ectonucleoside triphosphate diphosphohydrolase 1 measurement QTL GWAS1397819 (human) | | 2e-16 | ectonucleoside triphosphate diphosphohydrolase 1 measurement | | 10 | 95841162 | 95841163 | Human |
597137916 | GWAS1233990_H | glycochenodeoxycholate glucuronide (1) measurement QTL GWAS1233990 (human) | | 3e-11 | glycochenodeoxycholate glucuronide (1) measurement | | 10 | 99833993 | 99833994 | Human |
407093806 | GWAS742782_H | obsolete_red blood cell distribution width QTL GWAS742782 (human) | | 1e-18 | 1-palmitoleoyl-GPC (16:1) measurement | | 10 | 100315722 | 100315723 | Human |
597481970 | GWAS1578044_H | developmental dysplasia of the hip QTL GWAS1578044 (human) | | 0.000004 | developmental dysplasia of the hip | | 10 | 98351635 | 98351636 | Human |
597301748 | GWAS1397822_H | calpastatin measurement QTL GWAS1397822 (human) | | 7e-30 | calpastatin measurement | | 10 | 100069757 | 100069758 | Human |
597072359 | GWAS1168433_H | serum gamma-glutamyl transferase measurement QTL GWAS1168433 (human) | | 5e-26 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 77876403 | 77876404 | Human |
406889009 | GWAS537985_H | type 1 diabetes mellitus QTL GWAS537985 (human) | | 1e-28 | type 1 diabetes mellitus | | 10 | 88263276 | 88263277 | Human |
597154278 | GWAS1250352_H | colorectal cancer QTL GWAS1250352 (human) | | 1e-19 | colorectal cancer | | 10 | 99586852 | 99586853 | Human |
597154277 | GWAS1250351_H | colorectal cancer QTL GWAS1250351 (human) | | 1e-08 | colorectal cancer | | 10 | 99636807 | 99636808 | Human |
597318127 | GWAS1414201_H | X-12063 measurement QTL GWAS1414201 (human) | | 1e-57 | X-12063 measurement | | 10 | 94906747 | 94906748 | Human |
597383660 | GWAS1479734_H | platelet count QTL GWAS1479734 (human) | | 3e-11 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 93072371 | 93072372 | Human |
597391843 | GWAS1487917_H | BMI-adjusted waist circumference QTL GWAS1487917 (human) | | 3e-08 | body size trait (VT:0100005) | | 10 | 100329906 | 100329907 | Human |
597416422 | GWAS1512496_H | cognitive function measurement QTL GWAS1512496 (human) | | 5e-11 | cognitive behavior trait (VT:0010450) | | 10 | 91609339 | 91609340 | Human |
597391844 | GWAS1487918_H | BMI-adjusted waist circumference QTL GWAS1487918 (human) | | 3e-11 | body size trait (VT:0100005) | | 10 | 79380723 | 79380724 | Human |
597473567 | GWAS1569641_H | mitochondrial heteroplasmy measurement QTL GWAS1569641 (human) | | 2e-09 | mitochondrial heteroplasmy measurement | | 10 | 91547209 | 91547210 | Human |
597424408 | GWAS1520482_H | IGF-1 measurement QTL GWAS1520482 (human) | | 1e-16 | IGF-1 measurement | blood insulin-like growth factor 1 level (CMO:0001297) | 10 | 93072371 | 93072372 | Human |
597186843 | GWAS1282917_H | taurocholenate sulfate measurement QTL GWAS1282917 (human) | | 2e-10 | taurocholenate sulfate measurement | | 10 | 99802867 | 99802868 | Human |
597088530 | GWAS1184604_H | serum metabolite measurement QTL GWAS1184604 (human) | | 2e-15 | serum metabolite measurement | | 10 | 100315722 | 100315723 | Human |
597375263 | GWAS1471337_H | urinary arsenic measurement QTL GWAS1471337 (human) | | 2e-09 | urinary arsenic measurement | | 10 | 102868477 | 102868478 | Human |
597145874 | GWAS1241948_H | Dental enamel hypoplasia QTL GWAS1241948 (human) | | 0.000004 | Dental enamel hypoplasia | | 10 | 79127964 | 79127965 | Human |
597088531 | GWAS1184605_H | serum metabolite measurement QTL GWAS1184605 (human) | | 3e-17 | fatty acid amount (VT:0010046) | | 10 | 100315722 | 100315723 | Human |
597375262 | GWAS1471336_H | urinary arsenic measurement QTL GWAS1471336 (human) | | 6e-24 | urinary arsenic measurement | | 10 | 102888092 | 102888093 | Human |
597088528 | GWAS1184602_H | serum metabolite measurement QTL GWAS1184602 (human) | | 6e-18 | serum metabolite measurement | | 10 | 99840980 | 99840981 | Human |
597375261 | GWAS1471335_H | urinary arsenic measurement QTL GWAS1471335 (human) | | 1e-15 | urinary arsenic measurement | | 10 | 102888092 | 102888093 | Human |
597088529 | GWAS1184603_H | serum metabolite measurement QTL GWAS1184603 (human) | | 2e-13 | blood lipid amount (VT:0003949) | | 10 | 100315722 | 100315723 | Human |
597358877 | GWAS1454951_H | self reported educational attainment QTL GWAS1454951 (human) | | 5e-14 | self reported educational attainment | | 10 | 102230055 | 102230056 | Human |
597375260 | GWAS1471334_H | urinary arsenic measurement QTL GWAS1471334 (human) | | 8e-08 | urinary arsenic measurement | | 10 | 102888092 | 102888093 | Human |
597244179 | GWAS1340253_H | blood phosphate measurement QTL GWAS1340253 (human) | | 1e-10 | blood phosphate amount (VT:0001565) | blood phosphate level (CMO:0000504) | 10 | 100204779 | 100204780 | Human |
597424400 | GWAS1520474_H | age-related hearing impairment QTL GWAS1520474 (human) | | 8e-11 | age-related hearing impairment | | 10 | 80649861 | 80649862 | Human |
597244180 | GWAS1340254_H | blood phosphate measurement QTL GWAS1340254 (human) | | 6e-10 | blood phosphate amount (VT:0001565) | blood phosphate level (CMO:0000504) | 10 | 103288460 | 103288461 | Human |
597137689 | GWAS1233763_H | glycochenodeoxycholate glucuronide (1) measurement QTL GWAS1233763 (human) | | 4e-21 | glycochenodeoxycholate glucuronide (1) measurement | | 10 | 99849162 | 99849163 | Human |
597063940 | GWAS1160014_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS1160014 (human) | | 0.000007 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 10 | 89319671 | 89319672 | Human |
596965639 | GWAS1085158_H | colorectal cancer QTL GWAS1085158 (human) | | 6e-09 | colorectal cancer | | 10 | 79050586 | 79050587 | Human |
407020241 | GWAS669217_H | systolic blood pressure QTL GWAS669217 (human) | | 7e-24 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103086421 | 103086422 | Human |
597326094 | GWAS1422168_H | body mass index QTL GWAS1422168 (human) | | 0.000009 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 86336290 | 86336291 | Human |
597530889 | GWAS1626963_H | level of oxylipin in blood plasma QTL GWAS1626963 (human) | | 4e-38 | level of oxylipin in blood plasma | | 10 | 94972031 | 94972032 | Human |
597588232 | GWAS1645092_H | glucose measurement QTL GWAS1645092 (human) | | 1e-21 | glucose measurement | blood glucose level (CMO:0000046) | 10 | 79184390 | 79184391 | Human |
597088526 | GWAS1184600_H | serum metabolite measurement QTL GWAS1184600 (human) | | 4e-226 | serum metabolite measurement | | 10 | 98388419 | 98388420 | Human |
597088527 | GWAS1184601_H | serum metabolite measurement QTL GWAS1184601 (human) | | 3e-89 | serum metabolite measurement | | 10 | 98404685 | 98404686 | Human |
597104910 | GWAS1200984_H | coronary artery disease QTL GWAS1200984 (human) | | 2e-08 | coronary artery disease | | 10 | 103107929 | 103107930 | Human |
597088525 | GWAS1184599_H | serum metabolite measurement QTL GWAS1184599 (human) | | 1e-15 | serum metabolite measurement | | 10 | 98388419 | 98388420 | Human |
596957449 | GWAS1076968_H | Chronic pain, response to anticonvulsant QTL GWAS1076968 (human) | | 0.000007 | Chronic pain, response to anticonvulsant | | 10 | 89240844 | 89240845 | Human |
597309700 | GWAS1405774_H | Beta blocking agent use measurement QTL GWAS1405774 (human) | | 1e-18 | Beta blocking agent use measurement | | 10 | 103069712 | 103069713 | Human |
597498173 | GWAS1594247_H | tumor necrosis factor receptor superfamily member 6 measurement QTL GWAS1594247 (human) | | 9e-47 | tumor necrosis factor receptor superfamily member 6 measurement | | 10 | 89023216 | 89023217 | Human |
597498175 | GWAS1594249_H | tumor necrosis factor receptor superfamily member 6 measurement QTL GWAS1594249 (human) | | 1e-54 | tumor necrosis factor receptor superfamily member 6 measurement | | 10 | 89024178 | 89024179 | Human |
597399865 | GWAS1495939_H | vaginal microbiome measurement QTL GWAS1495939 (human) | | 0.000008 | vaginal microbiome measurement | | 10 | 89401598 | 89401599 | Human |
596965686 | GWAS1085205_H | colorectal cancer QTL GWAS1085205 (human) | | 1e-08 | colorectal cancer | | 10 | 99636807 | 99636808 | Human |
597498174 | GWAS1594248_H | tumor necrosis factor receptor superfamily member 6 measurement QTL GWAS1594248 (human) | | 6e-131 | tumor necrosis factor receptor superfamily member 6 measurement | | 10 | 89009208 | 89009209 | Human |
597268794 | GWAS1364868_H | diastolic blood pressure QTL GWAS1364868 (human) | | 7e-14 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 94140247 | 94140248 | Human |
597530942 | GWAS1627016_H | neutrophil measurement QTL GWAS1627016 (human) | | 1e-31 | neutrophil measurement | | 10 | 99485473 | 99485474 | Human |
597588283 | GWAS1645143_H | ferritin measurement QTL GWAS1645143 (human) | | 3e-13 | ferritin measurement | | 10 | 99584506 | 99584507 | Human |
596957500 | GWAS1077019_H | Chronic pain, response to anticonvulsant QTL GWAS1077019 (human) | | 0.000004 | Chronic pain, response to anticonvulsant | | 10 | 83023068 | 83023069 | Human |
597170481 | GWAS1266555_H | aortic measurement QTL GWAS1266555 (human) | | 6e-10 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 94140878 | 94140879 | Human |
597530935 | GWAS1627009_H | neutrophil measurement QTL GWAS1627009 (human) | | 9e-18 | neutrophil measurement | | 10 | 99477655 | 99477656 | Human |
597375287 | GWAS1471361_H | migraine disorder, endometriosis QTL GWAS1471361 (human) | | 0.000007 | migraine disorder, endometriosis | | 10 | 94283975 | 94283976 | Human |
597268788 | GWAS1364862_H | diastolic blood pressure QTL GWAS1364862 (human) | | 4e-14 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103026556 | 103026557 | Human |
596965690 | GWAS1085209_H | colorectal cancer QTL GWAS1085209 (human) | | 1e-19 | colorectal cancer | | 10 | 99586852 | 99586853 | Human |
597342506 | GWAS1438580_H | sarcoidosis QTL GWAS1438580 (human) | | 0.000003 | sarcoidosis | | 10 | 84641213 | 84641214 | Human |
597506345 | GWAS1602419_H | Antihypertensive use measurement QTL GWAS1602419 (human) | | 3e-29 | Antihypertensive use measurement | | 10 | 102845159 | 102845160 | Human |
597522729 | GWAS1618803_H | dihydroorotate measurement QTL GWAS1618803 (human) | | 3e-10 | dihydroorotate measurement | | 10 | 102873487 | 102873488 | Human |
597530920 | GWAS1626994_H | 3-hydroxy-2-ethylpropionate measurement QTL GWAS1626994 (human) | | 3e-13 | 3-hydroxy-2-ethylpropionate measurement | | 10 | 95142972 | 95142973 | Human |
597186848 | GWAS1282922_H | pregnenediol disulfate (C21H34O8S2) measurement QTL GWAS1282922 (human) | | 2e-13 | pregnenediol disulfate (C21H34O8S2) measurement | | 10 | 99845936 | 99845937 | Human |
597309731 | GWAS1405805_H | vaginal microbiome measurement QTL GWAS1405805 (human) | | 0.000006 | vaginal microbiome measurement | | 10 | 85953823 | 85953824 | Human |
596957485 | GWAS1077004_H | thyroid stimulating hormone measurement QTL GWAS1077004 (human) | | 1e-11 | hypothyroidism | | 10 | 99523573 | 99523574 | Human |
597186851 | GWAS1282925_H | glycocholenate sulfate measurement QTL GWAS1282925 (human) | | 1e-49 | glycocholenate sulfate measurement | | 10 | 99840980 | 99840981 | Human |
407020162 | GWAS669138_H | response to anticoagulant QTL GWAS669138 (human) | | 1e-31 | response to anticoagulant | | 10 | 94942290 | 94942291 | Human |
597317978 | GWAS1414052_H | 1-(1-enyl-stearoyl)-2-oleoyl-GPC (P-18:0/18:1) measurement QTL GWAS1414052 (human) | | 6e-24 | glycerophosphocholine amount (VT:0011004) | | 10 | 100315722 | 100315723 | Human |
597154134 | GWAS1250208_H | Alzheimer disease, educational attainment QTL GWAS1250208 (human) | | 0.0000001 | Alzheimer disease, educational attainment | | 10 | 102897543 | 102897544 | Human |
597293403 | GWAS1389477_H | serum alanine aminotransferase measurement QTL GWAS1389477 (human) | | 1e-14 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100207653 | 100207654 | Human |
597154133 | GWAS1250207_H | Alzheimer disease, educational attainment QTL GWAS1250207 (human) | | 4e-10 | Alzheimer disease, educational attainment | | 10 | 102411337 | 102411338 | Human |
597113173 | GWAS1209247_H | platelet count QTL GWAS1209247 (human) | | 2e-15 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 102600127 | 102600128 | Human |
597268826 | GWAS1364900_H | aortic measurement QTL GWAS1364900 (human) | | 2e-19 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 94142296 | 94142297 | Human |
597113172 | GWAS1209246_H | platelet count QTL GWAS1209246 (human) | | 2e-17 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 99512225 | 99512226 | Human |
597154132 | GWAS1250206_H | Alzheimer disease, educational attainment QTL GWAS1250206 (human) | | 2e-11 | Alzheimer disease, educational attainment | | 10 | 102042651 | 102042652 | Human |
597113171 | GWAS1209245_H | platelet count QTL GWAS1209245 (human) | | 1e-11 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 87926409 | 87926410 | Human |
597154131 | GWAS1250205_H | Alzheimer disease, educational attainment QTL GWAS1250205 (human) | | 6e-10 | Alzheimer disease, educational attainment | | 10 | 101800564 | 101800565 | Human |
597113170 | GWAS1209244_H | platelet count QTL GWAS1209244 (human) | | 1e-16 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 79404390 | 79404391 | Human |
597293404 | GWAS1389478_H | serum alanine aminotransferase measurement QTL GWAS1389478 (human) | | 1e-12 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100101865 | 100101866 | Human |
597113169 | GWAS1209243_H | platelet count QTL GWAS1209243 (human) | | 3e-13 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 79339955 | 79339956 | Human |
407020164 | GWAS669140_H | response to anticoagulant QTL GWAS669140 (human) | | 3e-79 | response to anticoagulant | | 10 | 94981296 | 94981297 | Human |
597440848 | GWAS1536922_H | tumor necrosis factor receptor superfamily member 6 measurement QTL GWAS1536922 (human) | | 3e-33 | tumor necrosis factor receptor superfamily member 6 measurement | | 10 | 89009208 | 89009209 | Human |
407134856 | GWAS783832_H | migraine disorder QTL GWAS783832 (human) | | 2e-14 | migraine disorder | | 10 | 94254865 | 94254866 | Human |
597440849 | GWAS1536923_H | tumor necrosis factor receptor superfamily member 6 measurement QTL GWAS1536923 (human) | | 2e-16 | tumor necrosis factor receptor superfamily member 6 measurement | | 10 | 89024178 | 89024179 | Human |
597440850 | GWAS1536924_H | tumor necrosis factor receptor superfamily member 6 measurement QTL GWAS1536924 (human) | | 4e-43 | tumor necrosis factor receptor superfamily member 6 measurement | | 10 | 89009208 | 89009209 | Human |
597186902 | GWAS1282976_H | thymol sulfate measurement QTL GWAS1282976 (human) | | 1e-11 | thymol sulfate measurement | | 10 | 94934834 | 94934835 | Human |
406921870 | GWAS570846_H | chronic obstructive pulmonary disease QTL GWAS570846 (human) | | 2e-08 | lung integrity trait (VT:0010906) | | 10 | 79946568 | 79946569 | Human |
597440851 | GWAS1536925_H | tumor necrosis factor receptor superfamily member 6 measurement QTL GWAS1536925 (human) | | 6e-17 | tumor necrosis factor receptor superfamily member 6 measurement | | 10 | 89024178 | 89024179 | Human |
597186888 | GWAS1282962_H | mitochondrial DNA measurement QTL GWAS1282962 (human) | | 2e-32 | mitochondrial DNA measurement | | 10 | 100992588 | 100992589 | Human |
597186889 | GWAS1282963_H | mitochondrial DNA measurement QTL GWAS1282963 (human) | | 3e-14 | mitochondrial DNA measurement | | 10 | 102578181 | 102578182 | Human |
597588301 | GWAS1645161_H | ferritin measurement QTL GWAS1645161 (human) | | 2e-13 | ferritin measurement | | 10 | 99584506 | 99584507 | Human |
597604682 | GWAS1661542_H | neuroendocrine neoplasm QTL GWAS1661542 (human) | | 9e-13 | neuroendocrine neoplasm | | 10 | 79433550 | 79433551 | Human |
597096782 | GWAS1192856_H | sex hormone-binding globulin measurement QTL GWAS1192856 (human) | | 3e-24 | sex hormone-binding globulin measurement | | 10 | 100152307 | 100152308 | Human |
597604676 | GWAS1661536_H | benign colon neoplasm QTL GWAS1661536 (human) | | 9e-21 | benign colon neoplasm | | 10 | 79059375 | 79059376 | Human |
597301569 | GWAS1397643_H | serum alanine aminotransferase measurement QTL GWAS1397643 (human) | | 3e-11 | serum alanine aminotransferase measurement | | 10 | 102406747 | 102406748 | Human |
596965705 | GWAS1085224_H | diet measurement, vitamin D measurement QTL GWAS1085224 (human) | | 0.000005 | diet measurement, vitamin D measurement | | 10 | 86536484 | 86536485 | Human |
597186887 | GWAS1282961_H | mitochondrial DNA measurement QTL GWAS1282961 (human) | | 2e-08 | mitochondrial DNA measurement | | 10 | 100853859 | 100853860 | Human |
597604734 | GWAS1661594_H | neuroendocrine neoplasm QTL GWAS1661594 (human) | | 4e-11 | neuroendocrine neoplasm | | 10 | 95630770 | 95630771 | Human |
597252473 | GWAS1348547_H | aspartate aminotransferase measurement QTL GWAS1348547 (human) | | 8e-39 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 100057584 | 100057585 | Human |
597285240 | GWAS1381314_H | triglyceride measurement QTL GWAS1381314 (human) | | 6e-15 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93083778 | 93083779 | Human |
597268849 | GWAS1364923_H | facial width measurement QTL GWAS1364923 (human) | | 0.000006 | facial morphology trait (VT:0003743) | | 10 | 98254220 | 98254221 | Human |
407052971 | GWAS701947_H | reticulocyte count QTL GWAS701947 (human) | | 1e-11 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 99514276 | 99514277 | Human |
597113213 | GWAS1209287_H | protein measurement QTL GWAS1209287 (human) | | 2e-08 | protein measurement | | 10 | 90681038 | 90681039 | Human |
596949368 | GWAS1068887_H | Red cell distribution width QTL GWAS1068887 (human) | | 2e-13 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 94423594 | 94423595 | Human |
597318007 | GWAS1414081_H | vaginal microbiome measurement QTL GWAS1414081 (human) | | 0.000002 | vaginal microbiome measurement | | 10 | 79304998 | 79304999 | Human |
597252470 | GWAS1348544_H | aspartate aminotransferase measurement QTL GWAS1348544 (human) | | 2e-15 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99830729 | 99830730 | Human |
597408107 | GWAS1504181_H | vaginal microbiome measurement QTL GWAS1504181 (human) | | 0.000001 | vaginal microbiome measurement | | 10 | 89401598 | 89401599 | Human |
407093939 | GWAS742915_H | spontaneous preterm birth QTL GWAS742915 (human) | | 0.000003 | spontaneous preterm birth | | 10 | 97502818 | 97502819 | Human |
597137767 | GWAS1233841_H | diastolic blood pressure, systolic blood pressure QTL GWAS1233841 (human) | | 0.000003 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 101351300 | 101351301 | Human |
597088614 | GWAS1184688_H | mean reticulocyte volume QTL GWAS1184688 (human) | | 4e-10 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 10 | 102134967 | 102134968 | Human |
597358954 | GWAS1455028_H | systolic blood pressure QTL GWAS1455028 (human) | | 3e-41 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 102834750 | 102834751 | Human |
597309803 | GWAS1405877_H | vaginal microbiome measurement QTL GWAS1405877 (human) | | 0.000008 | vaginal microbiome measurement | | 10 | 87513760 | 87513761 | Human |
597023079 | GWAS1119153_H | response to carboplatin QTL GWAS1119153 (human) | | 0.000005 | response to carboplatin | | 10 | 99850776 | 99850777 | Human |
597088612 | GWAS1184686_H | mean reticulocyte volume QTL GWAS1184686 (human) | | 4e-09 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 10 | 100068504 | 100068505 | Human |
597088613 | GWAS1184687_H | mean reticulocyte volume QTL GWAS1184687 (human) | | 4e-18 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 10 | 102120361 | 102120362 | Human |
597023073 | GWAS1119147_H | response to carboplatin QTL GWAS1119147 (human) | | 0.000007 | response to carboplatin | | 10 | 85041429 | 85041430 | Human |
597088610 | GWAS1184684_H | mean reticulocyte volume QTL GWAS1184684 (human) | | 9e-28 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 10 | 87966988 | 87966989 | Human |
597424494 | GWAS1520568_H | low density lipoprotein cholesterol measurement QTL GWAS1520568 (human) | | 2e-15 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 93072371 | 93072372 | Human |
597088611 | GWAS1184685_H | mean reticulocyte volume QTL GWAS1184685 (human) | | 2e-35 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 10 | 99518968 | 99518969 | Human |
597588331 | GWAS1645191_H | ferritin measurement QTL GWAS1645191 (human) | | 2e-12 | ferritin measurement | | 10 | 99583560 | 99583561 | Human |
597473641 | GWAS1569715_H | self reported educational attainment QTL GWAS1569715 (human) | | 8e-12 | self reported educational attainment | | 10 | 103217846 | 103217847 | Human |
597285231 | GWAS1381305_H | total cholesterol in medium VLDL QTL GWAS1381305 (human) | | 1e-14 | blood VLDL phospholipid amount (VT:0010507) | | 10 | 93083778 | 93083779 | Human |
597457249 | GWAS1553323_H | ulcerative colitis QTL GWAS1553323 (human) | | 1e-09 | ulcerative colitis | | 10 | 92669710 | 92669711 | Human |
597457250 | GWAS1553324_H | ulcerative colitis QTL GWAS1553324 (human) | | 3e-40 | ulcerative colitis | | 10 | 99524480 | 99524481 | Human |
406921919 | GWAS570895_H | lean body mass QTL GWAS570895 (human) | | 0.000004 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 100914591 | 100914592 | Human |
597465247 | GWAS1561321_H | BMI-adjusted waist-hip ratio QTL GWAS1561321 (human) | | 1e-12 | body size trait (VT:0100005) | | 10 | 87843667 | 87843668 | Human |
597301406 | GWAS1397480_H | 3-hydroxyanthranilate 3,4-dioxygenase measurement QTL GWAS1397480 (human) | | 1e-22 | 3-hydroxyanthranilate 3,4-dioxygenase measurement | | 10 | 100046495 | 100046496 | Human |
596981904 | GWAS1101423_H | telomere length QTL GWAS1101423 (human) | | 3e-41 | telomere length | | 10 | 94355078 | 94355079 | Human |
597309596 | GWAS1405670_H | metabolite measurement QTL GWAS1405670 (human) | | 7e-17 | metabolite measurement | | 10 | 88686312 | 88686313 | Human |
597325981 | GWAS1422055_H | pain QTL GWAS1422055 (human) | | 3e-09 | pain | | 10 | 98998562 | 98998563 | Human |
597604494 | GWAS1661354_H | triglyceride measurement QTL GWAS1661354 (human) | | 4e-65 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079885 | 93079886 | Human |
597301387 | GWAS1397461_H | redox-regulatory protein FAM213A measurement QTL GWAS1397461 (human) | | 6e-14 | redox-regulatory protein FAM213A measurement | | 10 | 80434508 | 80434509 | Human |
406963027 | GWAS612003_H | granulocyte count QTL GWAS612003 (human) | | 7e-09 | granulocyte quantity (VT:0000334) | blood granulocyte count (CMO:0000111) | 10 | 79287818 | 79287819 | Human |
597047428 | GWAS1143502_H | erythrocyte count QTL GWAS1143502 (human) | | 1e-10 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 102506502 | 102506503 | Human |
597047429 | GWAS1143503_H | erythrocyte count QTL GWAS1143503 (human) | | 2e-13 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 102836092 | 102836093 | Human |
597047426 | GWAS1143500_H | erythrocyte count QTL GWAS1143500 (human) | | 8e-20 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 99545585 | 99545586 | Human |
406963028 | GWAS612004_H | granulocyte count QTL GWAS612004 (human) | | 4e-38 | granulocyte quantity (VT:0000334) | blood neutrophil count (CMO:0000030) | 10 | 97314229 | 97314234 | Human |
597047427 | GWAS1143501_H | erythrocyte count QTL GWAS1143501 (human) | | 1e-08 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 99844724 | 99844725 | Human |
597047424 | GWAS1143498_H | erythrocyte count QTL GWAS1143498 (human) | | 1e-14 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 94469762 | 94469763 | Human |
597047425 | GWAS1143499_H | erythrocyte count QTL GWAS1143499 (human) | | 4e-10 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 95480024 | 95480025 | Human |
597407884 | GWAS1503958_H | X-21441 measurement QTL GWAS1503958 (human) | | 4e-16 | X-21441 measurement | | 10 | 99860022 | 99860023 | Human |
407135068 | GWAS784044_H | migraine disorder QTL GWAS784044 (human) | | 3e-10 | migraine disorder | | 10 | 98942980 | 98942981 | Human |
597276801 | GWAS1372875_H | X-21471 measurement QTL GWAS1372875 (human) | | 8e-42 | X-21471 measurement | | 10 | 99811603 | 99811604 | Human |
597211266 | GWAS1307340_H | mathematical ability QTL GWAS1307340 (human) | | 3e-08 | mathematical ability | | 10 | 97952377 | 97952378 | Human |
597317760 | GWAS1413834_H | systolic blood pressure QTL GWAS1413834 (human) | | 4e-26 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 100792995 | 100792996 | Human |
597596293 | GWAS1653153_H | eosinophil count QTL GWAS1653153 (human) | | 3e-16 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 92672243 | 92672244 | Human |
597276802 | GWAS1372876_H | X-21471 measurement QTL GWAS1372876 (human) | | 8e-16 | X-21471 measurement | | 10 | 99920364 | 99920365 | Human |
597416064 | GWAS1512138_H | mathematical ability QTL GWAS1512138 (human) | | 5e-09 | mathematical ability | | 10 | 101760027 | 101760028 | Human |
597211267 | GWAS1307341_H | mathematical ability QTL GWAS1307341 (human) | | 2e-23 | mathematical ability | | 10 | 102261328 | 102261329 | Human |
597457024 | GWAS1553098_H | blood barium measurement QTL GWAS1553098 (human) | | 0.000003 | blood barium measurement | | 10 | 91156221 | 91156222 | Human |
407126873 | GWAS775849_H | type 2 diabetes mellitus QTL GWAS775849 (human) | | 0.000009 | type 2 diabetes mellitus | | 10 | 92705802 | 92705803 | Human |
597284996 | GWAS1381070_H | triglycerides in large VLDL measurement QTL GWAS1381070 (human) | | 5e-12 | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | | 10 | 93083778 | 93083779 | Human |
597465217 | GWAS1561291_H | progesterone measurement QTL GWAS1561291 (human) | | 2e-09 | progesterone measurement | | 10 | 102838849 | 102838850 | Human |
597309572 | GWAS1405646_H | vaginal microbiome measurement QTL GWAS1405646 (human) | | 0.0000005 | vaginal microbiome measurement | | 10 | 89419538 | 89419539 | Human |
597465218 | GWAS1561292_H | 17-hydroxyprogesterone measurement QTL GWAS1561292 (human) | | 0.0000002 | 17-hydroxyprogesterone measurement | | 10 | 102838849 | 102838850 | Human |
597465278 | GWAS1561352_H | high density lipoprotein cholesterol measurement QTL GWAS1561352 (human) | | 0.000007 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93496443 | 93496444 | Human |
597448895 | GWAS1544969_H | cognitive decline measurement QTL GWAS1544969 (human) | | 0.000008 | cognitive behavior trait (VT:0010450) | | 10 | 96700991 | 96700992 | Human |
597301438 | GWAS1397512_H | serum alanine aminotransferase measurement QTL GWAS1397512 (human) | | 4e-106 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100164661 | 100164662 | Human |
597104818 | GWAS1200892_H | aspartate aminotransferase measurement QTL GWAS1200892 (human) | | 2e-08 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 94344908 | 94344909 | Human |
597489844 | GWAS1585918_H | S-6-hydroxywarfarin to S-warfarin ratio measurement QTL GWAS1585918 (human) | | 0.000001 | S-6-hydroxywarfarin to S-warfarin ratio measurement | | 10 | 94606348 | 94606349 | Human |
597342384 | GWAS1438458_H | body mass index QTL GWAS1438458 (human) | | 1e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 97229697 | 97229698 | Human |
597391530 | GWAS1487604_H | adolescent idiopathic scoliosis QTL GWAS1487604 (human) | | 1e-22 | adolescent idiopathic scoliosis | | 10 | 78533195 | 78533196 | Human |
597186729 | GWAS1282803_H | N6,N6-dimethyllysine measurement QTL GWAS1282803 (human) | | 9e-3246 | N6,N6-dimethyllysine measurement | | 10 | 98388419 | 98388420 | Human |
597579949 | GWAS1636809_H | high density lipoprotein cholesterol measurement QTL GWAS1636809 (human) | | 4e-14 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079885 | 93079886 | Human |
597186731 | GWAS1282805_H | metabolite measurement QTL GWAS1282805 (human) | | 6e-2075 | metabolite measurement | | 10 | 98388419 | 98388420 | Human |
597342382 | GWAS1438456_H | body mass index QTL GWAS1438456 (human) | | 5e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 92051115 | 92051116 | Human |
597342383 | GWAS1438457_H | body mass index QTL GWAS1438457 (human) | | 5e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 95494548 | 95494549 | Human |
597342380 | GWAS1438454_H | body mass index QTL GWAS1438454 (human) | | 4e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 85731093 | 85731094 | Human |
597325996 | GWAS1422070_H | andro steroid monosulfate C19H28O6S (1) measurement QTL GWAS1422070 (human) | | 3e-12 | andro steroid monosulfate C19H28O6S (1) measurement | | 10 | 95040017 | 95040018 | Human |
596957347 | GWAS1076866_H | Chronic pain, response to anticonvulsant QTL GWAS1076866 (human) | | 2e-08 | Chronic pain, response to anticonvulsant | | 10 | 82926222 | 82926223 | Human |
597342381 | GWAS1438455_H | body mass index QTL GWAS1438455 (human) | | 1e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 86336290 | 86336291 | Human |
597186721 | GWAS1282795_H | N6-methyllysine measurement QTL GWAS1282795 (human) | | 9e-318 | N6-methyllysine measurement | | 10 | 98385309 | 98385310 | Human |
406922107 | GWAS571083_H | lean body mass QTL GWAS571083 (human) | | 2e-09 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 100914591 | 100914592 | Human |
597325988 | GWAS1422062_H | androstenediol (3alpha, 17alpha) monosulfate (3) measurement QTL GWAS1422062 (human) | | 2e-17 | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | | 10 | 95000562 | 95000563 | Human |
597620957 | GWAS1677817_H | open-angle glaucoma QTL GWAS1677817 (human) | | 5e-20 | open-angle glaucoma | | 10 | 94279840 | 94279841 | Human |
597227740 | GWAS1323814_H | response to anticoagulant QTL GWAS1323814 (human) | | 3e-11 | response to anticoagulant | | 10 | 94645745 | 94645746 | Human |
597227741 | GWAS1323815_H | response to anticoagulant QTL GWAS1323815 (human) | | 8e-10 | response to anticoagulant | | 10 | 94645572 | 94645573 | Human |
597285087 | GWAS1381161_H | calcium measurement QTL GWAS1381161 (human) | | 3e-10 | calcium measurement | blood calcium level (CMO:0000502) | 10 | 98402882 | 98402883 | Human |
407061252 | GWAS710228_H | platelet count QTL GWAS710228 (human) | | 3e-29 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 93079885 | 93079886 | Human |
597620953 | GWAS1677813_H | open-angle glaucoma QTL GWAS1677813 (human) | | 8e-12 | open-angle glaucoma | | 10 | 93176866 | 93176867 | Human |
597366998 | GWAS1463072_H | intelligence QTL GWAS1463072 (human) | | 0.000008 | intelligence | | 10 | 87014361 | 87014362 | Human |
597268692 | GWAS1364766_H | taste liking measurement QTL GWAS1364766 (human) | | 1e-09 | taste liking measurement | | 10 | 100559264 | 100559265 | Human |
597407957 | GWAS1504031_H | alkaline phosphatase measurement QTL GWAS1504031 (human) | | 1e-14 | migraine disorder | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 94278929 | 94278930 | Human |
597407956 | GWAS1504030_H | alkaline phosphatase measurement QTL GWAS1504030 (human) | | 2e-10 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 89307012 | 89307013 | Human |
597579978 | GWAS1636838_H | hypothyroidism QTL GWAS1636838 (human) | | 1e-24 | hypothyroidism | | 10 | 99523573 | 99523574 | Human |
407020311 | GWAS669287_H | response to platelet aggregation inhibitor QTL GWAS669287 (human) | | 2e-13 | response to platelet aggregation inhibitor | | 10 | 94645745 | 94645746 | Human |
407061268 | GWAS710244_H | platelet count QTL GWAS710244 (human) | | 4e-12 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 87962505 | 87962506 | Human |
597022926 | GWAS1119000_H | overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1119000 (human) | | 0.0000008 | overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel | | 10 | 80608465 | 80608466 | Human |
407249691 | GWAS898667_H | mean corpuscular hemoglobin concentration QTL GWAS898667 (human) | | 6e-14 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 88031897 | 88031898 | Human |
597620928 | GWAS1677788_H | open-angle glaucoma QTL GWAS1677788 (human) | | 3e-18 | open-angle glaucoma | | 10 | 93201869 | 93201870 | Human |
597457091 | GWAS1553165_H | glutamine measurement QTL GWAS1553165 (human) | | 5e-96 | glutamine measurement | blood amino acid measurement (CMO:0003730) | 10 | 97599655 | 97599656 | Human |
597612798 | GWAS1669658_H | tooth disease QTL GWAS1669658 (human) | | 3e-12 | tooth disease | | 10 | 99330026 | 99330027 | Human |
597358842 | GWAS1454916_H | pulse pressure measurement QTL GWAS1454916 (human) | | 1e-13 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 102834750 | 102834751 | Human |
597367034 | GWAS1463108_H | triglyceride measurement QTL GWAS1463108 (human) | | 7e-12 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079967 | 93079968 | Human |
597358843 | GWAS1454917_H | pulse pressure measurement QTL GWAS1454917 (human) | | 3e-19 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 102834750 | 102834751 | Human |
597211376 | GWAS1307450_H | blood protein measurement QTL GWAS1307450 (human) | | 6e-74 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95747555 | 95747556 | Human |
597293299 | GWAS1389373_H | serum alanine aminotransferase measurement QTL GWAS1389373 (human) | | 5e-10 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 99811236 | 99811237 | Human |
597113082 | GWAS1209156_H | cognitive function measurement QTL GWAS1209156 (human) | | 4e-09 | cognitive behavior trait (VT:0010450) | | 10 | 100152437 | 100152438 | Human |
597620970 | GWAS1677830_H | coronary artery disease QTL GWAS1677830 (human) | | 8e-14 | coronary artery disease | | 10 | 102929908 | 102929909 | Human |
597522664 | GWAS1618738_H | mitochondrial DNA measurement QTL GWAS1618738 (human) | | 3e-12 | mitochondrial DNA measurement | | 10 | 100889008 | 100889009 | Human |
597620969 | GWAS1677829_H | coronary artery disease QTL GWAS1677829 (human) | | 1e-18 | coronary artery disease | | 10 | 89243047 | 89243048 | Human |
597211375 | GWAS1307449_H | blood protein measurement QTL GWAS1307449 (human) | | 4e-39 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95682419 | 95682420 | Human |
597596390 | GWAS1653250_H | diabetes mellitus, Drugs used in diabetes use measurement QTL GWAS1653250 (human) | | 7e-35 | pancreas integrity trait (VT:0010560) | | 10 | 79187681 | 79187682 | Human |
597203169 | GWAS1299243_H | psoriasis QTL GWAS1299243 (human) | | 0.0000001 | psoriasis | | 10 | 88732445 | 88732446 | Human |
407012155 | GWAS661131_H | platelet count QTL GWAS661131 (human) | | 9e-22 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 102600127 | 102600128 | Human |
597252323 | GWAS1348397_H | serum alanine aminotransferase measurement QTL GWAS1348397 (human) | | 9e-32 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 99643566 | 99643567 | Human |
597285092 | GWAS1381166_H | calcium measurement QTL GWAS1381166 (human) | | 4e-17 | calcium measurement | blood calcium level (CMO:0000502) | 10 | 79240172 | 79240174 | Human |
597383396 | GWAS1479470_H | type 2 diabetes mellitus QTL GWAS1479470 (human) | | 2e-08 | type 2 diabetes mellitus | | 10 | 101306032 | 101306033 | Human |
597350426 | GWAS1446500_H | lean body mass QTL GWAS1446500 (human) | | 2e-11 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 94462374 | 94462375 | Human |
597391387 | GWAS1487461_H | smoking behavior QTL GWAS1487461 (human) | | 1e-09 | smoking behavior | | 10 | 103253237 | 103253238 | Human |
597071895 | GWAS1167969_H | high density lipoprotein cholesterol measurement QTL GWAS1167969 (human) | | 1e-10 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93024020 | 93024021 | Human |
597301273 | GWAS1397347_H | docosahexaenoic acid measurement, fatty acid measurement QTL GWAS1397347 (human) | | 3e-08 | fatty acid amount (VT:0010046) | blood free fatty acids level (CMO:0000117) | 10 | 94990179 | 94990180 | Human |
597334046 | GWAS1430120_H | S-warfarin to R-warfarin ratio measurement QTL GWAS1430120 (human) | | 0.000006 | S-warfarin to R-warfarin ratio measurement | | 10 | 95783329 | 95783330 | Human |
597227549 | GWAS1323623_H | stroke outcome severity measurement QTL GWAS1323623 (human) | | 0.000001 | stroke outcome severity measurement | | 10 | 84732025 | 84732026 | Human |
597309471 | GWAS1405545_H | vaginal microbiome measurement QTL GWAS1405545 (human) | | 0.000008 | vaginal microbiome measurement | | 10 | 89419538 | 89419539 | Human |
597334047 | GWAS1430121_H | S-warfarin to R-warfarin ratio measurement QTL GWAS1430121 (human) | | 4e-10 | S-warfarin to R-warfarin ratio measurement | | 10 | 95026363 | 95026364 | Human |
597596185 | GWAS1653045_H | diastolic blood pressure change measurement QTL GWAS1653045 (human) | | 5e-15 | diastolic blood pressure change measurement | change in diastolic blood pressure (CMO:0001016) | 10 | 98254058 | 98254059 | Human |
597104668 | GWAS1200742_H | corneal topography QTL GWAS1200742 (human) | | 9e-09 | corneal topography | | 10 | 97315202 | 97315203 | Human |
597506065 | GWAS1602139_H | smoking initiation QTL GWAS1602139 (human) | | 1e-11 | smoking initiation | | 10 | 96184733 | 96184734 | Human |
407094223 | GWAS743199_H | spontaneous preterm birth QTL GWAS743199 (human) | | 0.000002 | spontaneous preterm birth | | 10 | 97502818 | 97502819 | Human |
597579795 | GWAS1636655_H | type 2 diabetes nephropathy QTL GWAS1636655 (human) | | 4e-14 | type 2 diabetes nephropathy | | 10 | 79184390 | 79184391 | Human |
597506064 | GWAS1602138_H | smoking initiation QTL GWAS1602138 (human) | | 2e-10 | smoking initiation | | 10 | 91153876 | 91153877 | Human |
407266251 | GWAS915227_H | obsolete_red blood cell distribution width QTL GWAS915227 (human) | | 5e-18 | obsolete_red blood cell distribution width | | 10 | 100315722 | 100315723 | Human |
597104665 | GWAS1200739_H | coronary artery disease QTL GWAS1200739 (human) | | 3e-16 | coronary artery disease | | 10 | 89249122 | 89249123 | Human |
597489683 | GWAS1585757_H | pulmonary surfactant-associated protein d measurement QTL GWAS1585757 (human) | | 3e-57 | pulmonary surfactant-associated protein d measurement | | 10 | 79934597 | 79934598 | Human |
406954958 | GWAS603934_H | self reported educational attainment QTL GWAS603934 (human) | | 6e-09 | self reported educational attainment | | 10 | 101790524 | 101790525 | Human |
597047302 | GWAS1143376_H | Red cell distribution width QTL GWAS1143376 (human) | | 3e-31 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 94596424 | 94596425 | Human |
597170184 | GWAS1266258_H | protein measurement QTL GWAS1266258 (human) | | 7e-15 | protein measurement | | 10 | 98010125 | 98010126 | Human |
597047303 | GWAS1143377_H | Red cell distribution width QTL GWAS1143377 (human) | | 1e-18 | glycerophosphocholine amount (VT:0011004) | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 100315722 | 100315723 | Human |
597391368 | GWAS1487442_H | lean body mass QTL GWAS1487442 (human) | | 2e-11 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 94278929 | 94278930 | Human |
597104644 | GWAS1200718_H | corneal topography QTL GWAS1200718 (human) | | 0.000002 | corneal topography | | 10 | 97315202 | 97315203 | Human |
597432328 | GWAS1528402_H | protein measurement QTL GWAS1528402 (human) | | 4e-11 | protein measurement | | 10 | 80157952 | 80157953 | Human |
596981761 | GWAS1101280_H | memory performance QTL GWAS1101280 (human) | | 0.000004 | memory performance | | 10 | 99156866 | 99156867 | Human |
597161986 | GWAS1258060_H | N-acetylmethionine measurement QTL GWAS1258060 (human) | | 0.000003 | N-acetylmethionine measurement | | 10 | 93581307 | 93581308 | Human |
597022722 | GWAS1118796_H | breast carcinoma QTL GWAS1118796 (human) | | 0.000001 | mammary gland integrity trait (VT:0010552) | | 10 | 92388574 | 92388575 | Human |
596973581 | GWAS1093100_H | telomere length QTL GWAS1093100 (human) | | 2e-11 | telomere length | | 10 | 92686878 | 92686879 | Human |
597211136 | GWAS1307210_H | blood protein measurement QTL GWAS1307210 (human) | | 8e-11 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95643491 | 95643492 | Human |
597293057 | GWAS1389131_H | physical activity measurement QTL GWAS1389131 (human) | | 1e-10 | wellness/fitness trait (VT:1000152) | voluntary body mobility/immobility measurement (CMO:0000954) | 10 | 102120361 | 102120362 | Human |
597448709 | GWAS1544783_H | fatty acid measurement QTL GWAS1544783 (human) | | 2e-09 | fatty acid measurement | | 10 | 92748298 | 92748299 | Human |
597227522 | GWAS1323596_H | anxiety measurement QTL GWAS1323596 (human) | | 2e-08 | anxiety measurement | | 10 | 102986892 | 102986893 | Human |
597104652 | GWAS1200726_H | corneal topography QTL GWAS1200726 (human) | | 4e-08 | corneal topography | | 10 | 101064592 | 101064593 | Human |
597260293 | GWAS1356367_H | cholesteryl ester measurement, high density lipoprotein cholesterol measurement QTL GWAS1356367 (human) | | 4e-13 | blood lipid amount (VT:0003949) | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079885 | 93079886 | Human |
597170181 | GWAS1266255_H | protein measurement QTL GWAS1266255 (human) | | 1e-26 | protein measurement | | 10 | 97914366 | 97914367 | Human |
597170182 | GWAS1266256_H | protein measurement QTL GWAS1266256 (human) | | 5e-224 | protein measurement | | 10 | 97882605 | 97882606 | Human |
597047304 | GWAS1143378_H | Red cell distribution width QTL GWAS1143378 (human) | | 6e-15 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 101438198 | 101438199 | Human |
597260294 | GWAS1356368_H | cholesteryl ester measurement, high density lipoprotein cholesterol measurement QTL GWAS1356368 (human) | | 7e-09 | blood lipid amount (VT:0003949) | blood lipid measurement (CMO:0000050) | 10 | 94741733 | 94741734 | Human |
597170183 | GWAS1266257_H | protein measurement QTL GWAS1266257 (human) | | 1e-11 | protein measurement | | 10 | 98150009 | 98150010 | Human |
597194808 | GWAS1290882_H | free androgen index QTL GWAS1290882 (human) | | 3e-16 | free androgen index | | 10 | 102863296 | 102863297 | Human |
597194810 | GWAS1290884_H | free androgen index QTL GWAS1290884 (human) | | 5e-10 | free androgen index | | 10 | 91748207 | 91748208 | Human |
597022768 | GWAS1118842_H | colorectal health QTL GWAS1118842 (human) | | 0.000006 | colorectal integrity trait (VT:0010901) | | 10 | 85333245 | 85333246 | Human |
597055539 | GWAS1151613_H | age at onset, Myopia QTL GWAS1151613 (human) | | 1e-08 | age at onset, Myopia | | 10 | 88295142 | 88295143 | Human |
597588016 | GWAS1644876_H | hypothyroidism QTL GWAS1644876 (human) | | 3e-18 | hypothyroidism | | 10 | 88089762 | 88089763 | Human |
407012333 | GWAS661309_H | platelet count QTL GWAS661309 (human) | | 3e-14 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 94253193 | 94253194 | Human |
597473331 | GWAS1569405_H | mathematical ability QTL GWAS1569405 (human) | | 6e-28 | mathematical ability | | 10 | 101760027 | 101760028 | Human |
597219371 | GWAS1315445_H | insulin measurement QTL GWAS1315445 (human) | | 4e-10 | insulin measurement | pancreatic islet insulin release measurement (CMO:0001216) | 10 | 87920874 | 87920875 | Human |
597129252 | GWAS1225326_H | heart rate response to exercise QTL GWAS1225326 (human) | | 6e-12 | heart rate response to exercise | | 10 | 100793890 | 100793891 | Human |
597162026 | GWAS1258100_H | platelet count QTL GWAS1258100 (human) | | 4e-15 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 93079885 | 93079886 | Human |
597162025 | GWAS1258099_H | platelet count QTL GWAS1258099 (human) | | 2e-09 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 79444551 | 79444552 | Human |
597293145 | GWAS1389219_H | FEV/FVC ratio, inflammatory bowel disease QTL GWAS1389219 (human) | | 3e-10 | FEV/FVC ratio, inflammatory bowel disease | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 80520381 | 80520382 | Human |
596990037 | GWAS1109556_H | systolic blood pressure QTL GWAS1109556 (human) | | 2e-34 | systolic blood pressure | | 10 | 94279840 | 94279841 | Human |
597317727 | GWAS1413801_H | body mass index QTL GWAS1413801 (human) | | 1e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100866753 | 100866754 | Human |
597055580 | GWAS1151654_H | age at onset, Myopia QTL GWAS1151654 (human) | | 2e-13 | age at onset, Myopia | | 10 | 84255817 | 84255818 | Human |
597366865 | GWAS1462939_H | lean body mass QTL GWAS1462939 (human) | | 0.0000003 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 94278929 | 94278930 | Human |
597178454 | GWAS1274528_H | protein measurement QTL GWAS1274528 (human) | | 2e-179 | protein measurement | | 10 | 91905711 | 91905712 | Human |
597383242 | GWAS1479316_H | monocyte count QTL GWAS1479316 (human) | | 2e-10 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 99524588 | 99524589 | Human |
596957255 | GWAS1076774_H | major depressive disorder QTL GWAS1076774 (human) | | 0.000002 | major depressive disorder | | 10 | 78574404 | 78574405 | Human |
407290773 | GWAS939749_H | retinal vasculature measurement QTL GWAS939749 (human) | | 0.000003 | retinal vasculature measurement | | 10 | 94278929 | 94278930 | Human |
596965447 | GWAS1084966_H | triglyceride measurement, diet measurement QTL GWAS1084966 (human) | | 0.000004 | triglyceride measurement, diet measurement | | 10 | 95615511 | 95615512 | Human |
597030982 | GWAS1127056_H | colorectal cancer QTL GWAS1127056 (human) | | 1e-08 | colorectal cancer | | 10 | 99585609 | 99585610 | Human |
597358670 | GWAS1454744_H | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis QTL GWAS1454744 (human) | | 4e-09 | intestine integrity trait (VT:0010554) | | 10 | 88990206 | 88990207 | Human |
597489737 | GWAS1585811_H | breast density QTL GWAS1585811 (human) | | 0.000009 | breast density | | 10 | 84255389 | 84255390 | Human |
597358671 | GWAS1454745_H | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis QTL GWAS1454745 (human) | | 6e-51 | intestine integrity trait (VT:0010554) | | 10 | 99523573 | 99523574 | Human |
407094164 | GWAS743140_H | body height QTL GWAS743140 (human) | | 9e-22 | body height | | 10 | 87839992 | 87839993 | Human |
597309517 | GWAS1405591_H | cortical thickness QTL GWAS1405591 (human) | | 3e-08 | cortical thickness | | 10 | 88504383 | 88504384 | Human |
596981838 | GWAS1101357_H | memory performance QTL GWAS1101357 (human) | | 0.000009 | memory performance | | 10 | 86005934 | 86005935 | Human |
597366848 | GWAS1462922_H | hemoglobin measurement QTL GWAS1462922 (human) | | 1e-13 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 102911075 | 102911076 | Human |
596990025 | GWAS1109544_H | monocyte count QTL GWAS1109544 (human) | | 1e-16 | monocyte count | | 10 | 94279840 | 94279841 | Human |
597317703 | GWAS1413777_H | X-16935 measurement QTL GWAS1413777 (human) | | 3e-08 | X-16935 measurement | | 10 | 95086085 | 95086086 | Human |
597481538 | GWAS1577612_H | lymphocyte count QTL GWAS1577612 (human) | | 4e-20 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95976817 | 95976818 | Human |
597186631 | GWAS1282705_H | metabolite measurement QTL GWAS1282705 (human) | | 1e-08 | metabolite measurement | | 10 | 93079885 | 93079886 | Human |
597088374 | GWAS1184448_H | sarcoidosis QTL GWAS1184448 (human) | | 0.000001 | sarcoidosis | | 10 | 80166946 | 80166947 | Human |
597186680 | GWAS1282754_H | androstenediol (3alpha, 17alpha) monosulfate (3) measurement QTL GWAS1282754 (human) | | 2e-24 | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | | 10 | 95080278 | 95080279 | Human |
597071989 | GWAS1168063_H | breast carcinoma QTL GWAS1168063 (human) | | 3e-15 | mammary gland integrity trait (VT:0010552) | | 10 | 79081391 | 79081392 | Human |
597112946 | GWAS1209020_H | bitter alcoholic beverage consumption measurement QTL GWAS1209020 (human) | | 0.0000001 | bitter alcoholic beverage consumption measurement | drink intake measurement (CMO:0000771) | 10 | 100866753 | 100866754 | Human |
597244031 | GWAS1340105_H | triglyceride measurement QTL GWAS1340105 (human) | | 3e-17 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 98013128 | 98013129 | Human |
597047422 | GWAS1143496_H | erythrocyte count QTL GWAS1143496 (human) | | 5e-12 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 89730330 | 89730331 | Human |
597047423 | GWAS1143497_H | erythrocyte count QTL GWAS1143497 (human) | | 5e-08 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 92686284 | 92686285 | Human |
597047420 | GWAS1143494_H | erythrocyte count QTL GWAS1143494 (human) | | 2e-11 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 88550323 | 88550324 | Human |
597088380 | GWAS1184454_H | type 2 diabetes mellitus QTL GWAS1184454 (human) | | 5e-89 | type 2 diabetes mellitus | | 10 | 92703125 | 92703126 | Human |
597047421 | GWAS1143495_H | erythrocyte count QTL GWAS1143495 (human) | | 2e-11 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 88994850 | 88994851 | Human |
597145724 | GWAS1241798_H | low density lipoprotein cholesterol measurement QTL GWAS1241798 (human) | | 2e-08 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 92771075 | 92771076 | Human |
597088381 | GWAS1184455_H | type 2 diabetes mellitus QTL GWAS1184455 (human) | | 2e-10 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 100152307 | 100152308 | Human |
597088378 | GWAS1184452_H | type 2 diabetes mellitus QTL GWAS1184452 (human) | | 4e-08 | type 2 diabetes mellitus | | 10 | 88008827 | 88008828 | Human |
597047419 | GWAS1143493_H | erythrocyte count QTL GWAS1143493 (human) | | 1e-16 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 87986057 | 87986058 | Human |
597088379 | GWAS1184453_H | type 2 diabetes mellitus QTL GWAS1184453 (human) | | 2e-19 | type 2 diabetes mellitus | | 10 | 92196795 | 92196796 | Human |
597604465 | GWAS1661325_H | prostate carcinoma QTL GWAS1661325 (human) | | 4e-13 | prostate carcinoma | | 10 | 78494331 | 78494332 | Human |
597088377 | GWAS1184451_H | type 2 diabetes mellitus QTL GWAS1184451 (human) | | 2e-40 | type 2 diabetes mellitus | | 10 | 79183098 | 79183099 | Human |
597211255 | GWAS1307329_H | birth weight, parental genotype effect measurement QTL GWAS1307329 (human) | | 4e-13 | birth weight, parental genotype effect measurement | neonatal body weight (CMO:0002079) | 10 | 94210156 | 94210157 | Human |
597276776 | GWAS1372850_H | diet measurement QTL GWAS1372850 (human) | | 5e-11 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 85717944 | 85717947 | Human |
407192500 | GWAS841476_H | executive function measurement, unipolar depression, cognitive function measurement QTL GWAS841476 (human) | | 4e-08 | executive function measurement, unipolar depression, cognitive function measurement | | 10 | 99548014 | 99548015 | Human |
597309544 | GWAS1405618_H | vaginal microbiome measurement QTL GWAS1405618 (human) | | 0.0000008 | vaginal microbiome measurement | | 10 | 89419538 | 89419539 | Human |
597309545 | GWAS1405619_H | vaginal microbiome measurement QTL GWAS1405619 (human) | | 0.0000007 | vaginal microbiome measurement | | 10 | 89422096 | 89422097 | Human |
597317742 | GWAS1413816_H | diastolic blood pressure QTL GWAS1413816 (human) | | 5e-28 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103141734 | 103141735 | Human |
597481579 | GWAS1577653_H | glucose-dependent insulinotropic peptide measurement QTL GWAS1577653 (human) | | 3e-09 | blood gastric inhibitory polypeptide amount (VT:0010916) | | 10 | 96766312 | 96766313 | Human |
597416034 | GWAS1512108_H | cognitive function measurement QTL GWAS1512108 (human) | | 5e-10 | cognitive behavior trait (VT:0010450) | | 10 | 91590110 | 91590111 | Human |
597080172 | GWAS1176246_H | Red cell distribution width QTL GWAS1176246 (human) | | 5e-18 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 100315722 | 100315723 | Human |
597497958 | GWAS1594032_H | hip geometry QTL GWAS1594032 (human) | | 3e-08 | hip geometry | hip circumference (CMO:0000014) | 10 | 98256556 | 98256557 | Human |
597080173 | GWAS1176247_H | Red cell distribution width QTL GWAS1176247 (human) | | 2e-15 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 102875591 | 102875592 | Human |
597309543 | GWAS1405617_H | vaginal microbiome measurement QTL GWAS1405617 (human) | | 0.000006 | vaginal microbiome measurement | | 10 | 89351930 | 89351931 | Human |
406995903 | GWAS644879_H | reticulocyte measurement QTL GWAS644879 (human) | | 4e-138 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 10 | 103046897 | 103046898 | Human |
406995900 | GWAS644876_H | reticulocyte measurement QTL GWAS644876 (human) | | 6e-18 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 10 | 79357419 | 79357420 | Human |
597530723 | GWAS1626797_H | dyslexia QTL GWAS1626797 (human) | | 1e-10 | dyslexia | | 10 | 98101555 | 98101556 | Human |
597458846 | GWAS1554920_H | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1554920 (human) | | 2e-11 | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079967 | 93079968 | Human |
597335966 | GWAS1432040_H | C-reactive protein measurement QTL GWAS1432040 (human) | | 7e-09 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 93086336 | 93086337 | Human |
597295005 | GWAS1391079_H | calcium measurement QTL GWAS1391079 (human) | | 0.000009 | calcium measurement | blood calcium level (CMO:0000502) | 10 | 98631661 | 98631662 | Human |
596950928 | GWAS1070447_H | Red cell distribution width QTL GWAS1070447 (human) | | 3e-14 | Red cell distribution width | | 10 | 101427425 | 101427426 | Human |
597303199 | GWAS1399273_H | mean corpuscular hemoglobin QTL GWAS1399273 (human) | | 2e-08 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 94432186 | 94432187 | Human |
596950929 | GWAS1070448_H | Red cell distribution width QTL GWAS1070448 (human) | | 6e-15 | Red cell distribution width | | 10 | 102875591 | 102875592 | Human |
597163921 | GWAS1259995_H | quinate measurement QTL GWAS1259995 (human) | | 0.000006 | quinate measurement | | 10 | 85789200 | 85789201 | Human |
597335965 | GWAS1432039_H | C-reactive protein measurement QTL GWAS1432039 (human) | | 3e-08 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 79328300 | 79328301 | Human |
597327773 | GWAS1423847_H | breast cancer QTL GWAS1423847 (human) | | 0.000003 | breast cancer | | 10 | 83996448 | 83996449 | Human |
597516183 | GWAS1612257_H | Vitiligo QTL GWAS1612257 (human) | | 2e-13 | Vitiligo | | 10 | 89860916 | 89860917 | Human |
407159886 | GWAS808862_H | gut microbiome measurement QTL GWAS808862 (human) | | 0.000001 | gut microbiome measurement | | 10 | 101036200 | 101036201 | Human |
597516182 | GWAS1612256_H | Vitiligo QTL GWAS1612256 (human) | | 6e-09 | Vitiligo | | 10 | 102618002 | 102618003 | Human |
597139334 | GWAS1235408_H | X-11787 measurement QTL GWAS1235408 (human) | | 1e-91 | X-11787 measurement | | 10 | 94906747 | 94906748 | Human |
597524367 | GWAS1620441_H | glutamine measurement QTL GWAS1620441 (human) | | 8e-63 | glutamine measurement | blood amino acid measurement (CMO:0003730) | 10 | 97599655 | 97599656 | Human |
597409672 | GWAS1505746_H | N2,N2-dimethylguanosine measurement QTL GWAS1505746 (human) | | 7e-22 | N2,N2-dimethylguanosine measurement | | 10 | 98383436 | 98383437 | Human |
597606282 | GWAS1663142_H | serum alanine aminotransferase measurement QTL GWAS1663142 (human) | | 1e-17 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100152307 | 100152308 | Human |
597180301 | GWAS1276375_H | retinol-binding protein 4 measurement QTL GWAS1276375 (human) | | 8e-24 | retinol-binding protein 4 measurement | | 10 | 93600270 | 93600271 | Human |
597245836 | GWAS1341910_H | serum alanine aminotransferase measurement QTL GWAS1341910 (human) | | 2e-35 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100152307 | 100152308 | Human |
597245839 | GWAS1341913_H | serum alanine aminotransferase measurement QTL GWAS1341913 (human) | | 3e-09 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 77920756 | 77920757 | Human |
597614472 | GWAS1671332_H | diabetes mellitus, family history QTL GWAS1671332 (human) | | 2e-11 | pancreas integrity trait (VT:0010560) | | 10 | 79194494 | 79194495 | Human |
597450629 | GWAS1546703_H | alkaline phosphatase measurement QTL GWAS1546703 (human) | | 6e-14 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 79336832 | 79336833 | Human |
597409666 | GWAS1505740_H | X-11308 measurement QTL GWAS1505740 (human) | | 2e-12 | X-11308 measurement | | 10 | 94646409 | 94646410 | Human |
597147533 | GWAS1243607_H | prostate carcinoma QTL GWAS1243607 (human) | | 6e-08 | prostate carcinoma | | 10 | 79076241 | 79076242 | Human |
597409664 | GWAS1505738_H | N2-acetyl,N6-methyllysine measurement QTL GWAS1505738 (human) | | 1e-885 | N2-acetyl,N6-methyllysine measurement | | 10 | 98383436 | 98383437 | Human |
597139340 | GWAS1235414_H | smoking initiation QTL GWAS1235414 (human) | | 1e-64 | smoking initiation | | 10 | 103037030 | 103037031 | Human |
597139339 | GWAS1235413_H | smoking initiation QTL GWAS1235413 (human) | | 5e-65 | smoking initiation | | 10 | 103063052 | 103063053 | Human |
597139338 | GWAS1235412_H | smoking initiation QTL GWAS1235412 (human) | | 8e-65 | smoking initiation | | 10 | 103039911 | 103039912 | Human |
597409669 | GWAS1505743_H | metabolite measurement QTL GWAS1505743 (human) | | 4e-1402 | metabolite measurement | | 10 | 98383436 | 98383437 | Human |
597139337 | GWAS1235411_H | smoking initiation QTL GWAS1235411 (human) | | 1e-64 | smoking initiation | | 10 | 103037666 | 103037667 | Human |
597278649 | GWAS1374723_H | insomnia QTL GWAS1374723 (human) | | 3e-09 | insomnia | | 10 | 103421153 | 103421154 | Human |
597245887 | GWAS1341961_H | serum alanine aminotransferase measurement QTL GWAS1341961 (human) | | 3e-33 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 77897947 | 77897948 | Human |
597319600 | GWAS1415674_H | diastolic blood pressure, systolic blood pressure QTL GWAS1415674 (human) | | 3e-10 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 101351300 | 101351301 | Human |
597262258 | GWAS1358332_H | free cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS1358332 (human) | | 2e-08 | free cholesterol measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 94741733 | 94741734 | Human |
597327785 | GWAS1423859_H | 1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) measurement QTL GWAS1423859 (human) | | 2e-22 | glycerophosphocholine amount (VT:0011004) | | 10 | 100315722 | 100315723 | Human |
596967330 | GWAS1086849_H | body height QTL GWAS1086849 (human) | | 5e-08 | body height | | 10 | 87834823 | 87834824 | Human |
597024686 | GWAS1120760_H | type 2 diabetes mellitus QTL GWAS1120760 (human) | | 7e-13 | type 2 diabetes mellitus | | 10 | 92703125 | 92703126 | Human |
597147563 | GWAS1243637_H | body mass index QTL GWAS1243637 (human) | | 2e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 97935213 | 97935214 | Human |
597163946 | GWAS1260020_H | schizophrenia QTL GWAS1260020 (human) | | 3e-08 | schizophrenia | | 10 | 89633532 | 89633533 | Human |
597327783 | GWAS1423857_H | palmitoleate 16:1n7 measurement QTL GWAS1423857 (human) | | 9e-37 | palmitoleate 16:1n7 measurement | | 10 | 100315722 | 100315723 | Human |
597163945 | GWAS1260019_H | sarcoidosis QTL GWAS1260019 (human) | | 1e-16 | sarcoidosis | | 10 | 80194524 | 80194525 | Human |
597278631 | GWAS1374705_H | QT interval QTL GWAS1374705 (human) | | 1e-10 | QT interval | QT interval (CMO:0000235) | 10 | 89514012 | 89514013 | Human |
597278630 | GWAS1374704_H | QT interval QTL GWAS1374704 (human) | | 3e-08 | QT interval | QT interval (CMO:0000235) | 10 | 79114766 | 79114767 | Human |
597147560 | GWAS1243634_H | body mass index QTL GWAS1243634 (human) | | 5e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 85653183 | 85653184 | Human |
597450659 | GWAS1546733_H | ulcerative colitis QTL GWAS1546733 (human) | | 0.0000006 | ulcerative colitis | | 10 | 99524480 | 99524481 | Human |
406955011 | GWAS603987_H | self reported educational attainment QTL GWAS603987 (human) | | 4e-08 | self reported educational attainment | | 10 | 102120361 | 102120362 | Human |
597581788 | GWAS1638648_H | pulse pressure measurement QTL GWAS1638648 (human) | | 1e-15 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 103146454 | 103146455 | Human |
406955010 | GWAS603986_H | self reported educational attainment QTL GWAS603986 (human) | | 1e-11 | self reported educational attainment | | 10 | 102057071 | 102057072 | Human |
597426143 | GWAS1522217_H | lysophosphatidylcholine measurement QTL GWAS1522217 (human) | | 2e-13 | lysophosphatidylcholine measurement | blood phospholipid level (CMO:0001169) | 10 | 100344764 | 100344765 | Human |
597426142 | GWAS1522216_H | lysophosphatidylcholine measurement QTL GWAS1522216 (human) | | 9e-12 | lysophosphatidylcholine measurement | blood phospholipid level (CMO:0001169) | 10 | 100329906 | 100329907 | Human |
597082065 | GWAS1178139_H | gut microbiome measurement QTL GWAS1178139 (human) | | 0.000001 | gut microbiome measurement | | 10 | 97959530 | 97959531 | Human |
597376979 | GWAS1473053_H | Crohn's disease QTL GWAS1473053 (human) | | 4e-10 | intestine integrity trait (VT:0010554) | | 10 | 99528007 | 99528008 | Human |
597106651 | GWAS1202725_H | cytokine measurement QTL GWAS1202725 (human) | | 0.000004 | cytokine measurement | blood cytokine measurement (CMO:0001924) | 10 | 82623352 | 82623353 | Human |
597450704 | GWAS1546778_H | electrocardiography QTL GWAS1546778 (human) | | 9e-15 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597499857 | GWAS1595931_H | diastolic blood pressure QTL GWAS1595931 (human) | | 0.000004 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 101353278 | 101353279 | Human |
597024728 | GWAS1120802_H | pursuit maintenance gain measurement QTL GWAS1120802 (human) | | 0.000003 | eye physiology trait (VT:0005253) | | 10 | 87574781 | 87574782 | Human |
597499856 | GWAS1595930_H | diastolic blood pressure QTL GWAS1595930 (human) | | 2e-16 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 94311804 | 94311805 | Human |
597163992 | GWAS1260066_H | cataract QTL GWAS1260066 (human) | | 3e-08 | cataract | | 10 | 80419943 | 80419944 | Human |
597450700 | GWAS1546774_H | electrocardiography QTL GWAS1546774 (human) | | 7e-19 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597450701 | GWAS1546775_H | electrocardiography QTL GWAS1546775 (human) | | 1e-16 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
596950981 | GWAS1070500_H | cataract QTL GWAS1070500 (human) | | 4e-08 | cataract | | 10 | 94279840 | 94279841 | Human |
597499855 | GWAS1595929_H | diastolic blood pressure QTL GWAS1595929 (human) | | 2e-08 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 92669710 | 92669711 | Human |
597450702 | GWAS1546776_H | electrocardiography QTL GWAS1546776 (human) | | 3e-14 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597450703 | GWAS1546777_H | electrocardiography QTL GWAS1546777 (human) | | 5e-14 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
406963221 | GWAS612197_H | Barrett's esophagus QTL GWAS612197 (human) | | 0.000006 | Barrett's esophagus | | 10 | 86356722 | 86356723 | Human |
597458889 | GWAS1554963_H | BMI-adjusted waist-hip ratio QTL GWAS1554963 (human) | | 3e-09 | body size trait (VT:0100005) | | 10 | 102727686 | 102727687 | Human |
597311437 | GWAS1407511_H | vaginal microbiome measurement QTL GWAS1407511 (human) | | 0.000006 | vaginal microbiome measurement | | 10 | 89422096 | 89422097 | Human |
597450699 | GWAS1546773_H | electrocardiography QTL GWAS1546773 (human) | | 1e-19 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
597581764 | GWAS1638624_H | pulse pressure measurement QTL GWAS1638624 (human) | | 2e-10 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 102814805 | 102814806 | Human |
597589956 | GWAS1646816_H | cardiac arrhythmia QTL GWAS1646816 (human) | | 3e-19 | cardiac arrhythmia | | 10 | 103582915 | 103582916 | Human |
597262274 | GWAS1358348_H | total cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS1358348 (human) | | 5e-09 | total cholesterol measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 94741733 | 94741734 | Human |
597581765 | GWAS1638625_H | pulse pressure measurement QTL GWAS1638625 (human) | | 3e-14 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 103090875 | 103090876 | Human |
597073864 | GWAS1169938_H | lobe attachment QTL GWAS1169938 (human) | | 0.000002 | lobe attachment | ear measurement (CMO:0002667) | 10 | 88768421 | 88768422 | Human |
597073865 | GWAS1169939_H | lobe attachment QTL GWAS1169939 (human) | | 0.000006 | lobe attachment | ear measurement (CMO:0002667) | 10 | 93515133 | 93515134 | Human |
407086114 | GWAS735090_H | preterm premature rupture of the membranes, spontaneous preterm birth QTL GWAS735090 (human) | | 0.000002 | preterm premature rupture of the membranes, spontaneous preterm birth | | 10 | 97520476 | 97520477 | Human |
597164021 | GWAS1260095_H | Vasodilators used in cardiac diseases use measurement QTL GWAS1260095 (human) | | 2e-09 | angina pectoris | | 10 | 103069712 | 103069713 | Human |
597532665 | GWAS1628739_H | body mass index QTL GWAS1628739 (human) | | 7e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 85599678 | 85599679 | Human |
596983792 | GWAS1103311_H | memory performance QTL GWAS1103311 (human) | | 0.000008 | memory performance | | 10 | 86569212 | 86569213 | Human |
597221375 | GWAS1317449_H | alkaline phosphatase measurement QTL GWAS1317449 (human) | | 3e-11 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 102978254 | 102978255 | Human |
597295088 | GWAS1391162_H | citrulline measurement QTL GWAS1391162 (human) | | 1e-13 | citrulline measurement | blood amino acid measurement (CMO:0003730) | 10 | 95637587 | 95637588 | Human |
597319664 | GWAS1415738_H | thymol sulfate measurement QTL GWAS1415738 (human) | | 2e-30 | thymol sulfate measurement | | 10 | 94939925 | 94939926 | Human |
597393392 | GWAS1489466_H | eosinophil count QTL GWAS1489466 (human) | | 3e-46 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 92669710 | 92669711 | Human |
597467120 | GWAS1563194_H | diastolic blood pressure QTL GWAS1563194 (human) | | 2e-08 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 93079967 | 93079968 | Human |
406938668 | GWAS587644_H | heel bone mineral density QTL GWAS587644 (human) | | 5e-25 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 100315722 | 100315723 | Human |
597590000 | GWAS1646860_H | type 2 diabetes mellitus QTL GWAS1646860 (human) | | 5e-22 | type 2 diabetes mellitus | | 10 | 79189126 | 79189127 | Human |
597467122 | GWAS1563196_H | systolic blood pressure QTL GWAS1563196 (human) | | 3e-12 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 102856906 | 102856907 | Human |
597614577 | GWAS1671437_H | mixed connective tissue disease QTL GWAS1671437 (human) | | 5e-14 | mixed connective tissue disease | | 10 | 92688993 | 92688994 | Human |
597590001 | GWAS1646861_H | type 2 diabetes mellitus QTL GWAS1646861 (human) | | 5e-47 | type 2 diabetes mellitus | | 10 | 92704022 | 92704023 | Human |
597442547 | GWAS1538621_H | high density lipoprotein cholesterol measurement QTL GWAS1538621 (human) | | 3e-10 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079967 | 93079968 | Human |
407045169 | GWAS694145_H | antioxidant measurement QTL GWAS694145 (human) | | 0.000002 | antioxidant measurement | | 10 | 100306428 | 100306429 | Human |
407135280 | GWAS784256_H | migraine disorder QTL GWAS784256 (human) | | 6e-09 | migraine disorder | | 10 | 94259272 | 94259273 | Human |
597606379 | GWAS1663239_H | metabolic disease QTL GWAS1663239 (human) | | 2e-17 | metabolic disease | | 10 | 93079885 | 93079886 | Human |
597409773 | GWAS1505847_H | saturated fatty acids measurement QTL GWAS1505847 (human) | | 8e-10 | fatty acid amount (VT:0010046) | | 10 | 93079967 | 93079968 | Human |
597368813 | GWAS1464887_H | hematocrit QTL GWAS1464887 (human) | | 8e-10 | hematocrit | hematocrit (CMO:0000037) | 10 | 102875346 | 102875347 | Human |
597401571 | GWAS1497645_H | systolic blood pressure QTL GWAS1497645 (human) | | 7e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 101353278 | 101353279 | Human |
597401570 | GWAS1497644_H | systolic blood pressure QTL GWAS1497644 (human) | | 8e-45 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94278929 | 94278930 | Human |
597401569 | GWAS1497643_H | systolic blood pressure QTL GWAS1497643 (human) | | 0.0000001 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 92669710 | 92669711 | Human |
597401568 | GWAS1497642_H | systolic blood pressure QTL GWAS1497642 (human) | | 3e-12 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 80298232 | 80298233 | Human |
597254117 | GWAS1350191_H | serum gamma-glutamyl transferase measurement QTL GWAS1350191 (human) | | 7e-192 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 77920676 | 77920677 | Human |
597606370 | GWAS1663230_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1663230 (human) | | 7e-93 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 10 | 100164661 | 100164662 | Human |
597057512 | GWAS1153586_H | Eczematoid dermatitis, allergic rhinitis QTL GWAS1153586 (human) | | 6e-12 | Eczematoid dermatitis, allergic rhinitis | | 10 | 102577229 | 102577230 | Human |
597278489 | GWAS1374563_H | N-methylpipecolate measurement QTL GWAS1374563 (human) | | 2e-1088 | N-methylpipecolate measurement | | 10 | 98391509 | 98391510 | Human |
597155606 | GWAS1251680_H | triglyceride measurement, intermediate density lipoprotein measurement QTL GWAS1251680 (human) | | 1e-10 | free cholesterol measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079885 | 93079886 | Human |
597376794 | GWAS1472868_H | monocyte count QTL GWAS1472868 (human) | | 2e-116 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 99532633 | 99532634 | Human |
597376793 | GWAS1472867_H | monocyte count QTL GWAS1472867 (human) | | 4e-13 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 88103196 | 88103197 | Human |
597155605 | GWAS1251679_H | triglyceride measurement, intermediate density lipoprotein measurement QTL GWAS1251679 (human) | | 4e-11 | triglyceride measurement, intermediate density lipoprotein measurement | blood intermediate density lipoprotein cholesterol level (CMO:0001562) | 10 | 91882000 | 91882001 | Human |
597147413 | GWAS1243487_H | self reported educational attainment QTL GWAS1243487 (human) | | 3e-10 | self reported educational attainment | | 10 | 101734655 | 101734656 | Human |
597606173 | GWAS1663033_H | serum alanine aminotransferase measurement QTL GWAS1663033 (human) | | 3e-213 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100152437 | 100152438 | Human |
597245725 | GWAS1341799_H | sex hormone-binding globulin measurement QTL GWAS1341799 (human) | | 4e-11 | sex hormone-binding globulin measurement | | 10 | 79327082 | 79327083 | Human |
596958993 | GWAS1078512_H | response to warfarin QTL GWAS1078512 (human) | | 4e-13 | response to warfarin | | 10 | 94998551 | 94998552 | Human |
596958995 | GWAS1078514_H | response to warfarin QTL GWAS1078514 (human) | | 0.0000009 | response to warfarin | | 10 | 94249870 | 94249871 | Human |
597106461 | GWAS1202535_H | sex hormone-binding globulin measurement QTL GWAS1202535 (human) | | 6e-17 | sex hormone-binding globulin measurement | | 10 | 96097142 | 96097143 | Human |
597106460 | GWAS1202534_H | sex hormone-binding globulin measurement QTL GWAS1202534 (human) | | 2e-26 | glomerular filtration rate | | 10 | 93079885 | 93079886 | Human |
597466896 | GWAS1562970_H | body mass index QTL GWAS1562970 (human) | | 7e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 78457709 | 78457710 | Human |
597106459 | GWAS1202533_H | sex hormone-binding globulin measurement QTL GWAS1202533 (human) | | 9e-25 | sex hormone-binding globulin measurement | | 10 | 91872199 | 91872200 | Human |
597614354 | GWAS1671214_H | potassium measurement QTL GWAS1671214 (human) | | 3e-24 | potassium measurement | blood potassium level (CMO:0000496) | 10 | 92708886 | 92708887 | Human |
597106458 | GWAS1202532_H | sex hormone-binding globulin measurement QTL GWAS1202532 (human) | | 1e-26 | sex hormone-binding globulin measurement | | 10 | 79314368 | 79314369 | Human |
597466897 | GWAS1562971_H | body mass index QTL GWAS1562971 (human) | | 2e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 97241501 | 97241502 | Human |
597466898 | GWAS1562972_H | body mass index QTL GWAS1562972 (human) | | 5e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102460544 | 102460545 | Human |
597491469 | GWAS1587543_H | body shape measurement QTL GWAS1587543 (human) | | 3e-08 | body conformation trait (VT:1000000) | | 10 | 101103942 | 101103943 | Human |
597245706 | GWAS1341780_H | serum alanine aminotransferase measurement QTL GWAS1341780 (human) | | 5e-10 | cup-to-disc ratio measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 94279840 | 94279841 | Human |
597081858 | GWAS1177932_H | monocyte count QTL GWAS1177932 (human) | | 7e-22 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 102794772 | 102794773 | Human |
597024515 | GWAS1120589_H | type 2 diabetes mellitus QTL GWAS1120589 (human) | | 2e-19 | type 2 diabetes mellitus | | 10 | 92703125 | 92703126 | Human |
597081856 | GWAS1177930_H | monocyte count QTL GWAS1177930 (human) | | 1e-16 | monocyte quantity (VT:0000223) | neonatal body weight (CMO:0002079) | 10 | 94279840 | 94279841 | Human |
597024514 | GWAS1120588_H | type 2 diabetes mellitus QTL GWAS1120588 (human) | | 1e-10 | type 2 diabetes mellitus | | 10 | 79182874 | 79182875 | Human |
407020757 | GWAS669733_H | response to anticoagulant QTL GWAS669733 (human) | | 6e-12 | response to anticoagulant | | 10 | 94947445 | 94947446 | Human |
597081857 | GWAS1177931_H | monocyte count QTL GWAS1177931 (human) | | 5e-132 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 97349165 | 97349166 | Human |
597229313 | GWAS1325387_H | BMI-adjusted waist-hip ratio QTL GWAS1325387 (human) | | 3e-11 | body size trait (VT:0100005) | | 10 | 94171330 | 94171331 | Human |
597270272 | GWAS1366346_H | arecaidine measurement QTL GWAS1366346 (human) | | 5e-13 | arecaidine measurement | | 10 | 97027597 | 97027598 | Human |
597581572 | GWAS1638432_H | coronary artery disease QTL GWAS1638432 (human) | | 4e-14 | coronary artery disease | | 10 | 89243088 | 89243089 | Human |
597458690 | GWAS1554764_H | body mass index QTL GWAS1554764 (human) | | 7e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 100875718 | 100875719 | Human |
597458691 | GWAS1554765_H | body mass index QTL GWAS1554765 (human) | | 3e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102460544 | 102460545 | Human |
597163831 | GWAS1259905_H | carpal tunnel syndrome QTL GWAS1259905 (human) | | 9e-10 | carpal tunnel syndrome | | 10 | 98166514 | 98166515 | Human |
407209184 | GWAS858160_H | hemoglobin measurement QTL GWAS858160 (human) | | 4e-11 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 80381806 | 80381807 | Human |
597311292 | GWAS1407366_H | Agents acting on the renin-angiotensin system use measurement QTL GWAS1407366 (human) | | 8e-24 | Agents acting on the renin-angiotensin system use measurement | | 10 | 103034147 | 103034148 | Human |
597221168 | GWAS1317242_H | age-related hearing impairment QTL GWAS1317242 (human) | | 5e-10 | age-related hearing impairment | | 10 | 93023116 | 93023117 | Human |
597491504 | GWAS1587578_H | executive function measurement QTL GWAS1587578 (human) | | 6e-10 | executive function measurement | | 10 | 80444940 | 80444941 | Human |
597016377 | GWAS1112451_H | psoriasis QTL GWAS1112451 (human) | | 3e-08 | psoriasis | | 10 | 88065014 | 88065015 | Human |
597491505 | GWAS1587579_H | executive function measurement QTL GWAS1587579 (human) | | 3e-09 | executive function measurement | | 10 | 101576645 | 101576646 | Human |
597024548 | GWAS1120622_H | type 2 diabetes mellitus QTL GWAS1120622 (human) | | 0.000001 | type 2 diabetes mellitus | | 10 | 79182874 | 79182875 | Human |
597516076 | GWAS1612150_H | educational attainment QTL GWAS1612150 (human) | | 2e-09 | educational attainment | | 10 | 91317318 | 91317319 | Human |
597491503 | GWAS1587577_H | executive function measurement QTL GWAS1587577 (human) | | 2e-10 | executive function measurement | | 10 | 102911075 | 102911076 | Human |
597516073 | GWAS1612147_H | educational attainment QTL GWAS1612147 (human) | | 1e-08 | educational attainment | | 10 | 78849378 | 78849379 | Human |
597327662 | GWAS1423736_H | breast density QTL GWAS1423736 (human) | | 0.000001 | breast density | | 10 | 97591077 | 97591078 | Human |
597516072 | GWAS1612146_H | educational attainment QTL GWAS1612146 (human) | | 1e-09 | educational attainment | | 10 | 78350669 | 78350670 | Human |
597516075 | GWAS1612149_H | educational attainment QTL GWAS1612149 (human) | | 8e-09 | educational attainment | | 10 | 91152831 | 91152832 | Human |
597417773 | GWAS1513847_H | platelet component distribution width QTL GWAS1513847 (human) | | 1e-12 | platelet size trait (VT:0010457) | platelet distribution width (CMO:0001350) | 10 | 101141267 | 101141268 | Human |
597516074 | GWAS1612148_H | educational attainment QTL GWAS1612148 (human) | | 1e-08 | educational attainment | | 10 | 85390571 | 85390572 | Human |
597417772 | GWAS1513846_H | platelet component distribution width QTL GWAS1513846 (human) | | 8e-12 | platelet size trait (VT:0010457) | platelet distribution width (CMO:0001350) | 10 | 95751714 | 95751715 | Human |
597163819 | GWAS1259893_H | non-alcoholic fatty liver disease QTL GWAS1259893 (human) | | 1e-08 | non-alcoholic fatty liver disease | | 10 | 100267779 | 100267780 | Human |
597163818 | GWAS1259892_H | non-alcoholic fatty liver disease QTL GWAS1259892 (human) | | 3e-11 | non-alcoholic fatty liver disease | | 10 | 79165820 | 79165821 | Human |
597163817 | GWAS1259891_H | non-alcoholic fatty liver disease QTL GWAS1259891 (human) | | 2e-13 | non-alcoholic fatty liver disease | | 10 | 77770455 | 77770456 | Human |
597606177 | GWAS1663037_H | serum alanine aminotransferase measurement QTL GWAS1663037 (human) | | 1e-192 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100152437 | 100152438 | Human |
597409627 | GWAS1505701_H | 4-hydroxyglutamate measurement QTL GWAS1505701 (human) | | 3e-11 | 4-hydroxyglutamate measurement | | 10 | 97599655 | 97599656 | Human |
597606238 | GWAS1663098_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1663098 (human) | | 2e-85 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 10 | 99397681 | 99397682 | Human |
597139286 | GWAS1235360_H | 5alpha-pregnan-diol disulfate measurement QTL GWAS1235360 (human) | | 9e-19 | 5alpha-pregnan-diol disulfate measurement | | 10 | 99833993 | 99833994 | Human |
597213019 | GWAS1309093_H | autoimmune disease QTL GWAS1309093 (human) | | 4e-15 | autoimmune disease | | 10 | 79285523 | 79285524 | Human |
597024598 | GWAS1120672_H | insulin measurement, glucose tolerance test QTL GWAS1120672 (human) | | 0.0000005 | insulin measurement, glucose tolerance test | pancreatic islet insulin release measurement (CMO:0001216) | 10 | 92705802 | 92705803 | Human |
597368671 | GWAS1464745_H | waist-hip ratio QTL GWAS1464745 (human) | | 2e-10 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 79012834 | 79012835 | Human |
597335902 | GWAS1431976_H | trait in response to triamcinolone acetonide, ocular hypertension QTL GWAS1431976 (human) | | 7e-13 | trait in response to triamcinolone acetonide, ocular hypertension | | 10 | 89743821 | 89743822 | Human |
597040978 | GWAS1137052_H | appendicular lean mass QTL GWAS1137052 (human) | | 5e-12 | appendicular lean mass | | 10 | 94409498 | 94409499 | Human |
596959056 | GWAS1078575_H | response to warfarin QTL GWAS1078575 (human) | | 0.000005 | response to warfarin | | 10 | 94580575 | 94580576 | Human |
597335901 | GWAS1431975_H | trait in response to triamcinolone acetonide, ocular hypertension QTL GWAS1431975 (human) | | 0.0000006 | trait in response to triamcinolone acetonide, ocular hypertension | | 10 | 88752562 | 88752563 | Human |
597516117 | GWAS1612191_H | mitochondrial DNA measurement QTL GWAS1612191 (human) | | 2e-14 | mitochondrial DNA measurement | | 10 | 100889008 | 100889009 | Human |
596983647 | GWAS1103166_H | telomere length QTL GWAS1103166 (human) | | 2e-24 | telomere length | | 10 | 102177487 | 102177488 | Human |
597376855 | GWAS1472929_H | erythrocyte count QTL GWAS1472929 (human) | | 1e-10 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 87203281 | 87203282 | Human |
597253973 | GWAS1350047_H | aspartate aminotransferase measurement QTL GWAS1350047 (human) | | 2e-13 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99692460 | 99692461 | Human |
597032793 | GWAS1128867_H | pulse pressure measurement QTL GWAS1128867 (human) | | 2e-10 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 102119174 | 102119175 | Human |
597376854 | GWAS1472928_H | erythrocyte count QTL GWAS1472928 (human) | | 7e-18 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 79045259 | 79045260 | Human |
597253974 | GWAS1350048_H | aspartate aminotransferase measurement QTL GWAS1350048 (human) | | 4e-13 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 100006605 | 100006606 | Human |
597581649 | GWAS1638509_H | hypertension, Antihypertensive use measurement QTL GWAS1638509 (human) | | 2e-17 | hypertension, Antihypertensive use measurement | | 10 | 103086421 | 103086422 | Human |
597278537 | GWAS1374611_H | electrocardiography QTL GWAS1374611 (human) | | 4e-09 | electrocardiography | | 10 | 79139212 | 79139213 | Human |
596950852 | GWAS1070371_H | Red cell distribution width QTL GWAS1070371 (human) | | 2e-15 | Red cell distribution width | | 10 | 102875591 | 102875592 | Human |
597278539 | GWAS1374613_H | electrocardiography QTL GWAS1374613 (human) | | 5e-09 | electrocardiography | | 10 | 79139212 | 79139213 | Human |
597278538 | GWAS1374612_H | electrocardiography QTL GWAS1374612 (human) | | 3e-08 | electrocardiography | | 10 | 79139212 | 79139213 | Human |
597417807 | GWAS1513881_H | heel bone mineral density QTL GWAS1513881 (human) | | 3e-10 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 100130207 | 100130208 | Human |
596950849 | GWAS1070368_H | Red cell distribution width QTL GWAS1070368 (human) | | 1e-20 | Red cell distribution width | | 10 | 79041217 | 79041218 | Human |
597278540 | GWAS1374614_H | electrocardiography QTL GWAS1374614 (human) | | 2e-08 | electrocardiography | | 10 | 79139212 | 79139213 | Human |
597417806 | GWAS1513880_H | heel bone mineral density QTL GWAS1513880 (human) | | 8e-15 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 93199149 | 93199150 | Human |
597393230 | GWAS1489304_H | total cortical area measurement QTL GWAS1489304 (human) | | 2e-09 | cerebral cortex morphology trait (VT:0000788) | | 10 | 103253237 | 103253238 | Human |
596950850 | GWAS1070369_H | Red cell distribution width QTL GWAS1070369 (human) | | 3e-38 | Red cell distribution width | | 10 | 94545747 | 94545748 | Human |
597131072 | GWAS1227146_H | insulin measurement QTL GWAS1227146 (human) | | 0.000007 | insulin measurement | pancreatic islet insulin release measurement (CMO:0001216) | 10 | 80671657 | 80671658 | Human |
596967235 | GWAS1086754_H | lean body mass QTL GWAS1086754 (human) | | 4e-21 | lean body mass | | 10 | 94278929 | 94278930 | Human |
596950851 | GWAS1070370_H | Red cell distribution width QTL GWAS1070370 (human) | | 5e-18 | Red cell distribution width | | 10 | 100315722 | 100315723 | Human |
597106496 | GWAS1202570_H | systemic lupus erythematosus QTL GWAS1202570 (human) | | 6e-08 | systemic lupus erythematosus | | 10 | 102203640 | 102203641 | Human |
597163855 | GWAS1259929_H | coronary artery disease, factor VII measurement QTL GWAS1259929 (human) | | 3e-10 | coronary artery disease, factor VII measurement | | 10 | 80482174 | 80482175 | Human |
597286721 | GWAS1382795_H | pulse pressure measurement QTL GWAS1382795 (human) | | 4e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 87962505 | 87962506 | Human |
597286722 | GWAS1382796_H | pulse pressure measurement QTL GWAS1382796 (human) | | 7e-17 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 94253193 | 94253194 | Human |
597221189 | GWAS1317263_H | cataract QTL GWAS1317263 (human) | | 6e-09 | cataract | | 10 | 99888212 | 99888213 | Human |
597221190 | GWAS1317264_H | cataract QTL GWAS1317264 (human) | | 4e-08 | cataract | | 10 | 94279840 | 94279841 | Human |
597139273 | GWAS1235347_H | neuroimaging measurement QTL GWAS1235347 (human) | | 3e-17 | neuroimaging measurement | | 10 | 102479343 | 102479344 | Human |
596950900 | GWAS1070419_H | Red cell distribution width QTL GWAS1070419 (human) | | 9e-16 | Red cell distribution width | | 10 | 100315722 | 100315723 | Human |
597073783 | GWAS1169857_H | coronary artery disease QTL GWAS1169857 (human) | | 2e-21 | coronary artery disease | | 10 | 89243170 | 89243171 | Human |
597024625 | GWAS1120699_H | type 2 diabetes mellitus QTL GWAS1120699 (human) | | 0.0000006 | type 2 diabetes mellitus | | 10 | 79182874 | 79182875 | Human |
597401470 | GWAS1497544_H | schizophrenia QTL GWAS1497544 (human) | | 0.000001 | schizophrenia | | 10 | 103213560 | 103213561 | Human |
596950898 | GWAS1070417_H | Red cell distribution width QTL GWAS1070417 (human) | | 3e-36 | Red cell distribution width | | 10 | 94593444 | 94593445 | Human |
597294975 | GWAS1391049_H | proline measurement QTL GWAS1391049 (human) | | 4e-10 | proline measurement | blood amino acid measurement (CMO:0003730) | 10 | 95666329 | 95666330 | Human |
597254014 | GWAS1350088_H | serum alanine aminotransferase measurement QTL GWAS1350088 (human) | | 1e-37 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 77897947 | 77897948 | Human |
596950899 | GWAS1070418_H | Red cell distribution width QTL GWAS1070418 (human) | | 9e-14 | Red cell distribution width | | 10 | 99499704 | 99499705 | Human |
597581689 | GWAS1638549_H | chloride measurement QTL GWAS1638549 (human) | | 6e-13 | chloride measurement | blood chloride level (CMO:0000497) | 10 | 102716535 | 102716536 | Human |
597221232 | GWAS1317306_H | bilirubin measurement QTL GWAS1317306 (human) | | 1e-10 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 10 | 92742487 | 92742488 | Human |
597589876 | GWAS1646736_H | diabetic neuropathy QTL GWAS1646736 (human) | | 6e-12 | diabetic neuropathy | | 10 | 79193636 | 79193637 | Human |
597237619 | GWAS1333693_H | neutrophil count QTL GWAS1333693 (human) | | 3e-38 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 97324669 | 97324670 | Human |
597270387 | GWAS1366461_H | pulse pressure measurement QTL GWAS1366461 (human) | | 4e-26 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 103192742 | 103192743 | Human |
597172083 | GWAS1268157_H | body mass index QTL GWAS1268157 (human) | | 1e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 85731093 | 85731094 | Human |
597589877 | GWAS1646737_H | diabetic neuropathy QTL GWAS1646737 (human) | | 2e-23 | diabetic neuropathy | | 10 | 92670740 | 92670741 | Human |
597270386 | GWAS1366460_H | pulse pressure measurement QTL GWAS1366460 (human) | | 1e-26 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 102922845 | 102922846 | Human |
597172084 | GWAS1268158_H | body mass index QTL GWAS1268158 (human) | | 5e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 92051115 | 92051116 | Human |
597262197 | GWAS1358271_H | high density lipoprotein cholesterol measurement QTL GWAS1358271 (human) | | 2e-22 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 100152437 | 100152438 | Human |
597262196 | GWAS1358270_H | high density lipoprotein cholesterol measurement QTL GWAS1358270 (human) | | 9e-19 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93581054 | 93581055 | Human |
597172085 | GWAS1268159_H | body mass index QTL GWAS1268159 (human) | | 5e-19 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98024795 | 98024796 | Human |
407053491 | GWAS702467_H | tri-iodothyronine/thyroxine ratio measurement QTL GWAS702467 (human) | | 0.0000004 | tri-iodothyronine/thyroxine ratio measurement | blood triiodothyronine to thyroxine ratio (CMO:0001361) | 10 | 79198872 | 79198873 | Human |
597245801 | GWAS1341875_H | IGF-1 measurement QTL GWAS1341875 (human) | | 2e-12 | IGF-1 measurement | blood insulin-like growth factor 1 level (CMO:0001297) | 10 | 93082720 | 93082721 | Human |
597114726 | GWAS1210800_H | protein measurement QTL GWAS1210800 (human) | | 2e-08 | protein measurement | | 10 | 79124449 | 79124450 | Human |
597139300 | GWAS1235374_H | Inguinal hernia QTL GWAS1235374 (human) | | 2e-09 | Inguinal hernia | | 10 | 94067138 | 94067139 | Human |
597057378 | GWAS1153452_H | intelligence QTL GWAS1153452 (human) | | 0.000001 | intelligence | | 10 | 99832865 | 99832866 | Human |
597385069 | GWAS1481143_H | cortical thickness, neuroimaging measurement QTL GWAS1481143 (human) | | 6e-09 | cortical thickness, neuroimaging measurement | | 10 | 103200707 | 103200708 | Human |
597368684 | GWAS1464758_H | triglyceride measurement QTL GWAS1464758 (human) | | 2e-18 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079967 | 93079968 | Human |
597368673 | GWAS1464747_H | waist-hip ratio QTL GWAS1464747 (human) | | 3e-09 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 102643553 | 102643554 | Human |
597368672 | GWAS1464746_H | waist-hip ratio QTL GWAS1464746 (human) | | 3e-09 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 87849022 | 87849023 | Human |
406971578 | GWAS620554_H | neutrophil count QTL GWAS620554 (human) | | 7e-09 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 89245159 | 89245160 | Human |
597221220 | GWAS1317294_H | bilirubin measurement QTL GWAS1317294 (human) | | 7e-11 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 10 | 99692460 | 99692461 | Human |
597327719 | GWAS1423793_H | sexual dimorphism measurement QTL GWAS1423793 (human) | | 1e-09 | sexual dimorphism measurement | | 10 | 102518519 | 102518520 | Human |
596950891 | GWAS1070410_H | Red cell distribution width QTL GWAS1070410 (human) | | 1e-18 | Red cell distribution width | | 10 | 79040331 | 79040332 | Human |
597212825 | GWAS1308899_H | type 2 diabetes mellitus QTL GWAS1308899 (human) | | 7e-12 | type 2 diabetes mellitus | | 10 | 88275897 | 88275898 | Human |
597253784 | GWAS1349858_H | serum alanine aminotransferase measurement QTL GWAS1349858 (human) | | 3e-12 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 97326875 | 97326876 | Human |
597253787 | GWAS1349861_H | serum alanine aminotransferase measurement QTL GWAS1349861 (human) | | 2e-11 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 88047609 | 88047610 | Human |
597180058 | GWAS1276132_H | low affinity immunoglobulin gamma Fc region receptor III-B measurement QTL GWAS1276132 (human) | | 1e-12 | low affinity immunoglobulin gamma Fc region receptor III-B measurement | | 10 | 92682235 | 92682236 | Human |
597474968 | GWAS1571042_H | cognitive function measurement, self reported educational attainment QTL GWAS1571042 (human) | | 6e-10 | cognitive behavior trait (VT:0010450) | | 10 | 91590110 | 91590111 | Human |
597098128 | GWAS1194202_H | creatine kinase measurement, protein measurement QTL GWAS1194202 (human) | | 4e-08 | creatine kinase measurement, protein measurement | blood creatine kinase activity level (CMO:0002242) | 10 | 100068504 | 100068505 | Human |
597294737 | GWAS1390811_H | migraine disorder QTL GWAS1390811 (human) | | 7e-16 | migraine disorder | | 10 | 98942980 | 98942981 | Human |
407209292 | GWAS858268_H | Calcium channel blocker use measurement QTL GWAS858268 (human) | | 6e-15 | pulse pressure measurement | | 10 | 94278929 | 94278930 | Human |
597294736 | GWAS1390810_H | migraine disorder QTL GWAS1390810 (human) | | 3e-26 | migraine disorder | | 10 | 94279840 | 94279841 | Human |
597253779 | GWAS1349853_H | serum alanine aminotransferase measurement QTL GWAS1349853 (human) | | 4e-14 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 96706525 | 96706526 | Human |
597581460 | GWAS1638320_H | chloride measurement QTL GWAS1638320 (human) | | 1e-13 | chloride measurement | blood chloride level (CMO:0000497) | 10 | 102725042 | 102725043 | Human |
597483159 | GWAS1579233_H | blood protein measurement QTL GWAS1579233 (human) | | 4e-82 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95848357 | 95848358 | Human |
597294738 | GWAS1390812_H | migraine disorder QTL GWAS1390812 (human) | | 7e-10 | migraine disorder | | 10 | 102981357 | 102981358 | Human |
597474962 | GWAS1571036_H | blood protein measurement QTL GWAS1571036 (human) | | 1e-14 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 100130207 | 100130208 | Human |
597589646 | GWAS1646506_H | hypothyroidism QTL GWAS1646506 (human) | | 5e-20 | hypothyroidism | | 10 | 99523573 | 99523574 | Human |
597114503 | GWAS1210577_H | protein measurement QTL GWAS1210577 (human) | | 6e-10 | protein measurement | | 10 | 100742278 | 100742279 | Human |
597073540 | GWAS1169614_H | coronary artery disease QTL GWAS1169614 (human) | | 0.000004 | coronary artery disease | | 10 | 93012138 | 93012139 | Human |
597409416 | GWAS1505490_H | triglyceride measurement QTL GWAS1505490 (human) | | 3e-08 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 79336314 | 79336315 | Human |
597589645 | GWAS1646505_H | hypothyroidism QTL GWAS1646505 (human) | | 2e-12 | hypothyroidism | | 10 | 88089762 | 88089763 | Human |
597073541 | GWAS1169615_H | coronary artery disease QTL GWAS1169615 (human) | | 0.000002 | coronary artery disease | | 10 | 93996743 | 93996744 | Human |
597474952 | GWAS1571026_H | blood protein measurement QTL GWAS1571026 (human) | | 8e-14 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 100130207 | 100130208 | Human |
597433994 | GWAS1530068_H | protein measurement QTL GWAS1530068 (human) | | 4e-09 | protein measurement | | 10 | 79334494 | 79334495 | Human |
597433995 | GWAS1530069_H | protein measurement QTL GWAS1530069 (human) | | 1e-11 | protein measurement | | 10 | 88793093 | 88793094 | Human |
597032589 | GWAS1128663_H | high density lipoprotein cholesterol measurement QTL GWAS1128663 (human) | | 5e-08 | free androgen index | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079885 | 93079886 | Human |
597384838 | GWAS1480912_H | age at menopause QTL GWAS1480912 (human) | | 3e-17 | age at menopause | | 10 | 96070326 | 96070327 | Human |
597474946 | GWAS1571020_H | self reported educational attainment QTL GWAS1571020 (human) | | 2e-08 | self reported educational attainment | | 10 | 102853598 | 102853599 | Human |
597450428 | GWAS1546502_H | insomnia, total blood protein measurement QTL GWAS1546502 (human) | | 1e-09 | insomnia, total blood protein measurement | blood protein measurement (CMO:0000028) | 10 | 90361580 | 90361581 | Human |
597450429 | GWAS1546503_H | insomnia, total blood protein measurement QTL GWAS1546503 (human) | | 9e-10 | insomnia, total blood protein measurement | blood protein measurement (CMO:0000028) | 10 | 90376055 | 90376056 | Human |
597180090 | GWAS1276164_H | body mass index QTL GWAS1276164 (human) | | 3e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 79283615 | 79283616 | Human |
597450430 | GWAS1546504_H | insomnia, total blood protein measurement QTL GWAS1546504 (human) | | 9e-10 | insomnia, total blood protein measurement | blood protein measurement (CMO:0000028) | 10 | 90382480 | 90382481 | Human |
406971747 | GWAS620723_H | femoral neck bone mineral density QTL GWAS620723 (human) | | 0.000005 | bone mineralization trait (VT:0002896) | bone mineral density (CMO:0001226) | 10 | 98458051 | 98458052 | Human |
597180091 | GWAS1276165_H | body mass index QTL GWAS1276165 (human) | | 3e-24 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 85651147 | 85651148 | Human |
597450431 | GWAS1546505_H | insomnia, total blood protein measurement QTL GWAS1546505 (human) | | 4e-08 | insomnia, total blood protein measurement | blood protein measurement (CMO:0000028) | 10 | 100346031 | 100346032 | Human |
597262013 | GWAS1358087_H | amino acid measurement QTL GWAS1358087 (human) | | 0.000005 | amino acid measurement | | 10 | 81493888 | 81493889 | Human |
597180092 | GWAS1276166_H | body mass index QTL GWAS1276166 (human) | | 2e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 85843694 | 85843695 | Human |
407045479 | GWAS694455_H | femoral neck bone mineral density QTL GWAS694455 (human) | | 9e-10 | bone mineralization trait (VT:0002896) | bone mineral density (CMO:0001226) | 10 | 100054045 | 100054046 | Human |
597180093 | GWAS1276167_H | body mass index QTL GWAS1276167 (human) | | 2e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 86336290 | 86336291 | Human |
597180094 | GWAS1276168_H | body mass index QTL GWAS1276168 (human) | | 3e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 91273186 | 91273187 | Human |
597597880 | GWAS1654740_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1654740 (human) | | 5e-67 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 10 | 100152307 | 100152308 | Human |
597450427 | GWAS1546501_H | insomnia, total blood protein measurement QTL GWAS1546501 (human) | | 9e-09 | insomnia, total blood protein measurement | blood protein measurement (CMO:0000028) | 10 | 90349570 | 90349571 | Human |
597180095 | GWAS1276169_H | body mass index QTL GWAS1276169 (human) | | 9e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 92725454 | 92725455 | Human |
597049009 | GWAS1145083_H | allergic rhinitis QTL GWAS1145083 (human) | | 5e-18 | allergic rhinitis | | 10 | 102469300 | 102469302 | Human |
597073595 | GWAS1169669_H | coronary artery disease QTL GWAS1169669 (human) | | 0.000003 | coronary artery disease | | 10 | 100315722 | 100315723 | Human |
597311156 | GWAS1407230_H | vaginal microbiome measurement QTL GWAS1407230 (human) | | 0.000007 | vaginal microbiome measurement | | 10 | 89422096 | 89422097 | Human |
597434029 | GWAS1530103_H | protein measurement QTL GWAS1530103 (human) | | 2e-56 | protein measurement | | 10 | 97805095 | 97805096 | Human |
597335725 | GWAS1431799_H | episodic memory QTL GWAS1431799 (human) | | 0.0000003 | episodic memory | | 10 | 84982256 | 84982257 | Human |
597466788 | GWAS1562862_H | colorectal cancer QTL GWAS1562862 (human) | | 0.000007 | colorectal cancer | | 10 | 79059375 | 79059376 | Human |
597049004 | GWAS1145078_H | intraocular pressure measurement QTL GWAS1145078 (human) | | 1e-09 | intraocular pressure measurement | | 10 | 80411803 | 80411804 | Human |
597614244 | GWAS1671104_H | potassium measurement QTL GWAS1671104 (human) | | 4e-14 | potassium measurement | blood potassium level (CMO:0000496) | 10 | 92672243 | 92672244 | Human |
597049005 | GWAS1145079_H | intraocular pressure measurement QTL GWAS1145079 (human) | | 2e-09 | intraocular pressure measurement | | 10 | 92670768 | 92670769 | Human |
407127423 | GWAS776399_H | type 2 diabetes mellitus QTL GWAS776399 (human) | | 6e-10 | type 2 diabetes mellitus | | 10 | 92703125 | 92703126 | Human |
597040813 | GWAS1136887_H | low density lipoprotein cholesterol measurement QTL GWAS1136887 (human) | | 6e-32 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 93079885 | 93079886 | Human |
596967124 | GWAS1086643_H | migraine disorder QTL GWAS1086643 (human) | | 1e-14 | electrocardiography | | 10 | 94278929 | 94278930 | Human |
596967125 | GWAS1086644_H | cervical artery dissection QTL GWAS1086644 (human) | | 2e-11 | cervical artery dissection | | 10 | 94278929 | 94278930 | Human |
597393113 | GWAS1489187_H | adolescent idiopathic scoliosis QTL GWAS1489187 (human) | | 0.0000001 | adolescent idiopathic scoliosis | | 10 | 78043832 | 78043833 | Human |
407020801 | GWAS669777_H | protein measurement QTL GWAS669777 (human) | | 0.000006 | protein measurement | | 10 | 89012072 | 89012073 | Human |
597049045 | GWAS1145119_H | intraocular pressure measurement QTL GWAS1145119 (human) | | 4e-11 | intraocular pressure measurement | | 10 | 93285032 | 93285033 | Human |
597139156 | GWAS1235230_H | thymol sulfate measurement QTL GWAS1235230 (human) | | 6e-17 | thymol sulfate measurement | | 10 | 94802231 | 94802232 | Human |
597057246 | GWAS1153320_H | adolescent idiopathic scoliosis QTL GWAS1153320 (human) | | 3e-42 | adolescent idiopathic scoliosis | | 10 | 88749723 | 88749724 | Human |
597024476 | GWAS1120550_H | type 2 diabetes mellitus QTL GWAS1120550 (human) | | 5e-12 | type 2 diabetes mellitus | | 10 | 92703125 | 92703126 | Human |
597597911 | GWAS1654771_H | serum alanine aminotransferase measurement QTL GWAS1654771 (human) | | 6e-15 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 96710097 | 96710098 | Human |
597098207 | GWAS1194281_H | sex hormone-binding globulin measurement QTL GWAS1194281 (human) | | 1e-17 | sex hormone-binding globulin measurement | | 10 | 100157116 | 100157117 | Human |
597368529 | GWAS1464603_H | risk-taking behaviour QTL GWAS1464603 (human) | | 1e-15 | risk-taking behaviour | | 10 | 102880295 | 102880296 | Human |
597499600 | GWAS1595674_H | protein measurement QTL GWAS1595674 (human) | | 3e-32 | protein measurement | | 10 | 100130207 | 100130208 | Human |
597237462 | GWAS1333536_H | C-reactive protein measurement QTL GWAS1333536 (human) | | 3e-35 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 89251701 | 89251702 | Human |
597491405 | GWAS1587479_H | triglyceride measurement QTL GWAS1587479 (human) | | 3e-09 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93079967 | 93079968 | Human |
597278410 | GWAS1374484_H | asthma exacerbation measurement QTL GWAS1374484 (human) | | 0.000005 | asthma exacerbation measurement | | 10 | 89616542 | 89616543 | Human |
406938901 | GWAS587877_H | hemoglobin measurement QTL GWAS587877 (human) | | 3e-15 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 87182813 | 87182814 | Human |
597188300 | GWAS1284374_H | 1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) measurement QTL GWAS1284374 (human) | | 2e-18 | glycerophosphocholine amount (VT:0011004) | | 10 | 100315722 | 100315723 | Human |
406938900 | GWAS587876_H | hemoglobin measurement QTL GWAS587876 (human) | | 3e-11 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 80404334 | 80404335 | Human |
406938903 | GWAS587879_H | hemoglobin measurement QTL GWAS587879 (human) | | 5e-12 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 91277652 | 91277653 | Human |
406938902 | GWAS587878_H | hemoglobin measurement QTL GWAS587878 (human) | | 3e-12 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 88536710 | 88536711 | Human |
597450443 | GWAS1546517_H | total cholesterol measurement QTL GWAS1546517 (human) | | 2e-11 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 93072371 | 93072372 | Human |
597089985 | GWAS1186059_H | serum metabolite measurement QTL GWAS1186059 (human) | | 1e-11 | serum metabolite measurement | | 10 | 95062526 | 95062527 | Human |
597483211 | GWAS1579285_H | blood protein measurement QTL GWAS1579285 (human) | | 1e-10 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 95799770 | 95799771 | Human |
597024461 | GWAS1120535_H | high density lipoprotein cholesterol measurement QTL GWAS1120535 (human) | | 5e-11 | blood lipid amount (VT:0003949) | blood triglyceride level (CMO:0000118) | 10 | 93079885 | 93079886 | Human |
597180096 | GWAS1276170_H | body mass index QTL GWAS1276170 (human) | | 4e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 95384069 | 95384070 | Human |
406938904 | GWAS587880_H | hemoglobin measurement QTL GWAS587880 (human) | | 4e-11 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 95240116 | 95240117 | Human |
597180098 | GWAS1276172_H | body mass index QTL GWAS1276172 (human) | | 7e-20 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98009631 | 98009632 | Human |
597024462 | GWAS1120536_H | high density lipoprotein cholesterol measurement QTL GWAS1120536 (human) | | 2e-13 | triglyceride measurement, high density lipoprotein cholesterol measurement | blood triglyceride level (CMO:0000118) | 10 | 93079885 | 93079886 | Human |
597442247 | GWAS1538321_H | lipid measurement, high density lipoprotein cholesterol measurement QTL GWAS1538321 (human) | | 5e-12 | lipid measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079967 | 93079968 | Human |
597180099 | GWAS1276173_H | body mass index QTL GWAS1276173 (human) | | 2e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98198523 | 98198524 | Human |
597180100 | GWAS1276174_H | body mass index QTL GWAS1276174 (human) | | 3e-29 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98257696 | 98257697 | Human |
597262022 | GWAS1358096_H | amino acid measurement QTL GWAS1358096 (human) | | 0.000005 | amino acid measurement | | 10 | 91826240 | 91826241 | Human |
597262073 | GWAS1358147_H | esophageal squamous cell carcinoma QTL GWAS1358147 (human) | | 1e-08 | esophageal squamous cell carcinoma | | 10 | 94305937 | 94305938 | Human |
597139191 | GWAS1235265_H | smoking initiation QTL GWAS1235265 (human) | | 1e-64 | smoking initiation | | 10 | 103035652 | 103035653 | Human |
596950773 | GWAS1070292_H | triglyceride measurement QTL GWAS1070292 (human) | | 0.000003 | triglyceride measurement | | 10 | 94279840 | 94279841 | Human |
597139190 | GWAS1235264_H | smoking initiation QTL GWAS1235264 (human) | | 1e-64 | smoking initiation | | 10 | 103033478 | 103033479 | Human |
597442302 | GWAS1538376_H | amino acid measurement QTL GWAS1538376 (human) | | 0.000008 | amino acid measurement | | 10 | 93061103 | 93061104 | Human |
597139189 | GWAS1235263_H | smoking initiation QTL GWAS1235263 (human) | | 5e-37 | smoking initiation | | 10 | 103031838 | 103031839 | Human |
597139188 | GWAS1235262_H | smoking initiation QTL GWAS1235262 (human) | | 1e-64 | smoking initiation | | 10 | 103031242 | 103031243 | Human |
597303038 | GWAS1399112_H | t-tau measurement QTL GWAS1399112 (human) | | 0.0000003 | t-tau measurement | | 10 | 90708933 | 90708934 | Human |
406971685 | GWAS620661_H | monocyte count QTL GWAS620661 (human) | | 1e-27 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 97384397 | 97384398 | Human |
597139187 | GWAS1235261_H | smoking initiation QTL GWAS1235261 (human) | | 6e-16 | smoking initiation | | 10 | 98034108 | 98034109 | Human |
597139186 | GWAS1235260_H | smoking initiation QTL GWAS1235260 (human) | | 2e-13 | smoking initiation | | 10 | 96119877 | 96119878 | Human |
406971684 | GWAS620660_H | monocyte count QTL GWAS620660 (human) | | 8e-43 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 97312750 | 97312751 | Human |
597139185 | GWAS1235259_H | smoking initiation QTL GWAS1235259 (human) | | 6e-17 | smoking initiation | | 10 | 92048385 | 92048386 | Human |
597581560 | GWAS1638420_H | chloride measurement QTL GWAS1638420 (human) | | 4e-18 | chloride measurement | blood chloride level (CMO:0000497) | 10 | 102716535 | 102716536 | Human |
597139184 | GWAS1235258_H | smoking initiation QTL GWAS1235258 (human) | | 7e-26 | smoking initiation | | 10 | 91994786 | 91994787 | Human |
597081855 | GWAS1177929_H | monocyte count QTL GWAS1177929 (human) | | 4e-17 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 80489996 | 80489997 | Human |
597384946 | GWAS1481020_H | response to clopidogrel, cardiovascular event measurement QTL GWAS1481020 (human) | | 0.000004 | response to clopidogrel, cardiovascular event measurement | cardiovascular measurement (CMO:0000001) | 10 | 88793660 | 88793661 | Human |
597360371 | GWAS1456445_H | granulocyte percentage of myeloid white cells QTL GWAS1456445 (human) | | 4e-19 | granulocyte quantity (VT:0000334) | | 10 | 99532633 | 99532634 | Human |
597311216 | GWAS1407290_H | vaginal microbiome measurement QTL GWAS1407290 (human) | | 0.000006 | vaginal microbiome measurement | | 10 | 79099945 | 79099946 | Human |
597516017 | GWAS1612091_H | educational attainment QTL GWAS1612091 (human) | | 2e-08 | educational attainment | | 10 | 103231120 | 103231121 | Human |
597516016 | GWAS1612090_H | educational attainment QTL GWAS1612090 (human) | | 1e-28 | educational attainment | | 10 | 102911111 | 102911112 | Human |
597139192 | GWAS1235266_H | smoking initiation QTL GWAS1235266 (human) | | 1e-64 | smoking initiation | | 10 | 103036588 | 103036589 | Human |
597516018 | GWAS1612092_H | educational attainment QTL GWAS1612092 (human) | | 6e-16 | educational attainment | | 10 | 103270400 | 103270401 | Human |
406897968 | GWAS546944_H | esophageal squamous cell carcinoma QTL GWAS546944 (human) | | 4e-18 | esophageal squamous cell carcinoma | | 10 | 94306584 | 94306585 | Human |
597057254 | GWAS1153328_H | adolescent idiopathic scoliosis QTL GWAS1153328 (human) | | 2e-32 | adolescent idiopathic scoliosis | | 10 | 96499114 | 96499115 | Human |
597516013 | GWAS1612087_H | educational attainment QTL GWAS1612087 (human) | | 2e-08 | educational attainment | | 10 | 101201977 | 101201978 | Human |
597384938 | GWAS1481012_H | lymphocyte percentage of leukocytes QTL GWAS1481012 (human) | | 6e-14 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 10 | 88991152 | 88991153 | Human |
597188329 | GWAS1284403_H | N6-methyllysine measurement QTL GWAS1284403 (human) | | 7e-5400 | N6-methyllysine measurement | | 10 | 98388419 | 98388420 | Human |
597516012 | GWAS1612086_H | educational attainment QTL GWAS1612086 (human) | | 2e-10 | educational attainment | | 10 | 100264501 | 100264502 | Human |
597057252 | GWAS1153326_H | adolescent idiopathic scoliosis QTL GWAS1153326 (human) | | 2e-33 | adolescent idiopathic scoliosis | | 10 | 99365419 | 99365420 | Human |
597516015 | GWAS1612089_H | educational attainment QTL GWAS1612089 (human) | | 2e-11 | educational attainment | | 10 | 102433069 | 102433070 | Human |
597516014 | GWAS1612088_H | educational attainment QTL GWAS1612088 (human) | | 3e-08 | educational attainment | | 10 | 101236605 | 101236606 | Human |
597057250 | GWAS1153324_H | adolescent idiopathic scoliosis QTL GWAS1153324 (human) | | 1e-33 | adolescent idiopathic scoliosis | | 10 | 91953606 | 91953607 | Human |
407225651 | GWAS874627_H | triglyceride measurement QTL GWAS874627 (human) | | 2e-11 | triglyceride measurement, very low density lipoprotein cholesterol measurement | | 10 | 93079885 | 93079886 | Human |
597417708 | GWAS1513782_H | smoking status measurement, Cannabis use, schizophrenia QTL GWAS1513782 (human) | | 2e-08 | smoking status measurement, Cannabis use, schizophrenia | | 10 | 102653628 | 102653629 | Human |
597098222 | GWAS1194296_H | myocardial infarction QTL GWAS1194296 (human) | | 3e-13 | myocardial infarction | | 10 | 89243662 | 89243663 | Human |
597139183 | GWAS1235257_H | smoking initiation QTL GWAS1235257 (human) | | 3e-26 | smoking initiation | | 10 | 91978893 | 91978894 | Human |
597376738 | GWAS1472812_H | ulcerative colitis QTL GWAS1472812 (human) | | 1e-08 | ulcerative colitis | | 10 | 99531836 | 99531837 | Human |
597139181 | GWAS1235255_H | smoking initiation QTL GWAS1235255 (human) | | 4e-26 | smoking initiation | | 10 | 91978208 | 91978209 | Human |
597139180 | GWAS1235254_H | smoking initiation QTL GWAS1235254 (human) | | 4e-26 | smoking initiation | | 10 | 91975613 | 91975614 | Human |
597311201 | GWAS1407275_H | Vasodilators used in cardiac diseases use measurement QTL GWAS1407275 (human) | | 7e-10 | Vasodilators used in cardiac diseases use measurement | | 10 | 103069712 | 103069713 | Human |
597155563 | GWAS1251637_H | colorectal cancer QTL GWAS1251637 (human) | | 3e-09 | colorectal cancer | | 10 | 89745536 | 89745537 | Human |
597139179 | GWAS1235253_H | smoking initiation QTL GWAS1235253 (human) | | 3e-26 | smoking initiation | | 10 | 91971860 | 91971861 | Human |
597139178 | GWAS1235252_H | smoking initiation QTL GWAS1235252 (human) | | 2e-26 | smoking initiation | | 10 | 91967824 | 91967825 | Human |
406889790 | GWAS538766_H | cardiac hypertrophy QTL GWAS538766 (human) | | 0.000001 | cardiac hypertrophy | | 10 | 80939735 | 80939736 | Human |
597139177 | GWAS1235251_H | smoking initiation QTL GWAS1235251 (human) | | 4e-16 | smoking initiation | | 10 | 91662412 | 91662413 | Human |
406963519 | GWAS612495_H | clopidogrel metabolite measurement QTL GWAS612495 (human) | | 7e-13 | clopidogrel metabolite measurement | | 10 | 94462695 | 94462696 | Human |
597597920 | GWAS1654780_H | serum alanine aminotransferase measurement QTL GWAS1654780 (human) | | 3e-104 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100152437 | 100152438 | Human |
597605918 | GWAS1662778_H | hyperlipidemia QTL GWAS1662778 (human) | | 4e-15 | hyperlipidemia | | 10 | 93079967 | 93079968 | Human |
597032469 | GWAS1128543_H | risk-taking behaviour QTL GWAS1128543 (human) | | 7e-09 | risk-taking behaviour | | 10 | 102466184 | 102466185 | Human |
597499417 | GWAS1595491_H | systolic blood pressure QTL GWAS1595491 (human) | | 4e-15 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 94279951 | 94279952 | Human |
597065235 | GWAS1161309_H | type 1 diabetes mellitus QTL GWAS1161309 (human) | | 4e-15 | type 1 diabetes mellitus | | 10 | 88275897 | 88275898 | Human |
597229085 | GWAS1325159_H | asthma QTL GWAS1325159 (human) | | 1e-12 | asthma | | 10 | 92624756 | 92624761 | Human |
597327391 | GWAS1423465_H | vital capacity QTL GWAS1423465 (human) | | 5e-10 | vital capacity | | 10 | 93999648 | 93999649 | Human |
597466650 | GWAS1562724_H | blood protein measurement QTL GWAS1562724 (human) | | 4e-18 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 89010241 | 89010242 | Human |
597270047 | GWAS1366121_H | arginine measurement QTL GWAS1366121 (human) | | 3e-24 | arginine measurement | | 10 | 98416609 | 98416610 | Human |
597245457 | GWAS1341531_H | aspartate aminotransferase measurement QTL GWAS1341531 (human) | | 5e-20 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 100152307 | 100152308 | Human |
597220881 | GWAS1316955_H | corneal resistance factor QTL GWAS1316955 (human) | | 6e-10 | corneal resistance factor | | 10 | 93309579 | 93309580 | Human |
597106203 | GWAS1202277_H | sex hormone-binding globulin measurement QTL GWAS1202277 (human) | | 5e-16 | sex hormone-binding globulin measurement | | 10 | 79314368 | 79314369 | Human |
597491217 | GWAS1587291_H | breast density QTL GWAS1587291 (human) | | 0.0000005 | breast density | | 10 | 91383678 | 91383679 | Human |
597499411 | GWAS1595485_H | bilirubin measurement QTL GWAS1595485 (human) | | 2e-10 | bilirubin measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079967 | 93079968 | Human |
597040646 | GWAS1136720_H | gout QTL GWAS1136720 (human) | | 9e-11 | gout | | 10 | 87083452 | 87083453 | Human |
597384714 | GWAS1480788_H | monocyte percentage of leukocytes QTL GWAS1480788 (human) | | 3e-18 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 10 | 88097115 | 88097116 | Human |
597532169 | GWAS1628243_H | X-13553 measurement QTL GWAS1628243 (human) | | 2e-10 | X-13553 measurement | | 10 | 87613727 | 87613728 | Human |
597581323 | GWAS1638183_H | uric acid measurement QTL GWAS1638183 (human) | | 6e-11 | uric acid measurement | blood uric acid level (CMO:0000501) | 10 | 87201645 | 87201646 | Human |
597360143 | GWAS1456217_H | chronic lymphocytic leukemia QTL GWAS1456217 (human) | | 2e-08 | leukocyte integrity trait (VT:0010898) | | 10 | 88990206 | 88990207 | Human |
597237260 | GWAS1333334_H | vascular brain injury QTL GWAS1333334 (human) | | 3e-08 | vascular brain injury | | 10 | 97429204 | 97429205 | Human |
597491210 | GWAS1587284_H | breast density QTL GWAS1587284 (human) | | 0.0000002 | breast density | | 10 | 91533154 | 91533155 | Human |
597491211 | GWAS1587285_H | breast density QTL GWAS1587285 (human) | | 0.0000002 | breast density | | 10 | 91582293 | 91582294 | Human |
407127512 | GWAS776488_H | platelet crit QTL GWAS776488 (human) | | 1e-10 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 10 | 79404390 | 79404391 | Human |
597532160 | GWAS1628234_H | X-17325 measurement QTL GWAS1628234 (human) | | 3e-08 | X-17325 measurement | | 10 | 89883930 | 89883931 | Human |
597507587 | GWAS1603661_H | N6,N6-dimethyllysine measurement QTL GWAS1603661 (human) | | 2e-132 | N6,N6-dimethyllysine measurement | | 10 | 98383436 | 98383437 | Human |
597204486 | GWAS1300560_H | brain aneurysm QTL GWAS1300560 (human) | | 2e-14 | brain aneurysm | | 10 | 103192742 | 103192743 | Human |
597507586 | GWAS1603660_H | N6-methyllysine measurement QTL GWAS1603660 (human) | | 1e-205 | N6-methyllysine measurement | | 10 | 98373752 | 98373753 | Human |
597294648 | GWAS1390722_H | cardiac troponin I measurement QTL GWAS1390722 (human) | | 0.000002 | cardiac troponin I measurement | blood troponin level (CMO:0001283) | 10 | 83307819 | 83307820 | Human |
597163571 | GWAS1259645_H | angina pectoris QTL GWAS1259645 (human) | | 5e-15 | angina pectoris | | 10 | 102876519 | 102876520 | Human |
597261873 | GWAS1357947_H | mean arterial pressure QTL GWAS1357947 (human) | | 7e-12 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 103153896 | 103153897 | Human |
597024313 | GWAS1120387_H | breast carcinoma QTL GWAS1120387 (human) | | 2e-35 | mammary gland integrity trait (VT:0010552) | | 10 | 79081391 | 79081392 | Human |
597335607 | GWAS1431681_H | S-warfarin measurement QTL GWAS1431681 (human) | | 0.000009 | S-warfarin measurement | | 10 | 94808278 | 94808279 | Human |
597483052 | GWAS1579126_H | level of lipase member N in blood serum QTL GWAS1579126 (human) | | 1e-77 | level of lipase member N in blood serum | | 10 | 88766035 | 88766036 | Human |
597433900 | GWAS1529974_H | sex hormone-binding globulin measurement QTL GWAS1529974 (human) | | 9e-54 | sex hormone-binding globulin measurement | | 10 | 91869742 | 91869743 | Human |
597155366 | GWAS1251440_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1251440 (human) | | 2e-11 | triglyceride measurement, phospholipid measurement | blood triglyceride level (CMO:0000118) | 10 | 93082456 | 93082457 | Human |
597589544 | GWAS1646404_H | diabetic eye disease QTL GWAS1646404 (human) | | 1e-28 | diabetic eye disease | | 10 | 92709177 | 92709178 | Human |
597106208 | GWAS1202282_H | sex hormone-binding globulin measurement QTL GWAS1202282 (human) | | 8e-15 | sex hormone-binding globulin measurement | | 10 | 93079885 | 93079886 | Human |
597065263 | GWAS1161337_H | BMI-adjusted waist circumference, physical activity measurement QTL GWAS1161337 (human) | | 5e-08 | wellness/fitness trait (VT:1000152) | waist to hip ratio (WHR) (CMO:0000020) | 10 | 79147390 | 79147391 | Human |
597589543 | GWAS1646403_H | diabetic eye disease QTL GWAS1646403 (human) | | 5e-12 | diabetic eye disease | | 10 | 79189126 | 79189127 | Human |
597106216 | GWAS1202290_H | protein measurement QTL GWAS1202290 (human) | | 5e-09 | protein measurement | | 10 | 100742278 | 100742279 | Human |
597073495 | GWAS1169569_H | coronary artery disease QTL GWAS1169569 (human) | | 3e-22 | coronary artery disease | | 10 | 89243170 | 89243171 | Human |
597360216 | GWAS1456290_H | pulse pressure measurement QTL GWAS1456290 (human) | | 2e-09 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 88027518 | 88027519 | Human |
597188188 | GWAS1284262_H | decadienedioic acid (C10:2-DC) measurement QTL GWAS1284262 (human) | | 4e-22 | decadienedioic acid (C10:2-DC) measurement | | 10 | 100315722 | 100315723 | Human |
407307650 | GWAS956626_H | lean body mass QTL GWAS956626 (human) | | 4e-21 | lean body mass | | 10 | 94278929 | 94278930 | Human |
597360223 | GWAS1456297_H | migraine disorder QTL GWAS1456297 (human) | | 1e-09 | migraine disorder | | 10 | 94278929 | 94278930 | Human |
597188176 | GWAS1284250_H | X-21834 measurement QTL GWAS1284250 (human) | | 3e-14 | X-21834 measurement | | 10 | 94735990 | 94735991 | Human |
597188177 | GWAS1284251_H | X-21467 measurement QTL GWAS1284251 (human) | | 3e-51 | X-21467 measurement | | 10 | 99835096 | 99835097 | Human |
597392976 | GWAS1489050_H | triglyceride measurement QTL GWAS1489050 (human) | | 2e-08 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 79336314 | 79336315 | Human |
597188182 | GWAS1284256_H | N2-acetyl,N6-methyllysine measurement QTL GWAS1284256 (human) | | 1e-1468 | N2-acetyl,N6-methyllysine measurement | | 10 | 98388419 | 98388420 | Human |
597188183 | GWAS1284257_H | N2-acetyl,N6-methyllysine measurement QTL GWAS1284257 (human) | | 1e-172 | N2-acetyl,N6-methyllysine measurement | | 10 | 98399616 | 98399617 | Human |
597188170 | GWAS1284244_H | X-21470 measurement QTL GWAS1284244 (human) | | 1e-10 | X-21470 measurement | | 10 | 99861975 | 99861976 | Human |
597278283 | GWAS1374357_H | diet measurement QTL GWAS1374357 (human) | | 9e-10 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 102814179 | 102814180 | Human |
596975171 | GWAS1094690_H | BMI-adjusted waist-hip ratio QTL GWAS1094690 (human) | | 1e-12 | BMI-adjusted waist-hip ratio | | 10 | 87843667 | 87843668 | Human |
596966988 | GWAS1086507_H | systolic blood pressure QTL GWAS1086507 (human) | | 6e-10 | systolic blood pressure | | 10 | 87844975 | 87844976 | Human |
407127455 | GWAS776431_H | serum alanine aminotransferase measurement QTL GWAS776431 (human) | | 4e-09 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100035604 | 100035605 | Human |
597196357 | GWAS1292431_H | uric acid measurement QTL GWAS1292431 (human) | | 2e-26 | uric acid measurement | blood uric acid level (CMO:0000501) | 10 | 87107094 | 87107097 | Human |
407143834 | GWAS792810_H | phospholipid measurement QTL GWAS792810 (human) | | 6e-14 | phospholipid measurement | | 10 | 100315722 | 100315723 | Human |
597532280 | GWAS1628354_H | N6-methyllysine measurement QTL GWAS1628354 (human) | | 1e-186 | N6-methyllysine measurement | | 10 | 98413671 | 98413672 | Human |
597532279 | GWAS1628353_H | N6-methyllysine measurement QTL GWAS1628353 (human) | | 3e-193 | N6-methyllysine measurement | | 10 | 98382920 | 98382921 | Human |
597606005 | GWAS1662865_H | serum alanine aminotransferase measurement QTL GWAS1662865 (human) | | 1e-15 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100152307 | 100152308 | Human |
597343857 | GWAS1439931_H | opioid use disorder QTL GWAS1439931 (human) | | 3e-08 | conditioned place preference behavior trait (VT:0010723) | | 10 | 102320061 | 102320062 | Human |
597442162 | GWAS1538236_H | Alzheimer disease, educational attainment QTL GWAS1538236 (human) | | 3e-11 | Alzheimer disease, educational attainment | | 10 | 102230055 | 102230056 | Human |
597319274 | GWAS1415348_H | body surface area QTL GWAS1415348 (human) | | 9e-19 | body surface area | | 10 | 79376373 | 79376374 | Human |
596975205 | GWAS1094724_H | myocardial infarction QTL GWAS1094724 (human) | | 5e-08 | myocardial infarction | | 10 | 89246195 | 89246196 | Human |
597319275 | GWAS1415349_H | body surface area QTL GWAS1415349 (human) | | 1e-09 | body surface area | | 10 | 86270684 | 86270685 | Human |
597589615 | GWAS1646475_H | type 2 diabetes nephropathy QTL GWAS1646475 (human) | | 6e-18 | type 2 diabetes nephropathy | | 10 | 92711838 | 92711839 | Human |
597319273 | GWAS1415347_H | body surface area QTL GWAS1415347 (human) | | 6e-16 | body surface area | | 10 | 79164501 | 79164502 | Human |
597614186 | GWAS1671046_H | sodium measurement QTL GWAS1671046 (human) | | 3e-11 | sodium measurement | blood sodium level (CMO:0000499) | 10 | 95875759 | 95875760 | Human |
597614187 | GWAS1671047_H | sodium measurement QTL GWAS1671047 (human) | | 8e-20 | sodium measurement | blood sodium level (CMO:0000499) | 10 | 102813260 | 102813261 | Human |
597319276 | GWAS1415350_H | body surface area QTL GWAS1415350 (human) | | 3e-09 | body surface area | | 10 | 98015363 | 98015364 | Human |
597360236 | GWAS1456310_H | hypothyroidism QTL GWAS1456310 (human) | | 1e-10 | hypothyroidism | | 10 | 99523573 | 99523574 | Human |
597614185 | GWAS1671045_H | sodium measurement QTL GWAS1671045 (human) | | 4e-12 | sodium measurement | blood sodium level (CMO:0000499) | 10 | 92704188 | 92704189 | Human |
597319277 | GWAS1415351_H | body surface area QTL GWAS1415351 (human) | | 2e-23 | body surface area | | 10 | 100913306 | 100913307 | Human |
597474912 | GWAS1570986_H | Cleft palate, cleft lip QTL GWAS1570986 (human) | | 0.000004 | Cleft palate, cleft lip | | 10 | 101559441 | 101559442 | Human |
597343844 | GWAS1439918_H | carpal tunnel syndrome QTL GWAS1439918 (human) | | 7e-18 | carpal tunnel syndrome | | 10 | 98186463 | 98186464 | Human |
596950420 | GWAS1069939_H | protein measurement QTL GWAS1069939 (human) | | 2e-17 | protein measurement | | 10 | 100130207 | 100130208 | Human |
597613983 | GWAS1670843_H | sodium measurement QTL GWAS1670843 (human) | | 8e-17 | sodium measurement | blood sodium level (CMO:0000499) | 10 | 102814572 | 102814573 | Human |
597474719 | GWAS1570793_H | cytokine measurement QTL GWAS1570793 (human) | | 0.0000003 | cytokine measurement | blood cytokine measurement (CMO:0001924) | 10 | 86960032 | 86960033 | Human |
597368216 | GWAS1464290_H | pulse pressure measurement QTL GWAS1464290 (human) | | 4e-15 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 102641729 | 102641730 | Human |
597056915 | GWAS1152989_H | basophil count QTL GWAS1152989 (human) | | 2e-19 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 87896399 | 87896400 | Human |
597589400 | GWAS1646260_H | monocyte count QTL GWAS1646260 (human) | | 5e-45 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 99522443 | 99522444 | Human |
597589401 | GWAS1646261_H | monocyte count QTL GWAS1646261 (human) | | 4e-11 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 102639493 | 102639494 | Human |
597605782 | GWAS1662642_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1662642 (human) | | 1e-109 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 10 | 100164661 | 100164662 | Human |
597335443 | GWAS1431517_H | S-warfarin measurement QTL GWAS1431517 (human) | | 0.000004 | S-warfarin measurement | | 10 | 92897586 | 92897587 | Human |
597589399 | GWAS1646259_H | monocyte count QTL GWAS1646259 (human) | | 9e-56 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 97354207 | 97354208 | Human |
597466518 | GWAS1562592_H | feeling tense measurement QTL GWAS1562592 (human) | | 2e-09 | feeling tense measurement | | 10 | 102876898 | 102876899 | Human |
407029321 | GWAS678297_H | periodontitis QTL GWAS678297 (human) | | 0.000004 | periodontitis | | 10 | 85875167 | 85875168 | Human |
597081496 | GWAS1177570_H | gut microbiome measurement QTL GWAS1177570 (human) | | 0.0000002 | gut microbiome measurement | | 10 | 96468674 | 96468675 | Human |
407086675 | GWAS735651_H | spontaneous preterm birth QTL GWAS735651 (human) | | 0.000004 | spontaneous preterm birth | | 10 | 86301682 | 86301683 | Human |
597024134 | GWAS1120208_H | breast carcinoma QTL GWAS1120208 (human) | | 0.000003 | mammary gland integrity trait (VT:0010552) | | 10 | 92172529 | 92172530 | Human |
407217746 | GWAS866722_H | reticulocyte count QTL GWAS866722 (human) | | 6e-09 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 79397838 | 79397839 | Human |
597237134 | GWAS1333208_H | mitochondrial heteroplasmy measurement QTL GWAS1333208 (human) | | 3e-12 | mitochondrial heteroplasmy measurement | | 10 | 101004581 | 101004582 | Human |
597187970 | GWAS1284044_H | X-12544 measurement QTL GWAS1284044 (human) | | 8e-11 | X-12544 measurement | | 10 | 94814942 | 94814943 | Human |
597450119 | GWAS1546193_H | aspartate aminotransferase measurement QTL GWAS1546193 (human) | | 2e-31 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99486773 | 99486774 | Human |
597196165 | GWAS1292239_H | triglyceride measurement QTL GWAS1292239 (human) | | 5e-10 | urine albumin amount (VT:0002871) | urine albumin level to urine creatinine level ratio (CMO:0000384) | 10 | 93079885 | 93079886 | Human |
597376443 | GWAS1472517_H | PR interval QTL GWAS1472517 (human) | | 9e-31 | PR interval | PR interval (CMO:0000233) | 10 | 95628822 | 95628823 | Human |
597188025 | GWAS1284099_H | X-21471 measurement QTL GWAS1284099 (human) | | 2e-20 | X-21471 measurement | | 10 | 99787519 | 99787520 | Human |
597188026 | GWAS1284100_H | X-21471 measurement QTL GWAS1284100 (human) | | 4e-19 | X-21471 measurement | | 10 | 99830729 | 99830730 | Human |
597278139 | GWAS1374213_H | dimethylglycine measurement QTL GWAS1374213 (human) | | 1e-14 | dimethylglycine measurement | | 10 | 102727625 | 102727626 | Human |
597188029 | GWAS1284103_H | X-21471 measurement QTL GWAS1284103 (human) | | 4e-70 | X-21471 measurement | | 10 | 99844724 | 99844725 | Human |
596983229 | GWAS1102748_H | memory performance QTL GWAS1102748 (human) | | 0.000007 | memory performance | | 10 | 86585711 | 86585712 | Human |
597171636 | GWAS1267710_H | triglyceride measurement, phospholipid measurement QTL GWAS1267710 (human) | | 1e-09 | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 93083778 | 93083779 | Human |
407127657 | GWAS776633_H | diastolic blood pressure QTL GWAS776633 (human) | | 6e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 94136183 | 94136184 | Human |
597155258 | GWAS1251332_H | triglyceride measurement, diet measurement QTL GWAS1251332 (human) | | 0.000004 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 95615511 | 95615512 | Human |
596950438 | GWAS1069957_H | COVID-19 QTL GWAS1069957 (human) | | 0.000008 | COVID-19 | | 10 | 80555977 | 80555978 | Human |
597499311 | GWAS1595385_H | protein measurement QTL GWAS1595385 (human) | | 6e-22 | protein measurement | | 10 | 100130207 | 100130208 | Human |
597450159 | GWAS1546233_H | major depressive disorder QTL GWAS1546233 (human) | | 2e-10 | major depressive disorder | | 10 | 102660997 | 102660998 | Human |
597523883 | GWAS1619957_H | gallstones QTL GWAS1619957 (human) | | 5e-08 | gallstones | | 10 | 97339640 | 97339641 | Human |
597581222 | GWAS1638082_H | calcium measurement QTL GWAS1638082 (human) | | 4e-17 | calcium measurement | blood calcium level (CMO:0000502) | 10 | 79243389 | 79243390 | Human |
597613990 | GWAS1670850_H | sodium measurement QTL GWAS1670850 (human) | | 4e-12 | sodium measurement | blood sodium level (CMO:0000499) | 10 | 102813260 | 102813261 | Human |
597613989 | GWAS1670849_H | sodium measurement QTL GWAS1670849 (human) | | 2e-12 | sodium measurement | blood sodium level (CMO:0000499) | 10 | 92704188 | 92704189 | Human |
596975017 | GWAS1094536_H | 2-O-methylascorbic acid measurement, sex interaction measurement QTL GWAS1094536 (human) | | 0.000003 | 2-O-methylascorbic acid measurement, sex interaction measurement | | 10 | 96247971 | 96247972 | Human |
597261732 | GWAS1357806_H | serum metabolite measurement QTL GWAS1357806 (human) | | 0.000004 | serum metabolite measurement | | 10 | 84127298 | 84127299 | Human |
597040555 | GWAS1136629_H | gout QTL GWAS1136629 (human) | | 0.0000002 | gout | | 10 | 85911274 | 85911275 | Human |
597499299 | GWAS1595373_H | smoking status measurement QTL GWAS1595373 (human) | | 1e-08 | smoking status measurement | | 10 | 102653628 | 102653629 | Human |
597237208 | GWAS1333282_H | basophil count QTL GWAS1333282 (human) | | 4e-09 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 97334679 | 97334680 | Human |
407029249 | GWAS678225_H | Vitiligo QTL GWAS678225 (human) | | 0.0000008 | Vitiligo | | 10 | 79256139 | 79256140 | Human |
597040597 | GWAS1136671_H | gout QTL GWAS1136671 (human) | | 4e-17 | gout | | 10 | 87155350 | 87155351 | Human |
597269978 | GWAS1366052_H | metabolite measurement QTL GWAS1366052 (human) | | 3e-91 | metabolite measurement | | 10 | 98416582 | 98416583 | Human |
597335516 | GWAS1431590_H | COVID-19, mortality QTL GWAS1431590 (human) | | 0.000004 | COVID-19, mortality | ratio of deaths to total study population during a period of time (CMO:0001023) | 10 | 77718029 | 77718030 | Human |
597245407 | GWAS1341481_H | triglyceride measurement QTL GWAS1341481 (human) | | 0.000003 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 94279840 | 94279841 | Human |
597343690 | GWAS1439764_H | diverticular disease QTL GWAS1439764 (human) | | 3e-18 | diverticular disease | | 10 | 99635064 | 99635065 | Human |
597114311 | GWAS1210385_H | protein measurement QTL GWAS1210385 (human) | | 2e-09 | protein measurement | | 10 | 100742278 | 100742279 | Human |
597310922 | GWAS1406996_H | Calcium channel blocker use measurement QTL GWAS1406996 (human) | | 4e-25 | Calcium channel blocker use measurement | | 10 | 103169157 | 103169158 | Human |
597056967 | GWAS1153041_H | intelligence QTL GWAS1153041 (human) | | 3e-08 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 10 | 91682622 | 91682623 | Human |
597188042 | GWAS1284116_H | glycine conjugate of C10H14O2 (1) measurement QTL GWAS1284116 (human) | | 2e-35 | glycine conjugate of C10H14O2 (1) measurement | | 10 | 94700521 | 94700522 | Human |
597343688 | GWAS1439762_H | diverticular disease QTL GWAS1439762 (human) | | 5e-18 | diverticular disease | | 10 | 95581276 | 95581277 | Human |
597507534 | GWAS1603608_H | high density lipoprotein cholesterol measurement QTL GWAS1603608 (human) | | 8e-27 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93079967 | 93079968 | Human |
597343689 | GWAS1439763_H | diverticular disease QTL GWAS1439763 (human) | | 4e-17 | diverticular disease | | 10 | 95894054 | 95894055 | Human |
596966850 | GWAS1086369_H | diastolic blood pressure QTL GWAS1086369 (human) | | 7e-16 | diastolic blood pressure | | 10 | 94136959 | 94136960 | Human |
597474758 | GWAS1570832_H | heel bone mineral density QTL GWAS1570832 (human) | | 2e-12 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 79379378 | 79379379 | Human |
597499329 | GWAS1595403_H | diffuse large B-cell lymphoma, marginal zone B-cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia QTL GWAS1595403 (human) | | 0.000006 | leukocyte integrity trait (VT:0010898) | | 10 | 80702590 | 80702591 | Human |
597392839 | GWAS1488913_H | high density lipoprotein cholesterol measurement QTL GWAS1488913 (human) | | 2e-16 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 93549265 | 93549266 | Human |
597335495 | GWAS1431569_H | COVID-19 QTL GWAS1431569 (human) | | 0.000003 | COVID-19 | | 10 | 88136050 | 88136051 | Human |
597482945 | GWAS1579019_H | birth weight, parental genotype effect measurement QTL GWAS1579019 (human) | | 2e-09 | birth weight, parental genotype effect measurement | neonatal body weight (CMO:0002079) | 10 | 102441313 | 102441314 | Human |
407004700 | GWAS653676_H | neutrophil count QTL GWAS653676 (human) | | 7e-14 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 97315182 | 97315183 | Human |
597056968 | GWAS1153042_H | intelligence QTL GWAS1153042 (human) | | 5e-09 | cognitive behavior trait (VT:0010450) | blood triglyceride level (CMO:0000118) | 10 | 100152437 | 100152438 | Human |
597122505 | GWAS1218579_H | mitochondrial DNA measurement QTL GWAS1218579 (human) | | 7e-12 | mitochondrial DNA measurement | | 10 | 102578181 | 102578182 | Human |
597483004 | GWAS1579078_H | low density lipoprotein cholesterol measurement QTL GWAS1579078 (human) | | 3e-09 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 100233804 | 100233805 | Human |
597278205 | GWAS1374279_H | age-related macular degeneration, COVID-19 QTL GWAS1374279 (human) | | 3e-08 | age-related macular degeneration, COVID-19 | | 10 | 100049236 | 100049237 | Human |
596975088 | GWAS1094607_H | body height QTL GWAS1094607 (human) | | 5e-22 | body height | | 10 | 77792334 | 77792335 | Human |
407053867 | GWAS702843_H | eosinophil percentage of leukocytes QTL GWAS702843 (human) | | 5e-28 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 10 | 87938433 | 87938434 | Human |
597474804 | GWAS1570878_H | triglyceride measurement QTL GWAS1570878 (human) | | 5e-18 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93071756 | 93071757 | Human |
597106174 | GWAS1202248_H | testosterone measurement QTL GWAS1202248 (human) | | 6e-15 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 102863821 | 102863822 | Human |
597286386 | GWAS1382460_H | free cholesterol in very large VLDL measurement QTL GWAS1382460 (human) | | 3e-13 | free cholesterol in very large VLDL measurement | | 10 | 93083778 | 93083779 | Human |
597237225 | GWAS1333299_H | lymphocyte:monocyte ratio QTL GWAS1333299 (human) | | 1e-19 | leukocyte quantity (VT:0000217) | | 10 | 99533278 | 99533279 | Human |
597163491 | GWAS1259565_H | breast carcinoma QTL GWAS1259565 (human) | | 2e-11 | mammary gland integrity trait (VT:0010552) | | 10 | 79092621 | 79092622 | Human |
597237229 | GWAS1333303_H | lymphocyte:monocyte ratio QTL GWAS1333303 (human) | | 2e-16 | leukocyte quantity (VT:0000217) | | 10 | 96620380 | 96620381 | Human |
597040610 | GWAS1136684_H | low density lipoprotein cholesterol measurement QTL GWAS1136684 (human) | | 3e-11 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 100315722 | 100315723 | Human |
597138912 | GWAS1234986_H | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement QTL GWAS1234986 (human) | | 1e-75 | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | | 10 | 95035530 | 95035531 | Human |
407021109 | GWAS670085_H | systolic blood pressure QTL GWAS670085 (human) | | 4e-17 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 103086421 | 103086422 | Human |
597368290 | GWAS1464364_H | cup-to-disc ratio measurement QTL GWAS1464364 (human) | | 3e-11 | cup-to-disc ratio measurement | | 10 | 93190956 | 93190957 | Human |
597278176 | GWAS1374250_H | testosterone measurement QTL GWAS1374250 (human) | | 7e-09 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 100001413 | 100001414 | Human |
597376481 | GWAS1472555_H | reticulocyte measurement QTL GWAS1472555 (human) | | 2e-12 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 10 | 79045259 | 79045260 | Human |
597073389 | GWAS1169463_H | coronary artery disease QTL GWAS1169463 (human) | | 2e-11 | coronary artery disease | | 10 | 80491758 | 80491759 | Human |
597482976 | GWAS1579050_H | birth weight QTL GWAS1579050 (human) | | 2e-08 | birth weight | neonatal body weight (CMO:0002079) | 10 | 88253438 | 88253439 | Human |
597122539 | GWAS1218613_H | blood protein measurement QTL GWAS1218613 (human) | | 4e-15 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 89247603 | 89247604 | Human |
597310948 | GWAS1407022_H | Thyroid preparation use measurement QTL GWAS1407022 (human) | | 3e-09 | Thyroid preparation use measurement | | 10 | 88047374 | 88047375 | Human |
597286169 | GWAS1382243_H | hypertension QTL GWAS1382243 (human) | | 2e-18 | hypertension | | 10 | 94140247 | 94140248 | Human |
597286168 | GWAS1382242_H | hypertension QTL GWAS1382242 (human) | | 1e-20 | hypertension | | 10 | 103186066 | 103186067 | Human |
597286171 | GWAS1382245_H | hypertension QTL GWAS1382245 (human) | | 2e-12 | hypertension | | 10 | 94546848 | 94546849 | Human |
597138709 | GWAS1234783_H | 4-allylphenol sulfate measurement QTL GWAS1234783 (human) | | 6e-13 | 4-allylphenol sulfate measurement | | 10 | 94793996 | 94793997 | Human |
597097748 | GWAS1193822_H | testosterone measurement QTL GWAS1193822 (human) | | 8e-11 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 95067165 | 95067166 | Human |
407389899 | GWAS1038875_H | obsolete_red blood cell distribution width QTL GWAS1038875 (human) | | 2e-13 | obsolete_red blood cell distribution width | | 10 | 94423594 | 94423595 | Human |
597097747 | GWAS1193821_H | testosterone measurement QTL GWAS1193821 (human) | | 1e-08 | sex hormone-binding globulin measurement | serum testosterone level (CMO:0000568) | 10 | 79314368 | 79314369 | Human |
597605659 | GWAS1662519_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1662519 (human) | | 2e-63 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 10 | 99397681 | 99397682 | Human |
596966673 | GWAS1086192_H | diastolic blood pressure QTL GWAS1086192 (human) | | 1e-18 | diastolic blood pressure | | 10 | 100792995 | 100792996 | Human |
597286175 | GWAS1382249_H | hypertension QTL GWAS1382249 (human) | | 1e-08 | hypertension | | 10 | 93983330 | 93983331 | Human |
597171487 | GWAS1267561_H | protein measurement QTL GWAS1267561 (human) | | 1e-73 | protein measurement | | 10 | 80191879 | 80191880 | Human |
597286174 | GWAS1382248_H | hypertension QTL GWAS1382248 (human) | | 5e-09 | hypertension | | 10 | 80439507 | 80439508 | Human |
597138704 | GWAS1234778_H | 4-androsten-3beta,17beta-diol disulfate 1 measurement QTL GWAS1234778 (human) | | 3e-12 | 4-androsten-3beta,17beta-diol disulfate 1 measurement | | 10 | 99820390 | 99820391 | Human |
597368080 | GWAS1464154_H | executive function measurement QTL GWAS1464154 (human) | | 2e-08 | executive function measurement | | 10 | 83925328 | 83925329 | Human |
597589267 | GWAS1646127_H | monocyte count QTL GWAS1646127 (human) | | 5e-30 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 99522443 | 99522444 | Human |
597400853 | GWAS1496927_H | FEV/FVC ratio, response to bronchodilator QTL GWAS1496927 (human) | | 0.000003 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 93556242 | 93556243 | Human |
597187851 | GWAS1283925_H | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement QTL GWAS1283925 (human) | | 7e-33 | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | | 10 | 95041116 | 95041117 | Human |
597056768 | GWAS1152842_H | basophil count QTL GWAS1152842 (human) | | 1e-16 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 87896399 | 87896400 | Human |
596966658 | GWAS1086177_H | diastolic blood pressure QTL GWAS1086177 (human) | | 5e-28 | diastolic blood pressure | | 10 | 103141734 | 103141735 | Human |
597327117 | GWAS1423191_H | schizophrenia QTL GWAS1423191 (human) | | 6e-18 | schizophrenia | | 10 | 102869708 | 102869709 | Human |
597507338 | GWAS1603412_H | diastolic blood pressure QTL GWAS1603412 (human) | | 2e-45 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103197872 | 103197873 | Human |
597286146 | GWAS1382220_H | mean arterial pressure QTL GWAS1382220 (human) | | 1e-25 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 94242603 | 94242604 | Human |
597187845 | GWAS1283919_H | deoxycholic acid (12 or 24)-sulfate measurement QTL GWAS1283919 (human) | | 4e-16 | deoxycholic acid (12 or 24)-sulfate measurement | | 10 | 99836239 | 99836240 | Human |
597294343 | GWAS1390417_H | phosphatidylethanolamine measurement QTL GWAS1390417 (human) | | 3e-08 | phosphatidylethanolamine measurement | | 10 | 83819699 | 83819700 | Human |
597318968 | GWAS1415042_H | short sleep QTL GWAS1415042 (human) | | 0.0000002 | short sleep | | 10 | 102814805 | 102814806 | Human |
597318969 | GWAS1415043_H | short sleep QTL GWAS1415043 (human) | | 0.0000003 | short sleep | | 10 | 102812324 | 102812325 | Human |
597507385 | GWAS1603459_H | N6,N6-dimethyllysine measurement QTL GWAS1603459 (human) | | 1e-60 | N6,N6-dimethyllysine measurement | | 10 | 98383436 | 98383437 | Human |
597400895 | GWAS1496969_H | systemic lupus erythematosus QTL GWAS1496969 (human) | | 1e-08 | systemic lupus erythematosus | | 10 | 103243964 | 103243965 | Human |
597073200 | GWAS1169274_H | multiple sclerosis QTL GWAS1169274 (human) | | 4e-17 | multiple sclerosis | | 10 | 92722160 | 92722161 | Human |
597015859 | GWAS1111933_H | intraocular pressure measurement QTL GWAS1111933 (human) | | 5e-11 | intraocular pressure measurement | | 10 | 93289640 | 93289641 | Human |
597491002 | GWAS1587076_H | pulse pressure measurement QTL GWAS1587076 (human) | | 7e-29 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 103199143 | 103199144 | Human |
597474619 | GWAS1570693_H | testosterone measurement QTL GWAS1570693 (human) | | 1e-25 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 102859535 | 102859536 | Human |
597065022 | GWAS1161096_H | BMI-adjusted waist-hip ratio, physical activity measurement QTL GWAS1161096 (human) | | 3e-09 | wellness/fitness trait (VT:1000152) | voluntary body mobility/immobility measurement (CMO:0000954) | 10 | 94133757 | 94133758 | Human |
597286193 | GWAS1382267_H | pulse pressure measurement QTL GWAS1382267 (human) | | 1e-15 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 94253193 | 94253194 | Human |
597065021 | GWAS1161095_H | BMI-adjusted waist-hip ratio, physical activity measurement QTL GWAS1161095 (human) | | 2e-08 | wellness/fitness trait (VT:1000152) | voluntary body mobility/immobility measurement (CMO:0000954) | 10 | 94133757 | 94133758 | Human |
407389927 | GWAS1038903_H | triglyceride measurement QTL GWAS1038903 (human) | | 3e-12 | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | | 10 | 93079885 | 93079886 | Human |
597146918 | GWAS1242992_H | triglyceride measurement QTL GWAS1242992 (human) | | 2e-13 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 98012433 | 98012434 | Human |
597146917 | GWAS1242991_H | triglyceride measurement QTL GWAS1242991 (human) | | 2e-14 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93279507 | 93279508 | Human |
406988528 | GWAS637504_H | mean corpuscular hemoglobin concentration QTL GWAS637504 (human) | | 6e-10 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 103042109 | 103042110 | Human |
597146916 | GWAS1242990_H | triglyceride measurement QTL GWAS1242990 (human) | | 2e-10 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93123644 | 93123645 | Human |
597064997 | GWAS1161071_H | BMI-adjusted waist-hip ratio, physical activity measurement QTL GWAS1161071 (human) | | 0.000005 | wellness/fitness trait (VT:1000152) | voluntary body mobility/immobility measurement (CMO:0000954) | 10 | 94133757 | 94133758 | Human |
597425454 | GWAS1521528_H | gout QTL GWAS1521528 (human) | | 8e-10 | gout | | 10 | 100716410 | 100716411 | Human |
597073199 | GWAS1169273_H | multiple sclerosis QTL GWAS1169273 (human) | | 3e-15 | multiple sclerosis | | 10 | 79288854 | 79288855 | Human |
597294373 | GWAS1390447_H | cardiovascular measurement QTL GWAS1390447 (human) | | 0.0000004 | cardiovascular measurement | cardiovascular measurement (CMO:0000001) | 10 | 99586708 | 99586709 | Human |
597417254 | GWAS1513328_H | body fat distribution QTL GWAS1513328 (human) | | 5e-08 | body fat distribution | body fat morphological measurement (CMO:0000089) | 10 | 78996172 | 78996173 | Human |
597294372 | GWAS1390446_H | cardiovascular measurement QTL GWAS1390446 (human) | | 8e-08 | cardiovascular measurement | cardiovascular measurement (CMO:0000001) | 10 | 99587221 | 99587222 | Human |
597376294 | GWAS1472368_H | systolic blood pressure QTL GWAS1472368 (human) | | 1e-10 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 102834750 | 102834751 | Human |
597327140 | GWAS1423214_H | body mass index QTL GWAS1423214 (human) | | 6e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 85850211 | 85850212 | Human |
597040425 | GWAS1136499_H | apolipoprotein A 1 measurement QTL GWAS1136499 (human) | | 3e-15 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 10 | 79182179 | 79182180 | Human |
597343578 | GWAS1439652_H | vital capacity QTL GWAS1439652 (human) | | 4e-11 | vital capacity | | 10 | 100687890 | 100687891 | Human |
597466460 | GWAS1562534_H | systolic blood pressure QTL GWAS1562534 (human) | | 0.000006 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 102834750 | 102834751 | Human |
597278042 | GWAS1374116_H | diet measurement QTL GWAS1374116 (human) | | 1e-10 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 86375624 | 86375626 | Human |
597179740 | GWAS1275814_H | amino acid measurement QTL GWAS1275814 (human) | | 1e-09 | amino acid measurement | | 10 | 87060835 | 87060836 | Human |
597204317 | GWAS1300391_H | brain aneurysm QTL GWAS1300391 (human) | | 7e-09 | brain aneurysm | | 10 | 103192742 | 103192743 | Human |
597081424 | GWAS1177498_H | monocyte count QTL GWAS1177498 (human) | | 3e-20 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 102799204 | 102799205 | Human |
597343571 | GWAS1439645_H | vital capacity QTL GWAS1439645 (human) | | 2e-11 | vital capacity | | 10 | 93143758 | 93143759 | Human |
597613908 | GWAS1670768_H | potassium measurement QTL GWAS1670768 (human) | | 7e-29 | potassium measurement | blood potassium level (CMO:0000496) | 10 | 92672243 | 92672244 | Human |
597024094 | GWAS1120168_H | breast carcinoma QTL GWAS1120168 (human) | | 4e-36 | mammary gland integrity trait (VT:0010552) | | 10 | 79092621 | 79092622 | Human |
597073245 | GWAS1169319_H | blood protein measurement QTL GWAS1169319 (human) | | 6e-28 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 91906592 | 91906593 | Human |
597245268 | GWAS1341342_H | HbA1c measurement QTL GWAS1341342 (human) | | 3e-09 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 10 | 92614846 | 92614847 | Human |
597474643 | GWAS1570717_H | schizophrenia QTL GWAS1570717 (human) | | 4e-10 | schizophrenia | | 10 | 102660261 | 102660262 | Human |
597253450 | GWAS1349524_H | apolipoprotein B measurement QTL GWAS1349524 (human) | | 4e-09 | apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 10 | 93012138 | 93012139 | Human |
407111319 | GWAS760295_H | eosinophil count QTL GWAS760295 (human) | | 3e-11 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 102583671 | 102583672 | Human |
407021201 | GWAS670177_H | diastolic blood pressure QTL GWAS670177 (human) | | 7e-12 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 103086421 | 103086422 | Human |
597114179 | GWAS1210253_H | platelet component distribution width QTL GWAS1210253 (human) | | 8e-12 | platelet size trait (VT:0010457) | platelet distribution width (CMO:0001350) | 10 | 93023116 | 93023117 | Human |
597032257 | GWAS1128331_H | heel bone mineral density QTL GWAS1128331 (human) | | 5e-10 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 101692045 | 101692046 | Human |
597114178 | GWAS1210252_H | platelet component distribution width QTL GWAS1210252 (human) | | 8e-11 | platelet size trait (VT:0010457) | platelet distribution width (CMO:0001350) | 10 | 80557402 | 80557403 | Human |
597327183 | GWAS1423257_H | glucose measurement QTL GWAS1423257 (human) | | 0.0000004 | glucose measurement | blood glucose level (CMO:0000046) | 10 | 93629326 | 93629327 | Human |
597032256 | GWAS1128330_H | heel bone mineral density QTL GWAS1128330 (human) | | 4e-41 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 100315722 | 100315723 | Human |
597187917 | GWAS1283991_H | peak expiratory flow QTL GWAS1283991 (human) | | 1e-10 | peak expiratory flow | maximum mid-expiratory flow (MMEF) (CMO:0000253) | 10 | 100804271 | 100804272 | Human |
597114177 | GWAS1210251_H | platelet component distribution width QTL GWAS1210251 (human) | | 7e-20 | platelet size trait (VT:0010457) | platelet distribution width (CMO:0001350) | 10 | 79178742 | 79178743 | Human |
597114176 | GWAS1210250_H | platelet component distribution width QTL GWAS1210250 (human) | | 2e-11 | platelet size trait (VT:0010457) | platelet distribution width (CMO:0001350) | 10 | 79139212 | 79139213 | Human |
597081422 | GWAS1177496_H | monocyte count QTL GWAS1177496 (human) | | 1e-18 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 80508189 | 80508190 | Human |
597081423 | GWAS1177497_H | monocyte count QTL GWAS1177497 (human) | | 1e-122 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 97349165 | 97349166 | Human |
597081421 | GWAS1177495_H | monocyte count QTL GWAS1177495 (human) | | 8e-12 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 79168564 | 79168565 | Human |
597269829 | GWAS1365903_H | arecaidine measurement QTL GWAS1365903 (human) | | 4e-14 | arecaidine measurement | | 10 | 91194742 | 91194743 | Human |
597269828 | GWAS1365902_H | asymmetrical dimethylarginine measurement QTL GWAS1365902 (human) | | 5e-18 | asymmetrical dimethylarginine measurement | | 10 | 98381270 | 98381271 | Human |
597269831 | GWAS1365905_H | arecaidine measurement QTL GWAS1365905 (human) | | 6e-90 | arecaidine measurement | | 10 | 98392298 | 98392299 | Human |
597269830 | GWAS1365904_H | arecaidine measurement QTL GWAS1365904 (human) | | 7e-13 | arecaidine measurement | | 10 | 93415061 | 93415062 | Human |
597409145 | GWAS1505219_H | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1505219 (human) | | 1e-09 | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 102358877 | 102358878 | Human |
597425535 | GWAS1521609_H | depressive symptom measurement, stressful life event measurement QTL GWAS1521609 (human) | | 0.000002 | depressive symptom measurement, stressful life event measurement | | 10 | 86613201 | 86613202 | Human |
597056882 | GWAS1152956_H | intelligence QTL GWAS1152956 (human) | | 1e-16 | intelligence | | 10 | 101806203 | 101806204 | Human |
597056883 | GWAS1152957_H | intelligence QTL GWAS1152957 (human) | | 2e-10 | cognitive behavior trait (VT:0010450) | | 10 | 102322931 | 102322932 | Human |
597441913 | GWAS1537987_H | type 2 diabetes mellitus, major depressive disorder, coronary artery disease QTL GWAS1537987 (human) | | 0.000005 | type 2 diabetes mellitus, major depressive disorder, coronary artery disease | | 10 | 102834750 | 102834751 | Human |
597327228 | GWAS1423302_H | vital capacity QTL GWAS1423302 (human) | | 5e-09 | vital capacity | | 10 | 98177769 | 98177770 | Human |
597171568 | GWAS1267642_H | hemorheological measurement QTL GWAS1267642 (human) | | 0.000004 | hemorheological measurement | | 10 | 84813648 | 84813649 | Human |
597097854 | GWAS1193928_H | coronary artery disease QTL GWAS1193928 (human) | | 0.000007 | coronary artery disease | | 10 | 89243170 | 89243171 | Human |
597269872 | GWAS1365946_H | metabolite measurement QTL GWAS1365946 (human) | | 2e-13 | metabolite measurement | | 10 | 93415061 | 93415062 | Human |
406890155 | GWAS539131_H | type 2 diabetes mellitus QTL GWAS539131 (human) | | 1e-15 | type 2 diabetes mellitus | | 10 | 92705802 | 92705803 | Human |
597400951 | GWAS1497025_H | mean reticulocyte volume QTL GWAS1497025 (human) | | 4e-24 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 10 | 102876898 | 102876899 | Human |
597400950 | GWAS1497024_H | mean reticulocyte volume QTL GWAS1497024 (human) | | 1e-33 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 10 | 94398458 | 94398459 | Human |
597400949 | GWAS1497023_H | mean reticulocyte volume QTL GWAS1497023 (human) | | 2e-46 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 10 | 79045259 | 79045260 | Human |
597114233 | GWAS1210307_H | bitter non-alcoholic beverage consumption measurement QTL GWAS1210307 (human) | | 0.000002 | bitter non-alcoholic beverage consumption measurement | drink intake measurement (CMO:0000771) | 10 | 98437675 | 98437676 | Human |
597384554 | GWAS1480628_H | body mass index QTL GWAS1480628 (human) | | 6e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 86400837 | 86400838 | Human |
597171561 | GWAS1267635_H | complement factor H-related protein 1 measurement QTL GWAS1267635 (human) | | 2e-93 | complement factor H-related protein 1 measurement | | 10 | 100043668 | 100043669 | Human |
597106020 | GWAS1202094_H | sex hormone-binding globulin measurement QTL GWAS1202094 (human) | | 3e-12 | sex hormone-binding globulin measurement | | 10 | 96097142 | 96097143 | Human |
597097826 | GWAS1193900_H | protein measurement QTL GWAS1193900 (human) | | 2e-08 | protein measurement | | 10 | 83190164 | 83190165 | Human |
597015904 | GWAS1111978_H | coronary artery disease QTL GWAS1111978 (human) | | 4e-15 | coronary artery disease | | 10 | 102878723 | 102878724 | Human |
597269871 | GWAS1365945_H | metabolite measurement QTL GWAS1365945 (human) | | 4e-16 | metabolite measurement | | 10 | 91194742 | 91194743 | Human |
597384556 | GWAS1480630_H | body mass index QTL GWAS1480630 (human) | | 4e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 78457709 | 78457710 | Human |
597269870 | GWAS1365944_H | metabolite measurement QTL GWAS1365944 (human) | | 2e-135 | metabolite measurement | | 10 | 98400642 | 98400643 | Human |
597319010 | GWAS1415084_H | retinol measurement QTL GWAS1415084 (human) | | 6e-30 | blood vitamin A amount (VT:0010627) | blood retinol level (CMO:0002457) | 10 | 93601207 | 93601208 | Human |
597392738 | GWAS1488812_H | body mass index, response to cranial radiation therapy QTL GWAS1488812 (human) | | 2e-08 | body mass index, response to cranial radiation therapy | body mass index (BMI) (CMO:0000105) | 10 | 78483013 | 78483014 | Human |
597040491 | GWAS1136565_H | soluble triggering receptor expressed on myeloid cells 2 measurement QTL GWAS1136565 (human) | | 5e-12 | soluble triggering receptor expressed on myeloid cells 2 measurement | | 10 | 94148915 | 94148916 | Human |
597532002 | GWAS1628076_H | cannabis dependence QTL GWAS1628076 (human) | | 1e-08 | cannabis dependence | | 10 | 102442972 | 102442973 | Human |
597449883 | GWAS1545957_H | lifestyle measurement, maximum cigarettes per day measurement QTL GWAS1545957 (human) | | 5e-08 | lifestyle measurement, maximum cigarettes per day measurement | | 10 | 84278158 | 84278159 | Human |
597261470 | GWAS1357544_H | tumor necrosis factor receptor superfamily member 6 measurement QTL GWAS1357544 (human) | | 2e-59 | tumor necrosis factor receptor superfamily member 6 measurement | | 10 | 89010797 | 89010798 | Human |
597105808 | GWAS1201882_H | protein measurement QTL GWAS1201882 (human) | | 3e-12 | protein measurement | | 10 | 100742278 | 100742279 | Human |
596982941 | GWAS1102460_H | memory performance QTL GWAS1102460 (human) | | 0.000005 | memory performance | | 10 | 86567650 | 86567651 | Human |
597171344 | GWAS1267418_H | diet measurement QTL GWAS1267418 (human) | | 0.000004 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 87986057 | 87986058 | Human |
597187731 | GWAS1283805_H | peak expiratory flow QTL GWAS1283805 (human) | | 6e-09 | peak expiratory flow | maximum mid-expiratory flow (MMEF) (CMO:0000253) | 10 | 102728114 | 102728115 | Human |
597261460 | GWAS1357534_H | COVID-19 QTL GWAS1357534 (human) | | 0.000009 | COVID-19 | | 10 | 79946568 | 79946569 | Human |
407070540 | GWAS719516_H | heel bone mineral density QTL GWAS719516 (human) | | 2e-32 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 77656609 | 77656610 | Human |
406972241 | GWAS621217_H | waist-hip ratio QTL GWAS621217 (human) | | 5e-08 | waist-hip ratio | | 10 | 87843667 | 87843668 | Human |
597040262 | GWAS1136336_H | urinary metabolite measurement QTL GWAS1136336 (human) | | 1e-234 | urinary metabolite measurement | | 10 | 98399379 | 98399380 | Human |
597335179 | GWAS1431253_H | RS-warfarin measurement QTL GWAS1431253 (human) | | 0.000007 | RS-warfarin measurement | | 10 | 87186270 | 87186271 | Human |
407136085 | GWAS785061_H | parental longevity QTL GWAS785061 (human) | | 0.000003 | total life span (VT:0001661) | | 10 | 87982049 | 87982050 | Human |
597523598 | GWAS1619672_H | pulmonary surfactant-associated protein d measurement QTL GWAS1619672 (human) | | 9e-137 | pulmonary surfactant-associated protein d measurement | | 10 | 79944400 | 79944401 | Human |
597367944 | GWAS1464018_H | gut microbiome measurement QTL GWAS1464018 (human) | | 0.000006 | gut microbiome measurement | | 10 | 89465191 | 89465192 | Human |
597425295 | GWAS1521369_H | lymphocyte:monocyte ratio QTL GWAS1521369 (human) | | 4e-11 | leukocyte quantity (VT:0000217) | | 10 | 97248311 | 97248312 | Human |
597613706 | GWAS1670566_H | skin disease QTL GWAS1670566 (human) | | 6e-12 | skin disease | | 10 | 100315722 | 100315723 | Human |
597474436 | GWAS1570510_H | prostate carcinoma QTL GWAS1570510 (human) | | 5e-15 | prostate carcinoma | | 10 | 78477242 | 78477243 | Human |
597286019 | GWAS1382093_H | diastolic blood pressure QTL GWAS1382093 (human) | | 3e-20 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 94242603 | 94242604 | Human |
597163147 | GWAS1259221_H | atrial fibrillation QTL GWAS1259221 (human) | | 5e-50 | atrial fibrillation | | 10 | 103574950 | 103574951 | Human |
597490817 | GWAS1586891_H | breast density QTL GWAS1586891 (human) | | 0.000003 | breast density | | 10 | 80405772 | 80405773 | Human |
597195909 | GWAS1291983_H | memory performance QTL GWAS1291983 (human) | | 0.000009 | memory performance | | 10 | 86005934 | 86005935 | Human |
597286020 | GWAS1382094_H | diastolic blood pressure QTL GWAS1382094 (human) | | 3e-43 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 102900247 | 102900248 | Human |
597040310 | GWAS1136384_H | heel bone mineral density QTL GWAS1136384 (human) | | 1e-12 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 87722114 | 87722115 | Human |
597195960 | GWAS1292034_H | erythrocyte count QTL GWAS1292034 (human) | | 2e-08 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 99542020 | 99542024 | Human |
597040311 | GWAS1136385_H | heel bone mineral density QTL GWAS1136385 (human) | | 2e-13 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 93161961 | 93161962 | Human |
597040308 | GWAS1136382_H | heel bone mineral density QTL GWAS1136382 (human) | | 2e-09 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 86721235 | 86721236 | Human |
597605564 | GWAS1662424_H | serum alanine aminotransferase measurement QTL GWAS1662424 (human) | | 5e-15 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100152437 | 100152438 | Human |
597023927 | GWAS1120001_H | allergic disease QTL GWAS1120001 (human) | | 2e-08 | allergic disease | | 10 | 102466075 | 102466076 | Human |
597040309 | GWAS1136383_H | heel bone mineral density QTL GWAS1136383 (human) | | 4e-11 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 87709196 | 87709197 | Human |
597040306 | GWAS1136380_H | heel bone mineral density QTL GWAS1136380 (human) | | 3e-29 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 77656609 | 77656610 | Human |
597040307 | GWAS1136381_H | heel bone mineral density QTL GWAS1136381 (human) | | 2e-12 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 80439507 | 80439508 | Human |
407078763 | GWAS727739_H | tuberculosis QTL GWAS727739 (human) | | 0.000003 | tuberculosis | | 10 | 95032445 | 95032446 | Human |
597073087 | GWAS1169161_H | feeling nervous measurement QTL GWAS1169161 (human) | | 1e-13 | feeling nervous measurement | | 10 | 102944260 | 102944261 | Human |
597490870 | GWAS1586944_H | breast density QTL GWAS1586944 (human) | | 9e-08 | breast density | | 10 | 91533154 | 91533155 | Human |
597073082 | GWAS1169156_H | response to perphenazine QTL GWAS1169156 (human) | | 0.000005 | response to perphenazine | | 10 | 93748796 | 93748797 | Human |
597171381 | GWAS1267455_H | aortic measurement QTL GWAS1267455 (human) | | 2e-19 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 94151004 | 94151005 | Human |
597146787 | GWAS1242861_H | triglyceride measurement QTL GWAS1242861 (human) | | 1e-08 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93050165 | 93050166 | Human |
597146786 | GWAS1242860_H | triglyceride measurement QTL GWAS1242860 (human) | | 9e-14 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 93031667 | 93031668 | Human |
597146785 | GWAS1242859_H | triglyceride measurement QTL GWAS1242859 (human) | | 3e-16 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 92780529 | 92780530 | Human |
407144306 | GWAS793282_H | metabolite measurement QTL GWAS793282 (human) | | 3e-57 | metabolite measurement | | 10 | 100315722 | 100315723 | Human |
597146784 | GWAS1242858_H | triglyceride measurement QTL GWAS1242858 (human) | | 2e-09 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 92515052 | 92515053 | Human |
596958381 | GWAS1077900_H | verbal-numerical reasoning measurement QTL GWAS1077900 (human) | | 7e-13 | verbal-numerical reasoning measurement | | 10 | 101845957 | 101845958 | Human |
597212322 | GWAS1308396_H | trait in response to ethanol QTL GWAS1308396 (human) | | 0.0000006 | trait in response to ethanol | | 10 | 83922871 | 83922872 | Human |
597146794 | GWAS1242868_H | diabetes mellitus QTL GWAS1242868 (human) | | 2e-10 | pancreas integrity trait (VT:0010560) | | 10 | 92443148 | 92443149 | Human |
597146793 | GWAS1242867_H | diabetes mellitus QTL GWAS1242867 (human) | | 1e-08 | pancreas integrity trait (VT:0010560) | | 10 | 79175326 | 79175327 | Human |
596958378 | GWAS1077897_H | risk-taking behaviour QTL GWAS1077897 (human) | | 2e-21 | risk-taking behaviour | | 10 | 102880295 | 102880296 | Human |
597507234 | GWAS1603308_H | aortic measurement QTL GWAS1603308 (human) | | 0.000001 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 94311455 | 94311456 | Human |
597089494 | GWAS1185568_H | hypertension QTL GWAS1185568 (human) | | 3e-08 | schizophrenia | | 10 | 103146454 | 103146455 | Human |
597368025 | GWAS1464099_H | hemoglobin measurement QTL GWAS1464099 (human) | | 8e-12 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 102911075 | 102911076 | Human |
597220571 | GWAS1316645_H | triglyceride change measurement, intermediate density lipoprotein measurement QTL GWAS1316645 (human) | | 5e-08 | triglyceride change measurement, intermediate density lipoprotein measurement | blood intermediate density lipoprotein cholesterol level (CMO:0001562) | 10 | 86906307 | 86906308 | Human |
596966615 | GWAS1086134_H | Calcium channel blocker use measurement QTL GWAS1086134 (human) | | 6e-15 | pulse pressure measurement | | 10 | 94278929 | 94278930 | Human |
597482719 | GWAS1578793_H | mean corpuscular hemoglobin QTL GWAS1578793 (human) | | 7e-42 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 99525359 | 99525360 | Human |
597064914 | GWAS1160988_H | BMI-adjusted waist circumference, physical activity measurement QTL GWAS1160988 (human) | | 0.0000001 | wellness/fitness trait (VT:1000152) | voluntary body mobility/immobility measurement (CMO:0000954) | 10 | 79147390 | 79147391 | Human |
597474521 | GWAS1570595_H | blood protein measurement QTL GWAS1570595 (human) | | 2e-57 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 100130207 | 100130208 | Human |
407250688 | GWAS899664_H | inflammatory bowel disease QTL GWAS899664 (human) | | 8e-10 | inflammatory bowel disease | | 10 | 96837270 | 96837271 | Human |
597089488 | GWAS1185562_H | hypertension QTL GWAS1185562 (human) | | 8e-09 | hypertension | | 10 | 103138144 | 103138145 | Human |
596966611 | GWAS1086130_H | pulse pressure measurement QTL GWAS1086130 (human) | | 6e-11 | pulse pressure measurement | | 10 | 87844975 | 87844976 | Human |
597089489 | GWAS1185563_H | hypertension QTL GWAS1185563 (human) | | 1e-08 | hypertension | | 10 | 103086421 | 103086422 | Human |
597359825 | GWAS1455899_H | pulse pressure measurement QTL GWAS1455899 (human) | | 1e-37 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 102834750 | 102834751 | Human |
597253323 | GWAS1349397_H | serum alanine aminotransferase measurement QTL GWAS1349397 (human) | | 9e-215 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 10 | 100152307 | 100152308 | Human |
597187786 | GWAS1283860_H | palmitoleoylcarnitine (C16:1) measurement QTL GWAS1283860 (human) | | 6e-12 | palmitoleoylcarnitine (C16:1) measurement | | 10 | 100315722 | 100315723 | Human |
407398174 | GWAS1047150_H | pulse pressure measurement QTL GWAS1047150 (human) | | 3e-09 | pulse pressure measurement | | 10 | 87844975 | 87844976 | Human |
597073088 | GWAS1169162_H | feeling nervous measurement QTL GWAS1169162 (human) | | 3e-13 | feeling nervous measurement | | 10 | 103081213 | 103081214 | Human |
596950211 | GWAS1069730_H | brain connectivity measurement QTL GWAS1069730 (human) | | 4e-09 | brain connectivity measurement | | 10 | 102981357 | 102981358 | Human |
597089487 | GWAS1185561_H | hypertension QTL GWAS1185561 (human) | | 5e-09 | hypertension | | 10 | 102959339 | 102959340 | Human |
407152414 | GWAS801390_H | heel bone mineral density QTL GWAS801390 (human) | | 1e-08 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 100519537 | 100519538 | Human |
597138633 | GWAS1234707_H | alpha fetoprotein measurement QTL GWAS1234707 (human) | | 7e-18 | blood alpha-fetoprotein amount (VT:0010776) | | 10 | 87135558 | 87135559 | Human |
597605569 | GWAS1662429_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1662429 (human) | | 6e-91 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 10 | 99397681 | 99397682 | Human |
597335291 | GWAS1431365_H | COVID-19 QTL GWAS1431365 (human) | | 0.000006 | COVID-19 | | 10 | 98656778 | 98656779 | Human |
597490937 | GWAS1587011_H | RS-warfarin measurement QTL GWAS1587011 (human) | | 0.000003 | RS-warfarin measurement | | 10 | 92799519 | 92799520 | Human |
407365409 | GWAS1014385_H | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis QTL GWAS1014385 (human) | | 6e-09 | intestine integrity trait (VT:0010554) | | 10 | 99518968 | 99518969 | Human |
597376243 | GWAS1472317_H | inflammatory bowel disease QTL GWAS1472317 (human) | | 1e-54 | inflammatory bowel disease | | 10 | 99524480 | 99524481 | Human |
597187825 | GWAS1283899_H | X-24546 measurement QTL GWAS1283899 (human) | | 4e-13 | X-24546 measurement | | 10 | 95068566 | 95068567 | Human |
597310710 | GWAS1406784_H | erythrocyte count QTL GWAS1406784 (human) | | 5e-15 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 94417882 | 94417883 | Human |
597163259 | GWAS1259333_H | serum metabolite measurement QTL GWAS1259333 (human) | | 1e-59 | serum metabolite measurement | | 10 | 98397096 | 98397097 | Human |
597318902 | GWAS1414976_H | JT interval QTL GWAS1414976 (human) | | 2e-17 | heart electrical impulse conduction trait (VT:2000017) | heart electrical conduction measurement (CMO:0000230) | 10 | 102300772 | 102300773 | Human |
597597427 | GWAS1654287_H | lymphocyte count QTL GWAS1654287 (human) | | 6e-22 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 97336188 | 97336189 | Human |
597310708 | GWAS1406782_H | erythrocyte count QTL GWAS1406782 (human) | | 6e-11 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 87986057 | 87986058 | Human |
406996780 | GWAS645756_H | mean corpuscular hemoglobin concentration QTL GWAS645756 (human) | | 5e-57 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 99549133 | 99549134 | Human |
406996781 | GWAS645757_H | mean corpuscular hemoglobin concentration QTL GWAS645757 (human) | | 1e-54 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 103120090 | 103120091 | Human |
596974823 | GWAS1094342_H | systolic blood pressure, major depressive disorder QTL GWAS1094342 (human) | | 8e-10 | systolic blood pressure, major depressive disorder | | 10 | 102937759 | 102937760 | Human |
597187821 | GWAS1283895_H | X-24556 measurement QTL GWAS1283895 (human) | | 2e-17 | X-24556 measurement | | 10 | 95064055 | 95064056 | Human |
597073123 | GWAS1169197_H | feeling nervous measurement QTL GWAS1169197 (human) | | 3e-13 | feeling nervous measurement | | 10 | 103185994 | 103185995 | Human |
597466347 | GWAS1562421_H | creatine kinase measurement QTL GWAS1562421 (human) | | 3e-09 | creatine kinase measurement | blood creatine kinase activity level (CMO:0002242) | 10 | 102909864 | 102909865 | Human |
407037754 | GWAS686730_H | body mass index QTL GWAS686730 (human) | | 0.000003 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 102599593 | 102599594 | Human |
597417187 | GWAS1513261_H | smoking status measurement QTL GWAS1513261 (human) | | 4e-22 | smoking status measurement | | 10 | 102880295 | 102880296 | Human |
597417186 | GWAS1513260_H | smoking status measurement QTL GWAS1513260 (human) | | 1e-10 | smoking status measurement | | 10 | 102643553 | 102643554 | Human |
597531879 | GWAS1627953_H | vitamin D measurement QTL GWAS1627953 (human) | | 1e-08 | vitamin D measurement | | 10 | 80283026 | 80283027 | Human |
597589220 | GWAS1646080_H | monocyte count QTL GWAS1646080 (human) | | 5e-36 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 97351994 | 97351995 | Human |
597417185 | GWAS1513259_H | smoking status measurement QTL GWAS1513259 (human) | | 5e-08 | smoking status measurement | | 10 | 102360765 | 102360766 | Human |
597589221 | GWAS1646081_H | monocyte count QTL GWAS1646081 (human) | | 3e-29 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 99522443 | 99522444 | Human |
597482720 | GWAS1578794_H | mean corpuscular hemoglobin QTL GWAS1578794 (human) | | 9e-34 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 102911455 | 102911456 | Human |
597097707 | GWAS1193781_H | sex hormone-binding globulin measurement QTL GWAS1193781 (human) | | 2e-36 | sex hormone-binding globulin measurement | | 10 | 79314368 | 79314369 | Human |
596974824 | GWAS1094343_H | systolic blood pressure, major depressive disorder QTL GWAS1094343 (human) | | 6e-09 | systolic blood pressure, major depressive disorder | | 10 | 103051446 | 103051447 | Human |
597015787 | GWAS1111861_H | selective IgA deficiency disease QTL GWAS1111861 (human) | | 7e-08 | selective IgA deficiency disease | | 10 | 89023070 | 89023071 | Human |
597277720 | GWAS1373794_H | glycochenodeoxycholate glucuronide (1) measurement QTL GWAS1373794 (human) | | 3e-14 | glycochenodeoxycholate glucuronide (1) measurement | | 10 | 99811603 | 99811604 | Human |
597507102 | GWAS1603176_H | glycocholenate sulfate measurement QTL GWAS1603176 (human) | | 5e-44 | glycocholenate sulfate measurement | | 10 | 99843765 | 99843766 | Human |
597376030 | GWAS1472104_H | migraine disorder QTL GWAS1472104 (human) | | 0.000004 | migraine disorder | | 10 | 94774506 | 94774507 | Human |
597040147 | GWAS1136221_H | apolipoprotein A 1 measurement QTL GWAS1136221 (human) | | 2e-29 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 10 | 100164661 | 100164662 | Human |
597072915 | GWAS1168989_H | schizophrenia QTL GWAS1168989 (human) | | 4e-17 | schizophrenia | | 10 | 103089359 | 103089360 | Human |
597089296 | GWAS1185370_H | type 2 diabetes mellitus QTL GWAS1185370 (human) | | 2e-08 | type 2 diabetes mellitus | | 10 | 100060908 | 100060909 | Human |
597097502 | GWAS1193576_H | sex hormone-binding globulin measurement QTL GWAS1193576 (human) | | 1e-08 | functional brain measurement | | 10 | 94253193 | 94253194 | Human |
597376019 | GWAS1472093_H | triacylglycerol 48:0 measurement QTL GWAS1472093 (human) | | 0.000009 | blood triglyceride amount (VT:0002644) | | 10 | 100685137 | 100685138 | Human |
407152589 | GWAS801565_H | triglyceride change measurement, intermediate density lipoprotein measurement QTL GWAS801565 (human) | | 5e-08 | triglyceride change measurement, intermediate density lipoprotein measurement | | 10 | 86906307 | 86906308 | Human |
597392395 | GWAS1488469_H | risk-taking behaviour QTL GWAS1488469 (human) | | 7e-20 | risk-taking behaviour | | 10 | 97337434 | 97337435 | Human |
597179402 | GWAS1275476_H | AMSH-like protease measurement QTL GWAS1275476 (human) | | 3e-91 | AMSH-like protease measurement | | 10 | 88863615 | 88863616 | Human |
597179403 | GWAS1275477_H | AMSH-like protease measurement QTL GWAS1275477 (human) | | 7e-33 | AMSH-like protease measurement | | 10 | 88729035 | 88729036 | Human |
406964181 | GWAS613157_H | basophil count, eosinophil count QTL GWAS613157 (human) | | 1e-13 | eosinophil quantity (VT:0002602) | blood granulocyte count (CMO:0000111) | 10 | 92693718 | 92693719 | Human |
406964182 | GWAS613158_H | basophil count, eosinophil count QTL GWAS613158 (human) | | 3e-09 | eosinophil quantity (VT:0002602) | blood granulocyte count (CMO:0000111) | 10 | 102578181 | 102578182 | Human |
407119827 | GWAS768803_H | body mass index QTL GWAS768803 (human) | | 4e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 103146454 | 103146455 | Human |
597089294 | GWAS1185368_H | type 2 diabetes mellitus QTL GWAS1185368 (human) | | 2e-14 | type 2 diabetes mellitus | | 10 | 79184084 | 79184085 | Human |
597482500 | GWAS1578574_H | blood protein measurement QTL GWAS1578574 (human) | | 3e-08 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 92756251 | 92756252 | Human |
597466117 | GWAS1562191_H | serum gamma-glutamyl transferase measurement QTL GWAS1562191 (human) | | 3e-17 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 77928450 | 77928451 | Human |
597089295 | GWAS1185369_H | type 2 diabetes mellitus QTL GWAS1185369 (human) | | 5e-40 | type 2 diabetes mellitus | | 10 | 92706682 | 92706683 | Human |
597187585 | GWAS1283659_H | X-11787 measurement QTL GWAS1283659 (human) | | 1e-73 | X-11787 measurement | | 10 | 94965778 | 94965779 | Human |
597138442 | GWAS1234516_H | 1-palmitoleoyl-GPC (16:1) measurement QTL GWAS1234516 (human) | | 1e-24 | glycerophosphocholine amount (VT:0011004) | | 10 | 100315722 | 100315723 | Human |
597212165 | GWAS1308239_H | schizophrenia QTL GWAS1308239 (human) | | 5e-11 | schizophrenia | | 10 | 103089359 | 103089360 | Human |
597449731 | GWAS1545805_H | bilirubin measurement QTL GWAS1545805 (human) | | 6e-13 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 10 | 93072371 | 93072372 | Human |
597589053 | GWAS1645913_H | diabetic ketoacidosis QTL GWAS1645913 (human) | | 6e-13 | diabetic ketoacidosis | | 10 | 91894078 | 91894079 | Human |
597212209 | GWAS1308283_H | schizophrenia QTL GWAS1308283 (human) | | 7e-18 | schizophrenia | | 10 | 103169157 | 103169158 | Human |
597113895 | GWAS1209969_H | erythrocyte count QTL GWAS1209969 (human) | | 4e-13 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 88996199 | 88996201 | Human |
597113894 | GWAS1209968_H | erythrocyte count QTL GWAS1209968 (human) | | 3e-16 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 87884529 | 87884530 | Human |
597113893 | GWAS1209967_H | erythrocyte count QTL GWAS1209967 (human) | | 2e-09 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 87120932 | 87120933 | Human |
597097509 | GWAS1193583_H | sex hormone-binding globulin measurement QTL GWAS1193583 (human) | | 2e-08 | sex hormone-binding globulin measurement | | 10 | 77781881 | 77781882 | Human |
597204011 | GWAS1300085_H | systolic blood pressure QTL GWAS1300085 (human) | | 0.0000009 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 102836092 | 102836093 | Human |
597040175 | GWAS1136249_H | urinary metabolite measurement QTL GWAS1136249 (human) | | 2e-14 | urinary metabolite measurement | | 10 | 95068566 | 95068567 | Human |
597023791 | GWAS1119865_H | breast carcinoma QTL GWAS1119865 (human) | | 0.000004 | mammary gland integrity trait (VT:0010552) | | 10 | 81950055 | 81950056 | Human |
597154861 | GWAS1250935_H | BMI-adjusted waist-hip ratio QTL GWAS1250935 (human) | | 7e-10 | body size trait (VT:0100005) | | 10 | 93578182 | 93578183 | Human |
597154860 | GWAS1250934_H | BMI-adjusted waist-hip ratio QTL GWAS1250934 (human) | | 2e-09 | body size trait (VT:0100005) | | 10 | 87899396 | 87899397 | Human |
597154859 | GWAS1250933_H | BMI-adjusted waist-hip ratio QTL GWAS1250933 (human) | | 1e-09 | body size trait (VT:0100005) | | 10 | 79169036 | 79169037 | Human |
597277735 | GWAS1373809_H | retinol measurement QTL GWAS1373809 (human) | | 6e-12 | blood vitamin A amount (VT:0010627) | blood retinol level (CMO:0002457) | 10 | 93601207 | 93601208 | Human |
597326938 | GWAS1423012_H | schizophrenia QTL GWAS1423012 (human) | | 4e-25 | schizophrenia | | 10 | 102760520 | 102760521 | Human |
597253208 | GWAS1349282_H | aspartate aminotransferase measurement QTL GWAS1349282 (human) | | 8e-45 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 99406195 | 99406196 | Human |
597613660 | GWAS1670520_H | sarcoidosis QTL GWAS1670520 (human) | | 7e-25 | sarcoidosis | | 10 | 80193615 | 80193616 | Human |
597589080 | GWAS1645940_H | monocyte count QTL GWAS1645940 (human) | | 9e-13 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 97384397 | 97384398 | Human |
597089374 | GWAS1185448_H | monocyte percentage of leukocytes QTL GWAS1185448 (human) | | 2e-15 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 10 | 79145785 | 79145786 | Human |
597482580 | GWAS1578654_H | lymphocyte count QTL GWAS1578654 (human) | | 1e-34 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95792195 | 95792196 | Human |
597589079 | GWAS1645939_H | monocyte count QTL GWAS1645939 (human) | | 2e-11 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 96709357 | 96709358 | Human |
597482577 | GWAS1578651_H | lymphocyte count QTL GWAS1578651 (human) | | 3e-607 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95810558 | 95810559 | Human |
597040219 | GWAS1136293_H | urinary metabolite measurement QTL GWAS1136293 (human) | | 2e-309 | urinary metabolite measurement | | 10 | 98388419 | 98388420 | Human |
597482578 | GWAS1578652_H | lymphocyte count QTL GWAS1578652 (human) | | 2e-16 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95921212 | 95921213 | Human |
597482579 | GWAS1578653_H | lymphocyte count QTL GWAS1578653 (human) | | 5e-630 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95847887 | 95847888 | Human |
597236822 | GWAS1332896_H | monocyte count QTL GWAS1332896 (human) | | 6e-19 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 97318726 | 97318727 | Human |
597245000 | GWAS1341074_H | aging QTL GWAS1341074 (human) | | 5e-08 | aging | | 10 | 99512225 | 99512226 | Human |
597187658 | GWAS1283732_H | tetradecadienedioate (C14:2-DC) measurement QTL GWAS1283732 (human) | | 4e-17 | tetradecadienedioate (C14:2-DC) measurement | | 10 | 100315722 | 100315723 | Human |
597072964 | GWAS1169038_H | schizophrenia QTL GWAS1169038 (human) | | 4e-20 | schizophrenia | | 10 | 102866129 | 102866130 | Human |
597138500 | GWAS1234574_H | 4-androsten-3beta,17beta-diol disulfate 2 measurement QTL GWAS1234574 (human) | | 2e-13 | 4-androsten-3beta,17beta-diol disulfate 2 measurement | | 10 | 99814162 | 99814167 | Human |
597417039 | GWAS1513113_H | brain aneurysm QTL GWAS1513113 (human) | | 2e-08 | brain aneurysm | | 10 | 94278929 | 94278930 | Human |
597482568 | GWAS1578642_H | lymphocyte count QTL GWAS1578642 (human) | | 4e-304 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95847887 | 95847888 | Human |
597433416 | GWAS1529490_H | psoriasis, type 2 diabetes mellitus QTL GWAS1529490 (human) | | 1e-09 | psoriasis, type 2 diabetes mellitus | | 10 | 100251454 | 100251455 | Human |
597367887 | GWAS1463961_H | smoking behavior QTL GWAS1463961 (human) | | 5e-08 | smoking behavior | | 10 | 103245744 | 103245745 | Human |
597482569 | GWAS1578643_H | lymphocyte count QTL GWAS1578643 (human) | | 1e-43 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95751710 | 95751711 | Human |
597482570 | GWAS1578644_H | lymphocyte count QTL GWAS1578644 (human) | | 6e-444 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95810558 | 95810559 | Human |
597294158 | GWAS1390232_H | cardiac troponin T measurement QTL GWAS1390232 (human) | | 0.000005 | cardiac troponin T measurement | blood troponin T level (CMO:0001284) | 10 | 84042882 | 84042883 | Human |
597482571 | GWAS1578645_H | lymphocyte count QTL GWAS1578645 (human) | | 4e-631 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95843406 | 95843407 | Human |
597482565 | GWAS1578639_H | lymphocyte count QTL GWAS1578639 (human) | | 1e-311 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95843406 | 95843407 | Human |
597482566 | GWAS1578640_H | lymphocyte count QTL GWAS1578640 (human) | | 3e-22 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 95976817 | 95976818 | Human |
407013276 | GWAS662252_H | trans/cis-18:2 fatty acid measurement, trans fatty acid measurement QTL GWAS662252 (human) | | 0.000004 | trans/cis-18:2 fatty acid measurement, trans fatty acid measurement | milk trans fatty acid measurement (CMO:0000824) | 10 | 83345853 | 83345854 | Human |
597367929 | GWAS1464003_H | risk-taking behaviour QTL GWAS1464003 (human) | | 1e-15 | risk-taking behaviour | | 10 | 97238438 | 97238439 | Human |
597064818 | GWAS1160892_H | celiac disease QTL GWAS1160892 (human) | | 8e-17 | celiac disease | | 10 | 79298270 | 79298271 | Human |
597466234 | GWAS1562308_H | hypertension QTL GWAS1562308 (human) | | 4e-10 | hypertension | | 10 | 102856906 | 102856907 | Human |
597490811 | GWAS1586885_H | breast density QTL GWAS1586885 (human) | | 0.000005 | breast density | | 10 | 95851294 | 95851295 | Human |
597384307 | GWAS1480381_H | Red cell distribution width QTL GWAS1480381 (human) | | 1e-12 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 99496351 | 99496352 | Human |
597589110 | GWAS1645970_H | monocyte count QTL GWAS1645970 (human) | | 2e-35 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 99522443 | 99522444 | Human |
597384306 | GWAS1480380_H | Red cell distribution width QTL GWAS1480380 (human) | | 3e-21 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 79041217 | 79041218 | Human |
597466229 | GWAS1562303_H | hypertension QTL GWAS1562303 (human) | | 5e-09 | hypertension | | 10 | 102834750 | 102834751 | Human |
597589109 | GWAS1645969_H | monocyte count QTL GWAS1645969 (human) | | 1e-43 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 97354207 | 97354208 | Human |
597040248 | GWAS1136322_H | diet measurement QTL GWAS1136322 (human) | | 7e-10 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 85559131 | 85559132 | Human |
597384308 | GWAS1480382_H | Red cell distribution width QTL GWAS1480382 (human) | | 9e-08 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 102875346 | 102875347 | Human |
596974695 | GWAS1094214_H | vitamin D measurement QTL GWAS1094214 (human) | | 2e-09 | vitamin D measurement | | 10 | 86321681 | 86321682 | Human |
597163108 | GWAS1259182_H | erythrocyte count QTL GWAS1259182 (human) | | 9e-17 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 99514668 | 99514669 | Human |
597474408 | GWAS1570482_H | intraocular pressure measurement QTL GWAS1570482 (human) | | 2e-08 | intraocular pressure measurement | | 10 | 90925196 | 90925197 | Human |
407127985 | GWAS776961_H | type 2 diabetes mellitus QTL GWAS776961 (human) | | 0.000005 | type 2 diabetes mellitus | | 10 | 92705802 | 92705803 | Human |
597466217 | GWAS1562291_H | body mass index QTL GWAS1562291 (human) | | 7e-22 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 98038477 | 98038478 | Human |
597220463 | GWAS1316537_H | BMI-adjusted waist-hip ratio QTL GWAS1316537 (human) | | 2e-12 | body size trait (VT:0100005) | | 10 | 79158760 | 79158761 | Human |
597179503 | GWAS1275577_H | interferon-induced protein with tetratricopeptide repeats 3 measurement QTL GWAS1275577 (human) | | 1e-18 | interferon-induced protein with tetratricopeptide repeats 3 measurement | | 10 | 89342341 | 89342342 | Human |
597498981 | GWAS1595055_H | apolipoprotein L1 measurement QTL GWAS1595055 (human) | | 5e-382 | apolipoprotein L1 measurement | | 10 | 100130207 | 100130208 | Human |
597179492 | GWAS1275566_H | insulin-degrading enzyme measurement QTL GWAS1275566 (human) | | 4e-14 | enzyme/coenzyme activity trait (VT:0005584) | | 10 | 92524244 | 92524245 | Human |
597154923 | GWAS1250997_H | diet measurement, alanine aminotransferase 1 measurement QTL GWAS1250997 (human) | | 0.000002 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 98711875 | 98711876 | Human |